Citrus Sinensis ID: 001816
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1010 | 2.2.26 [Sep-21-2011] | |||||||
| O49545 | 1003 | Leucine-rich repeat recep | yes | no | 0.973 | 0.980 | 0.810 | 0.0 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.970 | 0.978 | 0.794 | 0.0 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.934 | 0.951 | 0.556 | 0.0 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.926 | 0.955 | 0.559 | 0.0 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.911 | 0.884 | 0.419 | 0.0 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.932 | 0.929 | 0.410 | 0.0 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.901 | 0.914 | 0.416 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.915 | 0.840 | 0.381 | 0.0 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.929 | 0.912 | 0.395 | 0.0 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.928 | 0.822 | 0.363 | 1e-180 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1639 bits (4245), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 816/1007 (81%), Positives = 894/1007 (88%), Gaps = 24/1007 (2%)
Query: 13 HISQ----SRTVPEYKALLSIKSSIT---DDPQSSLAAWNATTSHCTWPGVTCD-SRRHV 64
HIS SR + E++ALLS+K+S+T DD S L++W +TS CTW GVTCD SRRHV
Sbjct: 12 HISHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHV 71
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
TSLDLSGLNLSG LSPDV+HLR LQNLS+A N +SGPIPPEIS+LS LR LNLSNNVFNG
Sbjct: 72 TSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNG 131
Query: 125 SFPPQLSQ-LASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
SFP ++S L +L+VLD+YNNN+TGDLP++VT L LRHLHLGGN+F+G+IPP YG W
Sbjct: 132 SFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPV 191
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGL 243
+EYLAVSGNEL GKIP EIGNLT L++LYIGYYN++ GLPPEIGNLS LVRFD ANCGL
Sbjct: 192 IEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGL 251
Query: 244 SGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELK 303
+GEIP +IG+LQ LDTLFLQVN SGPLT ELG L SLKSMDLSNN+FTGEIPASFAELK
Sbjct: 252 TGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELK 311
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKL 363
NLTLLNLFRNKLHG IPEFIG +P LEVLQLWENNFTGSIPQ+LG NGKL ++DLSSNKL
Sbjct: 312 NLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKL 371
Query: 364 TGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLP 423
TGTLPP+MC+GN L+TLITLGNFLFG IP+SLGKC+SL+R+RMGENFLNGSIPKGLFGLP
Sbjct: 372 TGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLP 431
Query: 424 SLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKF 483
L+QVELQDNYL+G+ PV+ +SVNLGQI LSNNQLSG LP +IG F+GVQKLLLDGNKF
Sbjct: 432 KLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKF 491
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543
G IP+E+GKLQQLSK+DFSHN FSGRIAPEIS+CKLLTFVDLSRNELSGEIPN++T M+
Sbjct: 492 QGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMK 551
Query: 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSEL 603
ILNYLNLSRNHLVGSIP SI+SMQSLTS+DFSYNNLSGLVPGTGQFSYFNYTSFLGN +L
Sbjct: 552 ILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDL 611
Query: 604 CGPYLGPCKDGVANGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASE 663
CGPYLGPCKDGVA G HQ H KGPLSAS+KLLLV+GLLVCSIAFAV AIIKARSLKKASE
Sbjct: 612 CGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASE 671
Query: 664 SRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGS 723
SRAW+LTAFQRLDFTCDDVLD LKEDNIIGKGGAGIVYKG+MPNGD VAVKRL AMSRGS
Sbjct: 672 SRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGS 731
Query: 724 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 783
SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW
Sbjct: 732 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 791
Query: 784 DTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843
DTRYKIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQDSGTS
Sbjct: 792 DTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTS 851
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903
ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL+TGRKPVGEFGDGVDIVQWVR
Sbjct: 852 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVR 911
Query: 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963
KMTDS K+ VLK+LDPRL S+P+HEV HVFYVAMLCVEEQAVERPTMREVVQILTE+PK
Sbjct: 912 KMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKL 971
Query: 964 PTSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
P SK D P + + + + QS PPDLL++
Sbjct: 972 PPSK--------------DQPMTESAPESELSPKSGVQS-PPDLLNL 1003
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1579 bits (4088), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 798/1005 (79%), Positives = 871/1005 (86%), Gaps = 25/1005 (2%)
Query: 13 HISQSRTVP----EYKALLSIKSSITDDPQSSL-AAWNATTSHCTWPGVTCD-SRRHVTS 66
HIS S TV E ALLS+KSS T D S L +WN +T+ C+W GVTCD S RHVTS
Sbjct: 14 HISHSFTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTS 73
Query: 67 LDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSF 126
LDLSGLNLSG LS DVAHL LQNLS+AANQ+SGPIPP+IS L LR LNLSNNVFNGSF
Sbjct: 74 LDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSF 133
Query: 127 PPQLSQ-LASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLE 185
P +LS L +L+VLDLYNNN+TGDLP+++T L LRHLHLGGN+FSG+IP YG W LE
Sbjct: 134 PDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLE 193
Query: 186 YLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSG 245
YLAVSGNEL GKIP EIGNLT L++LYIGYYN++ GLPPEIGNLS LVRFDAANCGL+G
Sbjct: 194 YLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTG 253
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
EIP +IG+LQ LDTLFLQVNA +G +T ELG + SLKSMDLSNN+FTGEIP SF++LKNL
Sbjct: 254 EIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNL 313
Query: 306 TLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTG 365
TLLNLFRNKL+GAIPEFIG MP LEVLQLWENNFTGSIPQ+LG NG+L ILDLSSNKLTG
Sbjct: 314 TLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTG 373
Query: 366 TLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSL 425
TLPP+MC+GN L TLITLGNFLFG IP+SLGKC+SL+R+RMGENFLNGSIPK LFGLP L
Sbjct: 374 TLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKL 433
Query: 426 SQVELQDNYLTGQFPVSDS-ISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFS 484
SQVELQDNYLTG+ P+S +S +LGQI LSNNQLSGSLPA+IG SGVQKLLLDGNKFS
Sbjct: 434 SQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFS 493
Query: 485 GQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRI 544
G IP EIG+LQQLSK+DFSHN FSGRIAPEIS+CKLLTFVDLSRNELSG+IPN+LTGM+I
Sbjct: 494 GSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKI 553
Query: 545 LNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELC 604
LNYLNLSRNHLVGSIP +IASMQSLTSVDFSYNNLSGLVP TGQFSYFNYTSF+GNS LC
Sbjct: 554 LNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLC 613
Query: 605 GPYLGPCKDGVANGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASES 664
GPYLGPC GTHQ HVK PLSA+ KLLLV+GLL CS+ FA+ AIIKARSL+ ASE+
Sbjct: 614 GPYLGPC----GKGTHQSHVK-PLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEA 668
Query: 665 RAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS 724
+AW+LTAFQRLDFTCDDVLD LKEDNIIGKGGAGIVYKG MP GD VAVKRL MS GSS
Sbjct: 669 KAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSS 728
Query: 725 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD 784
HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW+
Sbjct: 729 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWN 788
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
TRYKIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQDSGTSE
Sbjct: 789 TRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSE 848
Query: 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904
CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG+KPVGEFGDGVDIVQWVR
Sbjct: 849 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRS 908
Query: 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
MTDS K+ VLK++D RL SVP+HEV HVFYVA+LCVEEQAVERPTMREVVQILTE+PK P
Sbjct: 909 MTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIP 968
Query: 965 TSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLS 1009
SKQ ++ T + N S +P PPDLLS
Sbjct: 969 LSKQ--QAAESDVTEKAPAINES----------SPDSGSPPDLLS 1001
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 1047 bits (2708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/962 (55%), Positives = 692/962 (71%), Gaps = 18/962 (1%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAWNATT--SHCTWPGVTCDS-RRHVTSLDLSGLNLSG 76
+ + L+S+K S D SL +WN S C+W GV+CD+ + +T LDLS LN+SG
Sbjct: 32 IRQANVLISLKQSF-DSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISG 90
Query: 77 ALSPDVAHLR-FLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQ-LSQLA 134
+SP+++ L L L +++N SG +P EI LS L +LN+S+NVF G + SQ+
Sbjct: 91 TISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMT 150
Query: 135 SLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL 194
L LD Y+N+ G LPL++T L L HL LGGN+F G+IP YG + L++L++SGN+L
Sbjct: 151 QLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDL 210
Query: 195 GGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRL 254
G+IP E+ N+T L QLY+GYYN Y GG+P + G L +LV D ANC L G IP ++G L
Sbjct: 211 RGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNL 270
Query: 255 QNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNK 314
+NL+ LFLQ N L+G + ELG + SLK++DLSNN GEIP + L+ L L NLF N+
Sbjct: 271 KNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNR 330
Query: 315 LHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAG 374
LHG IPEF+ +P L++L+LW NNFTG IP +LGSNG L +DLS+NKLTG +P +C G
Sbjct: 331 LHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFG 390
Query: 375 NCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNY 434
L+ LI NFLFGP+PE LG+C+ L R R+G+NFL +PKGL LP+LS +ELQ+N+
Sbjct: 391 RRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNF 450
Query: 435 LTGQFPVSDSISV---NLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEI 491
LTG+ P ++ + +L QI LSNN+LSG +P SI +Q LLL N+ SGQIP EI
Sbjct: 451 LTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEI 510
Query: 492 GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLS 551
G L+ L K+D S N FSG+ PE C LT++DLS N++SG+IP Q++ +RILNYLN+S
Sbjct: 511 GSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVS 570
Query: 552 RNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPC 611
N S+P + M+SLTS DFS+NN SG VP +GQFSYFN TSFLGN LCG PC
Sbjct: 571 WNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPC 630
Query: 612 KDGVANGTHQ------PHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESR 665
Q +G +SA KL +GLL + F V A++K R ++K +
Sbjct: 631 NGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRK-NNPN 689
Query: 666 AWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSH 725
WKL FQ+L F + +L+C+KE+++IGKGG GIVYKG+MPNG++VAVK+L +++GSSH
Sbjct: 690 LWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSH 749
Query: 726 DHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDT 785
D+G AEIQTLGRIRHR+IVRLL FCSN + NLLVYEYMPNGSLGEVLHGK G L W+T
Sbjct: 750 DNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWET 809
Query: 786 RYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF-LQDSGTSE 844
R +IA+EAAKGLCYLHHDCSPLI+HRDVKSNNILL FEAHVADFGLAKF +QD+G SE
Sbjct: 810 RLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASE 869
Query: 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFG-DGVDIVQWVR 903
CMS+IAGSYGYIAPEYAYTL++DEKSDVYSFGVVLLELITGRKPV FG +G+DIVQW +
Sbjct: 870 CMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQWSK 929
Query: 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963
T+ ++GV+KI+D RL ++PL E M +F+VAMLCV+E +VERPTMREVVQ++++ +P
Sbjct: 930 IQTNCNRQGVVKIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQP 989
Query: 964 PT 965
T
Sbjct: 990 NT 991
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 1037 bits (2681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/951 (55%), Positives = 673/951 (70%), Gaps = 15/951 (1%)
Query: 22 EYKALLSIKSSITDDPQSSLAAWNATTS---HCTWPGVTCDSRRHVTSLDLSGLNLSGAL 78
+ + LL++KSS+ L W ++S HC++ GV+CD V SL++S L G +
Sbjct: 27 DMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLFGTI 86
Query: 79 SPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNN-VFNGSFPPQ-LSQLASL 136
SP++ L L NL++AAN +G +P E+ +L+SL++LN+SNN G+FP + L + L
Sbjct: 87 SPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAMVDL 146
Query: 137 QVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
+VLD YNNN G LP +++L+ L++L GGNFFSG+IP YG + LEYL ++G L G
Sbjct: 147 EVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAGLSG 206
Query: 197 KIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQN 256
K P + L L+++YIGYYNSYTGG+PPE G L+ L D A+C L+GEIPT + L++
Sbjct: 207 KSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKH 266
Query: 257 LDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLH 316
L TLFL +N L+G + EL L SLKS+DLS N TGEIP SF L N+TL+NLFRN L+
Sbjct: 267 LHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLY 326
Query: 317 GAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNC 376
G IPE IG +P+LEV ++WENNFT +P LG NG L LD+S N LTG +P D+C G
Sbjct: 327 GQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEK 386
Query: 377 LQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLT 436
L+ LI NF FGPIPE LGKC SL+++R+ +N LNG++P GLF LP ++ +EL DN+ +
Sbjct: 387 LEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFS 446
Query: 437 GQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQ 496
G+ PV+ S V L QI LSNN SG +P +IG F +Q L LD N+F G IP EI +L+
Sbjct: 447 GELPVTMSGDV-LDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELKH 505
Query: 497 LSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLV 556
LS+++ S N +G I IS+C L VDLSRN ++GEIP + ++ L LN+S N L
Sbjct: 506 LSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLT 565
Query: 557 GSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVA 616
GSIP I +M SLT++D S+N+LSG VP GQF FN TSF GN+ LC P+ C
Sbjct: 566 GSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPTRPG 625
Query: 617 NGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLD 676
+ H S S ++ V+ + I +VA I+ + KK +S AWKLTAFQ+LD
Sbjct: 626 QTSDHNHT-ALFSPSRIVITVIAAITGLILISVA--IRQMNKKKNQKSLAWKLTAFQKLD 682
Query: 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTL 736
F +DVL+CLKE+NIIGKGGAGIVY+G MPN VA+KRL G S DHGF AEIQTL
Sbjct: 683 FKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRS-DHGFTAEIQTL 741
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
GRIRHRHIVRLLG+ +N +TNLL+YEYMPNGSLGE+LHG KGGHL W+TR+++AVEAAKG
Sbjct: 742 GRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKG 801
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
LCYLHHDCSPLI+HRDVKSNNILLDS FEAHVADFGLAKFL D SECMS+IAGSYGYI
Sbjct: 802 LCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYI 861
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD-----SKKE 911
APEYAYTLKVDEKSDVYSFGVVLLELI G+KPVGEFG+GVDIV+WVR + S
Sbjct: 862 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDAA 921
Query: 912 GVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
V+ I+DPRL PL V+HVF +AM+CVEE+A RPTMREVV +LT PK
Sbjct: 922 IVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPK 972
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/974 (41%), Positives = 580/974 (59%), Gaps = 53/974 (5%)
Query: 37 PQSSLAAWNATTS------HCTWPGVTCDS-RRHVTSLDLSGLNLSGALSPDVAHLRFLQ 89
P S+ W + C+W GV CD+ V SLDLS NLSG + + +L L
Sbjct: 49 PPSAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSSLL 108
Query: 90 NLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGD 149
L+++ N L G P I L+ L L++S N F+ SFPP +S+L L+V + ++NN G
Sbjct: 109 YLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFEGL 168
Query: 150 LPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQ 209
LP V++LR L L+ GG++F G+IP YG + L+++ ++GN LGGK+P +G LT+LQ
Sbjct: 169 LPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTELQ 228
Query: 210 QLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSG 269
+ IGY N + G +P E LS+L FD +NC LSG +P ++G L NL+TLFL N +G
Sbjct: 229 HMEIGY-NHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTG 287
Query: 270 PLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRL 329
+ LKSLK +D S+N +G IP+ F+ LKNLT L+L N L G +PE IG +P L
Sbjct: 288 EIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPEL 347
Query: 330 EVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFG 389
L LW NNFTG +P +LGSNGKL +D+S+N TGT+P +C GN L LI N G
Sbjct: 348 TTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEG 407
Query: 390 PIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNL 449
+P+SL +C+SL R R N LNG+IP G L +L+ V+L +N T Q P + + L
Sbjct: 408 ELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVL 467
Query: 450 GQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSG 509
+ LS N LP +I K +Q + G+IP +G + +++ N +G
Sbjct: 468 QYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVG-CKSFYRIELQGNSLNG 526
Query: 510 RIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSL 569
I +I C+ L ++LS+N L+G IP +++ + + ++LS N L G+IP+ S +++
Sbjct: 527 TIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTI 586
Query: 570 TSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLG-PCKDGVAN-------GTHQ 621
T+ + SYN L G +P +G F++ N + F N LCG +G PC N G H+
Sbjct: 587 TTFNVSYNQLIGPIP-SGSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHK 645
Query: 622 PHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKA-RSLKKASESRA------------WK 668
+ + +V +L +I ++ A R +K+ +R WK
Sbjct: 646 EERPKKTAGA-----IVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWK 700
Query: 669 LTAFQRLDFTCDDVLDCL-KEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS--- 724
LTAFQRL+FT DDV++CL K DNI+G G G VYK MPNG+ +AVK+L ++ +
Sbjct: 701 LTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIR 760
Query: 725 -HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHG---KKGGH 780
G AE+ LG +RHR+IVRLLG C+N + +L+YEYMPNGSL ++LHG
Sbjct: 761 RRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAA 820
Query: 781 LHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840
W Y+IA+ A+G+CYLHHDC P+IVHRD+K +NILLD+ FEA VADFG+AK +Q
Sbjct: 821 AEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQ-- 878
Query: 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVG-EFGDGVDIV 899
T E MS +AGSYGYIAPEYAYTL+VD+KSD+YS+GV+LLE+ITG++ V EFG+G IV
Sbjct: 879 -TDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIV 937
Query: 900 QWVRKMTDSKKEGVLKILDP---RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956
WVR + KE V ++LD R S+ E+ + +A+LC +RP MR+V+ I
Sbjct: 938 DWVRSKLKT-KEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLI 996
Query: 957 LTELPKPPTSKQGE 970
L E KP G+
Sbjct: 997 LQE-AKPKRKTVGD 1009
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 675 bits (1741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/975 (41%), Positives = 568/975 (58%), Gaps = 33/975 (3%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAW--NATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGA 77
V E LLS+KS++ D P + L W + T+ HC W GV C+S +V LDL+G+NL+G
Sbjct: 28 VNELSVLLSVKSTLVD-PLNFLKDWKLSDTSDHCNWTGVRCNSNGNVEKLDLAGMNLTGK 86
Query: 78 LSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQ 137
+S ++ L L + +++ N +P I L S+ ++S N F+GS ++ L
Sbjct: 87 ISDSISQLSSLVSFNISCNGFESLLPKSIPPLKSI---DISQNSFSGSLFLFSNESLGLV 143
Query: 138 VLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGK 197
L+ NN++G+L + L +L L L GNFF G +P + + L +L +SGN L G+
Sbjct: 144 HLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNLTGE 203
Query: 198 IPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNL 257
+P +G L L+ +GY N + G +PPE GN++SL D A LSGEIP+++G+L++L
Sbjct: 204 LPSVLGQLPSLETAILGY-NEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSL 262
Query: 258 DTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG 317
+TL L N +G + E+G + +LK +D S+N TGEIP +LKNL LLNL RNKL G
Sbjct: 263 ETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSG 322
Query: 318 AIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCL 377
+IP I + +L+VL+LW N +G +P LG N L+ LD+SSN +G +P +C L
Sbjct: 323 SIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNL 382
Query: 378 QTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTG 437
LI N G IP +L C SL R+RM N LNGSIP G L L ++EL N L+G
Sbjct: 383 TKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSG 442
Query: 438 QFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQL 497
P S SV+L I S NQ+ SLP++I +Q L+ N SG++P + L
Sbjct: 443 GIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSL 502
Query: 498 SKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVG 557
S +D S N +G I I+ C+ L ++L N L+GEIP Q+T M L L+LS N L G
Sbjct: 503 SNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTG 562
Query: 558 SIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVAN 617
+P SI + +L ++ SYN L+G VP G N GNS LCG L PC
Sbjct: 563 VLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSKFQRA 622
Query: 618 GTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSL-------KKASESR-AWKL 669
+ + G + L+ + +L I V + + + AS+ W+L
Sbjct: 623 TSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRL 682
Query: 670 TAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQV-AVKRL----PAMSRGSS 724
AF RL FT D+L C+KE N+IG G GIVYK M V AVK+L + G++
Sbjct: 683 MAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTT 742
Query: 725 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH---L 781
D F E+ LG++RHR+IVRLLGF N + ++VYE+M NG+LG+ +HGK +
Sbjct: 743 GD--FVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLV 800
Query: 782 HWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841
W +RY IA+ A GL YLHHDC P ++HRD+KSNNILLD+ +A +ADFGLA+ + +
Sbjct: 801 DWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--AR 858
Query: 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVG-EFGDGVDIVQ 900
E +S +AGSYGYIAPEY YTLKVDEK D+YS+GVVLLEL+TGR+P+ EFG+ VDIV+
Sbjct: 859 KKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVE 918
Query: 901 WV-RKMTDSKKEGVLKILDPRLPSVPL--HEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957
WV RK+ D+ + + LDP + + E++ V +A+LC + +RP+MR+V+ +L
Sbjct: 919 WVRRKIRDNIS--LEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISML 976
Query: 958 TELPKPPTSKQGEES 972
E S EE+
Sbjct: 977 GEAKPRRKSNSNEEN 991
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 674 bits (1739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/947 (41%), Positives = 559/947 (59%), Gaps = 36/947 (3%)
Query: 35 DDPQSSLAAWNAT-TSHCTWPGVTCDSR-RHVTSLDLSGLNLSGALSPDVAHLRFLQNLS 92
DDP S L++WN+ S C W GV+C VTS+DLS NL+G + L L +LS
Sbjct: 31 DDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPFPSVICRLSNLAHLS 90
Query: 93 VAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPL 152
+ N ++ +P I+A SL+ L+LS N+ G P L+ + +L LDL NN +GD+P
Sbjct: 91 LYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPA 150
Query: 153 AVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELG-GKIPGEIGNLTKLQQL 211
+ + NL L L N G IPP G L+ L +S N +IP E GNLT L+ +
Sbjct: 151 SFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEVM 210
Query: 212 YIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPL 271
++ + G +P +G LS LV D A L G IP +G L N+ + L N+L+G +
Sbjct: 211 WLTECH-LVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEI 269
Query: 272 TTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEV 331
ELG LKSL+ +D S N TG+IP + L LNL+ N L G +P I + P L
Sbjct: 270 PPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNLEGELPASIALSPNLYE 328
Query: 332 LQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPI 391
++++ N TG +P+ LG N LR LD+S N+ +G LP D+CA L+ L+ + N G I
Sbjct: 329 IRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVI 388
Query: 392 PESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQ 451
PESL C SL+R+R+ N +GS+P G +GLP ++ +EL +N +G+ S + NL
Sbjct: 389 PESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSL 448
Query: 452 ICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRI 511
+ LSNN+ +GSLP IG + +L GNKFSG +P + L +L +D N+FSG +
Sbjct: 449 LILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGEL 508
Query: 512 APEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTS 571
I K L ++L+ NE +G+IP+++ + +LNYL+LS N G IP S+ S++ L
Sbjct: 509 TSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLK-LNQ 567
Query: 572 VDFSYNNLSG-LVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVANGTHQPHVKGPLSA 630
++ SYN LSG L P + Y N SF+GN LCG G C G+ K
Sbjct: 568 LNLSYNRLSGDLPPSLAKDMYKN--SFIGNPGLCGDIKGLC------GSENEAKKRGYVW 619
Query: 631 SVKLLLVVGLLVCSIAFAVAAIIKARSLKKAS--ESRAWKLTAFQRLDFTCDDVLDCLKE 688
++ + V+ +V +A K R+ KKA E W L +F +L F+ ++L+ L E
Sbjct: 620 LLRSIFVLAAMVL-LAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILESLDE 678
Query: 689 DNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS-------------HDHGFNAEIQT 735
DN+IG G +G VYK ++ NG+ VAVKRL S + D F AE++T
Sbjct: 679 DNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVET 738
Query: 736 LGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK 795
LG+IRH++IV+L CS + LLVYEYMPNGSLG++LH KGG L W TR+KI ++AA+
Sbjct: 739 LGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAE 798
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS-ECMSAIAGSYG 854
GL YLHHD P IVHRD+KSNNIL+D + A VADFG+AK + +G + + MS IAGS G
Sbjct: 799 GLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCG 858
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVG-EFGDGVDIVQWVRKMTDSKKEGV 913
YIAPEYAYTL+V+EKSD+YSFGVV+LE++T ++PV E G+ D+V+WV D K G+
Sbjct: 859 YIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEK-DLVKWVCSTLDQK--GI 915
Query: 914 LKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++DP+L S E+ + V +LC + RP+MR VV++L E+
Sbjct: 916 EHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQEI 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/1067 (38%), Positives = 568/1067 (53%), Gaps = 142/1067 (13%)
Query: 16 QSRTVPEYKALLSIKSSITDDPQSSLAAWNATTSH-CTWPGVTCDSRRHVTSLDLSGLNL 74
+ R + E+KA L +D LA+WN S+ C W G+ C R VTS+DL+G+NL
Sbjct: 27 EGRVLLEFKAFL-------NDSNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNL 79
Query: 75 SGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG---------- 124
SG LSP + L L+ L+V+ N +SGPIP ++S SL +L+L N F+G
Sbjct: 80 SGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMII 139
Query: 125 --------------SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFF 170
S P Q+ L+SLQ L +Y+NN+TG +P ++ +LR LR + G N F
Sbjct: 140 TLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGF 199
Query: 171 SGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNL 230
SG IP E E L+ L ++ N L G +P ++ L L L I + N +G +PP +GN+
Sbjct: 200 SGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDL-ILWQNRLSGEIPPSVGNI 258
Query: 231 SSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNI 290
S L +G IP +IG+L + L+L N L+G + E+G L +D S N
Sbjct: 259 SRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQ 318
Query: 291 FTGEIPASFAELKNLTLLNLFRN------------------------KLHGAIPEFIGVM 326
TG IP F + NL LL+LF N +L+G IP+ + +
Sbjct: 319 LTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFL 378
Query: 327 PRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLG-- 384
P L LQL++N G IP +G +LD+S+N L+G +P C QTLI L
Sbjct: 379 PYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCR---FQTLILLSLG 435
Query: 385 -NFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSD 443
N L G IP L C SL+++ +G+N L GS+P LF L +L+ +EL N+L+G
Sbjct: 436 SNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADL 495
Query: 444 SISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFS 503
NL ++ L+NN +G +P IG + + + N+ +G IP E+G + ++D S
Sbjct: 496 GKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLS 555
Query: 504 HNKFSGRIAPEISQCKLLTFVDLSRNELSGEIP--------------------------- 536
NKFSG IA E+ Q L + LS N L+GEIP
Sbjct: 556 GNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVEL 615
Query: 537 --------------NQLTG--------MRILNYLNLSRNHLVGSIPASIASMQSLTSVDF 574
N L+G +++L L L+ N L G IPASI ++ SL +
Sbjct: 616 GKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNI 675
Query: 575 SYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVANGTHQPHVKGPL------ 628
S NNL G VP T F + ++F GN LC C+ V PH L
Sbjct: 676 SNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLV------PHSDSKLNWLING 729
Query: 629 SASVKLLLVVGLLVCSIAF----AVAAIIKAR-----SLKKASESRAWKLTAFQRLDFTC 679
S K+L + +++ S+ + IK R +L+ ++ F + FT
Sbjct: 730 SQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTY 789
Query: 680 DDVLDCLK---EDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTL 736
++D + ED ++G+G G VYK M G+ +AVK+L + G+S D+ F AEI TL
Sbjct: 790 QGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTL 849
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLH-GKKGGHLHWDTRYKIAVEAAK 795
G+IRHR+IV+L GFC + +NLL+YEYM GSLGE L G+K L W+ RY+IA+ AA+
Sbjct: 850 GKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAE 909
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 855
GLCYLHHDC P IVHRD+KSNNILLD F+AHV DFGLAK + D S+ MSA+AGSYGY
Sbjct: 910 GLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI-DLSYSKSMSAVAGSYGY 968
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
IAPEYAYT+KV EK D+YSFGVVLLELITG+ PV G D+V WVR+ + + +
Sbjct: 969 IAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTI-E 1027
Query: 916 ILDPRLPS---VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
+ D RL + +HE+ V +A+ C RPTMREVV ++TE
Sbjct: 1028 MFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 651 bits (1679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/1003 (39%), Positives = 561/1003 (55%), Gaps = 64/1003 (6%)
Query: 22 EYKALLSIKSSITDDPQSSLAAW----NATT----SHCTWPGVTCDSRRHVTSLDLSGLN 73
E + LL+ KS + D P ++L W NATT HC W GV CD+ +V L LS +N
Sbjct: 30 EQEILLAFKSDLFD-PSNNLQDWKRPENATTFSELVHCHWTGVHCDANGYVAKLLLSNMN 88
Query: 74 LSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQL 133
LSG +S + LQ L ++ N +P +S L+SL+++++S N F G+FP L
Sbjct: 89 LSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMA 148
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNE 193
L ++ +NN +G LP + L L G +F G +P + + L++L +SGN
Sbjct: 149 TGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNN 208
Query: 194 LGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGR 253
GGK+P IG L+ L+ + +GY N + G +P E G L+ L D A L+G+IP+ +G+
Sbjct: 209 FGGKVPKVIGELSSLETIILGY-NGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQ 267
Query: 254 LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRN 313
L+ L T++L N L+G L ELG + SL +DLS+N TGEIP ELKNL LLNL RN
Sbjct: 268 LKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLMRN 327
Query: 314 KLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCA 373
+L G IP I +P LEVL+LW+N+ GS+P LG N L+ LD+SSNKL+G +P +C
Sbjct: 328 QLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCY 387
Query: 374 GNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDN 433
L LI N G IPE + C +L R+R+ +N ++GSIP G LP L +EL N
Sbjct: 388 SRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELAKN 447
Query: 434 YLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGK 493
LTG+ P ++S +L I +S N LS +SI +Q + N F+G+IP +I
Sbjct: 448 NLTGKIPDDIALSTSLSFIDISFNHLSSLS-SSIFSSPNLQTFIASHNNFAGKIPNQIQD 506
Query: 494 LQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRN 553
LS +D S N FSG I I+ + L ++L N+L GEIP L GM +L L+LS N
Sbjct: 507 RPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSNN 566
Query: 554 HLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKD 613
L G+IPA + + +L ++ S+N L G +P F+ + +GN+ LCG L PC
Sbjct: 567 SLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLFAAIDPKDLVGNNGLCGGVLPPCSK 626
Query: 614 GVA--------NGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARS-------- 657
+A H H +++ +G++ F I R
Sbjct: 627 SLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMM-----FLAGRWIYTRWDLYSNFAR 681
Query: 658 ----LKKASESRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGD--QV 711
KK E W+L AFQRL FT D+L +KE NIIG G GIVYK + V
Sbjct: 682 EYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTV 741
Query: 712 AVKRLPAMSRGSSHDHGFNA-------------EIQTLGRIRHRHIVRLLGFCSNHETNL 758
AVK+L R S + E+ LG +RHR+IV++LG+ N +
Sbjct: 742 AVKKL---WRSPSPQNDIEDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVM 798
Query: 759 LVYEYMPNGSLGEVLHGKKGGHL--HWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSN 816
+VYEYMPNG+LG LH K L W +RY +AV +GL YLH+DC P I+HRD+KSN
Sbjct: 799 MVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSN 858
Query: 817 NILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFG 876
NILLDS EA +ADFGLAK + +E +S +AGSYGYIAPEY YTLK+DEKSD+YS G
Sbjct: 859 NILLDSNLEARIADFGLAKMMLHK--NETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLG 916
Query: 877 VVLLELITGRKPVG-EFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH---EVMHV 932
VVLLEL+TG+ P+ F D +D+V+W+R+ K E + +++D + H E++
Sbjct: 917 VVLLELVTGKMPIDPSFEDSIDVVEWIRRKV-KKNESLEEVIDASIAGDCKHVIEEMLLA 975
Query: 933 FYVAMLCVEEQAVERPTMREVVQILTEL-PKPPTSKQGEESLP 974
+A+LC + +RP++R+V+ +L E P+ + Q LP
Sbjct: 976 LRIALLCTAKLPKDRPSIRDVITMLAEAKPRRKSVCQVAGDLP 1018
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 633 bits (1633), Expect = e-180, Method: Compositional matrix adjust.
Identities = 390/1073 (36%), Positives = 569/1073 (53%), Gaps = 135/1073 (12%)
Query: 44 WNA--TTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGP 101
WN+ T W +TC S+ +T +D+ + L +L ++ R LQ L+++ L+G
Sbjct: 61 WNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGT 120
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
+P + L++L+LS+N G P LS+L +L+ L L +N +TG +P +++ L+
Sbjct: 121 LPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLK 180
Query: 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGN-ELGGKIPGEIGN---------------- 204
L L N +G IP E G LE + + GN E+ G+IP EIG+
Sbjct: 181 SLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSG 240
Query: 205 --------LTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQN 256
L KL+ L I Y +G +P ++GN S LV LSG IP +IG+L
Sbjct: 241 NLPSSLGKLKKLETLSI-YTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTK 299
Query: 257 LDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL-------------- 302
L+ LFL N+L G + E+G +LK +DLS N+ +G IP+S L
Sbjct: 300 LEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFS 359
Query: 303 ----------KNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGK 352
+L L L +N++ G IP +G + +L + W N GSIP L
Sbjct: 360 GSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTD 419
Query: 353 LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLN 412
L+ LDLS N LTGT+P + L L+ + N L G IP+ +G C SL R+R+G N +
Sbjct: 420 LQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRIT 479
Query: 413 GSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSG 472
G IP G+ L ++ ++ N L G+ P L I LSNN L GSLP + SG
Sbjct: 480 GEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSG 539
Query: 473 VQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELS 532
+Q L + N+FSG+IPA +G+L L+K+ S N FSG I + C L +DL NELS
Sbjct: 540 LQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELS 599
Query: 533 GEIPNQLTGMRILNY-LNLSRNHLVGSIPASIASM-----------------------QS 568
GEIP++L + L LNLS N L G IP+ IAS+ ++
Sbjct: 600 GEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIEN 659
Query: 569 LTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPC-----------KDGVAN 617
L S++ SYN+ SG +P F + GN +LC C DG A+
Sbjct: 660 LVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDAS 719
Query: 618 GTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKAR------SLKKASESRAWKLTA 671
T + + L ++ ++L++ A+I+AR + E+ W+ T
Sbjct: 720 RTRKLRLTLALLITLTVVLMI--------LGAVAVIRARRNIDNERDSELGETYKWQFTP 771
Query: 672 FQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRL-PAMSRGSSHDH--- 727
FQ+L+F+ D ++ CL E N+IGKG +G+VY+ + NG+ +AVK+L PAM G HD
Sbjct: 772 FQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNG-GHDEKTK 830
Query: 728 ----GFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 783
F+AE++TLG IRH++IVR LG C N T LL+Y+YMPNGSLG +LH ++G L W
Sbjct: 831 NVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDW 890
Query: 784 DTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843
D RY+I + AA+GL YLHHDC P IVHRD+K+NNIL+ FE ++ADFGLAK + +
Sbjct: 891 DLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIG 950
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVG-EFGDGVDIVQWV 902
C + +AGSYGYIAPEY Y++K+ EKSDVYS+GVV+LE++TG++P+ +G+ +V WV
Sbjct: 951 RCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWV 1010
Query: 903 RKMTDSKKEGVLKILDPRLPS---VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
R + G L++LD L S E+M V A+LCV ERPTM++V +L E
Sbjct: 1011 R-----QNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKE 1065
Query: 960 LPK----------------PPTSKQGEESLPPSGTTSLDSPNASNKDQKDHQR 996
+ + PPT+ EE + +S+K+ + +R
Sbjct: 1066 IKQEREEYAKVDLLLKKSPPPTTTMQEECRKNEMMMIPAAAASSSKEMRREER 1118
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1010 | ||||||
| 255582421 | 1021 | Receptor protein kinase CLAVATA1 precurs | 0.988 | 0.977 | 0.854 | 0.0 | |
| 359497545 | 1017 | PREDICTED: leucine-rich repeat receptor- | 0.963 | 0.956 | 0.852 | 0.0 | |
| 351726467 | 1012 | receptor-like protein kinase 3 precursor | 0.978 | 0.976 | 0.821 | 0.0 | |
| 351721253 | 1012 | receptor-like protein kinase 2 precursor | 0.978 | 0.976 | 0.822 | 0.0 | |
| 339790467 | 1015 | leucine rich repeat receptor protein kin | 0.979 | 0.974 | 0.796 | 0.0 | |
| 339790463 | 1016 | leucine rich repeat receptor protein kin | 0.979 | 0.973 | 0.795 | 0.0 | |
| 339790465 | 1016 | leucine rich repeat receptor protein kin | 0.979 | 0.973 | 0.795 | 0.0 | |
| 351727889 | 1010 | receptor-like protein kinase precursor [ | 0.996 | 0.996 | 0.807 | 0.0 | |
| 15239123 | 1003 | leucine-rich receptor-like protein kinas | 0.973 | 0.980 | 0.810 | 0.0 | |
| 351726026 | 1008 | receptor-like protein kinase 1 precursor | 0.997 | 0.999 | 0.809 | 0.0 |
| >gi|255582421|ref|XP_002531999.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223528358|gb|EEF30398.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1716 bits (4443), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 860/1006 (85%), Positives = 924/1006 (91%), Gaps = 8/1006 (0%)
Query: 12 LHISQSRTVPEYKALLSIKSSITDDPQSSLAAWNATTSH--CTWPGVTCD-SRRHVTSLD 68
+ S R + EY+ALLS+KS+I DDPQ +LA+WN+T + CTW VTCD + RH+TSLD
Sbjct: 17 IFTSLGRVISEYQALLSLKSAI-DDPQGALASWNSTNKNNLCTWSFVTCDYNNRHITSLD 75
Query: 69 LSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPP 128
LS LNLSG LSPD+AHLR+LQNL++AANQ+SGPIP ++SA+S LR LNLSNNVFNGSFP
Sbjct: 76 LSSLNLSGTLSPDIAHLRYLQNLTLAANQISGPIPIQLSAISGLRCLNLSNNVFNGSFPT 135
Query: 129 QLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLA 188
QLSQL +LQVLDLYNNNMTGDLPLAVT++ NLRHLHLGGNFFSG IP EYG WEFLEYLA
Sbjct: 136 QLSQLKNLQVLDLYNNNMTGDLPLAVTEMPNLRHLHLGGNFFSGAIPREYGKWEFLEYLA 195
Query: 189 VSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIP 248
VSGNEL G IP EIGNLTKLQQLYIGYYN+Y GGLPPEIGNLS LVRFDAANC LSGEIP
Sbjct: 196 VSGNELEGPIPPEIGNLTKLQQLYIGYYNTYEGGLPPEIGNLSDLVRFDAANCMLSGEIP 255
Query: 249 TDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLL 308
+IG+LQ LDTLFLQVN LSG L ELG LKSLKSMDLSNN+ +GEIP SFA+L NLTLL
Sbjct: 256 KEIGKLQKLDTLFLQVNGLSGSLIEELGNLKSLKSMDLSNNMLSGEIPTSFAQLSNLTLL 315
Query: 309 NLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLP 368
NLFRNKLHGAIPEFIG +P+LEVLQLWENNFTGSIPQ LG NG L ++DLSSNKLTG LP
Sbjct: 316 NLFRNKLHGAIPEFIGDLPQLEVLQLWENNFTGSIPQGLGKNGNLVLVDLSSNKLTGNLP 375
Query: 369 PDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQV 428
PDMC+G+ LQTLITL NFLFGPIPESLGKC SLSR+RMGENFLNGS+PKGLFGLP L+QV
Sbjct: 376 PDMCSGDRLQTLITLSNFLFGPIPESLGKCQSLSRIRMGENFLNGSLPKGLFGLPKLTQV 435
Query: 429 ELQDNYLTGQFPVSDS-ISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQI 487
ELQDN LTG+FPV+D I+VNLGQI LSNN L+GSLP+SIGKFSGVQKLLLDGNKFSG I
Sbjct: 436 ELQDNLLTGEFPVTDDKIAVNLGQISLSNNHLTGSLPSSIGKFSGVQKLLLDGNKFSGPI 495
Query: 488 PAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNY 547
P EIGKLQQLSK+DFSHNKFSG IAPEISQCKLLTFVDLSRNELSG IP ++TGMRILNY
Sbjct: 496 PPEIGKLQQLSKVDFSHNKFSGPIAPEISQCKLLTFVDLSRNELSGAIPTEITGMRILNY 555
Query: 548 LNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPY 607
LNLSRNHLVGSIPASIA+MQSLTSVDFSYNNL+GLVPGTGQFSYFNYTSFLGN++LCGPY
Sbjct: 556 LNLSRNHLVGSIPASIATMQSLTSVDFSYNNLTGLVPGTGQFSYFNYTSFLGNTDLCGPY 615
Query: 608 LGPCKDGVANGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAW 667
LGPCKDG ANGTHQ HVKGPLSAS+KLLLV+GLLVCSIAFAVAAIIKARSLKK +ESRAW
Sbjct: 616 LGPCKDGDANGTHQAHVKGPLSASLKLLLVIGLLVCSIAFAVAAIIKARSLKKVNESRAW 675
Query: 668 KLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDH 727
+LTAFQRLDFT DDVLDCLKEDNIIGKGGAGIVYKG MPNGDQVAVKRLPAMSRGSSHDH
Sbjct: 676 RLTAFQRLDFTVDDVLDCLKEDNIIGKGGAGIVYKGSMPNGDQVAVKRLPAMSRGSSHDH 735
Query: 728 GFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY 787
GFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY
Sbjct: 736 GFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY 795
Query: 788 KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847
KIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQDSGTSECMS
Sbjct: 796 KIAIEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMS 855
Query: 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD 907
AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL+TGRKPVGEFGDGVDIVQWVRKMTD
Sbjct: 856 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTD 915
Query: 908 SKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSK 967
S KEGVLK+LDPRLPSVPLHEVMHVFYVAMLCVEEQA+ERPTMREVVQILTELPKPP SK
Sbjct: 916 SNKEGVLKVLDPRLPSVPLHEVMHVFYVAMLCVEEQAIERPTMREVVQILTELPKPPNSK 975
Query: 968 QGEESL---PPSGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
QG+ ++ P TSLDSP A++KD KD+Q+PA PQSPPPDLLSI
Sbjct: 976 QGDSTVTESSPQSATSLDSPKATSKDPKDNQQPALPQSPPPDLLSI 1021
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497545|ref|XP_003635561.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1701 bits (4404), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 835/979 (85%), Positives = 902/979 (92%), Gaps = 6/979 (0%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALS 79
+PEY+ALLS++++I+ DP+S LAAWN +TSHCTW GVTCD+RRHV +L+LSGLNLSG+LS
Sbjct: 26 IPEYRALLSLRTAISYDPESPLAAWNISTSHCTWTGVTCDARRHVVALNLSGLNLSGSLS 85
Query: 80 PDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVL 139
D+AHLRFL NL++AANQ GPIPPE+S +S LR LNLSNNVFN +FP QL++L L+VL
Sbjct: 86 SDIAHLRFLVNLTLAANQFVGPIPPELSLVSGLRQLNLSNNVFNETFPSQLARLKRLEVL 145
Query: 140 DLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIP 199
DLYNNNMTGDLPLAVT++ NLRHLHLGGNFF+G IPP YG WEFLEYLAVSGNEL G IP
Sbjct: 146 DLYNNNMTGDLPLAVTEMPNLRHLHLGGNFFTGIIPPAYGQWEFLEYLAVSGNELHGPIP 205
Query: 200 GEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDT 259
EIGNLT LQQLY+GYYN+Y GG+PPEIGNL+SLVR D ANC LSGEIP +IG+LQNLDT
Sbjct: 206 PEIGNLTSLQQLYVGYYNTYDGGIPPEIGNLTSLVRLDMANCLLSGEIPPEIGKLQNLDT 265
Query: 260 LFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAI 319
LFLQVN LSGPLT ELG LKSLKSMDLSNN+ GEIP +FAELKNLTLLNLFRNKLHGAI
Sbjct: 266 LFLQVNTLSGPLTPELGNLKSLKSMDLSNNVLAGEIPEAFAELKNLTLLNLFRNKLHGAI 325
Query: 320 PEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQT 379
PEFIG +P LEVLQLWENNFTGSIPQ LG NGKL++LD+SSNKLTG LPPDMC+GN LQT
Sbjct: 326 PEFIGDLPELEVLQLWENNFTGSIPQGLGKNGKLQLLDVSSNKLTGNLPPDMCSGNRLQT 385
Query: 380 LITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQF 439
LITLGNFLFGPIPESLG+C+SLSR+RMGENFLNGSIPKGLF LP L+QVELQDNYLTG+F
Sbjct: 386 LITLGNFLFGPIPESLGRCESLSRIRMGENFLNGSIPKGLFDLPKLTQVELQDNYLTGEF 445
Query: 440 PVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSK 499
P DS +LGQI LSNNQL+GSLP S+G FSG+QKLLLDGNKFSG+IP EIG LQQLSK
Sbjct: 446 PEIDSTPDSLGQISLSNNQLTGSLPPSVGNFSGLQKLLLDGNKFSGRIPPEIGMLQQLSK 505
Query: 500 MDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSI 559
MDFS+NKFSG I PEISQCK+LTFVDLSRNEL G+IP ++TGMRILNYLNLSRNHL+GSI
Sbjct: 506 MDFSNNKFSGEITPEISQCKVLTFVDLSRNELFGDIPTEITGMRILNYLNLSRNHLIGSI 565
Query: 560 PASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVANGT 619
PAS+ASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGN ELCGPYLG CKDGVANGT
Sbjct: 566 PASLASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNPELCGPYLGACKDGVANGT 625
Query: 620 HQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLDFTC 679
HQPHVKGPLSAS+KLLLV+GLLVCSIAFAVAAIIKARSLKKASESR+WKLTAFQRLDFTC
Sbjct: 626 HQPHVKGPLSASLKLLLVIGLLVCSIAFAVAAIIKARSLKKASESRSWKLTAFQRLDFTC 685
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
DDVLD LKEDNIIGKGGAGIVYKG MPNG+ VAVKRLPAMSRGSSHDHGFNAEIQTLGRI
Sbjct: 686 DDVLDSLKEDNIIGKGGAGIVYKGAMPNGELVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 745
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY
Sbjct: 746 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 805
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
LHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE
Sbjct: 806 LHHDCSPLIVHRDVKSNNILLDSSFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 865
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
YAYTLKVDEKSDVYSFGVVLLEL++GRKPVGEFGDGVDIVQWVRKMTDS KEGVLKILD
Sbjct: 866 YAYTLKVDEKSDVYSFGVVLLELVSGRKPVGEFGDGVDIVQWVRKMTDSNKEGVLKILDT 925
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGE----ESLPP 975
RLP+VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP+SKQG+ ES PP
Sbjct: 926 RLPTVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPSSKQGDSIVTESSPP 985
Query: 976 SGTTSLDSPNASNKDQKDH 994
S T L+SP + K+ KDH
Sbjct: 986 SCT--LESPTTTIKETKDH 1002
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351726467|ref|NP_001235080.1| receptor-like protein kinase 3 precursor [Glycine max] gi|9651945|gb|AAF91324.1|AF244890_1 receptor-like protein kinase 3 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1657 bits (4291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 819/997 (82%), Positives = 901/997 (90%), Gaps = 9/997 (0%)
Query: 17 SRTVPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSG 76
S + EY+ALLS++S+ITD L +WN++T +C+W GVTCD+RRHVTSLDL+GL+LSG
Sbjct: 22 SAPISEYRALLSLRSAITDATPPLLTSWNSSTPYCSWLGVTCDNRRHVTSLDLTGLDLSG 81
Query: 77 ALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASL 136
LS DVAHL FL NLS+A+N+ SGPIPP +SALS LR LNLSNNVFN +FP +LS+L +L
Sbjct: 82 PLSADVAHLPFLSNLSLASNKFSGPIPPSLSALSGLRFLNLSNNVFNETFPSELSRLQNL 141
Query: 137 QVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
+VLDLYNNNMTG LPLAV Q++NLRHLHLGGNFFSGQIPPEYG W+ L+YLAVSGNEL G
Sbjct: 142 EVLDLYNNNMTGVLPLAVAQMQNLRHLHLGGNFFSGQIPPEYGRWQRLQYLAVSGNELEG 201
Query: 197 KIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQN 256
IP EIGNL+ L++LYIGYYN+YTGG+PPEIGNLS LVR DAA CGLSGEIP +G+LQ
Sbjct: 202 TIPPEIGNLSSLRELYIGYYNTYTGGIPPEIGNLSELVRLDAAYCGLSGEIPAALGKLQK 261
Query: 257 LDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLH 316
LDTLFLQVNALSG LT ELG LKSLKSMDLSNN+ +GEIPA F ELKN+TLLNLFRNKLH
Sbjct: 262 LDTLFLQVNALSGSLTPELGNLKSLKSMDLSNNMLSGEIPARFGELKNITLLNLFRNKLH 321
Query: 317 GAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNC 376
GAIPEFIG +P LEV+QLWENNFTGSIP+ LG NG+L ++DLSSNKLTGTLP +C+GN
Sbjct: 322 GAIPEFIGELPALEVVQLWENNFTGSIPEGLGKNGRLNLVDLSSNKLTGTLPTYLCSGNT 381
Query: 377 LQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLT 436
LQTLITLGNFLFGPIPESLG C+SL+R+RMGENFLNGSIP+GLFGLP L+QVELQDNYL+
Sbjct: 382 LQTLITLGNFLFGPIPESLGSCESLTRIRMGENFLNGSIPRGLFGLPKLTQVELQDNYLS 441
Query: 437 GQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQ 496
G+FP S++VNLGQI LSNNQLSG LP SIG FS VQKL+LDGN F+G+IP +IG+LQQ
Sbjct: 442 GEFPEVGSVAVNLGQITLSNNQLSGVLPPSIGNFSSVQKLILDGNMFTGRIPPQIGRLQQ 501
Query: 497 LSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLV 556
LSK+DFS NKFSG I PEISQCKLLTF+DLSRNELSG+IPN++TGMRILNYLNLSRNHLV
Sbjct: 502 LSKIDFSGNKFSGPIVPEISQCKLLTFLDLSRNELSGDIPNEITGMRILNYLNLSRNHLV 561
Query: 557 GSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVA 616
G IP+SI+SMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGN +LCGPYLG CKDGVA
Sbjct: 562 GGIPSSISSMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGACKDGVA 621
Query: 617 NGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLD 676
NG HQPHVKG LS+S KLLLVVGLL+CSIAFAVAAI KARSLKKAS +RAWKLTAFQRLD
Sbjct: 622 NGAHQPHVKG-LSSSFKLLLVVGLLLCSIAFAVAAIFKARSLKKASGARAWKLTAFQRLD 680
Query: 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTL 736
FT DDVL CLKEDNIIGKGGAGIVYKG MPNGD VAVKRLPAMSRGSSHDHGFNAEIQTL
Sbjct: 681 FTVDDVLHCLKEDNIIGKGGAGIVYKGAMPNGDHVAVKRLPAMSRGSSHDHGFNAEIQTL 740
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG
Sbjct: 741 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 800
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
LCYLHHDCSPLIVHRDVKSNNILLDS EAHVADFGLAKFLQDSGTSECMSAIAGSYGYI
Sbjct: 801 LCYLHHDCSPLIVHRDVKSNNILLDSNHEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 860
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS KEGVLK+
Sbjct: 861 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSNKEGVLKV 920
Query: 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESLPPS 976
LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP SK+G ++ S
Sbjct: 921 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPDSKEGNLTITES 980
Query: 977 GTTS---LDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
+S L+SP++++K+ ++ PPQSPPPDLLSI
Sbjct: 981 SLSSSNALESPSSASKEDQN-----PPQSPPPDLLSI 1012
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721253|ref|NP_001237715.1| receptor-like protein kinase 2 precursor [Glycine max] gi|9651943|gb|AAF91323.1|AF244889_1 receptor-like protein kinase 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1650 bits (4274), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 820/997 (82%), Positives = 902/997 (90%), Gaps = 9/997 (0%)
Query: 17 SRTVPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSG 76
S + EY+ALLS++S ITD L++WNA+ +C+W GVTCD+RRHVT+L+L+GL+LSG
Sbjct: 22 SAPISEYRALLSLRSVITDATPPVLSSWNASIPYCSWLGVTCDNRRHVTALNLTGLDLSG 81
Query: 77 ALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASL 136
LS DVAHL FL NLS+AAN+ SGPIPP +SALS LR LNLSNNVFN +FP +L +L SL
Sbjct: 82 TLSADVAHLPFLSNLSLAANKFSGPIPPSLSALSGLRYLNLSNNVFNETFPSELWRLQSL 141
Query: 137 QVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
+VLDLYNNNMTG LPLAV Q++NLRHLHLGGNFFSGQIPPEYG W+ L+YLAVSGNEL G
Sbjct: 142 EVLDLYNNNMTGVLPLAVAQMQNLRHLHLGGNFFSGQIPPEYGRWQRLQYLAVSGNELDG 201
Query: 197 KIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQN 256
IP EIGNLT L++LYIGYYN+YTGG+PPEIGNLS LVR D A C LSGEIP +G+LQ
Sbjct: 202 TIPPEIGNLTSLRELYIGYYNTYTGGIPPEIGNLSELVRLDVAYCALSGEIPAALGKLQK 261
Query: 257 LDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLH 316
LDTLFLQVNALSG LT ELG LKSLKSMDLSNN+ +GEIPASF ELKN+TLLNLFRNKLH
Sbjct: 262 LDTLFLQVNALSGSLTPELGNLKSLKSMDLSNNMLSGEIPASFGELKNITLLNLFRNKLH 321
Query: 317 GAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNC 376
GAIPEFIG +P LEV+QLWENN TGSIP+ LG NG+L ++DLSSNKLTGTLPP +C+GN
Sbjct: 322 GAIPEFIGELPALEVVQLWENNLTGSIPEGLGKNGRLNLVDLSSNKLTGTLPPYLCSGNT 381
Query: 377 LQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLT 436
LQTLITLGNFLFGPIPESLG C+SL+R+RMGENFLNGSIPKGLFGLP L+QVELQDNYL+
Sbjct: 382 LQTLITLGNFLFGPIPESLGTCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLS 441
Query: 437 GQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQ 496
G+FP S++VNLGQI LSNNQLSG+L SIG FS VQKLLLDGN F+G+IP +IG+LQQ
Sbjct: 442 GEFPEVGSVAVNLGQITLSNNQLSGALSPSIGNFSSVQKLLLDGNMFTGRIPTQIGRLQQ 501
Query: 497 LSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLV 556
LSK+DFS NKFSG IAPEISQCKLLTF+DLSRNELSG+IPN++TGMRILNYLNLS+NHLV
Sbjct: 502 LSKIDFSGNKFSGPIAPEISQCKLLTFLDLSRNELSGDIPNEITGMRILNYLNLSKNHLV 561
Query: 557 GSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVA 616
GSIP+SI+SMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGN +LCGPYLG CK GVA
Sbjct: 562 GSIPSSISSMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGACKGGVA 621
Query: 617 NGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLD 676
NG HQPHVKG LS+S+KLLLVVGLL+CSIAFAVAAI KARSLKKASE+RAWKLTAFQRLD
Sbjct: 622 NGAHQPHVKG-LSSSLKLLLVVGLLLCSIAFAVAAIFKARSLKKASEARAWKLTAFQRLD 680
Query: 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTL 736
FT DDVL CLKEDNIIGKGGAGIVYKG MPNGD VAVKRLPAMSRGSSHDHGFNAEIQTL
Sbjct: 681 FTVDDVLHCLKEDNIIGKGGAGIVYKGAMPNGDHVAVKRLPAMSRGSSHDHGFNAEIQTL 740
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG
Sbjct: 741 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 800
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
LCYLHHDCSPLIVHRDVKSNNILLDS EAHVADFGLAKFLQDSGTSECMSAIAGSYGYI
Sbjct: 801 LCYLHHDCSPLIVHRDVKSNNILLDSNHEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 860
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS KEGVLK+
Sbjct: 861 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSNKEGVLKV 920
Query: 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESLPPS 976
LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP SK+G+ ++ S
Sbjct: 921 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPGSKEGDLTITES 980
Query: 977 GTTS---LDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
+S L+SP++++K+ ++ PPQSPPPDLLSI
Sbjct: 981 SLSSSNALESPSSASKEDQN-----PPQSPPPDLLSI 1012
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|339790467|dbj|BAK52390.1| leucine rich repeat receptor protein kinase CLAVATA1 [Solanum peruvianum] | Back alignment and taxonomy information |
|---|
Score = 1643 bits (4255), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 793/995 (79%), Positives = 894/995 (89%), Gaps = 6/995 (0%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALS 79
+PEY+ALL++K++ITDDPQ +LA+WN +TSHCTW GVTCD+ RHVTSLD+SG NL+G L
Sbjct: 23 LPEYQALLALKTAITDDPQLTLASWNISTSHCTWNGVTCDTHRHVTSLDISGFNLTGTLP 82
Query: 80 PDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVL 139
P+V +LRFLQNLSVA NQ +GP+P EIS + +L LNLSNN+F FP QL++L +LQVL
Sbjct: 83 PEVGNLRFLQNLSVAVNQFTGPVPVEISFIPNLSYLNLSNNIFGMEFPSQLTRLRNLQVL 142
Query: 140 DLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIP 199
DLYNNNMTG+LP+ V Q+ LRHLHLGGNFFSG+IPPEYG + LEYLAVSGN L G+IP
Sbjct: 143 DLYNNNMTGELPVEVYQMTKLRHLHLGGNFFSGRIPPEYGRFSSLEYLAVSGNALVGEIP 202
Query: 200 GEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDT 259
EIGN+ LQQLY+GYYN++TGG+PP IGNLS L+RFDAANCGLSG+IP +IG+LQNLDT
Sbjct: 203 PEIGNIATLQQLYVGYYNTFTGGIPPAIGNLSQLLRFDAANCGLSGKIPREIGKLQNLDT 262
Query: 260 LFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAI 319
LFLQVN+LSG LT E+GYLKSLKS+DLSNN+F+GEIP +FAELKN+TL+NLFRNKL+G+I
Sbjct: 263 LFLQVNSLSGSLTPEIGYLKSLKSLDLSNNMFSGEIPPTFAELKNITLVNLFRNKLYGSI 322
Query: 320 PEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQT 379
PEFI +P LEVLQLWENNFTGSIPQ LG+ KL+ LDLSSNKLTG LPP+MC+GN LQT
Sbjct: 323 PEFIEDLPELEVLQLWENNFTGSIPQGLGTKSKLKTLDLSSNKLTGNLPPNMCSGNNLQT 382
Query: 380 LITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQF 439
+ITLGNFLFGPIPESLG+C+SL+R+RMGEN+LNGSIPKGL LP LSQVELQ+N LTG F
Sbjct: 383 IITLGNFLFGPIPESLGRCESLNRIRMGENYLNGSIPKGLLSLPHLSQVELQNNILTGTF 442
Query: 440 PVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSK 499
P S S +LGQI LSNN+L+G LP SIG F+ QKLLLDGNKFSG+IPAEIGKLQQLSK
Sbjct: 443 PDISSKSNSLGQIILSNNRLTGPLPPSIGNFAVAQKLLLDGNKFSGRIPAEIGKLQQLSK 502
Query: 500 MDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSI 559
+DFSHN SG IAPEISQCKLLT+VDLSRN+LSGEIP ++TGMRILNYLNLSRNHLVGSI
Sbjct: 503 IDFSHNNLSGPIAPEISQCKLLTYVDLSRNQLSGEIPTEITGMRILNYLNLSRNHLVGSI 562
Query: 560 PASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVANGT 619
PA I+SMQSLTSVDFSYNN SGLVPGTGQFSYFNYTSFLGN +LCGPYLGPCK+GV +G
Sbjct: 563 PAPISSMQSLTSVDFSYNNFSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKEGVVDGV 622
Query: 620 HQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLDFTC 679
QPH +G L+ S+KLLLV+GLLVCSI FAVAAIIKARSLKKASE+RAWKLTAFQRLDFTC
Sbjct: 623 SQPHQRGALTPSMKLLLVIGLLVCSIVFAVAAIIKARSLKKASEARAWKLTAFQRLDFTC 682
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
DD+LD LKEDN+IGKGGAGIVYKG+MP+G+ VAVKRLPAMSRGSSHDHGFNAEIQTLGRI
Sbjct: 683 DDILDSLKEDNVIGKGGAGIVYKGVMPSGEHVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 742
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE+LHGKKGGHLHWDTRYKIA+E+AKGLCY
Sbjct: 743 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEMLHGKKGGHLHWDTRYKIALESAKGLCY 802
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
LHHDCSPLI+HRDVKSNNILLDS FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE
Sbjct: 803 LHHDCSPLILHRDVKSNNILLDSSFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 862
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
YAYTLKVDEKSDVYSFGVVLLEL++G+KPVGEFGDGVDIVQWVRKMTD KK+GVLKILDP
Sbjct: 863 YAYTLKVDEKSDVYSFGVVLLELVSGKKPVGEFGDGVDIVQWVRKMTDGKKDGVLKILDP 922
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQ----GEESLPP 975
RL +VPL+EVMHVFYVA+LCVEEQAVERPTMREVVQILTELPKPP +K G + PP
Sbjct: 923 RLSTVPLNEVMHVFYVALLCVEEQAVERPTMREVVQILTELPKPPGAKSDDSTGTDHSPP 982
Query: 976 SGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
S ++L+SP + D KDH +P PQSPPPDLLSI
Sbjct: 983 SA-SALESPTSIPGDTKDHHQPT-PQSPPPDLLSI 1015
|
Source: Solanum peruvianum Species: Solanum peruvianum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|339790463|dbj|BAK52388.1| leucine rich repeat receptor protein kinase CLAVATA1 [Solanum lycopersicum] gi|339790469|dbj|BAK52391.1| leucine rich repeat receptor protein kinase CLAVATA1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1641 bits (4249), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 792/995 (79%), Positives = 895/995 (89%), Gaps = 6/995 (0%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALS 79
+PEY+ALL++K++ITDDPQ +LA+WN +TSHCTW GVTCD+ RHVTSLD+SG NL+G L
Sbjct: 24 LPEYQALLALKTAITDDPQLTLASWNISTSHCTWNGVTCDTHRHVTSLDISGFNLTGTLP 83
Query: 80 PDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVL 139
P+V +LRFLQNLSVA NQ +GP+P EIS + +L LNLSNN+F FP QL++L +LQVL
Sbjct: 84 PEVGNLRFLQNLSVAVNQFTGPVPVEISFIPNLSYLNLSNNIFGMEFPSQLTRLRNLQVL 143
Query: 140 DLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIP 199
DLYNNNMTG+LP+ V Q+ LRHLHLGGNFFSG+IPPEYG + LEYLAVSGN L G+IP
Sbjct: 144 DLYNNNMTGELPVEVYQMTKLRHLHLGGNFFSGRIPPEYGRFPSLEYLAVSGNALVGEIP 203
Query: 200 GEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDT 259
EIGN+ LQQLY+GYYN++TGG+PP IGNLS L+RFDAANCGLSG+IP +IG+LQNLDT
Sbjct: 204 PEIGNIATLQQLYVGYYNTFTGGIPPAIGNLSQLLRFDAANCGLSGKIPPEIGKLQNLDT 263
Query: 260 LFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAI 319
LFLQVN+LSG LT E+GYLKSLKS+DLSNN+F+GEIP +FAELKN+TL+NLFRNKL+G+I
Sbjct: 264 LFLQVNSLSGSLTPEIGYLKSLKSLDLSNNMFSGEIPPTFAELKNITLVNLFRNKLYGSI 323
Query: 320 PEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQT 379
PEFI +P LEVLQLWENNFTGSIPQ LG+ KL+ LDLSSNKLTG LPP+MC+GN LQT
Sbjct: 324 PEFIEDLPELEVLQLWENNFTGSIPQGLGTKSKLKTLDLSSNKLTGNLPPNMCSGNNLQT 383
Query: 380 LITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQF 439
+ITLGNFLFGPIPESLG+C+SL+R+RMGEN+LNGSIPKGL LP LSQVELQ+N LTG F
Sbjct: 384 IITLGNFLFGPIPESLGRCESLNRIRMGENYLNGSIPKGLLSLPHLSQVELQNNILTGTF 443
Query: 440 PVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSK 499
P S S +LGQI LSNN+L+G LP SIG F+ QKLLLDGNKFSG+IPAEIGKLQQLSK
Sbjct: 444 PDISSKSNSLGQIILSNNRLTGPLPPSIGNFAVAQKLLLDGNKFSGRIPAEIGKLQQLSK 503
Query: 500 MDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSI 559
+DFSHN SG IAPEISQCKLLT+VDLSRN+LSGEIP ++TGMRILNYLNLSRNHLVGSI
Sbjct: 504 IDFSHNNLSGPIAPEISQCKLLTYVDLSRNQLSGEIPTEITGMRILNYLNLSRNHLVGSI 563
Query: 560 PASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVANGT 619
PA I+SMQSLTSVDFSYNN SGLVPGTGQFSYFNYTSFLGN +LCGPYLGPCK+GV +G
Sbjct: 564 PAPISSMQSLTSVDFSYNNFSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKEGVVDGV 623
Query: 620 HQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLDFTC 679
QPH +G L+ S+KLLLV+GLLVCSI FAVAAIIKARSLKKASE+RAWKLTAFQRLDFTC
Sbjct: 624 SQPHQRGALTPSMKLLLVIGLLVCSIVFAVAAIIKARSLKKASEARAWKLTAFQRLDFTC 683
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
DD+LD LKEDN+IGKGGAGIVYKG+MP+G+ VAVKRLPAMSRGSSHDHGFNAEIQTLGRI
Sbjct: 684 DDILDSLKEDNVIGKGGAGIVYKGVMPSGEHVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 743
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE+LHGKKGGHLHWDTRYKIA+E+AKGLCY
Sbjct: 744 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEMLHGKKGGHLHWDTRYKIALESAKGLCY 803
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
LHHDCSPLI+HRDVKSNNILLDS FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE
Sbjct: 804 LHHDCSPLILHRDVKSNNILLDSSFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 863
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
YAYTLKVDEKSDVYSFGVVLLEL++G+KPVGEFGDGVDIVQWVRKMTD KK+GVLKILDP
Sbjct: 864 YAYTLKVDEKSDVYSFGVVLLELVSGKKPVGEFGDGVDIVQWVRKMTDGKKDGVLKILDP 923
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESL----PP 975
RL +VPL+EVMHVFYVA+LCVEEQAVERPTMREVVQILTELPKPP +K + ++ PP
Sbjct: 924 RLSTVPLNEVMHVFYVALLCVEEQAVERPTMREVVQILTELPKPPGAKSDDSTVTDQSPP 983
Query: 976 SGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
S ++L+SP + D KDH +P PQSPPPDLLSI
Sbjct: 984 SA-SALESPTSIPGDTKDHHQPT-PQSPPPDLLSI 1016
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|339790465|dbj|BAK52389.1| leucine rich repeat receptor protein kinase CLAVATA1 [Solanum pennellii] | Back alignment and taxonomy information |
|---|
Score = 1641 bits (4249), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 792/995 (79%), Positives = 894/995 (89%), Gaps = 6/995 (0%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALS 79
+PEY+ALL++K++ITDDPQ +LA+WN +TSHCTW GVTCD+ RHVTSLD+SG NL+G L
Sbjct: 24 LPEYQALLALKTAITDDPQLTLASWNISTSHCTWNGVTCDTHRHVTSLDISGFNLTGTLP 83
Query: 80 PDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVL 139
P+V +LRFLQNLSVA NQ +GP+P EIS + +L LNLSNN+F FP QL++L +LQVL
Sbjct: 84 PEVGNLRFLQNLSVAVNQFTGPVPVEISFIPNLSYLNLSNNIFGMEFPSQLTRLRNLQVL 143
Query: 140 DLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIP 199
DLYNNNMTG+LP+ V Q+ LRHLHLGGNFF G+IPPEYG + LEYLAVSGN L G+IP
Sbjct: 144 DLYNNNMTGELPVEVYQMTKLRHLHLGGNFFGGRIPPEYGRFPSLEYLAVSGNALVGEIP 203
Query: 200 GEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDT 259
EIGN+ LQQLY+GYYN++TGG+PP IGNLS L+RFDAANCGLSGEIP +IG+LQNLDT
Sbjct: 204 PEIGNIATLQQLYVGYYNTFTGGIPPAIGNLSQLLRFDAANCGLSGEIPPEIGKLQNLDT 263
Query: 260 LFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAI 319
LFLQVN+LSG LT E+GYLKSLKS+DLSNN+F+GEIP +FAELKN+TL+NLFRNKL+G+I
Sbjct: 264 LFLQVNSLSGSLTPEIGYLKSLKSLDLSNNMFSGEIPPTFAELKNITLVNLFRNKLYGSI 323
Query: 320 PEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQT 379
PEFI +P LEVLQLWENNFTGSIPQ LG+ KL+ LDLSSNKLTG LPP+MC+GN LQT
Sbjct: 324 PEFIEDLPELEVLQLWENNFTGSIPQGLGTKSKLKTLDLSSNKLTGNLPPNMCSGNNLQT 383
Query: 380 LITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQF 439
+ITLGNFLFGPIPESLG+C+SL+R+RMGEN+LNGSIPKGL LP LSQVELQ+N LTG F
Sbjct: 384 IITLGNFLFGPIPESLGRCESLNRIRMGENYLNGSIPKGLLSLPHLSQVELQNNILTGTF 443
Query: 440 PVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSK 499
P S S +LGQI LSNN+L+G LP SIG F+ QKLLLDGNKFSG+IPAEIGKLQQLSK
Sbjct: 444 PDISSKSNSLGQIILSNNRLTGPLPPSIGNFAVAQKLLLDGNKFSGRIPAEIGKLQQLSK 503
Query: 500 MDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSI 559
+DFSHN SG IAPEISQCKLLT+VDLSRN+LSGEIP ++TGMRILNYLNLSRNHLVGSI
Sbjct: 504 IDFSHNNLSGPIAPEISQCKLLTYVDLSRNQLSGEIPTEITGMRILNYLNLSRNHLVGSI 563
Query: 560 PASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVANGT 619
PA I+SMQSLTSVDFSYNN SGLVPGTGQFSYFNYTSFLGN +LCGPYLGPCK+GV +G
Sbjct: 564 PAPISSMQSLTSVDFSYNNFSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCKEGVVDGV 623
Query: 620 HQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLDFTC 679
QPH +G L+ S+KLLLV+GLLVCSI FAVAAIIKARSLKKASE+RAWKLTAFQRLDFTC
Sbjct: 624 SQPHQRGALTPSMKLLLVIGLLVCSIVFAVAAIIKARSLKKASEARAWKLTAFQRLDFTC 683
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
DD+LD LKEDN+IGKGGAGIVYKG+MP+G+ VAVKRLPAMSRGSSHDHGFNAEIQTLGRI
Sbjct: 684 DDILDSLKEDNVIGKGGAGIVYKGVMPSGEHVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 743
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE+LHGKKGGHLHWDTRYKIA+E+AKGLCY
Sbjct: 744 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEMLHGKKGGHLHWDTRYKIALESAKGLCY 803
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
LHHDCSPLI+HRDVKSNNILLDS FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE
Sbjct: 804 LHHDCSPLILHRDVKSNNILLDSSFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 863
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
YAYTLKVDEKSDVYSFGVVLLEL++G+KPVGEFGDGVDIVQWVRKMTD KK+GVLKILDP
Sbjct: 864 YAYTLKVDEKSDVYSFGVVLLELVSGKKPVGEFGDGVDIVQWVRKMTDGKKDGVLKILDP 923
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESL----PP 975
RL +VPL+EVMHVFYVA+LCVEEQAVERPTMREVVQILTELPKPP +K + ++ PP
Sbjct: 924 RLSTVPLNEVMHVFYVALLCVEEQAVERPTMREVVQILTELPKPPGAKSDDSTVTDQSPP 983
Query: 976 SGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
S ++L+SP + D KDH +P PQSPPPDLLSI
Sbjct: 984 SA-SALESPTSIPGDTKDHHQPT-PQSPPPDLLSI 1016
|
Source: Solanum pennellii Species: Solanum pennellii Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727889|ref|NP_001237688.1| receptor-like protein kinase precursor [Glycine max] gi|223452472|gb|ACM89563.1| receptor-like protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1640 bits (4247), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 819/1014 (80%), Positives = 910/1014 (89%), Gaps = 8/1014 (0%)
Query: 1 MRLLLLLLLLLLHISQSRTVPEYKALLSIK-SSITDDPQSSLAAWNATTSHCTWPGVTCD 59
MR+L+LL+L L + +R + EY+ALLS K SSIT+DP +L++WN++T C+W GVTCD
Sbjct: 1 MRVLVLLMLFLHSLHAAR-ISEYRALLSFKASSITNDPTHALSSWNSSTPFCSWFGVTCD 59
Query: 60 SRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSN 119
SRRHVT L+L+ L+LS L ++HL FL +LS+A NQ SGPIP SALS+LR LNLSN
Sbjct: 60 SRRHVTGLNLTSLSLSATLYDHLSHLPFLSHLSLADNQFSGPIPVSFSALSALRFLNLSN 119
Query: 120 NVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYG 179
NVFN +FP QL++L++L+VLDLYNNNMTG LPLAV + LRHLHLGGNFFSGQIPPEYG
Sbjct: 120 NVFNQTFPSQLARLSNLEVLDLYNNNMTGPLPLAVASMPLLRHLHLGGNFFSGQIPPEYG 179
Query: 180 IWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAA 239
W+ L YLA+SGNEL G I E+GNL+ L++LYIGYYN+Y+GG+PPEIGNLS+LVR DAA
Sbjct: 180 TWQHLRYLALSGNELAGYIAPELGNLSALRELYIGYYNTYSGGIPPEIGNLSNLVRLDAA 239
Query: 240 NCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASF 299
CGLSGEIP ++G+LQNLDTLFLQVN+LSG LT+ELG LKSLKSMDLSNN+ +GE+PASF
Sbjct: 240 YCGLSGEIPAELGKLQNLDTLFLQVNSLSGSLTSELGNLKSLKSMDLSNNMLSGEVPASF 299
Query: 300 AELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLS 359
AELKNLTLLNLFRNKLHGAIPEF+G +P LEVLQLWENNFTGSIPQ LG NG+L ++DLS
Sbjct: 300 AELKNLTLLNLFRNKLHGAIPEFVGELPALEVLQLWENNFTGSIPQSLGKNGRLTLVDLS 359
Query: 360 SNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGL 419
SNK+TGTLPP MC GN LQTLITLGN+LFGPIP+SLGKC+SL+R+RMGENFLNGSIPKGL
Sbjct: 360 SNKITGTLPPYMCYGNRLQTLITLGNYLFGPIPDSLGKCESLNRIRMGENFLNGSIPKGL 419
Query: 420 FGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLD 479
FGLP L+QVELQDN LTGQFP SI+ +LGQI LSNN+LSG LP++IG F+ +QKLLLD
Sbjct: 420 FGLPKLTQVELQDNLLTGQFPEYGSIATDLGQISLSNNKLSGPLPSTIGNFTSMQKLLLD 479
Query: 480 GNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQL 539
GN+FSG+IP +IG+LQQLSK+DFSHNKFSG IAPEIS+CKLLTF+DLS NELSGEIPNQ+
Sbjct: 480 GNEFSGRIPPQIGRLQQLSKIDFSHNKFSGPIAPEISRCKLLTFIDLSGNELSGEIPNQI 539
Query: 540 TGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLG 599
T MRILNYLNLSRNHL GSIP SIASMQSLTSVDFSYNN SGLVPGTGQF YFNYTSFLG
Sbjct: 540 TSMRILNYLNLSRNHLDGSIPGSIASMQSLTSVDFSYNNFSGLVPGTGQFGYFNYTSFLG 599
Query: 600 NSELCGPYLGPCKDGVANGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLK 659
N ELCGPYLGPCKDGVANG QPHVKGPLS+S+KLLLV+GLLVCSI FAVAAIIKAR+LK
Sbjct: 600 NPELCGPYLGPCKDGVANGPRQPHVKGPLSSSLKLLLVIGLLVCSILFAVAAIIKARALK 659
Query: 660 KASESRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAM 719
KASE+RAWKLTAFQRLDFT DDVLDCLKEDNIIGKGGAGIVYKG MPNGD VAVKRLPAM
Sbjct: 660 KASEARAWKLTAFQRLDFTVDDVLDCLKEDNIIGKGGAGIVYKGAMPNGDNVAVKRLPAM 719
Query: 720 SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG 779
SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG
Sbjct: 720 SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG 779
Query: 780 HLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839
HLHW TRYKIAVEA+KGLCYLHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQD
Sbjct: 780 HLHWYTRYKIAVEASKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQD 839
Query: 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIV 899
SG SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL+TGRKPVGEFGDGVDIV
Sbjct: 840 SGASECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIV 899
Query: 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
QWVRKMTDS KEGVLK+LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE
Sbjct: 900 QWVRKMTDSNKEGVLKVLDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
Query: 960 LPKPPTSKQGEESLP---PSGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
LPKPP+SKQG+ ++ S + SL+SP ++K+ KD PPQSPP DLLSI
Sbjct: 960 LPKPPSSKQGDLTITESSLSSSNSLESPTTASKEPKDQH---PPQSPPTDLLSI 1010
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15239123|ref|NP_201371.1| leucine-rich receptor-like protein kinase BAM1 [Arabidopsis thaliana] gi|334188646|ref|NP_001190624.1| leucine-rich receptor-like protein kinase BAM1 [Arabidopsis thaliana] gi|75219638|sp|O49545.1|BAME1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1; AltName: Full=Protein BARELY ANY MERISTEM 1; Flags: Precursor gi|2827715|emb|CAA16688.1| receptor protein kinase - like protein [Arabidopsis thaliana] gi|10177328|dbj|BAB10677.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|20466696|gb|AAM20665.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|31711786|gb|AAP68249.1| At5g65700 [Arabidopsis thaliana] gi|110741066|dbj|BAE98627.1| receptor protein kinase like protein [Arabidopsis thaliana] gi|224589751|gb|ACN59407.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010708|gb|AED98091.1| leucine-rich receptor-like protein kinase BAM1 [Arabidopsis thaliana] gi|332010709|gb|AED98092.1| leucine-rich receptor-like protein kinase BAM1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1639 bits (4245), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 816/1007 (81%), Positives = 894/1007 (88%), Gaps = 24/1007 (2%)
Query: 13 HISQ----SRTVPEYKALLSIKSSIT---DDPQSSLAAWNATTSHCTWPGVTCD-SRRHV 64
HIS SR + E++ALLS+K+S+T DD S L++W +TS CTW GVTCD SRRHV
Sbjct: 12 HISHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHV 71
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
TSLDLSGLNLSG LSPDV+HLR LQNLS+A N +SGPIPPEIS+LS LR LNLSNNVFNG
Sbjct: 72 TSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNG 131
Query: 125 SFPPQLSQ-LASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
SFP ++S L +L+VLD+YNNN+TGDLP++VT L LRHLHLGGN+F+G+IPP YG W
Sbjct: 132 SFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPV 191
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGL 243
+EYLAVSGNEL GKIP EIGNLT L++LYIGYYN++ GLPPEIGNLS LVRFD ANCGL
Sbjct: 192 IEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGL 251
Query: 244 SGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELK 303
+GEIP +IG+LQ LDTLFLQVN SGPLT ELG L SLKSMDLSNN+FTGEIPASFAELK
Sbjct: 252 TGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELK 311
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKL 363
NLTLLNLFRNKLHG IPEFIG +P LEVLQLWENNFTGSIPQ+LG NGKL ++DLSSNKL
Sbjct: 312 NLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKL 371
Query: 364 TGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLP 423
TGTLPP+MC+GN L+TLITLGNFLFG IP+SLGKC+SL+R+RMGENFLNGSIPKGLFGLP
Sbjct: 372 TGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLP 431
Query: 424 SLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKF 483
L+QVELQDNYL+G+ PV+ +SVNLGQI LSNNQLSG LP +IG F+GVQKLLLDGNKF
Sbjct: 432 KLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKF 491
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543
G IP+E+GKLQQLSK+DFSHN FSGRIAPEIS+CKLLTFVDLSRNELSGEIPN++T M+
Sbjct: 492 QGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMK 551
Query: 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSEL 603
ILNYLNLSRNHLVGSIP SI+SMQSLTS+DFSYNNLSGLVPGTGQFSYFNYTSFLGN +L
Sbjct: 552 ILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDL 611
Query: 604 CGPYLGPCKDGVANGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASE 663
CGPYLGPCKDGVA G HQ H KGPLSAS+KLLLV+GLLVCSIAFAV AIIKARSLKKASE
Sbjct: 612 CGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASE 671
Query: 664 SRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGS 723
SRAW+LTAFQRLDFTCDDVLD LKEDNIIGKGGAGIVYKG+MPNGD VAVKRL AMSRGS
Sbjct: 672 SRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGS 731
Query: 724 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 783
SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW
Sbjct: 732 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 791
Query: 784 DTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843
DTRYKIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQDSGTS
Sbjct: 792 DTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTS 851
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903
ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL+TGRKPVGEFGDGVDIVQWVR
Sbjct: 852 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVR 911
Query: 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963
KMTDS K+ VLK+LDPRL S+P+HEV HVFYVAMLCVEEQAVERPTMREVVQILTE+PK
Sbjct: 912 KMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKL 971
Query: 964 PTSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
P SK D P + + + + QS PPDLL++
Sbjct: 972 PPSK--------------DQPMTESAPESELSPKSGVQS-PPDLLNL 1003
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351726026|ref|NP_001235065.1| receptor-like protein kinase 1 precursor [Glycine max] gi|9651941|gb|AAF91322.1|AF244888_1 receptor-like protein kinase 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1639 bits (4244), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 818/1011 (80%), Positives = 908/1011 (89%), Gaps = 4/1011 (0%)
Query: 1 MRLLLLLLLLLLHISQSRTVPEYKALLSIK-SSITDDPQSSLAAWNATTSHCTWPGVTCD 59
MR+L+L L L H Q+ + EY+ALLS K SS+TDDP +L++WN++T C+W G+TCD
Sbjct: 1 MRVLVLFFLFL-HSLQAARISEYRALLSFKASSLTDDPTHALSSWNSSTPFCSWFGLTCD 59
Query: 60 SRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSN 119
SRRHVTSL+L+ L+LSG LS D++HL FL +LS+A N+ SGPIP SALS+LR LNLSN
Sbjct: 60 SRRHVTSLNLTSLSLSGTLSDDLSHLPFLSHLSLADNKFSGPIPASFSALSALRFLNLSN 119
Query: 120 NVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYG 179
NVFN +FP QL++LA+L+VLDLYNNNMTG+LPL+V + LRHLHLGGNFFSGQIPPEYG
Sbjct: 120 NVFNATFPSQLNRLANLEVLDLYNNNMTGELPLSVAAMPLLRHLHLGGNFFSGQIPPEYG 179
Query: 180 IWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAA 239
W+ L+YLA+SGNEL G I E+GNL+ L++LYIGYYN+Y+GG+PPEIGNLS+LVR DAA
Sbjct: 180 TWQHLQYLALSGNELAGTIAPELGNLSSLRELYIGYYNTYSGGIPPEIGNLSNLVRLDAA 239
Query: 240 NCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASF 299
CGLSGEIP ++G+LQNLDTLFLQVNALSG LT ELG LKSLKSMDLSNN+ +GE+PASF
Sbjct: 240 YCGLSGEIPAELGKLQNLDTLFLQVNALSGSLTPELGSLKSLKSMDLSNNMLSGEVPASF 299
Query: 300 AELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLS 359
AELKNLTLLNLFRNKLHGAIPEF+G +P LEVLQLWENNFTGSIPQ LG+NG+L ++DLS
Sbjct: 300 AELKNLTLLNLFRNKLHGAIPEFVGELPALEVLQLWENNFTGSIPQNLGNNGRLTLVDLS 359
Query: 360 SNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGL 419
SNK+TGTLPP+MC GN LQTLITLGN+LFGPIP+SLGKC SL+R+RMGENFLNGSIPKGL
Sbjct: 360 SNKITGTLPPNMCYGNRLQTLITLGNYLFGPIPDSLGKCKSLNRIRMGENFLNGSIPKGL 419
Query: 420 FGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLD 479
FGLP L+QVELQDN LTGQFP SI+ +LGQI LSNNQLSGSLP++IG F+ +QKLLL+
Sbjct: 420 FGLPKLTQVELQDNLLTGQFPEDGSIATDLGQISLSNNQLSGSLPSTIGNFTSMQKLLLN 479
Query: 480 GNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQL 539
GN+F+G+IP +IG LQQLSK+DFSHNKFSG IAPEIS+CKLLTF+DLS NELSGEIPN++
Sbjct: 480 GNEFTGRIPPQIGMLQQLSKIDFSHNKFSGPIAPEISKCKLLTFIDLSGNELSGEIPNKI 539
Query: 540 TGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLG 599
T MRILNYLNLSRNHL GSIP +IASMQSLTSVDFSYNN SGLVPGTGQF YFNYTSFLG
Sbjct: 540 TSMRILNYLNLSRNHLDGSIPGNIASMQSLTSVDFSYNNFSGLVPGTGQFGYFNYTSFLG 599
Query: 600 NSELCGPYLGPCKDGVANGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLK 659
N ELCGPYLGPCKDGVANG QPHVKGP S+S+KLLLV+GLLVCSI FAVAAI KAR+LK
Sbjct: 600 NPELCGPYLGPCKDGVANGPRQPHVKGPFSSSLKLLLVIGLLVCSILFAVAAIFKARALK 659
Query: 660 KASESRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAM 719
KASE+RAWKLTAFQRLDFT DDVLDCLKEDNIIGKGGAGIVYKG MPNG VAVKRLPAM
Sbjct: 660 KASEARAWKLTAFQRLDFTVDDVLDCLKEDNIIGKGGAGIVYKGAMPNGGNVAVKRLPAM 719
Query: 720 SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG 779
SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG
Sbjct: 720 SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG 779
Query: 780 HLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839
HLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQD
Sbjct: 780 HLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQD 839
Query: 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIV 899
SG SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL+TGRKPVGEFGDGVDIV
Sbjct: 840 SGASECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIV 899
Query: 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
QWVRKMTDS KEGVLK+LD RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE
Sbjct: 900 QWVRKMTDSNKEGVLKVLDSRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
Query: 960 LPKPPTSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
LPKPP+SK S + SL SP ++K+ KD+Q PPQSPPPDLLSI
Sbjct: 960 LPKPPSSKHAITESSLSSSNSLGSPTTASKEPKDNQH--PPQSPPPDLLSI 1008
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1010 | ||||||
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.969 | 0.976 | 0.801 | 0.0 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.961 | 0.969 | 0.787 | 0.0 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.933 | 0.950 | 0.545 | 1.1e-279 | |
| TAIR|locus:2204350 | 980 | CLV1 "AT1G75820" [Arabidopsis | 0.926 | 0.955 | 0.550 | 7.6e-270 | |
| UNIPROTKB|Q5Z9N5 | 994 | P0481E08.42 "Os06g0717200 prot | 0.930 | 0.945 | 0.525 | 2.4e-257 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.684 | 0.663 | 0.384 | 2e-208 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.685 | 0.672 | 0.379 | 7.5e-187 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.927 | 0.924 | 0.409 | 7.6e-183 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.909 | 0.922 | 0.408 | 6.5e-177 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.926 | 0.936 | 0.405 | 2.7e-171 |
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 4129 (1458.5 bits), Expect = 0., P = 0.
Identities = 793/990 (80%), Positives = 868/990 (87%)
Query: 13 HISQ----SRTVPEYKALLSIKSSIT---DDPQSSLAAWNATTSHCTWPGVTCD-SRRHV 64
HIS SR + E++ALLS+K+S+T DD S L++W +TS CTW GVTCD SRRHV
Sbjct: 12 HISHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHV 71
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISAXXXXXXXXXXXXVFNG 124
TSLDLSGLNLSG LSPDV+HLR LQNLS+A N +SGPIPPEIS+ VFNG
Sbjct: 72 TSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNG 131
Query: 125 SFPPQLSQ-LASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
SFP ++S L +L+VLD+YNNN+TGDLP++VT L LRHLHLGGN+F+G+IPP YG W
Sbjct: 132 SFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPV 191
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGL 243
+EYLAVSGNEL GKIP EIGNLT L++LYIGYYN++ GLPPEIGNLS LVRFD ANCGL
Sbjct: 192 IEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGL 251
Query: 244 SGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELK 303
+GEIP +IG+LQ LDTLFLQVN SGPLT ELG L SLKSMDLSNN+FTGEIPASFAELK
Sbjct: 252 TGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELK 311
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKL 363
NLTLLNLFRNKLHG IPEFIG +P LEVLQLWENNFTGSIPQ+LG NGKL ++DLSSNKL
Sbjct: 312 NLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKL 371
Query: 364 TGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLP 423
TGTLPP+MC+GN L+TLITLGNFLFG IP+SLGKC+SL+R+RMGENFLNGSIPKGLFGLP
Sbjct: 372 TGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLP 431
Query: 424 SLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKF 483
L+QVELQDNYL+G+ PV+ +SVNLGQI LSNNQLSG LP +IG F+GVQKLLLDGNKF
Sbjct: 432 KLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKF 491
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543
G IP+E+GKLQQLSK+DFSHN FSGRIAPEIS+CKLLTFVDLSRNELSGEIPN++T M+
Sbjct: 492 QGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMK 551
Query: 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSEL 603
ILNYLNLSRNHLVGSIP SI+SMQSLTS+DFSYNNLSGLVPGTGQFSYFNYTSFLGN +L
Sbjct: 552 ILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDL 611
Query: 604 CGPYLGPCKDGVANGTHQPHVKGPLSASXXXXXXXXXXXCSIAFAVAAIIKARSLKKASE 663
CGPYLGPCKDGVA G HQ H KGPLSAS CSIAFAV AIIKARSLKKASE
Sbjct: 612 CGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASE 671
Query: 664 SRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGS 723
SRAW+LTAFQRLDFTCDDVLD LKEDNIIGKGGAGIVYKG+MPNGD VAVKRL AMSRGS
Sbjct: 672 SRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGS 731
Query: 724 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 783
SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW
Sbjct: 732 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW 791
Query: 784 DTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843
DTRYKIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQDSGTS
Sbjct: 792 DTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTS 851
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903
ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL+TGRKPVGEFGDGVDIVQWVR
Sbjct: 852 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVR 911
Query: 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963
KMTDS K+ VLK+LDPRL S+P+HEV HVFYVAMLCVEEQAVERPTMREVVQILTE+PK
Sbjct: 912 KMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKL 971
Query: 964 PTSKQGEESLPPSGTTSLDSPNASNKDQKD 993
P SK ++ + S S SP + + D
Sbjct: 972 PPSK--DQPMTESAPESELSPKSGVQSPPD 999
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3968 (1401.9 bits), Expect = 0., P = 0.
Identities = 776/986 (78%), Positives = 848/986 (86%)
Query: 13 HISQSRTV--P--EYKALLSIKSSITDDPQSSL-AAWNATTSHCTWPGVTCD-SRRHVTS 66
HIS S TV P E ALLS+KSS T D S L +WN +T+ C+W GVTCD S RHVTS
Sbjct: 14 HISHSFTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTS 73
Query: 67 LDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISAXXXXXXXXXXXXVFNGSF 126
LDLSGLNLSG LS DVAHL LQNLS+AANQ+SGPIPP+IS VFNGSF
Sbjct: 74 LDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSF 133
Query: 127 PPQLSQ-LASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLE 185
P +LS L +L+VLDLYNNN+TGDLP+++T L LRHLHLGGN+FSG+IP YG W LE
Sbjct: 134 PDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLE 193
Query: 186 YLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSG 245
YLAVSGNEL GKIP EIGNLT L++LYIGYYN++ GLPPEIGNLS LVRFDAANCGL+G
Sbjct: 194 YLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTG 253
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
EIP +IG+LQ LDTLFLQVNA +G +T ELG + SLKSMDLSNN+FTGEIP SF++LKNL
Sbjct: 254 EIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNL 313
Query: 306 TLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTG 365
TLLNLFRNKL+GAIPEFIG MP LEVLQLWENNFTGSIPQ+LG NG+L ILDLSSNKLTG
Sbjct: 314 TLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTG 373
Query: 366 TLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSL 425
TLPP+MC+GN L TLITLGNFLFG IP+SLGKC+SL+R+RMGENFLNGSIPK LFGLP L
Sbjct: 374 TLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKL 433
Query: 426 SQVELQDNYLTGQFPVSDS-ISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFS 484
SQVELQDNYLTG+ P+S +S +LGQI LSNNQLSGSLPA+IG SGVQKLLLDGNKFS
Sbjct: 434 SQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFS 493
Query: 485 GQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRI 544
G IP EIG+LQQLSK+DFSHN FSGRIAPEIS+CKLLTFVDLSRNELSG+IPN+LTGM+I
Sbjct: 494 GSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKI 553
Query: 545 LNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELC 604
LNYLNLSRNHLVGSIP +IASMQSLTSVDFSYNNLSGLVP TGQFSYFNYTSF+GNS LC
Sbjct: 554 LNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLC 613
Query: 605 GPYLGPCKDGVANGTHQPHVKGPLSASXXXXXXXXXXXCSIAFAVAAIIKARSLKKASES 664
GPYLGPC GTHQ HVK PLSA+ CS+ FA+ AIIKARSL+ ASE+
Sbjct: 614 GPYLGPC----GKGTHQSHVK-PLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEA 668
Query: 665 RAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS 724
+AW+LTAFQRLDFTCDDVLD LKEDNIIGKGGAGIVYKG MP GD VAVKRL MS GSS
Sbjct: 669 KAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSS 728
Query: 725 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD 784
HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHW+
Sbjct: 729 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWN 788
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
TRYKIA+EAAKGLCYLHHDCSPLIVHRDVKSNNILLDS FEAHVADFGLAKFLQDSGTSE
Sbjct: 789 TRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSE 848
Query: 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904
CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG+KPVGEFGDGVDIVQWVR
Sbjct: 849 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRS 908
Query: 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
MTDS K+ VLK++D RL SVP+HEV HVFYVA+LCVEEQAVERPTMREVVQILTE+PK P
Sbjct: 909 MTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQILTEIPKIP 968
Query: 965 TSKQGEESLPPSGTTSLDSPNASNKD 990
SKQ ++ T + N S+ D
Sbjct: 969 LSKQ--QAAESDVTEKAPAINESSPD 992
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2688 (951.3 bits), Expect = 1.1e-279, P = 1.1e-279
Identities = 525/963 (54%), Positives = 682/963 (70%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAWNATT--SHCTWPGVTCDS-RRHVTSLDLSGLNLSG 76
+ + L+S+K S D SL +WN S C+W GV+CD+ + +T LDLS LN+SG
Sbjct: 32 IRQANVLISLKQSF-DSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISG 90
Query: 77 ALSPDVAHLR-FLQNLSVAANQLSGPIPPEISAXXXXXXXXXXXXVFNGSFPPQ-LSQLA 134
+SP+++ L L L +++N SG +P EI VF G + SQ+
Sbjct: 91 TISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMT 150
Query: 135 SLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL 194
L LD Y+N+ G LPL++T L L HL LGGN+F G+IP YG + L++L++SGN+L
Sbjct: 151 QLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDL 210
Query: 195 GGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRL 254
G+IP E+ N+T L QLY+GYYN Y GG+P + G L +LV D ANC L G IP ++G L
Sbjct: 211 RGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNL 270
Query: 255 QNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNK 314
+NL+ LFLQ N L+G + ELG + SLK++DLSNN GEIP + L+ L L NLF N+
Sbjct: 271 KNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNR 330
Query: 315 LHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAG 374
LHG IPEF+ +P L++L+LW NNFTG IP +LGSNG L +DLS+NKLTG +P +C G
Sbjct: 331 LHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFG 390
Query: 375 NCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNY 434
L+ LI NFLFGP+PE LG+C+ L R R+G+NFL +PKGL LP+LS +ELQ+N+
Sbjct: 391 RRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNF 450
Query: 435 LTGQFPVSDSISV---NLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEI 491
LTG+ P ++ + +L QI LSNN+LSG +P SI +Q LLL N+ SGQIP EI
Sbjct: 451 LTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEI 510
Query: 492 GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLS 551
G L+ L K+D S N FSG+ PE C LT++DLS N++SG+IP Q++ +RILNYLN+S
Sbjct: 511 GSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVS 570
Query: 552 RNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPC 611
N S+P + M+SLTS DFS+NN SG VP +GQFSYFN TSFLGN LCG PC
Sbjct: 571 WNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPC 630
Query: 612 KDGVANGT-----HQPHVK--GPLSASXXXXXXXXXXXCSIAFAVAAIIKARSLKKASES 664
+G N + +Q + + G +SA + F V A++K R ++K +
Sbjct: 631 -NGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRK-NNP 688
Query: 665 RAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS 724
WKL FQ+L F + +L+C+KE+++IGKGG GIVYKG+MPNG++VAVK+L +++GSS
Sbjct: 689 NLWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSS 748
Query: 725 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD 784
HD+G AEIQTLGRIRHR+IVRLL FCSN + NLLVYEYMPNGSLGEVLHGK G L W+
Sbjct: 749 HDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWE 808
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL-QDSGTS 843
TR +IA+EAAKGLCYLHHDCSPLI+HRDVKSNNILL FEAHVADFGLAKF+ QD+G S
Sbjct: 809 TRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGAS 868
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGD-GVDIVQWV 902
ECMS+IAGSYGYIAPEYAYTL++DEKSDVYSFGVVLLELITGRKPV FG+ G+DIVQW
Sbjct: 869 ECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQWS 928
Query: 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
+ T+ ++GV+KI+D RL ++PL E M +F+VAMLCV+E +VERPTMREVVQ++++ +
Sbjct: 929 KIQTNCNRQGVVKIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQ 988
Query: 963 PPT 965
P T
Sbjct: 989 PNT 991
|
|
| TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2595 (918.5 bits), Expect = 7.6e-270, P = 7.6e-270
Identities = 524/951 (55%), Positives = 656/951 (68%)
Query: 22 EYKALLSIKSSITDDPQSSLAAWNATTS---HCTWPGVTCDSRRHVTSLDLSGLNLSGAL 78
+ + LL++KSS+ L W ++S HC++ GV+CD V SL++S L G +
Sbjct: 27 DMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDARVISLNVSFTPLFGTI 86
Query: 79 SPDVAHLRFLQNLSVAANQLSGPIPPEI-SAXXXXXXXXXXXXVFNGSFPPQ-LSQLASL 136
SP++ L L NL++AAN +G +P E+ S G+FP + L + L
Sbjct: 87 SPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILKAMVDL 146
Query: 137 QVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
+VLD YNNN G LP +++L+ L++L GGNFFSG+IP YG + LEYL ++G L G
Sbjct: 147 EVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNGAGLSG 206
Query: 197 KIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQN 256
K P + L L+++YIGYYNSYTGG+PPE G L+ L D A+C L+GEIPT + L++
Sbjct: 207 KSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSLSNLKH 266
Query: 257 LDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLH 316
L TLFL +N L+G + EL L SLKS+DLS N TGEIP SF L N+TL+NLFRN L+
Sbjct: 267 LHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLY 326
Query: 317 GAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNC 376
G IPE IG +P+LEV ++WENNFT +P LG NG L LD+S N LTG +P D+C G
Sbjct: 327 GQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDLCRGEK 386
Query: 377 LQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLT 436
L+ LI NF FGPIPE LGKC SL+++R+ +N LNG++P GLF LP ++ +EL DN+ +
Sbjct: 387 LEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFS 446
Query: 437 GQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQ 496
G+ PV+ S V L QI LSNN SG +P +IG F +Q L LD N+F G IP EI +L+
Sbjct: 447 GELPVTMSGDV-LDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELKH 505
Query: 497 LSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLV 556
LS+++ S N +G I IS+C L VDLSRN ++GEIP + ++ L LN+S N L
Sbjct: 506 LSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLT 565
Query: 557 GSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVA 616
GSIP I +M SLT++D S+N+LSG VP GQF FN TSF GN+ LC P+ C
Sbjct: 566 GSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPTRPG 625
Query: 617 NGTHQPHVKGPLSASXXXXXXXXXXXCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLD 676
+ H S S I +VA I+ + KK +S AWKLTAFQ+LD
Sbjct: 626 QTSDHNHT-ALFSPSRIVITVIAAITGLILISVA--IRQMNKKKNQKSLAWKLTAFQKLD 682
Query: 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTL 736
F +DVL+CLKE+NIIGKGGAGIVY+G MPN VA+KRL G S DHGF AEIQTL
Sbjct: 683 FKSEDVLECLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRS-DHGFTAEIQTL 741
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
GRIRHRHIVRLLG+ +N +TNLL+YEYMPNGSLGE+LHG KGGHL W+TR+++AVEAAKG
Sbjct: 742 GRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRHRVAVEAAKG 801
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
LCYLHHDCSPLI+HRDVKSNNILLDS FEAHVADFGLAKFL D SECMS+IAGSYGYI
Sbjct: 802 LCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMSSIAGSYGYI 861
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD-----SKKE 911
APEYAYTLKVDEKSDVYSFGVVLLELI G+KPVGEFG+GVDIV+WVR + S
Sbjct: 862 APEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGEFGEGVDIVRWVRNTEEEITQPSDAA 921
Query: 912 GVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
V+ I+DPRL PL V+HVF +AM+CVEE+A RPTMREVV +LT PK
Sbjct: 922 IVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTNPPK 972
|
|
| UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2477 (877.0 bits), Expect = 2.4e-257, P = 2.4e-257
Identities = 510/971 (52%), Positives = 655/971 (67%)
Query: 25 ALLSIKSSITDDPQSS----LAAWN-ATTS--HCTWPGVTCDSRRHVTSLDLSGLNL-SG 76
AL +K+++ P ++ LA W+ A TS HCT+ GVTCD R V +++L+ L L SG
Sbjct: 25 ALAKLKAALVPSPSATAPPPLADWDPAATSPAHCTFSGVTCDGRSRVVAINLTALPLHSG 84
Query: 77 ALSPDVAHLRFLQNLSVAANQLSGPIPPEISAXXXXXXXXXXXXVFNGSFP-PQLSQLAS 135
L P++A L L NL++AA L G +P E+ +G FP P AS
Sbjct: 85 YLPPEIALLDSLANLTIAACCLPGHVPLELPTLPSLRHLNLSNNNLSGHFPVPDSGGGAS 144
Query: 136 -----LQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVS 190
L+++D YNNN++G LP LR+LHLGGN+F+G IP YG LEYL ++
Sbjct: 145 PYFPSLELIDAYNNNLSGLLPPFSASHARLRYLHLGGNYFTGAIPDSYGDLAALEYLGLN 204
Query: 191 GNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTD 250
GN L G +P + LT+L+++YIGYYN Y GG+PPE G+L +L+R D ++C L+G +P +
Sbjct: 205 GNTLSGHVPVSLSRLTRLREMYIGYYNQYDGGVPPEFGDLGALLRLDMSSCNLTGPVPPE 264
Query: 251 IGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNL 310
+GRLQ LDTLFLQ N LSG + +LG L SL S+DLS N GEIP S A L NL LLNL
Sbjct: 265 LGRLQRLDTLFLQWNRLSGEIPPQLGDLSSLASLDLSVNDLAGEIPPSLANLSNLKLLNL 324
Query: 311 FRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPD 370
FRN L G+IP+F+ +LEVLQLW+NN TG+IP LG NG+L+ LDL++N LTG +P D
Sbjct: 325 FRNHLRGSIPDFVAGFAQLEVLQLWDNNLTGNIPAGLGKNGRLKTLDLATNHLTGPIPAD 384
Query: 371 MCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVEL 430
+CAG L+ L+ + N LFGPIP+SLG C +L+R+R+ +NFL G +P GLF LP + VEL
Sbjct: 385 LCAGRRLEMLVLMENGLFGPIPDSLGDCKTLTRVRLAKNFLTGPVPAGLFNLPQANMVEL 444
Query: 431 QDNYLTGQFPVSDSISVN-LGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPA 489
DN LTG+ P D I + +G + L NN + G +P +IG +Q L L+ N FSG +P
Sbjct: 445 TDNLLTGELP--DVIGGDKIGMLLLGNNGIGGRIPPAIGNLPALQTLSLESNNFSGALPP 502
Query: 490 EIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLN 549
EIG L+ LS+++ S N +G I E+ +C L VDLSRN SGEIP +T ++IL LN
Sbjct: 503 EIGNLKNLSRLNVSGNALTGAIPDELIRCASLAAVDLSRNGFSGEIPESITSLKILCTLN 562
Query: 550 LSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCG-PYL 608
+SRN L G +P +++M SLT++D SYN+LSG VP GQF FN +SF+GN LCG P
Sbjct: 563 VSRNRLTGELPPEMSNMTSLTTLDVSYNSLSGPVPMQGQFLVFNESSFVGNPGLCGGPVA 622
Query: 609 GPCKDGVANGTHQPHVKGPLS-ASXXXXXXXXXXXCSIAFAVAAIIKARSLKKASESR-- 665
C +A G + L S ++A A K S +++ R
Sbjct: 623 DACPPSMAGGGGGAGSQLRLRWDSKKMLVALVAAFAAVAVAFLGARKGCSAWRSAARRRS 682
Query: 666 -AWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS 724
AWK+TAFQ+L+F+ +DV++C+KEDNIIGKGGAGIVY G+ G ++A+KRL G
Sbjct: 683 GAWKMTAFQKLEFSAEDVVECVKEDNIIGKGGAGIVYHGVT-RGAELAIKRLVGRG-GGE 740
Query: 725 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD 784
HD GF+AE+ TLGRIRHR+IVRLLGF SN ETNLL+YEYMPNGSLGE+LHG KGGHL W+
Sbjct: 741 HDRGFSAEVTTLGRIRHRNIVRLLGFVSNRETNLLLYEYMPNGSLGEMLHGGKGGHLGWE 800
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
R ++A EAA GLCYLHHDC+P I+HRDVKSNNILLDS FEAHVADFGLAKFL TSE
Sbjct: 801 ARARVAAEAACGLCYLHHDCAPRIIHRDVKSNNILLDSAFEAHVADFGLAKFL-GGATSE 859
Query: 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904
CMSAIAGSYGYIAPEYAYTL+VDEKSDVYSFGVVLLELITGR+PVG FGDGVDIV WVRK
Sbjct: 860 CMSAIAGSYGYIAPEYAYTLRVDEKSDVYSFGVVLLELITGRRPVGGFGDGVDIVHWVRK 919
Query: 905 MT-----DSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
+T +S VL + D RL P+ +++++ VAM CVEE + RPTMREVV +L+
Sbjct: 920 VTAELPDNSDTAAVLAVADRRLTPEPVALMVNLYKVAMACVEEASTARPTMREVVHMLSN 979
Query: 960 LPKPPTSKQGE 970
P G+
Sbjct: 980 -PNSAQPNSGD 989
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 2.0e-208, Sum P(2) = 2.0e-208
Identities = 277/721 (38%), Positives = 401/721 (55%)
Query: 21 PEYKALLSIKSSITDDPQSSLAAWNATTSH------CTWPGVTCDS-RRHVTSLDLSGLN 73
P+ +LLS+K+S++ P S+ W + C+W GV CD+ V SLDLS N
Sbjct: 34 PQLLSLLSLKTSLSGPP-SAFQDWKVPVNGQNDAVWCSWSGVVCDNVTAQVISLDLSHRN 92
Query: 74 LSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISAXXXXXXXXXXXXVFNGSFPPQLSQL 133
LSG + + +L L L+++ N L G P I F+ SFPP +S+L
Sbjct: 93 LSGRIPIQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKL 152
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNE 193
L+V + ++NN G LP V++LR L L+ GG++F G+IP YG + L+++ ++GN
Sbjct: 153 KFLKVFNAFSNNFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNV 212
Query: 194 LGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGR 253
LGGK+P +G LT+LQ + IGY N + G +P E LS+L FD +NC LSG +P ++G
Sbjct: 213 LGGKLPPRLGLLTELQHMEIGY-NHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGN 271
Query: 254 LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRN 313
L NL+TLFL N +G + LKSLK +D S+N +G IP+ F+ LKNLT L+L N
Sbjct: 272 LSNLETLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISN 331
Query: 314 KLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCA 373
L G +PE IG +P L L LW NNFTG +P +LGSNGKL +D+S+N TGT+P +C
Sbjct: 332 NLSGEVPEGIGELPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCH 391
Query: 374 GNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDN 433
GN L LI N G +P+SL +C+SL R R N LNG+IP G L +L+ V+L +N
Sbjct: 392 GNKLYKLILFSNMFEGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNN 451
Query: 434 YLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGK 493
T Q P + + L + LS N LP +I K +Q + G+IP +G
Sbjct: 452 RFTDQIPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVG- 510
Query: 494 LQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRN 553
+ +++ N +G I +I C+ L ++LS+N L+G IP +++ + + ++LS N
Sbjct: 511 CKSFYRIELQGNSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHN 570
Query: 554 HLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLG-PCK 612
L G+IP+ S +++T+ + SYN L G +P +G F++ N + F N LCG +G PC
Sbjct: 571 LLTGTIPSDFGSSKTITTFNVSYNQLIGPIP-SGSFAHLNPSFFSSNEGLCGDLVGKPCN 629
Query: 613 D---GVANGTHQPHVKGPLSASXXXXXX-XXXXXCSIAFAVAAIIKARSLKKASESRA-- 666
N H K + F V + R +K+ +R
Sbjct: 630 SDRFNAGNADIDGHHKEERPKKTAGAIVWILAAAIGVGFFVL-VAATRCFQKSYGNRVDG 688
Query: 667 ----------WKLTAFQRLDFTCDDVLDCL-KEDNIIGKGGAGIVYKGLMPNGDQVAVKR 715
WKLTAFQRL+FT DDV++CL K DNI+G G G VYK MPNG+ +AVK+
Sbjct: 689 GGRNGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKK 748
Query: 716 L 716
L
Sbjct: 749 L 749
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 7.5e-187, Sum P(2) = 7.5e-187
Identities = 273/720 (37%), Positives = 380/720 (52%)
Query: 22 EYKALLSIKSSITDDPQSSLAAW----NATTS----HCTWPGVTCDSRRHVTSLDLSGLN 73
E + LL+ KS + D P ++L W NATT HC W GV CD+ +V L LS +N
Sbjct: 30 EQEILLAFKSDLFD-PSNNLQDWKRPENATTFSELVHCHWTGVHCDANGYVAKLLLSNMN 88
Query: 74 LSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISAXXXXXXXXXXXXVFNGSFPPQLSQL 133
LSG +S + LQ L ++ N +P +S F G+FP L
Sbjct: 89 LSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMA 148
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNE 193
L ++ +NN +G LP + L L G +F G +P + + L++L +SGN
Sbjct: 149 TGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNN 208
Query: 194 LGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGR 253
GGK+P IG L+ L+ + +GY N + G +P E G L+ L D A L+G+IP+ +G+
Sbjct: 209 FGGKVPKVIGELSSLETIILGY-NGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQ 267
Query: 254 LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRN 313
L+ L T++L N L+G L ELG + SL +DLS+N TGEIP ELKNL LLNL RN
Sbjct: 268 LKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLMRN 327
Query: 314 KLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCA 373
+L G IP I +P LEVL+LW+N+ GS+P LG N L+ LD+SSNKL+G +P +C
Sbjct: 328 QLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCY 387
Query: 374 GNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDN 433
L LI N G IPE + C +L R+R+ +N ++GSIP G LP L +EL N
Sbjct: 388 SRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELAKN 447
Query: 434 YLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGK 493
LTG+ P ++S +L I +S N LS SL +SI +Q + N F+G+IP +I
Sbjct: 448 NLTGKIPDDIALSTSLSFIDISFNHLS-SLSSSIFSSPNLQTFIASHNNFAGKIPNQIQD 506
Query: 494 LQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRN 553
LS +D S N FSG I I+ + L ++L N+L GEIP L GM +L L+LS N
Sbjct: 507 RPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSNN 566
Query: 554 HLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKD 613
L G+IPA + + +L ++ S+N L G +P F+ + +GN+ LCG L PC
Sbjct: 567 SLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLFAAIDPKDLVGNNGLCGGVLPPCSK 626
Query: 614 GVA---NGTHQPHVKGPLSASXXXXXXXXXXXCSIAFAVAAIIKAR-SL----------- 658
+A G + + + + F I R L
Sbjct: 627 SLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMMFLAGRWIYTRWDLYSNFAREYIFC 686
Query: 659 KKASESRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGD--QVAVKRL 716
KK E W+L AFQRL FT D+L +KE NIIG G GIVYK + VAVK+L
Sbjct: 687 KKPREEWPWRLVAFQRLCFTAGDILSHIKESNIIGMGAIGIVYKAEVMRRPLLTVAVKKL 746
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1774 (629.5 bits), Expect = 7.6e-183, P = 7.6e-183
Identities = 401/980 (40%), Positives = 559/980 (57%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAWNA--TTSHCTWPGVTCDSRRHVTSLDLSGLNLSGA 77
V E LLS+KS++ D P + L W T+ HC W GV C+S +V LDL+G+NL+G
Sbjct: 28 VNELSVLLSVKSTLVD-PLNFLKDWKLSDTSDHCNWTGVRCNSNGNVEKLDLAGMNLTGK 86
Query: 78 LSPDVAHLRFLQNLSVAANQLSGPIPPEISAXXXXXXXXXXXXVFNGSFPPQLSQLASLQ 137
+S ++ L L + +++ N +P I F+GS ++ L
Sbjct: 87 ISDSISQLSSLVSFNISCNGFESLLPKSIPPLKSIDISQNS---FSGSLFLFSNESLGLV 143
Query: 138 VLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGK 197
L+ NN++G+L + L +L L L GNFF G +P + + L +L +SGN L G+
Sbjct: 144 HLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNLTGE 203
Query: 198 IPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNL 257
+P +G L L+ +GY N + G +PPE GN++SL D A LSGEIP+++G+L++L
Sbjct: 204 LPSVLGQLPSLETAILGY-NEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSL 262
Query: 258 DTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG 317
+TL L N +G + E+G + +LK +D S+N TGEIP +LKNL LLNL RNKL G
Sbjct: 263 ETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSG 322
Query: 318 AIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCL 377
+IP I + +L+VL+LW N +G +P LG N L+ LD+SSN +G +P +C L
Sbjct: 323 SIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNL 382
Query: 378 QTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTG 437
LI N G IP +L C SL R+RM N LNGSIP G L L ++EL N L+G
Sbjct: 383 TKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSG 442
Query: 438 QFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQL 497
P S SV+L I S NQ+ SLP++I +Q L+ N SG++P + L
Sbjct: 443 GIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSL 502
Query: 498 SKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVG 557
S +D S N +G I I+ C+ L ++L N L+GEIP Q+T M L L+LS N L G
Sbjct: 503 SNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTG 562
Query: 558 SIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPC-KDGVA 616
+P SI + +L ++ SYN L+G VP G N GNS LCG L PC K A
Sbjct: 563 VLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSKFQRA 622
Query: 617 NGTHQPHVKGPLSASXXXXXXXXXXXCSIAFAVAAIIKARSLKK-----------ASESR 665
+H L +A + I+ KK AS+
Sbjct: 623 TSSHSS-----LHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGE 677
Query: 666 -AWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQV-AVKRL----PAM 719
W+L AF RL FT D+L C+KE N+IG G GIVYK M V AVK+L +
Sbjct: 678 WPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADI 737
Query: 720 SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG- 778
G++ D F E+ LG++RHR+IVRLLGF N + ++VYE+M NG+LG+ +HGK
Sbjct: 738 EDGTTGD--FVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAA 795
Query: 779 GHL--HWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836
G L W +RY IA+ A GL YLHHDC P ++HRD+KSNNILLD+ +A +ADFGLA+
Sbjct: 796 GRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARM 855
Query: 837 LQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVG-EFGDG 895
+ + E +S +AGSYGYIAPEY YTLKVDEK D+YS+GVVLLEL+TGR+P+ EFG+
Sbjct: 856 M--ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGES 913
Query: 896 VDIVQWVR-KMTDSKKEGVLKILDPRLPSVPL--HEVMHVFYVAMLCVEEQAVERPTMRE 952
VDIV+WVR K+ D+ + + LDP + + E++ V +A+LC + +RP+MR+
Sbjct: 914 VDIVEWVRRKIRDNIS--LEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRD 971
Query: 953 VVQILTELPKPPTSKQGEES 972
V+ +L E S EE+
Sbjct: 972 VISMLGEAKPRRKSNSNEEN 991
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1718 (609.8 bits), Expect = 6.5e-177, P = 6.5e-177
Identities = 391/956 (40%), Positives = 553/956 (57%)
Query: 26 LLSIKSSITDDPQSSLAAWNAT-TSHCTWPGVTCDSR-RHVTSLDLSGLNLSGALSPDVA 83
L +K S+ DDP S L++WN+ S C W GV+C VTS+DLS NL+G +
Sbjct: 23 LQQVKLSL-DDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPFPSVIC 81
Query: 84 HLRFLQNLSVAANQLSGPIPPEISAXXXXXXXXXXXXVFNGSFPPQLSQLASLQVLDLYN 143
L L +LS+ N ++ +P I+A + G P L+ + +L LDL
Sbjct: 82 RLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVHLDLTG 141
Query: 144 NNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELG-GKIPGEI 202
NN +GD+P + + NL L L N G IPP G L+ L +S N +IP E
Sbjct: 142 NNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEF 201
Query: 203 GNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFL 262
GNLT L+ +++ + G +P +G LS LV D A L G IP +G L N+ + L
Sbjct: 202 GNLTNLEVMWLTECH-LVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIEL 260
Query: 263 QVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEF 322
N+L+G + ELG LKSL+ +D S N TG+IP + L LNL+ N L G +P
Sbjct: 261 YNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNLEGELPAS 319
Query: 323 IGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLIT 382
I + P L ++++ N TG +P+ LG N LR LD+S N+ +G LP D+CA L+ L+
Sbjct: 320 IALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELLI 379
Query: 383 LGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVS 442
+ N G IPESL C SL+R+R+ N +GS+P G +GLP ++ +EL +N +G+ S
Sbjct: 380 IHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKS 439
Query: 443 DSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDF 502
+ NL + LSNN+ +GSLP IG + +L GNKFSG +P + L +L +D
Sbjct: 440 IGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDL 499
Query: 503 SHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPAS 562
N+FSG + I K L ++L+ NE +G+IP+++ + +LNYL+LS N G IP S
Sbjct: 500 HGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVS 559
Query: 563 IASMQSLTSVDFSYNNLSG-LVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVANGTHQ 621
+ S++ L ++ SYN LSG L P + Y N SF+GN LCG G C G N +
Sbjct: 560 LQSLK-LNQLNLSYNRLSGDLPPSLAKDMYKN--SFIGNPGLCGDIKGLC--GSENEAKK 614
Query: 622 PHVKGPLSASXXXXXXXXXXXCSIAFAVAAIIKARSLKKAS--ESRAWKLTAFQRLDFTC 679
L + +A+ K R+ KKA E W L +F +L F+
Sbjct: 615 RGYVWLLRS--IFVLAAMVLLAGVAWFY---FKYRTFKKARAMERSKWTLMSFHKLGFSE 669
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMS----------RGSS---HD 726
++L+ L EDN+IG G +G VYK ++ NG+ VAVKRL S +G D
Sbjct: 670 HEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQD 729
Query: 727 HGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTR 786
F AE++TLG+IRH++IV+L CS + LLVYEYMPNGSLG++LH KGG L W TR
Sbjct: 730 EAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTR 789
Query: 787 YKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS-EC 845
+KI ++AA+GL YLHHD P IVHRD+KSNNIL+D + A VADFG+AK + +G + +
Sbjct: 790 FKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKS 849
Query: 846 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVG-EFGDGVDIVQWVRK 904
MS IAGS GYIAPEYAYTL+V+EKSD+YSFGVV+LE++T ++PV E G+ D+V+WV
Sbjct: 850 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEK-DLVKWVCS 908
Query: 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
D K G+ ++DP+L S E+ + V +LC + RP+MR VV++L E+
Sbjct: 909 TLDQK--GIEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQEI 962
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1665 (591.2 bits), Expect = 2.7e-171, P = 2.7e-171
Identities = 395/974 (40%), Positives = 562/974 (57%)
Query: 36 DPQSSLAAW--NATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSV 93
DP SL++W N + C W GV+CD+ +V S+DLS L G + HL L +LS+
Sbjct: 37 DPAQSLSSWSDNNDVTPCKWLGVSCDATSNVVSVDLSSFMLVGPFPSILCHLPSLHSLSL 96
Query: 94 AANQLSGPIPPE-ISAXXXXXXXXXXXXVFNGSFPPQLS-QLASLQVLDLYNNNMTGDLP 151
N ++G + + + GS P L L +L+ L++ NN++ +P
Sbjct: 97 YNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIP 156
Query: 152 LAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELG-GKIPGEIGNLTKLQQ 210
+ + R L L+L GNF SG IP G L+ L ++ N +IP ++GNLT+LQ
Sbjct: 157 SSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQV 216
Query: 211 LYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGP 270
L++ N G +PP + L+SLV D L+G IP+ I +L+ ++ + L N+ SG
Sbjct: 217 LWLAGCN-LVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGE 275
Query: 271 LTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLE 330
L +G + +LK D S N TG+IP + L NL LNLF N L G +PE I L
Sbjct: 276 LPESMGNMTTLKRFDASMNKLTGKIPDNL-NLLNLESLNLFENMLEGPLPESITRSKTLS 334
Query: 331 VLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGP 390
L+L+ N TG +P +LG+N L+ +DLS N+ +G +P ++C L+ LI + N G
Sbjct: 335 ELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGE 394
Query: 391 IPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLG 450
I +LGKC SL+R+R+ N L+G IP G +GLP LS +EL DN TG P + + NL
Sbjct: 395 ISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLS 454
Query: 451 QICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGR 510
+ +S N+ SGS+P IG +G+ ++ N FSG+IP + KL+QLS++D S N+ SG
Sbjct: 455 NLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGE 514
Query: 511 IAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLT 570
I E+ K L ++L+ N LSGEIP ++ + +LNYL+LS N G IP + +++ L
Sbjct: 515 IPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLK-LN 573
Query: 571 SVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKDGVANGTHQPHVKGPLSA 630
++ SYN+LSG +P + + F+GN LC G C+ + + +V L+
Sbjct: 574 VLNLSYNHLSGKIPPLYANKIYAH-DFIGNPGLCVDLDGLCRK-ITRSKNIGYVWILLTI 631
Query: 631 SXXXXXXXXXXXCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLDFTCDDVLDCLKEDN 690
I +A K R+LK +S A K +F +L F+ ++ DCL E N
Sbjct: 632 ---FLLAGLVFVVGIVMFIAKCRKLRALK-SSTLAASKWRSFHKLHFSEHEIADCLDEKN 687
Query: 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHG--------FNAEIQTLGRIRHR 742
+IG G +G VYK + G+ VAVK+L +G ++ F AE++TLG IRH+
Sbjct: 688 VIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHK 747
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHG-KKGGH-LHWDTRYKIAVEAAKGLCYL 800
IVRL CS+ + LLVYEYMPNGSL +VLHG +KGG L W R +IA++AA+GL YL
Sbjct: 748 SIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYL 807
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG--TSECMSAIAGSYGYIAP 858
HHDC P IVHRDVKS+NILLDS + A VADFG+AK Q SG T E MS IAGS GYIAP
Sbjct: 808 HHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAP 867
Query: 859 EYAYTLKVDEKSDVYSFGVVLLELITGRKPV-GEFGDGVDIVQWVRKMTDSKKEGVLKIL 917
EY YTL+V+EKSD+YSFGVVLLEL+TG++P E GD D+ +WV D K G+ ++
Sbjct: 868 EYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDK-DMAKWVCTALD--KCGLEPVI 924
Query: 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL----P--KPPTSKQGEE 971
DP+L E+ V ++ +LC + RP+MR+VV +L E+ P P TSK+ +
Sbjct: 925 DPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQEVSGAVPCSSPNTSKRSKT 984
Query: 972 S--LPPSGTTSLDS 983
L P T L+S
Sbjct: 985 GGKLSPYYTEDLNS 998
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O49545 | BAME1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8103 | 0.9732 | 0.9800 | yes | no |
| Q9M2Z1 | BAME2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7940 | 0.9702 | 0.9780 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1010 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.0 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-11 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 604 bits (1559), Expect = 0.0
Identities = 361/978 (36%), Positives = 540/978 (55%), Gaps = 46/978 (4%)
Query: 3 LLLLLLLLLLHISQSRTVPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRR 62
L+ +L L L+ S E + LLS KSSI +DP L+ WN++ C W G+TC++
Sbjct: 12 LIFMLFFLFLNFSMLHA-EELELLLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCNNSS 69
Query: 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALS-SLRLLNLSNNV 121
V S+DLSG N+SG +S + L ++Q ++++ NQLSGPIP +I S SLR LNLSNN
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIW 181
F GS P + +L+ LDL NN ++G++P + +L+ L LGGN G+IP
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 182 EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANC 241
LE+L ++ N+L G+IP E+G + L+ +Y+GY N+ +G +P EIG L+SL D
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY-NNLSGEIPYEIGGLTSLNHLDLVYN 246
Query: 242 GLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAE 301
L+G IP+ +G L+NL LFL N LSGP+ + L+ L S+DLS+N +GEIP +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 302 LKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSN 361
L+NL +L+LF N G IP + +PRL+VLQLW N F+G IP+ LG + L +LDLS+N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 362 KLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFG 421
LTG +P +C+ L LI N L G IP+SLG C SL R+R+ +N +G +P
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 422 LPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGN 481
LP + +++ +N L G+ +L + L+ N+ G LP S G ++ L L N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRN 485
Query: 482 KFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTG 541
+FSG +P ++G L +L ++ S NK SG I E+S CK L +DLS N+LSG+IP +
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE 545
Query: 542 MRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNS 601
M +L+ L+LS+N L G IP ++ +++SL V+ S+N+L G +P TG F N ++ GN
Sbjct: 546 MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNI 605
Query: 602 ELCG----PYLGPCKDGVANGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARS 657
+LCG L PCK + ++ L A + L LV AF I +
Sbjct: 606 DLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALV--------AFGFVFIRGRNN 657
Query: 658 L---KKASESRAWKLTAFQR---LDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGD-Q 710
L + +E W+L F T +D+L LKE+N+I +G G YKG Q
Sbjct: 658 LELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQ 717
Query: 711 VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLG 770
VK + ++ S +EI +G+++H +IV+L+G C + + L++EY+ +L
Sbjct: 718 FVVKEINDVNSIPS------SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771
Query: 771 EVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVAD 830
EVL L W+ R KIA+ AK L +LH CSP +V ++ I++D E H+
Sbjct: 772 EVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR- 825
Query: 831 FGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPV- 889
L L SA Y+APE T + EKSD+Y FG++L+EL+TG+ P
Sbjct: 826 LSLPGLLCTDTKCFISSA------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
Query: 890 GEFGDGVDIVQWVR-KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERP 948
EFG IV+W R +D + + SV +E++ V +A+ C RP
Sbjct: 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
Query: 949 TMREVVQILTELPKPPTS 966
+V++ L + +S
Sbjct: 940 CANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 4e-48
Identities = 85/285 (29%), Positives = 132/285 (46%), Gaps = 40/285 (14%)
Query: 686 LKEDNIIGKGGAGIVYKG-LMPNGD----QVAVKRLPAMSRGSSHDH--GFNAEIQTLGR 738
L+ +G+G G VYKG L +G+ +VAVK L G+S + F E + +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKE---GASEEEREEFLEEASIMKK 57
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
+ H +IVRLLG C+ E +V EYMP G L + L K G L ++A++ AKG+
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGME 116
Query: 799 YLH-HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG----TSECMSAIAGSY 853
YL + VHRD+ + N L+ ++DFGL++ + + I
Sbjct: 117 YLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK--- 169
Query: 854 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
++APE K KSDV+SFGV+L E+ T G +P ++++ +
Sbjct: 170 -WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLELLEDG------Y 221
Query: 913 VLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957
L P L+E+M + C +RPT E+V+ L
Sbjct: 222 RLPR--PENCPDELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 78/281 (27%), Positives = 124/281 (44%), Gaps = 33/281 (11%)
Query: 686 LKEDNIIGKGGAGIVYKG-----LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
L +G+G G VYKG +VAVK L + F E + + ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
H ++V+LLG C+ E +V EYM G L L K L A++ A+G+ YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYL 118
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---TSECMSAIAGSYGYIA 857
+HRD+ + N L+ ++DFGL++ L D I ++A
Sbjct: 119 ESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMA 171
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
PE K KSDV+SFGV+L E+ T G +P +++++++
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLEYLKNGY---------- 220
Query: 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957
RLP P + ++ + + C E +RPT E+V+IL
Sbjct: 221 ---RLPQ-PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 80/281 (28%), Positives = 128/281 (45%), Gaps = 32/281 (11%)
Query: 686 LKEDNIIGKGGAGIVYKG-----LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
L +G+G G VYKG +VAVK L + F E + + ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
H +IV+LLG C+ E ++V EYMP G L + L + L A++ A+G+ YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT---SECMSAIAGSYGYIA 857
+HRD+ + N L+ ++DFGL++ L D I ++A
Sbjct: 120 ESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMA 172
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
PE K KSDV+SFGV+L E+ T G +P +++++++K
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM-SNAEVLEYLKKGY---------- 221
Query: 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957
RLP P + ++ + + C E +RPT E+V+IL
Sbjct: 222 ---RLPK-PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 5e-46
Identities = 71/194 (36%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G+GG G VY G +VA+K + S + EI+ L ++ H +IV+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
+ LV EY GSL ++L + G L D +I ++ +GL YLH S I+H
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 811 RDVKSNNILLDSG-FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-YAYTLKVDE 868
RD+K NILLDS + +ADFGL+K L + I G+ Y+APE E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 869 KSDVYSFGVVLLEL 882
KSD++S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 89/267 (33%), Positives = 122/267 (45%), Gaps = 18/267 (6%)
Query: 691 IIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+G G G VYK G VAVK L S S D EI+ L R+ H +IVRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ + LV EY G L + L +GG L D KIA++ +GL YLH + I+
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSNG---II 120
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-YAYTLKVDE 868
HRD+K NILLD +ADFGLAK L +S ++ G+ Y+APE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 869 KSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHE 928
K DV+S GV+L EL+TG+ P F + Q ++ L+ E
Sbjct: 179 KVDVWSLGVILYELLTGKPP---FSGENILDQ--LQLIRRILGPPLEF--DEPKWSSGSE 231
Query: 929 VMHVFYVAMLCVEEQAVERPTMREVVQ 955
L + +RPT E++Q
Sbjct: 232 EAKDLIKKCLNKDPS--KRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 24/268 (8%)
Query: 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+G+G G VY G VA+K + + EI+ L +++H +IVRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIK-KKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHL-HWDTRYKIAVEAAKGLCYLHHDCSPL 807
+ + LV EY G L ++L KK G L + R+ + L YLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHSKG--- 117
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
IVHRD+K NILLD +ADFGLA+ L ++ G+ Y+APE
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGYG 174
Query: 868 EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927
+ D++S GV+L EL+TG+ P F +++ +K+ K P +
Sbjct: 175 KAVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGKPKPP-----FPPPEWDIS-P 225
Query: 928 EVMHVFYVAMLCVEEQAVERPTMREVVQ 955
E + +L + + +R T E +Q
Sbjct: 226 EAKDLIR-KLLVKDPE--KRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 81/285 (28%), Positives = 125/285 (43%), Gaps = 39/285 (13%)
Query: 690 NIIGKGGAGIVYKGLMPNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G+G G VYKG + D +VAVK L + F E + + ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERK-DFLKEARVMKKLGHPNVV 59
Query: 746 RLLGFCSNHETNLLVYEYMPNGSL-------GEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
RLLG C+ E LV EYM G L V + L A++ AKG+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG----TSECMSAIAGSYG 854
YL S VHRD+ + N L+ ++DFGL++ + D + I
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913
++APE KSDV+SFGV+L E+ T G P ++++++RK G
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK-------G- 223
Query: 914 LKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
++ P L+E+M C + +RPT E+V+ L
Sbjct: 224 YRLPKPEYCPDELYELML------SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
++G+G G VY L G+ +AVK + EI+ L ++H +IVR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 749 GFCSNHETN-LLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH-HDCS 805
G + E N L ++ EY+ GSL +L KK G L K + +GL YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
IVHRD+K NIL+DS +ADFG AK L D T E ++ G+ ++APE +
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 866 VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIV 899
+D++S G ++E+ TG+ P E G+ + +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 72/207 (34%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IGKGG G VYK G +VA+K + S+ EIQ L + +H +IV+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII--NEIQILKKCKHPNIVKYYG- 64
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDCSP 806
+ L +V E+ GSL ++L T +IA E KGL YLH S
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQT----LTESQIAYVCKELLKGLEYLH---SN 117
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
I+HRD+K+ NILL S E + DFGL+ L D+ M G+ ++APE
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVINGKPY 174
Query: 867 DEKSDVYSFGVVLLELITGRKPVGEFG 893
D K+D++S G+ +EL G+ P E
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELP 201
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 91/289 (31%), Positives = 130/289 (44%), Gaps = 25/289 (8%)
Query: 686 LKEDNIIGKGGAGIVYKG-LMPNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
LK +G+G G V P GD QVAVK L H F EI+ L +
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLD 64
Query: 741 HRHIVRLLGFC-SNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
H +IV+ G C +L L+ EY+P+GSL + L + + + KG+
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL-KRLLLFSSQICKGMD 123
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL-QDSGTSECMSAIAGSYGYIA 857
YL S +HRD+ + NIL++S ++DFGLAK L +D + A
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRK---PVGEFGDGVDIVQWVRKMTDSKKEGV 913
PE T K SDV+SFGV L EL T G P EF + I Q +T +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR-----L 235
Query: 914 LKILDP--RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
L++L RLP P V+ + LC E + +RP+ +++ I+ L
Sbjct: 236 LELLKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 84/329 (25%), Positives = 127/329 (38%), Gaps = 19/329 (5%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRH-RHIVRLLG 749
+G+G G VY + VA+K L + S F EIQ L + H +IV+L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 750 FCSNHETNLLVYEYMPNGSLGEVL-HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
F + + LV EY+ GSL ++L + G L I + L YLH S I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 809 VHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTS----ECMSAIAGSYGYIAPEYAYT 863
+HRD+K NILLD G + DFGLAK L D G++ S G+ GY+APE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 864 L---KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920
L SD++S G+ L EL+TG P + Q ++ + + + L P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESLPPSGTTS 980
P + + + + R + + + L P +
Sbjct: 243 NPELISKAASDLL---KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAP 299
Query: 981 LDSPNASNKDQKDHQRPAPPQSPPPDLLS 1009
L + + + S L
Sbjct: 300 LRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 25/262 (9%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
+G G G V++GL N +VA+K L + D F E+Q L R+RH+H++ L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLISLFAVC 71
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
S E ++ E M GSL L +G L + +A + A+G+ YL +HR
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHR 128
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 871
D+ + NIL+ VADFGLA+ +++ I Y + APE A KSD
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSD 186
Query: 872 VYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVM 930
V+SFG++L E+ T G+ P G++ + ++T G R+P +
Sbjct: 187 VWSFGILLYEMFTYGQVPY----PGMNNHEVYDQIT----AGY------RMPCPA--KCP 230
Query: 931 HVFYVAML-CVEEQAVERPTMR 951
Y ML C + +RP+ +
Sbjct: 231 QEIYKIMLECWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 85/271 (31%), Positives = 129/271 (47%), Gaps = 47/271 (17%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+G G G V+ G +VAVK L MS + F E Q + ++RH +V+L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-----FLQEAQIMKKLRHDKLVQLYA 68
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
CS E +V EYM GSL + L +G L +A + A+G+ YL S +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA---IAGSYGYIAPEYAYTLKV 866
HRD+ + NIL+ +ADFGLA+ ++D + A I + APE A +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----WTAPEAANYGRF 181
Query: 867 DEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD-----PR 920
KSDV+SFG++L E++T GR P MT+ + VL+ ++ PR
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP-------------YPGMTNRE---VLEQVERGYRMPR 225
Query: 921 LPSVP--LHEVMHVFYVAMLCVEEQAVERPT 949
P+ P L+++M + C ++ ERPT
Sbjct: 226 PPNCPEELYDLM------LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 84/262 (32%), Positives = 124/262 (47%), Gaps = 29/262 (11%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
+G G G V++GL N VAVK L G+ F AE Q + ++RH +++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP---GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
+ E +V E M GSL E L G G L +A + A G+ YL + +HR
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 871
D+ + N+L+ VADFGLA+ +++ E + APE A + KSD
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 872 VYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP--RLPSVPLHE 928
V+SFG++L E++T GR P MT+++ VL+ +D R+P P
Sbjct: 187 VWSFGILLTEIVTYGRMPYP-------------GMTNAE---VLQQVDQGYRMPCPPGCP 230
Query: 929 VMHVFYVAML-CVEEQAVERPT 949
Y ML C +E +RPT
Sbjct: 231 K--ELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 68/214 (31%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH 741
L+ +K +G+G +G+VYK P G A+K++ E++TL
Sbjct: 3 LERVKV---LGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-EEFRKQLLRELKTLRSCES 58
Query: 742 RHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
++V+ G F E ++ V EYM GSL ++L KK G + IA + KGL YL
Sbjct: 59 PYVVKCYGAFYKEGEISI-VLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE- 859
H I+HRD+K +N+L++S E +ADFG++K L+++ +C + + G+ Y++PE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFV-GTVTYMSPER 171
Query: 860 -----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y+Y +D++S G+ LLE G+ P
Sbjct: 172 IQGESYSY------AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ + +IG G G V +G + + VA+K L A S F E +G+
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQF 62
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
H +I+RL G + +++ EYM NGSL + L + G + A G+ Y
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKY 121
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS-GTSECMSAIAGSYGYI-- 856
L VHRD+ + NIL++S V+DFGL++ L+DS T G I
Sbjct: 122 LSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG------GKIPI 172
Query: 857 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
APE K SDV+SFG+V+ E+++ G +P + M++
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD-------------MSNQD--- 216
Query: 913 VLKILDP--RLPS-----VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
V+K ++ RLP L+++M + C ++ ERPT ++V L ++
Sbjct: 217 VIKAVEDGYRLPPPMDCPSALYQLM------LDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
++IG+G G+VYKGL + GD VA+K++ EI L ++H +IV+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
G ++ ++ EY NGSL +++ KK G + +GL YLH +
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQG---V 120
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
+HRD+K+ NIL +ADFG+A L D + +++ G+ ++APE
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGAST 178
Query: 869 KSDVYSFGVVLLELITGRKP 888
SD++S G ++EL+TG P
Sbjct: 179 ASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 78/292 (26%), Positives = 114/292 (39%), Gaps = 76/292 (26%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHG-----FNAEIQTLGRIRHRHIVR 746
IGKG G V G G +VAVK L D F AE + +RH ++V+
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL--------KDDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
LLG +V EYM GSL + L + + + A++ +G+ YL
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EK 121
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY--GYIAPEYAYTL 864
VHRD+ + N+L+ A V+DFGLAK +G + APE
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREK 174
Query: 865 KVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
K KSDV+SFG++L E+ + GR P P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP--------------------------------YPR 202
Query: 924 VPLHEVM-----------------HVFYVAMLCVEEQAVERPTMREVVQILT 958
+PL +V+ V+ V C E +RPT +++ + L
Sbjct: 203 IPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 51/282 (18%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGF-NAEIQTLGRIRHRHIVRLLG 749
IGKG G VY +G +K + +S S + E++ L ++ H +I++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEID-LSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 750 FCSNHETN---LLVYEYMPNGSLGEVLH--GKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
+ + E +V EY G L + + K+G + V+ L YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----Y 860
S I+HRD+K NI L S + DFG++K L T + + G+ Y++PE
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELCQNK 178
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD-- 918
Y + KSD++S G VL EL T + P F +G ++ E LKIL
Sbjct: 179 PY----NYKSDIWSLGCVLYELCTLKHP---F-EG-----------ENLLELALKILKGQ 219
Query: 919 -PRLP---SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956
P +P S L ++ ++L + + ERP++ +++Q
Sbjct: 220 YPPIPSQYSSELRNLVS----SLLQKDPE--ERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 27/263 (10%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQV-AVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
N IGKG G+V+K + +V A+K++ E + L ++ +I+R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 749 -GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
F + N+++ EY NG L ++L ++G L D ++ ++ GL +LH S
Sbjct: 66 ESFLDKGKLNIVM-EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
I+HRD+KS N+ LD+ + D G+AK L D+ + + I G+ Y++PE +
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPELCEDKPYN 179
Query: 868 EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG--VLKILDPRLPSVP 925
EKSDV++ GVVL E TG+ P D+ +G +LKI+ P V
Sbjct: 180 EKSDVWALGVVLYECCTGKHPF-----------------DANNQGALILKIIRGVFPPVS 222
Query: 926 LHEVMHVFYVAMLCVEEQAVERP 948
+ + C+ + +RP
Sbjct: 223 QMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 75/284 (26%), Positives = 130/284 (45%), Gaps = 41/284 (14%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR 742
L LKE +G G G+V+ G VA+K + G+ + F E + + ++ H
Sbjct: 6 LTFLKE---LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHP 59
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
++V+L G C+ +V EYM NG L L +K G L + + + + + YL
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES 118
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF-LQDSGTSECMSAIAGSYG------Y 855
+ +HRD+ + N L+ V+DFGLA++ L D TS S G +
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS--------SQGTKFPVKW 167
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914
PE + KSDV+SFGV++ E+ + G+ P F + ++ +S G
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAG-Y 218
Query: 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
++ P+L ++ +M+ C E+ +RP ++++ LT
Sbjct: 219 RLYRPKLAPTEVYTIMY------SCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 84/284 (29%), Positives = 137/284 (48%), Gaps = 42/284 (14%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKR--LPAMSRGSSHD------HGFNAEIQTLGRIRH 741
+IGKG G VY L + G+ +AVK+ LPA G +EI+TL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+IV+ LGF + E + EY+P GS+G L + G + +GL YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-- 859
S I+HRD+K++N+L+D+ ++DFG++K D ++ ++ GS ++APE
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 860 ----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
Y+ KV D++S G V+LE+ GR+P + + + + K+ + +
Sbjct: 183 HSYSQGYSAKV----DIWSLGCVVLEMFAGRRPWSD----EEAIAAMFKLGNKRSA---- 230
Query: 916 ILDPRLPSVPLHEVMHVFYVAM----LCVEEQAVERPTMREVVQ 955
P +P M++ VA+ C RPT RE++Q
Sbjct: 231 ------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 86/295 (29%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 686 LKEDNIIGKGGAGIVYKGL-MPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
L++ ++G G G VYKG+ +P G++ VA+K L + + E + +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVD 67
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG-----HLHWDTRYKIAVEAAK 795
H H+VRLLG C + L+ + MP G L + + K L+W V+ AK
Sbjct: 68 HPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAK 120
Query: 796 GLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY 853
G+ YL +VHRD+ + N+L+ + + DFGLAK L D E A G
Sbjct: 121 GMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLL-DVDEKE-YHAEGGKV 173
Query: 854 --GYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
++A E KSDV+S+GV + EL+T G KP E V+I + K
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY-EGIPAVEIPDLLEK------ 226
Query: 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT 965
RLP P+ + V+ V + C A RPT +E++ +++ + P
Sbjct: 227 -------GERLPQPPICTI-DVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 84/269 (31%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
+G+G G V+ G +VA+K L G+ F E Q + ++RH +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
S E +V EYM GSL + L G+ G +L +A + A G+ Y+ VHR
Sbjct: 71 S-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 871
D+++ NIL+ VADFGLA+ ++D+ + A + APE A + KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 185
Query: 872 VYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVM 930
V+SFG++L EL T GR P + R++ D + G P P LH++M
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCPPECPE-SLHDLM 236
Query: 931 HVFYVAMLCVEEQAVERPTMREVVQILTE 959
C ++ ERPT E +Q E
Sbjct: 237 ------CQCWRKEPEERPTF-EYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 85/277 (30%), Positives = 131/277 (47%), Gaps = 30/277 (10%)
Query: 692 IGKGGAGIVYKG--LMPNGDQ--VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+G G G V KG LM +G + VAVK L + F E + ++ H IVRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE-FLREASVMAQLDHPCIVRL 61
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+G C E +LV E P G L + L KK + ++A + A G+ YL S
Sbjct: 62 IGVCKG-EPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLE---SKH 115
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY--GYIAPEYAYTLK 865
VHRD+ + N+LL + +A ++DFG+++ L +G+ + AG + + APE K
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALG-AGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 866 VDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924
KSDV+S+GV L E + G KP GE G +++ M +S + RLP
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVI----AMLESGE---------RLPR- 219
Query: 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961
P ++ + + C + + +RPT E+ P
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 69/260 (26%), Positives = 125/260 (48%), Gaps = 26/260 (10%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
IG G G+V+ G +VA+K + G+ + F E Q + ++ H +V+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIK---TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
+ LV+E+M +G L + L ++ G +T + ++ +G+ YL ++HR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 812 DVKSNNILLDSGFEAHVADFGLAKF-LQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS 870
D+ + N L+ V+DFG+ +F L D TS + + +PE K KS
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS--SPEVFSFSKYSSKS 182
Query: 871 DVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEV 929
DV+SFGV++ E+ + G+ P + ++V+ + ++ PRL S ++E+
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNS-EVVETI--------NAGFRLYKPRLASQSVYEL 233
Query: 930 MHVFYVAMLCVEEQAVERPT 949
M C +E+ +RP+
Sbjct: 234 MQ------HCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 687 KEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+ +IG G +VY + +PN ++VA+KR+ +S D E+Q + + H ++V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHPNVV 62
Query: 746 RLLGFCSNHETNLL--VYEYMPNGSLGEVL-HGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
+ + S + L V Y+ GSL +++ G L + E KGL YLH
Sbjct: 63 KY--YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH- 119
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS--AIAGSYGYIAPEY 860
S +HRD+K+ NILL +ADFG++ L D G G+ ++APE
Sbjct: 120 --SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 861 AYTLK-VDEKSDVYSFGVVLLELITGRKP 888
+ D K+D++SFG+ +EL TG P
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 82/284 (28%), Positives = 117/284 (41%), Gaps = 42/284 (14%)
Query: 692 IGKGGAGIVYKG--LMPNGD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+G G G+V +G G VAVK L + D F E + + H +++RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLIRL 61
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
G H ++V E P GSL + L GH T AV+ A G+ YL S
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA-----IAGSYGYIAPEYAY 862
+HRD+ + NILL S + + DFGL + L + M A + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAPESLR 173
Query: 863 TLKVDEKSDVYSFGVVLLELIT-GRKP-VGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920
T SDV+ FGV L E+ T G +P G G I+ K D + E + R
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQIL----KKIDKEGERL-----ER 222
Query: 921 LPSVP--LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
+ P ++ VM + C +RPT + LP+
Sbjct: 223 PEACPQDIYNVM------LQCWAHNPADRPTF---AALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 96/317 (30%), Positives = 152/317 (47%), Gaps = 48/317 (15%)
Query: 686 LKEDNIIGKGGAGIVYKGL-MPNGDQVAVK---RLPAMSRGSSHDHGFNAEIQTLGRIRH 741
LK ++G G G VYKG+ +P G+ V + ++ + G + F E + + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK---GGHL--HWDTRYKIAVEAAKG 796
H+VRLLG C + T LV + MP+G L + +H K G L +W V+ AKG
Sbjct: 69 PHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKG 121
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY--G 854
+ YL +VHRD+ + N+L+ S + DFGLA+ L+ G + +A G
Sbjct: 122 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIK 176
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913
++A E + K +SDV+S+GV + EL+T G KP DG+ R++ D ++G
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY----DGIP----TREIPDLLEKG- 227
Query: 914 LKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSK---QGE 970
RLP P+ + V+ V + C A RP +E+ + + + P QG+
Sbjct: 228 -----ERLPQPPICTI-DVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGD 281
Query: 971 ESLPPSGTTSLDSPNAS 987
+ + L SPN S
Sbjct: 282 DRM------KLPSPNDS 292
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 82/274 (29%), Positives = 125/274 (45%), Gaps = 37/274 (13%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSS---HDHGFNAEIQTLGRIRHRHIVRL 747
+G G G VY+GL + +GD AVK + G + EI L +++H +IV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 748 LGFCSNHETNLLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
LG E NL ++ E +P GSL ++L KK G + GL YLH
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLH---DR 121
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY-----A 861
VHRD+K NIL+D+ +ADFG+AK + + + GS ++APE
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGG 178
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
Y L D++S G +LE+ TG+ P + + V V K+ SK+ L
Sbjct: 179 YGLAA----DIWSLGCTVLEMATGKPPWSQL----EGVAAVFKIGRSKE----------L 220
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
P +P H + C++ RPT E+++
Sbjct: 221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 89/288 (30%), Positives = 124/288 (43%), Gaps = 55/288 (19%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQT------ 735
L+ L E +G G +G+V K L P G +AVK + N IQ
Sbjct: 3 LEYLGE---LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---------NEAIQKQILREL 50
Query: 736 --LGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--KIAV 791
L + +IV G N+ + EYM GSL ++L +G R KIAV
Sbjct: 51 DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR---IPERILGKIAV 107
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
KGL YLH I+HRDVK +NIL++S + + DFG++ L +S G
Sbjct: 108 AVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVG 161
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911
+ Y+APE KSD++S G+ L+EL TGR P D D
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-------------- 207
Query: 912 GVLKILD-------PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMRE 952
G+ ++L PRLPS F LC+ + ERP+ +E
Sbjct: 208 GIFELLQYIVNEPPPRLPSGKFSPDFQDF--VNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 82/271 (30%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA---EIQTLGRIRHRHIVR 746
++G+G G VY + G ++AVK++P NA EIQ L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
G + ET + EYMP GS+ + L K G L K + +G+ YLH S
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLH---SN 123
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD---SGTSECMSAIAGSYGYIAPEYAYT 863
+IVHRD+K NIL DS + DFG +K LQ SGT M ++ G+ +++PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG--MKSVTGTPYWMSPEVISG 181
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
K+DV+S G ++E++T + P EF I + + T+ P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--------------PQ 227
Query: 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954
+P H E A +RP+ E++
Sbjct: 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 74/269 (27%), Positives = 131/269 (48%), Gaps = 26/269 (9%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
+G G G+V+ G +VA+K A++ G+ + F E + + ++ H +V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIK---AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
+ + +V E+M NG L L ++ G L D + + +G+ YL + +HR
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 812 DVKSNNILLDSGFEAHVADFGLAKF-LQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS 870
D+ + N L+ S V+DFG+ ++ L D TS + + PE K KS
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS--PPEVFNFSKYSSKS 182
Query: 871 DVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEV 929
DV+SFGV++ E+ T G+ P E ++V+ + + ++ P+L S+ ++EV
Sbjct: 183 DVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRGF--------RLYRPKLASMTVYEV 233
Query: 930 MHVFYVAMLCVEEQAVERPTMREVVQILT 958
M C E+ RPT E+++ +T
Sbjct: 234 M------YSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 24/215 (11%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
++GKG GIVY + ++A+K +P R S + + EI ++HR+IV+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGG-HLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
S + + E +P GSL +L K G + T + +GL YLH + I
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QI 129
Query: 809 VHRDVKSNNILLD--SGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
VHRD+K +N+L++ SG ++DFG +K L +G + C G+ Y+APE +
Sbjct: 130 VHRDIKGDNVLVNTYSGV-VKISDFGTSKRL--AGINPCTETFTGTLQYMAPEV-----I 181
Query: 867 DE-------KSDVYSFGVVLLELITGRKPVGEFGD 894
D+ +D++S G ++E+ TG+ P E G+
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 69/229 (30%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 683 LDCLKEDNIIGKGGAGIVYKG----LMPNGD--QVAVKRLPAMSRGSSHDHGFNAEIQTL 736
D + +G+G G V+ G L P D VAVK L + + F E + L
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELL 62
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--HG----------KKGGHLHWD 784
+H +IV+ G C+ + ++V+EYM +G L + L HG G L
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
+IAV+ A G+ YL S VHRD+ + N L+ + DFG+++ D T++
Sbjct: 123 QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTD 176
Query: 845 CMSAIAGS----YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKP 888
+ G ++ PE K +SDV+SFGVVL E+ T G++P
Sbjct: 177 -YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 83/289 (28%), Positives = 140/289 (48%), Gaps = 40/289 (13%)
Query: 685 CLKEDNIIGKGGAGIVYKGL--MPNGDQ--VAVKRL-PAMSRGSSHDHGFNAEIQTLGRI 739
+ + +IG G G V++G+ MP + VA+K L P + D F +E +G+
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD--FLSEASIMGQF 63
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA---VEAAKG 796
H +I+RL G + + +++ EYM NG+L + L G + Y++ A G
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEF----SSYQLVGMLRGIAAG 119
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS---Y 853
+ YL D + VHRD+ + NIL++S E V+DFGL++ L+D E +G
Sbjct: 120 MKYLS-DMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD--PEGTYTTSGGKIPI 174
Query: 854 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913
+ APE K SDV+SFG+V+ E+++ FG+ R D V
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS-------FGE--------RPYWDMSNHEV 219
Query: 914 LKILDP--RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+K ++ RLP+ P+ V+ + + C ++ RP ++V +L +L
Sbjct: 220 MKAINDGFRLPA-PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 83/269 (30%), Positives = 129/269 (47%), Gaps = 25/269 (9%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
+G G G V+ G +VAVK L G+ F E Q + ++RH +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP---GTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
S E +V EYM GSL + L +G L +A + A G+ Y+ +HR
Sbjct: 71 S-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 871
D++S NIL+ G +ADFGLA+ ++D+ + A + APE A + KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 185
Query: 872 VYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVM 930
V+SFG++L EL+T GR P + R++ + + G ++ P+ + LHE+M
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERG-YRMPCPQDCPISLHELM 236
Query: 931 HVFYVAMLCVEEQAVERPTMREVVQILTE 959
+ C ++ ERPT E +Q E
Sbjct: 237 ------LQCWKKDPEERPTF-EYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 13/210 (6%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAM-SRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
N IG G G VY + + G+ +AVK + + + E++ L ++H ++V+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVKY 64
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
G + E + EY G+L E+L + H Y ++ +GL YLH S
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLH---SHG 119
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS--ECMSAIAGSYGYIAPEYAYTLK 865
IVHRD+K NI LD + DFG A L+++ T+ E + ++AG+ Y+APE K
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 866 VDEK---SDVYSFGVVLLELITGRKPVGEF 892
+D++S G V+LE+ TG++P E
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 82/287 (28%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ LK +G G G V+ G +VA+K ++ +GS F AE + +++H
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIK---SLKQGSMSPEAFLAEANLMKQLQHPR 62
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+VRL + E ++ EYM NGSL + L +G L + +A + A+G+ ++
Sbjct: 63 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS---YGYIAPEY 860
+HRD+++ NIL+ +ADFGLA+ ++D+ +A G+ + APE
Sbjct: 122 NY---IHRDLRAANILVSETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPEA 174
Query: 861 AYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD- 918
KSDV+SFG++L E++T GR P MT+ + V++ L+
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIP-------------YPGMTNPE---VIQNLER 218
Query: 919 ----PRLPSVP--LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
PR + P L+E+M LC +E+ ERPT + +L +
Sbjct: 219 GYRMPRPDNCPEELYELM------RLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKR----LPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
IGKG G VYKG++ +VAVK LP + F E + L + H +IV+L
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVKL 57
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+G C + +V E +P GSL L KK L +++++AA G+ YL
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNC-- 114
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-----APEYAY 862
+HRD+ + N L+ ++DFG+++ ++ G + ++ I APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR-EEEGG----IYTVSDGLKQIPIKWTAPEALN 168
Query: 863 TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922
+ +SDV+S+G++L E + GD + T + E ++ P+L
Sbjct: 169 YGRYTSESDVWSYGILLWETFS-------LGDT-PYPGMSNQQTRERIESGYRMPAPQLC 220
Query: 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
++ +M + C RP+ E+ L
Sbjct: 221 PEEIYRLM------LQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 92/284 (32%), Positives = 122/284 (42%), Gaps = 29/284 (10%)
Query: 686 LKEDNIIGKGGAGIV----YKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
LK +GKG G V Y L N G+ VAVK+L + H F EI+ L ++
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQ 63
Query: 741 HRHIVRLLGFC-SNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
H +IV+ G C S NL LV EY+P GSL + L K L A + KG+
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGME 122
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL-QDSGTSECMSAIAGSYGYIA 857
YL S VHRD+ + NIL++S + DFGL K L QD + + A
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELIT----GRKPVGEF----GDGVDIVQWVRKMTDSK 909
PE K SDV+SFGVVL EL T P EF G+ V + +
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239
Query: 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREV 953
K RLP P ++ + C +RP+ E+
Sbjct: 240 KNN------GRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 37/290 (12%)
Query: 686 LKEDNIIGKGGAGIVYKGL-MPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
L++ ++G G G V+KG+ +P GD VA+K + S G + +G +
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLD 67
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG-----HLHWDTRYKIAVEAAK 795
H +IVRLLG C L V + P GSL + + + L+W V+ AK
Sbjct: 68 HAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAK 120
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 855
G+ YL +VHR++ + NILL S +ADFG+A L S +
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914
+A E + +SDV+S+GV + E+++ G +P ++ D ++G
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--------PHEVPDLLEKGE- 228
Query: 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
++ P++ ++ ++ VM V ++E RPT +E+ T + + P
Sbjct: 229 RLAQPQICTIDVYMVM----VKCWMIDENV--RPTFKELANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 31/274 (11%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
+G G G V+ G N +VAVK L G+ F E + ++H +VRL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
+ E ++ EYM GSL + L +GG + + + A+G+ Y+ +HR
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHR 127
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 871
D+++ N+L+ +ADFGLA+ ++D+ + A + APE KSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTIKSD 186
Query: 872 VYSFGVVLLELITGRK---PVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP--L 926
V+SFG++L E++T K P D + +Q +M PR+ + P L
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------PRMENCPDEL 233
Query: 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+++M C +E+A ERPT + +L +
Sbjct: 234 YDIMK------TCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 78/306 (25%), Positives = 123/306 (40%), Gaps = 67/306 (21%)
Query: 686 LKEDNI-----IGKGGAGIVYKGL---MPNGD---QVAVKRLPAMSRGSSHDH-GFNAEI 733
L + I +G+G G+VY+GL + G+ +VA+K + S + F E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE--NASMRERIEFLNEA 60
Query: 734 QTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK--------GGHLHWDT 785
+ H+VRLLG S + L+V E M G L L ++ G
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 786 RYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---- 841
++A E A G+ YL + VHRD+ + N ++ + DFG+ + + ++
Sbjct: 121 FIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKP--------VGEF 892
+ + + ++APE KSDV+SFGVVL E+ T +P V +F
Sbjct: 178 GGKGLLPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233
Query: 893 -GDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMR 951
DG G L + P L E+M +C + RPT
Sbjct: 234 VIDG----------------GHLDL--PENCPDKLLELM------RMCWQYNPKMRPTFL 269
Query: 952 EVVQIL 957
E+V L
Sbjct: 270 EIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-21
Identities = 80/279 (28%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 687 KEDNIIGKGGAGIVYKGL-MPNGDQVAVKRL---PAMSRGSSHDHGFNAEIQTLGRIRHR 742
+ ++G+G G VY + G ++A K++ P S EIQ L ++H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 743 HIVRLLGFCSNH-ETNLLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
IV+ G + E L ++ EYMP GS+ + L K G L K + +G+ YL
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYL 122
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD---SGTSECMSAIAGSYGYIA 857
H S +IVHRD+K NIL DS + DFG +K LQ SGT + ++ G+ +++
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG--IRSVTGTPYWMS 177
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI- 916
PE K+DV+S G ++E++T + P E+ + KI
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY---------------EAMAAIFKIA 222
Query: 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
P P +P H H + C+ +A RP+ E+++
Sbjct: 223 TQPTNPQLPSHISEHARDF-LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRL---PAMSRGSSHDH-GFNAEIQTLGRIRHRHIV 745
++GKG G VY GL G +AVK++ + + ++ E+ L ++H +IV
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
+ LG C + T + E++P GS+ +L + G L K + G+ YLH++C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNC- 122
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT----SECMSAIAGSYGYIAPEYA 861
+VHRD+K NN++L + DFG A+ L G S + ++ G+ ++APE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKP 888
KSD++S G + E+ TG+ P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 23/229 (10%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYKIA 790
EI+ + R+ H HI+R+LG + +++ ++ E+M GS+ +L K G
Sbjct: 53 EIRLMARLNHPHIIRMLG-ATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYT 109
Query: 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFL--QDSGTSECMS 847
+ +GL YLH + I+HRDVK N+L+DS G +ADFG A L + +G E
Sbjct: 110 EQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166
Query: 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD 907
+ G+ ++APE + DV+S G V++E+ T + P W +
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP------------WNAEKHS 214
Query: 908 SKKEGVLKILDPR-LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+ + KI PS+P H + V + C+E Q +RP RE+++
Sbjct: 215 NHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 80/255 (31%), Positives = 123/255 (48%), Gaps = 16/255 (6%)
Query: 708 GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN--LLVYEYMP 765
G+QVAVK L S G+ H EI+ L + H +IV+ G C+ N L+ E++P
Sbjct: 33 GEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE 825
+GSL E L K ++ + K AV+ KG+ YL S VHRD+ + N+L++S +
Sbjct: 92 SGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 147
Query: 826 AHVADFGLAKFLQ-DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 884
+ DFGL K ++ D + + APE K SDV+SFGV L EL+T
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
Query: 885 ----GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCV 940
P+ F + +MT ++ VL+ RLP P + V+ + C
Sbjct: 208 YCDSESSPMTLFLKMIGPTH--GQMTVTRLVRVLE-EGKRLP-RPPNCPEEVYQLMRKCW 263
Query: 941 EEQAVERPTMREVVQ 955
E Q +R T + +++
Sbjct: 264 EFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 9e-21
Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 31/275 (11%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR 742
L LKE +G G G+V G VA+K + GS + F E + + ++ H
Sbjct: 6 LTFLKE---LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
+V+L G C+ +V EYM NG L L + G ++ + +G+ YL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLE- 117
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY--GYIAPEY 860
S +HRD+ + N L+D V+DFGL++++ D E S++ + + PE
Sbjct: 118 --SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEV 172
Query: 861 AYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
K KSDV++FGV++ E+ + G+ P F + + + +G L++ P
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQG-LRLYRP 223
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954
L S ++ +M+ C E+A ERPT ++++
Sbjct: 224 HLASEKVYAIMYS------CWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 82/277 (29%), Positives = 131/277 (47%), Gaps = 25/277 (9%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ L+ D +G+G G V+ G +VA+K L G+ F E Q + ++RH
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKKLRHDK 62
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+V L S E +V E+M GSL + L G +L +A + A G+ Y+
Sbjct: 63 LVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
+HRD+++ NIL+ +ADFGLA+ ++D+ + A + APE A
Sbjct: 122 N---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALY 177
Query: 864 LKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922
+ KSDV+SFG++L EL+T GR P + R++ + + G ++ P+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVERG-YRMPCPQGC 228
Query: 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
LHE+M LC ++ ERPT E +Q E
Sbjct: 229 PESLHELMK------LCWKKDPDERPTF-EYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 692 IGKGGAGIVY----KGLMPNGDQ--VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G+G G V+ L+P D+ VAVK L S + D F E + L ++H+HIV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVL--HGKKG-----------GHLHWDTRYKIAVE 792
R G C+ L+V+EYM +G L L HG G L IA +
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS 852
A G+ YL S VHRD+ + N L+ G + DFG+++ + +
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 853 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKP 888
++ PE K +SD++SFGVVL E+ T G++P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLP---AMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
++G+G G VY G ++AVK++P S + EIQ L +RH IV+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 747 LLGFCSNHETNLL--VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
G + E L EYMP GS+ + L K G L + + + +G+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYLH--- 123
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD---SGTSECMSAIAGSYGYIAPEYA 861
S +IVHRD+K NIL DS + DFG +K +Q SGT + ++ G+ +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG--IKSVTGTPYWMSPEVI 181
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEF 892
K+DV+S ++E++T + P E+
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 42/217 (19%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHI 744
IG+G G VYK G+ VA+K++ R + GF EI+ L ++RH +I
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 745 VRLLGFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK------- 795
VRL ++ +V+EYM + L G L K K
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHD-----LTG-----LLDSPEVKFTESQIKCYMKQLL 110
Query: 796 -GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG 854
GL YLH + I+HRD+K +NIL+++ +ADFGLA+ +++ + + +
Sbjct: 111 EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW- 166
Query: 855 YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 886
Y PE Y +V D++S G +L EL G+
Sbjct: 167 YRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 81/273 (29%), Positives = 123/273 (45%), Gaps = 50/273 (18%)
Query: 707 NGDQVA-VKRLPA---MSRGSSHDHGFNA-------EIQTLGRIRHRHIVRLLGFCSNHE 755
NG V+ VK +P M++ H ++ E+Q + R +IV G N
Sbjct: 17 NGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN 76
Query: 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL---HHDCSPLIVHRD 812
+ E+M GSL + KKGG + + KIAV +GL YL H I+HRD
Sbjct: 77 NICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNVHR-----IMHRD 129
Query: 813 VKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIA----GSYGYIAPEYAYTLKVDE 868
+K +NIL++S + + DFG+ SG E +++IA G+ Y++PE K
Sbjct: 130 IKPSNILVNSRGQIKLCDFGV------SG--ELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 869 KSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD-------PRL 921
KSDV+S G+ ++EL G+ P D G+L +L PRL
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDD--------GQDDPMGILDLLQQIVQEPPPRL 233
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954
PS E + F C+ + ERPT +++
Sbjct: 234 PSSDFPEDLRDF--VDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 16/211 (7%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRL---PAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
++G+G G VY G ++AVK++ P S + EIQ L + H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 747 LLGFCSN-HETNLLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
G + E L ++ E+MP GS+ + L K G L + K + +G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYLH--- 123
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD---SGTSECMSAIAGSYGYIAPEYA 861
S +IVHRD+K NIL DS + DFG +K LQ SGT M ++ G+ +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG--MKSVTGTPYWMSPEVI 181
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEF 892
K+D++S G ++E++T + P EF
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-20
Identities = 91/320 (28%), Positives = 146/320 (45%), Gaps = 50/320 (15%)
Query: 686 LKEDNIIGKGGAGIVYKGL-MPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
K+ ++G G G VYKGL +P G++ VA+K L + ++ + E + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVD 67
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK---GGH--LHWDTRYKIAVEAAK 795
+ H+ RLLG C T L+ + MP G L + + K G L+W V+ AK
Sbjct: 68 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY-- 853
G+ YL +VHRD+ + N+L+ + + DFGLAK L + A G
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVPI 175
Query: 854 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
++A E +SDV+S+GV + EL+T G KP DG+ S+
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGIPA---------SEISS 222
Query: 913 VLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSK---QG 969
+L+ + RLP P+ + V+ + + C A RP RE++ +++ + P QG
Sbjct: 223 ILEKGE-RLPQPPICTI-DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 280
Query: 970 EESLPPSGTTSLDSPNASNK 989
+E + L SP SN
Sbjct: 281 DERM------HLPSPTDSNF 294
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+G+G G VYK + G VA+K +P + EI L + +IV+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQE--IIKEISILKQCDSPYIVKYYG 65
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLH--GKKGGHLHWDTRYKIAV---EAAKGLCYLHHDC 804
+ +V EY GS+ +++ K L T +IA + KGL YLH
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKT---L---TEEEIAAILYQTLKGLEYLH--- 116
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
S +HRD+K+ NILL+ +A +ADFG++ L D+ + + G+ ++APE +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEI 174
Query: 865 KVDEKSDVYSFGVVLLELITGRKPVGEF 892
+ K+D++S G+ +E+ G+ P +
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 83/272 (30%), Positives = 121/272 (44%), Gaps = 26/272 (9%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+IGKG G VY G + + D AVK L ++ + F E + H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 746 RLLGFCSNHE-TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
LLG C E + L+V YM +G L + + D ++ AKG+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-IGFGLQVAKGMEYL---A 115
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY--GYIAPEYAY 862
S VHRD+ + N +LD F VADFGLA+ + D + ++A E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 863 TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922
T K KSDV+SFGV+L EL+T P D DI ++ + ++L P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--------RLLQPEYC 227
Query: 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954
PL+EVM + C + RPT E+V
Sbjct: 228 PDPLYEVM------LSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 76/279 (27%), Positives = 113/279 (40%), Gaps = 57/279 (20%)
Query: 709 DQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767
VAVK L P S + D F E++ L R+ +I RLLG C+ ++ EYM NG
Sbjct: 47 VLVAVKVLRPDASDNARED--FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 768 SLGEVL-----------HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSN 816
L + L K L + T +A + A G+ YL S VHRD+ +
Sbjct: 105 DLNQFLQKHVAETSGLACNSKS--LSFSTLLYMATQIASGMRYLE---SLNFVHRDLATR 159
Query: 817 NILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-----------APEYAYTLK 865
N L+ + +ADFG+ + + Y + A E K
Sbjct: 160 NCLVGKNYTIKIADFGM-----------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208
Query: 866 VDEKSDVYSFGVVLLELIT--GRKPVGEFGDGVDIVQWV-RKMTDSKKEGVLKILDPRLP 922
KSDV++FGV L E++T +P D Q V ++ +I PR P
Sbjct: 209 FTTKSDVWAFGVTLWEILTLCREQPYEHLTD-----QQVIENAGHFFRDDGRQIYLPRPP 263
Query: 923 SVP--LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
+ P ++E+M + C +RPT RE+ L
Sbjct: 264 NCPKDIYELM------LECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 38/289 (13%)
Query: 685 CLKEDNIIGKGGAGIVYKG-LMPNGDQ---VAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
C+K + +IG G G V +G L G + VA+K L + F +E +G+
Sbjct: 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFD 63
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
H +I+ L G + +++ E+M NG+L L + G + A G+ YL
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC-MSAIAGSYG--YIA 857
+ + VHRD+ + NIL++S V+DFGL++FL+D + S++ G + A
Sbjct: 123 S-EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
PE K SDV+S+G+V+ E+++ G +P + + D++ + +
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAIEQ------------ 226
Query: 917 LDPRLPSVP-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
D RLP LH++M + C ++ RP ++V L ++
Sbjct: 227 -DYRLPPPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 9e-20
Identities = 89/298 (29%), Positives = 136/298 (45%), Gaps = 45/298 (15%)
Query: 686 LKEDNIIGKGGAG--IVYKGLMPN---GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
LK+ ++G+G G +Y N G+ VAVK L G + G+ EI L +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNTSGWKKEINILKTLY 64
Query: 741 HRHIVRLLGFCSNH--ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
H +IV+ G CS + L+ EY+P GSL + L K L+ A + +G+
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMA 121
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL---------QDSGTSECMSAI 849
YLH S +HRD+ + N+LLD+ + DFGLAK + ++ G S
Sbjct: 122 YLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF--- 175
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT----GRKPVGEFGDGVDIVQW---V 902
+ A E K SDV+SFGV L EL+T + P +F + + Q V
Sbjct: 176 -----WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++ + + G+ RLP P + V+ + C E +A RPT R ++ IL E+
Sbjct: 231 VRLIELLERGM------RLPC-PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 9e-20
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQV-AVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR 742
+ + E + +G+G G V K + N + A+K + E++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSP 59
Query: 743 HIVRLLG-FCSNHETNL-LVYEYMPNGSL----GEVLHGKKGGHLHWDTRYKIAVEAAKG 796
+IV+ G F +++ + EY GSL +V K+GG + KIA KG
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK--KRGGRIGEKVLGKIAESVLKG 117
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
L YLH S I+HRD+K +NILL + + DFG++ L S + S+ Y+
Sbjct: 118 LSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL---VNSLAGTFTGTSF-YM 170
Query: 857 APEY----AYTLKVDEKSDVYSFGVVLLELITGRKP 888
APE Y++ SDV+S G+ LLE+ R P
Sbjct: 171 APERIQGKPYSI----TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 9e-20
Identities = 86/291 (29%), Positives = 135/291 (46%), Gaps = 44/291 (15%)
Query: 685 CLKEDNIIGKGGAGIVYKGLM--PNGDQ--VAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
C+K + +IG G G V G + P + VA+K L A F +E +G+
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA-GYTEKQRRDFLSEASIMGQFD 63
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
H +I+ L G + + ++V EYM NGSL L K G + A G+ YL
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI---- 856
D VHRD+ + NIL++S V+DFGL++ L+D +A G I
Sbjct: 123 S-DMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE----AAYTTRGGKIPIRW 175
Query: 857 -APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914
APE K SDV+S+G+V+ E+++ G +P E + D+++ + +EG
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAI-------EEGY- 226
Query: 915 KILDPRLPS-----VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
RLP+ LH++M + C ++ ERP ++V IL +L
Sbjct: 227 -----RLPAPMDCPAALHQLM------LDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 30/276 (10%)
Query: 690 NIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+ +G G G VY+G+ VAVK + + F E + I+H ++V+LL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
G C+ ++ E+M G+L + L ++ +A + + + YL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS---YGYIAPEYAYTLK 865
+HRD+ + N L+ VADFGL++ + + +A AG+ + APE K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 866 VDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924
KSDV++FGV+L E+ T G P G+D+ Q + E ++ P
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQVYELL-----EKGYRMERPEGCPP 232
Query: 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++E+M C + +RP+ E+ Q +
Sbjct: 233 KVYELMRA------CWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G +G VYK G +VA+K+ M + EI + +H +IV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKK---MRLRKQNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 751 CSNHETN---LLVYEYMPNGSLGEVLHGKKG----GHLHWDTRYKIAVEAAKGLCYLHHD 803
++ +V EYM GSL +++ + + + E +GL YLH
Sbjct: 83 --SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLEYLH-- 133
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL---QDSGTSECMSAIAGSYGYIAPEY 860
S ++HRD+KS+NILL +ADFG A L + S + G+ ++APE
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-----VVGTPYWMAPEV 187
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP 888
K D++S G++ +E+ G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 77/293 (26%), Positives = 135/293 (46%), Gaps = 43/293 (14%)
Query: 692 IGKGGAGIVY----KGLMPNGDQ--VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G+G G V+ L P D+ VAVK L + + D F E + L ++H HIV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIV 70
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVL--HG------------KKGGHLHWDTRYKIAV 791
+ G C + + ++V+EYM +G L + L HG + G L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ A G+ YL S VHRD+ + N L+ + + DFG+++ + +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
++ PE K +SDV+SFGV+L E+ T G++P + + I +
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI--------ECIT 239
Query: 911 EGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
+G ++L+ PR+ ++++M + C + + +R ++E+ +IL L K
Sbjct: 240 QG--RVLERPRVCPKEVYDIM------LGCWQREPQQRLNIKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 67/211 (31%), Positives = 112/211 (53%), Gaps = 19/211 (9%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKR--LPAMS-----RGSSHDHGFNAEIQTLGRIRHR 742
+IG G G VY G+ +G+ +AVK+ LP++S R S EI L ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 743 HIVRLLGFCSNHETNLLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+IV+ LG S +L ++ EY+P GS+ +L+ G + KGL YLH
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLH 123
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ----DSGTSECMSAIAGSYGYIA 857
+ I+HRD+K NIL+D+ ++DFG++K L+ + T+ ++ GS ++A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
PE K+D++S G +++E++TG+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 66/218 (30%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 692 IGKGGAGIVY---KGLMPNGDQVAVKRLPAMS-RGSSHDHGFNAEIQTLGRIRHRHIVRL 747
I KG G V+ K GD A+K + + E L + + ++V+L
Sbjct: 1 ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 748 LGFCS-NHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
+ S + NL LV EY+P G L +L G L D E L YLH S
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLH---S 111
Query: 806 PLIVHRDVKSNNILLDSGFEAHV--ADFGLAKF-------LQDSGTSECMSAIAGSYGYI 856
I+HRD+K +NIL+DS H+ DFGL+K + E I G+ YI
Sbjct: 112 NGIIHRDLKPDNILIDS--NGHLKLTDFGLSKVGLVRRQINLNDDEKED-KRIVGTPDYI 168
Query: 857 APE------YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
APE ++ T D +S G +L E + G P
Sbjct: 169 APEVILGQGHSKT------VDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 55/160 (34%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 732 EIQTLGRIRHRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA 790
E++ L +IV G F S+ E ++ + E+M GSL +VL KK G + + KI+
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KKAGRIPENILGKIS 105
Query: 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS-AI 849
+ +GL YL I+HRDVK +NIL++S E + DFG++ L DS M+ +
Sbjct: 106 IAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSF 158
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPV 889
G+ Y++PE +SD++S G+ L+E+ GR P+
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G GIV+K G+ VA+K++ + EI+ L +H ++V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK--------GLCYLH 801
H + LV EYMP L EVL D + K G+ Y+H
Sbjct: 68 -FPHGSGFVLVMEYMP-SDLSEVLR---------DEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
+ I+HRD+K N+L+ + +ADFGLA+ L S + Y APE
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELL 172
Query: 862 Y-TLKVDEKSDVYSFGVVLLELITGR 886
Y K D D+++ G + EL+ G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 65/236 (27%), Positives = 108/236 (45%), Gaps = 30/236 (12%)
Query: 692 IGKGGAGIVYKG--LMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G+G G VYKG PN VA+K L + F E + + ++H +IV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAELMSDLQHPNIV 71
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVL-------------HGKKGGH-LHWDTRYKIAV 791
LLG C+ + +++EY+ +G L E L + L IA+
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 792 EAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
+ A G+ YL HH VHRD+ + N L+ G ++DFGL++ + + S
Sbjct: 132 QIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRK 904
++ PE K +SD++SFGVVL E+ + G +P F + ++++ +R
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EVIEMIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 692 IGKGGAGIVYKGLMPNGDQV-AVKRLPAMSRGSSHDHG----FNAEIQTLGRIRHRHIVR 746
+GKG G V + ++ A+K + + E L RI H IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMK---VLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 747 LLGFCSNH-ETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH-HD 803
L + E L LV EY P G L L K+G R+ A E L YLH
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEERARF-YAAEIVLALEYLHSLG 113
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
I++RD+K NILLD+ + H+ DFGLAK + S + G+ Y+APE
Sbjct: 114 ----IIYRDLKPENILLDA--DGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVL 165
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKP 888
+ D +S GV+L E++TG+ P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIV 745
+G+G G+VYK G+ VA+K++ R + + G + EI L ++H +IV
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI----RLDNEEEGIPSTALREISLLKELKHPNIV 61
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
+LL LV+EY L + L K+ G L + I + +GL Y H S
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCH---S 116
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ---DSGTSECMSAIAGSYGYIAPE--- 859
I+HRD+K NIL++ +ADFGLA+ + T E + + Y APE
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAPEILL 171
Query: 860 --YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y+ V D++S G + E+ITG+
Sbjct: 172 GSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 37/291 (12%)
Query: 686 LKEDNIIGKGGAGIVYKGL-MPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
LK+ ++G G G VYKG+ +P+G+ VA+K L + ++ + E + +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVG 67
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG-----GHLHWDTRYKIAVEAAK 795
++ RLLG C T LV + MP G L + + K L+W V+ AK
Sbjct: 68 SPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAK 120
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 855
G+ YL +VHRD+ + N+L+ S + DFGLA+ L T +
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914
+A E + +SDV+S+GV + EL+T G KP DG+ R++ D ++G
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY----DGIP----AREIPDLLEKG-- 227
Query: 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT 965
RLP P+ + V+ + + C + RP RE+V + + + P+
Sbjct: 228 ----ERLPQPPICTI-DVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNA-EIQTLGRIRHRHIVRLLG 749
+G+G G+V K G+ VA+K+ S E++ L ++RH +IV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKE-SEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH-HDCSPLI 808
LV+EY+ +L E+L GG L D + + + Y H H+ I
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGG-LPPDAVRSYIWQLLQAIAYCHSHN----I 121
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
+HRD+K NIL+ + DFG A+ L+ S +A + Y APE L V +
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW-YRAPE----LLVGD 176
Query: 869 KS-----DVYSFGVVLLELITGR 886
+ DV++ G ++ EL+ G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
LK IGKG G V G G++VAVK + + + F AE + ++RH ++V
Sbjct: 8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 746 RLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
+LLG + L +V EYM GSL + L + L D K +++ + + YL +
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAK---FLQDSGTSECMSAIAGSYGYIAPEYA 861
VHRD+ + N+L+ A V+DFGL K QD+G + APE
Sbjct: 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPEAL 171
Query: 862 YTLKVDEKSDVYSFGVVLLELIT-GRKP 888
K KSDV+SFG++L E+ + GR P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 58/207 (28%), Positives = 84/207 (40%), Gaps = 22/207 (10%)
Query: 690 NIIGKGGAGIVYK-GLMPNGDQVAVKRLPAMSRGSSHDHG-----FNAEIQTLGRIRHRH 743
+IGKG G V A+K M++ + G N E + L + H
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMK---YMNKQKCVEKGSVRNVLN-ERRILQELNHPF 61
Query: 744 IVRL-LGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+V L F E N+ LV + + G L H + + E L YLH
Sbjct: 62 LVNLWYSFQD--EENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
S I+HRD+K +NILLD H+ DF +A + + S G+ GY+APE
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVL 171
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKP 888
D +S GV E + G++P
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGF--NAEIQTLGRIRHRHIVRLL 748
IGKG G VYK + VA+K + + D EIQ L + R +I +
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVI---DLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 749 GFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
G + L ++ EY GS ++L K G L I E GL YLH +
Sbjct: 66 G-SFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGK-- 119
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
+HRD+K+ NILL + +ADFG++ Q + T + G+ ++APE D
Sbjct: 120 -IHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 868 EKSDVYSFGVVLLELITGRKP 888
EK+D++S G+ +EL G P
Sbjct: 177 EKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
LK + +G G G V+ +VAVK M GS F AE + ++H +V
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
+L + E ++ E+M GSL + L +G + + A+G+ ++
Sbjct: 65 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN- 122
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY--GYIAPEYAYT 863
+HRD+++ NIL+ + +ADFGLA+ ++D +E + + + APE
Sbjct: 123 --YIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINF 177
Query: 864 LKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922
KSDV+SFG++L+E++T GR P G+ + +R + + PR
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPY----PGMSNPEVIRALERGYRM-------PRPE 226
Query: 923 SVP--LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+ P L+ +M M C + + ERPT + +L +
Sbjct: 227 NCPEELYNIM------MRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 71/275 (25%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 692 IGKGGAGIVYKGLMPNGDQV-AVKR--LPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+GKG G VYK + +Q A+K L +MS+ D N EI+ L + H +I+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVN-EIRILASVNHPNIISY- 64
Query: 749 GFCSNHETNLL------VYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGLCYL 800
E L V EY P G L + + KK + ++I ++ +GL L
Sbjct: 65 -----KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H I+HRD+KS NILL + + D G++K L G+ Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEV 172
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920
KSD++S G +L E+ T P R M D + K+ +
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFE-----------ARSMQDLR----YKVQRGK 217
Query: 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
P +P + ++ + RP +++
Sbjct: 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 692 IGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG- 749
IG G G VYK G+ VA+K + + G + EI L RH +IV G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFEI-IQQEISMLKECRHPNIVAYFGS 68
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ + +V EY GSL ++ G L + E KGL YLH +
Sbjct: 69 YLRRDKL-WIVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETLKGLAYLHETG---KI 123
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV--- 866
HRD+K NILL + +ADFG++ L + ++ S I Y ++APE A +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPY-WMAPEVAAVERKGGY 181
Query: 867 DEKSDVYSFGVVLLELITGRKP 888
D K D+++ G+ +EL + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 21/225 (9%)
Query: 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQV-AVKRLPAMSRGSSHDHGFNAEIQT 735
FT +D+ D IG+G G V K L + AVKR+ + ++
Sbjct: 1 FTAEDLKDL----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR-LLMDLDV 55
Query: 736 LGRIRH-RHIVRLLGFCSNHETNLLVYEYMPNG--SLGEVLHGKKGGHLHWDTRYKIAVE 792
+ R +IV+ G + E M + ++ + + KIAV
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS--GTSECMSAIA 850
K L YL + I+HRDVK +NILLD + DFG++ L DS T + A
Sbjct: 116 TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-----A 168
Query: 851 GSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRKPVGEF 892
G Y+APE D +SDV+S G+ L E+ TG+ P ++
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 71/290 (24%), Positives = 121/290 (41%), Gaps = 37/290 (12%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQ------VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
L+E +G+G G V+ ++ V VK L + F E+ ++
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-FRRELDMFRKL 65
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH-------LHWDTRYKIAVE 792
H+++VRLLG C E + ++ EY G L + L K L + + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 793 AAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIA 850
A G+ +L VHRD+ + N L+ S E V+ L+K + +S + +A+
Sbjct: 126 IALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSK 909
++APE KSDV+SFGV++ E+ T G P D ++ +
Sbjct: 181 -PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNRL 231
Query: 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
+ G L++ P L+++M C +RP+ E+V L E
Sbjct: 232 QAGKLELPVPEGCPSRLYKLM------TRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 686 LKEDNII-----GKGGAGIVY----KGLMPNGDQ--VAVKRLPAMSRGSSHDHGFNAEIQ 734
+K NI+ G+G G V+ L P D+ VAVK L S + D F+ E +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAE 59
Query: 735 TLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL-----------HGKKGGHLHW 783
L ++H HIV+ G C + ++V+EYM +G L + L G + L
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 784 DTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843
IA + A G+ YL S VHRD+ + N L+ + DFG+++ + +
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKP 888
++ PE K +SDV+S GVVL E+ T G++P
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 8/197 (4%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
IGKG G VYKG+ +V ++ + EI L + +I R G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
++ EY+ GS ++L K G L I E KGL YLH S +HR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLH---SERKIHR 125
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 871
D+K+ N+LL + +ADFG+A L D+ + G+ ++APE D K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 872 VYSFGVVLLELITGRKP 888
++S G+ +EL G P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 50/150 (33%), Positives = 82/150 (54%), Gaps = 14/150 (9%)
Query: 15 SQSRTVP-EYKALLSIKSSITDDPQSSLAAWN----ATTSHCTWPGVTCD-----SRRHV 64
++S+T+ E AL ++KSS+ WN H W G C + +
Sbjct: 365 AESKTLLEEVSALQTLKSSLG---LPLRFGWNGDPCVPQQH-PWSGADCQFDSTKGKWFI 420
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
L L L G + D++ LR LQ+++++ N + G IPP + +++SL +L+LS N FNG
Sbjct: 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAV 154
S P L QL SL++L+L N+++G +P A+
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 8/196 (4%)
Query: 691 IIGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
++G+G GIV+ + V +K++P E Q L + H +I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ ++V EY P G+L E + + L DT V+ L LHH + LI+
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKLIL 123
Query: 810 HRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
HRD+K+ NILLD + DFG++K L + + G+ YI+PE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 869 KSDVYSFGVVLLELIT 884
KSD+++ G VL EL +
Sbjct: 181 KSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 33/279 (11%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IGKG +VYK + + +G VA+K++ M + EI L ++ H ++++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYL 68
Query: 749 -GFCSNHETNLLVYEYMPNGSLGEVL-HGKKGGHLHWD-TRYKIAVEAAKGLCYLHHDCS 805
F N+E N+ V E G L ++ H KK L + T +K V+ L ++H S
Sbjct: 69 ASFIENNELNI-VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---S 124
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
I+HRD+K N+ + + + D GL +F S T+ S + Y Y++PE +
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPY-YMSPERIHENG 182
Query: 866 VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP--- 922
+ KSD++S G +L E+ + P +GD +++ +K+ P LP
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEKCDY--------PPLPADH 232
Query: 923 -SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
S L ++ V+ C+ +RP + V+Q+ E+
Sbjct: 233 YSEELRDL-----VSR-CINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 686 LKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA---EIQTLGRIRH 741
L+ N IG G G VYK + P G A+K + G+ D EI+ L + H
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRDVNH 131
Query: 742 RHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--KIAVEAAKGLC 798
++V+ F N E +L+ E+M GSL +G H+ D ++ +A + G+
Sbjct: 132 PNVVKCHDMFDHNGEIQVLL-EFMDGGSL-------EGTHI-ADEQFLADVARQILSGIA 182
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 858
YLH IVHRD+K +N+L++S +ADFG+++ L + C S++ G+ Y++P
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSV-GTIAYMSP 237
Query: 859 EYAYTLKVDEK-----SDVYSFGVVLLELITGRKP--VGEFGD 894
E T D++S GV +LE GR P VG GD
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 78/289 (26%), Positives = 120/289 (41%), Gaps = 51/289 (17%)
Query: 689 DNIIGKGGAGIVYKGLM--PNGD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
IG+G G VY+G+ P + VAVK + S + F E + + H HI
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
V+L+G + + +V E P G L L K L + + + + L YL
Sbjct: 70 VKLIGVITENPV-WIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLE--- 124
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG-----YIAPE 859
S VHRD+ + N+L+ S + DFGL+++L+D S S G ++APE
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE------SYYKASKGKLPIKWMAPE 178
Query: 860 YAYTLKVDEKSDVYSFGVVLLE-LITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918
+ SDV+ FGV + E L+ G KP Q V K V+ ++
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKP----------FQGV------KNNDVIGRIE 222
Query: 919 --PRLPSVP-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
RLP P L+ +M C +RP E+ L+++
Sbjct: 223 NGERLPMPPNCPPTLYSLM------TKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 36/272 (13%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH---RHIVR 746
+IG+G G VY+G +P G VA+K + + E+ L ++R +I +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 747 LLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHH 802
G L ++ EY GS+ ++ K G + +Y I+V E L Y+H
Sbjct: 67 YYG-SYLKGPRLWIIMEYAEGGSVRTLM---KAGPI--AEKY-ISVIIREVLVALKYIHK 119
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
++HRD+K+ NIL+ + + DFG+A L +S+ S G+ ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSK-RSTFVGTPYWMAPEVIT 174
Query: 863 TLKV-DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
K D K+D++S G+ + E+ TG P VD + + + SK PRL
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYS----DVDAFRAMMLIPKSKP--------PRL 222
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREV 953
+++ F A C++E+ ER + E+
Sbjct: 223 EDNGYSKLLREFVAA--CLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 32/222 (14%)
Query: 691 IIGKGGAGIVYKG-LMPNGDQVAVKRLPA--MSRGSSHDHGFNAEIQTLGRI-RHRHIVR 746
IIG+G V + A+K L + + + E + L R+ H I++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-EKEVLTRLNGHPGIIK 66
Query: 747 LLGFCSNH-ETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
L + + E NL V EY PNG L + + K G TR+ A E L YLH
Sbjct: 67 L--YYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAA-EILLALEYLH--- 119
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE--------CMSAIAGSYG-- 854
S I+HRD+K NILLD + DFG AK L + + E S I +
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 855 --------YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y++PE + SD+++ G ++ +++TG+ P
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-16
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 686 LKEDNI-----IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
LK+D+ +G G G+V+K + ++L + + + E+Q L
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 741 HRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
+IV G F S+ E ++ + E+M GSL +VL KK G + K+++ KGL Y
Sbjct: 62 SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTY 118
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
L I+HRDVK +NIL++S E + DFG++ L DS ++ G+ Y++PE
Sbjct: 119 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 172
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPV 889
+SD++S G+ L+E+ GR P+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 68/258 (26%), Positives = 122/258 (47%), Gaps = 30/258 (11%)
Query: 710 QVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGS 768
+VAVK L + SS +E++ + + H +IV LLG C+ L++ EY G
Sbjct: 67 KVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 769 LGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV 828
L L K+ L + + + AKG+ +L S +HRD+ + N+LL G +
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKI 182
Query: 829 ADFGLAK-FLQDSGTSECMSAIAGS----YGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 883
DFGLA+ + DS + G+ ++APE + +SDV+S+G++L E+
Sbjct: 183 CDFGLARDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 884 T-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEE 942
+ G P G+ + K+ KEG ++ P ++++M C +
Sbjct: 238 SLGSNPY----PGMPVDSKFYKLI---KEG-YRMAQPEHAPAEIYDIM------KTCWDA 283
Query: 943 QAVERPTMREVVQILTEL 960
++RPT +++VQ++ +
Sbjct: 284 DPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 5e-16
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 39/215 (18%)
Query: 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
+G+G +VYK G VA+K++ R G N EI+ L ++H +I+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGER-KEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 747 LLG-FCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYK------IAVEAAKGLC 798
LL F H++N+ LV+E+M L +V+ K + +GL
Sbjct: 67 LLDVFG--HKSNINLVFEFME-TDLEKVIKDKS-------IVLTPADIKSYMLMTLRGLE 116
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 858
YLH S I+HRD+K NN+L+ S +ADFGLA+ M+ + Y AP
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAP 171
Query: 859 EY-----AYTLKVDEKSDVYSFGVVLLELITGRKP 888
E Y + V D++S G + EL+ R P
Sbjct: 172 ELLFGARHYGVGV----DMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 70/264 (26%), Positives = 114/264 (43%), Gaps = 23/264 (8%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
IGKG G V+KG+ +V ++ + EI L + ++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
++ EY+ GS ++L + G L I E KGL YLH S +HR
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLH---SEKKIHR 125
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 871
D+K+ N+LL E +ADFG+A L D+ + G+ ++APE D K+D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 872 VYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMH 931
++S G+ +EL G P E + ++ + K EG S PL E +
Sbjct: 184 IWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEGNY--------SKPLKEFVE 234
Query: 932 VFYVAMLCVEEQAVERPTMREVVQ 955
C+ ++ RPT +E+++
Sbjct: 235 A------CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IIG+G G V +G G +VAVK + + F E + ++ H+++VRLLG
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
H +V E M G+L L + + + +++ A+G+ YL S +VH
Sbjct: 68 IL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123
Query: 811 RDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS 870
RD+ + NIL+ A V+DFGLA+ + + + APE K KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSKS 178
Query: 871 DVYSFGVVLLELIT-GRKP 888
DV+S+GV+L E+ + GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 37/287 (12%)
Query: 691 IIGKGGAGIVYKGLMPNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
I+G+G G V +G + D +VAVK + S F +E + H ++++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 747 LLGFCSNHETN------LLVYEYMPNGSLGEVLHGKKGG----HLHWDTRYKIAVEAAKG 796
L+G C + +++ +M +G L L + G L T K V+ A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK--FLQDSGTSECMSAIAGSYG 854
+ YL + +HRD+ + N +L VADFGL+K + D ++ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVK 180
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913
+IA E KSDV++FGV + E+ T G+ P + +I ++R K+
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYDYLRHGNRLKQ--- 236
Query: 914 LKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
P + ++ + C +RPT ++ ++L +
Sbjct: 237 -----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 8/197 (4%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
IGKG G V+KG+ QV ++ + EI L + ++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
++ EY+ GS ++L T K E KGL YLH S +HR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLH---SEKKIHR 125
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD 871
D+K+ N+LL + +ADFG+A L D+ + G+ ++APE D K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 872 VYSFGVVLLELITGRKP 888
++S G+ +EL G P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 691 IIGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLL 748
+IG+G G VYK Q VA+K + + + E L + H +I
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFY 69
Query: 749 G--FCSNHETN----LLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYL 800
G N N LV E GS+ +++ G KKG L + I E +GL YL
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS--------GTSECMS--AIA 850
H ++HRD+K NILL E + DFG++ L + GT M+ IA
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA 186
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGE 891
P+ +Y D +SDV+S G+ +EL G+ P+ +
Sbjct: 187 CDE---QPDASY----DARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 44/277 (15%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
I+G G G VYK + +AVK +P + +E++ L + +I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 749 G--FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
G F N + + E+M GSL ++ K H+ +IAV KGL YL S
Sbjct: 66 GAFFVENRIS--ICTEFMDGGSLD--VYRKIPEHV----LGRIAVAVVKGLTYL---WSL 114
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
I+HRDVK +N+L+++ + + DFG++ L +S G+ Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQY 170
Query: 867 DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK-------ILDP 919
SDV+S G+ +EL GR P + K +G L I+D
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQI---------------QKNQGSLMPLQLLQCIVDE 215
Query: 920 RLPSVPLHEVMHVF--YVAMLCVEEQAVERPTMREVV 954
P +P+ + F ++ C+ +Q ERP ++
Sbjct: 216 DPPVLPVGQFSEKFVHFITQ-CMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 691 IIGKGGAGIVYKGLMPNGDQVAVKR----LPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
++GKG G V+KG + + VAVK LP F +E + L + H +IV+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-----QELKIKFLSEARILKQYDHPNIVK 56
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
L+G C+ + +V E +P G L KK L K A++AA G+ YL S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SK 112
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
+HRD+ + N L+ ++DFG+++ +D G + APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 867 DEKSDVYSFGVVLLE 881
+SDV+S+G++L E
Sbjct: 172 SSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 691 IIGKGGAGIVY--KGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG+G G +Y K + + +K + E+ L +++H +IV
Sbjct: 7 KIGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 749 GFCSNHETNLL--VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
F S E L V EY G L + ++ ++G D V+ + GL ++H
Sbjct: 65 -FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DR 120
Query: 807 LIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
I+HRD+KS NI L G A + DFG+A+ L DS E G+ Y++PE
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSPEICQNRP 178
Query: 866 VDEKSDVYSFGVVLLELITGRKP 888
+ K+D++S G VL EL T + P
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 55/174 (31%), Positives = 85/174 (48%), Gaps = 25/174 (14%)
Query: 788 KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847
K+ V K L YL ++HRDVK +NILLD+ + DFG++ L D S+ +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKT 172
Query: 848 AIAGSYGYIAPEY----AYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903
AG Y+APE K D ++DV+S G+ L+EL TG+ P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY-------------- 218
Query: 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAML--CVEEQAVERPTMREVVQ 955
K ++ E + KIL PS+P +E + + + C+ + +RP RE++Q
Sbjct: 219 KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 45/292 (15%)
Query: 690 NIIGKGGAGIVYKGLMPNGD-------QVAVKRLPAMSRGS--SHDHGFNAEIQTLGRIR 740
N +G G G VY+G + +VAVK L +G+ F E +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK-----GGHLHWDTRYKIAVEAAK 795
H +IV+LLG C +E ++ E M G L L + L I ++ AK
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 796 GLCYLH--HDCSPLIVHRDVKSNNILL-DSGFEA----HVADFGLAKFLQDSGTSECMSA 848
G YL H +HRD+ + N L+ + G++A + DFGLA+ + S
Sbjct: 118 GCVYLEQMH-----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172
Query: 849 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTD 907
++APE K +SDV+SFGV++ E++T G++P + +++Q V
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVT---- 227
Query: 908 SKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
G L+ P ++++M C + ERPT + +IL
Sbjct: 228 --AGGRLQ--KPENCPDKIYQLM------TNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 38/216 (17%)
Query: 692 IGKGGAGIVYK-GLMPNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+G GG G V + A+K + + +H F+ E + L H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKL- 58
Query: 749 GFCSNHET---NLLVY---EYMPNGSLGEVLHGKKGGHL-HWDTRYKIA--VEAAKGLCY 799
+ T +Y EY G L +L + G + R+ IA V A Y
Sbjct: 59 -----YRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLA---FEY 108
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
LH+ I++RD+K N+LLDS + DFG AK L+ + G+ Y+APE
Sbjct: 109 LHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPE 162
Query: 860 Y----AYTLKVDEKSDVYSFGVVLLELITGRKPVGE 891
Y VD +S G++L EL+TGR P GE
Sbjct: 163 IILNKGYDFSVD----YWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-15
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 686 LKEDNI-----IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
LK+D+ +G G G+V K + ++L + + + E+Q L
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 741 HRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
+IV G F S+ E ++ + E+M GSL +VL K+ + + K+++ +GL Y
Sbjct: 62 SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAY 118
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
L I+HRDVK +NIL++S E + DFG++ L DS ++ G+ Y++PE
Sbjct: 119 LREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 172
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPV 889
+SD++S G+ L+EL GR P+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 692 IGKGGAGIVYKGLMPNGDQ--VAVKRL----PAMSRGS-SHDHGFNAEIQTLGRI----R 740
+G G G VYK N Q +A+K + PA + D + + I R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 741 HRHIVRLL-GFCSNHETNLLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGL 797
H +IVR F N +V + + LGE + +K + + I V+ L
Sbjct: 68 HPNIVRYYKTFLENDRL-YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 857
YLH + IVHRD+ NNI+L + + DFGLAK ++++ G+ Y
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSC 181
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
PE EK+DV++FG +L ++ T + P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 77/284 (27%), Positives = 117/284 (41%), Gaps = 35/284 (12%)
Query: 692 IGKGGAGIVYKGLMPNG---DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG G G V G G +V VK L A + F E+Q + H ++++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQCL 61
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKG---GHLHWDTRYKIAVEAAKGLCYLHHDCS 805
G C LLV E+ P G L L +G D ++A E A GL +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLA--KFLQDS-GTSECMSAIAGSYGYIAPEYA- 861
+H D+ N L + + D+GLA ++ +D T +C A ++APE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH---AVPLRWLAPELVE 175
Query: 862 ------YTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914
+KS+++S GV + EL T +P + D + Q VR E +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR-------EQDI 228
Query: 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
K+ P+L + + + V C RPT EV ++LT
Sbjct: 229 KLPKPQL-DLKYSD--RWYEVMQFC-WLDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 75/301 (24%), Positives = 133/301 (44%), Gaps = 49/301 (16%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL---MPNGDQ---VAVKRLPAMSRGSSHDHGFN---AEI 733
D L +G+G G V K + N ++ VAVK M + + + + +E+
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK----MLKDDATEKDLSDLVSEM 66
Query: 734 QTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK---------GGHLHW 783
+ + I +H++I+ LLG C+ +V EY +G+L + L ++
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 784 D--TRYKI---AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838
+ T+ + A + A+G+ +L S +HRD+ + N+L+ +ADFGLA+ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVD 897
+ ++APE + +SDV+SFGV+L E+ T G P G+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY----PGIP 239
Query: 898 IVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAML-CVEEQAVERPTMREVVQI 956
V ++ KEG ++ P E+ Y M C E +RPT +++V+
Sbjct: 240 ----VEELFKLLKEG--YRMEK--PQNCTQEL----YHLMRDCWHEVPSQRPTFKQLVED 287
Query: 957 L 957
L
Sbjct: 288 L 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 686 LKEDNIIGKGGAGIVYKGLM--PNGDQ--VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH 741
+K + I+G G G + +G + P+ + VA+ L A GF AE TLG+ H
Sbjct: 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA-GCSDKQRRGFLAEALTLGQFDH 65
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+IVRL G + T ++V EYM NG+L L K G L + A G+ YL
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYL- 123
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG--YIAPE 859
VH+ + ++ +L++S ++ F LQ+ + + ++G + APE
Sbjct: 124 --SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 860 YAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918
SDV+SFG+V+ E+++ G +P + G D+++ V E ++
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-GQDVIKAV--------EDGFRLPA 229
Query: 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
PR LH++M + C +++ ERP ++ IL+++
Sbjct: 230 PRNCPNLLHQLM------LDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
IG+G G+VYK G+ VA+K+ + G EI+ L + H +I++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKK---IKLRF-ESEGIPKTALREIKLLKELNHPNIIK 62
Query: 747 LLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
LL H+ +L LV+E+M + L +++ ++ G + + +GL + H S
Sbjct: 63 LLDVFR-HKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKS-YLYQLLQGLAFCH---S 116
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
I+HRD+K N+L+++ +ADFGLA+ + + Y APE K
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 866 V-DEKSDVYSFGVVLLELITGR 886
D++S G + EL++ R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 686 LKEDNIIGKGGAGIVYKGL------MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
L +G+G G V K VAVK L + SS +E L ++
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQV 60
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK---------GGHLHWDTRYKIA 790
H H+++L G CS LL+ EY GSL L + G+ +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 791 VEA-------------AKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK-- 835
A ++G+ YL +VHRD+ + N+L+ G + ++DFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 884
+ +DS I ++A E + +SDV+SFGV+L E++T
Sbjct: 178 YEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 72/271 (26%), Positives = 116/271 (42%), Gaps = 37/271 (13%)
Query: 711 VAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769
VAVK L P ++ + +D F E++ L R++ +I+RLLG C + + ++ EYM NG L
Sbjct: 49 VAVKILRPDANKNARND--FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 770 GEVLHGKK-----------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRD 812
+ L + + + +A++ A G+ YL S VHRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 813 VKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDV 872
+ + N L+ +ADFG+++ L ++A E K SDV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 873 YSFGVVLLELIT--GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP--LHE 928
++FGV L E++ +P GE D I D ++ L R P P L+E
Sbjct: 224 WAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLF----RPPPCPQGLYE 279
Query: 929 VMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
+M + C ERP+ ++ LTE
Sbjct: 280 LM------LQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 26/262 (9%)
Query: 711 VAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769
VAVK L +++ + +D F EI+ + R+++ +I+RLLG C + + ++ EYM NG L
Sbjct: 47 VAVKMLRADVTKTARND--FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 770 GEVL----------HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNIL 819
+ L H + +AV+ A G+ YL S VHRD+ + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 820 LDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 879
+ + + +ADFG+++ L ++A E K SDV++FGV L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 880 LELIT--GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAM 937
E+ T +P D +++ + ++ + P PS P+ ++M M
Sbjct: 222 WEMFTLCKEQPYSLLSDE-QVIENTGEFFRNQGRQIYLSQTPLCPS-PVFKLM------M 273
Query: 938 LCVEEQAVERPTMREVVQILTE 959
C +RPT ++ L E
Sbjct: 274 RCWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 79/276 (28%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH-RHIVRLLG 749
+G+G G+V K +P G +AVKR+ A + S ++ R + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+ E M + SL + KG + D KIAV K L YLH S
Sbjct: 68 ALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-- 124
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-------- 859
++HRDVK +N+L++ + + DFG++ +L DS ++ + AG Y+APE
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTID--AGCKPYMAPERINPELNQ 181
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
Y D KSDV+S G+ ++EL TGR P W + K+ V++ P
Sbjct: 182 KGY----DVKSDVWSLGITMIELATGRFPYD---------SW-KTPFQQLKQ-VVEEPSP 226
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+LP+ F C+++ ERP E++Q
Sbjct: 227 QLPAEKFSPEFQDF--VNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 69/261 (26%), Positives = 110/261 (42%), Gaps = 25/261 (9%)
Query: 711 VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLG 770
VAVK L + ++ + F EI+ + R++ +I+RLL C + ++ EYM NG L
Sbjct: 49 VAVKMLREDANKNARND-FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 771 EVL--HGKKGGHLHWDTRY-------KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD 821
+ L H + D +A + A G+ YL S VHRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 822 SGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 881
+ +ADFG+++ L +++ E K SDV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 882 LIT--GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAML- 938
++T +P + D I D ++ L P+ P Y ML
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYL----PKPALCP-----DSLYKLMLS 275
Query: 939 CVEEQAVERPTMREVVQILTE 959
C A ERP+ +E+ L E
Sbjct: 276 CWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 58/191 (30%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 706 PNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYE 762
+G A+K L + + +H N E + L IRH +V L G ++NL LV E
Sbjct: 24 GSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSIRHPFLVNLYG-SFQDDSNLYLVME 81
Query: 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS 822
Y+P G L L +K G A + L YLH IV+RD+K N+LLDS
Sbjct: 82 YVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHS-LD--IVYRDLKPENLLLDS 136
Query: 823 GFEAHVADFGLAKFLQD-----SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGV 877
+ DFG AK ++ GT E Y+APE + + D ++ G+
Sbjct: 137 DGYIKITDFGFAKRVKGRTYTLCGTPE----------YLAPEIILSKGYGKAVDWWALGI 186
Query: 878 VLLELITGRKP 888
++ E++ G P
Sbjct: 187 LIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 50/286 (17%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLP--------AMSRGSSHDHGFN---AEIQTLGR 738
IGKG G V K V+R + G+ + +E+ L
Sbjct: 6 ETIGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRE 55
Query: 739 IRHRHIVRLLGFCSNHETNLL--VYEYMPNGSLGEVL-HGKK-GGHLHWDTRYKIAVEAA 794
++H +IVR + L V EY G L +++ KK ++ + ++I +
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 795 KGLCYLHH--DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS 852
L H+ D ++HRD+K NI LD+ + DFGLAK L +S + +
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGTP 174
Query: 853 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
Y Y++PE + DEKSD++S G ++ EL P F + +Q K+ KEG
Sbjct: 175 Y-YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP---F-TARNQLQLASKI----KEG 225
Query: 913 VLKILDPRLP---SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
R+P S L+EV+ +ML V+ +RP+ E++Q
Sbjct: 226 KF----RRIPYRYSSELNEVIK----SMLNVDPD--KRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 690 NIIGKGGAGI---VYKGLMPNGDQV-AVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
IIG+ G G VYK A K + S D F EI L +H +IV
Sbjct: 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED--FMVEIDILSECKHPNIV 65
Query: 746 RLLGFCSNHETNLLVY-EYMPNGSLGEVL----HGKKGGHLHWDTRYKIAVEAAKGLCYL 800
L +E L + E+ G+L ++ G + + R + + L +L
Sbjct: 66 GLYEAYF-YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFL 119
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H S ++HRD+K+ NILL + +ADFG++ + T + G+ ++APE
Sbjct: 120 H---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEV 174
Query: 861 AY--TLK---VDEKSDVYSFGVVLLELITGRKP 888
T K D K+D++S G+ L+EL P
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 26/234 (11%)
Query: 692 IGKGGAGIVYKG--LMPNGDQ---VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
+G+ G +YKG +P D VA+K L ++ F E + + H +IV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVC 71
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVL-----HGKKGGHLHWDTRYK----------IAV 791
LLG + + +++EY+ G L E L H G D K IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ A G+ YL S VH+D+ + NIL+ ++D GL++ + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRK 904
++ PE K SD++SFGVVL E+ + G +P F + ++++ VRK
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-EVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-14
Identities = 36/85 (42%), Positives = 51/85 (60%)
Query: 284 MDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI 343
+ L N G IP ++L++L +NL N + G IP +G + LEVL L N+F GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 344 PQRLGSNGKLRILDLSSNKLTGTLP 368
P+ LG LRIL+L+ N L+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 40/233 (17%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV 791
EI L ++H +I+ + T L+ EY G+L + + +KG ++ +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWY 106
Query: 792 --EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS-A 848
+ + Y+H I+HRD+K+ NI L + DFG++K L G+ M+
Sbjct: 107 LFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAET 160
Query: 849 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG-------VDIVQW 901
+ G+ Y++PE +K + KSD+++ G VL EL+T ++ D V IVQ
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQG 216
Query: 902 VRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954
S S L ++H +++ +RPT EV+
Sbjct: 217 NYTPVVSVY------------SSELISLVHS------LLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 70/242 (28%), Positives = 108/242 (44%), Gaps = 33/242 (13%)
Query: 692 IGKGGAGIVYKGLMPNGDQ-VAVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+G G G V+ + A+K + P + R H N E + L + H I+RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-EKRVLKEVSHPFIIRL- 66
Query: 749 GFCSNHETNLL--VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
F + H+ L + EY+P G L L + G T A E L YLH S
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH---SK 120
Query: 807 LIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
IV+RD+K NILLD E H+ DFG AK L+D + C G+ Y+APE +
Sbjct: 121 EIVYRDLKPENILLDK--EGHIKLTDFGFAKKLRDRTWTLC-----GTPEYLAPEVIQSK 173
Query: 865 KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD---------IVQWVRKMTDSKKEGVLK 915
++ D ++ G+++ E++ G P F D +++ R + K+ + K
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPF--FDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK 231
Query: 916 IL 917
+L
Sbjct: 232 LL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 692 IGKGGAGIVYKGLMPNGDQ---VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+G G G V KG+ + VA+K L + S D E + + ++ + +IVR++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMR-EAEIMHQLDNPYIVRMI 61
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
G C E +LV E G L + L GKK + ++ + + G+ YL
Sbjct: 62 GVCEA-EALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKN---F 116
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFL-QDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
VHRD+ + N+LL + A ++DFGL+K L D + SA + APE K
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 868 EKSDVYSFGVVLLELIT-GRKP 888
+SDV+S+G+ + E + G+KP
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 65/224 (29%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLM--PNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
D + +G G G VY+GL +GD QVAVK LP + F E +
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD-ESDFLMEALIMS 64
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL-----HGKKGGHLHWDTRYKIAVE 792
+ H++IVRL+G ++ E M G L L ++ L A +
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDS---GFEAHVADFGLAKFLQDSG----TSEC 845
AKG YL +HRD+ + N LL G A +ADFG+A+ + +
Sbjct: 125 VAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 846 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKP 888
M I ++ PE K+DV+SFGV+L E+ + G P
Sbjct: 182 MLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 692 IGKGGAGIVYKGL--MPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+G G G V KG+ M ++ VAVK L + + E + ++ + +IVR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
G C E+ +LV E G L + L +K H+ ++ + + G+ YL
Sbjct: 63 GICEA-ESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETN---F 116
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFL-QDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
VHRD+ + N+LL + A ++DFGL+K L D + + + APE K
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 868 EKSDVYSFGVVLLELIT-GRKP 888
KSDV+SFGV++ E + G+KP
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-13
Identities = 58/195 (29%), Positives = 87/195 (44%), Gaps = 21/195 (10%)
Query: 708 GDQVAVKRLPAMSRGSSHDHG-FNAEIQTLGRIRHRHIVRLL--GFCSNHETNLL--VYE 762
G +VA+K L + H F E R+ H +IV LL G LL V+E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFE 59
Query: 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL-- 820
Y+P +L EVL G L ++ ++ L H+ IVHRD+K NI++
Sbjct: 60 YVPGRTLREVLAAD--GALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 821 -DSGFEAHVADFGLAKFLQDSGTSECMSAIA-----GSYGYIAPEYAYTLKVDEKSDVYS 874
A V DFG+ L ++ + G+ Y APE V SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 875 FGVVLLELITGRKPV 889
+G++ LE +TG++ V
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 39/228 (17%)
Query: 692 IGKGGAGIVYK----GLMPNGDQ--VAVKRLPAMSRGSSHD--HGFNAEIQTLGRIRHRH 743
IG+G G V++ GL+P VAVK L +S D F E + H +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYK--------------- 788
IV+LLG C+ + L++EYM G L E L + +
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 789 -----IAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK--FLQDSG 841
IA + A G+ YL VHRD+ + N L+ +ADFGL++ + D
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKP 888
+ AI ++ PE + + +SDV+++GVVL E+ + G +P
Sbjct: 187 KASENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-13
Identities = 36/88 (40%), Positives = 52/88 (59%)
Query: 240 NCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASF 299
N GL G IP DI +L++L ++ L N++ G + LG + SL+ +DLS N F G IP S
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 300 AELKNLTLLNLFRNKLHGAIPEFIGVMP 327
+L +L +LNL N L G +P +G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 72/272 (26%), Positives = 114/272 (41%), Gaps = 30/272 (11%)
Query: 692 IGKGGAGIVYKG-LMPNGDQVAVKR----LPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
IG+G G V+ G L + VAVK LP + F E + L + H +IVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
L+G C+ + +V E + G L +G L ++ AA G+ YL
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
+HRD+ + N L+ ++DFG+++ +D + + APE +
Sbjct: 116 --IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 867 DEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925
+SDV+SFG++L E + G P + Q R+ + +GV RLP P
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREAIE---QGV------RLP-CP 218
Query: 926 LHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957
V+ + C E +RP+ V Q L
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 47/297 (15%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGD---QVAVKRLPAMSRGSSHDH-GFNAEIQTLGRI-R 740
+K ++IG+G G V K + A+KR+ + S DH F E++ L ++
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGH 66
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA---------- 790
H +I+ LLG C + L EY P+G+L + L +K L D + IA
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQ 124
Query: 791 ------VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
+ A+G+ YL +HRD+ + NIL+ + A +ADFGL++ Q+ +
Sbjct: 125 QLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKK 180
Query: 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVR 903
M + ++A E SDV+S+GV+L E+++ G P G+ +
Sbjct: 181 TMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC----GMTCAELYE 234
Query: 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
K+ RL PL+ V+ + C E+ ERP+ +++ L +
Sbjct: 235 KLP----------QGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-13
Identities = 52/182 (28%), Positives = 74/182 (40%), Gaps = 36/182 (19%)
Query: 473 VQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELS 532
+ L LD G IP +I KL+ L ++ S N G I P + L +DLS N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 533 GEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYF 592
G IP L + L LNL+ N L G +PA++ L+ F
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR---------------LLHRAS----F 520
Query: 593 NYTSFLGNSELCG-PYLGPCKDGVANGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAA 651
N+T N+ LCG P L C PH LS K+ + G+ V + + A
Sbjct: 521 NFTD---NAGLCGIPGLRACG---------PH----LSVGAKIGIAFGVSVAFLFLVICA 564
Query: 652 II 653
+
Sbjct: 565 MC 566
|
Length = 623 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 686 LKEDNIIGKGGAGIVYKGLMP---NGDQVAVKRLPAMSRGSSHDH-GFNAEIQTLGRI-R 740
+K +++IG+G G V + ++ A+K L + S +DH F E++ L ++
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGH 61
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY------------- 787
H +I+ LLG C N + EY P G+L + L +K L D +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 788 ---KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
+ A + A G+ YL +HRD+ + N+L+ + +ADFGL++ ++ +
Sbjct: 120 QLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG-EEVYVKK 175
Query: 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 884
M + ++A E KSDV+SFGV+L E+++
Sbjct: 176 TMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 55/223 (24%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKR---------LPAMS-RGSSHDHGFNAEIQTLGR 738
N IG+G GIVY+ +G+ VA+K+ +P S R EI L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR----------EITLLLN 62
Query: 739 IRHRHIVRLLGFC-SNHETNL-LVYEY-----------MPNG-SLGEVLHGKKGGHLHWD 784
+RH +IV L H ++ LV EY MP S +V K
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQV----KC------ 112
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
+ ++ +GL YLH + I+HRD+K +N+LL +ADFGLA+
Sbjct: 113 ----LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP- 164
Query: 845 CMSAIAGSYGYIAPEYAYTLKVDEKS-DVYSFGVVLLELITGR 886
M+ + Y APE + D+++ G +L EL+ +
Sbjct: 165 -MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRHIVRLLG 749
IG G G VY + + VA+K++ + S+ E++ L ++RH + + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
T LV EY GS ++L K L I A +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHSHER---I 137
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE- 868
HRD+K+ NILL +ADFG A + + + G+ ++APE L +DE
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPE--VILAMDEG 189
Query: 869 ----KSDVYSFGVVLLELITGRKP 888
K DV+S G+ +EL RKP
Sbjct: 190 QYDGKVDVWSLGITCIEL-AERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 36/215 (16%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRH 743
+ IG+G G+V P G +VA+K++ S +H EI+ L R +H +
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI------SPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 744 IVRLL------GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDT----RYKIAVEA 793
I+ +L F S ++ +V E M L +++ K HL D Y+I
Sbjct: 65 IIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLI---KTQHLSNDHIQYFLYQIL--- 116
Query: 794 AKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF-LQDSGTSECMSAIAGS 852
+GL Y+H S ++HRD+K +N+LL++ + + DFGLA+ + + ++ +
Sbjct: 117 -RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 853 YGYIAPEYAYTLKVDEKS-DVYSFGVVLLELITGR 886
Y APE K K+ D++S G +L E+++ R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 70/278 (25%), Positives = 137/278 (49%), Gaps = 29/278 (10%)
Query: 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G GIV + G QVAVK++ + + + FN E+ + H ++V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD-LRKQQRRELLFN-EVVIMRDYHHENVVDMYNS 87
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
+ +V E++ G+L +++ + ++ + + + + L YLH+ ++H
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 811 RDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS 870
RD+KS++ILL S ++DFG Q S ++ G+ ++APE L +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 871 DVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVM 930
D++S G++++E+I G P F + +Q +R++ D+ L PR+ H+V
Sbjct: 200 DIWSLGIMVIEMIDGEPPY--FNE--PPLQAMRRIRDN--------LPPRVKD--SHKVS 245
Query: 931 HVF--YVAMLCVEEQAVERPTMREVVQ-ILTELPKPPT 965
V ++ ++ V E + +R T +E++Q +L PP+
Sbjct: 246 SVLRGFLDLMLVREPS-QRATAQELLQHPFLKLAGPPS 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 72/231 (31%), Positives = 107/231 (46%), Gaps = 36/231 (15%)
Query: 678 TCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----E 732
C D D + IG+G G VYK G+ VA+K++ R + GF E
Sbjct: 4 RCVDKFDII---GQIGEGTYGQVYKARDKDTGELVALKKV----RLDNEKEGFPITAIRE 56
Query: 733 IQTLGRIRHRHIVRL----------LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLH 782
I+ L ++ HR+IV L L F + LV+EYM + +G + G H
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--HFS 114
Query: 783 WDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842
D + +GL Y H +HRD+K +NILL++ + +ADFGLA+ L +S
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEE 170
Query: 843 SECMSAIAGSYGYIAPEYAYTLKVDEKS----DVYSFGVVLLELITGRKPV 889
S + + Y PE L +E+ DV+S G +L EL T +KP+
Sbjct: 171 SRPYTNKVITLWYRPPEL---LLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 57/202 (28%), Positives = 80/202 (39%), Gaps = 18/202 (8%)
Query: 692 IGKGGAGIVY---KGLMPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRHIVRL 747
I KG G VY K GD A+K L + + AE + V
Sbjct: 4 ISKGAFGSVYLAKKRS--TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 748 LGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
L + + L LV EY+ G ++ K G L D + E G+ LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRG-- 117
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
I+HRD+K N+L+D + DFGL S G+ Y+APE +
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGL------SRNGLENKKFVGTPDYLAPETILGVGD 170
Query: 867 DEKSDVYSFGVVLLELITGRKP 888
D+ SD +S G V+ E + G P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLG 749
++G G G VYKG Q+A + M + EI L + HR+I G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAA--IKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 750 -FCSN----HETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
F H+ L LV E+ GS+ +++ KG L D I E +GL +LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-- 138
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
+ ++HRD+K N+LL E + DFG++ L D + I Y ++APE
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPY-WMAPE---V 192
Query: 864 LKVDE--------KSDVYSFGVVLLELITGRKPV 889
+ DE +SD++S G+ +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 65/239 (27%), Positives = 97/239 (40%), Gaps = 58/239 (24%)
Query: 691 IIGKGGAGIVYKGLMPNGDQV-AVKRLP---AMSRG-SSHDHGFNAEIQTLGRIRHRHIV 745
+IG+G G V+ + QV A+K L + R +H AE L IV
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH---VRAERDILADADSPWIV 64
Query: 746 RLLGFCS-NHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI-----AVEAAKGLC 798
+L + S E +L LV EYMP G L +L K R+ I A+++ L
Sbjct: 65 KL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLALDSVHKLG 121
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMS--------- 847
+ +HRD+K +NIL+D+ + H+ ADFGL K + + E
Sbjct: 122 F---------IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 848 ------------------AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ G+ YIAPE + D +S GV+L E++ G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
++G+G G N DQ + + + SS E L +++H +IV F
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV---AF 63
Query: 751 CSNHETN---LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+ E + +V EY G L + + ++G DT + V+ G+ ++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKR 120
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
++HRD+KS NI L + + DFG A+ L G C G+ Y+ PE + +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC--TYVGTPYYVPPEIWENMPYN 178
Query: 868 EKSDVYSFGVVLLELITGRKP 888
KSD++S G +L EL T + P
Sbjct: 179 NKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 27/276 (9%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRL---PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
IG+G VY+ + + VA+K++ M + D EI L ++ H ++++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQD--CVKEIDLLKQLNHPNVIKY 67
Query: 748 L-GFCSNHETNLLVYEYMPNGSLGE-VLHGKKGGHLHWD-TRYKIAVEAAKGLCYLHHDC 804
L F ++E N+ V E G L + + + KK L + T +K V+ + ++H
Sbjct: 68 LDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--- 123
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
S ++HRD+K N+ + + + D GL +F S T+ S + Y Y++PE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPY-YMSPERIHEN 181
Query: 865 KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924
+ KSD++S G +L E+ + P +GD +++ +K+ P LP+
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDY--------PPLPTE 231
Query: 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
H + + +C+ +RP + V QI ++
Sbjct: 232 --HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 4e-12
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 42/219 (19%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRH 743
IG G G+V + G +VA+K++ + D +A EI+ L +RH +
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-----FDDLIDAKRILREIKLLRHLRHEN 60
Query: 744 IVRLLG-FCSNHETNL----LVYEYMPNGSLGEVLH-GKKGGHLHWDTRYKIAVEAAKGL 797
I+ LL + +V E M L +V+ + H +Y + +GL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDH--IQY-FLYQILRGL 116
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ-DSGTSECMSAIAGSY--- 853
YLH S ++HRD+K +NIL++S + + DFGLA+ + D ++ Y
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT----EYVVT 169
Query: 854 -GYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y APE YT + D++S G + EL+T +
Sbjct: 170 RWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 42/188 (22%)
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
L +HH S ++HRD+KS NILL S + DFG +K + + + G+ Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
APE +K+D++S GV+L EL+T ++P DG ++ + + K +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPF----DGENMEEVMHKTLAGR------- 261
Query: 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESLPPS 976
DP PS+ P M+E+V L + PS
Sbjct: 262 YDPLPPSI----------------------SPEMQEIVTALL---------SSDPKRRPS 290
Query: 977 GTTSLDSP 984
+ L+ P
Sbjct: 291 SSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-12
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG G GIV G VAVK+L + +H E+ L + H++I+ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 751 CSNHET------NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
+ ++ LV E M + +L +V+H + Y++ LC + H
Sbjct: 89 FTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQM-------LCGIKHLH 140
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
S I+HRD+K +NI++ S + DFGLA+ + T+ M+ + Y APE +
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 865 KVDEKSDVYSFGVVLLELITG 885
E D++S G ++ EL+ G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 7e-12
Identities = 68/225 (30%), Positives = 102/225 (45%), Gaps = 59/225 (26%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA------------EIQTLGR 738
+GKG GIV+K + + VA+K++ F+A EI L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI------------FDAFRNATDAQRTFREIMFLQE 62
Query: 739 IR-HRHIVRLLGF--CSNHETNLLVYEYMPNGSLGEV-LHG--KKG--GHLHWDTRYKIA 790
+ H +IV+LL N + LV+EYM E LH + +H RY I
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM------ETDLHAVIRANILEDVH--KRY-IM 113
Query: 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA-- 848
+ K L Y+H S ++HRD+K +NILL+S +ADFGLA+ L + +
Sbjct: 114 YQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 849 --IAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
+A + Y APE YT V D++S G +L E++ G+
Sbjct: 171 DYVATRW-YRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 29/241 (12%)
Query: 692 IGKG--GAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
IG+G G I+ K +G Q +K + E+ L ++H +IV+
Sbjct: 8 IGEGSFGKAILVKS-KEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ--- 63
Query: 750 FCSNHETN---LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
+ + E N +V +Y G L + ++ ++G D V+ L ++H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DR 120
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
I+HRD+KS NI L + DFG+A+ L T E G+ Y++PE
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYYLSPEICENRPY 178
Query: 867 DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926
+ KSD+++ G VL E+ T K E G + K VLKI+ P V
Sbjct: 179 NNKSDIWALGCVLYEMCT-LKHAFEAG--------------NMKNLVLKIIRGSYPPVSS 223
Query: 927 H 927
H
Sbjct: 224 H 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLG 749
IGKG G V+K L NG + AVK L + D AE L + H ++V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 750 F-----CSNHETNLLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHH 802
N + LV E GS+ +++ G K+G + I EA GL +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY-- 860
+ + +HRDVK NNILL + + DFG++ Q + T + G+ ++APE
Sbjct: 143 NKT---IHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 861 ---AYTLKVDEKSDVYSFGVVLLELITGRKPVGEF 892
D + DV+S G+ +EL G P+ +
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLG 749
++G G G VYKG Q+A + M + EI L + HR+I G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAA--IKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 750 -FCSNHETNL-----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
F + + LV E+ GS+ +++ KG L + I E +GL +LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
++HRD+K N+LL E + DFG++ L D + I Y ++APE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPY-WMAPE---V 182
Query: 864 LKVDE--------KSDVYSFGVVLLELITGRKPV 889
+ DE KSD++S G+ +E+ G P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSH-----DHGFNAEIQTLGRIRHRHIV 745
+G+GG G V+ + G+ VA+KR M + H E L + +V
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKR---MKKSLLFKLNEVRHVLT-ERDILTTTKSEWLV 64
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIA--VEAAKGLCYLHH 802
+LL + E L EY+P G +L+ G L D R+ +A EA L L
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG- 121
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
+HRD+K N L+D+ + DFGL+K G +++ GS Y+APE
Sbjct: 122 -----YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLR 171
Query: 863 TLKVDEKSDVYSFGVVLLELITGRKP 888
D D +S G +L E + G P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 82/283 (28%), Positives = 127/283 (44%), Gaps = 33/283 (11%)
Query: 692 IGKGGAGIVYKGLMPNG---DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG G G V G + +G QV VK L S F E Q ++H ++++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRV-SASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHL---HWDTRYKIAVEAAKGLCYLHHDCS 805
G C+ LLV E+ P G L L + L T ++A E A GL +LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLA--KFLQDSGTSECMSAIAGSYGYIAPE---- 859
+H D+ N LL + + D+GL+ K+ +D + + +IAPE
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDE 176
Query: 860 -YAYTLKVDE--KSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
+ L VD+ +S+V+S GV + EL G +P D + V +T + +E LK
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQV--LTYTVREQQLK 229
Query: 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
+ PRL +PL + +Y M Q +RP+ EV +L+
Sbjct: 230 LPKPRL-KLPLSD---RWYEVMQFCWLQPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 692 IGKGGAGIVYK-GLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLG 749
IGKG G VYK +G AVK L +S D AE L + H ++V+ G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 750 --FCSNHETN---LLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHH 802
+ ++ LV E GS+ E++ G G L I A GL +LH+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY-- 860
+ I+HRDVK NNILL + + DFG++ L + S G+ ++APE
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIA 201
Query: 861 ---AYTLKVDEKSDVYSFGVVLLELITGRKPVGE 891
Y D + DV+S G+ +EL G P+ +
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 51/143 (35%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 750 FCS--NHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+C+ E V EY+ G L + L T Y A E GL +LH S
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLH---SKG 116
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAK--FLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
IV+RD+K +NILLD+ +ADFG+ K L D+ T G+ YIAPE K
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT----CTFCGTPDYIAPEILLGQK 172
Query: 866 VDEKSDVYSFGVVLLELITGRKP 888
+ D +SFGV+L E++ G+ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 674 RLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAE 732
R D ++V + + E +G G G VYK G A K + S D + E
Sbjct: 5 RRDLDPNEVWEIIGE---LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YMVE 59
Query: 733 IQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV 791
I+ L H +IV+LLG + L ++ E+ P G++ ++ G + I
Sbjct: 60 IEILATCNHPYIVKLLG-AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICR 117
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ + L YLH S I+HRD+K+ N+LL + +ADFG++ ++ T + + G
Sbjct: 118 QMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIG 172
Query: 852 SYGYIAPEYAY--TLK---VDEKSDVYSFGVVLLEL 882
+ ++APE T+K D K+D++S G+ L+E+
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 42/127 (33%), Positives = 59/127 (46%), Gaps = 25/127 (19%)
Query: 777 KGG----HLHWDTRYK------IAVEAAKGLCYLH-HDCSPLIVHRDVKSNNILLDSGFE 825
GG H+ R+ A E GL +LH I++RD+K +N+LLDS E
Sbjct: 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG----IIYRDLKLDNVLLDS--E 132
Query: 826 AHV--ADFGLAK--FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 881
H+ ADFG+ K L T S G+ YIAPE D ++ GV+L E
Sbjct: 133 GHIKIADFGMCKEGILGGVTT----STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 882 LITGRKP 888
++ G+ P
Sbjct: 189 MLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 690 NIIGKGGAGIVYKGLMPNGD---QVAVKRLPAMSRGSSHDH-GFNAEIQTLGRI-RHRHI 744
++IG+G G V K + A+KR+ + S DH F E++ L ++ H +I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNI 58
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY----------------K 788
+ LLG C + L EY P+G+L + L +K L D +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 789 IAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA 848
A + A+G+ YL +HRD+ + NIL+ + A +ADFGL++ Q+ + M
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGR 172
Query: 849 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 884
+ ++A E SDV+S+GV+L E+++
Sbjct: 173 L--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 53/178 (29%), Positives = 74/178 (41%), Gaps = 53/178 (29%)
Query: 687 KEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIR- 740
+E IG+G G VYK + G VA+K++ R + G EI L ++
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLES 57
Query: 741 --HRHIVRLLGFCSNHETN-----LLVYEYMPNGSLGEVLHGKKGGHLHWD-TRY----- 787
H +IVRLL C T+ LV+E H+ D Y
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFE-----------------HVDQDLATYLSKCP 100
Query: 788 --KIAVEAAK--------GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835
+ E K G+ +LH S IVHRD+K NIL+ S + +ADFGLA+
Sbjct: 101 KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 9/141 (6%)
Query: 750 FCS--NHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
FC+ E V EY+ G L + Y A E GL +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY--AAEIICGLQFLH---KKG 116
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
I++RD+K +N+LLD +ADFG+ K +G + S G+ YIAPE K +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKA-STFCGTPDYIAPEILKGQKYN 174
Query: 868 EKSDVYSFGVVLLELITGRKP 888
E D +SFGV+L E++ G+ P
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G +G VY + + G +VA+K++ + + + N EI + +H +IV L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIIN-EILVMRENKHPNIVNYLDS 84
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV--EAAKGLCYLHHDCSPLI 808
+ +V EY+ GSL +V+ D AV E + L +LH S +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH---SNQV 136
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
+HRD+KS+NILL + DFG Q + S + G+ ++APE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 869 KSDVYSFGVVLLELITGRKP 888
K D++S G++ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-11
Identities = 19/39 (48%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 22 EYKALLSIKSSITDDPQSSLAAWNATTS-HCTWPGVTCD 59
+ ALL+ KSS+ DP +L++WN ++S C+W GVTCD
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 692 IGKGGAGIVYKGLMPNGD---QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+G+G G V +G + D +VAVK + S F +E + H +++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 749 GFC------SNHETNLLVYEYMPNGSLGEVLHGKKGG----HLHWDTRYKIAVEAAKGLC 798
G C + + +++ +M +G L L + G +L K + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 858
YL S +HRD+ + N +L+ VADFGL+K + + +IA
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 859 EYAYTLKVDEKSDVYSFGVVLLELIT-GRKP 888
E KSDV+SFGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 34/295 (11%)
Query: 669 LTAFQRLDFTCDDVLDCLKEDNIIGK-GGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHD- 726
+T D C + D K +++ K +YKG+ N +V ++ +G
Sbjct: 4 ITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLI 62
Query: 727 HGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL----LVYEYMPNGSLGEVLHGKKGGHLH 782
EI+ L RI +I+++ GF + +L L+ EY G L EVL +K L
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLS 120
Query: 783 WDTRYKIAVEAAKGLCYLH-HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841
+ T+ +A++ KGL L+ + P ++++ S + L+ ++ + GL K L S
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILS-SP 176
Query: 842 TSECMSAIAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIV 899
+ ++ + Y + + + + K D+YS GVVL E+ TG+ P E +I
Sbjct: 177 PFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIY 231
Query: 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954
+ +S K +PL + + + C +++RP ++E++
Sbjct: 232 DLIINKNNSLK-------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG- 749
IG+G GIV G QVAVK++ + + + FN E+ + +H +IV +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-LRKQQRRELLFN-EVVIMRDYQHPNIVEMYSS 84
Query: 750 FCSNHETNLLVYEYMPNGSLGE-VLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
+ E +V E++ G+L + V H + ++ + + + K L +LH + +
Sbjct: 85 YLVGDEL-WVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLH---AQGV 136
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
+HRD+KS++ILL S ++DFG Q S ++ G+ ++APE L
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194
Query: 869 KSDVYSFGVVLLELITGRKP 888
+ D++S G++++E++ G P
Sbjct: 195 EVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR----HIVR 746
+GKG G VYK L P G +A+K + R + FN I L I H+ +IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI----RLELDESKFNQIIMEL-DILHKAVSPYIVD 63
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHG-KKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
G + EYM GSL ++ G + D +I KGL +L + +
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY----- 860
I+HRDVK N+L++ + + DFG++ L S + G Y+APE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGG 177
Query: 861 -----AYTLKVDEKSDVYSFGVVLLELITGRKP 888
YT+ +SDV+S G+ +LE+ GR P
Sbjct: 178 PNQNPTYTV----QSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPA----MSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
+GKGG G V + G A K+L +G E + L ++ R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQ---MALNEKKILEKVSSRFIVS 57
Query: 747 LLGFCSNHETNL-LVYEYMPNGSLG-EVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
L + + +L LV M G L + + + G + A + GL +LH
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQR- 114
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
IV+RD+K N+LLD ++D GLA L+ + AG+ GY+APE
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGE 169
Query: 865 KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD 897
D D ++ G L E+I GR P + + V+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 32/88 (36%), Positives = 45/88 (51%)
Query: 454 LSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAP 513
L N L G +P I K +Q + L GN G IP +G + L +D S+N F+G I
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 514 EISQCKLLTFVDLSRNELSGEIPNQLTG 541
+ Q L ++L+ N LSG +P L G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 692 IGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRIR---HRHIVRL 747
IG G G VYK P+ VA+K + + E+ L R+ H +IVRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 748 LGFCSNHETN-----LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
+ C+ T+ LV+E++ + L L L +T + + +GL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
+C IVHRD+K NIL+ SG + +ADFGLA+ ++ + + Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLL 180
Query: 863 TLKVDEKSDVYSFGVVLLELITGRKPV 889
D++S G + E+ RKP+
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-11
Identities = 87/303 (28%), Positives = 128/303 (42%), Gaps = 43/303 (14%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISAL-SSLRLLNLSNNVFN 123
SLDL+ L +S + L L +L + N ++ IPP I L S+L+ L+LS+N
Sbjct: 96 PSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI- 152
Query: 124 GSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
S P L L +L+ LDL N+++ DLP ++ L NL +L L GN S
Sbjct: 153 ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS------------ 199
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGL 243
+P EI L+ L++L + NS L + NL +L + +N
Sbjct: 200 -------------DLPPEIELLSALEELDLS-NNSII-ELLSSLSNLKNLSGLELSN-NK 243
Query: 244 SGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFA--E 301
++P IG L NL+TL L N +S + LG L +L+ +DLS N + +P
Sbjct: 244 LEDLPESIGNLSNLETLDLSNNQISSI--SSLGSLTNLRELDLSGNSLSNALPLIALLLL 301
Query: 302 LKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSN 361
L L L L K I + + S P+ L L L N
Sbjct: 302 LLELLLNLLLTLKALELKLNSILLNNNILSNGE------TSSPEALSILESLNNLWTLDN 355
Query: 362 KLT 364
L
Sbjct: 356 ALD 358
|
Length = 394 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-11
Identities = 46/134 (34%), Positives = 68/134 (50%), Gaps = 13/134 (9%)
Query: 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNN 817
V E++ G L + K L+ T Y A E GL +LH S I++RD+K +N
Sbjct: 72 FFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLH---SKGIIYRDLKLDN 126
Query: 818 ILLDSGFEAHVADFGLAK---FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYS 874
++LD +ADFG+ K F + ++ C G+ YIAPE LK D +S
Sbjct: 127 VMLDRDGHIKIADFGMCKENVFGDNRASTFC-----GTPDYIAPEILQGLKYTFSVDWWS 181
Query: 875 FGVVLLELITGRKP 888
FGV+L E++ G+ P
Sbjct: 182 FGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-11
Identities = 77/330 (23%), Positives = 128/330 (38%), Gaps = 16/330 (4%)
Query: 291 FTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIG------VMPRLEVLQLWENNFTGSIP 344
T + L + TL + + + P+ I + + V +L N + ++
Sbjct: 1 STPAENLLKSALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLL 60
Query: 345 QRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTL--ITLGNFLFGPIPESLGKCDSLS 402
S +L LDL S +L L L + L L + +L+
Sbjct: 61 LLPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLPLPSLDLNLNRLRSNISELLELTNLT 119
Query: 403 RMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGS 462
+ + N + P +L +++L DN + P NL + LS N LS
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 463 LPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLT 522
LP + S + L L GNK S +P EI L L ++D S+N + +S K L+
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 523 FVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGL 582
++LS N+L ++P + + L L+LS N S +S+ S+ +L +D S N+LS
Sbjct: 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNA 292
Query: 583 VPGTGQFSYFNYTSFLGNSELCGPYLGPCK 612
+P L L
Sbjct: 293 LPLIALLLLLLELLLNLLLTLKALELKLNS 322
|
Length = 394 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK--------------GGHLHWDT 785
+H++I+ LLG C+ ++ EY G+L E L ++ L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 786 RYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845
A + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ + D +
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 846 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 884
S ++APE + +SDV+SFG+++ E+ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 87/363 (23%), Positives = 142/363 (39%), Gaps = 47/363 (12%)
Query: 223 LPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLK 282
LP + L SL + S + ++ L L +L L +N L ++ L L +L
Sbjct: 62 LPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLT 119
Query: 283 SMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGS 342
S+DL NN T P NL L+L NK+ ++P + +P L+ L L N+ +
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 343 IPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLS 402
+P+ L + L LDLS NK++ +P + +L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-------------------------DLPPEIELLSALE 212
Query: 403 RMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGS 462
+ + N + + L L +LS +EL +N L P S NL + LSNNQ+S S
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-S 269
Query: 463 LPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLT 522
+ S+G + +++L L GN S I L L ++ + A E+ +L
Sbjct: 270 IS-SLGSLTNLRELDLSGNSLSN-ALPLIALLLLLLELLLNLLLTL--KALELKLNSILL 325
Query: 523 FVDLSRNEL--------SGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDF 574
++ N E N L + + ++V + A L V
Sbjct: 326 NNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIG---SLLDLVKK 382
Query: 575 SYN 577
N
Sbjct: 383 HVN 385
|
Length = 394 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 45/231 (19%)
Query: 679 CDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EI 733
C V D ++ N I +G G+VY+ G+ VA+K+L + GF EI
Sbjct: 1 CRSV-DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREI 55
Query: 734 QTLGRIRHRHIVRL----LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI 789
L +++H +IV + +G SN + +V EY+ H K +
Sbjct: 56 NILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQ 105
Query: 790 A------VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843
+ ++ G+ +LH + I+HRD+K++N+LL++ + DFGLA+
Sbjct: 106 SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162
Query: 844 ECMSAIAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGRKPV 889
+ + + Y APE Y+ + D++S G + EL+T +KP+
Sbjct: 163 --YTQLVVTLWYRAPELLLGAKEYSTAI----DMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 1e-10
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRHIVRLLG 749
IG G G VY + + VA+K++ + S+ E++ L RI+H + + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
T LV EY GS ++L K L I A +GL YLH S ++
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLH---SHNMI 147
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL---KV 866
HRD+K+ NILL + +ADFG A + ++ G+ ++APE + +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQY 201
Query: 867 DEKSDVYSFGVVLLELITGRKPV 889
D K DV+S G+ +EL + P+
Sbjct: 202 DGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 45/171 (26%), Positives = 83/171 (48%), Gaps = 22/171 (12%)
Query: 731 AEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI 789
+E++ + I +H++I+ LLG C+ ++ EY G+L E L ++ + + Y I
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS--YDI 126
Query: 790 A----------------VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833
A + A+G+ YL S +HRD+ + N+L+ +ADFGL
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 183
Query: 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 884
A+ + + + + ++APE + +SDV+SFGV++ E+ T
Sbjct: 184 ARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 66/243 (27%), Positives = 101/243 (41%), Gaps = 36/243 (14%)
Query: 653 IKARSLKKASESRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIV----YKGLMPNG 708
+KA + ++ +WKL+ F+ + E +G G G V +KG G
Sbjct: 1 MKAAYMFTKPDTSSWKLSDFE------------MGE--TLGTGSFGRVRIAKHKG---TG 43
Query: 709 DQVAVKRLPAMS--RGSSHDHGFNAEIQTLGRIRHRHIVRLL-GFCSNHETNLLVYEYMP 765
+ A+K L + H E L + H IV ++ F + L+ E++
Sbjct: 44 EYYAIKCLKKREILKMKQVQH-VAQEKSILMELSHPFIVNMMCSFQDENRVYFLL-EFVV 101
Query: 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE 825
G L H +K G D E YLH S I++RD+K N+LLD+
Sbjct: 102 GGEL--FTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGH 156
Query: 826 AHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 885
V DFG AK + D + C G+ Y+APE + + D ++ GV+L E I G
Sbjct: 157 VKVTDFGFAKKVPDRTFTLC-----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
Query: 886 RKP 888
P
Sbjct: 212 YPP 214
|
Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 33/87 (37%), Positives = 46/87 (52%)
Query: 356 LDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSI 415
L L + L G +P D+ LQ++ GN + G IP SLG SL + + N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 416 PKGLFGLPSLSQVELQDNYLTGQFPVS 442
P+ L L SL + L N L+G+ P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
A E A GL +LH S I++RD+K +N++LD+ +ADFG+ K G +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TF 161
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD 897
G+ YIAPE + D ++FGV+L E++ G+ P DG D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF----DGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 48/294 (16%)
Query: 692 IGKGGAGIVYKGLMPN---GD---QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G+G G+VY+G + G+ +VAVK + + N G H H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLH----------GKKGGHLHWDTRYKIAVEAAK 795
RLLG S + L+V E M +G L L G+ L ++A E A
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIAD 130
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG- 854
G+ YL+ + VHRD+ + N ++ F + DFG+ + + ++ G G
Sbjct: 131 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGL 182
Query: 855 ----YIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSK 909
++APE SD++SFGVVL E+ + +P G+ Q ++ + D
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY----QGLSNEQVLKFVMDG- 237
Query: 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963
G L P + ++M +C + RPT E+V +L + P
Sbjct: 238 --GYLD--QPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLKDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 684 DCLKEDNIIGKGGAGIVYKG--LMPNGDQVAVKRLPAMSRGSSHDHGFN-------AEIQ 734
+C+ E IG+G G V+K L G VA+KR+ R + + G A ++
Sbjct: 4 ECVAE---IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLR 56
Query: 735 TLGRIRHRHIVRLLGFCS----NHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI 789
L H ++VRL C+ + ET L LV+E++ + L L + +T +
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 115
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
+ +GL +LH S +VHRD+K NIL+ S + +ADFGLA+ ++++
Sbjct: 116 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSV 169
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD 897
+ Y APE D++S G + E+ RKP+ VD
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 58/240 (24%), Positives = 111/240 (46%), Gaps = 32/240 (13%)
Query: 731 AEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK--GGHLHWDT-- 785
+E++ + I +H++I+ LLG C+ ++ EY G+L E L ++ G +DT
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 786 ----------RYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835
A + A+G+ YL S +HRD+ + N+L+ +ADFGLA+
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG 895
+ + + + ++APE + +SDV+SFGV+L E+ T G G
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LGGSPYPG 239
Query: 896 VDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+ + + + + + + +D P+ HE ++ + C +RPT +++V+
Sbjct: 240 IPVEELFKLLKEGHR------MDK--PANCTHE---LYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 54/167 (32%), Positives = 75/167 (44%), Gaps = 34/167 (20%)
Query: 735 TLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDT----RYKI 789
T RH +V L C E ++ V EY G L H+H D R
Sbjct: 55 TANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMM--------HIHTDVFSEPRAVF 105
Query: 790 -AVEAAKGLCYLH-HDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSEC 845
A GL YLH + IV+RD+K +N+LLD+ E V ADFGL K + G +
Sbjct: 106 YAACVVLGLQYLHENK----IVYRDLKLDNLLLDT--EGFVKIADFGLCK--EGMGFGDR 157
Query: 846 MSAIAGSYGYIAPEY----AYTLKVDEKSDVYSFGVVLLELITGRKP 888
S G+ ++APE +YT V D + GV++ E++ G P
Sbjct: 158 TSTFCGTPEFLAPEVLTETSYTRAV----DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 69/266 (25%), Positives = 127/266 (47%), Gaps = 26/266 (9%)
Query: 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G GIV +G QVAVK + + + + FN E+ + +H+++V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD-LRKQQRRELLFN-EVVIMRDYQHQNVVEMYKS 86
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
E ++ E++ G+L +++ + L+ + + + LCYLH S ++H
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 811 RDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS 870
RD+KS++ILL ++DFG Q S ++ G+ ++APE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 871 DVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV-PLHEV 929
D++S G++++E++ G P F D VQ ++++ DS P+L + + V
Sbjct: 199 DIWSLGIMVIEMVDGEPPY--FSDSP--VQAMKRLRDSPP--------PKLKNAHKISPV 246
Query: 930 MHVFYVAMLCVEEQAVERPTMREVVQ 955
+ F ML E Q ER T +E++
Sbjct: 247 LRDFLERMLTREPQ--ERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 691 IIGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIV 745
++G+G G+V K Q VA+K+ S D EI+ L ++RH ++V
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLE----SEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
L+ + LV+E++ + L ++ G +Y + C+ H+
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
I+HRD+K NIL+ + DFG A+ L G +A + Y APE L
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRW-YRAPEL---LV 173
Query: 866 VDEKS----DVYSFGVVLLELITG 885
D K D+++ G ++ E++TG
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRHIVRLLG 749
IG G G VY + N + VA+K++ + S+ E++ L ++RH + ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
T LV EY GS ++L K L + A +GL YLH S ++
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH---SHNMI 137
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL---KV 866
HRDVK+ NILL + DFG A + + + G+ ++APE + +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQY 191
Query: 867 DEKSDVYSFGVVLLELITGRKP 888
D K DV+S G+ +EL RKP
Sbjct: 192 DGKVDVWSLGITCIEL-AERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 692 IGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRHIVRLLG 749
IG G G VY + ++ VAVK++ + ++ E++ L +++H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
T LV EY GS ++L K L I A +GL YLH ++
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHSHN---MI 143
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL---KV 866
HRD+K+ NILL + +ADFG A S +S S + Y ++APE + +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPY-WMAPEVILAMDEGQY 197
Query: 867 DEKSDVYSFGVVLLELITGRKP 888
D K DV+S G+ +EL RKP
Sbjct: 198 DGKVDVWSLGITCIEL-AERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G +G VY + + G +VA+K++ + + + N EI + ++ +IV L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIIN-EILVMRENKNPNIVNYLDS 84
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV--EAAKGLCYLHHDCSPLI 808
+ +V EY+ GSL +V+ D AV E + L +LH S +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLH---SNQV 136
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
+HRD+KS+NILL + DFG Q + S + G+ ++APE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 869 KSDVYSFGVVLLELITGRKP 888
K D++S G++ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-10
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 1/158 (0%)
Query: 731 AEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA 790
+E+ L H IV+ + + LL+ EY G L + + + HL + Y++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIA 850
+ + + L S ++HRD+KS NI L + DFG +K DS + + S+
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ Y+APE + +K+D++S GV+L EL+T +P
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 12/207 (5%)
Query: 686 LKEDNIIGKGGAGIVYK-GLMPNGDQVAVKRLPA--MSRGSSHDHGFNAEIQTLGRIRHR 742
++ ++GKGG G V + G A K+L + + N E Q L ++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSR 60
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLG-EVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+V L + LV M G L + H + G + AA+ C L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF----EEGRAVFYAAEICCGLE 116
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
IV+RD+K NILLD ++D GLA + + T + G+ GY+APE
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVV 173
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKP 888
+ D ++ G +L E+I G+ P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 27/190 (14%)
Query: 708 GDQVAVKRL------PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG-FCSNHETNLLV 760
G VA+K++ P +++ + E++ L +RH +I+ L F S E V
Sbjct: 35 GQNVAIKKIMKPFSTPVLAK-----RTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFV 88
Query: 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL 820
E + L +L L + +GL Y+H S +VHRD+K +NIL+
Sbjct: 89 TELLGT-DLHRLL---TSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILI 141
Query: 821 DSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVL 879
+ + + DFGLA+ +QD M+ + Y APE T K D + D++S G +
Sbjct: 142 NENCDLKICDFGLAR-IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIF 196
Query: 880 LELITGRKPV 889
E++ G KP+
Sbjct: 197 AEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 66/272 (24%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 692 IGKGGAGIVYKG-LMPNGDQVAVKRLPA---MSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
IG+G VY+ + +G VA+K++ M + D EI L ++ H ++++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLNHPNVIKY 67
Query: 748 LG-FCSNHETNLLVYEYMPNGSLGEVL-HGKKGGHLHWD-TRYKIAVEAAKGLCYLHHDC 804
F ++E N+ V E G L ++ H KK L + T +K V+ L ++H
Sbjct: 68 YASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--- 123
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
S ++HRD+K N+ + + + D GL +F T+ ++ G+ Y++PE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN 181
Query: 865 KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924
+ KSD++S G +L E+ + P +GD +++ +K+ P LPS
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEQCDY--------PPLPSD 231
Query: 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956
H + + +C+ +RP + V +
Sbjct: 232 --HYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 30/235 (12%)
Query: 692 IGKGGAGIVYKGLM---PNGDQ---VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G+ G VYKG + G+Q VA+K L + G + F E R++H +IV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE-FKHEAMMRSRLQHPNIV 71
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVL-----HGKKG---------GHLHWDTRYKIAV 791
LLG + + +++ Y + L E L H G L I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 792 EAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
+ A G+ +L HH +VH+D+ + N+L+ ++D GL + + + + M
Sbjct: 132 QIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVR 903
+++PE K SD++S+GVVL E+ + G +P + + D+++ +R
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 70/266 (26%), Positives = 121/266 (45%), Gaps = 39/266 (14%)
Query: 710 QVAVKRLPAMSRGSSHD-HGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNG 767
+VAVK L S + D +E++ + I +H++I+ LLG C+ ++ EY G
Sbjct: 52 KVAVKMLK--SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 768 SLGEVLHGKKGGHLHW--------------DTRYKIAVEAAKGLCYLHHDCSPLIVHRDV 813
+L E L ++ + + A + A+G+ YL S +HRD+
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDL 166
Query: 814 KSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVY 873
+ N+L+ +ADFGLA+ + + + ++APE + +SDV+
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226
Query: 874 SFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHV 932
SFGV+L E+ T G P GV + + + + KEG +D PS +E+
Sbjct: 227 SFGVLLWEIFTLGGSPY----PGVPVEELFKLL----KEG--HRMDK--PSNCTNEL--- 271
Query: 933 FYVAML-CVEEQAVERPTMREVVQIL 957
Y+ M C +RPT +++V+ L
Sbjct: 272 -YMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-10
Identities = 42/118 (35%), Positives = 57/118 (48%), Gaps = 6/118 (5%)
Query: 308 LNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTL 367
L L L G IP I + L+ + L N+ G+IP LGS L +LDLS N G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 368 PPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSL 425
P + L+ L GN L G +P +LG L R NF + + GL G+P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGG-RLLHRASF--NFTDNA---GLCGIPGL 534
|
Length = 623 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 64/269 (23%), Positives = 117/269 (43%), Gaps = 26/269 (9%)
Query: 691 IIGKGGAGIVYKGLM---PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
++GKG G V L+ +G Q +K+L + E Q L +++H +IV
Sbjct: 7 VVGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 748 LGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
+ L +V + G L L +KG L + + V+ A L YLH
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
I+HRD+K+ N+ L V D G+A+ L++ + S + G+ Y++PE
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLIGTPYYMSPELFSNKPY 179
Query: 867 DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926
+ KSDV++ G + E+ T + + D+ V ++ + K + K P L +
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAF----NAKDMNSLVYRIIEGKLPPMPKDYSPELGEL-- 233
Query: 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
ML ++ +RP+++ +++
Sbjct: 234 -------IATMLS--KRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G +G VY + + G +VA++++ + + + N EI + ++ +IV L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIIN-EILVMRENKNPNIVNYLDS 85
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV--EAAKGLCYLHHDCSPLI 808
+ +V EY+ GSL +V+ D AV E + L +LH S +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
+HRD+KS+NILL + DFG Q + S + G+ ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 869 KSDVYSFGVVLLELITGRKP 888
K D++S G++ +E+I G P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-10
Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 1/90 (1%)
Query: 139 LDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKI 198
L L N + G +P +++LR+L+ ++L GN G IPP G LE L +S N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 199 PGEIGNLTKLQQLYIGYYNSYTGGLPPEIG 228
P +G LT L+ L + NS +G +P +G
Sbjct: 483 PESLGQLTSLRILNLN-GNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 43/139 (30%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNI 818
V EY+ G L + H ++ G A E + GL +LH I++RD+K +N+
Sbjct: 78 FVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNV 132
Query: 819 LLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 878
+LDS +ADFG+ K G G+ YIAPE + D +++GV+
Sbjct: 133 MLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190
Query: 879 LLELITGRKPVGEFGDGVD 897
L E++ G+ P DG D
Sbjct: 191 LYEMLAGQPPF----DGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 9e-10
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 692 IGKGGAGIV---YKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG G GIV Y ++ VA+K+L + +H E+ + + H++I+ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 749 GFCSNHET------NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
+ ++ LV E M + +L +V+ + D +++ + LC + H
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ------MELDHE-RMSYLLYQMLCGIKH 134
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
S I+HRD+K +NI++ S + DFGLA+ +GTS M+ + Y APE
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 863 TLKVDEKSDVYSFGVVLLELI 883
+ E D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNA--EIQTLGRIRHRHIVRLL 748
+G+G VYKG+ NG VA+K +S + F A E L ++H +IV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK---VISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
ET V+EYM + L + + GG LH + +GL Y+H I
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP-------EYA 861
+HRD+K N+L+ E +ADFGLA+ S S+ S+ + Y P +Y+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 862 YTLKVDEKSDVYSFGVVLLELITGR 886
L D++ G + +E++ G+
Sbjct: 183 SAL------DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 48/198 (24%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 692 IGKGGAGIV-YKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G GIV + +G VAVK++ + + + FN E+ + +H ++V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD-LRKQQRRELLFN-EVVIMRDYQHENVVEMYNS 85
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
+ +V E++ G+L +++ + ++ + + + K L LH + ++H
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLH---AQGVIH 139
Query: 811 RDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS 870
RD+KS++ILL ++DFG Q S ++ G+ ++APE L +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 871 DVYSFGVVLLELITGRKP 888
D++S G++++E++ G P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 24/155 (15%)
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
+ + ++L + + ++L+ +Y+ +G L ++L KK G L KI + + L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 801 HHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
H I+H D+K N+L D ++ D+GL K GT C G+ Y +PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYD---GTLDYFSPE 176
Query: 860 ------YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y + D ++ GV+ EL+TG+ P
Sbjct: 177 KIKGHNYDVSF------DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 61/225 (27%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 692 IGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNA---EIQTLGRIRHRHIVRL 747
+GKGG G V M G A K+L + G+ E + L ++ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLN--KKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI---------------AVE 792
Y + L V+ GG D RY I
Sbjct: 59 ------------AYAFQTKTDLCLVMTIMNGG----DLRYHIYNVDEENPGFPEPRACFY 102
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS 852
A+ + L H I++RD+K N+LLD+ ++D GLA L+D + AG+
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160
Query: 853 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD 897
G++APE + D D ++ GV L E+I R P G+ V+
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 28/87 (32%), Positives = 46/87 (52%)
Query: 425 LSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFS 484
+ + L + L G P S +L I LS N + G++P S+G + ++ L L N F+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 485 GQIPAEIGKLQQLSKMDFSHNKFSGRI 511
G IP +G+L L ++ + N SGR+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRL------PAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
IG+G G+V+K G VA+K+ P + + + EI+ L +++H ++
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR------EIRMLKQLKHPNL 62
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH-HD 803
V L+ LV+EY + L E+ +G + KI + + + + H H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY--- 860
C +HRDVK NIL+ + + DFG A+ L +G + + + Y APE
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLVG 174
Query: 861 --AYTLKVDEKSDVYSFGVVLLELITG 885
Y V DV++ G V EL+TG
Sbjct: 175 DTQYGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 11/201 (5%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
IG G G VYK N ++A ++ + G EI + +H +IV G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
+ + E+ GSL ++ H G L ++ E +GL YLH +HR
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK---VDE 868
D+K NILL +ADFG++ Q + T + G+ ++APE A + ++
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 869 KSDVYSFGVVLLELITGRKPV 889
D+++ G+ +EL + P+
Sbjct: 189 LCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 692 IGKGGAGIV---YKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG G GIV Y ++ VA+K+L + +H E+ + + H++I+ LL
Sbjct: 32 IGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 749 GFCSNHET-----NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+ ++ ++ + + + +L +V+ + D +++ + LC + H
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHE-RMSYLLYQMLCGIKHL 142
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
S I+HRD+K +NI++ S + DFGLA+ +GTS M+ + Y APE
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 864 LKVDEKSDVYSFGVVLLELITGR 886
+ E D++S G ++ E+I G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVK--RLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG+G G+VYK G+ VA+K RL + G EI L + H +IV+LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 65
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
LV+E++ + L + + + + +GL + H S +
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRV 121
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQ---DSGTSECMSAIAGSYGYIAPEYA---- 861
+HRD+K N+L+++ +ADFGLA+ + T E + + Y APE
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEILLGCK 176
Query: 862 -YTLKVDEKSDVYSFGVVLLELITGR 886
Y+ V D++S G + E++T R
Sbjct: 177 YYSTAV----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G +G V+ + + G +VA+K++ + + + N EI + +++ +IV L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIIN-EILVMKELKNPNIVNFLDS 84
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV--EAAKGLCYLHHDCSPLI 808
+ +V EY+ GSL +V+ D AV E + L +LH + +
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHAN---QV 136
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
+HRD+KS+N+LL + DFG Q + S + G+ ++APE
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 869 KSDVYSFGVVLLELITGRKP 888
K D++S G++ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 21/149 (14%)
Query: 750 FCSNHETNLL--VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA----VEAAKGLCYLHHD 803
FC+ + L V EYMP G L ++ ++D K A E L +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMS-------NYDVPEKWAKFYTAEVVLALDAIH-- 159
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
S ++HRDVK +N+LLD +ADFG + ++G C +A+ G+ YI+PE +
Sbjct: 160 -SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKS 217
Query: 864 LKVD----EKSDVYSFGVVLLELITGRKP 888
D + D +S GV L E++ G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 673 QRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA 731
Q L+ T +V + + + +G G G V G +VAVK+L + H
Sbjct: 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHET-----NLLVYEYMPNGSLGEVLHGKKGGHLHWDTR 786
E++ L ++H +++ LL + + ++ + ++ L ++ +K L D
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHV 122
Query: 787 YKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846
+ + +GL Y+H S I+HRD+K +N+ ++ E + DFGLA+ T + M
Sbjct: 123 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEM 174
Query: 847 SAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGR 886
+ + Y APE + ++ D++S G ++ EL+TGR
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 686 LKEDNIIGKGGAGIVYK-GLMPNGDQVAVKRLPA--MSRGSSHDHGFNAEIQTLGRIRHR 742
++ ++GKGG G V + G A KRL + + N E Q L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQ 60
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
+V L + LV M G L H G+ ++ + AA+ LC L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEE-RALFYAAEILCGLED 117
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
V+RD+K NILLD ++D GLA + + E + G+ GY+APE
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GESIRGRVGTVGYMAPEVLN 174
Query: 863 TLKVDEKSDVYSFGVVLLELITGRKP 888
+ D + G ++ E+I G+ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 692 IGKGGAGIVYKGLMPN------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G+G G+VY+G+ +VA+K + + N E + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-EASVMKEFNCHHVV 72
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTR--------YKIAVEAAKGL 797
RLLG S + L++ E M G L L + + + ++A E A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 857
YL+ + VHRD+ + N ++ F + DFG+ + + ++ +++
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELIT 884
PE SDV+SFGVVL E+ T
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 23/243 (9%)
Query: 673 QRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA 731
Q ++ T +V D ++ +G G G V L G +VA+K+L +
Sbjct: 4 QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNL-------LVYEYMPNGSLGEVLHGKKGGHLHWD 784
E++ L ++H +++ LL + + +L LV +M LG+++ +K L D
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTP-DLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSED 118
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
+ + KGL Y+H + I+HRD+K N+ ++ E + DFGLA+ T
Sbjct: 119 RIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDS 170
Query: 845 CMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903
M+ + Y APE + + D++S G ++ E++TG KP+ + D +D + +
Sbjct: 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLMEIM 229
Query: 904 KMT 906
K+T
Sbjct: 230 KVT 232
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 691 IIGKGGAGIVYKGLMPNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
++GKG G V + + + D +VAVK L A SS F E + H ++++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 747 LLGFCSNHETN------LLVYEYMPNGSLGEVLHGKKGGH----LHWDTRYKIAVEAAKG 796
L+G +++ +M +G L L + G L T + ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK--FLQDSGTSECMSAIAGSYG 854
+ YL S +HRD+ + N +L+ VADFGL+K + D C S +
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVK 180
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKP 888
++A E SDV++FGV + E++T G+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 692 IGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
IG+G G+VYKG Q VA+K++ R S + G + EI L ++H +IV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHG-KKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
L L++E++ + L + L KG ++ + + +G+ + H S
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---S 119
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG------TSECMSAIAGSYGYIAPE 859
++HRD+K N+L+D+ +ADFGLA+ G T E + + Y APE
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF---GIPVRVYTHEVV-----TLWYRAPE 171
Query: 860 Y-----AYTLKVDEKSDVYSFGVVLLELITGRKPV 889
Y+ V D++S G + E+ T +KP+
Sbjct: 172 VLLGSPRYSTPV----DIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 63/272 (23%), Positives = 117/272 (43%), Gaps = 44/272 (16%)
Query: 687 KEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA---------EIQTL 736
K IG G G+V + +G +VA+K++P H F+ E++ L
Sbjct: 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIP---------HAFDVPTLAKRTLRELKIL 58
Query: 737 GRIRHRHIVRLLGFC---SNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVE 792
+H +I+ + ++ +V + M + L ++H + RY +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEH-IRY-FLYQ 115
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC--MSAIA 850
+GL Y+H S ++HRD+K +N+L++ E + DFG+A+ L S T M+
Sbjct: 116 LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 851 GSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909
+ Y APE +L + D++S G + E++ GR+ + + V ++ + + S
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 910 KEGVLKILD-----------PRLPSVPLHEVM 930
E VL + PR VP ++
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF 263
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 43/131 (32%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNI 818
V EY+ G L + ++ G A E A GL +LH S I++RD+K +N+
Sbjct: 78 FVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNV 132
Query: 819 LLDSGFEAHVADFGLAK-FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGV 877
+LDS +ADFG+ K + D T++ G+ YIAPE + D ++FGV
Sbjct: 133 MLDSEGHIKIADFGMCKENMWDGVTTK---TFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189
Query: 878 VLLELITGRKP 888
+L E++ G+ P
Sbjct: 190 LLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 38/99 (38%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
A E A L YLH S I++RD+K NILLDS + DFGL K + S+ S
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTF 156
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ Y+APE D D + G VL E++ G P
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 45/169 (26%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ AKG+ +L S +HRD+ + NILL G + DFGLA+ +++
Sbjct: 222 QVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
++APE + +SDV+S+G++L E+ + G P G+ + KM K
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGMPVDSKFYKMI---K 331
Query: 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
EG ++L P ++++M C + ++RPT +++VQ++ +
Sbjct: 332 EG-YRMLSPECAPSEMYDIMKS------CWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
+G G G VYK + ++A ++ + G EI + +H +IV G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIVAYFGSY 75
Query: 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811
+ E + EY GSL ++ H G L + E +GL YLH S +HR
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHR 130
Query: 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK---VDE 868
D+K NILL + +ADFG+A + + T + G+ ++APE A K ++
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 869 KSDVYSFGVVLLELITGRKPV 889
D+++ G+ +EL + P+
Sbjct: 189 LCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 18/189 (9%)
Query: 713 VKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGE 771
+K+ + + + +H E Q L IR + L + +T L L+ +Y+ G L
Sbjct: 36 LKKATIVQKAKTTEHT-RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT 94
Query: 772 VLHGKKGGHLHWDTRYK---IAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV 828
HL R+K + + + + + L H I++RD+K NILLDS +
Sbjct: 95 --------HLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 146
Query: 829 ADFGLAK-FLQDSGTSECMSAIAGSYGYIAPEYAYTLKV--DEKSDVYSFGVVLLELITG 885
DFGL+K F +D E + G+ Y+AP+ D+ D +S GV++ EL+TG
Sbjct: 147 TDFGLSKEFHEDE--VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
Query: 886 RKPVGEFGD 894
P G+
Sbjct: 205 ASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 691 IIGKGGAGIVYKGLMPNGDQV-AVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+IGKG G V ++ AVK L A+ + H + L ++H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI-AVEAAKGLCYLHHDCSP 806
+ V +Y+ NG GE+ + + + R + A E A L YLH S
Sbjct: 62 HFSFQTADKLYFVLDYI-NG--GELFYHLQRERCFLEPRARFYAAEIASALGYLH---SL 115
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAK-FLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
IV+RD+K NILLDS + DFGL K ++ +GT+ S G+ Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPEVLHKQP 172
Query: 866 VDEKSDVYSFGVVLLELITGRKP 888
D D + G VL E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 27/220 (12%)
Query: 691 IIGKGGAG-IVYKGLMPNGDQVAVKRLPAMS--RGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+IGKG G ++ +G AVK L + + +H L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYK------IAVEAAKGLCYLH 801
E V +Y+ NG GE+ HL + + A E A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYV-NG--GELFF-----HLQRERCFLEPRARFYAAEVASAIGYLH 113
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
S I++RD+K NILLDS + DFGL K + E S G+ Y+APE
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVL 168
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKP-----VGEFGDGV 896
D D + G VL E++ G P V + D +
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNA--EIQTLGRIRHRHIVRLL 748
+G+G VYKG NG VA+K + + F A E L ++H +IV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT---PFTAIREASLLKGLKHANIVLLH 69
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
ET LV+EY+ + L + + GG LH + + +GL Y+H I
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQR---YI 124
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP-------EYA 861
+HRD+K N+L+ E +ADFGLA+ S S S + Y P EY+
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 862 YTLKVDEKSDVYSFGVVLLELITG 885
L D++ G + +E+I G
Sbjct: 183 TCL------DMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
C + L LV EY+ G L + H ++ L + A E L +LH I+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---II 118
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEK 869
+RD+K +N+LLD+ + D+G+ K + G + S G+ YIAPE +
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 870 SDVYSFGVVLLELITGRKPVGEFGDGVDI 898
D ++ GV++ E++ GR P D D+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDM 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 51/168 (30%), Positives = 75/168 (44%), Gaps = 29/168 (17%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHL---------- 781
E L + H IV+L H Y + G L +L +GG L
Sbjct: 48 ERDILAEVNHPFIVKL------H------YAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 95
Query: 782 -HWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840
D ++ +A E A L +LH S I++RD+K NILLD + DFGL+K D
Sbjct: 96 TEEDVKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151
Query: 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ G+ Y+APE + +D +SFGV++ E++TG P
Sbjct: 152 EKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-09
Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNI 818
+V EYMP G L ++ W R+ A E L +H S +HRDVK +N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-KW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNM 173
Query: 819 LLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD----EKSDVYS 874
LLD +ADFG + +G C +A+ G+ YI+PE + D + D +S
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 875 FGVVLLELITGRKP 888
GV L E++ G P
Sbjct: 233 VGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-08
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 692 IGKGGAGIV---YKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG G GIV Y + G VA+K+L + +H E+ + + H++I+ LL
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 749 GFCSNHETNL-------LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+ +L LV E M + +L +V+ H Y + + LC +
Sbjct: 82 N-VFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLD---HERMSYLLY----QMLCGIK 132
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
H S I+HRD+K +NI++ S + DFGLA+ +GTS M+ + Y APE
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 189
Query: 862 YTLKVDEKSDVYSFGVVLLELITGR 886
+ E D++S G ++ E+I G
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G+G VYKG G+ VA+K + + + EI + ++H +IVRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 751 CSNHETNLLVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
+LV+EYM + L + + HG +G L +T + KG+ + H + +
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQ---DSGTSECMSAIAGSYGYIAPEYAYTLK 865
+HRD+K N+L++ E +ADFGLA+ ++ ++E + + Y AP+ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-----TLWYRAPDVLLGSR 176
Query: 866 VDEKS-DVYSFGVVLLELITGR 886
S D++S G ++ E+ITGR
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-EIQTLGRI-RHRHIVRLL 748
+G G G VY G+ VA+K++ + S + N E+++L ++ H +IV+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM--KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 749 G-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
F N E V+EYM G+L +++ +KG I + +GL ++H
Sbjct: 65 EVFRENDELYF-VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--- 119
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAK 835
HRD+K N+L+ +ADFGLA+
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 69/251 (27%), Positives = 110/251 (43%), Gaps = 34/251 (13%)
Query: 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
IG+G G V+K + VA+KR+ R D G + EI L ++H++IVR
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKK-----GGHLHWDTRYKIAVEAAKGLCYLH 801
L + + LV+EY KK G + + + KGL + H
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDL-------KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS-ECMSAIAGSYGYIAPEY 860
S ++HRD+K N+L++ E +ADFGLA+ G C SA + Y P+
Sbjct: 117 ---SHNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPPDV 170
Query: 861 AYTLKVDEKS-DVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE----GVLK 915
+ K+ S D++S G + EL +P+ D D ++ + ++ + E GV K
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 916 ILD-PRLPSVP 925
+ D P P
Sbjct: 231 LPDYKPYPMYP 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRG-----SSHDHGFNAEIQTLGRIRHRHIVR 746
IGKG G V + + D + L + + S H AE L ++ IV
Sbjct: 1 IGKGSFGKVMQ--VRKRDTQRIYALKTIRKAHIVSRSEVTHTL-AERTVLAQVNCPFIVP 57
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTR---YKIAVEAAKGLCYLHHD 803
L + E LV ++ NG GE+ H HL + R + A+ LC L +
Sbjct: 58 LKFSFQSPEKLYLVLAFI-NG--GELFH-----HLQREGRFDLSRARFYTAELLCALENL 109
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVA--DFGLAKF-LQDSGTSECMSAIAGSYGYIAPEY 860
+++RD+K NILLD ++ H+A DFGL K ++D + G+ Y+APE
Sbjct: 110 HKFNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTN---TFCGTPEYLAPEL 164
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ D ++ GV+L E++TG P
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-08
Identities = 61/230 (26%), Positives = 95/230 (41%), Gaps = 40/230 (17%)
Query: 691 IIGKGGAGIVYKGLMPN-GDQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+IGKGG G VY P +VA+K++ +S F E + + H IV +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 749 GFCSNHETNLLVYEYMP---NGSLGEVLHG-------KKGGHLHWDTRYK----IAVEAA 794
CS+ + VY MP +L +L K L T I +
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSK--ELAEKTSVGAFLSIFHKIC 123
Query: 795 KGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ---------DSGTSEC 845
+ Y+H S ++HRD+K +NILL E + D+G A F + D
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 846 MSA-------IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ I G+ Y+APE + E +D+Y+ GV+L +++T P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 24/160 (15%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLV--------YEYMPNGSLGEVLHGKKGGHLHW 783
E L + H ++R+ + +V Y Y+ S L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS----------RPLPI 156
Query: 784 DTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843
D I + +GL YLH + I+HRDVK+ NI ++ + + D G A+F +
Sbjct: 157 DQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVA 210
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 883
+AG+ APE K + K+D++S G+VL E++
Sbjct: 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 45/142 (31%), Positives = 65/142 (45%), Gaps = 17/142 (11%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIA--VEAAKGLCYLHHDCSPLIVHRDVKS 815
LV EY P G L +L+ + D ++ +A V A + + + VHRD+K
Sbjct: 78 LVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLAELVLAIHSVHQMGY------VHRDIKP 130
Query: 816 NNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS----- 870
N+L+D +ADFG A L + + G+ YIAPE T+ D K
Sbjct: 131 ENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTYGVE 189
Query: 871 -DVYSFGVVLLELITGRKPVGE 891
D +S GV+ E+I GR P E
Sbjct: 190 CDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 10/201 (4%)
Query: 691 IIGKGGAGIVYK-GLMPNGDQVAVKRLPA--MSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
++GKGG G V + G A K+L + + N E Q L ++ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSRFVVSL 65
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+ LV M G L H G+ +D + AA+ C L
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEE-RAVFYAAEITCGLEDLHRER 122
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
IV+RD+K NILLD ++D GLA + + E + G+ GY+APE +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVGYMAPEVVKNERYT 179
Query: 868 EKSDVYSFGVVLLELITGRKP 888
D + G ++ E+I G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 692 IGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG- 749
+G G G V + VA+K+L + + H E++ L + H +++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 750 FC-----SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
F + + LV M L ++ +K L D + + +GL Y+H
Sbjct: 83 FTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK---LSDDHIQFLVYQILRGLKYIH--- 135
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----- 859
S I+HRD+K +NI ++ E + DFGLA+ T + M+ + Y APE
Sbjct: 136 SAGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRAPEIMLNW 190
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y V D++S G ++ EL+TG+
Sbjct: 191 MHYNQTV----DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 692 IGKGGAGIVYKGLMPNGD--QVAVKRLPA--MSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+G G G V N D VA+KR + + DH F +E + L I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDC 804
G + LV E++ G L K R+ V AA+ + +
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNK--------RFPNDVGCFYAAQIVLIFEYLQ 148
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
S IV+RD+K N+LLD + DFG AK + + C G+ YIAPE +
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-----GTPEYIAPEILLNV 203
Query: 865 KVDEKSDVYSFGVVLLELITGRKP 888
+ +D ++ G+ + E++ G P
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 35/160 (21%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
IG+G G+VYK G+ VA+K++ R + D G + EI L + H +IVR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 747 LLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAA----------K 795
LL + E L LV+E++ L KK + D+ ++ +
Sbjct: 63 LLDVV-HSENKLYLVFEFLD-------LDLKK----YMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835
G+ Y H S ++HRD+K N+L+D +ADFGLA+
Sbjct: 111 GIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 40/269 (14%)
Query: 687 KEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGF-NAEIQTLGRIRHRHI 744
K NIIG G G+VY+ + + ++VA+K++ D + N E+ + + H +I
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLNHINI 121
Query: 745 VRLLGF-----CSNHETNL---LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI-AVEAAK 795
+ L + +E N+ +V E++P + H + H K+ + + +
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEA-HVADFGLAKFLQDSGTSECMSAIAGSYG 854
L Y+H S I HRD+K N+L+D + DFG AK L +S I +
Sbjct: 182 ALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL--AGQRSVSYICSRF- 235
Query: 855 YIAPEYA-----YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909
Y APE YT + D++S G ++ E+I G P+ VD + + ++ +
Sbjct: 236 YRAPELMLGATNYTTHI----DLWSLGCIIAEMILGY-PIFSGQSSVDQLVRIIQVLGTP 290
Query: 910 KEGVLKILDP-----RLPSVPLHEVMHVF 933
E LK ++P + P V ++ VF
Sbjct: 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVF 319
|
Length = 440 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPAMS-RGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+GKGG G V + N G A K+L + S + E + L ++ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 750 FCSNHETNL-LVYEYMPNGSLG-EVLH-GKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
+ +T+L LV M G L + + G++G + Y + + G+ +LH S
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY--SAQITCGILHLH---SM 114
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
IV+RD+K N+LLD ++D GLA L+D T ++ AG+ GY+APE
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPY 171
Query: 867 DEKSDVYSFGVVLLELITGRKPVGEFGDGVD 897
D ++ G + E++ GR P + + V
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 44/138 (31%), Positives = 64/138 (46%), Gaps = 19/138 (13%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA----VEAAKGLCYLHHDCSPLIVHRDVK 814
+V EYMP G L ++ ++D K A E L +H S +HRDVK
Sbjct: 120 MVMEYMPGGDLVNLMS-------NYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVK 169
Query: 815 SNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD----EKS 870
+N+LLD +ADFG + G C +A+ G+ YI+PE + D +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228
Query: 871 DVYSFGVVLLELITGRKP 888
D +S GV L E++ G P
Sbjct: 229 DWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 38/99 (38%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
A E A L YLH S IV+RD+K NILLDS + DFGL K + S+ +
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTF 156
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ Y+APE D D + G VL E++ G P
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 47/158 (29%), Positives = 65/158 (41%), Gaps = 9/158 (5%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIA 790
E + L RH + L H+ V EY G L H + D R+ A
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIA 850
E L YLH S +V+RD+K N++LD + DFGL K + M
Sbjct: 103 -EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 156
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ Y+APE D + GVV+ E++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 14/226 (6%)
Query: 691 IIGKGGAGIVYK-GLMPNGDQVAVKRLPA--MSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
++GKGG G V + G A K+L + + N E + L ++ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRILEKVNSRFVVSL 65
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI--AVEAAKGLCYLHHDCS 805
+ LV M G L H G+ +D + I A E GL L +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
IV+RD+K NILLD ++D GLA + + E + G+ GY+APE K
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRGRVGTVGYMAPEVINNEK 177
Query: 866 VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911
D + G ++ E+I G+ P + + V + R++ + ++E
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 50/223 (22%), Positives = 84/223 (37%), Gaps = 49/223 (21%)
Query: 692 IGKGGAGIVYKGLMPNGDQ---VAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHI 744
IG+G G VYK NG A+K+ G + EI L ++H ++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKG---DKEQYTGISQSACREIALLRELKHENV 64
Query: 745 VRLLGFCSNHETNL--LVYEYMPNGSLGEVLH---GKKGGHLHWDTRYKIAVEAAKGLCY 799
V L+ H L+++Y + L +++ K + + + G+ Y
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTSECMSAIAGSYG- 854
LH S ++HRD+K NIL+ + D GLA+ + +
Sbjct: 124 LH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN--------APLKPLADL 172
Query: 855 --------YIAPEYA-----YTLKVDEKSDVYSFGVVLLELIT 884
Y APE YT + D+++ G + EL+T
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 19/226 (8%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+IGKG G+V + G++VA+K++ + S EI+ L +RH IV +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 750 FC---SNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
S E +V+E M L +V+ K L + + + L Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-ESDLHQVI--KANDDLTPEHHQFFLYQLLRALKYIH--- 120
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKF-LQDSGTSECMSAIAGSYGYIAPEY--A 861
+ + HRD+K NIL ++ + + DFGLA+ D+ T+ + + Y APE +
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD 907
+ K D++S G + E++TG KP+ F G ++V + +TD
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTG-KPL--F-PGKNVVHQLDLITD 222
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 58/243 (23%), Positives = 89/243 (36%), Gaps = 72/243 (29%)
Query: 687 KEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDH--GFNA----EIQTLGRIR 740
+ +G+G G VYK Q+ R+ A+ + H+ GF EI+ L +++
Sbjct: 11 EILGKLGEGTFGEVYKAR-----QIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG--------------GHLHWDTR 786
H ++V L+ + E K+G G L +
Sbjct: 66 HPNVVPLID---------MAVERPDKS------KRKRGSVYMVTPYMDHDLSGLLE-NPS 109
Query: 787 YKIAVEAAK--------GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838
K+ K G+ YLH I+HRD+K+ NIL+D+ +ADFGLA+
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 839 DSGTSECMSAIAGS---YG-------YIAPEYA-----YTLKVDEKSDVYSFGVVLLELI 883
+ G Y Y PE YT V D++ G V E+
Sbjct: 167 GPPPNP-KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMF 221
Query: 884 TGR 886
T R
Sbjct: 222 TRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G G G VYK G A K + S D + EI L H +IV+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED--YMVEIDILASCDHPNIVKLLD- 69
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD---TRYKIAV---EAAKGLCYLHHD 803
+E NL ++ E+ G++ V+ L + T +I V + + L YLH +
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVM-------LELERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY- 862
I+HRD+K+ NIL + +ADFG++ +++ T + + G+ ++APE
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 863 -TLK---VDEKSDVYSFGVVLLELITGRKPVGEF 892
T K D K+DV+S G+ L+E+ P E
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-08
Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 179 GIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDA 238
G W F++ L + L G IP +I L LQ + + NS G +PP +G+++SL D
Sbjct: 416 GKW-FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSG-NSIRGNIPPSLGSITSLEVLDL 473
Query: 239 ANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELG 276
+ +G IP +G+L +L L L N+LSG + LG
Sbjct: 474 SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 790 AVEAAKGLCYLH-HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA 848
A E L +LH H +++RD+K +NILLD+ +ADFG+ K + +
Sbjct: 102 AAEVTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTT 155
Query: 849 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ YIAPE L+ D ++ GV++ E++ G+ P
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 34/214 (15%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRHIV 745
IG+G GIV ++VA+K++ ++ D+ +A EI+ L + H +++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-----ANAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 746 RLLGFCS-NHETNL----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
+ H +VYE M + L +++ + L D + +GL Y+
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQT--LSDDHCQYFLYQLLRGLKYI 124
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H S ++HRD+K +N+LL++ + + DFGLA+ S + M+ + Y APE
Sbjct: 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPEL 179
Query: 861 -----AYTLKVDEKSDVYSFGVVLLELITGRKPV 889
YT + DV+S G + EL+ GRKP+
Sbjct: 180 LLNCSEYTTAI----DVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 692 IGKGGAGIVYKG-LMPNGDQVAVKRLPAMSR-----GSSH--DHGFNAEIQTLGRIRHRH 743
+G+G +YKG L D V +S GS H F + ++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG-HLHWDTRYKIAVEAAKGLCYLHH 802
+V+L G C E N++V EY+ G L LH +K LHW + +A + A L YL
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118
Query: 803 DCSPLIVHRDVKSNNILL--DSGFEAHVADFGLAKFLQDSG-------TSECMSAIAGSY 853
+VH +V NIL+ E +V K L D G E + I
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPF---IK-LSDPGIPITVLSREERVERIP--- 169
Query: 854 GYIAPEYAYTL--KVDEKSDVYSFGVVLLEL 882
+IAPE + +D +SFG LLE+
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 52/140 (37%), Positives = 74/140 (52%), Gaps = 26/140 (18%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIAVEAAKGLCYLH-HDCSPLIVHRDVKSN 816
LV +YM G L H +K G D ++ IA E L +LH +D IV+RD+K
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD----IVYRDLKPE 125
Query: 817 NILLDSGFEAHVA--DFGLAKF-LQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS--- 870
NILLD+ H+A DFGL+K L D+ T+ + G+ Y+APE + +DEK
Sbjct: 126 NILLDA--TGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPE----VLLDEKGYTK 176
Query: 871 --DVYSFGVVLLELITGRKP 888
D +S GV++ E+ G P
Sbjct: 177 HVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 64/230 (27%)
Query: 689 DNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH--RHIV 745
D IG G G+V+ P +G +VA+K++P + F Q L + R +
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMP---------NVF----QNLVSCKRVFREL- 50
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLG---------EVLHGKKGGHLHWDTRYKIAV----- 791
++L F H+ L + + + E++ LH KI V
Sbjct: 51 KMLCFF-KHDNVLSALDILQPPHIDPFEEIYVVTELMQSD----LH-----KIIVSPQPL 100
Query: 792 ----------EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841
+ +GL YLH S I+HRD+K N+L++S + DFGLA+ +++
Sbjct: 101 SSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPD 156
Query: 842 TSECMSAIAGSYGYIAPEYA-----YTLKVDEKSDVYSFGVVLLELITGR 886
S+ M+ + Y APE YT V D++S G + EL+ R
Sbjct: 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 47/158 (29%), Positives = 65/158 (41%), Gaps = 9/158 (5%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV 791
E + L RH + L + V EY+ G L H + D
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA 102
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK-FLQDSGTSECMSAIA 850
E L YLH S IV+RD+K N++LD + DFGL K + D+ T M
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT---MKTFC 156
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ Y+APE D + GVV+ E++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 8/139 (5%)
Query: 751 CSNHETNLL-VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
C E+ L V EY+ G L + H ++ L + + E + L YLH I+
Sbjct: 64 CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 118
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEK 869
+RD+K +N+LLDS + D+G+ K + + S G+ YIAPE
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 870 SDVYSFGVVLLELITGRKP 888
D ++ GV++ E++ GR P
Sbjct: 177 VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 55/164 (33%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 731 AEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI 789
E Q L +R + L + +T L L+ +Y+ G L L+ ++ + R I
Sbjct: 53 TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYI 111
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAK-FLQDSGTSECM 846
A E L +LH I++RD+K NILLDS E HV DFGL+K FL + E
Sbjct: 112 A-EIVLALDHLHQLG---IIYRDIKLENILLDS--EGHVVLTDFGLSKEFLAEEE--ERA 163
Query: 847 SAIAGSYGYIAPEYAYTLKV--DEKSDVYSFGVVLLELITGRKP 888
+ G+ Y+APE D+ D +S GV+ EL+TG P
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 47/220 (21%)
Query: 691 IIGKGGAGIVY------KGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
IIG+GG G VY G M + KR+ M +G + N I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETL--ALNERI----------- 46
Query: 745 VRLLGFCSNHETNLLV---YEYMPNGSLGEVLHGKKGGHLHW-----------DTRYKIA 790
+L S + +V Y + L +L GG LH+ + R+ A
Sbjct: 47 --MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YA 103
Query: 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA-KFLQDSGTSECMSAI 849
E GL ++H+ +V+RD+K NILLD ++D GLA F + + A
Sbjct: 104 AEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF-----SKKKPHAS 155
Query: 850 AGSYGYIAPE-YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G++GY+APE + D +D +S G +L +L+ G P
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
C E+ L V E++ G L + H ++ L + + E + L +LH I+
Sbjct: 64 CFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGII 118
Query: 810 HRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
+RD+K +N+LLD+ E H+ D+G+ K + + S G+ YIAPE
Sbjct: 119 YRDLKLDNVLLDA--EGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 868 EKSDVYSFGVVLLELITGRKP 888
D ++ GV++ E++ GR P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 46/158 (29%), Positives = 64/158 (40%), Gaps = 9/158 (5%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV 791
E + L RH + L H+ V EY G L H + +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 102
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK-FLQDSGTSECMSAIA 850
E L YLH S +V+RD+K N++LD + DFGL K + D T M
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFC 156
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ Y+APE D + GVV+ E++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 46/158 (29%), Positives = 66/158 (41%), Gaps = 8/158 (5%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV 791
E + L RH + L H+ V EY G L H + D
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK-FLQDSGTSECMSAIA 850
E L YLH + + +V+RD+K N++LD + DFGL K ++D T M
Sbjct: 103 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFC 157
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ Y+APE D + GVV+ E++ GR P
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 28/146 (19%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHW-----------DTRYKIAVEAAKGLCYLHHDCSPL 807
+ Y + L +L GG LH+ + R+ A E GL ++H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNR---F 117
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY-----AY 862
+V+RD+K NILLD ++D GLA + + A G++GY+APE AY
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGTAY 173
Query: 863 TLKVDEKSDVYSFGVVLLELITGRKP 888
D +D +S G +L +L+ G P
Sbjct: 174 ----DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 36/234 (15%)
Query: 739 IRHRHIVRLLGFCS-NHETNLLVYEYMPNGSLGEVL----HGKKGGHLHWDTR--YKIAV 791
+ H++I+ +L C + E ++Y YM G+L L G+ T+ +A+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK--FLQDS---GTSECM 846
+ A G+ YLH ++H+D+ + N ++D + + D L++ F D G +E
Sbjct: 125 QIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKM 905
++A E + SDV+SFGV+L EL+T G+ P E +D + M
Sbjct: 182 PV-----KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE----IDPFE----M 228
Query: 906 TDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
K+G RL P++ +F V C ERP+ ++VQ LT+
Sbjct: 229 AAYLKDGY------RLAQ-PINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG- 749
+G G G V + G++VA+K+L + E+ L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 750 FCS-----NHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
F S + LV YM L G L D + + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDKVQYLVYQMLCGLKYIH--- 134
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT- 863
S I+HRD+K N+ ++ E + DFGLA+ +E M+ + Y APE
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAE-MTGYVVTRWYRAPEVILNW 189
Query: 864 LKVDEKSDVYSFGVVLLELITGR 886
+ ++ D++S G ++ E++TG+
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 52/234 (22%)
Query: 692 IGKGGAGIV----YKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+G+G GIV + VA+K++ + F+ +I +R ++L
Sbjct: 8 LGQGAYGIVCSARNAETSE-EETVAIKKITNV---------FSKKILAKRALRE---LKL 54
Query: 748 LGFCSNHE--TNLL--------------VYEYMPNGSLGEVLH-GKKGGHLHWDT-RYKI 789
L H+ T L +YE + L +++ G+ H+ + Y+I
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK-----FLQDSGTSE 844
GL Y+H S ++HRD+K N+L+++ E + DFGLA+ +++G
Sbjct: 115 LC----GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF-- 165
Query: 845 CMSAIAGSYGYIAPEYAYTLKVDEKS-DVYSFGVVLLELITGRKPVGEFGDGVD 897
M+ + Y APE + + K+ DV+S G +L EL+ GRKPV + D VD
Sbjct: 166 -MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVD 217
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 51/219 (23%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
IG+G G+VYK + +A+K++ R D G + EI L ++H +IVR
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI----RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA----------VEAAKG 796
L + + LV+EY+ L KK H D+ A + +G
Sbjct: 66 LQDVVHSEKRLYLVFEYLD-------LDLKK----HMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEA-HVADFGLAKFLQ---DSGTSECMSAIAGS 852
+ Y H S ++HRD+K N+L+D A +ADFGLA+ + T E + +
Sbjct: 115 IAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----T 166
Query: 853 YGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y APE Y+ V D++S G + E++ +
Sbjct: 167 LWYRAPEILLGSRHYSTPV----DIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGL 797
++ H+HIV L G C N++V E++ G L +H +K L ++K+A + A L
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASAL 118
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT-------SECMSAIA 850
YL +VH +V + NILL E + G L D G EC+ I
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAR--EGIDGECGPFIKLSDPGIPITVLSRQECVERIP 173
Query: 851 GSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLEL 882
+IAPE K +D +SFG L E+
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 18/148 (12%)
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSL----GEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
++V L + + ++ LV ++ G L + L+ + W +A++A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 858
LH + IV RD+ NNILLD + F ++DS E + + Y AP
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 859 EYAYTLKVDEKSDVYSFGVVLLELITGR 886
E + E D +S G +L EL+TG+
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 733 IQTLGRIRHRHIVRLLGFCSNHETNLL--VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA 790
I +L R H + +L +C + L V E++ G L + H +K A
Sbjct: 48 ILSLAR-NHPFLTQL--YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYA 102
Query: 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIA 850
E L +LH I++RD+K +N+LLD +ADFG+ K +G + S
Sbjct: 103 AEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFC 157
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ YIAPE + D ++ GV+L E++ G P
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 40/213 (18%)
Query: 691 IIGKGGAGI---VYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIV 745
I+GK G G V K G A+K + + + EIQ L R+ H +I+
Sbjct: 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNIL 61
Query: 746 RLLGFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
RL+ + +T LV+E M + +L E++ G+K L + K L ++H +
Sbjct: 62 RLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG------------TSECMSAIAG 851
I HRD+K NIL+ +ADFG + + EC+ G
Sbjct: 120 G---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL-LTDG 174
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 884
YG K D+++ G V E+++
Sbjct: 175 YYGP-------------KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 6/85 (7%)
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL---- 864
VHRD+K +N+LLD +ADFG + GT + A+ G+ YI+PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAMEDGM 182
Query: 865 -KVDEKSDVYSFGVVLLELITGRKP 888
K + D +S GV + E++ G P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 50/161 (31%), Positives = 70/161 (43%), Gaps = 24/161 (14%)
Query: 750 FCSNHETN---LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
FCS ET +V EY+ G +L K G L D E L YLH +
Sbjct: 67 FCS-FETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLH---NY 120
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKF------------LQDSGTSECM-SAIAGSY 853
IVHRD+K +N+L+ S + DFGL+K + T E + + G+
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 854 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGD 894
YIAPE + D ++ G++L E + G P FGD
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF--FGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-07
Identities = 66/246 (26%), Positives = 103/246 (41%), Gaps = 63/246 (25%)
Query: 691 IIGKGGAG---IVYKGLMPNGDQVAVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+IG+G G +V K G A+K+L M H AE L + +V
Sbjct: 8 VIGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEADNPWVV 64
Query: 746 RLLGFCS-NHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI-----AVEAAKGLC 798
+L + S E L L+ EY+P G + +L KK +TR+ I A+++ L
Sbjct: 65 KL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE-------------- 844
Y +HRD+K +N+LLD+ ++DFGL L+ S +E
Sbjct: 122 Y---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 845 -----CMS-------------AIA----GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 882
MS A+A G+ YIAPE +++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 883 ITGRKP 888
+ G P
Sbjct: 233 LVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 16/199 (8%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHG------FNAEIQTLGRIRHRHIV 745
+GKG G VY L+ + VA +RL + + N E Q L ++ H IV
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLH--GKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+ + ++ EY L L G L + + ++ G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
I+HRD+K+ NI L + + DFG+++ L G+ + + G+ Y++PE
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTGTPYYMSPEALKH 179
Query: 864 LKVDEKSDVYSFGVVLLEL 882
D KSD++S G +L E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 13/204 (6%)
Query: 691 IIGKGGAGIVYKGLMPNGDQ----VAVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
++GKGG G V++ G A+K L + R AE L ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
V L+ L+ EY+ G L +H ++ G DT E + L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
I++RD+K NILLD+ + DFGL K G G+ Y+APE
Sbjct: 121 ---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRS 175
Query: 865 KVDEKSDVYSFGVVLLELITGRKP 888
+ D +S G ++ +++TG P
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 60/229 (26%), Positives = 90/229 (39%), Gaps = 48/229 (20%)
Query: 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGR 738
D ++ IG+G G VYK G VA+K+ +R + G EI L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTALREISLLQM 56
Query: 739 IRHR-HIVRLLGFCSNHETN-----LLVYEYMPNGSLGEVL--HGKKGGH-LHWDTRYKI 789
+ +IVRLL E N LV+EY+ + L + + +G+ G L T
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD-SGFEAHVADFGLAKFLQDSGTSECMSA 848
+ KG+ + H ++HRD+K N+L+D +AD GL S
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL---------GRAFSI 163
Query: 849 IAGSYG-------YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITG 885
SY Y APE Y+ V D++S G + E+
Sbjct: 164 PVKSYTHEIVTLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 36/85 (42%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 808 IVHRDVKSNNILLDSGFEAHV--ADFGLAK-FLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
IV+RD+K NILLDS E HV DFGL+K FL + E + G+ Y+APE
Sbjct: 126 IVYRDIKLENILLDS--EGHVVLTDFGLSKEFLSEE--KERTYSFCGTIEYMAPEIIRGK 181
Query: 865 KVDEKS-DVYSFGVVLLELITGRKP 888
K+ D +S G+++ EL+TG P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 26/179 (14%)
Query: 728 GFNAEIQTLGRIRHRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTR 786
G E L I H I++L G F N T L++ Y K + + +
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY------------KTDLYCYLAAK 176
Query: 787 YKIAV--------EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838
IA+ + + YLH + I+HRD+K+ NI ++ + + DFG A F
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233
Query: 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD 897
D + AG+ APE D++S G+VL E+ T + E DG+D
Sbjct: 234 DI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE-KDGLD 290
|
Length = 391 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ A+G+ +L S +HRD+ + NILL + DFGLA+ + +
Sbjct: 182 QVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQ-WVRKMTDSK 909
++APE + +SDV+SFGV+L E+ + G P GV I + + +++ D
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQINEEFCQRLKDGT 294
Query: 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++ P + ++ +M + C + ERPT +V+IL +L
Sbjct: 295 -----RMRAPENATPEIYRIM------LACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 64/273 (23%), Positives = 118/273 (43%), Gaps = 21/273 (7%)
Query: 673 QRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNA 731
Q L+ T +V + + +G G G V Q VAVK+L + H
Sbjct: 4 QELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR 63
Query: 732 EIQTLGRIRHRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHG-KKGGHLHWDTRYKI 789
E++ L ++H +++ LL F Y+ +G L+ K L + +
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
+ +GL Y+H S I+HRD+K +N+ ++ E + DFGLA+ + M+
Sbjct: 124 IYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGY 175
Query: 850 AGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS 908
+ Y APE + ++ D++S G ++ EL+ G K + D +D ++ + ++ +
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG-KALFPGNDYIDQLKRIMEVVGT 234
Query: 909 KKEGVLKILDPR--------LPSVPLHEVMHVF 933
VLK + LP +P ++ +F
Sbjct: 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF 267
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 50/168 (29%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV 791
EI L I HR I+ L+ T +V MP + + G L + I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQR 192
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ L YLH I+HRDVK+ NI LD A + DFG A L + +G
Sbjct: 193 RLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 852 SYGYIAPEYAYTLKVD---EKSDVYSFGVVLLELITGRKPVGEFGDGV 896
+ +PE L +D K+D++S G+VL E+ + FG V
Sbjct: 250 TLETNSPEL---LALDPYCAKTDIWSAGLVLFEMSVKNVTL--FGKQV 292
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 691 IIGKGGAGIVYKGLMPNGDQV-AVKRL---PAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
+IG+G G V + N D+V A+K L + R + F E L ++ I
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA--CFREERDVLVNGDNQWITT 65
Query: 747 LLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIA--VEAAKGLCYLHH 802
L + E NL LV +Y G L +L K L D R+ +A V A + LH+
Sbjct: 66 L-HYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDSVHQLHY 123
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
VHRD+K +NIL+D +ADFG L + GT + A+ G+ YI+PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQ 176
Query: 863 TL-----KVDEKSDVYSFGVVLLELITGRKP 888
+ K + D +S GV + E++ G P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 706 PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV----- 760
P +++ KR+ A SR + EI LGR+ H +I+++ + ++
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ---LENEILALGRLNHENILKIEEILRSEANTYMITQKYD 246
Query: 761 ---YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNN 817
Y +M + + K L TR I + + Y+H ++HRD+K N
Sbjct: 247 FDLYSFMYDEAFDW-----KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLEN 297
Query: 818 ILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI------APEYAYTLKVDEKSD 871
I L+ + + DFG A + A YG++ +PE E +D
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEK-------EREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 872 VYSFGVVLLELITGR-KPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925
++S G++LL++++ P+G G + + K+ DS L + D P P
Sbjct: 351 IWSCGLILLDMLSHDFCPIG--DGGGKPGKQLLKIIDS-----LSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-06
Identities = 22/59 (37%), Positives = 31/59 (52%)
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNL 579
L +DLS N L+ G+ L L+LS N+L P + + + SL S+D S NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 44/230 (19%)
Query: 689 DNIIGKGGAGIVYKGLMPNGDQ-VAVKRLP--AMSRGSSHDH------GFN----AEIQT 735
+G+G G V K + VA+K++ +S + D G + E++
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 736 LGRIRHRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYK-IAVEA 793
+ I+H +I+ L+ + NL V + M L +V+ K +++ K I ++
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINL-VMDIM-ASDLKKVVDRKI---RLTESQVKCILLQI 128
Query: 794 AKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA-KFLQDSGTSEC------- 845
GL LH +HRD+ NI ++S +ADFGLA ++ +
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 846 ----MSAIAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 886
M++ + Y APE Y V D++S G + EL+TG+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAV----DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 66/212 (31%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 691 IIGKGGAGIVYKGLMPNGDQV-AVKRL---PAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
+IG+G G V M N QV A+K L + R + F E L R I
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETA--CFREERDVLVNGDRRWITN 65
Query: 747 LLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIA--VEAAKGLCYLHH 802
L + E NL LV +Y G L +L K L D R+ +A V A + L +
Sbjct: 66 L-HYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVLAIDSVHQLGY 123
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIA-GSYGYIAPEYA 861
VHRD+K +N+LLD +ADFG L GT S +A G+ YI+PE
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEIL 175
Query: 862 YTL-----KVDEKSDVYSFGVVLLELITGRKP 888
+ + + D +S GV + E++ G P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 48/151 (31%), Positives = 70/151 (46%), Gaps = 19/151 (12%)
Query: 692 IGKGGAGIVYKGLMP-NGDQVAVK--RLPAMSRGSSHDHG--FNA--EIQTLGRIRHRHI 744
+G+G VYKG G VA+K RL H+ G F A E L ++H +I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRL-------EHEEGAPFTAIREASLLKDLKHANI 65
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
V L +T LV+EY+ + L + + GG L + +GL Y H
Sbjct: 66 VTLHDIIHTKKTLTLVFEYL-DTDLKQYMD-DCGGGLSMHNVRLFLFQLLRGLAYCHQR- 122
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835
++HRD+K N+L+ E +ADFGLA+
Sbjct: 123 --RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 24/173 (13%)
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL-QDSGTSECMSAIA 850
+ A+G+ +L S +HRD+ + NILL + DFGLA+ + +D A
Sbjct: 181 QVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQ-WVRKMTDS 908
++APE + +SDV+SFGV+L E+ + G P GV I + + R++
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQIDEEFCRRL--- 289
Query: 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAML-CVEEQAVERPTMREVVQILTEL 960
KEG R P E+ Y ML C +RPT E+V+IL +L
Sbjct: 290 -KEGTRM----RAPEYATPEI----YSIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 18/170 (10%)
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ A+G+ +L S +HRDV + N+LL G A + DFGLA+ + +
Sbjct: 220 QVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
++APE + +SDV+S+G++L E+ + G+ P G V+ K K
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP--GILVN-----SKFYKMVK 329
Query: 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
G ++ P ++ +M +C + ERPT ++ Q++
Sbjct: 330 RG-YQMSRPDFAPPEIYSIMK------MCWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
+G+G V+KG + VA+K + H+ G E+ L ++H +IV
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRL-----EHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV-EAAKGLCYLHHDCS 805
L LV+EY+ + L + L G+L KI + + +GL Y H
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
I+HRD+K N+L++ E +ADFGLA+ S ++ S + Y P+ L
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPD--VLLG 177
Query: 866 VDEKS---DVYSFGVVLLELITGR 886
E S D++ G +L E+ TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 24/78 (30%), Positives = 43/78 (55%)
Query: 221 GGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKS 280
G +P +I L L + + + G IP +G + +L+ L L N+ +G + LG L S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 281 LKSMDLSNNIFTGEIPAS 298
L+ ++L+ N +G +PA+
Sbjct: 492 LRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 692 IGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
+G+G VYKG D VA+K + H+ G E+ L ++H +IV
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRL-----EHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
L ++ LV+EY+ + L + L G ++ + +GL Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLD-DCGNSINMHNVKLFLFQLLRGLNYCHRR--- 123
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY-TLK 865
++HRD+K N+L++ E +ADFGLA+ S ++ S + Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181
Query: 866 VDEKSDVYSFGVVLLELITGR 886
+ D++ G + E+ TGR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ AKG+ +L S +HRD+ + NILL + DFGLA+ +
Sbjct: 187 QVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDI-VQWVRKMTDSK 909
++APE + +SDV+SFGV+L E+ + G P GV I ++ R++
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRRL---- 295
Query: 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
KEG ++ P + +++ M + C + +RPT E+V+ L L
Sbjct: 296 KEGT-RMRAPDYTTPEMYQTM------LDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 39/178 (21%)
Query: 679 CDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EI 733
CD+V ++ IG+G G V+K VA+K++ + GF EI
Sbjct: 8 CDEV-SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREI 62
Query: 734 QTLGRIRHRHIVRLLGFCSNHETN--------LLVYEYMPNGSLGEVLHGKKGGHLHWDT 785
+ L ++H ++V L+ C T LV+E+ + L +L K
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-------- 113
Query: 786 RYKIAVEAAK--------GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835
K + K GL Y+H I+HRD+K+ NIL+ +ADFGLA+
Sbjct: 114 -VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 50/233 (21%), Positives = 91/233 (39%), Gaps = 58/233 (24%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNI 818
L+ E++P G + +L KK +T++ IA E + +H +HRD+K +N+
Sbjct: 78 LIMEFLPGGDMMTLLM-KKDTLTEEETQFYIA-ETVLAIDSIHQLG---FIHRDIKPDNL 132
Query: 819 LLDSGFEAHVADFGLAKFLQDSGTSECMS------------------------------- 847
LLDS ++DFGL L+ + +E
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 848 --AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKM 905
+ G+ YIAPE ++ D +S GV++ E++ G P
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF---------------C 237
Query: 906 TDSKKEGVLKILDPRL-----PSVPLHEVMHVFYVAMLCVEEQAVERPTMREV 953
+++ +E K+++ + P VP+ E + C E + P + E+
Sbjct: 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEI 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 1e-05
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 30/184 (16%)
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLL--VYEYMPNGSLGEVLHG--KKGGHLHWDTRY 787
E+ + ++H++IVR + N L + E+ G L + K G +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 788 KIAVEAAKGLCYLHH----DCSPLIVHRDVKSNNILLDSGFE-----------------A 826
I + L Y H+ ++HRD+K NI L +G A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 827 HVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELIT 884
+ DFGL+K + G + G+ Y +PE T D+KSD+++ G ++ EL +
Sbjct: 182 KIGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
Query: 885 GRKP 888
G+ P
Sbjct: 239 GKTP 242
|
Length = 1021 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 7/197 (3%)
Query: 691 IIGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
++G+G G+V K + VA+K+ E++ L ++ +IV L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
LV+EY+ L E+L G R I + K + + H + IV
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---DIV 122
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEK 869
HRD+K N+L+ + DFG A+ L + + +A + Y +PE +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELLLGAPYGKA 181
Query: 870 SDVYSFGVVLLELITGR 886
D++S G +L EL G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 19/129 (14%)
Query: 58 CDSRRHVTSLDLSGLNLSGALSPDVA----HLRFLQNLSVAANQLSGP----IPPEISAL 109
D + L L L GA +A R L+ L++A N + + + A
Sbjct: 133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN 192
Query: 110 SSLRLLNLSNNVFN----GSFPPQLSQLASLQVLDLYNNNMTGDLPLA--VTQLRN---- 159
+L +L+L+NN + L+ L SL+VL+L +NN+T D A + L +
Sbjct: 193 CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT-DAGAAALASALLSPNIS 251
Query: 160 LRHLHLGGN 168
L L L N
Sbjct: 252 LLTLSLSCN 260
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 692 IGKGGAGIVYKGLM---PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG G G V + +V VK L A + S + F + ++H +I++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKA-NASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGLCYLH-HDCS 805
G C LLV+EY G L L + ++A E A G+ ++H H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGL--AKFLQDSGTSECMSAIAGSYGYIAPEYA-- 861
+H D+ N L S V D+G+ +++ +D +E + ++APE
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP--LRWLAPELVGE 175
Query: 862 -----YTLKVDEKSDVYSFGVVLLELI-TGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
T + + S+V++ GV L EL +P D +++ V K+ +K
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHV------IKDQQVK 228
Query: 916 ILDPRLP---SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
+ P+L S +EV+ +++ +R T EV ++LT
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWLS-------PEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 53/194 (27%), Positives = 75/194 (38%), Gaps = 48/194 (24%)
Query: 731 AEIQTLGRIRHRHIVRLLG-FCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYK 788
E + L + H + L F + ET L LV +Y P G L +L + G L +
Sbjct: 50 TEQEILATLDHPFLPTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF 107
Query: 789 IAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL-DSGFEAHV--ADFGLAKFLQDSGTSEC 845
A E L YLH IV+RD+K NILL +SG H+ +DF L+K
Sbjct: 108 YAAEVLLALEYLHLLG---IVYRDLKPENILLHESG---HIMLSDFDLSKQSDVEPPPVS 161
Query: 846 MSAIAGSYG---------------------------YIAPE----YAYTLKVDEKSDVYS 874
+ GS YIAPE + V D ++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWT 217
Query: 875 FGVVLLELITGRKP 888
G++L E++ G P
Sbjct: 218 LGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 27/77 (35%), Positives = 40/77 (51%), Gaps = 5/77 (6%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNI 818
LV EY+ G + +LH G+ + K E A L YLH I+HRD+K +N+
Sbjct: 81 LVMEYLIGGDVKSLLH--IYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNM 135
Query: 819 LLDSGFEAHVADFGLAK 835
L+ + + DFGL+K
Sbjct: 136 LISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 8/78 (10%)
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY----AYT 863
I+HRD+K+ N+L++ + + DFG A F + S ++ IAG+ APE YT
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 864 LKVDEKSDVYSFGVVLLE 881
V D++S G+V+ E
Sbjct: 341 PSV----DIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 18/170 (10%)
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
+ A+G+ +L S VHRD+ + N+LL G + DFGLA+ + +
Sbjct: 245 QVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 852 SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
++APE + SDV+S+G++L E+ + G P + + DS
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP------------YPGMIVDSTF 349
Query: 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
KI + P H V+ + + C + +RP+ + I+ L
Sbjct: 350 YN--KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 20/182 (10%)
Query: 781 LHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK-FLQD 839
L + + + A G+ +L S VHRD+ + N+L+ G + DFGLA+ ++D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDI 898
S S ++APE + SDV+SFG++L E+ T G P E
Sbjct: 293 SNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE------- 344
Query: 899 VQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
+ + ++ K G R+ + P H ++ + C EE+ RP ++V ++
Sbjct: 345 LPMNEQFYNAIKRGY------RM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
Query: 959 EL 960
+L
Sbjct: 398 DL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 24/58 (41%), Positives = 32/58 (55%)
Query: 111 SLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGN 168
+L+ L+LSNN L +L+VLDL NN+T P A + L +LR L L GN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNI 818
L+ E++P G + +L KK T++ IA E + +H +HRD+K +N+
Sbjct: 78 LIMEFLPGGDMMTLLM-KKDTLSEEATQFYIA-ETVLAIDAIHQLG---FIHRDIKPDNL 132
Query: 819 LLDSGFEAHVADFGLAKFLQDSGTSE---------------------------------C 845
LLD+ ++DFGL L+ + +E
Sbjct: 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192
Query: 846 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ G+ YIAPE ++ D +S GV++ E++ G P
Sbjct: 193 AYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 736 LGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK 795
+ ++ H+H+V G C + +++V EY+ GSL L KK +L + +K+ E AK
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNL-INISWKL--EVAK 107
Query: 796 GLCY-LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA---IAG 851
L + LH + H +V + N+LL + + K L D G S + +
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLPKEILLE 166
Query: 852 SYGYIAPE---YAYTLKVDEKSDVYSFGVVLLELITG-RKPV 889
++ PE L + +D +SFG L E+ +G KP+
Sbjct: 167 RIPWVPPECIENPQNLSL--AADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 53/233 (22%), Positives = 85/233 (36%), Gaps = 59/233 (25%)
Query: 689 DNIIGKG--GAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGF-NAEIQTLGRIRHRHI 744
+IGK IV+ P VAVK++ + S D EI T +++H +I
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 745 VRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYK----------IAVEA 793
+ + F + E +V M GS ++L T + I +
Sbjct: 62 LPYVTSFIVDSEL-YVVSPLMAYGSCEDLL----------KTHFPEGLPELAIAFILKDV 110
Query: 794 AKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS- 852
L Y+H +HR VK+++ILL + + SG +S I
Sbjct: 111 LNALDYIHSKG---FIHRSVKASHILLSGDGKVVL-----------SGLRYSVSMIKHGK 156
Query: 853 -----YGY----------IAPEYAYT--LKVDEKSDVYSFGVVLLELITGRKP 888
+ + ++PE +EKSD+YS G+ EL G P
Sbjct: 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 692 IGKGGAGIVYKGLMPNGD-QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG- 749
+G G G+V+ + + D +VAVK++ ++ S H EI+ + R+ H +IV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI-VLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEV 70
Query: 750 -FCSNHETN------------LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
S + +V EYM L VL + G L + + +G
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL---EQGPLSEEHARLFMYQLLRG 126
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFL-QDSGTSECMSAIAGSYG 854
L Y+H S ++HRD+K N+ +++ + DFGLA+ + +S +
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 855 YIAPEYA-----YTLKVDEKSDVYSFGVVLLELITGR 886
Y +P YT + D+++ G + E++TG+
Sbjct: 184 YRSPRLLLSPNNYT----KAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 40/234 (17%)
Query: 736 LGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK 795
+ ++ H H+ + G C N++V E++ +G L +V K+ G + + +A + A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLAS 128
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK----FLQDSGTSECMSAIAG 851
L YL +VH +V + NILL A GLA+ F++ S +A++
Sbjct: 129 ALSYLEDKN---LVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 852 S-----YGYIAPEYAYTL-KVDEKSDVYSFGVVLLEL-ITGRKPVGEFGDGVDIVQWVRK 904
+IAPE + +D +SFG LLE+ G P+ E
Sbjct: 178 EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE------------- 224
Query: 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
T S+KE + RLP E+ + C+ + +RP+ R +++ LT
Sbjct: 225 RTPSEKERFYE-KKHRLPEPSCKELATLI---SQCLTYEPTQRPSFRTILRDLT 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 55/295 (18%)
Query: 321 EFIGVMPRLEVLQLWENNFTGS----IPQRLGSNGKLRILDLSSNKL------TGTLPPD 370
E + + L+VL+L N + L L+ L LS N+ +L
Sbjct: 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQG 76
Query: 371 MCAGNCLQTLITLGNFLFGP----IPESLGKCDSLSRMRMGENFLNGS----IPKGLFGL 422
+ G LQ L L + GP + ESL + SL +++ N L + KGL L
Sbjct: 77 LTKGCGLQEL-DLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL 135
Query: 423 -PSLSQVELQDNYLTGQ--FPVSDSISVN--LGQICLSNNQLSGSLPASIGK----FSGV 473
P+L ++ L N L G ++ ++ N L ++ L+NN + + ++ + +
Sbjct: 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL 195
Query: 474 QKLLLDGNKF----SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRN 529
+ L L+ N + + + L+ L ++ N + A ++
Sbjct: 196 EVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA------------- 242
Query: 530 ELSGEIPNQLTGMRILNYLNLSRNHL----VGSIPASIASMQSLTSVDFSYNNLS 580
L+ L L+LS N + + +A +SL +D N
Sbjct: 243 ------SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 692 IGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
+G+G V+KG + VA+K + H+ G E+ L ++H +IV
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRL-----EHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV-EAAKGLCYLHHDCS 805
L ++ LV+EY+ + L + + G++ KI + + +GL Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYL-DKDLKQYM--DDCGNIMSMHNVKIFLYQILRGLAYCHRR-- 123
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY-TL 864
++HRD+K N+L++ E +ADFGLA+ S ++ S + Y P+ +
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 865 KVDEKSDVYSFGVVLLELITGR 886
+ + D++ G + E+ +GR
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 2/59 (3%)
Query: 88 LQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNN 145
L++L ++ N+L+ IP L +L++L+LS N P S L SL+ LDL NN
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 46/186 (24%)
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+V+L + + V +Y+P G + +L + G R+ IA E + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLARFYIA-ELTCAIESVHKM 120
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGL---------AKFLQDSGTS--ECMS----- 847
+HRD+K +NIL+D + DFGL +K+ Q + M
Sbjct: 121 G---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 848 -------------------------AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 882
++ G+ YIAPE + D +S GV+L E+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 883 ITGRKP 888
+ G+ P
Sbjct: 238 LVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 48/209 (22%), Positives = 77/209 (36%), Gaps = 62/209 (29%)
Query: 731 AEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKI 789
AE L + +VRL + + V +Y+P G + +L + G D R+ I
Sbjct: 50 AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDLARFYI 107
Query: 790 A-----VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL---------AK 835
A VE+ + + +HRD+K +NIL+D + DFGL +K
Sbjct: 108 AELTCAVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 836 FLQ-----------------DSGTSEC-------------------MSAIAGSYGYIAPE 859
+ Q D C ++ G+ YIAPE
Sbjct: 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE 218
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ D +S GV+L E++ G+ P
Sbjct: 219 VLLRTGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 22/60 (36%), Positives = 30/60 (50%)
Query: 256 NLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKL 315
NL +L L N L+ L +LK +DLS N T P +F+ L +L L+L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 27/61 (44%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE-FIGVMPRLEVLQLWENN 338
+LKS+DLSNN T +F L NL +L+L N L PE F G +P L L L NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSG-LPSLRSLDLSGNN 59
Query: 339 F 339
Sbjct: 60 L 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1010 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.02 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.99 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.71 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.64 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.52 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-116 Score=1124.94 Aligned_cols=927 Identities=38% Similarity=0.669 Sum_probs=795.5
Q ss_pred HHHHHHHHHHHhccCCChhHHHHHHHHHHhcCCCCCCCCCCcCCCCCCCCCCceEeCCCCcEEEEEcCCCCcccccCccc
Q 001816 3 LLLLLLLLLLHISQSRTVPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDV 82 (1010)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~all~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~l 82 (1010)
+++|+++++....+.....|+.||++||+++. +|...+.+|+...+||.|.||+|+..++|+.|||+++++++.++..+
T Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~ 89 (968)
T PLN00113 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSIN-DPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAI 89 (968)
T ss_pred hHHHHHHHHHHHccCCCHHHHHHHHHHHHhCC-CCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHH
Confidence 34444444444444456789999999999995 67777899988889999999999988899999999999999999999
Q ss_pred CCCCCCCEEEccccccCCCCCcccc-cccccceeccccccccCCCCccccccCccceecccCcccCCCCCcchhcccccc
Q 001816 83 AHLRFLQNLSVAANQLSGPIPPEIS-ALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161 (1010)
Q Consensus 83 ~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 161 (1010)
..+++|+.|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|+
T Consensus 90 ~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 167 (968)
T PLN00113 90 FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLK 167 (968)
T ss_pred hCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCC
Confidence 9999999999999999988888765 999999999999999988886 5689999999999999999999999999999
Q ss_pred ceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCCCCCCccccCCCCCcEEEccCC
Q 001816 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANC 241 (1010)
Q Consensus 162 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~~p~~l~~l~~L~~L~l~~n 241 (1010)
+|+|++|.+.+.+|..++.+++|++|+|++|++.+.+|..++++++|++|+++ ++.+.+.+|..++++++|++|++++|
T Consensus 168 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~-~n~l~~~~p~~l~~l~~L~~L~L~~n 246 (968)
T PLN00113 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG-YNNLSGEIPYEIGGLTSLNHLDLVYN 246 (968)
T ss_pred EEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECc-CCccCCcCChhHhcCCCCCEEECcCc
Confidence 99999999999999999999999999999999999999999999999999998 46778899999999999999999999
Q ss_pred CCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCc
Q 001816 242 GLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE 321 (1010)
Q Consensus 242 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 321 (1010)
++.+.+|..++++++|++|+|++|.+.+..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|++++|.+.+..|.
T Consensus 247 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~ 326 (968)
T PLN00113 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326 (968)
T ss_pred eeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCCh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCcchhhhccccccccccccccccCCCC
Q 001816 322 FIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSL 401 (1010)
Q Consensus 322 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~p~~l~~l~~L 401 (1010)
.++.+++|+.|++++|++++.+|..++.+++|+.|+|++|++.+.+|..++...+|+.|++.+|.+.+.+|..++.+++|
T Consensus 327 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L 406 (968)
T PLN00113 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSL 406 (968)
T ss_pred hHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCccCceEEecCCC
Q 001816 402 SRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGN 481 (1010)
Q Consensus 402 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 481 (1010)
+.|++++|.+++.+|..+..+++|+.|++++|.+++.++..+..+++|+.|+|++|++.+.+|..++ .++|+.|++++|
T Consensus 407 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n 485 (968)
T PLN00113 407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRN 485 (968)
T ss_pred CEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCC
Confidence 9999999999999999999999999999999999999999888999999999999999999988764 589999999999
Q ss_pred cccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccccCCchh
Q 001816 482 KFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPA 561 (1010)
Q Consensus 482 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 561 (1010)
++++.+|..+..+++|++|+|++|++++.+|..++.+++|++|+|++|.+++.+|..|..+++|+.|+|++|+++|.+|.
T Consensus 486 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 565 (968)
T PLN00113 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565 (968)
T ss_pred ccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCCh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhcccccceeccCCCcccCCCCCCccccCCcccccCCCccCcCCC----CCCCCCCCCCCCCCCCcCCCCCcchhhhhH
Q 001816 562 SIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPY----LGPCKDGVANGTHQPHVKGPLSASVKLLLV 637 (1010)
Q Consensus 562 ~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~~g~~----~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (1010)
.+.++++|+.|++++|+++|.+|..+++.++...++.||+.+||+. .++|..... .. .....++.+
T Consensus 566 ~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~---------~~-~~~~~~~~~ 635 (968)
T PLN00113 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---------TP-SWWFYITCT 635 (968)
T ss_pred hHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc---------cc-eeeeehhHH
Confidence 9999999999999999999999999999999999999999999954 346642200 00 011112222
Q ss_pred HHHHHHHHHHHHHHHHHHHhccch-h----hhhhhhhcccce---eeeeeccccccCCcCCeEeecCcEEEEEEEe-cCC
Q 001816 638 VGLLVCSIAFAVAAIIKARSLKKA-S----ESRAWKLTAFQR---LDFTCDDVLDCLKEDNIIGKGGAGIVYKGLM-PNG 708 (1010)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g 708 (1010)
+++++++++++++.++++++.... . +...|....+.. ..+..+++.+.++..++||+|+||.||+|.. .+|
T Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~ 715 (968)
T PLN00113 636 LGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNG 715 (968)
T ss_pred HHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCC
Confidence 222222222222222222221111 0 111122111111 1123445566788889999999999999996 578
Q ss_pred CEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHH
Q 001816 709 DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYK 788 (1010)
Q Consensus 709 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~ 788 (1010)
..||||+++.... ....|++.+++++|||||++++++.+++..|+||||+++|+|.++++ .++|.++.+
T Consensus 716 ~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~ 784 (968)
T PLN00113 716 MQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRK 784 (968)
T ss_pred cEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHH
Confidence 9999999864221 12457899999999999999999999999999999999999999994 388999999
Q ss_pred HHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCc
Q 001816 789 IAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868 (1010)
Q Consensus 789 i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 868 (1010)
++.|+|+|++|||..++++|+||||||+||+++.++.+++. ||.+...... ....||+.|+|||++.+..++.
T Consensus 785 i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~ 857 (968)
T PLN00113 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITE 857 (968)
T ss_pred HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCc
Confidence 99999999999997656679999999999999999888875 6665433211 1236889999999999999999
Q ss_pred cCceehhhHHHHHHHhCCCCCCCC-CCCccHHHHHHHHhhhcccccccccCCCCC---CCCHHHHHHHHHHHHhccccCC
Q 001816 869 KSDVYSFGVVLLELITGRKPVGEF-GDGVDIVQWVRKMTDSKKEGVLKILDPRLP---SVPLHEVMHVFYVAMLCVEEQA 944 (1010)
Q Consensus 869 ~~Dv~slG~il~elltg~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P 944 (1010)
++|||||||++|||+||+.||... +.......|.+..... ......+|+... ..+..+..++.+++.+||+.+|
T Consensus 858 ~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P 935 (968)
T PLN00113 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD--CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDP 935 (968)
T ss_pred ccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc--cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCc
Confidence 999999999999999999998542 2234566666543322 122334444442 2345667788899999999999
Q ss_pred CCCCCHHHHHHHHhcCCCCC
Q 001816 945 VERPTMREVVQILTELPKPP 964 (1010)
Q Consensus 945 ~~RPs~~ev~~~L~~~~~~~ 964 (1010)
++||+|+|+++.|+++.+..
T Consensus 936 ~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 936 TARPCANDVLKTLESASRSS 955 (968)
T ss_pred hhCcCHHHHHHHHHHhhccc
Confidence 99999999999999886543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-61 Score=614.19 Aligned_cols=515 Identities=37% Similarity=0.560 Sum_probs=489.5
Q ss_pred CCCCEEEccccccCCCCCcccccccccceeccccccccCCCCcccc-ccCccceecccCcccCCCCCcchhcccccccee
Q 001816 86 RFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLS-QLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLH 164 (1010)
Q Consensus 86 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 164 (1010)
..++.|+|++|.+++.++..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4689999999999999999999999999999999999988888765 999999999999999988875 4689999999
Q ss_pred cccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCCCCCCccccCCCCCcEEEccCCCCC
Q 001816 165 LGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLS 244 (1010)
Q Consensus 165 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~ 244 (1010)
|++|.+++.+|..++.+++|++|+|++|.+.+.+|..|+++++|++|+++ +|.+.+.+|..++++++|++|++++|++.
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~-~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA-SNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeecc-CCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999999999999999998 46678889999999999999999999999
Q ss_pred CCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCcccc
Q 001816 245 GEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIG 324 (1010)
Q Consensus 245 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 324 (1010)
+.+|..++++++|++|+|++|.+++..|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|.+.+.+|..+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCcchhhhccccccccccccccccCCCCceE
Q 001816 325 VMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRM 404 (1010)
Q Consensus 325 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 404 (1010)
.+++|++|++++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+..+.+|+.|++.+|.+.+.+|..+..+++|+.|
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L 385 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCccCceEEecCCCccc
Q 001816 405 RMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFS 484 (1010)
Q Consensus 405 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 484 (1010)
++++|.+.+.+|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.
T Consensus 386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~ 465 (968)
T PLN00113 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465 (968)
T ss_pred ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccccCCchhhhh
Q 001816 485 GQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIA 564 (1010)
Q Consensus 485 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 564 (1010)
+.+|..++ .++|+.|||++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|+++|.+|..|.
T Consensus 466 ~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 544 (968)
T PLN00113 466 GGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS 544 (968)
T ss_pred eecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh
Confidence 88887764 58999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccceeccCCCcccCCCCCC-ccccCCcccccCCCccCc
Q 001816 565 SMQSLTSVDFSYNNLSGLVPGT-GQFSYFNYTSFLGNSELC 604 (1010)
Q Consensus 565 ~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~~ 604 (1010)
++++|+.|||++|+++|.+|.. ..+..+....+.+|+..+
T Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 9999999999999999998875 445667777788886443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=422.12 Aligned_cols=279 Identities=48% Similarity=0.832 Sum_probs=238.2
Q ss_pred eccccccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC-cc
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE-TN 757 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 757 (1010)
+..+++.|...++||+|+||.||+|...+|+.||||++....... ..+|.+|+.++.+++|||+|+++|||.+.+ +.
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 456788999999999999999999999999999999886544332 455999999999999999999999999998 49
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
++|||||++|+|.++++......++|.++.+|+.++|+||+|||+...++||||||||+|||+|+++++||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999999999998654438999999999999999999999988889999999999999999999999999999765
Q ss_pred cCCCCcceeeee-cccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCC--CCccHHHHHHHHhhhcccccc
Q 001816 838 QDSGTSECMSAI-AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFG--DGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 838 ~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
.... ...... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... ....+..|........ .+.
T Consensus 228 ~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--~~~ 303 (361)
T KOG1187|consen 228 PEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--KLR 303 (361)
T ss_pred Cccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--chh
Confidence 4311 111222 79999999999999999999999999999999999999887532 3445788886655443 788
Q ss_pred cccCCCCC--CCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 001816 915 KILDPRLP--SVPL-HEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 915 ~~~~~~~~--~~~~-~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (1010)
+++|+.+. ..+. .+..++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 89999976 3343 5778899999999999999999999999999665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=406.43 Aligned_cols=259 Identities=36% Similarity=0.570 Sum_probs=215.3
Q ss_pred CCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC-ccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE-TNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~~ 764 (1010)
....+.||+|+||+||+|.|.....||||++.....+....+.|.+|+.++++++|||||+++|++.+.. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445569999999999999954444999999876555444668999999999999999999999999887 789999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-ceEEeeccccccccCCCCc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~DFGla~~~~~~~~~ 843 (1010)
++|+|.++++..+...+++..+.+++.|||+||.|||+.+. ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 99999999986556889999999999999999999995542 99999999999999997 99999999998754322
Q ss_pred ceeeeecccccccChhhhc--cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
..+....||+.|||||+++ ...|+.|+|||||||++|||+||+.||..... ......+ . .....
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v---~----------~~~~R 264 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAV---V----------VGGLR 264 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHH---H----------hcCCC
Confidence 2334468999999999999 66999999999999999999999999987544 2222111 1 12233
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
+..+......+..++.+||+.||++||++.|++..|+.+..
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 44444466778889999999999999999999999987654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=386.05 Aligned_cols=251 Identities=29% Similarity=0.428 Sum_probs=213.5
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc-cEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET-NLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~e 762 (1010)
..+..+.||+|..|+|||++++ +++.+|+|++.. ..+....+++.+|++++++.+||+||++||.|..++. ..|+||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 4455678999999999999964 688999999943 3344556678999999999999999999999999884 999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||++|+|++++. ..+++++....+++.++++||.|||+ ++ ||||||||+|||++..|.+||||||.++.+...
T Consensus 159 YMDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999995 34789999999999999999999996 55 999999999999999999999999999987543
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCC-CCCccHHHHHHHHhhhcccccccccCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEF-GDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||... .+..++.+.+.. +.+..
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~-----------Iv~~p 298 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA-----------IVDEP 298 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH-----------HhcCC
Confidence 345778999999999999999999999999999999999999999764 223344443333 33334
Q ss_pred CCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 921 LPSVPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~-~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.|..|.. .+.++..++..|+++||.+||+++|++++
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 4445554 67789999999999999999999999885
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=370.06 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=214.2
Q ss_pred cccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeee-eEecC-CccEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG-FCSNH-ETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~-~~~~l 759 (1010)
...|++.++||+|.||+|||+. ..+|..||.|.++-...+....+....|+.++++++|||||++++ .+.++ +..+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3568888999999999999998 678999999999865556666777889999999999999999998 34444 44899
Q ss_pred EEEecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCc--eEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 760 VYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL--IVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
|||||.+|+|...++. +....+++..+++++.|+++||.++|..- ++ |+||||||.||+++..|.|||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999864 34567999999999999999999999632 44 9999999999999999999999999999
Q ss_pred cccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccc
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
.+.... ......+|||.||+||.+.+.+|++|+||||+||++|||+.-++||.+. ...+..+++.
T Consensus 177 ~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~--------- 241 (375)
T KOG0591|consen 177 FLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIE--------- 241 (375)
T ss_pred Hhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHH---------
Confidence 886433 3345678999999999999999999999999999999999999999653 3444444432
Q ss_pred ccCCCCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 916 ILDPRLPSVP-LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 916 ~~~~~~~~~~-~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....++.| ..++..+.++|..|+..||+.||+...+++.
T Consensus 242 --qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 242 --QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred --cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 23555566 6778889999999999999999985444443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=378.39 Aligned_cols=203 Identities=33% Similarity=0.514 Sum_probs=180.5
Q ss_pred cccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
+....|...+.||+|+||+||+|++ +++..||||.+....-.....+.+..|+.+++.++|||||++++++..++..|+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 3456788888899999999999995 468999999997654444445567899999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC------CceEEeeccc
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG------FEAHVADFGL 833 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~------~~~kl~DFGl 833 (1010)
|||||.||+|.+|++. .+.+++++++.++.|||.||++||+++ ||||||||+|||++.. -.+||+|||+
T Consensus 87 VMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999964 458999999999999999999999777 9999999999999764 4689999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCC
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGE 891 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~ 891 (1010)
|+.+... ....+.+|+|.|||||+++...|+.|+|+||+|+|+|+|++|+.||..
T Consensus 162 AR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9988643 344578999999999999999999999999999999999999999964
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=380.93 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=207.9
Q ss_pred ccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCC-----CcccchHHHHHHHhccCCcccceeeeeEecCC
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGS-----SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 755 (1010)
+.+.|.+.+.+|+|+||.|-+|. .++|+.||||+++...... ......++|+++|++++|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678888999999999999998 5679999999997533322 12233579999999999999999999999999
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC---CceEEeecc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG---FEAHVADFG 832 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~---~~~kl~DFG 832 (1010)
..||||||++||+|.+.+- ..+.+.++....+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999984 4567888889999999999999999877 9999999999999655 789999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhccCCC---CccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV---DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 909 (1010)
+|+... ....+.+.+|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||.+.-......+.+.+ .
T Consensus 325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---G- 397 (475)
T KOG0615|consen 325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---G- 397 (475)
T ss_pred hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc---C-
Confidence 999754 4566789999999999999986643 34789999999999999999999764333222221111 0
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
+ -...|....+...+...+|.+|+..||++|||++|++++-
T Consensus 398 ~-------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 398 R-------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred c-------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 0 0111222334456788899999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=396.91 Aligned_cols=250 Identities=27% Similarity=0.394 Sum_probs=212.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
..|+..+.||+|||+.||+++. .+|+.||+|++++... .......+.+||++.+.++|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999996 7899999999975333 2334556889999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|+|+.++|.++++ +.+.+++.+++.+++||+.|+.|||+.+ |+|||||-.|++++++.++||+|||+|..+...
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 9999999999996 5578999999999999999999999777 999999999999999999999999999987643
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.....+.+|||.|.|||++....++..+||||+|||+|.|++|++||+.. .+.+..+++.. -+..+
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk----~vkety~~Ik~---------~~Y~~ 237 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK----TVKETYNKIKL---------NEYSM 237 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc----hHHHHHHHHHh---------cCccc
Confidence 23456889999999999999999999999999999999999999999752 11111111111 12223
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
| ...+....++|.++++.+|.+|||+++|+.+
T Consensus 238 P---~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 P---SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c---cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3 3445567789999999999999999999884
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=400.09 Aligned_cols=493 Identities=26% Similarity=0.364 Sum_probs=330.2
Q ss_pred cEEEEEcCCCCcccccCcccCCCCCCCEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceeccc
Q 001816 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLY 142 (1010)
Q Consensus 63 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 142 (1010)
....+++++|.++ .+.+++.++..|.+|++++|++. ..|.+++.+..++.|+.++|+++ .+|.+++.+.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 3556666666666 44555666666666666666666 45666666666666666666666 566666666666666666
Q ss_pred CcccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCCCC
Q 001816 143 NNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGG 222 (1010)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~ 222 (1010)
+|.+. .+|..++.+..|..|+..+|+++ ..|+.+..+.+|..|++.+|++....
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~------------------------ 176 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALP------------------------ 176 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCC------------------------
Confidence 66666 45556666666666666666665 44555555555555555555555222
Q ss_pred CCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCcccc-c
Q 001816 223 LPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFA-E 301 (1010)
Q Consensus 223 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-~ 301 (1010)
+..-+++.|++||+..|-++ .+|..++.+.+|+-|||.+|+|.. .| .|..+..|+.|+++.|+|+ .+|+... .
T Consensus 177 --~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~ 250 (565)
T KOG0472|consen 177 --ENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIE-MLPAEHLKH 250 (565)
T ss_pred --HHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHH-hhHHHHhcc
Confidence 22222555555555555555 566666666666666777776663 33 6666677777777777776 4454433 6
Q ss_pred cCCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCc---ch
Q 001816 302 LKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNC---LQ 378 (1010)
Q Consensus 302 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~---L~ 378 (1010)
+.+|..|||..|+++ ..|+.++.+.+|++||+++|.|+ .+|..++++ .|+.|-+.||.+. .+..++-.... |+
T Consensus 251 L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLK 326 (565)
T KOG0472|consen 251 LNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLK 326 (565)
T ss_pred cccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHH
Confidence 677777777777776 66777777777777777777776 566667777 6777777777765 33333333322 22
Q ss_pred hhhc--c----ccc-----ccc----ccccccccCCCCceEEcCCCcccCCCccccCCCCC---CCeEEecCcccccccc
Q 001816 379 TLIT--L----GNF-----LFG----PIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPS---LSQVELQDNYLTGQFP 440 (1010)
Q Consensus 379 ~L~l--~----~n~-----~~~----~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~ 440 (1010)
+|-- . .+. -.. ..........+.+.|+++.-+++ .+|...+.-.+ ...++++.|++...+.
T Consensus 327 yLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~elPk 405 (565)
T KOG0472|consen 327 YLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCELPK 405 (565)
T ss_pred HHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhhhhh
Confidence 2211 0 000 000 11122344567888888888888 67777765544 7889999999985433
Q ss_pred CCcccccccceEeccCccccCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCc
Q 001816 441 VSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKL 520 (1010)
Q Consensus 441 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 520 (1010)
.-.....-++.+++++|+++ .+|..+..+++|..|+|++|-+. .+|.+++.+..|+.||+|+|+|. .+|..+..+..
T Consensus 406 ~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~ 482 (565)
T KOG0472|consen 406 RLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQT 482 (565)
T ss_pred hhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHH
Confidence 33333334566788888887 88999999999999999999998 89999999999999999999998 78888877888
Q ss_pred ccEEEccCcccccccchhcccccccceEEecCccccCCchhhhhcccccceeccCCCcccCCCCCCcc-ccCCcccccCC
Q 001816 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQ-FSYFNYTSFLG 599 (1010)
Q Consensus 521 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~-~~~~~~~~~~~ 599 (1010)
|+.+-.++|++....|..+.+|.+|..|||.+|.|. .+|+.++++++|+.|++++|++. .|+...- -.+..-.+|.+
T Consensus 483 lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylr 560 (565)
T KOG0472|consen 483 LETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLR 560 (565)
T ss_pred HHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhc
Confidence 888888889999777777999999999999999998 78889999999999999999999 3333211 12333345555
Q ss_pred C
Q 001816 600 N 600 (1010)
Q Consensus 600 n 600 (1010)
+
T Consensus 561 d 561 (565)
T KOG0472|consen 561 D 561 (565)
T ss_pred c
Confidence 5
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=387.46 Aligned_cols=255 Identities=31% Similarity=0.483 Sum_probs=213.6
Q ss_pred CCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecC
Q 001816 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
++..+.||+|.||+||.|.+.....||+|.++.. ......|.+|+++|++++|++||+++++|..++..|||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 4456789999999999999977779999999764 2335668999999999999999999999999889999999999
Q ss_pred CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce
Q 001816 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 766 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
.|+|.++|+...+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+...+. ....
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTA 360 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC-ceee
Confidence 999999998767788999999999999999999999766 999999999999999999999999999955433 2222
Q ss_pred eeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCC
Q 001816 846 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (1010)
.....-...|.|||.+....++.|+|||||||+||||+| |+.||..+... +.+..+... ..-+.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----ev~~~le~G-----------yRlp~ 425 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----EVLELLERG-----------YRLPR 425 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----HHHHHHhcc-----------CcCCC
Confidence 233334568999999999999999999999999999999 99999765432 222222111 11223
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 925 ~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
|..++..+++++..||..+|++|||++.+...++++..
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 55677789999999999999999999999998887754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=365.90 Aligned_cols=251 Identities=27% Similarity=0.346 Sum_probs=207.9
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCC-cccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSS-HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.++||+|+||.||.++. .+++.+|+|++++...... ..+...+|..++.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46788899999999999999984 4688999999976444332 455688999999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
+||+.||.|...|+ +.+.++++.++.++.+|+.||.|||+.+ |||||+||+|||+|.+|+++|+|||+++..-..
T Consensus 104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999994 5678999999999999999999999777 999999999999999999999999999864332
Q ss_pred CCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
.....+.+||+.|||||++.+..|+.++|.||+||++|||++|.+||... +...+.+++... .
T Consensus 179 --~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~----~~~~~~~~I~~~-----------k 241 (357)
T KOG0598|consen 179 --GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE----DVKKMYDKILKG-----------K 241 (357)
T ss_pred --CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc----cHHHHHHHHhcC-----------c
Confidence 23345689999999999999999999999999999999999999999652 223333333322 1
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERP----TMREVVQ 955 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RP----s~~ev~~ 955 (1010)
.+..+........+++...+..+|++|- ++.++.+
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 2222333345677899999999999994 4555543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=347.03 Aligned_cols=265 Identities=19% Similarity=0.292 Sum_probs=210.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+...++|+|+||+|||++.+ +|+.||||++.....++...+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999954 69999999997665555555567899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
||+.. +-+.+.+.. ..++.+.+.++++|+++|+.|+|.++ +|||||||+|||++..|.+||||||.|+.+.. .
T Consensus 82 ~~dhT-vL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p 154 (396)
T KOG0593|consen 82 YCDHT-VLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--P 154 (396)
T ss_pred ecchH-HHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence 99764 444454333 34788899999999999999999777 99999999999999999999999999998864 3
Q ss_pred cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc---------
Q 001816 843 SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG--------- 912 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------- 912 (1010)
....+.++.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+..|-+++..+.+.+.+...+.
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 344567889999999999987 6899999999999999999999999988766665555544433222111
Q ss_pred c--ccccCCCCCC-CC---HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 913 V--LKILDPRLPS-VP---LHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 913 ~--~~~~~~~~~~-~~---~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
+ ..+.++.-++ .. +....-+.++++.|+..||++|++-++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0 0111111111 11 111234778999999999999999998865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=367.82 Aligned_cols=269 Identities=20% Similarity=0.270 Sum_probs=218.2
Q ss_pred ccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCC-c
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHE-T 756 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~-~ 756 (1010)
..+.++|...+.||.|.||.||+|+ ..+|+.||||+++..... .++..-.+|++.++++. |||||++.+++.+.+ .
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4456789999999999999999999 567999999999865443 22333468999999998 999999999999888 9
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
.|+||||| ..+|++.++++ +..+++..++.|+.||++||+|+|++| ++|||+||+|||+.....+||+|||+|+.
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 99999999 57999999876 789999999999999999999999888 99999999999999888999999999998
Q ss_pred ccCCCCcceeeeecccccccChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc---
Q 001816 837 LQDSGTSECMSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG--- 912 (1010)
Q Consensus 837 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 912 (1010)
+.... -.+.++.|.+|.|||++. .+.|+.+.||||+|||++|+.+-++-|.+..+-+++.....-+....++.
T Consensus 160 v~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 75433 345778999999999864 66799999999999999999999999987665555555444332222221
Q ss_pred ---cccccCCCCCC---C-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 913 ---VLKILDPRLPS---V-----PLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 913 ---~~~~~~~~~~~---~-----~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
+...++-.+|. . -.....+..+++.+|+++||++|||+.|++++-
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11222222221 1 122456788899999999999999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=379.11 Aligned_cols=477 Identities=28% Similarity=0.352 Sum_probs=351.5
Q ss_pred cEEEEEcCCCCcccccCcccCCCCCCCEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceeccc
Q 001816 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLY 142 (1010)
Q Consensus 63 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 142 (1010)
-+++|++++|++. .+|++++.+..++.|+.++|.+. .+|+.++.+.+|+.|+.++|.+. .+|+.++.+..|+.||..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 5889999999998 78889999999999999999999 89999999999999999999999 889999999999999999
Q ss_pred CcccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCCCC
Q 001816 143 NNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGG 222 (1010)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~ 222 (1010)
+|+++ ..|.++..+.+|..|++.+|.++...|..+. ++.|++||+..|.++ .+|..++.|.+|..||+..|.. ..
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki--~~ 220 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKI--RF 220 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccc--cc
Confidence 99999 7899999999999999999999955555554 999999999999998 8888899999999999874332 23
Q ss_pred CCccccCCCCCcEEEccCCCCCCCcCcccc-CCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccc
Q 001816 223 LPPEIGNLSSLVRFDAANCGLSGEIPTDIG-RLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAE 301 (1010)
Q Consensus 223 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 301 (1010)
+| +|..++.|++|+++.|+|+ .+|.... ++.++..|||..|+++ ..|+.++-+.+|++||+|+|.|+ ..|..+++
T Consensus 221 lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgn 296 (565)
T KOG0472|consen 221 LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGN 296 (565)
T ss_pred CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCccccc
Confidence 44 6667777777777777776 4555443 6677777777777776 46666666777777777777777 45666777
Q ss_pred cCCCCEEecCCccccCCCCccccCCC--ccccccc--ccCcccccCCcCCCCCCCccEEEccCcccccCCCc----ccCC
Q 001816 302 LKNLTLLNLFRNKLHGAIPEFIGVMP--RLEVLQL--WENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPP----DMCA 373 (1010)
Q Consensus 302 l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L--~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~ 373 (1010)
+ .|++|-+.+|.+...-.+.+..-+ -|++|.= ..-.++.. + ++-.-++..++ ....
T Consensus 297 l-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s--e-------------~~~e~~~t~~~~~~~~~~~ 360 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS--E-------------GGTETAMTLPSESFPDIYA 360 (565)
T ss_pred c-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC--c-------------ccccccCCCCCCcccchhh
Confidence 6 677777777766532111111111 1222211 00011000 0 00000000011 1112
Q ss_pred CCcchhhhccccccccccccccccCC--CCceEEcCCCcccCCCccccCCCCCCCeE-EecCccccccccCCcccccccc
Q 001816 374 GNCLQTLITLGNFLFGPIPESLGKCD--SLSRMRMGENFLNGSIPKGLFGLPSLSQV-ELQDNYLTGQFPVSDSISVNLG 450 (1010)
Q Consensus 374 ~~~L~~L~l~~n~~~~~~p~~l~~l~--~L~~L~l~~N~l~~~~p~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~~~~L~ 450 (1010)
..+.+.|+.++-+++....+.|..-. -....+++.|++. ++|..+..+..+.+. .+++|.+ +-+|..++.+++|.
T Consensus 361 ~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt 438 (565)
T KOG0472|consen 361 IITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLT 438 (565)
T ss_pred hhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcce
Confidence 23344444444444333333343322 2567888888887 778877777666544 4444444 46777888889999
Q ss_pred eEeccCccccCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcc
Q 001816 451 QICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNE 530 (1010)
Q Consensus 451 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 530 (1010)
.|+|++|-+. .+|..++.+..|+.|+++.|+|. .+|..+..++.|+.+-.++|++....|..+.++.+|..|||.+|.
T Consensus 439 ~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNd 516 (565)
T KOG0472|consen 439 FLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNND 516 (565)
T ss_pred eeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCc
Confidence 9999999888 89999999999999999999999 899999999999999999999986666669999999999999999
Q ss_pred cccccchhcccccccceEEecCccccCCchhhhhcccccceec
Q 001816 531 LSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVD 573 (1010)
Q Consensus 531 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ 573 (1010)
|. .+|..+++|.+|+.|+|++|++. .++..+-.......|.
T Consensus 517 lq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ 557 (565)
T KOG0472|consen 517 LQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILS 557 (565)
T ss_pred hh-hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHH
Confidence 99 88999999999999999999998 5555443333333333
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.74 Aligned_cols=263 Identities=26% Similarity=0.366 Sum_probs=212.7
Q ss_pred cccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|+..++||.|..++||+|+ .+.++.||||++........ .+.+.+|++.|+.++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 4678888999999999999998 67789999999987666554 567899999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
.||.+|++.++++..-...+++..+..|.+++++||.|||++| .||||||+.||||+++|.|||+|||.+..+.+.+
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999997654556999999999999999999999888 9999999999999999999999999987766554
Q ss_pred Cccee--eeecccccccChhhhc--cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 842 TSECM--SAIAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 842 ~~~~~--~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
..... ...+||+.|||||+++ ...|+.|+|||||||+..||.+|..||..+..-..+.. ++............
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~---tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL---TLQNDPPTLLTSGL 257 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH---HhcCCCCCcccccC
Confidence 32221 4568999999999955 34799999999999999999999999987654332222 22211111000001
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
+. +........+.+++..|+++||.+|||++++++
T Consensus 258 ~~---d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 DK---DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred Ch---HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 10 001112236778999999999999999999976
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=360.93 Aligned_cols=258 Identities=29% Similarity=0.452 Sum_probs=206.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC--ccEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE--TNLLV 760 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv 760 (1010)
..|...+.||+|+||+||++... +|+..|||.+...... ..+.+.+|++++++++|||||+++|...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 34667789999999999999964 4999999998654221 1455899999999999999999999855544 58999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-CCceEEeeccccccccC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DFGla~~~~~ 839 (1010)
|||+++|+|.+++.+..+ .+++..+..+.+||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999976554 8999999999999999999999666 999999999999999 79999999999987653
Q ss_pred C-CCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 840 S-GTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 840 ~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
. ..........||+.|||||++..+ ...+++||||+||++.||+||+.||... .+...++-.+. .
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig----------~ 237 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIG----------R 237 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHh----------c
Confidence 1 112234457899999999999953 3446999999999999999999999763 11111111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
....|.+|...+....+++.+|+..+|++||||+|++++....
T Consensus 238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 1233455555666788899999999999999999999875443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=328.38 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=212.5
Q ss_pred ccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
++|...+++|+|.||.||+|+ .++|+.||||+++.............+||+.++.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467778899999999999999 5689999999998765554455567899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|++ .+|+..+++ +...++..++..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 82 fm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 994 699999975 4467899999999999999999999777 99999999999999999999999999998875544
Q ss_pred cceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc---cccccC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG---VLKILD 918 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 918 (1010)
.. ...+-|.+|.|||.+.+. .|+..+||||.|||+.||+-|.+-|.+..|-+++...++.+.....+. +..+.|
T Consensus 157 ~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 157 IQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 32 233789999999999876 599999999999999999998887776555444444444432221111 111111
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 ---------PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ---------~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+.....=........+++..++..||.+|.++.|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111112233456889999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=355.33 Aligned_cols=268 Identities=25% Similarity=0.336 Sum_probs=211.6
Q ss_pred cccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--Ccc
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETN 757 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 757 (1010)
.-.+.|+..++||+|.||.||+|+ ..+|+.||+|++......+....-..+||.++++++||||+++.+...+. +..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 335677788899999999999999 56899999999987665555566678999999999999999999998776 689
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
|+|+|||+ -||.-++. ..+-.|++.++..++.|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||+|+++
T Consensus 194 YlVFeYMd-hDL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 194 YLVFEYMD-HDLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEeccc-chhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999995 58888875 34567999999999999999999999666 999999999999999999999999999987
Q ss_pred cCCCCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
..... ..++..+-|.+|.|||.+.+. .|+.+.|+||.|||+.||++|++.|.+..+.+++.. +-++.....+..-..
T Consensus 269 ~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k-IfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 269 TPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK-IFKLCGSPTEDYWPV 346 (560)
T ss_pred cCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH-HHHHhCCCChhcccc
Confidence 65433 335677889999999998865 699999999999999999999999987544333333 333322222222111
Q ss_pred --------cCCCCC------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 917 --------LDPRLP------SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 917 --------~~~~~~------~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
+.+..+ +.-...+....+++..++..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111 000011234667888999999999999999987
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.17 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=213.7
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
++|.+.+.||+|+||.||||+. .+.+.||+|.+.+..+.+...+.+.+|++++++++|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4677778999999999999994 468899999998877777777889999999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+.| +|..++. .++.++++.+..++.++..||.|||..+ |.|||+||.|||++..|++|+||||+|+.+.. .
T Consensus 82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9966 9999995 5578999999999999999999999666 99999999999999999999999999997643 4
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
......+.|||.|||||.+.+..|+..+|+||+|||+||+++|++||.. ..+.+.++.+... +..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d----------~v~- 218 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKD----------PVK- 218 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcC----------CCC-
Confidence 4556678899999999999999999999999999999999999999953 2334444433221 222
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.|......+..++...+.+||..|.+-.+++.+
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 233455567789999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=361.72 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=206.6
Q ss_pred ccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCC-CCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 760 (1010)
..|...+.||+|+|++||+|+ ..+++.||||++.+...- +...+-...|-.+|.+| .||.|++++.-|.++...|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 456778899999999999999 457899999998542221 22234467788999999 899999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
+||+++|+|.++|+ +.+.+++..++.++.||+.|++|||..| ||||||||+|||+|++|++||+|||.|+.+.+.
T Consensus 153 Le~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999995 4588999999999999999999999777 999999999999999999999999999987653
Q ss_pred CCc---------c--eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc
Q 001816 841 GTS---------E--CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909 (1010)
Q Consensus 841 ~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 909 (1010)
... . .....+||..|++||++.....++.+|+|+||||+|+|+.|++||....+... ++++..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----FqkI~~-- 301 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----FQKIQA-- 301 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH----HHHHHH--
Confidence 222 1 12458999999999999999999999999999999999999999976433221 122211
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
++..++ ...+..+.+++.+.+..||.+|+|..++.++
T Consensus 302 -------l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 -------LDYEFP---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------hcccCC---CCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 122222 2223467789999999999999999999774
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=366.32 Aligned_cols=262 Identities=30% Similarity=0.440 Sum_probs=215.3
Q ss_pred cccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.+...+.+.||+|.||+||||+|. | .||||+++......+..+.|+.|+.++++.+|.||+-+.|||..++. .||+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 345567789999999999999984 3 69999998877777778889999999999999999999999998777 99999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
||+|-+|+.++|..+ ..++..+.+.|++|||+||.|||..+ |||||||..||++.++++|||+|||++..-.....
T Consensus 468 wCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999998544 67999999999999999999999666 99999999999999999999999999976544434
Q ss_pred cceeeeecccccccChhhhccC---CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
........|...|||||+++.. +|++.+||||||+++|||+||..||.. ...+.+ -|. +-++ ..-+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqI-ifm------VGrG---~l~p 612 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQI-IFM------VGRG---YLMP 612 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhhe-EEE------eccc---ccCc
Confidence 4444556789999999999854 589999999999999999999999972 222111 110 0000 0112
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
++......++.++.+++..||..++++||.+.+++..|+++..
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 2222344566789999999999999999999999998888765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=364.76 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=211.2
Q ss_pred eccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
..+....|..-+.||+|+.|.||.|. ..+++.||||++....... .+-+.+|+.+|+..+|+|||.+++.|..+++.
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 45556778888899999999999998 5578899999997644332 44478999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
|+||||++||+|.+.+.. ..+++.++..|+++++.||+|||..+ |+|||||.+|||++.+|.+||+|||++..+
T Consensus 346 WVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred EEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 999999999999999853 34999999999999999999999777 999999999999999999999999999887
Q ss_pred cCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
..... ...+.+|||.|||||++....|++|+||||||+|++||+.|++||-.. +.. +.+..+.
T Consensus 420 ~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-~Pl---rAlyLIa----------- 482 (550)
T KOG0578|consen 420 SEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPL---RALYLIA----------- 482 (550)
T ss_pred ccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-ChH---HHHHHHh-----------
Confidence 65433 456789999999999999999999999999999999999999999531 111 1111111
Q ss_pred CCCCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 DPRLPS--VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~--~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+...|. .+...+..+.+++.+|++.||++||++.|++++
T Consensus 483 ~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 483 TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 111111 233445678899999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=362.96 Aligned_cols=253 Identities=27% Similarity=0.382 Sum_probs=207.7
Q ss_pred cccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCC---CCcccchHHHHHHHhccC-CcccceeeeeEecCC
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRG---SSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHE 755 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 755 (1010)
.....|...+.||+|+||.||.|. ..+|+.||+|++...... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345788999999999999999997 457899999977553111 123455778999999998 999999999999999
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC-CceEEeecccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGLA 834 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DFGla 834 (1010)
..|+||||+.||+|.+++.. .+++.+.++.++++|++.|++|+|..| |+||||||+|||+|.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999964 578999999999999999999999777 9999999999999999 99999999999
Q ss_pred ccccCCCCcceeeeecccccccChhhhccCC-CC-ccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLK-VD-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 912 (1010)
.... .......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.+. ......+++...
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~----~~~~l~~ki~~~---- 238 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS----NVPNLYRKIRKG---- 238 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc----cHHHHHHHHhcC----
Confidence 8763 2334456789999999999999877 76 7899999999999999999999762 111222221111
Q ss_pred cccccCCCCCCCCHHH-HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKILDPRLPSVPLHE-VMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
... +|... ...+..++.+|+..+|.+|+++.|++.+
T Consensus 239 -----~~~---~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 239 -----EFK---IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred -----Ccc---CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 011 12222 5577889999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=353.03 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=210.3
Q ss_pred ccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
..|+..+.||+|.||.||||. .+.++.||+|++..... .....++++|+.++.+++++||.++|+.+..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 456667899999999999999 45689999999976443 3445668999999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
||.||++.+.++ .+..+.+.++.-+++++..|+.|+|.++ .+|||||+.||++..+|.+|++|||++..+....
T Consensus 92 y~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred HhcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 999999999994 4455688899999999999999999776 9999999999999999999999999998875433
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
....+.+|||.|||||++....|+.|+||||||++.|||.+|.+|+.+... ...+.-+.....|
T Consensus 166 -~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------------mrvlflIpk~~PP 229 (467)
T KOG0201|consen 166 -KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------------MRVLFLIPKSAPP 229 (467)
T ss_pred -hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------------ceEEEeccCCCCC
Confidence 333678999999999999999999999999999999999999999976432 1111112222223
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+....+.+++..|++++|+.||++.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3344566678999999999999999999999763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=358.51 Aligned_cols=253 Identities=28% Similarity=0.398 Sum_probs=214.2
Q ss_pred cccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccC-CCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAM-SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
..-|+..+-||+|+.|.|..|+ ..+|+.+|||++... .........+++|+-+|+.+.|||++++|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 4557788899999999999998 568999999999765 33344566789999999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
.||++||.|.+++ .+.+++++.++.++++||+.|+.|+|..+ |+|||+||+|+|+|..+.+||+|||+|..-.
T Consensus 91 lEyv~gGELFdyl--v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYL--VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EEecCCchhHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 9999999999999 45688999999999999999999999887 9999999999999999999999999997532
Q ss_pred CCcceeeeecccccccChhhhccCCCC-ccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
......+.+|+|.|.|||++++.+|+ .++||||+|||+|.|+||+.||++ +.+.....++... ..
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G----~f----- 229 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRG----VF----- 229 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcC----cc-----
Confidence 33456678999999999999999985 789999999999999999999963 2333344443322 11
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
++|...+.+..+++.+|+..||++|.|++||.++..-
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 1233444567789999999999999999999987443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=370.07 Aligned_cols=265 Identities=29% Similarity=0.501 Sum_probs=222.1
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC-C---CEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-G---DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
...++.++||.|.||.||+|+++- | ..||||.+|... .++...+|..|+.+|.+++||||+++.|+.......+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 345567899999999999999642 3 469999998644 35567789999999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
|+|||++|+|+.+|+.+ ++.+++.+...+.++||.||+||.+++ +|||||.++|||++.+..+|++|||+++.+.+
T Consensus 708 iTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999999854 467999999999999999999999888 99999999999999999999999999998765
Q ss_pred CCCcceeeeecc--cccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 840 SGTSECMSAIAG--SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 840 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.. .....+..| ..+|.|||.+..++++.++|||||||++||.++ |..||.++.+.+.+ +.+. +
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----kaIe----~----- 849 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----KAIE----Q----- 849 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----HHHH----h-----
Confidence 43 222222222 369999999999999999999999999999997 99999886543221 1111 1
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQG 969 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~~~~ 969 (1010)
+.++ +.|.+++..+.+++..||++|-.+||++++++..|.++.+.|.+...
T Consensus 850 -gyRL-PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~ 900 (996)
T KOG0196|consen 850 -GYRL-PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT 900 (996)
T ss_pred -ccCC-CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence 1223 34778889999999999999999999999999999999887776543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=380.16 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=216.2
Q ss_pred cCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 688 EDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
..+.||+|+||+||+|+.. +...||||.++..... ...++|++|++++..++|||||+++|+|.+++..++|+
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 4567999999999999842 2346999999865442 34667999999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCC--------C----CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEe
Q 001816 762 EYMPNGSLGEVLHGKK--------G----GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVA 829 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~--------~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~ 829 (1010)
|||..|||.++|.... + .+++..+.+.|+.|||.||+||-+++ +|||||..+|+||.++..|||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEec
Confidence 9999999999996421 2 23788899999999999999999776 9999999999999999999999
Q ss_pred eccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhh
Q 001816 830 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 830 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
|||+++..-..+.+.......-..+|||||.+..++++.++|||||||++||+++ |+.||.+..+.+. .+.++
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-Ie~i~----- 719 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-IECIR----- 719 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-HHHHH-----
Confidence 9999998765555544333445679999999999999999999999999999998 9999987654322 22221
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 001816 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964 (1010)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~ 964 (1010)
+..+.+.|..++.+++.++..||+..|++||+++||...|+......
T Consensus 720 ---------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 720 ---------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 23344567788889999999999999999999999999999886543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=321.15 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=213.6
Q ss_pred cccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCC-CCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMS-RGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|.||.||.|+ .+++-.||+|++.+.. ......+++.+|+++-+.++||||.++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4678899999999999999999 4567789999985432 2233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
+||..+|++...+...+..++++.....++.|+|.|+.|+|..+ |+||||||+|+|++..+..|++|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998778888999999999999999999999555 9999999999999999999999999998643
Q ss_pred CCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||.... ..+..+.++++. -.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~------------~~ 240 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD------------LK 240 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc------------cc
Confidence 234457899999999999999999999999999999999999999997644 333333333321 11
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
. |...+....++|.+|+..+|.+|.+..|++++-+
T Consensus 241 ~---p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 241 F---PSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred C---CcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 1 2233446778999999999999999999998643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=325.11 Aligned_cols=269 Identities=21% Similarity=0.248 Sum_probs=211.3
Q ss_pred cccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--Ccc
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETN 757 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 757 (1010)
.-.+.|+..+.|++|.||.||+|+. ++++.||+|+++.........-.-.+||.++.+.+|||||.+-.+.... +..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3356788899999999999999995 5688999999986554333333457899999999999999999987553 578
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
|+|||||+ .+|...++..+ .++...++..++.|+++|++|||.+. |+|||||++|+|+...|.+||+|||+|+.+
T Consensus 153 y~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999995 59999997654 68999999999999999999999888 999999999999999999999999999988
Q ss_pred cCCCCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc---cccc
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK---KEGV 913 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~ 913 (1010)
... ...++..+-|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+..+-.++..+++.+.... ..++
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 654 2335567789999999998865 599999999999999999999999987655555555544332111 1111
Q ss_pred cccc---CCCCCCCCH---------H-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 LKIL---DPRLPSVPL---------H-EVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ~~~~---~~~~~~~~~---------~-~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.. .-.++..+. . -...-++++...+..||.+|-|+.|.+++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111 001111111 0 22456789999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.50 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=203.1
Q ss_pred ccCCcCCeEeecCcEEEEEEEe------cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC-C
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM------PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH-E 755 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~ 755 (1010)
++|++.++||+|+||.||+|.. .+++.||||+++... .......+.+|+++++++ +||||+++++++... +
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 5788889999999999999973 235689999986432 222345688999999999 899999999988764 4
Q ss_pred ccEEEEEecCCCCHHhhhccCC----------------------------------------------------------
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKK---------------------------------------------------------- 777 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 777 (1010)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999986421
Q ss_pred --CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeecccccc
Q 001816 778 --GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 855 (1010)
Q Consensus 778 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 855 (1010)
...+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 124778888999999999999999776 999999999999999999999999999865433222222334567899
Q ss_pred cChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHH
Q 001816 856 IAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFY 934 (1010)
Q Consensus 856 ~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1010)
+|||++.+..++.++|||||||++|||++ |..||.......... ..+... .....+...+..+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~---~~~~~~-----------~~~~~~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC---QRLKDG-----------TRMRAPENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHhcC-----------CCCCCCCCCCHHHHH
Confidence 99999999999999999999999999997 999997543222211 111111 111112233456788
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 935 VAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 935 li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
++.+||+.||++|||+.|+++.|+++.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=354.04 Aligned_cols=241 Identities=28% Similarity=0.466 Sum_probs=203.3
Q ss_pred CcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCC
Q 001816 687 KEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 687 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
...+-+|.|+.|.||+|++ .++.||||+++.. -+.+|+-+++++||||+.|.|+|.....++||||||+.
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 3467899999999999998 5789999988642 24589999999999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|-|..+|+ .+..+.......|..+||.||.|||.+. |||||||.-||||..+..|||+|||.++...+. ..+
T Consensus 197 GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STk 268 (904)
T KOG4721|consen 197 GQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STK 268 (904)
T ss_pred ccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhh
Confidence 99999994 5567888999999999999999999776 999999999999999999999999999876543 334
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
-.++||..|||||+++..+.++|+||||||||||||+||..||.+.+.... +..+.. +.....+|.
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVGs----------NsL~LpvPs 334 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVGS----------NSLHLPVPS 334 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEeccC----------CcccccCcc
Confidence 467899999999999999999999999999999999999999965432211 111110 111123456
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.++..+.-+++.||+..|..||++.+++.+|.-
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 667778889999999999999999999988754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=346.02 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=201.6
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|+..++||+|+||.||.|+. .+|+.+|+|++++..... .+......|-.+|...++|+||+++..|.+.+..|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46789999999999999999994 469999999997643322 2345578899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||++||++..+|. +.+.++++.++.++.+++.|++.+|+.| ||||||||+|+|||..|++||+|||++.-+...
T Consensus 220 MEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999994 5678999999999999999999999888 999999999999999999999999998543210
Q ss_pred C----------------------Cc-----cee------------------eeecccccccChhhhccCCCCccCceehh
Q 001816 841 G----------------------TS-----ECM------------------SAIAGSYGYIAPEYAYTLKVDEKSDVYSF 875 (1010)
Q Consensus 841 ~----------------------~~-----~~~------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 875 (1010)
. .. ... -..+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 00 000 13469999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCC---CHHH
Q 001816 876 GVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERP---TMRE 952 (1010)
Q Consensus 876 G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP---s~~e 952 (1010)
|||+|||+.|.+||.... ..+..+-+...... +. .|. ......+..++|.+|+. ||++|- .+.|
T Consensus 375 G~ImyEmLvGyPPF~s~t-p~~T~rkI~nwr~~----l~------fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSET-PQETYRKIVNWRET----LK------FPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhhh----cc------CCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 999999999999997532 22222222111100 00 010 11112466789999988 999995 5777
Q ss_pred HHHH
Q 001816 953 VVQI 956 (1010)
Q Consensus 953 v~~~ 956 (1010)
|.++
T Consensus 442 IK~H 445 (550)
T KOG0605|consen 442 IKKH 445 (550)
T ss_pred HhcC
Confidence 7653
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=351.56 Aligned_cols=245 Identities=29% Similarity=0.483 Sum_probs=206.6
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGS 768 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 768 (1010)
-++|+|.||+||.|++. +..++|||.++.... ...+-+..||.+.+.++|.|||+++|.+.+++..-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 37999999999999954 567899999875433 335558899999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCC--ChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEc-CCCceEEeeccccccccCCCCcce
Q 001816 769 LGEVLHGKKGGHL--HWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD-SGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 769 L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
|.+.++... +++ .+.+.-.+.+||++||.|||++. |||||||-+|||++ -.|.+||+|||.++.+. +...+
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~ 732 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPC 732 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcc
Confidence 999997655 445 67788899999999999999877 99999999999996 47899999999999874 34566
Q ss_pred eeeecccccccChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 846 MSAIAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
+.+..||..|||||++..+ .|+.++|||||||++.||.||++||.+.+.+..-. +.-.+-+..|+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------------FkVGmyKvHP~ 799 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------------FKVGMYKVHPP 799 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------------hhhcceecCCC
Confidence 7788999999999999865 58999999999999999999999998765433210 00111234466
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
+|.+...+...+|.+|+.++|.+||++.++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 77788888999999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=323.30 Aligned_cols=239 Identities=24% Similarity=0.328 Sum_probs=198.5
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|+..+.||.|+||.|..++.+ +|..+|+|+++....- -...+...+|.++++.+.||.++++++.+.+.+..|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 456778889999999999999954 5889999999653221 12234567899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||++||.|..+++ +.+++++..++.++.||+.|++|||..+ |++||+||+|||+|.+|.+||+|||.|+.....
T Consensus 123 meyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999995 5578999999999999999999999776 999999999999999999999999999986532
Q ss_pred CCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
.-+.+|||.|+|||++....|+.++|.|||||++|||+.|.+||..... .+...++... .
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~-----------~ 257 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEG-----------K 257 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhC-----------c
Confidence 4478999999999999999999999999999999999999999975332 2222222211 1
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCC
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVER 947 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~R 947 (1010)
. ..|..-...+.+++...++.|-.+|
T Consensus 258 v-~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 V-KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c-cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 1233444567788888999888888
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.16 Aligned_cols=270 Identities=23% Similarity=0.356 Sum_probs=212.4
Q ss_pred ccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec-----
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN----- 753 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 753 (1010)
.++...|...+.||+|+||.|+.|. ..+|+.||||++..........++..+|+++++.++|+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3455667777899999999999998 4579999999998666666666778899999999999999999998865
Q ss_pred CCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 754 HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 754 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
-...|+|+|+| +.+|...++ .+..++.+.+..++.||++||+|+|+.+ |+|||+||+|++++.+..+||+|||+
T Consensus 98 f~DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred cceeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 35679999999 789999995 4455999999999999999999999666 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 912 (1010)
|+..........++.++.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+.+ ..+..+.+..+.....+.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-YVHQLQLILELLGTPSEE 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-hHHHHHHHHHhcCCCCHH
Confidence 99876543344567788999999999865 5689999999999999999999999997643 333333333322222111
Q ss_pred cccccC-----------CCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKILD-----------PRLPSVPL-----HEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~-----------~~~~~~~~-----~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+. |..+..+. .......+++.+|+..||.+|+|++|++++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111 11222221 122346789999999999999999999885
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=353.13 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=220.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc-cEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET-NLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv 760 (1010)
.++|...+++|+|+||.++..+.+ ++..|++|.+..........+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467888999999999999988743 57789999998776666666678899999999999999999999999988 8999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|+||+||++.+.+.++++..++++++..|+.|++.|+.|||+.+ |+|||||+.||+++.++.|||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998888888999999999999999999999766 999999999999999999999999999987654
Q ss_pred CCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
. ....+.+|||.||.||++.+.+|+.|+|||||||++|||++-+++|...+ ....+.++. ...
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~----m~~Li~ki~-----------~~~ 222 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN----MSELILKIN-----------RGL 222 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc----hHHHHHHHh-----------hcc
Confidence 3 23457789999999999999999999999999999999999999996532 222333222 222
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+.|..+...+..++..|++.+|..||++.+++..
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 445667778889999999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=377.13 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=210.7
Q ss_pred CCcCCeEeecCcEEEEEEEec--CCC----EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP--NGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
.+..+.||+|+||.||+|... +|. .||||.++.... ..+..+|.+|+.+|+.++|||||+++|.+.+.+..+|
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 345578999999999999853 344 489999875433 3446679999999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCC-----CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccc
Q 001816 760 VYEYMPNGSLGEVLHGKK-----GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla 834 (1010)
++|||+||+|..+|++.+ ...++....+.++.|||+|+.||++.+ +|||||..+|+|+++...|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999997542 356888899999999999999999776 999999999999999999999999999
Q ss_pred ccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccc
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
+.+.+...+.......-...|||||.+..+.++.|+|||||||++||++| |..||....+.+.+..+.+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~---------- 919 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE---------- 919 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh----------
Confidence 96544443332222233469999999999999999999999999999999 9999987543322221211
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 914 LKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
...-+.|..++..+++++..||+.+|++||++..+++.+..+..
T Consensus 920 -----ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 -----GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -----CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 11223466777889999999999999999999999998777653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.00 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=209.5
Q ss_pred cccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.-+|++.+.||+|.||.|-+|. ...|+.||||.+++.... +.....+.+||++|+.++||||+.+|++|+..+..+||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3467778899999999999998 578999999999764433 22334578999999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||..+|.|++|+. ..+.+++.+++.+++||..|+.|+|+++ |+|||+|.+|||+|.++++||+|||++-.+.+.
T Consensus 132 MEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999995 4578999999999999999999999877 999999999999999999999999999876543
Q ss_pred CCcceeeeecccccccChhhhccCCCC-ccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
....+++|+|-|.+||++.+.+|. +.+|-||+||++|.++.|..||++.+ ....++.+.... ...|
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~Ga------YrEP 273 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGA------YREP 273 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhccc------ccCC
Confidence 334678999999999999999884 78999999999999999999997643 333444433221 1122
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
.- |. ...-+|++|+..+|++|.|+.+|..+-+
T Consensus 274 ~~---PS----dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 274 ET---PS----DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred CC---Cc----hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 22 22 3345899999999999999999988654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=355.90 Aligned_cols=258 Identities=27% Similarity=0.374 Sum_probs=206.4
Q ss_pred cCCeEeecCcEEEEEEEecC--C---CEEEEEEeccCC-CCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 688 EDNIIGKGGAGIVYKGLMPN--G---DQVAVKRLPAMS-RGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~~~--g---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
..++||+|+||.||+|.++. + ..||||..+... .......+|.+|+++|+.++|||||++||++..+...|+||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 34799999999999998543 2 238999987522 34455677999999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|+|.||+|.++|++.+ ..++..+...++.++|+||+|||..+ ++||||.++|+|++.++.+||+|||+++...
T Consensus 241 El~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--- 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS--- 313 (474)
T ss_pred EecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc---
Confidence 9999999999997543 36999999999999999999999766 9999999999999999999999999987543
Q ss_pred Ccceee-eecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 842 TSECMS-AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 842 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
...... ...-...|+|||.+....|++++|||||||++||+++ |..||.+.... +....+.. +.
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~----------~~ 379 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVK----------NG 379 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHh----------cC
Confidence 111111 1224579999999999999999999999999999999 88899764322 11111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCCC
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTS 966 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~~ 966 (1010)
-....+...+..+..++.+||..+|++||+|.++.+.++.+......
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11122334556777888999999999999999999999888765443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.41 Aligned_cols=244 Identities=23% Similarity=0.257 Sum_probs=197.1
Q ss_pred CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
++||+|+||.||+|.. .+|+.||||+++.... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 4689999999875322 1222345778999999999999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceee
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 847 (1010)
+|.+++. +.+.+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 81 ELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 9999985 3457899999999999999999999777 999999999999999999999999999753222 12234
Q ss_pred eecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHH
Q 001816 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927 (1010)
Q Consensus 848 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1010)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... +. ..+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~~~~~---------~~---~~p~~ 217 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME---------EI---RFPRT 217 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----HHHHHHHHcC---------CC---CCCCC
Confidence 56799999999999999999999999999999999999999964321 1111111111 11 12223
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 928 EVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 928 ~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
....+.+++.+|++.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 345678899999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=361.51 Aligned_cols=255 Identities=26% Similarity=0.341 Sum_probs=206.1
Q ss_pred cCCcCCeEeecCcEEEEEEEecCC-CEEEEEEeccCCCCCCcccchHHHHHHHhccC-Ccccceeeee-Eec------CC
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPNG-DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGF-CSN------HE 755 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~~------~~ 755 (1010)
++++.++|.+|||+.||.|....+ ..||+|++-.. ++.......+||++|++|+ |+|||.+++. ... .-
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 345667899999999999997665 99999998654 4444666889999999996 9999999993 221 13
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
+++|.||||+||.|-+++..+-...|++.++++|+.|+++|+++||.. +++|||||||-+||||+.++..||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 568999999999999999866666799999999999999999999977 6789999999999999999999999999996
Q ss_pred cccCCCCcc-e------eeeecccccccChhhh---ccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 001816 836 FLQDSGTSE-C------MSAIAGSYGYIAPEYA---YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKM 905 (1010)
Q Consensus 836 ~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~ 905 (1010)
......... . .-....|+.|+|||++ ++..+++|+|||||||+||-|+....||++.+.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 543222111 0 0123478999999986 477899999999999999999999999976422
Q ss_pred hhhcccccccccCC--CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 906 TDSKKEGVLKILDP--RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 906 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
..+++. .+|.. ..+...+..+|+.|++++|++||++.+|+..+.++..
T Consensus 264 --------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 --------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred --------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 122222 22332 4567788999999999999999999999998877653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.57 Aligned_cols=390 Identities=22% Similarity=0.233 Sum_probs=285.0
Q ss_pred EEEEEcCCCCcccccCcccCCC--CCCCEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceecc
Q 001816 64 VTSLDLSGLNLSGALSPDVAHL--RFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDL 141 (1010)
Q Consensus 64 v~~L~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 141 (1010)
...||++++.|...--..+.++ +.-+.|++++|.+..+-+..|.++++|+.++|.+|.++ .+|...+...+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 4567777777764332333333 35667999999999888889999999999999999999 88987777788999999
Q ss_pred cCcccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCCC
Q 001816 142 YNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG 221 (1010)
Q Consensus 142 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~ 221 (1010)
.+|.|+..-..++..++.|+.||||.|.|+...-..|..-.++++|+|++|+|+....+.|.+
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~----------------- 195 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDS----------------- 195 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccc-----------------
Confidence 999999877888999999999999999999666677888789999999999998655554444
Q ss_pred CCCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccc
Q 001816 222 GLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAE 301 (1010)
Q Consensus 222 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 301 (1010)
+.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-.---.|..+++|+.|.|..|.|+..-...|-.
T Consensus 196 --------lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~ 267 (873)
T KOG4194|consen 196 --------LNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYG 267 (873)
T ss_pred --------cchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceee
Confidence 456667777788888666667777888888888888887544567888888888888888888777778888
Q ss_pred cCCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCcchhhh
Q 001816 302 LKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLI 381 (1010)
Q Consensus 302 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ 381 (1010)
+.++++|+|..|++...-..++-+++.|+.|+|++|.|..+.++.+...++|++|||++|+|+...+..|..+.
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~------ 341 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS------ 341 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH------
Confidence 88888888888888877777888888888888888888888888888888899999999988855444444444
Q ss_pred ccccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCcccccccc---CCcccccccceEeccCcc
Q 001816 382 TLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFP---VSDSISVNLGQICLSNNQ 458 (1010)
Q Consensus 382 l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~~~~L~~L~Ls~N~ 458 (1010)
.|++|+|++|.++..-...|.++++|++|||++|.|+..+. ..|..+++|+.|+|.+|+
T Consensus 342 ------------------~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 342 ------------------QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred ------------------HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 44444444444443333344445555555555555544322 234445555555555555
Q ss_pred ccCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecC
Q 001816 459 LSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSH 504 (1010)
Q Consensus 459 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 504 (1010)
|....-..|..+.+|++|+|.+|.|..+-|..|..+ .|++|-+..
T Consensus 404 lk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 404 LKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred eeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 553333455666666666666666665556666655 666665543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=346.98 Aligned_cols=264 Identities=25% Similarity=0.397 Sum_probs=202.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC-----------------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccce
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-----------------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 746 (1010)
++|++.+.||+|+||.||+|.+.+ +..||+|.+..... ......|.+|++++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCeeE
Confidence 567888899999999999997532 33699999865322 223456889999999999999999
Q ss_pred eeeeEecCCccEEEEEecCCCCHHhhhccCC-----------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceE
Q 001816 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKK-----------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809 (1010)
Q Consensus 747 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 809 (1010)
+++++.+.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885321 124678889999999999999999777 99
Q ss_pred eecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh--CCC
Q 001816 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRK 887 (1010)
Q Consensus 810 HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~ 887 (1010)
||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986544332222333456789999999998899999999999999999987 567
Q ss_pred CCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 888 PVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 888 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
||....+. +....+....... .... ....+...+..+.+++.+||+.+|++|||+.|+.+.|++
T Consensus 241 p~~~~~~~-~~~~~~~~~~~~~---~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE-QVIENAGEFFRDQ---GRQV----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH-HHHHHHHHHhhhc---cccc----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 77654322 2222221111110 0000 011122334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=342.89 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=201.8
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
|+..+.||+|+||+||+|.. .+|+.||||.+...... ......+.+|++++++++|++|+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56678899999999999985 57899999998643222 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++|+|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999998886545557899999999999999999999776 9999999999999999999999999998653321
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. ....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~------------~~~~ 223 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE------------DQEE 223 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc------------cccc
Confidence 223457999999999999999999999999999999999999999764332211111111110 0011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPT-----MREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs-----~~ev~~~ 956 (1010)
.+......+.+++.+||+.||++||+ ++|++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 12223446778999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=341.29 Aligned_cols=246 Identities=23% Similarity=0.392 Sum_probs=198.5
Q ss_pred CeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCc-ccchHHHHHHHhccCCcccceeeeeEec----CCccEEEEEec
Q 001816 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSH-DHGFNAEIQTLGRIRHRHIVRLLGFCSN----HETNLLVYEYM 764 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~ 764 (1010)
..||+|++|.||+|.+ +|+.||||+++........ .+.|.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 7899999999754332221 3567899999999999999999999876 34678999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhc-CCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD-CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
++|+|.+++.. ...+++.....++.|++.|++|||+. + ++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999964 35789999999999999999999973 5 8899999999999999999999999998654321
Q ss_pred ceeeeecccccccChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+.... ..
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~----------~~ 240 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDLIINKN----------NS 240 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcC----------CC
Confidence 13458899999999976 6899999999999999999999999975421 12222211110 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
+..+...+..+.+++.+||+.||++|||++|+++.|+..
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 112223455788999999999999999999999998765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=331.03 Aligned_cols=267 Identities=27% Similarity=0.400 Sum_probs=202.7
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhc--cCCcccceeeeeEecCC----cc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGR--IRHRHIVRLLGFCSNHE----TN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~----~~ 757 (1010)
+.....++||+|.||.||||.+ +++.||||+++.. ..+.|++|-++++. |+|+||++|+++-...+ ++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 3455567899999999999998 5699999999742 34558888777765 58999999999876655 78
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcC------CCceEeecCCCCcEEEcCCCceEEeec
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC------SPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
+||+||.+.|+|.+||. ...++|....+++..+++||+|||+.. .++|+|||||.+||||.+|+++.|+||
T Consensus 284 wLVt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999995 356999999999999999999999754 567999999999999999999999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhccCC-C-----CccCceehhhHHHHHHHhCCCCCC--CCCCCccH-----
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK-V-----DEKSDVYSFGVVLLELITGRKPVG--EFGDGVDI----- 898 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~Dv~slG~il~elltg~~P~~--~~~~~~~~----- 898 (1010)
|+|..+............+||.+|||||++.+.- . -.+.||||+|.|+|||+++..-+. ..++..-.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999887665555555689999999999987642 1 236899999999999998654432 11111100
Q ss_pred -----HHHHHHHhhhcccccccccCCCCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCC
Q 001816 899 -----VQWVRKMTDSKKEGVLKILDPRLPSV--PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT 965 (1010)
Q Consensus 899 -----~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~ 965 (1010)
..-++.... .+...|.++.. ....+.-+.+.+..||+.||+.|-|+.=|.+.+.++.....
T Consensus 441 G~hPt~e~mq~~VV------~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPTLEEMQELVV------RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCCHHHHHHHHH------hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 011111111 11111222221 11234457889999999999999999999998888876544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=356.34 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=203.8
Q ss_pred cccCCcCCeEeecCcEEEEEEEe------cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCC
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM------PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 755 (1010)
.++|+..+.||+|+||.||+|.+ .++..||||+++.... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34688889999999999999963 2356899999864332 22345688999999999 8999999999999999
Q ss_pred ccEEEEEecCCCCHHhhhccCC----------------------------------------------------------
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKK---------------------------------------------------------- 777 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 777 (1010)
..++||||+++|+|.++++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999885422
Q ss_pred ---------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 778 ---------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 778 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124778889999999999999999776 99999999999999999999999999986644322
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
........++..|+|||++.+..++.++|||||||++|||++ |..||..........+++.. .. .+..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---~~--------~~~~ 338 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE---GY--------RMLS 338 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh---Cc--------cCCC
Confidence 222223345678999999999999999999999999999998 88998654332222222211 10 0111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
+...+.++.+++.+||+.||++||+++|+++.|++
T Consensus 339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.81 Aligned_cols=358 Identities=24% Similarity=0.213 Sum_probs=290.2
Q ss_pred cEEEEEcCCCCcccccCcccCCCCCCCEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceeccc
Q 001816 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLY 142 (1010)
Q Consensus 63 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 142 (1010)
.+..||+++|.|...-...|-++++|+.+++..|.++ .+|...+...+|+.|+|.+|.|+..-.+++..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 6788999999999888888999999999999999999 788888888899999999999998888899999999999999
Q ss_pred CcccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCCCC
Q 001816 143 NNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGG 222 (1010)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~ 222 (1010)
.|.|+.+.-..|..-.++++|+|++|+|+...-..|..+.+|.+|.|++|+++...+..|.+|++|+.|+|.. |.+.-.
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnr-N~iriv 236 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNR-NRIRIV 236 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccc-cceeee
Confidence 9999965556777778999999999999998899999999999999999999988888999999999999964 333333
Q ss_pred CCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCcccccc
Q 001816 223 LPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL 302 (1010)
Q Consensus 223 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 302 (1010)
---.|..+.+|+.|.|..|++...-...|..+.++++|+|+.|++......++-++++|+.|+||+|.|+.+.++.+.-.
T Consensus 237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence 34577888999999999999887777788889999999999999988777888889999999999999988888888888
Q ss_pred CCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCcchhhhc
Q 001816 303 KNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLIT 382 (1010)
Q Consensus 303 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l 382 (1010)
++|+.|+|++|+|+...+..|..+.+|++|+|++|+++..-...|..+++|+.|||++|.+...+.+
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED------------- 383 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED------------- 383 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec-------------
Confidence 8999999999999988888888889999999999998876667788888888888888888754322
Q ss_pred cccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCc
Q 001816 383 LGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSD 443 (1010)
Q Consensus 383 ~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 443 (1010)
-...|..+++|+.|++.+|++..+.-.+|.+++.|+.|||.+|.|..+-+.+|
T Consensus 384 --------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAF 436 (873)
T KOG4194|consen 384 --------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAF 436 (873)
T ss_pred --------chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccc
Confidence 11233444455555555555543333344444444444444444443333333
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.91 Aligned_cols=261 Identities=23% Similarity=0.290 Sum_probs=203.9
Q ss_pred ccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCC------------CcccchHHHHHHHhccCCcccce
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGS------------SHDHGFNAEIQTLGRIRHRHIVR 746 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~ 746 (1010)
....+.|++.+.||+|.||.|-+|+ ..+++.||||++.+..... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456889999999999999999999 4578999999996432211 11235789999999999999999
Q ss_pred eeeeEecC--CccEEEEEecCCCCHHhhhccCCCCC-CChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC
Q 001816 747 LLGFCSNH--ETNLLVYEYMPNGSLGEVLHGKKGGH-LHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG 823 (1010)
Q Consensus 747 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~ 823 (1010)
++++..+. +..|||+|||..|.+...- .... +++.+++++++++..||+|||.++ ||||||||+|+|++++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99998764 5789999999998876543 2334 899999999999999999999877 9999999999999999
Q ss_pred CceEEeeccccccccCC---CCcceeeeecccccccChhhhccCC----CCccCceehhhHHHHHHHhCCCCCCCCCCCc
Q 001816 824 FEAHVADFGLAKFLQDS---GTSECMSAIAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELITGRKPVGEFGDGV 896 (1010)
Q Consensus 824 ~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~P~~~~~~~~ 896 (1010)
|+|||+|||.+...... +........+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||-+.
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~---- 322 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD---- 322 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc----
Confidence 99999999999866322 1222334478999999999887633 457889999999999999999999542
Q ss_pred cHHHHHHHHhhhcccccccccCCCC--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 897 DIVQWVRKMTDSKKEGVLKILDPRL--PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
.......++ ++..+ |.. .+....+.++|.+++.+||+.|.+..+|..+.+....
T Consensus 323 ~~~~l~~KI-----------vn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 FELELFDKI-----------VNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hHHHHHHHH-----------hcCcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 112222222 22211 221 1344567889999999999999999999888765543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=325.05 Aligned_cols=267 Identities=25% Similarity=0.358 Sum_probs=203.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC-----cc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE-----TN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~ 757 (1010)
-.|...+++|.|+||.||+|.. .+++.||||+.-...+. -.+|+++|++++|||||++.-+|.... ..
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3566678999999999999994 45789999998543321 247999999999999999999885532 23
Q ss_pred EEEEEecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC-CceEEeecccc
Q 001816 758 LLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGLA 834 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DFGla 834 (1010)
.+|||||+ .+|.++++. ..+.+++.-.++-++.||++||+|||..+ |+||||||.|+|+|.+ |.+||||||.|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 48999996 599998863 23467888899999999999999999776 9999999999999976 89999999999
Q ss_pred ccccCCCCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccc
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
+.+...... ..+..|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+...++..+++-+....++.+
T Consensus 174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987654433 456789999999998875 6999999999999999999999999875544445544443322222222
Q ss_pred cccc-------CCCCCC------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCCCC
Q 001816 914 LKIL-------DPRLPS------VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI--LTELPKP 963 (1010)
Q Consensus 914 ~~~~-------~~~~~~------~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~--L~~~~~~ 963 (1010)
..+- .|.... .......+..+++.+++..+|.+|.++.|++++ +.++..+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111 111111 122334567889999999999999999999873 4444433
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=350.11 Aligned_cols=248 Identities=23% Similarity=0.275 Sum_probs=200.9
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||.||+|... +|+.||||+++.... .....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 356788889999999999999964 688999999864321 122345588999999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999953 457889999999999999999999777 999999999999999999999999999865432
Q ss_pred CCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+... ...
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~---------~~~ 233 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----PFRIYEKILAG---------RLK 233 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----HHHHHHHHhcC---------CcC
Confidence 123579999999999999999999999999999999999999996422 11112221111 011
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPT-----MREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~ev~~~ 956 (1010)
.+......+.+++.+||+.||.+||+ +++++.+
T Consensus 234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11222345778999999999999986 6777654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.25 Aligned_cols=271 Identities=23% Similarity=0.291 Sum_probs=209.5
Q ss_pred ccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcc-cceeeeeEecCC------
Q 001816 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH-IVRLLGFCSNHE------ 755 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~------ 755 (1010)
..|...++||+|+||+||+|+ ..+|+.||+|++......+.......+|+.++++++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345566789999999999999 557899999999876554334445689999999999999 999999998877
Q ss_pred ccEEEEEecCCCCHHhhhccCCC--CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKG--GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
..++|+||+ .-+|.+++..... ..++...+..+++||++|++|||+++ |+||||||+||++++.|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 5799999975442 35667889999999999999999777 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc--
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK-- 910 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 910 (1010)
|+...-. .......++|..|.|||++.+. .|+...||||+|||++||++++.-|.+..+..++....+.+.....
T Consensus 167 Ara~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9965422 2224556789999999999887 7999999999999999999999999876664444444443322211
Q ss_pred -cccccccCC--CCCCC--CH-------HHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 001816 911 -EGVLKILDP--RLPSV--PL-------HEVMHVFYVAMLCVEEQAVERPTMREVVQI--LTEL 960 (1010)
Q Consensus 911 -~~~~~~~~~--~~~~~--~~-------~~~~~~~~li~~cl~~~P~~RPs~~ev~~~--L~~~ 960 (1010)
..+....+. ..+.. +. .......+++.+|++.+|.+|.|++.++++ +.+.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111111111 11111 00 001357789999999999999999999886 4444
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=355.28 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=202.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 756 (1010)
++|++.+.||+|+||.||+|.+. ++..||||+++..... .....+.+|+++++.+ +||||+++++++...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 46888899999999999998742 2357999999754322 2244578899999999 89999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCC-----------------------------------------------------------
Q 001816 757 NLLVYEYMPNGSLGEVLHGKK----------------------------------------------------------- 777 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 777 (1010)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ---------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeee
Q 001816 778 ---------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA 848 (1010)
Q Consensus 778 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 848 (1010)
...+++.++.+++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124778889999999999999999766 99999999999999999999999999986543322222223
Q ss_pred ecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHH
Q 001816 849 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927 (1010)
Q Consensus 849 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1010)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||.............. .. ..+.. +..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~---~~--------~~~~~---~~~ 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK---RG--------YQMSR---PDF 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH---cc--------cCccC---CCC
Confidence 345678999999999999999999999999999997 9999975432222111111 00 01111 111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 928 EVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 928 ~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.40 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=206.2
Q ss_pred ccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
+.+.|++.+.||+|.|+.||+.. ..+|+.+|+|.+..........+.+.+|+++-+.++|||||++.+.+.+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45778888999999999999987 56799999999876555555566789999999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC---CCceEEeeccccccc
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS---GFEAHVADFGLAKFL 837 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~---~~~~kl~DFGla~~~ 837 (1010)
+|+|.|++|..-+-.+ ..+++..+-.+++||++|+.|+|.++ |||||+||+|+++.+ ..-+||+|||+|..+
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997665322 45788888999999999999999777 999999999999943 446999999999987
Q ss_pred cCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
. ........+|||+|||||+++..+|+..+|||+.|||+|-++.|++||.+.+ ..++.+ .+. ..-.+.-
T Consensus 164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-~~rlye---~I~----~g~yd~~ 232 (355)
T KOG0033|consen 164 N---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYE---QIK----AGAYDYP 232 (355)
T ss_pred C---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-HHHHHH---HHh----ccccCCC
Confidence 6 2334456789999999999999999999999999999999999999997532 222222 211 1111222
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
.+..+.+ ......++++|+..||.+|.|+.|.+.+-
T Consensus 233 ~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 233 SPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred CcccCcC----CHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 2222222 23456799999999999999999997643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=345.96 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=200.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 759 (1010)
.+.|...++||+|+||+|+.|..+ +++.+|||++++...- ....+....|.+++... +||.++.++..|.+.++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 356778889999999999999954 5889999999865442 23345577888888877 59999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+.||++..+. ..+.+++..+..++..++.||+|||+++ |||||||.+|||+|.+|.+||+|||+++.-.
T Consensus 447 vmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC-
Confidence 99999999954443 4567999999999999999999999888 9999999999999999999999999998643
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
.....+.+.+|||.|||||++.+..|+.++|.|||||++|||+.|+.||.+. +++++..-+.. .++
T Consensus 520 -~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-dEee~FdsI~~------------d~~ 585 (694)
T KOG0694|consen 520 -GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-DEEEVFDSIVN------------DEV 585 (694)
T ss_pred -CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhc------------CCC
Confidence 2344667899999999999999999999999999999999999999999753 33332222211 112
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTM 950 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 950 (1010)
..|...+.+...++.+++.++|++|--+
T Consensus 586 ---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2344455567789999999999999654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=345.66 Aligned_cols=253 Identities=23% Similarity=0.262 Sum_probs=198.9
Q ss_pred CCcCCeEeecCcEEEEEEEe----cCCCEEEEEEeccCCC--CCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccE
Q 001816 686 LKEDNIIGKGGAGIVYKGLM----PNGDQVAVKRLPAMSR--GSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 758 (1010)
|++.+.||+|+||.||+++. .+|+.||+|+++.... .......+..|+++++.+ +||+|+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 67788999999999999874 3578999999864321 122234577899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999853 356899999999999999999999777 9999999999999999999999999998653
Q ss_pred CCCCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...............+.. .
T Consensus 157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------~ 226 (332)
T cd05614 157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---------C 226 (332)
T ss_pred ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc---------C
Confidence 3222 222345799999999998865 4789999999999999999999999754333222222222111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
++.. +......+.+++.+|++.||++|| ++++++++
T Consensus 227 ~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1222 222344677899999999999999 67788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.61 Aligned_cols=266 Identities=18% Similarity=0.219 Sum_probs=203.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
++|++.+.||+|+||.||+|+.+ +++.||||+++.........+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36788899999999999999965 57899999997654444445568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 999887766543 2356899999999999999999999776 9999999999999999999999999998764322
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc-cc---------
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK-EG--------- 912 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~--------- 912 (1010)
........|++.|+|||++.+..++.++||||+||++|||++|+.||............ ........ +.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI-QKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHhhCCCCHHHHHhhhccch
Confidence 12223457899999999999989999999999999999999999999764332222111 11100000 00
Q ss_pred cccccCCCCCC-------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKILDPRLPS-------VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
......+.... .....+..+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 001123458899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.14 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=199.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-c-CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc---CCcccceeeeeEec-----
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-P-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI---RHRHIVRLLGFCSN----- 753 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~----- 753 (1010)
++|++.+.||+|+||+||+|.. . +|+.||||+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688889999999999999985 3 467899999876544333344566788777766 69999999998852
Q ss_pred CCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 754 HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 754 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
....++||||++ ++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456799999995 69999987655566899999999999999999999777 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccc
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||....+.......+........+..
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9865432 2233456899999999999889999999999999999999999999764433222222221110000000
Q ss_pred c-------cccCCCCCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 L-------KILDPRLPS----VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ~-------~~~~~~~~~----~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
. ..+.+..+. ........+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 001110000 011223456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=345.51 Aligned_cols=244 Identities=23% Similarity=0.252 Sum_probs=196.6
Q ss_pred CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
++||+|+||.||++.. .+|+.||||+++.... .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 4689999999975322 1223446788999999999999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceee
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 847 (1010)
+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 99998853 457899999999999999999999776 999999999999999999999999998753221 12233
Q ss_pred eecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHH
Q 001816 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927 (1010)
Q Consensus 848 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1010)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... +. ..+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~~~~~---------~~---~~p~~ 217 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME---------DI---KFPRT 217 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HHHHHHhccC---------Cc---cCCCC
Confidence 45799999999999999999999999999999999999999964321 1111111100 11 11223
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 928 EVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 928 ~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
....+.+++.+|++.||++|| ++.|++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 344677899999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=343.93 Aligned_cols=247 Identities=25% Similarity=0.303 Sum_probs=200.7
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
++|++.+.||+|+||.||+|... +|+.||+|++..... .......+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 35778899999999999999964 689999999864322 1123445788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 99999999999953 456899999999999999999999777 999999999999999999999999999865432
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~------------ 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGIYEKILAGK------------ 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCC------------
Confidence 1235699999999999999999999999999999999999999965321 11222211110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPT-----MREVVQI 956 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~ev~~~ 956 (1010)
...+......+.+++.+|++.||.+||+ ++|++++
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1112222446778999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=320.64 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=208.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|.+.+++|+|+||.||+|.+ .+|..||||.++... ..+++.+|+.+|++++.|++|++||.|......|+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3466778899999999999985 569999999987533 36678899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
||..|++.+.++ .++.++++.++..+++..+.||+|||... -+|||||+.|||++.+|.+||+|||.|..+.+.
T Consensus 109 YCGAGSiSDI~R-~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-- 182 (502)
T KOG0574|consen 109 YCGAGSISDIMR-ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-- 182 (502)
T ss_pred hcCCCcHHHHHH-HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--
Confidence 999999999986 35578999999999999999999999776 899999999999999999999999999877543
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
-....+..|||.|||||++..-.|+.++||||+|++..||..|++||.+... .+.+..+.....|
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---------------MRAIFMIPT~PPP 247 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---------------MRAIFMIPTKPPP 247 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---------------cceeEeccCCCCC
Confidence 2334567899999999999999999999999999999999999999976432 1222222222222
Q ss_pred C--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 S--VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~--~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
. -|...+..+-++++.|+-+.|++|.|+.++.++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2 245556678899999999999999999988764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=345.31 Aligned_cols=247 Identities=22% Similarity=0.300 Sum_probs=194.0
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHH---hccCCcccceeeeeEecCCccEEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTL---GRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
|++.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56678999999999999985 4689999999974321 122234466676655 466899999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++|+|..+++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988843 46999999999999999999999777 999999999999999999999999998753222
Q ss_pred CCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
........|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+... ...
T Consensus 155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~~~~i~~~---------~~~ 219 (324)
T cd05589 155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEVFDSIVND---------EVR 219 (324)
T ss_pred --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC---------CCC
Confidence 2223456799999999999999999999999999999999999999965321 1122221111 011
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
.+...+..+.+++.+|++.||.+|| ++.+++++
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1222345677899999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.90 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=203.3
Q ss_pred ccCCcCCeEeecCcEEEEEEEec----CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP----NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
+.|++.+.||+|+||.||+|.++ .+..||+|.++.... ......+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 45777889999999999999753 356899999875432 2234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++|+|.+++... ...+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999998643 357899999999999999999999777 99999999999999999999999998765322
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .....+...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~~~~~---------- 224 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKAVEDG---------- 224 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHHCC----------
Confidence 111 11112345678999999999999999999999999999875 99999754321 112221111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.....+...+..+.+++.+||+.+|++||+++++.+.|..+
T Consensus 225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112333455688899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.23 Aligned_cols=258 Identities=26% Similarity=0.481 Sum_probs=206.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC-C-----CEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-G-----DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
+.|+..+.||+|+||.||+|.... + ..||+|.++.... ......|.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 457788899999999999998533 2 5799998864322 22344588999999999999999999999998999
Q ss_pred EEEEEecCCCCHHhhhccCCC--------------CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC
Q 001816 758 LLVYEYMPNGSLGEVLHGKKG--------------GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG 823 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~ 823 (1010)
+++|||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 999999999999999864321 45788899999999999999999776 9999999999999999
Q ss_pred CceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHH
Q 001816 824 FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWV 902 (1010)
Q Consensus 824 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~ 902 (1010)
+.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~-- 237 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIE-- 237 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH--
Confidence 9999999999986543332223334457889999999998899999999999999999998 9999965332 11211
Q ss_pred HHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.+.. ...+..+...+..+.+++.+||+.+|++||++.|+.+.|+.+
T Consensus 238 -~i~~-----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 -MIRS-----------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHc-----------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111 112223344556788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=346.16 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=202.5
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.|++.+.||+|+||.||+|... +|+.||||+++..... ......+.+|++++..++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5778889999999999999965 5889999999753221 1234457889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++|+|.+++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 82 YVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999995 3456899999999999999999999777 99999999999999999999999999976533
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.. ..+.... ... ..+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~---~~i~~~~-~~~---~~~~~~ 223 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-NETW---ENLKYWK-ETL---QRPVYD 223 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-HHHH---HHHHhcc-ccc---cCCCCC
Confidence 22345799999999999999999999999999999999999999965321 1111 1111110 000 011111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.........+.+++.+|+..+|++||+++|++++
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011234567789999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=337.59 Aligned_cols=250 Identities=33% Similarity=0.549 Sum_probs=196.0
Q ss_pred CCeEeecCcEEEEEEEec-----CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 689 DNIIGKGGAGIVYKGLMP-----NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 689 ~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.+.||+|.||.||+|.+. .+..|+||.++.. ........|.+|++.+++++||||++++|++...+..++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccccc
Confidence 467999999999999976 2567999999542 2222356789999999999999999999999988889999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++|+|.+++.......+++.++..++.||++||+|||+.+ ++||||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998765678999999999999999999999776 999999999999999999999999999876333232
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......+...|+|||.+....++.++||||||+++||+++ |+.||.... ..++...+.... ..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~----~~~~~~~~~~~~-----------~~ 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD----NEEIIEKLKQGQ-----------RL 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC----HHHHHHHHHTTE-----------ET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccccccc-----------cc
Confidence 33334457789999999999999999999999999999999 788986542 222233322211 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
..+...+..+..++..||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12233455688999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.95 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=205.5
Q ss_pred cccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-----Cc
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH-----ET 756 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 756 (1010)
.++|++.+.+|+|||+.||.++ ..+++.||+|++..... +......+|++..++++|||+++++++...+ .+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3679999999999999999998 66788999999976442 3355678999999999999999999987443 35
Q ss_pred cEEEEEecCCCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla 834 (1010)
.|++++|+..|+|.+.+... ++..+++.+++.|+.++++||++||+.. ++++||||||.||++.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999998653 3457999999999999999999999774 46999999999999999999999999999
Q ss_pred ccccCCCCc-------ceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 001816 835 KFLQDSGTS-------ECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 835 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~ 904 (1010)
....-.-.. +.......|..|.|||.+. +...++++|||||||++|+|+.|..||+..-....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg------- 249 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG------- 249 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-------
Confidence 764321111 0112345889999999875 56789999999999999999999999964211000
Q ss_pred HhhhcccccccccCC--CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 905 MTDSKKEGVLKILDP--RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 905 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.....+..+ ..|..+ ..+..+.+++++|++.||.+||++.|++..+..+
T Consensus 250 ------SlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 ------SLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------eEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 000111111 122222 2667889999999999999999999999887654
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=349.18 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=205.3
Q ss_pred cccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCC
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHE 755 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 755 (1010)
.+.|.+.++||+|+||.||+|... .+..||||+++.... ....+.+.+|+++++++. ||||+++++++.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 457788899999999999999842 234699999965332 223456889999999996 999999999999999
Q ss_pred ccEEEEEecCCCCHHhhhccCC----------------------------------------------------------
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKK---------------------------------------------------------- 777 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 777 (1010)
..|+||||+++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999885421
Q ss_pred ------------------------------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEc
Q 001816 778 ------------------------------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD 821 (1010)
Q Consensus 778 ------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~ 821 (1010)
...+++.++..++.|+++|++|||+.+ |+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124778888999999999999999776 99999999999999
Q ss_pred CCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHH
Q 001816 822 SGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQ 900 (1010)
Q Consensus 822 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~ 900 (1010)
.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999986543322222233457789999999999999999999999999999997 9999865322211111
Q ss_pred HHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 901 WVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
.+... .....+...+..+.+++.+||+.+|++||++.++.+.|+++.+
T Consensus 352 ---~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 ---KIKSG-----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHhcC-----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11110 0111222334568889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.50 Aligned_cols=244 Identities=23% Similarity=0.262 Sum_probs=195.6
Q ss_pred CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
++||+|+||.||++.. .+|..||+|+++.... .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 4689999999975322 1223345678999999999999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceee
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 847 (1010)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 153 (323)
T cd05595 81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence 99998853 457899999999999999999999777 999999999999999999999999998753221 12223
Q ss_pred eecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHH
Q 001816 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927 (1010)
Q Consensus 848 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1010)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... +.. .+..
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~~~~---------~~~---~p~~ 217 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILME---------EIR---FPRT 217 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHhcC---------CCC---CCCC
Confidence 457999999999999999999999999999999999999999653221 111111110 011 1222
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 928 EVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 928 ~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
....+.+++.+|++.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 344677899999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=361.62 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=207.1
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC---
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE--- 755 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 755 (1010)
+...++|.+.+.||+|+||+||+|.. .+|+.||||++............+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999984 57899999999765444444556788999999999999999988765432
Q ss_pred -----ccEEEEEecCCCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEE
Q 001816 756 -----TNLLVYEYMPNGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV 828 (1010)
Q Consensus 756 -----~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl 828 (1010)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|+|+.+ |+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 357999999999999998642 2456899999999999999999999766 999999999999999999999
Q ss_pred eeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh
Q 001816 829 ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 829 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||... .....+.....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~~~~~~~- 259 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEVMHKTLA- 259 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHhc-
Confidence 9999998765433333334567999999999999999999999999999999999999999642 12222222111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
......+...+..+.+++.+||+.+|++||++.+++++
T Consensus 260 ----------~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 ----------GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11112233344568889999999999999999999764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.92 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=218.2
Q ss_pred eeccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc
Q 001816 678 TCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 678 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 756 (1010)
....+..-|...+.||+|.|++|-.|+ .-+|+.||||++.+...+......+.+|++.|+.++|||||++|++......
T Consensus 12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 345567788999999999999999998 4489999999998776666556668889999999999999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE-cCCCceEEeeccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL-DSGFEAHVADFGLAK 835 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill-~~~~~~kl~DFGla~ 835 (1010)
.|+|.|+-++|+|++|+-+. ...+.++-+.+++.||+.|+.|+|+.+ |||||+||+||.+ ..-|-|||.|||++-
T Consensus 92 lyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccc
Confidence 99999999999999999643 345899999999999999999999988 9999999999876 567899999999997
Q ss_pred cccCCCCcceeeeecccccccChhhhccCCCC-ccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccc
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
.+.+. ....+.+|+..|-|||++.+..|+ +++||||+|||+|.+++|+.||....+.+.+ .
T Consensus 168 kf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------T 229 (864)
T KOG4717|consen 168 KFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------T 229 (864)
T ss_pred cCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------h
Confidence 66543 345677999999999999999987 5789999999999999999999876554332 2
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+++|- -..+|.+-..++.++|..|+..||++|.+.+|++..
T Consensus 230 mImDC-KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 230 MIMDC-KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhcc-cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 23332 123566777889999999999999999999999873
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=341.41 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=191.0
Q ss_pred CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCC-CCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||.||+|.. .+++.||||+++..... ......+..|..++... +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 45889999999753221 12233455666666654 899999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 999999853 356899999999999999999999776 9999999999999999999999999997643222 223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.. ..+..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~------------~~~~~~~ 217 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSILN------------DRPHFPR 217 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHc------------CCCCCCC
Confidence 355799999999999999999999999999999999999999975322 112222111 1111222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMR-EVVQ 955 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~-ev~~ 955 (1010)
.....+.+++.+|++.+|++||++. ++.+
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 3344677899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=345.17 Aligned_cols=240 Identities=23% Similarity=0.264 Sum_probs=193.2
Q ss_pred CeEeecCcEEEEEEEe----cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecC
Q 001816 690 NIIGKGGAGIVYKGLM----PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
+.||+|+||.||++.. .+|+.||+|+++...........+..|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997543332334456789999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce
Q 001816 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 766 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
+|+|.+++. +...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 999999985 3456899999999999999999999777 9999999999999999999999999997653321 22
Q ss_pred eeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCC
Q 001816 846 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (1010)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... ....+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~i~~~------------~~~~p 218 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KETMTMILKA------------KLGMP 218 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHHHHHHHcC------------CCCCC
Confidence 2345799999999999998999999999999999999999999965321 1111111111 01112
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHH
Q 001816 926 LHEVMHVFYVAMLCVEEQAVERPTMRE 952 (1010)
Q Consensus 926 ~~~~~~~~~li~~cl~~~P~~RPs~~e 952 (1010)
......+.+++.+|++.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 223346778999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=318.01 Aligned_cols=257 Identities=22% Similarity=0.254 Sum_probs=212.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|+..+.||+|.-|+||.++..+ +..+|+|++.+.... .....+.+.|.+|++.++||.++.+|+.++.++..++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3567778899999999999999654 588999999754333 23345578899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
||||+||+|....+++.+..+++..++.++.+++-||+|||..| ||.|||||+||||.++|++-|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999999999999999999999999999999999888 999999999999999999999999988654210
Q ss_pred --------------------------------C-C---------------------cceeeeecccccccChhhhccCCC
Q 001816 841 --------------------------------G-T---------------------SECMSAIAGSYGYIAPEYAYTLKV 866 (1010)
Q Consensus 841 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 866 (1010)
. . .......+||-.|+|||++++...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 011123569999999999999999
Q ss_pred CccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCC
Q 001816 867 DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVE 946 (1010)
Q Consensus 867 ~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~ 946 (1010)
+.++|.|+|||++|||+.|..||-+....+.+...+.+ +..++..+ ..+....++|++.+.+||.+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-------------~l~Fp~~~-~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-------------PLKFPEEP-EVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-------------CCcCCCCC-cchhHHHHHHHHHhccChhh
Confidence 99999999999999999999999876655544333221 22334333 44567889999999999999
Q ss_pred CCC----HHHHHHH
Q 001816 947 RPT----MREVVQI 956 (1010)
Q Consensus 947 RPs----~~ev~~~ 956 (1010)
|-- ++||-++
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 987 7887663
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=341.66 Aligned_cols=249 Identities=20% Similarity=0.272 Sum_probs=195.7
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||.||+|... +++.||||+++..... ......+.+|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999854 6889999999753322 22234577899999888 799999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++. +.+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (329)
T cd05588 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT 153 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence 99999885 3457999999999999999999999777 999999999999999999999999998753221 1223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc----cHHHHHHHHhhhcccccccccCCCCC
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV----DIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~ 222 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-----------KQI 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----------CCC
Confidence 35679999999999999999999999999999999999999996422111 111121111110 011
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPT------MREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs------~~ev~~~ 956 (1010)
..|......+.+++.+|++.||.+||+ +++++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 122233456788999999999999997 6677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=331.14 Aligned_cols=255 Identities=26% Similarity=0.456 Sum_probs=207.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 5678889999999999999998888899999876422 2245688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.++++......+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 99999999997665667899999999999999999999776 99999999999999999999999999987643221
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......++..|+|||+..+..++.++|||||||++|||++ |+.||...... .. ...+... .. .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~---~~~~~~~--------~~---~ 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DV---MSALQRG--------YR---M 223 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HH---HHHHHcC--------CC---C
Confidence 11223346678999999998889999999999999999998 99999653221 11 1111111 00 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
+.....+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11112334678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=340.97 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=204.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCC----EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
..|+..+.||+|+||.||+|.+. +|+ .||+|+++.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 45788899999999999999853 344 389999864322 22345688899999999999999999998764 578
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+|+||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999999643 346889999999999999999999776 9999999999999999999999999998765
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
............++..|+|||++.+..++.++|||||||++|||++ |+.||..... .++.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~~~~~~~~--------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEKG--------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHhCC---------
Confidence 4332222223345678999999999999999999999999999998 9999865321 1111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCCC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT 965 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~~ 965 (1010)
.....+......+..++.+||+.+|++||++.+++..+..+...+.
T Consensus 228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0111122234567889999999999999999999999988865543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=368.27 Aligned_cols=487 Identities=27% Similarity=0.316 Sum_probs=229.6
Q ss_pred EcCCCCcccccCcccCCCCCCCEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceecccCcccC
Q 001816 68 DLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMT 147 (1010)
Q Consensus 68 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 147 (1010)
|+++.+++ .+|..+-.-..++.|++..|-+-...-+.+.+.-+|+.|||++|++. ..|..+..+.+|+.|+++.|.|.
T Consensus 4 d~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~ 81 (1081)
T KOG0618|consen 4 DASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR 81 (1081)
T ss_pred ccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh
Confidence 44444444 33333333333555555555443222222333334555555555554 45555555555555555555555
Q ss_pred CCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccc-----------
Q 001816 148 GDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYY----------- 216 (1010)
Q Consensus 148 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~----------- 216 (1010)
..|.+...+.+|++|+|.+|++. ..|..+..+.+|++|+++.|++. .+|..+..++.+..+..++|
T Consensus 82 -~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~i 158 (1081)
T KOG0618|consen 82 -SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSI 158 (1081)
T ss_pred -hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccc
Confidence 44555555555555555555554 45555555555555555555554 45555555555555555533
Q ss_pred -------cCCCCCCCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCC
Q 001816 217 -------NSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNN 289 (1010)
Q Consensus 217 -------~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N 289 (1010)
+.+.+.++..+.+++. .|||++|.+. -..+..+.+|+.|....|++.... -..++|+.|+.++|
T Consensus 159 k~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n 229 (1081)
T KOG0618|consen 159 KKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHN 229 (1081)
T ss_pred hhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccC
Confidence 2223333333333333 3444444443 112333444444444444444211 11234555555555
Q ss_pred cCccccCccccccCCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCc
Q 001816 290 IFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPP 369 (1010)
Q Consensus 290 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 369 (1010)
.++...+ ...-.+|+++++++|+++ .+|++++.+.+|+.+...+|+++ .+|..+...++|+.|++.+|.+. -+|+
T Consensus 230 ~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~ 304 (1081)
T KOG0618|consen 230 PLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPP 304 (1081)
T ss_pred cceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCC
Confidence 5441111 111234555555555555 33455555555555555555553 44555555555555555555554 3444
Q ss_pred ccCCCCcchhhhccccccccccccccccCCC-CceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccc
Q 001816 370 DMCAGNCLQTLITLGNFLFGPIPESLGKCDS-LSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVN 448 (1010)
Q Consensus 370 ~~~~~~~L~~L~l~~n~~~~~~p~~l~~l~~-L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 448 (1010)
......+|++|++..|++....+..+..+.. |..|+.+.|++....-..=...+.|+.|++.+|.++...-..+....+
T Consensus 305 ~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~h 384 (1081)
T KOG0618|consen 305 FLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKH 384 (1081)
T ss_pred cccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccc
Confidence 4444555555555555544333333333322 444444444444211111112344555555555555544444445555
Q ss_pred cceEeccCccccCCCCC-CCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEcc
Q 001816 449 LGQICLSNNQLSGSLPA-SIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLS 527 (1010)
Q Consensus 449 L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 527 (1010)
|+.|+|++|+|. .+|+ .+.++..|+.|+||||+++ .+|..+..+..|++|..-.|+|. ..| ++.+++.|+.+|+|
T Consensus 385 LKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS 460 (1081)
T KOG0618|consen 385 LKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLS 460 (1081)
T ss_pred eeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecc
Confidence 555555555555 2332 3345555555555555555 45555555555555555555554 344 55555555555555
Q ss_pred CcccccccchhcccccccceEEecCccccCCchhhhhcccccceeccCCC
Q 001816 528 RNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYN 577 (1010)
Q Consensus 528 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N 577 (1010)
.|+|+...-..--.-++|++|||++|.=....-..|..+.++..+++.-|
T Consensus 461 ~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 461 CNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 55555322111111155555555555522233344444445555554444
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=336.33 Aligned_cols=265 Identities=20% Similarity=0.259 Sum_probs=199.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+..+.||+|+||.||+|..+ +++.||+|+++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 56888899999999999999854 688999999865332 2233457789999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|++ |+|.+++... +..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 84 YLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 996 5999888532 345788999999999999999999776 9999999999999999999999999997643221
Q ss_pred cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc---------
Q 001816 843 SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG--------- 912 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------- 912 (1010)
.......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.............+.......+.
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 12234568999999998875 5689999999999999999999999975432222222221111111110
Q ss_pred cccccCCCCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKILDPRLPSV-----PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
......+..... .........+++.+|++.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 011111111000 01122356789999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=340.03 Aligned_cols=242 Identities=24% Similarity=0.251 Sum_probs=193.8
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
||+|+||.||+|... +++.||+|+++.... .......+.+|++++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 588999999864321 222344577899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeee
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 999953 457899999999999999999999776 9999999999999999999999999997543221 223456
Q ss_pred cccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHH
Q 001816 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEV 929 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1010)
.||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+..+..... ....+....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~----~~~~~~~~~~~------------~~~~~~~~~ 217 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN----VNEMYRKILQE------------PLRFPDGFD 217 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC----HHHHHHHHHcC------------CCCCCCcCC
Confidence 79999999999999999999999999999999999999996532 12222222111 011122233
Q ss_pred HHHHHHHHhccccCCCCCCC---HHHHHHH
Q 001816 930 MHVFYVAMLCVEEQAVERPT---MREVVQI 956 (1010)
Q Consensus 930 ~~~~~li~~cl~~~P~~RPs---~~ev~~~ 956 (1010)
..+.+++.+|++.||++||+ +.|++.+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 46778999999999999975 5666553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.33 Aligned_cols=265 Identities=26% Similarity=0.360 Sum_probs=215.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+...+.++||+|.||.|..+....+..||||.++..... ....+|.+|+++|.+++|||||+++|+|..++..++||||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 445667899999999999999877899999999764432 2356799999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
|++|+|.+++..........+...+|+.||+.||+||.+.+ +||||+.++|+|+|+++++||+|||+++.+-.....
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999997554344556677889999999999999555 999999999999999999999999999977666566
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh--CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
......+-..+|||+|.+..++++.++|||+||+++||+++ .+.||.+..++... +-...+.+. .-....
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-en~~~~~~~-------~~~~~~ 765 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-ENAGEFFRD-------QGRQVV 765 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-HhhhhhcCC-------CCccee
Confidence 55556667789999999999999999999999999999875 78899765443211 111111111 001112
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
...|.-++..+++++.+||..+-++||+++++...|.+.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 234566677889999999999999999999999988764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=344.84 Aligned_cols=248 Identities=22% Similarity=0.252 Sum_probs=200.1
Q ss_pred cccCCcCCeEeecCcEEEEEEEecC--CCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN--GDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
.+.|++.+.||+|+||.||+|.... +..||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4678888999999999999998543 36899999864322 22234457889999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999953 456899999999999999999999777 99999999999999999999999999986532
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.... .
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~~---------~ 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQKILEGI---------I 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHHHhcCC---------C
Confidence 1 2345799999999999999999999999999999999999999965321 11111211110 0
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
.. +......+.+++.+|++.+|++|+ +++|+.++
T Consensus 246 ~~---p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC---CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 112234567899999999999995 88888775
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=329.20 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=201.3
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.|+..+.||+|+||.||+|.++++..+|+|.++... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 3466678899999999999998888899999876332 2245688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++|+|.++++... +.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 81 MENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 99999999986433 46899999999999999999999777 99999999999999999999999999976533211
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+..+.... .+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~~~-----------~~ 220 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISRGF-----------RL 220 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCC-----------CC
Confidence 11122345678999999998889999999999999999999 8999865321 11222221110 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
..+......+.+++.+||+++|++||+++|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11122335678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.25 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=208.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 762 (1010)
..|++.+.||+||.+.||++...+.+.||+|++.....+......|..|+..+.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 458889999999999999999878889999998877777777788999999999994 9999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|= ..+|..+|..+......| .++.+..|++.|+.++|++| |||.||||.|+|+-. |.+||+|||+|..+....+
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 75 679999997554333334 78889999999999999988 999999999999854 6899999999999887777
Q ss_pred cceeeeecccccccChhhhccC-----------CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 843 SECMSAIAGSYGYIAPEYAYTL-----------KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
.-.....+||+.||+||.+... ..++++||||+|||+|+|+.|+.||+.+.. .+.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~a-------- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIA-------- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHH--------
Confidence 7777888999999999987632 256899999999999999999999975321 111
Q ss_pred ccccccCC----CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 912 GVLKILDP----RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 ~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+..+.+| +++..+... ++.++++.|++.||++||++.|++++
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhhcCCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12233344 344444333 27789999999999999999999885
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=345.68 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=196.6
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC-----ccE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE-----TNL 758 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~ 758 (1010)
+|++.+.||+|+||.||+|.. .+|+.||||+++...........+.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 467788999999999999995 46899999998754333333446889999999999999999999875432 479
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+ +++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 578999885 3456899999999999999999999777 9999999999999999999999999998643
Q ss_pred CCCC-cceeeeecccccccChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHH----------
Q 001816 839 DSGT-SECMSAIAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKM---------- 905 (1010)
Q Consensus 839 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~---------- 905 (1010)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHH
Confidence 2221 112234579999999999875 6789999999999999999999999965322 1111111110
Q ss_pred --hhhcccccccccCCCCCCC----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 906 --TDSKKEGVLKILDPRLPSV----PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 906 --~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...........+....+.. -......+.+++.+|++.+|++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000000 00122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=346.20 Aligned_cols=255 Identities=23% Similarity=0.285 Sum_probs=196.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|++.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3577889999999999999985 4789999999864221 1223445788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999853 456899999999999999999999777 9999999999999999999999999996432110
Q ss_pred Ccc---------------------------------------------eeeeecccccccChhhhccCCCCccCceehhh
Q 001816 842 TSE---------------------------------------------CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFG 876 (1010)
Q Consensus 842 ~~~---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 876 (1010)
... .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 00124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCC---CCHHHH
Q 001816 877 VVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVER---PTMREV 953 (1010)
Q Consensus 877 ~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R---Ps~~ev 953 (1010)
|++|||++|+.||..... . .....+.... . . ...+. .......+.+++.+|+. +|.+| +++.|+
T Consensus 236 vil~elltG~~Pf~~~~~-~---~~~~~i~~~~-~---~---~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 236 AIMFECLIGWPPFCSENS-H---ETYRKIINWR-E---T---LYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhhcCCCCCCCCCH-H---HHHHHHHccC-C---c---cCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999965322 1 1111111110 0 0 01111 11123456788999997 66665 699999
Q ss_pred HHH
Q 001816 954 VQI 956 (1010)
Q Consensus 954 ~~~ 956 (1010)
+++
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=340.23 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=195.4
Q ss_pred CeEeecCcEEEEEEEe----cCCCEEEEEEeccCCC--CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 690 NIIGKGGAGIVYKGLM----PNGDQVAVKRLPAMSR--GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.||+|+||.||++.. .+|+.||||+++.... .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 3578999999864321 122234577899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++|+|.+++. +.+.+.+..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999985 3456888999999999999999999777 9999999999999999999999999987543221
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+... . ..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~~~~~~~~~~-----------~-~~ 218 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----KKTIDKILKG-----------K-LN 218 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----HHHHHHHHcC-----------C-CC
Confidence 122345799999999999998999999999999999999999999965321 1112221111 0 11
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
.+......+.+++.+|++.+|++|| ++.+++++
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1222334678899999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=342.59 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=202.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC-C
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH-E 755 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~ 755 (1010)
++|++.+.||+|+||.||+|... +++.||+|+++.... ......+.+|+++++++ +||||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 57888999999999999999632 357899999864322 22234577899999999 899999999987654 5
Q ss_pred ccEEEEEecCCCCHHhhhccCC----------------------------------------------------------
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKK---------------------------------------------------------- 777 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 777 (1010)
..+++|||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999885321
Q ss_pred -CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeeccccccc
Q 001816 778 -GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856 (1010)
Q Consensus 778 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 856 (1010)
...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 126789999999999999999999776 9999999999999999999999999998764332222223345677899
Q ss_pred ChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHH
Q 001816 857 APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYV 935 (1010)
Q Consensus 857 aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 935 (1010)
|||++.+..++.++|||||||++|||++ |..||........... .+... .....+......+.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR---RLKEG-----------TRMRAPEYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH---HHhcc-----------CCCCCCccCCHHHHHH
Confidence 9999999999999999999999999998 9999965332222111 11111 0011122234567889
Q ss_pred HHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 936 AMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 936 i~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
+.+||+.+|++||++.|++++|+++.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.50 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=194.8
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||.||+|... +++.||+|+++..... ......+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 6889999999754322 22234567888888776 799999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (329)
T cd05618 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT 153 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence 99998885 3457999999999999999999999777 9999999999999999999999999997532221 222
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc----cHHHHHHHHhhhcccccccccCCCCC
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV----DIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....++...... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----------~~~ 222 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------KQI 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-----------CCC
Confidence 34679999999999999999999999999999999999999996422111 111122111110 111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPT------MREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs------~~ev~~~ 956 (1010)
..|......+.+++.+|++.||++||+ +++++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 123334456778999999999999998 4676553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=358.90 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=202.5
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-C-CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-N-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
...|...+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+++++.++|||||++++++..++..|+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 344888899999999999999843 3 6788998764322 22234577899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 761 YEYMPNGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
|||+++|+|.+++... ....+++.++..++.||+.||+|+|+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999987532 3456889999999999999999999776 9999999999999999999999999998765
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~~~~~~~~----------- 285 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLY----------- 285 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh-----------
Confidence 43332333456799999999999999999999999999999999999999964321 122222111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
......+......+.+++.+|++.+|++||++++++.
T Consensus 286 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111122233456788999999999999999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.43 Aligned_cols=266 Identities=24% Similarity=0.318 Sum_probs=200.0
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.++|++.+.||+|+||.||+|... +|+.||||+++..... .....+.+|+++++.++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 367888999999999999999964 6889999998654322 22335678999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||++ ++|.+++.. ..+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred ECCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9995 688877753 3356889999999999999999999777 9999999999999999999999999997543221
Q ss_pred CcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc-cccc----
Q 001816 842 TSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE-GVLK---- 915 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~---- 915 (1010)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+..+....+......... ....
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 12234568999999999875 458899999999999999999999997654432222222111111000 0000
Q ss_pred -ccCCC-C----CCC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 916 -ILDPR-L----PSV------PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 916 -~~~~~-~----~~~------~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..++. . +.. .......+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 0 000 00112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=346.03 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=195.5
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.|+..+.||+|+||+||+|.. .+++.||||+++.... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 467778999999999999984 4688999999965322 22234568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999853 356889999999999999999999777 99999999999999999999999999864321100
Q ss_pred c---------------------------------------------ceeeeecccccccChhhhccCCCCccCceehhhH
Q 001816 843 S---------------------------------------------ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGV 877 (1010)
Q Consensus 843 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 877 (1010)
. ......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 0012347999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHh--ccccCCCCCCCHHHHHH
Q 001816 878 VLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAML--CVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 878 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~~P~~RPs~~ev~~ 955 (1010)
++|||++|+.||.......... .+.... . ....+. .........+++.+ |+..+|..||+++|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~----~i~~~~-~------~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL----KVINWE-N------TLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH----HHHccc-c------ccCCCC-CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999997533221111 111000 0 001111 11122345567766 56677777999999988
Q ss_pred H
Q 001816 956 I 956 (1010)
Q Consensus 956 ~ 956 (1010)
+
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=341.22 Aligned_cols=265 Identities=24% Similarity=0.306 Sum_probs=203.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|++.+.||+|+||.||++... +|..||+|.+..... ......+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 367888899999999999999964 688999999865322 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.. ...+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 83 EHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 99999999999953 346899999999999999999999632 3999999999999999999999999999765332
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc-cc---------
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK-KE--------- 911 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~--------- 911 (1010)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+....... .+
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCccc
Confidence 12345699999999999999999999999999999999999999964321 11111111000000 00
Q ss_pred ----------------------ccccccCCCCCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 912 ----------------------GVLKILDPRLPSV-PLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 912 ----------------------~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
....+.....+.. .......+.+++.+||+.||++|||+.|++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000011111 112345688999999999999999999998864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=346.77 Aligned_cols=255 Identities=26% Similarity=0.292 Sum_probs=203.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
++|++.+.||+|+||+||+|... +|+.||||+++..... ......+.+|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 35788899999999999999964 6899999999753222 133456888999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++++|.+++... +.+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999643 67899999999999999999999776 9999999999999999999999999998664432
Q ss_pred ---------------------------CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCC
Q 001816 842 ---------------------------TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGD 894 (1010)
Q Consensus 842 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~ 894 (1010)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00122345699999999999999999999999999999999999999975431
Q ss_pred CccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 001816 895 GVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPT-MREVVQI 956 (1010)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-~~ev~~~ 956 (1010)
......+.... + . ...+... ..+..+.+++.+|+. +|.+||+ ++|++++
T Consensus 236 ----~~~~~~i~~~~-~---~---~~~p~~~-~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 ----QETYNKIINWK-E---S---LRFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----HHHHHHHhccC-C---c---ccCCCCC-CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11112211100 0 0 0111111 134567789999997 9999999 9999885
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=342.99 Aligned_cols=255 Identities=23% Similarity=0.251 Sum_probs=200.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|++.+.||+|+||+||+|.. .+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3577888999999999999985 4689999999975432 2223455788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999643 357899999999999999999999777 9999999999999999999999999998764332
Q ss_pred CcceeeeecccccccChhhhc------cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccc
Q 001816 842 TSECMSAIAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.... .
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~~~~-----~ 226 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----AKTYNNIMNFQ-----R 226 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH----HHHHHHHHcCC-----C
Confidence 21 223457999999999986 45678999999999999999999999965322 11122211110 0
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.. ..+. .......+.+++..|+. +|++||++++++++
T Consensus 227 ~~--~~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FL--KFPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cc--CCCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 1111 11223456788999997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=340.05 Aligned_cols=239 Identities=25% Similarity=0.276 Sum_probs=188.2
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHH-HHhccCCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQ-TLGRIRHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
+.||+|+||+||+|... +|+.||||++...... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999964 6899999998643221 112233444544 56788999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (323)
T cd05575 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT 153 (323)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence 999999853 457899999999999999999999777 999999999999999999999999998753221 1223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+.... ...+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~------------~~~~~ 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----TAEMYDNILNKP------------LRLKP 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC----HHHHHHHHHcCC------------CCCCC
Confidence 34579999999999999999999999999999999999999996532 122222221110 01111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMR 951 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~ 951 (1010)
.....+.+++.+|++.+|++||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2245678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.61 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=206.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.|++.+.||+|+||.||+|...+++.||+|.++.... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 55777889999999999999987788999999864322 245688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++....+..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997655567899999999999999999999777 99999999999999999999999999987653211
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
........+..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+... .. .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~--------~~---~ 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQVDQG--------YR---M 223 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcC--------CC---C
Confidence 11112223468999999999999999999999999999999 99999653211 111111111 00 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
..+...+..+.+++.+|++.+|++||++.++.+.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11223345788899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.31 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=206.1
Q ss_pred ccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCc------ccchHHHHHHHhcc-CCcccceeeeeE
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSH------DHGFNAEIQTLGRI-RHRHIVRLLGFC 751 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l-~hpniv~~~~~~ 751 (1010)
++..+.|+..+++|.|..++|.+.. .++|..+|+|++......... .+...+|+.+++++ .||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 4556778888999999999999887 456889999999654433221 12345689999998 699999999999
Q ss_pred ecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeec
Q 001816 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 752 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
+.+...++|+|.|+.|.|.|++. ....+++++..++++|+.+|++|||... |||||+||+|||+|++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 99999999999999999999994 4567999999999999999999999776 999999999999999999999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhc------cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAY------TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKM 905 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~ 905 (1010)
|.|..+.+. ......+|||+|.|||.+. ...|+..+|+||+|||+|.++.|.+||..... . -+
T Consensus 168 GFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------m--lM 236 (411)
T KOG0599|consen 168 GFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------M--LM 236 (411)
T ss_pred ceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------H--HH
Confidence 999987653 3445789999999999875 34688899999999999999999999964211 0 01
Q ss_pred hhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 906 TDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.....++-..+-.|+ -.+.+....++|.+|++.||.+|-|++|++++
T Consensus 237 LR~ImeGkyqF~spe----Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 237 LRMIMEGKYQFRSPE----WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHhcccccCCcc----hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111111111111221 12334567889999999999999999999884
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.90 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=205.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC----CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
+.|+..+.||+|+||+||+|.++. ...||||.++.... ......|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 467888999999999999998642 35799998864332 2234568889999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++++|.+++... .+.+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999643 347899999999999999999999776 99999999999999999999999999987652
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
...........+++.|+|||...+..++.++||||||+++|||++ |..||...... +....+...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~---------- 224 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAVEDG---------- 224 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHHcC----------
Confidence 222222223345678999999999999999999999999999998 99998653221 111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
...+.+...+..+.+++.+|++.+|++||++.|++++|.++
T Consensus 225 -~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 -YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.35 Aligned_cols=253 Identities=23% Similarity=0.266 Sum_probs=202.0
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
|+..++||+|+||+||++.. .+++.||||++...... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 66778999999999999985 46899999998643221 12234567899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++|+|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 99999999886554567999999999999999999999777 9999999999999999999999999998653221
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...............+. .....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~------------~~~~~ 223 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK------------EDQEE 223 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh------------hcccc
Confidence 12244689999999999999999999999999999999999999975432221111111111 11111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
.+...+..+.+++.+|++.||++|| +++++.++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 2223445678899999999999999 78888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.36 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=202.7
Q ss_pred CCcCCeEeecCcEEEEEEEecC----CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc-----
Q 001816 686 LKEDNIIGKGGAGIVYKGLMPN----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET----- 756 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----- 756 (1010)
|++.+.||+|+||.||+|.... +..||+|+++...........+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998542 3679999987544433334568899999999999999999998866554
Q ss_pred -cEEEEEecCCCCHHhhhccC----CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeec
Q 001816 757 -NLLVYEYMPNGSLGEVLHGK----KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 757 -~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999988543 2246889999999999999999999776 999999999999999999999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcc
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 910 (1010)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+ .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~---~~~~~~~--- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HE---IYDYLRH--- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HH---HHHHHHc---
Confidence 99987644332222222345678999999988899999999999999999999 8889865322 11 1221111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
......+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 --------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111222334455788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=341.19 Aligned_cols=244 Identities=24% Similarity=0.269 Sum_probs=195.5
Q ss_pred CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
+.||+|+||.||++.. .+|+.||+|+++..... ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 47899999999753221 222345678999999999999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
+|.+++. +...+++..+..++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (325)
T cd05594 81 ELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM 153 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence 9999885 34568999999999999999999996 56 9999999999999999999999999987543221 223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .....+... ... .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~---~~~~~i~~~---------~~~---~p~ 217 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-E---KLFELILME---------EIR---FPR 217 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-H---HHHHHHhcC---------CCC---CCC
Confidence 345799999999999999999999999999999999999999964321 1 111111110 011 122
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
.....+.+++.+|++.||++|+ ++.+++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2344677899999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.55 Aligned_cols=256 Identities=29% Similarity=0.485 Sum_probs=209.5
Q ss_pred cccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
...|+..++||+|+||.||+|...+++.||+|.++.... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 346788899999999999999988899999999865332 224458899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++....+..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999998766677999999999999999999999777 99999999999999999999999999987643221
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
......++..|+|||...+..++.++||||||+++|+|++ |+.||..... .+. ....... ..
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-~~~---~~~~~~~-----------~~ 222 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEV---YDQITAG-----------YR 222 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-HHH---HHHHHhC-----------Cc
Confidence 1223446778999999998899999999999999999998 8999965321 111 1111111 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
+..+...+..+.+++.+|++.+|++|||++++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 112233445678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=341.86 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=194.8
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++|+||+++++++...+..|+||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 345667788999999999999854 689999999864322 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+.. ...+..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999999986543 3466788899999999999999777 9999999999999999999999999998654321
Q ss_pred CcceeeeecccccccChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 842 TSECMSAIAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||.... ..+..........
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~--------- 290 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICM--------- 290 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CccHHHHHHHHhc---------
Confidence 12234579999999998743 234568999999999999999999997322 1222111111110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+..+......+.+++.+||+.+|++||++.|++++
T Consensus 291 --~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 --SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112223344568899999999999999999999885
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=347.24 Aligned_cols=365 Identities=28% Similarity=0.411 Sum_probs=224.9
Q ss_pred CccceecccCcccC-CCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHh
Q 001816 134 ASLQVLDLYNNNMT-GDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLY 212 (1010)
Q Consensus 134 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 212 (1010)
+-.+-.|+++|.++ +..|..+..+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+.++++.|+.|+.+.
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 33444555566555 345666666666666666666665 55666666666666666666665 5566777788888888
Q ss_pred hccccCCCCCCCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCc
Q 001816 213 IGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFT 292 (1010)
Q Consensus 213 l~~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 292 (1010)
+..|+.....+|..+..+..|+.||||+|++. +.|..+..-+++-.|+|++|+|..++...|-+++.|-.||||+|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 87777777777777777777777777777777 66666666666666666666666555555556666666666666666
Q ss_pred cccCccccccCCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccC
Q 001816 293 GEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMC 372 (1010)
Q Consensus 293 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 372 (1010)
.+|..+..+.+|++|+|++|.+.-.--. .+.++++|+.|.+++.+-+
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLr------------------------QLPsmtsL~vLhms~TqRT-------- 210 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLR------------------------QLPSMTSLSVLHMSNTQRT-------- 210 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHh------------------------cCccchhhhhhhcccccch--------
Confidence 4555556666666666666655422222 2333444444444444332
Q ss_pred CCCcchhhhccccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccccceE
Q 001816 373 AGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQI 452 (1010)
Q Consensus 373 ~~~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L 452 (1010)
...+|.++..+.+|..++++.|.+. ..|+++..+++|+.|+|++|+|+. +........+|+.|
T Consensus 211 ---------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtL 273 (1255)
T KOG0444|consen 211 ---------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETL 273 (1255)
T ss_pred ---------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhh
Confidence 1235555666666666666666665 677777777777777777777763 23334445566666
Q ss_pred eccCccccCCCCCCCCCccCceEEecCCCccc-CCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCccc
Q 001816 453 CLSNNQLSGSLPASIGKFSGVQKLLLDGNKFS-GQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNEL 531 (1010)
Q Consensus 453 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 531 (1010)
+||.|+++ .+|..++++++|+.|++.+|++. .-||+.++.+.+|+.+..++|++. ..|..++.+..|+.|.|+.|++
T Consensus 274 NlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 274 NLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRL 351 (1255)
T ss_pred ccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccce
Confidence 67777776 67777777777777777777765 245666666666666666666665 4555555555555555555555
Q ss_pred ccccchhcccccccceEEecCcc
Q 001816 532 SGEIPNQLTGMRILNYLNLSRNH 554 (1010)
Q Consensus 532 ~~~~p~~~~~l~~L~~L~Ls~N~ 554 (1010)
. ..|+++.-++.|+.|||..|.
T Consensus 352 i-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 352 I-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred e-echhhhhhcCCcceeeccCCc
Confidence 4 444444444444445544443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.05 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=202.1
Q ss_pred ccccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 755 (1010)
..++|+..+.||+|+||.||+|.+. .+..||||+++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567888999999999999998753 356799998854322 122345889999999999999999999999999
Q ss_pred ccEEEEEecCCCCHHhhhccCC--------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceE
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKK--------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH 827 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~k 827 (1010)
..++||||+++|+|.+++...+ ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999986422 123577888999999999999999776 99999999999999999999
Q ss_pred EeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHh
Q 001816 828 VADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMT 906 (1010)
Q Consensus 828 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 906 (1010)
|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||..... ..... ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~---~~~ 235 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLR---FVM 235 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH---HHH
Confidence 999999976543322221222345788999999999899999999999999999999 7888865322 11111 111
Q ss_pred hhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 907 DSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
. ...+..+...+..+.+++.+|++.+|++||++.|+++.+++
T Consensus 236 ~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 E-----------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred c-----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 11111222334567889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=344.16 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=198.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|++.+.||+|+||+||+|... +|+.||||+++.... .......+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 35788899999999999999954 689999999964321 1222345788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999853 456999999999999999999999777 9999999999999999999999999997643211
Q ss_pred Ccc------------------------------------eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhC
Q 001816 842 TSE------------------------------------CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 885 (1010)
Q Consensus 842 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg 885 (1010)
... .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 100 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 001816 886 RKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPT---MREVVQI 956 (1010)
Q Consensus 886 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs---~~ev~~~ 956 (1010)
+.||..... .+....+.... . . ...+. .......+.+++.+|+. +|.+|++ ++|++++
T Consensus 236 ~~Pf~~~~~----~~~~~~i~~~~-~---~---~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNP----QETYRKIINWK-E---T---LQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCH----HHHHHHHHcCC-C---c---cCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999965321 11112211110 0 0 00111 01123456778888886 8999997 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.80 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=204.3
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|...+.||+|+||.||+|.+. .++.||+|+++.. ......+.+|++++++++||||+++++++..++..++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 4566788999999999999954 5889999998642 22245688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.......+++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 99999999997655567899999999999999999999776 99999999999999999999999999986543211
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ........... ..+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~----~~~~~~~~~~~--------~~~--- 224 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKG--------YRM--- 224 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHCC--------CCC---
Confidence 11122234678999999999999999999999999999998 899986432 11222221111 111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
..+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12223345788899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.77 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=211.5
Q ss_pred CcCCeEeecCcEEEEEEEec---CCC--EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 687 KEDNIIGKGGAGIVYKGLMP---NGD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 687 ~~~~~lG~G~~g~Vy~~~~~---~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
...++||+|.||.||+|.+. .|+ .||||.-+.... ....+.|.+|+.+|+.++|||||+++|.|.+. ..||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 44578999999999999842 344 488888765333 34467799999999999999999999999874 569999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|+++-|.|..|++.++ ..++......++.||+.||+||| ++++|||||..+|||+.+.-.|||+|||+++.+.+..
T Consensus 470 EL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999997543 57888999999999999999999 5559999999999999999999999999999987765
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
.+... ...-...|||||-+.-.+++.++|||.|||.+||++. |..||.+..+. +.+..+-+.+
T Consensus 546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------DVI~~iEnGe 609 (974)
T KOG4257|consen 546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------DVIGHIENGE 609 (974)
T ss_pred hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------ceEEEecCCC
Confidence 54433 2334568999999999999999999999999999987 99999764332 2333444556
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
..+.|..++..++.++.+||+.+|.+||++.|+...|.++.
T Consensus 610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 66778888889999999999999999999999998887654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.72 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=204.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
+.|.+.+.||+|+||.||+|...+ ++.||||.++..... .....+.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457778899999999999998533 478999998654332 2345689999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCC------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCc
Q 001816 758 LLVYEYMPNGSLGEVLHGKK------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE 825 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~ 825 (1010)
++||||+++++|.+++.... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999986432 245788999999999999999999776 999999999999999999
Q ss_pred eEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHH
Q 001816 826 AHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 826 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 904 (1010)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... + .+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~---~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-E---VIEC 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-H---HHHH
Confidence 99999999976533222222223346789999999999999999999999999999998 99998653321 1 1111
Q ss_pred HhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
... ......+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 237 ~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ITQ-----------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHc-----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 11111222344567889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=337.54 Aligned_cols=242 Identities=22% Similarity=0.280 Sum_probs=191.8
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
|+..+.||+|+||.||+|... +++.||||+++..... ......+..|..++..+ +|++|+++++++...+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 667789999999999999854 5789999998753221 12233456678888777 58999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++|+|.+++.. .+.+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 82 YVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 9999999998853 356899999999999999999999777 9999999999999999999999999997543211
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ...+... ..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~---~~~i~~~---------~~--- 218 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DEL---FQSIMEH---------NV--- 218 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHH---HHHHHhC---------CC---
Confidence 122345799999999999999999999999999999999999999975322 111 1111111 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTM 950 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~ 950 (1010)
..+......+.+++.+|++.+|++|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122234467789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=339.29 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=197.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467888899999999999999964 588999999864221 122234577899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+|......
T Consensus 122 ~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999999853 35888999999999999999999776 999999999999999999999999999876432
Q ss_pred CCcceeeeecccccccChhhhccCC----CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.. .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ......+.....
T Consensus 196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~~~~~i~~~~~------ 264 (370)
T cd05621 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VGTYSKIMDHKN------ 264 (370)
T ss_pred Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCc------
Confidence 21 1223567999999999987543 78899999999999999999999965321 111122111100
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVE--RPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~ev~~~ 956 (1010)
....+. .......+..++..|+..++.+ |+++.|++++
T Consensus 265 -~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -SLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -ccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011111 1122345667888888755544 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=336.91 Aligned_cols=244 Identities=22% Similarity=0.297 Sum_probs=193.9
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||.||+|... +|+.||||+++.... .......+..|++++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999864 578999999865322 122234567788888866 799999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 99999885 3456899999999999999999999777 9999999999999999999999999997543221 223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... . .....+... +.. .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~---~~~~~i~~~---------~~~---~p~ 217 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-D---DLFESILHD---------DVL---YPV 217 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-H---HHHHHHHcC---------CCC---CCC
Confidence 345799999999999999999999999999999999999999975321 1 112221111 011 111
Q ss_pred HHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERP-------TMREVVQI 956 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RP-------s~~ev~~~ 956 (1010)
.....+.+++.+|++.+|++|| ++.+++++
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 2234677899999999999999 77888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.02 Aligned_cols=243 Identities=24% Similarity=0.304 Sum_probs=191.8
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||.||+|..+ +|+.||+|+++..... ......+..|.+++... +||+|+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 6889999999753221 12233456777777754 899999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence 999998853 456899999999999999999999777 999999999999999999999999998753221 1223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... . +....+... .+. .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~---~~~~~~~~~---------~~~---~~~ 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-D---ELFESIRVD---------TPH---YPR 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-H---HHHHHHHhC---------CCC---CCC
Confidence 456799999999999999999999999999999999999999964321 1 112211111 111 122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMR-EVVQ 955 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~-ev~~ 955 (1010)
.....+.+++.+|++.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 2344677899999999999999984 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=337.09 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=194.5
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||+||+|... +++.||||+++.... .......+..|+++++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 578999999975321 122234567888888887 699999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++. +.+.+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (318)
T cd05570 81 GDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT 153 (318)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence 99999885 3457999999999999999999999776 9999999999999999999999999987532211 122
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+... .. ..+.
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~~~i~~~---------~~---~~~~ 217 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELFQSILED---------EV---RYPR 217 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcC---------CC---CCCC
Confidence 34569999999999999999999999999999999999999996432 11222221111 01 1122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTM-----REVVQI 956 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~-----~ev~~~ 956 (1010)
.....+.+++.+|++.||++||++ .+++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 234567889999999999999999 777664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.78 Aligned_cols=257 Identities=24% Similarity=0.430 Sum_probs=202.7
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-----cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-----PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
+.|++.+.||+|+||.||+|.. .++..||+|.++.... ......+.+|++++++++||||+++++++..++..|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4566778999999999999974 2467899999864322 223356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCC---------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC
Q 001816 759 LVYEYMPNGSLGEVLHGKK---------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG 823 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~ 823 (1010)
+||||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 9999999999999985321 234788889999999999999999776 9999999999999999
Q ss_pred CceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHH
Q 001816 824 FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWV 902 (1010)
Q Consensus 824 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~ 902 (1010)
+.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||..... ....+.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH
Confidence 9999999999987644332222334456778999999988889999999999999999998 9999865321 1111211
Q ss_pred HHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
. .. .....+...+..+.+++.+|++.+|++||++.++.+.+..
T Consensus 240 ~---~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 R---KR-----------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H---cC-----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 11 0111222234567889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=340.95 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=196.4
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
...|++.+.||+|+||.||+|.. .+++.||+|+.. ...+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 35688899999999999999985 568899999643 234678999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|++ +++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+|+......
T Consensus 163 e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 163 PRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred ecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999 4788888853 346889999999999999999999776 9999999999999999999999999997543221
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCC-------ccHHHHHHHHhhhccc---
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG-------VDIVQWVRKMTDSKKE--- 911 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~-------~~~~~~~~~~~~~~~~--- 911 (1010)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+...++.......+
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 12223457999999999999999999999999999999999999887432210 0111111111000000
Q ss_pred ----ccccc---------cCCC-CCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 912 ----GVLKI---------LDPR-LPSV--PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 ----~~~~~---------~~~~-~~~~--~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..... ..+. .+.. ....+..+.+++.+|++.||++|||++|++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0000 0000 01224467889999999999999999999874
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.52 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=206.6
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|...+.||+|+||.||+|..+ +|+.|++|.+............+.+|++++++++|||++++++++.+++..|+||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 566788999999999999864 6889999998754444444567889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
++++|.++++......+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-- 156 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-- 156 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc--
Confidence 9999999997655567999999999999999999999776 99999999999999999999999999987644322
Q ss_pred eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCC
Q 001816 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (1010)
......|++.|+|||+..+..++.++||||||+++|||++|+.||..... ........ ....+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-----------~~~~~~~ 221 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALILKII-----------RGVFPPV 221 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-----------cCCCCCC
Confidence 22345688999999999999999999999999999999999999965331 11111111 1112222
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 925 ~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 32344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=332.75 Aligned_cols=257 Identities=25% Similarity=0.321 Sum_probs=211.5
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCCC-CcccchHHHHHHHhccC-CcccceeeeeEecCCc
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHET 756 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 756 (1010)
+.+.+.|+..+.||+|.||.||+++.+. |+.+|+|+++...... .....+.+|+++|+++. |||||.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 4556778888999999999999999654 9999999997644432 23456889999999998 9999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC----CCceEEeecc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS----GFEAHVADFG 832 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~----~~~~kl~DFG 832 (1010)
.++|||++.||.|.+.+... .+++..+..++.|++.|++|||..| |+|||+||+|+|+.. ++.+|++|||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 99999999999999999654 3999999999999999999999776 999999999999954 3579999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 912 (1010)
+|..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||....+..... .+...
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~---- 253 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRG---- 253 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcC----
Confidence 9998754 445678899999999999999999999999999999999999999997644333222 11111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 913 VLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
-..+.++..+ .......+++..|+..||.+|+|+.+++++.
T Consensus 254 ~~~f~~~~w~----~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 254 DFDFTSEPWD----DISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred CCCCCCCCcc----ccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 0111122222 2245677899999999999999999999963
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=337.68 Aligned_cols=203 Identities=24% Similarity=0.335 Sum_probs=173.3
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|+..+.||+|+||+||+|... +|+.||||+++.... .......+.+|+.++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 35778899999999999999854 688999999864322 1222345788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999999953 457999999999999999999999776 9999999999999999999999999997643211
Q ss_pred Cc---------------------------------ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCC
Q 001816 842 TS---------------------------------ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888 (1010)
Q Consensus 842 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P 888 (1010)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001235799999999999999999999999999999999999999
Q ss_pred CCC
Q 001816 889 VGE 891 (1010)
Q Consensus 889 ~~~ 891 (1010)
|..
T Consensus 236 f~~ 238 (363)
T cd05628 236 FCS 238 (363)
T ss_pred CCC
Confidence 965
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.87 Aligned_cols=256 Identities=22% Similarity=0.370 Sum_probs=203.1
Q ss_pred cCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
.|++.+.||+|+||.||+|... .+..||+|+++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4666788999999999999853 246899999874332 122345888999999999999999999999999999
Q ss_pred EEEEecCCCCHHhhhccC--------------CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC
Q 001816 759 LVYEYMPNGSLGEVLHGK--------------KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF 824 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~ 824 (1010)
+++||+++++|.+++... ....+++..+..++.|++.||+|+|+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998421 1235788889999999999999999777 99999999999999999
Q ss_pred ceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHH
Q 001816 825 EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVR 903 (1010)
Q Consensus 825 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~ 903 (1010)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||..... .++..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVIE 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999986544332222334456789999999998889999999999999999998 8888865321 12222
Q ss_pred HHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.+... .....+...+..+..++.+|++.+|++||+++|+++.|+.
T Consensus 238 ~i~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNR-----------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcC-----------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22111 1112233445568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=342.91 Aligned_cols=254 Identities=21% Similarity=0.244 Sum_probs=195.2
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.|++.+.||+|+||.||+|+. .+|+.||||++..... .......+.+|++++++++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 578889999999999999985 4689999999864221 12234457889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+|..+.....
T Consensus 82 ~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999953 456889999999999999999999777 99999999999999999999999999853310000
Q ss_pred -----------------------------------------cceeeeecccccccChhhhccCCCCccCceehhhHHHHH
Q 001816 843 -----------------------------------------SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLE 881 (1010)
Q Consensus 843 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~e 881 (1010)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 001816 882 LITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERP---TMREVVQI 956 (1010)
Q Consensus 882 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP---s~~ev~~~ 956 (1010)
|++|+.||....... ....+.... . .. ..+. .......+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~~----~~~~i~~~~-~---~~---~~~~-~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE----TQLKVINWE-T---TL---HIPS-QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH----HHHHHhccC-c---cc---cCCC-CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997533211 111111100 0 00 0110 0112234556777766 5999999 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=335.42 Aligned_cols=238 Identities=22% Similarity=0.275 Sum_probs=190.1
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||+||+|..+ +++.||||+++.... .......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 588999999864321 122334567788888776 699999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 999998853 356899999999999999999999777 999999999999999999999999998753221 1223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+... ....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~~~------------~~~~~~ 217 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILND------------EVVYPT 217 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHhcC------------CCCCCC
Confidence 345799999999999999999999999999999999999999975321 1122221111 011122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTM 950 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~ 950 (1010)
.....+.+++.+|++.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 233467789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=326.53 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=197.8
Q ss_pred EeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 692 IGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
||+|+||.||++.. .+|+.||+|++....... .....+..|++++++++||||+++++++..+...|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 468999999986422211 1233456799999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeee
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 99886555556889999999999999999999776 9999999999999999999999999997654321 22345
Q ss_pred cccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHH
Q 001816 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEV 929 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1010)
.|++.|+|||++.+..++.++||||+||++|||++|+.||.............+.... ...........
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ 223 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-----------DEVKFEHQNFT 223 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-----------cccccccccCC
Confidence 6899999999999888999999999999999999999999754332222222221111 01110111233
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 930 MHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 930 ~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
..+.+++.+|++.+|++||+++|+++.+...
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h 254 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPRKH 254 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence 4678899999999999999998877554443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=323.35 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=200.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.|+..+.||+|+||+||+|.+.++..||||.++.... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 34667788999999999999987777899998864322 235688999999999999999999999998899999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++|+|.+++.... ..+++..++.++.||+.|++|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 81 MSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence 99999999986433 36899999999999999999999776 99999999999999999999999999986543221
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......++..|+|||+..+..++.++||||||+++|||++ |+.||...... + ........ ...
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~---~~~~~~~~-----------~~~ 220 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-E---TVEKVSQG-----------LRL 220 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-H---HHHHHhcC-----------CCC
Confidence 11112335678999999998889999999999999999998 99998654321 1 11111111 011
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
..+......+.+++.+||+.+|++||++.++++.++
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111123457788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=331.58 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=204.7
Q ss_pred ccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 756 (1010)
++|+..+.||+|+||.||+|... ....||+|.++.... ......+.+|+++++++ +||||+++++++..++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 56777889999999999999853 235799998865322 22234578899999999 89999999999999999
Q ss_pred cEEEEEecCCCCHHhhhcc--------------CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC
Q 001816 757 NLLVYEYMPNGSLGEVLHG--------------KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS 822 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~--------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~ 822 (1010)
.++||||+++|+|.++++. .....+++..+..++.|++.|++|||+.+ |+||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 9999999999999999854 22456889999999999999999999776 999999999999999
Q ss_pred CCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHH
Q 001816 823 GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQW 901 (1010)
Q Consensus 823 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~ 901 (1010)
++.+||+|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||...... + .
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~---~ 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-E---L 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-H---H
Confidence 99999999999987654332222223345678999999999999999999999999999997 99998653211 1 1
Q ss_pred HHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 902 VRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
...+.. ......+......+.+++.+|++.+|++|||+.|+++.|+.+
T Consensus 244 ~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKLLKE-----------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHc-----------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111 111122333445788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.09 Aligned_cols=260 Identities=20% Similarity=0.330 Sum_probs=208.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
++|++.+.||+|+||.||+|.. .+|+.||||.++.... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5688889999999999999995 4789999998864322 2233445888999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 762 EYMPNGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 2345788999999999999999999776 99999999999999999999999999987543
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
.. .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||... ......+...+...
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~--~~~~~~~~~~~~~~----------- 223 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLFSLCQKIEQC----------- 223 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc--cccHHHHHHHHhcC-----------
Confidence 22 1122456889999999999888999999999999999999999998542 22222222222111
Q ss_pred CCCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 920 RLPSV-PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 920 ~~~~~-~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
..++. +......+.+++.+||+.+|++||++.|+++.++.+.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11111 2234456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=331.60 Aligned_cols=259 Identities=26% Similarity=0.446 Sum_probs=205.2
Q ss_pred cCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
.|...+.||+|+||.||+|... ++..||+|.++.... .....+.+|++++++++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 4666788999999999999742 345689998754222 22346889999999999999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCC--------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC
Q 001816 759 LVYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF 824 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~ 824 (1010)
+||||+++++|.+++.... .+.+++..++.++.||+.|++|||+.+ |+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 9999999999999986422 245889999999999999999999777 99999999999999999
Q ss_pred ceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHH
Q 001816 825 EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVR 903 (1010)
Q Consensus 825 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~ 903 (1010)
.++|+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ..+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~ 236 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIE 236 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence 999999999976543322222233456789999999999999999999999999999999 99998653221 1111
Q ss_pred HHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 001816 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (1010)
.+.. ...+..+...+..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 237 ~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CITQ-----------GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhC-----------CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111 111111222345688999999999999999999999999988553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=322.67 Aligned_cols=254 Identities=29% Similarity=0.465 Sum_probs=204.6
Q ss_pred cccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.++|++.+.||+|+||.||+|..+++..||+|.++.... ..+.+.+|+.++++++||+++++++++. ....++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 356888899999999999999988888999999865332 2346889999999999999999999875 456899999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.++++......+++.++..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999997655566899999999999999999999777 99999999999999999999999999986543221
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
. ......++..|+|||+..+..++.++||||||+++|||++ |..||..... . .....+... ..
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~---~~~~~~~~~-----------~~ 221 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-R---EVLEQVERG-----------YR 221 (260)
T ss_pred c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-H---HHHHHHHcC-----------CC
Confidence 1 1122345678999999998899999999999999999999 8899865321 1 112221111 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
...+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11222344578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=326.30 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=197.6
Q ss_pred CcCCeEeecCcEEEEEEEecC-CC--EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC------Ccc
Q 001816 687 KEDNIIGKGGAGIVYKGLMPN-GD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------ETN 757 (1010)
Q Consensus 687 ~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~ 757 (1010)
.+.++||+|+||.||+|.+.. +. .||+|.++.........+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 356789999999999999654 33 699998875443334455688899999999999999999987432 246
Q ss_pred EEEEEecCCCCHHhhhccC----CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 758 LLVYEYMPNGSLGEVLHGK----KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
++||||+++|+|.+++... ....+++..+..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887421 2345889999999999999999999776 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccc
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 912 (1010)
++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||..... .+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~---- 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDYLRQG---- 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcC----
Confidence 987643322111223346778999999999999999999999999999999 7889865322 1222221111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 913 VLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.....+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 -------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111222334678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=364.01 Aligned_cols=463 Identities=28% Similarity=0.326 Sum_probs=383.4
Q ss_pred cEEEEEcCCCCcccccCcccCCCCCCCEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceeccc
Q 001816 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLY 142 (1010)
Q Consensus 63 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 142 (1010)
++.+||+++|.+. ..|..+..+..|+.|+++.|.|. ..|.+..++++|++|+|.+|.+. ..|..+..+++|++||++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 4888899888887 67788888889999999999888 67788888899999999999888 788889999999999999
Q ss_pred CcccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCCCC
Q 001816 143 NNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGG 222 (1010)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~ 222 (1010)
.|++. .+|..+..++.+..+..++|..... ++... .+.+++..|.+.+.++..+..++. .|+|.+|+..
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~--- 191 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME--- 191 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---
Confidence 99988 7888888888899999998832212 22222 888999999999999999988887 7899876543
Q ss_pred CCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCcccccc
Q 001816 223 LPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL 302 (1010)
Q Consensus 223 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 302 (1010)
--.+.++.+|+.+....|++... --..++|+.|+.++|.++...+ -..-.+|+++|+++|+++ .+|.++..+
T Consensus 192 -~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~ 263 (1081)
T KOG0618|consen 192 -VLDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGAC 263 (1081)
T ss_pred -hhhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhc
Confidence 24567789999999999998732 1234689999999999983322 223468999999999999 567999999
Q ss_pred CCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccC-CCCc-chhh
Q 001816 303 KNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMC-AGNC-LQTL 380 (1010)
Q Consensus 303 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~~-L~~L 380 (1010)
.+|+.++..+|.++ .+|..+..+.+|+.|.+..|.+. .+|.....++.|++|||..|+|.. +|+.+. -... |..|
T Consensus 264 ~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~l 340 (1081)
T KOG0618|consen 264 ANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTL 340 (1081)
T ss_pred ccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHH
Confidence 99999999999997 88888999999999999999998 788888999999999999999984 555443 3333 7777
Q ss_pred hccccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccccceEeccCcccc
Q 001816 381 ITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLS 460 (1010)
Q Consensus 381 ~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~ 460 (1010)
..+.|.+....-..=..+..|+.|++.+|.++...-..+.+.+.|+.|+|++|+|...+...+..+..|++|+||+|+|+
T Consensus 341 n~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~ 420 (1081)
T KOG0618|consen 341 NVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT 420 (1081)
T ss_pred hhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh
Confidence 77777665433222334567999999999999887778889999999999999999777778899999999999999999
Q ss_pred CCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcc
Q 001816 461 GSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLT 540 (1010)
Q Consensus 461 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 540 (1010)
.+|..+..+..|++|...+|++. .+| ++..+++|+.+|+|.|+|+...-..--..++|++|||++|.-....-..|.
T Consensus 421 -~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~ 497 (1081)
T KOG0618|consen 421 -TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLK 497 (1081)
T ss_pred -hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhH
Confidence 89999999999999999999999 788 899999999999999999854333333338999999999995446667778
Q ss_pred cccccceEEecCc
Q 001816 541 GMRILNYLNLSRN 553 (1010)
Q Consensus 541 ~l~~L~~L~Ls~N 553 (1010)
.++.+...++.-|
T Consensus 498 ~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 498 VLKSLSQMDITLN 510 (1081)
T ss_pred HhhhhhheecccC
Confidence 8888888888877
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=328.11 Aligned_cols=248 Identities=24% Similarity=0.289 Sum_probs=195.4
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
||+|+||+||++... +|+.||+|++....... .....+..|++++++++||||+++.+++..+...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 68899999986432211 1224567899999999999999999999999999999999999999
Q ss_pred Hhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceee
Q 001816 770 GEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847 (1010)
Q Consensus 770 ~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 847 (1010)
.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988743 23456899999999999999999999776 99999999999999999999999999976543221 223
Q ss_pred eecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHH
Q 001816 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927 (1010)
Q Consensus 848 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1010)
...||+.|+|||++.+..++.++|||||||++|||++|+.||................. .. ....+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-----------~~-~~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-----------ND-SVTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-----------cc-CCCCccc
Confidence 45799999999999999999999999999999999999999975433222111111111 10 0112223
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 928 EVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 928 ~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
.+..+.+++.+|++.||++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 445678899999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=335.45 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=192.5
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCC-cccceeeeeEecCCccEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRH-RHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~ 761 (1010)
.|++.+.||+|+||.||+|... +++.||||+++.... .......+..|++++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3677889999999999999854 578999999865322 12234457789999999976 56888999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 9999999999985 3456899999999999999999999776 999999999999999999999999998753221
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+ ....+... ..
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~---~~~~i~~~---------~~-- 218 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DE---LFQSIMEH---------NV-- 218 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HH---HHHHHHcC---------CC--
Confidence 1223456799999999999999999999999999999999999999965321 11 11111111 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTM 950 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 950 (1010)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122233467789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=322.65 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=205.5
Q ss_pred cccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.+.|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 356788899999999999999988899999999864332 2456889999999999999999999874 467899999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++....+..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999987666667899999999999999999999776 99999999999999999999999999976542221
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.......++..|+|||++.+..++.++||||||+++||+++ |+.||...... +....+... ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~-----------~~ 221 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQNLERG-----------YR 221 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHHHHcC-----------CC
Confidence 12223346778999999998899999999999999999999 99999653321 111111111 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.+.+...+..+.+++.+|++.+|++||+++++...|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11122234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=323.30 Aligned_cols=254 Identities=29% Similarity=0.444 Sum_probs=203.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
++|++.++||+|+||.||+|.+.++..||+|+++.... ....+.+|++++++++||||+++++++.+ +..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 56888899999999999999987777899999864222 23468899999999999999999998754 567999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++|+|.+++.......+++..+..++.|+++||+|+|+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 99999999997555556899999999999999999999776 99999999999999999999999999986643322
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......++..|+|||+..+..++.++||||||+++|||++ |..||...... ......... ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~-----------~~~ 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERG-----------YRM 222 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHHHHhcC-----------CCC
Confidence 11223346778999999999999999999999999999999 88888653221 111111100 001
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
..+...+..+.+++.+|++.+|++||+++++.+.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223445678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=330.49 Aligned_cols=260 Identities=26% Similarity=0.433 Sum_probs=204.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
+.|.+.+.||+|+||.||++... ++..||+|.+.... ......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 45677889999999999999742 34568999886432 22244588999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCC-----------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCce
Q 001816 758 LLVYEYMPNGSLGEVLHGKK-----------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEA 826 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~ 826 (1010)
++||||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999999986322 235899999999999999999999776 9999999999999999999
Q ss_pred EEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHH
Q 001816 827 HVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKM 905 (1010)
Q Consensus 827 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 905 (1010)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----~~~~~i 235 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECI 235 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH
Confidence 9999999986543322222223345788999999999999999999999999999998 89998653221 111111
Q ss_pred hhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 001816 906 TDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (1010)
... .....+...+..+.+++.+||+.+|.+|||+.|+.+.|+.+.+.
T Consensus 236 ~~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQG-----------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HcC-----------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111 11111222335688999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=329.88 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=205.5
Q ss_pred cccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCC
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 755 (1010)
.+.|...+.||+|+||.||+|... .+..||||+++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 356778889999999999999741 345799998865322 22345688999999999 7999999999999999
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
..|+||||+++|+|.++++......+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.++++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997555455899999999999999999999776 9999999999999999999999999998
Q ss_pred cccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccc
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
...............+++.|+|||++.+..++.++||||+||++|||++ |..||.............. ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~---~~------ 260 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK---EG------ 260 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH---cC------
Confidence 6543322222223446788999999999999999999999999999998 9999865432222111111 00
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
. ....+......+.+++.+|++.+|++||++.|+++.|++.
T Consensus 261 --~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 --Y---RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --C---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0111122234688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=334.81 Aligned_cols=247 Identities=24% Similarity=0.254 Sum_probs=190.5
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHH-HHHhccCCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEI-QTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
+.||+|+||+||+|+.. +++.||+|++...... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999964 5778999998643211 11222344444 456778999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++.. ...+.+..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~ 153 (325)
T cd05602 81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT 153 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence 999999853 456888999999999999999999777 9999999999999999999999999997543221 223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.... . ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~-----------~-~~~~ 217 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKP-----------L-QLKP 217 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHHHHHHHhCC-----------c-CCCC
Confidence 456799999999999999999999999999999999999999965321 11222211110 0 0111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.....+.+++.+|++.+|.+||++.+.+..+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 223467789999999999999998755444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=334.69 Aligned_cols=257 Identities=23% Similarity=0.228 Sum_probs=196.3
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
++|++.+.||+|+||+||+++.. +++.||+|++..... .......+.+|+.++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999954 678899999864211 1222344778999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999642 356899999999999999999999776 9999999999999999999999999998664332
Q ss_pred CcceeeeecccccccChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 842 TSECMSAIAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~------ 225 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHEE------ 225 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----HHHHHHHHcCCC------
Confidence 2 12234569999999999875 4678999999999999999999999964321 111222111100
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVE--RPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~ev~~~ 956 (1010)
...++......+..+.+++.+|+..++++ |++++++.++
T Consensus 226 -~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 -RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 01111111122346777888888765544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=327.03 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=200.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCC----EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
+.|+..+.||+|+||+||+|.+. +|+ .|++|.+.... ......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 45677889999999999999863 455 47777764321 11223457778888999999999999998754 5678
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
++|||+++|+|.+++... .+.+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 85 ~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999999643 356899999999999999999999776 9999999999999999999999999998664
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
............++..|+|||++.+..++.++||||||+++||+++ |+.||.+... ....+++. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~----~~-------- 227 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLE----KG-------- 227 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH----CC--------
Confidence 3332222334457789999999998899999999999999999998 9999965321 11111111 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~ 964 (1010)
..+..+......+..++.+||+.+|++|||+.|+++.|..+...+
T Consensus 228 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 228 --ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 001111122345678999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=323.18 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=197.4
Q ss_pred eEeecCcEEEEEEEe---cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 691 IIGKGGAGIVYKGLM---PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
.||+|+||.||+|.+ .++..||+|+++.........+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 35788999998754443344566889999999999999999999875 45679999999999
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc-ee
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE-CM 846 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~ 846 (1010)
+|.+++.. ...+++..+..++.|++.|++|+|+.+ |+||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999953 346899999999999999999999777 9999999999999999999999999998764332211 11
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCC
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (1010)
....+++.|+|||.+....++.++|||||||++|||++ |+.||..... .. +...+... ..+..+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~---~~~~i~~~-----------~~~~~~ 220 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NE---VTQMIESG-----------ERMECP 220 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HH---HHHHHHCC-----------CCCCCC
Confidence 12234679999999988889999999999999999998 9999975322 11 22222111 111122
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 926 LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 926 ~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
...+..+.+++.+||+.+|++||++++|++.|++.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 23445678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=333.59 Aligned_cols=239 Identities=26% Similarity=0.296 Sum_probs=187.9
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHH-HHHhccCCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEI-QTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||.||+|+.. +|+.||+|++..... .......+.+|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 688999999864321 112233345554 457888999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++. +...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 99998885 3456889999999999999999999776 999999999999999999999999998753221 1223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ..+....+... ....+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~------------~~~~~~ 217 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYDNILHK------------PLQLPG 217 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHHHHhcC------------CCCCCC
Confidence 34579999999999999999999999999999999999999996532 12222222111 011222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMR 951 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~ 951 (1010)
.....+.+++.+|++.+|.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3345678899999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=334.80 Aligned_cols=247 Identities=26% Similarity=0.294 Sum_probs=191.5
Q ss_pred CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHH-HHhccCCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQ-TLGRIRHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||+||+|.. .+|+.||+|++..... .......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999985 4689999999864322 1122234455554 46778999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT 153 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence 99998885 3457899999999999999999999777 999999999999999999999999998753221 1223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+..... .. ..+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~~~~~-----------~~-~~~~ 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD----VAEMYDNILHK-----------PL-VLRP 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC----HHHHHHHHHcC-----------Cc-cCCC
Confidence 35579999999999999999999999999999999999999996532 11122221111 00 0111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.....+.+++.+|++.+|.+||++.+.++.+.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 233467789999999999999988654444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=332.98 Aligned_cols=257 Identities=24% Similarity=0.256 Sum_probs=195.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|++.+.||+|+||+||++.. .+++.||+|++..... .......+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4678889999999999999995 4688999999864211 1223445788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99999999999953 2456899999999999999999999777 9999999999999999999999999997654322
Q ss_pred CcceeeeecccccccChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 842 TSECMSAIAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ..+....+.... . .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~----~~~~~~~i~~~~-~----~ 226 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHK-E----H 226 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC----HHHHHHHHHcCC-C----c
Confidence 2 12223469999999999873 457889999999999999999999996432 112222221110 0 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEE--QAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~--~P~~RPs~~ev~~~ 956 (1010)
...+......+..+.+++.+|+.. ++..||++.+++++
T Consensus 227 --~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 --FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011111111234566777776654 33447899999886
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.12 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=209.8
Q ss_pred cCCcCCeEeecCcEEEEEEEec--CCC--EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP--NGD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
..+..+.||+|.||+|++|.|. +|+ .||||.++...... ...+|.+|+.+|.+|+|||++++||...+ ....+|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 3445578999999999999975 344 58999998655443 46679999999999999999999999987 677899
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
||+++.|+|.+.|++.....+.......++.|||.||+||...+ +||||+..+|+++-....|||+|||+.+-+...
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999998867778999999999999999999999555 999999999999999999999999999988765
Q ss_pred CCcceeee-ecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 841 GTSECMSA-IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 841 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
...+.+.. ..-...|+|||.++...++.++|||+|||++|||++ |+.||-+. .-.++++.+. +
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~----~g~qIL~~iD-----------~ 330 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC----RGIQILKNID-----------A 330 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC----CHHHHHHhcc-----------c
Confidence 55444432 334568999999999999999999999999999998 88999653 2233333322 2
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.-..|..++..++++++.||..+|++|||+..+++.
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 23334566788899999999999999999999999853
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.79 Aligned_cols=257 Identities=23% Similarity=0.242 Sum_probs=196.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|++.++||+|+||+||++..+ +++.||+|++..... .......+..|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 35778889999999999999964 477899999854211 1222344788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.+. ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999642 356899999999999999999999777 9999999999999999999999999997653322
Q ss_pred CcceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 842 TSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+....+.....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~------ 225 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKE------ 225 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC----HHHHHHHHhCCCc------
Confidence 2 2223457999999999986 3468899999999999999999999996432 2222222221110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVE--RPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~ev~~~ 956 (1010)
....+.........+.+++.+|+..++++ |++++|++++
T Consensus 226 -~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 -RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01112212223445677888877554443 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.96 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=195.6
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGS 768 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 768 (1010)
+.||+|+||.||+|... +|+.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36899999999999864 68899999875432 22234568899999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeee
Q 001816 769 LGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA 848 (1010)
Q Consensus 769 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 848 (1010)
|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..............
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99998632 346899999999999999999999776 99999999999999999999999999976432211111111
Q ss_pred ecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHH
Q 001816 849 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927 (1010)
Q Consensus 849 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1010)
..++..|+|||.+.+..++.++||||||+++|||++ |..||...... . ........ .....+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-~---~~~~~~~~-----------~~~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-Q---TREAIEQG-----------VRLPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-H---HHHHHHcC-----------CCCCCccc
Confidence 223467999999998899999999999999999998 88888643211 1 11111100 01112223
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 928 EVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 928 ~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
.+..+.+++.+|++.+|++||++.|+.+.|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3457888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=338.98 Aligned_cols=266 Identities=23% Similarity=0.295 Sum_probs=199.2
Q ss_pred cccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE---- 755 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 755 (1010)
.+.++|+..+.||+|+||.||++.. .+|+.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3568899999999999999999985 46899999999754444444556788999999999999999999986543
Q ss_pred --ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 756 --TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 756 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
..|+||||+++ ++.+.++ ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999964 6666653 24788999999999999999999777 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc---
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK--- 910 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--- 910 (1010)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.................
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9754321 2223457899999999999999999999999999999999999999754322111111111000000
Q ss_pred ----ccccccc--CCCCC-----------------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 911 ----EGVLKIL--DPRLP-----------------SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 911 ----~~~~~~~--~~~~~-----------------~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
....... .+..+ .........+.+++.+|++.||++|||++|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000 00000 01111234577899999999999999999998853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.39 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=209.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
++|+..+.||+|+||.||+|... +|+.||+|.++..... ....+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888899999999999999965 7899999998643222 223556889999999999999999999999999999999
Q ss_pred EecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 762 EYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 762 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||+++|+|.+++.. .....+++.++..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 23456899999999999999999999777 99999999999999999999999999876543
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
... ......|++.|+|||...+..++.++|||||||++|+|++|+.||... .....+....... .
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~-----------~ 223 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLYSLCKKIEK-----------C 223 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC--CccHHHHHhhhhc-----------C
Confidence 221 123346889999999999989999999999999999999999998542 2222222222111 1
Q ss_pred CCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 920 RLPSVPL-HEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 920 ~~~~~~~-~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
..++.+. .....+.+++.+|+..+|++||++.++++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1122222 34456788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=340.94 Aligned_cols=254 Identities=20% Similarity=0.232 Sum_probs=192.9
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.|+..++||+|+||+||+|+. .+++.||+|++..... .......+.+|++++++++||||+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 467788999999999999985 4688999999864321 12224457889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++|+|.+++.+ .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999853 356889999999999999999999777 99999999999999999999999999753211000
Q ss_pred ---------------------------------------------cceeeeecccccccChhhhccCCCCccCceehhhH
Q 001816 843 ---------------------------------------------SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGV 877 (1010)
Q Consensus 843 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ 877 (1010)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHH
Q 001816 878 VLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPT---MREVV 954 (1010)
Q Consensus 878 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs---~~ev~ 954 (1010)
++|||++|+.||........ ...+.... . ....+. .........+++.+++ .+|++|++ ++|++
T Consensus 237 il~elltG~~Pf~~~~~~~~----~~~i~~~~----~---~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET----QMKVINWQ----T---SLHIPP-QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH----HHHHHccC----C---CcCCCC-cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 99999999999975322111 11111100 0 001111 1112234556666665 48999987 88887
Q ss_pred HH
Q 001816 955 QI 956 (1010)
Q Consensus 955 ~~ 956 (1010)
++
T Consensus 304 ~h 305 (382)
T cd05625 304 AH 305 (382)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=326.82 Aligned_cols=269 Identities=28% Similarity=0.389 Sum_probs=201.6
Q ss_pred ccC-CcCCeEeecCcEEEEEEEe-----cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--C
Q 001816 684 DCL-KEDNIIGKGGAGIVYKGLM-----PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--E 755 (1010)
Q Consensus 684 ~~~-~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~ 755 (1010)
++| +..+.||+|+||+||++.. .++..||+|.++.... ......+.+|++++++++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 344 7788999999999988652 3577899999865322 22345688999999999999999999987654 3
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
..++||||+++++|.+++.. ..+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 57899999999999999853 35899999999999999999999777 9999999999999999999999999998
Q ss_pred cccCCCCcce-eeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHh-hhccccc
Q 001816 836 FLQDSGTSEC-MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMT-DSKKEGV 913 (1010)
Q Consensus 836 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~ 913 (1010)
.......... .....++..|+|||+..+..++.++||||||+++|||++|+.||........ ....... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQGQMTVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhcccccccchhhh
Confidence 7643222111 1223456779999999988999999999999999999999999865322110 0000000 0000000
Q ss_pred ccccCC-CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 914 LKILDP-RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 914 ~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
.+..+. ...+.+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111 111223344567889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=333.24 Aligned_cols=243 Identities=24% Similarity=0.325 Sum_probs=191.4
Q ss_pred CeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
+.||+|+||+||+|... +++.||||+++.... .......+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 578999999875321 112233456677777764 899999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 999999853 356889999999999999999999776 9999999999999999999999999987532211 223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .. ..+.+... .+.. +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~---~~~~i~~~---------~~~~---~~ 217 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EE---LFQSIRMD---------NPCY---PR 217 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HH---HHHHHHhC---------CCCC---Cc
Confidence 355799999999999999999999999999999999999999965321 11 11111110 1111 12
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMR-EVVQ 955 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~-ev~~ 955 (1010)
.....+.+++.+|++.+|++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2334577899999999999999997 5644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=328.59 Aligned_cols=264 Identities=26% Similarity=0.367 Sum_probs=201.1
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC---------------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceee
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN---------------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 748 (1010)
++|++.+.||+|+||.||++.... ...||+|+++.... ......+.+|++++++++|||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 468888999999999999987532 22589999864322 22344688999999999999999999
Q ss_pred eeEecCCccEEEEEecCCCCHHhhhccCC----------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcE
Q 001816 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKK----------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNI 818 (1010)
Q Consensus 749 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Ni 818 (1010)
+++...+..++||||+++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985421 124678889999999999999999777 99999999999
Q ss_pred EEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh--CCCCCCCCCCCc
Q 001816 819 LLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRKPVGEFGDGV 896 (1010)
Q Consensus 819 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~P~~~~~~~~ 896 (1010)
+++.++.+||+|||++................+++.|+|||+..+..++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543322222233445779999999998899999999999999999998 567776533221
Q ss_pred cHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 897 DIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
............. . ......+...+..+.+++.+|++.+|++||++++|++.|++
T Consensus 241 -~~~~~~~~~~~~~---~----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 -VIENTGEFFRNQG---R----QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHhhhhcc---c----cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111000 0 00011122234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.73 Aligned_cols=264 Identities=26% Similarity=0.380 Sum_probs=203.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC-----------------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccce
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-----------------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 746 (1010)
++|++.+.||+|+||.||+|.... +..||+|.+...... .....+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEeE
Confidence 568888999999999999987532 245899988643322 23456889999999999999999
Q ss_pred eeeeEecCCccEEEEEecCCCCHHhhhccCC---------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCc
Q 001816 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKK---------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNN 817 (1010)
Q Consensus 747 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~N 817 (1010)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986432 126889999999999999999999776 9999999999
Q ss_pred EEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh--CCCCCCCCCCC
Q 001816 818 ILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRKPVGEFGDG 895 (1010)
Q Consensus 818 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~P~~~~~~~ 895 (1010)
|+++.++.++|+|||+++...............+++.|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986543332223334456789999999998889999999999999999998 67787653321
Q ss_pred ccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 896 VDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
+........... .. .......+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 241 -~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 -QVIENAGHFFRD---DG----RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHHHhcccc---cc----ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111000 00 000011122334578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=338.86 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=202.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCCc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHET 756 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 756 (1010)
++|.+.+.||+|+||.||+|.+. .++.||||+++..... ...+.+.+|++++.++. ||||+++++++...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 45677889999999999999853 3458999999754322 22345889999999997 9999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCCC----------------------------------------------------------
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKG---------------------------------------------------------- 778 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 778 (1010)
.++||||+++|+|.++++..+.
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999864211
Q ss_pred --------------------------------------CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE
Q 001816 779 --------------------------------------GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL 820 (1010)
Q Consensus 779 --------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill 820 (1010)
..+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 13567778899999999999999666 9999999999999
Q ss_pred cCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHH
Q 001816 821 DSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIV 899 (1010)
Q Consensus 821 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~ 899 (1010)
++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999986533222111223457889999999998889999999999999999998 899986543222111
Q ss_pred HHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
. .+... ..+..+......+.+++.+||..+|.+||+++|+++.|+.+
T Consensus 353 ~---~~~~~-----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 353 N---AIKRG-----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H---HHHcC-----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 11100 00112223345788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=354.99 Aligned_cols=263 Identities=21% Similarity=0.334 Sum_probs=203.0
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec--CCc
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN--HET 756 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 756 (1010)
+...+.|++.+.||+|+||+||+|... ++..||+|++............+..|+.++++++|||||++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345678999999999999999999954 57789999987554444445568899999999999999999998854 356
Q ss_pred cEEEEEecCCCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhcCC----CceEeecCCCCcEEEcC--------
Q 001816 757 NLLVYEYMPNGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHDCS----PLIVHRDVKSNNILLDS-------- 822 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~i~HrDlkp~Nill~~-------- 822 (1010)
.|+||||+++|+|.+++... ..+.+++..++.|+.||+.||+|||..+. .+||||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998642 23579999999999999999999997431 45999999999999964
Q ss_pred ---------CCceEEeeccccccccCCCCcceeeeecccccccChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCC
Q 001816 823 ---------GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRKPVGE 891 (1010)
Q Consensus 823 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~P~~~ 891 (1010)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||+|||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998654321 2234579999999999864 4588999999999999999999999965
Q ss_pred CCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 001816 892 FGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ--ILTEL 960 (1010)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~--~L~~~ 960 (1010)
... ..+.+..+... +.++. ...+..+.+++..||+.+|.+||++.|+++ .+..+
T Consensus 246 ~~~---~~qli~~lk~~----------p~lpi--~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANN---FSQLISELKRG----------PDLPI--KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCc---HHHHHHHHhcC----------CCCCc--CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 332 22222222111 11111 112356788999999999999999999985 44443
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.12 Aligned_cols=264 Identities=25% Similarity=0.338 Sum_probs=201.1
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.++|++.+.||+|+||.||+|... +|..||+|.++.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 367888999999999999999965 688899998865322 223445889999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.. .+.+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 83 EHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999999953 356889999999999999999999631 3999999999999999999999999999765322
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc---------ccc
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK---------KEG 912 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------~~~ 912 (1010)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .............. ...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA-KELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch-hHHHHHhcCcccCCccccccCcccCC
Confidence 12235689999999999998999999999999999999999999964322 11111100000000 000
Q ss_pred ---------------------cccccCCCCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 ---------------------VLKILDPRLPSVP-LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ---------------------~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+.....+..+ ......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000001111 0123457789999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=321.44 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=200.3
Q ss_pred cCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
.|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..|+||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 467788999999999999998777889999885422 22345888999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
++++|.+++.... ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||.++...+... .
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~ 156 (256)
T cd05059 82 ANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T 156 (256)
T ss_pred CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence 9999999986433 46899999999999999999999777 99999999999999999999999999976543211 1
Q ss_pred eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....+. + ....+... ... .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~---~~~~~~~~--------~~~---~ 221 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-E---VVESVSAG--------YRL---Y 221 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-H---HHHHHHcC--------CcC---C
Confidence 1112234468999999999999999999999999999999 89998653321 1 11111111 111 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
.+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1222445788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.09 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=197.0
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc---CCcccceeeeeEec-----CC
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI---RHRHIVRLLGFCSN-----HE 755 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~-----~~ 755 (1010)
+|++.+.||+|+||+||+|... +|+.||+|.++...........+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999854 688999999875443333334466788777766 69999999998764 24
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5789999996 58988887555556899999999999999999999777 9999999999999999999999999998
Q ss_pred cccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccc-
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL- 914 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 914 (1010)
...... ......||+.|+|||++.+..++.++||||+||++|||++|++||.........................
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 654321 1233568999999999999999999999999999999999999996543322222222111100000000
Q ss_pred ------cccCCCCC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 915 ------KILDPRLP----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ------~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+.+..+ .........+.+++.+|++.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 0111223456789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=326.01 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=203.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
++|.+.+.||+|+||.||+|..+. +..||+|.+..... ......+.+|+++++.++||||+++++++......
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 567778899999999999998542 36899999854321 12234578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCC--------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEe
Q 001816 758 LLVYEYMPNGSLGEVLHGKK--------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVA 829 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~ 829 (1010)
++||||+++|+|.+++.... ...+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986422 234788899999999999999999776 9999999999999999999999
Q ss_pred eccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhh
Q 001816 830 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 830 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |+.||.... .......+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~----- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVI----- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHh-----
Confidence 9999986544332222233457789999999998889999999999999999998 999986432 112111111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
+...+..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 236 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 ---------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111112222335678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.30 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=202.3
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
++|++.+.||+|+||.||+|....+..||+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 5577788999999999999998777789999875422 22356889999999999999999999875 4567999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.++++......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 99999999997655556899999999999999999999777 99999999999999999999999999976543221
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......++..|+|||...+..++.++||||||+++|||++ |+.||....+. +... ..... . .+
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~---~~~~~--------~---~~ 222 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLE---QVERG--------Y---RM 222 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH---HHHcC--------C---CC
Confidence 11122346778999999998899999999999999999999 89998653221 1111 11110 0 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
..+...+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122334568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=325.82 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=200.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEecC------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 756 (1010)
.+.|.+.+.||+|+||.||+|.+.. +..||+|.++.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567888899999999999998643 56799998764322 2223458889999999999999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCCC-----CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC---ceEE
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKG-----GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF---EAHV 828 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~---~~kl 828 (1010)
.++||||+++++|.+++..... ..+++..+..++.||+.|++|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999864331 35889999999999999999999776 99999999999998654 5999
Q ss_pred eeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhh
Q 001816 829 ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTD 907 (1010)
Q Consensus 829 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 907 (1010)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... . ....+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~---~~~~~~~ 236 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-E---VMEFVTG 236 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-H---HHHHHHc
Confidence 99999987633222111112234568999999999999999999999999999997 99999653221 1 1111111
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 908 SKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
. .....+...+..+.+++.+|++.+|++||++.+|+++|.+
T Consensus 237 ~-----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 G-----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred C-----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1 0111223334577889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=338.72 Aligned_cols=255 Identities=23% Similarity=0.274 Sum_probs=199.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457888899999999999999854 688999999864221 122234477899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999853 35888899999999999999999776 999999999999999999999999999865432
Q ss_pred CCcceeeeecccccccChhhhccC----CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTL----KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.... . .
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~-~---~- 265 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMDHK-N---S- 265 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHHHHHHHcCC-C---c-
Confidence 21 122345799999999998653 478999999999999999999999975322 11112211110 0 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVE--RPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~ev~~~ 956 (1010)
...+. ....+..+.+++.+|++.+|++ ||+++|++++
T Consensus 266 --~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01111 1123456778999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=330.04 Aligned_cols=262 Identities=23% Similarity=0.384 Sum_probs=206.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEe--------cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEec
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM--------PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSN 753 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 753 (1010)
.++|.+.+.||+|+||.||+|.. .++..||+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 45677889999999999999973 134579999886432 223345688999999999 89999999999999
Q ss_pred CCccEEEEEecCCCCHHhhhccCC--------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEE
Q 001816 754 HETNLLVYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNIL 819 (1010)
Q Consensus 754 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nil 819 (1010)
.+..|+||||+++|+|.+++.... ...+++.++..++.||++||+|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999986532 235778889999999999999999777 999999999999
Q ss_pred EcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccH
Q 001816 820 LDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDI 898 (1010)
Q Consensus 820 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~ 898 (1010)
++.++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|||++ |..||... ..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PV 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----CH
Confidence 99999999999999987644332222233346778999999999899999999999999999998 78888543 22
Q ss_pred HHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 001816 899 VQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (1010)
..+...+... .....+...+..+..++.+||+.+|++||++.|+++.|+++...
T Consensus 246 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKEG-----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHcC-----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2222222111 01111223445678899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.37 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=206.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.++|++.++||+|+||.||+|..+++..||||.+..... ....+.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 467888899999999999999987888999999864322 24568899999999999999999999999899999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++....+..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 999999999997655567999999999999999999999777 9999999999999999999999999998664321
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
........++..|+|||...+..++.++||||+|+++||+++ |+.||...... ......... ..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~~~~--------~~--- 222 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQVERG--------YR--- 222 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcC--------CC---
Confidence 111122335678999999998899999999999999999998 99999653221 111111111 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
...+...+..+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01112224568889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=324.90 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=200.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-----------------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccce
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-----------------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 746 (1010)
++|++.+.||+|+||.||++... ++..||+|+++.... ......+.+|+++++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcce
Confidence 46888899999999999998532 234689999864322 223456889999999999999999
Q ss_pred eeeeEecCCccEEEEEecCCCCHHhhhccCC---------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCc
Q 001816 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKK---------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNN 817 (1010)
Q Consensus 747 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~N 817 (1010)
+++++...+..++||||+++|+|.+++.... ...+++.++..++.|++.|++|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986432 124677889999999999999999776 9999999999
Q ss_pred EEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh--CCCCCCCCCCC
Q 001816 818 ILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT--GRKPVGEFGDG 895 (1010)
Q Consensus 818 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~P~~~~~~~ 895 (1010)
|+++.++.++|+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986543322222222345678999999888889999999999999999998 77888654322
Q ss_pred ccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 896 VDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.. .......... ....... ..+...+..+.+++.+||+.+|++||++.|+.+.|++
T Consensus 241 ~~-~~~~~~~~~~---~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QV-IENTGEFFRD---QGRQVYL----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-HHHHHHHHhh---ccccccC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21 1111111000 0000011 1122233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.55 Aligned_cols=254 Identities=30% Similarity=0.454 Sum_probs=202.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC---CcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS---SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
+.|+..+.||+|+||.||+|.. .+|+.||+|.++...... .....+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999985 468999999986433221 123458889999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++++|.+++.. .+.+++..+..++.|++.|++|||+.+ |+||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999999853 346889999999999999999999777 99999999999999999999999999976543
Q ss_pred CCCcc-eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 840 SGTSE-CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 840 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
..... ......|+..|+|||+..+..++.++||||+|+++|||++|+.||........ .......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~---------- 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA----IFKIATQ---------- 222 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH----HHHHhcc----------
Confidence 21111 11234678899999999998999999999999999999999999965322111 1111100
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+..+......+.+++.+|++.+|++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112233344567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.61 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=202.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 756 (1010)
.++|++.++||+|+||.||+|..+ .+..||+|.++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 467888999999999999999743 245799998764322 1223357789999999999999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCC--------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEE
Q 001816 757 NLLVYEYMPNGSLGEVLHGKK--------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV 828 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl 828 (1010)
.|+||||+++|+|.+++.... ....++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996422 123456778899999999999999776 999999999999999999999
Q ss_pred eeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhh
Q 001816 829 ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTD 907 (1010)
Q Consensus 829 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 907 (1010)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~- 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLKFVM- 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH-
Confidence 99999986543322222222345678999999998899999999999999999998 7888864321 11111111
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 908 SKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
+...+..+...+..+.+++.+|++.+|++|||+.++++.+++..
T Consensus 236 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 ----------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111222233457889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.41 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=203.4
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|++.+.||+|+||.||++... +++.||+|.++.... ....+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 3667789999999999999854 688999999864332 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++|+|.+++....+..+++..+..++.|++.|+.|||+.+ |+|+||||+||++++++.++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 99999999987555667899999999999999999999777 9999999999999999999999999997654322
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .......... .....
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~----~~~~~~~~~~-----------~~~~~ 219 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKNLILKVCQ-----------GSYKP 219 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC----HHHHHHHHhc-----------CCCCC
Confidence 12234568999999999999899999999999999999999999996421 1111111111 11111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+......+.+++.+||+.+|++||++.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 222334567889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.37 Aligned_cols=249 Identities=21% Similarity=0.271 Sum_probs=194.2
Q ss_pred CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCC-CCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
++||+|+||.||+|.. .+++.||+|+++..... ......+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 45789999999753322 22234577899999888 699999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++. ..+.+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 99998885 3356999999999999999999999777 999999999999999999999999999753221 1223
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc--cHHHHHHHHhhhcccccccccCCCCCCC
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV--DIVQWVRKMTDSKKEGVLKILDPRLPSV 924 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (1010)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ....+....... .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~ 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-----------KPIRI 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-----------CCCCC
Confidence 35679999999999999999999999999999999999999996432211 111111111111 00112
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 001816 925 PLHEVMHVFYVAMLCVEEQAVERPTM------REVVQI 956 (1010)
Q Consensus 925 ~~~~~~~~~~li~~cl~~~P~~RPs~------~ev~~~ 956 (1010)
|......+.+++.+|++.||++|+++ .++.++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 22233456789999999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=337.03 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=199.2
Q ss_pred cccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH----- 754 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 754 (1010)
.+.++|+..+.||+|+||.||+|.. ..++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3567899999999999999999985 4688999999875444444445677899999999999999999988643
Q ss_pred -CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 755 -ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 755 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
...|+||||+++ ++.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999964 6766663 24788999999999999999999777 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc---
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK--- 910 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--- 910 (1010)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............+........
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9864322 2223457899999999999999999999999999999999999999754322211111111100000
Q ss_pred ----ccccccc----------------CCCCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 911 ----EGVLKIL----------------DPRLP---SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 911 ----~~~~~~~----------------~~~~~---~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....... +...+ ..+......+.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000 0111123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=330.18 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=203.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEec--------CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEec
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP--------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSN 753 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 753 (1010)
.++|.+.+.||+|+||.||+|... ++..||+|.++.... ......+..|+++++++ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 367888899999999999999742 234799999875322 22334578899999999 79999999999999
Q ss_pred CCccEEEEEecCCCCHHhhhccCC--------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEE
Q 001816 754 HETNLLVYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNIL 819 (1010)
Q Consensus 754 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nil 819 (1010)
.+..|+||||+++|+|.+++...+ ...+++.++..++.|++.||+|||+.+ ++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 999999999999999999996532 135888999999999999999999777 999999999999
Q ss_pred EcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccH
Q 001816 820 LDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDI 898 (1010)
Q Consensus 820 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~ 898 (1010)
++.++.+||+|||.++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----~ 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----V 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----H
Confidence 99999999999999976543221111122234578999999999999999999999999999998 888885421 1
Q ss_pred HHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 899 VQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
.+....+... .....+......+.+++.+|+..+|++||++.|+++.|+++.
T Consensus 249 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 EELFKLLKEG-----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHHHHHcC-----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1222221111 111222334457788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=353.52 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=201.1
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
++|++.++||+|+||.||+|... +|+.||||+++..... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 56888899999999999999954 5899999998653322 222456889999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCC---------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecc
Q 001816 762 EYMPNGSLGEVLHGKK---------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFG 832 (1010)
||++||+|.+++.... ....++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885311 234566778899999999999999776 9999999999999999999999999
Q ss_pred ccccccCCCC----------------cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc
Q 001816 833 LAKFLQDSGT----------------SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV 896 (1010)
Q Consensus 833 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~ 896 (1010)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986521110 01112356999999999999999999999999999999999999999652211
Q ss_pred cHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCC
Q 001816 897 DIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERP-TMREVVQILTELP 961 (1010)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-s~~ev~~~L~~~~ 961 (1010)
.... ... ..++.........+..+.+++.+|++.||++|| +++++.+.++...
T Consensus 238 ki~~-~~~-----------i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 238 KISY-RDV-----------ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhh-hhh-----------ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1100 000 001100000112234577899999999999995 5677777776653
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=337.03 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=195.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|+..+.||+|+||.||+|..+ +|+.||||+++.... .......+.+|+.++..++||+|+++++.+.+++..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35777889999999999999854 689999999964322 2223456788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999853 456899999999999999999999776 9999999999999999999999999987543211
Q ss_pred Cc---------------------------------ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCC
Q 001816 842 TS---------------------------------ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888 (1010)
Q Consensus 842 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P 888 (1010)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 001134699999999999999999999999999999999999999
Q ss_pred CCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 001816 889 VGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPT---MREVVQI 956 (1010)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs---~~ev~~~ 956 (1010)
|..... ......+.... . .. ..+.. ........+++.+++ .+|.+|++ +.|+.++
T Consensus 236 f~~~~~----~~~~~~i~~~~-~---~~---~~p~~-~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETP----QETYRKVMNWK-E---TL---VFPPE-VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCH----HHHHHHHHcCC-C---ce---ecCCC-CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 965322 11112211110 0 00 01110 012235566777766 49999985 6677654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=344.05 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=193.6
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-------
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------- 754 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------- 754 (1010)
.+.|+..++||+|+||.||+|.. .+++.||||++... .....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 35688889999999999999985 46889999988532 12346799999999999999999886432
Q ss_pred -CccEEEEEecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-ceEEee
Q 001816 755 -ETNLLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVAD 830 (1010)
Q Consensus 755 -~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~D 830 (1010)
...++||||++ +++.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 13568999996 577776642 23467899999999999999999999776 99999999999998654 799999
Q ss_pred ccccccccCCCCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc
Q 001816 831 FGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909 (1010)
Q Consensus 831 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 909 (1010)
||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|++||............++......
T Consensus 215 FGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 215 FGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred cccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99998654322 22345789999999998764 689999999999999999999999976443333333322211111
Q ss_pred cccccc----ccCCCCCC---------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 910 KEGVLK----ILDPRLPS---------VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 910 ~~~~~~----~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.... ..+..++. .+...+..+.+++.+||+.+|.+|||+.|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 00001111 122234567889999999999999999999874
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=333.21 Aligned_cols=256 Identities=23% Similarity=0.265 Sum_probs=197.5
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||.||++..+ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 478889999999999999999964 588999999864221 122234477899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 122 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999853 35888899999999999999999777 999999999999999999999999999876432
Q ss_pred CCcceeeeecccccccChhhhccC----CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTL----KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~------ 264 (371)
T cd05622 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKN------ 264 (371)
T ss_pred Cc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCC------
Confidence 21 122355799999999998754 378999999999999999999999965321 112222211100
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVE--RPTMREVVQIL 957 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~ev~~~L 957 (1010)
....+. .......+..++..|+..++.+ ||+++|+.++.
T Consensus 265 -~~~~~~-~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 -SLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -cccCCC-cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 001111 1123445678899999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.66 Aligned_cols=249 Identities=30% Similarity=0.417 Sum_probs=200.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEe-cCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCS-NHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e 762 (1010)
+.|++.+.||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.++++++|+|++++++++. .++..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 4577788999999999999987 4788999988542 22446889999999999999999999764 4567899999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999997655556899999999999999999999776 9999999999999999999999999987543221
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+... ..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~~~~--------~~--- 217 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPRVEKG--------YK--- 217 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHhcC--------CC---
Confidence 12345678999999999999999999999999999997 999986432 12222222111 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
+..+...+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 112223345778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=334.89 Aligned_cols=265 Identities=23% Similarity=0.281 Sum_probs=199.4
Q ss_pred cccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH----- 754 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 754 (1010)
.+.++|+..+.||+|+||.||+|.. ..++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3568899999999999999999985 4688999999975444444455678899999999999999999987543
Q ss_pred -CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 755 -ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 755 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
...|+||||++ +++.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 35699999996 57777763 24788999999999999999999776 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc--
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE-- 911 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 911 (1010)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............+........+
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9865322 12234578999999999999999999999999999999999999997543322211111111000000
Q ss_pred -----ccc---------------cccC----CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 912 -----GVL---------------KILD----PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 -----~~~---------------~~~~----~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+. +.+. +............+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0000 00000111123457789999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.51 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=206.9
Q ss_pred cCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..++||+|+||.||.++ ..+++.|++|.+............+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47778899999999999988 45688999999876544444456688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.......+++.++..++.|++.|++|||+.+ ++||||+|+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999997655667899999999999999999999776 99999999999999999999999999986643321
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+....... .....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~~-----------~~~~~ 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN----PLNLVVKIVQ-----------GNYTP 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHc-----------CCCCC
Confidence 2234568999999999998889999999999999999999999996422 1122222111 11111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
.+......+.+++.+|++.+|++||++.|+++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1223345677899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.16 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=208.7
Q ss_pred cCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCC
Q 001816 688 EDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
..++||.|.||.||.|.|+. .-.||||.++.. ....++|.+|+.+|+.++|||+|+++|+|..+..+|||+|||..
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 45789999999999999875 557999999753 34577899999999999999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+|+++-....++.-..+.++.||+.||+||...+ +|||||.++|+|+.++..||++|||+++.+..... ...
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAH 423 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAH 423 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce-ecc
Confidence 99999998766666777778899999999999999776 99999999999999999999999999998864332 222
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCC
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (1010)
....-...|.|||-+....++.|+|||+|||++||+.| |-.||.+.+ ..+...-+... .+ ..-|
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----lSqVY~LLEkg----------yR-M~~P 488 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYGLLEKG----------YR-MDGP 488 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHhcc----------cc-ccCC
Confidence 23334578999999999999999999999999999998 888986532 22211111111 01 1235
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 926 LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 926 ~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
..++..++++++.||++.|.+||+++|+.+.++.+.
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 566778999999999999999999999999998764
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.68 Aligned_cols=250 Identities=29% Similarity=0.444 Sum_probs=203.9
Q ss_pred CeEeecCcEEEEEEEecC----CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecC
Q 001816 690 NIIGKGGAGIVYKGLMPN----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
+.||+|+||.||+|.... +..||+|.++...... ..+.+.+|++.++.++|+|++++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999999643 7889999997544332 35668899999999999999999999999999999999999
Q ss_pred CCCHHhhhccCC-------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 766 NGSLGEVLHGKK-------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 766 ~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+++|.+++.... ...+++.+++.++.|++.|++|||+.+ |+||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 999999996532 367999999999999999999999766 9999999999999999999999999998765
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
............+++.|+|||.+....++.++||||+|+++|||++ |..||.... . .+.......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~---~~~~~~~~~---------- 222 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-N---EEVLEYLRK---------- 222 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-H---HHHHHHHHc----------
Confidence 4432233344567889999999998899999999999999999999 699997642 1 122222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
......+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111222333567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.73 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=195.3
Q ss_pred EeecCcEEEEEEEec---CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCC
Q 001816 692 IGKGGAGIVYKGLMP---NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGS 768 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 768 (1010)
||+|+||.||+|.+. .+..||+|+++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 899999999999753 355799999865322 223456889999999999999999999875 457899999999999
Q ss_pred HHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc-eee
Q 001816 769 LGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE-CMS 847 (1010)
Q Consensus 769 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~ 847 (1010)
|.+++... ...+++..+.+++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998633 357899999999999999999999776 9999999999999999999999999997654332211 111
Q ss_pred eecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 848 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
...+++.|+|||++.+..++.++||||||+++||+++ |+.||...... .+...+... ..+..+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~-----------~~~~~~~ 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMSFIEQG-----------KRLDCPA 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHHCC-----------CCCCCCC
Confidence 2234578999999998889999999999999999996 99999754321 111111111 1112223
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
..+..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 3456788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.75 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=200.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
.+|...++||+|+||.||++... ++..||+|.++... ......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 34566788999999999999632 35679999876432 22345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCCC-------------CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC
Q 001816 758 LLVYEYMPNGSLGEVLHGKKG-------------GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF 824 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~ 824 (1010)
++||||+++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence 999999999999999864321 35889999999999999999999777 99999999999999999
Q ss_pred ceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHH
Q 001816 825 EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVR 903 (1010)
Q Consensus 825 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~ 903 (1010)
.+||+|||++................+++.|+|||+..+..++.++|||||||++|||++ |..||...... ....
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~ 235 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EAIE 235 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HHHH
Confidence 999999999976543222122223345788999999999999999999999999999998 89998653221 1111
Q ss_pred HHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
..... .....+...+..+.+++.+||+.||.+||+++|+.+.|+.
T Consensus 236 ~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQG-----------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcC-----------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111 1111122334567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.64 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=203.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|++..-||.|+||.||+|..+. +-..|.|++... ......+|.-||+++..++||+||++++.|..++..||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 557777889999999999998654 445677777532 23446678999999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
||.||-.+.++-. -+..+.++++..+++|++.||.|||... |||||||+.|||++-+|.++|+|||.+.... ..
T Consensus 110 FC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST 183 (1187)
T ss_pred ecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hH
Confidence 9999999888753 3467999999999999999999999665 9999999999999999999999999986432 23
Q ss_pred cceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 843 SECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
......+.|||.|||||++. ..+|+.++||||||+++.||..+.+|..+.. ..+.+-++...
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllKiaKS--------- 250 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKIAKS--------- 250 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHHHhhc---------
Confidence 34456788999999999865 5689999999999999999999999975432 22222222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+|.-.-.|.+....+.+++.+|+.++|..||++++++++
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 122222356667788899999999999999999999764
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.74 Aligned_cols=260 Identities=21% Similarity=0.350 Sum_probs=208.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|++.+.||+|+||.||+|.. .+|+.||||.+..... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678888999999999999994 5789999998864322 2223456888999999999999999999999999999999
Q ss_pred EecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 762 EYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 762 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||+++++|.+++.. .....+++..++.++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 23456899999999999999999999777 99999999999999999999999999876543
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
... ......|+..|+|||+..+..++.++||||||+++|||++|..||.... .+...+.+.... ...+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~--------~~~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEQ--------CDYP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc--chHHHHhhhhhc--------CCCC
Confidence 221 1234568999999999998899999999999999999999999996422 222222222111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
..+ +......+.+++.+||+.+|++|||+.+|++.++++
T Consensus 227 ~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111 123445688899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.88 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=205.0
Q ss_pred cccCCcCCeEeecCcEEEEEEEecC-----CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec-CCc
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN-----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-HET 756 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 756 (1010)
.++|+..++||+|+||.||+|.... +..||+|+++... .......+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3567788899999999999999765 6789999886432 22334568889999999999999999998766 567
Q ss_pred cEEEEEecCCCCHHhhhccCCC------CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEee
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKG------GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVAD 830 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~D 830 (1010)
.++++||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999864322 46899999999999999999999776 99999999999999999999999
Q ss_pred ccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhc
Q 001816 831 FGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSK 909 (1010)
Q Consensus 831 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 909 (1010)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||... +..+...+ +...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~---~~~~- 235 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAY---LKDG- 235 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHH---HHcC-
Confidence 999986543322222223346778999999998899999999999999999999 99999653 22222221 1111
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
.. ...+...+..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 236 -------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 236 -------YR---LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -------CC---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 0111223346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=339.03 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=197.7
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC-----ccEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE-----TNLL 759 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l 759 (1010)
|+..+.||+|+||.||+|.. .+|+.||||++............+.+|+++++.++||||+++++++...+ ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 66778999999999999995 47899999998654333333456789999999999999999999998776 7899
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred Eeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 999995 68888774 3457899999999999999999999777 99999999999999999999999999986543
Q ss_pred CCCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh-ccc------
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS-KKE------ 911 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~------ 911 (1010)
.. ........+++.|+|||++.+. .++.++||||+||++|||++|+.||........ ...+...... ..+
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhh
Confidence 22 1222344688999999998874 478999999999999999999999975432211 1111110000 000
Q ss_pred -cccccc--CCC-CC------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 912 -GVLKIL--DPR-LP------SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 -~~~~~~--~~~-~~------~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.....+ .+. .+ .........+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 000 00 1111224467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.82 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=198.8
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
|+..+.||+|+||+||+|.. .+|+.||+|.+....... .....+.+|++++++++|++|+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55567899999999999985 468899999986532221 1233467899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999886555557999999999999999999999776 9999999999999999999999999997643221
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......|++.|+|||++.+..++.++|+||+||++|||++|+.||....+......+....... . ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~-----------~~ 223 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-E-----------EV 223 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-c-----------cc
Confidence 1234468999999999999999999999999999999999999997543222211111111110 0 01
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPT-----MREVVQ 955 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs-----~~ev~~ 955 (1010)
.+......+.+++..|++.+|++||+ ++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11122345678999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.22 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=202.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
+.|+..+.||+|+||.||+|... ++..||+|+++.... ......+.+|+.++++++||||+++++++..++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 56788889999999999999853 467899999864322 22234588899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCC--------------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCc
Q 001816 758 LLVYEYMPNGSLGEVLHGKK--------------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNN 817 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~N 817 (1010)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986322 124778889999999999999999776 9999999999
Q ss_pred EEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCc
Q 001816 818 ILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGV 896 (1010)
Q Consensus 818 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~ 896 (1010)
|+++.++.++|+|||.+................+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876533222111222345678999999998899999999999999999998 8888854321
Q ss_pred cHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 897 DIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.+....+.. ......+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 --~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 --EEVIYYVRD-----------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHHhc-----------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122222111 11111222334578889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.49 Aligned_cols=253 Identities=28% Similarity=0.393 Sum_probs=190.3
Q ss_pred eEeecCcEEEEEEEecC---CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 691 IIGKGGAGIVYKGLMPN---GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
.||+|+||.||+|.+.+ +..+|+|.++..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998643 457999988654322 22346888999999999999999999999999999999999999
Q ss_pred CHHhhhccCC---CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 768 SLGEVLHGKK---GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 768 ~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
+|.++++..+ ....++..+..++.|++.|++|||+.+ ++||||||+||+++.++++||+|||.++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 234567788899999999999999776 9999999999999999999999999997543322222
Q ss_pred eeeeecccccccChhhhccC-------CCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 845 CMSAIAGSYGYIAPEYAYTL-------KVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
......|++.|+|||++.+. .++.++||||||+++|||++ |+.||........ .... .. ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~--~~----~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYT--VR----EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHH--hh----cccCCC
Confidence 22234578899999988642 35789999999999999996 9999975432221 1111 10 111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
.++... ......+..++..|| .+|++|||++||++.|+
T Consensus 231 ~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222221 122334667888998 58999999999998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.90 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=199.2
Q ss_pred ccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|...+-||+|+||.||-|+ ..+.+.||||++...... .+...++.+|++.+++++|||+|.+-|+|-.+.+.|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 345556779999999999999 456789999998654332 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||| -|+-.|++.- ...++.+.++..|..+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.|....+.
T Consensus 106 EYC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 106 EYC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 999 5677777642 2356889999999999999999999776 999999999999999999999999999876543
Q ss_pred CcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 842 TSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
..++|||.|||||++. .+.|+-++||||+||+..|+...++|+..+..-..++.+. .
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA---------------Q 239 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------------Q 239 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH---------------h
Confidence 3568999999999875 5679999999999999999999999975543222222211 1
Q ss_pred CCCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVP-LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~-~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+-|..+ .+.+..+..++..|+++-|.+|||.++++.+
T Consensus 240 NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 240 NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1222222 3344557789999999999999999998764
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.60 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=202.5
Q ss_pred cCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
+|++.+.||+|+||.||+|... ....||+|.+..... ......+.+|+.+++.++||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3667789999999999999852 235689888864322 222356888999999999999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCC----------------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCC
Q 001816 759 LVYEYMPNGSLGEVLHGKK----------------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSN 816 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~ 816 (1010)
+||||+++|+|.+++.... ...+++..++.++.|++.|++|||+.+ |+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence 9999999999999875321 234788899999999999999999776 999999999
Q ss_pred cEEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCC
Q 001816 817 NILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDG 895 (1010)
Q Consensus 817 Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~ 895 (1010)
||++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.... .
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~ 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-P 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-H
Confidence 99999999999999999986543322222223346678999999998899999999999999999998 999986432 1
Q ss_pred ccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 896 VDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
..+.++... . ... ..+......+.+++.+|++.+|++||+++|+++.|+++..
T Consensus 236 ~~~~~~~~~---~--------~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKT---G--------YRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhC---C--------CCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 222221110 0 011 1122334568889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=328.31 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=203.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEec--------CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP--------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH 754 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 754 (1010)
++|.+.+.||+|+||.||+|... .+..||+|.++.... ......+.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 56778899999999999999742 245799998864322 22344578899999999 699999999999998
Q ss_pred CccEEEEEecCCCCHHhhhccCC--------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL 820 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill 820 (1010)
+..|+||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999986432 245888999999999999999999777 9999999999999
Q ss_pred cCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHH
Q 001816 821 DSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIV 899 (1010)
Q Consensus 821 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~ 899 (1010)
+.++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|||++ |..||.... ..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-HHHHH
Confidence 9999999999999986643222211122234568999999999899999999999999999999 888986432 11111
Q ss_pred HHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
...... .....+...+..+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 247 ---~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 247 ---KLLREG-----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ---HHHHcC-----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111110 1111223334567889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.30 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=200.4
Q ss_pred cccCCcCCeEeecCcEEEEEEEe------cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC-
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM------PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH- 754 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~- 754 (1010)
.++|++.+.||+|+||+||+|.+ .+++.||||+++.... ......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35788999999999999999973 3567899999864322 22344578899999999 689999999988654
Q ss_pred CccEEEEEecCCCCHHhhhccCC---------------------------------------------------------
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKK--------------------------------------------------------- 777 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 777 (1010)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 46789999999999999985321
Q ss_pred --------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeee
Q 001816 778 --------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 778 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
...+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 123677888999999999999999776 999999999999999999999999999865332222222233
Q ss_pred cccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHH
Q 001816 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHE 928 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1010)
.+++.|+|||++.+..++.++||||||+++|||++ |..||.......... ..+... .....+...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~-----------~~~~~~~~~ 307 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---RRLKEG-----------TRMRAPDYT 307 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH---HHHhcc-----------CCCCCCCCC
Confidence 45678999999999899999999999999999997 999986533221111 111111 001111112
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 929 VMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 929 ~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
...+.+++..||+.+|++||++.|++++|+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.40 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=199.8
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
|+..++||+|+||.||++... +++.||||.+....... .....+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 556678999999999999854 68899999986533222 2234467899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999986555556899999999999999999999766 9999999999999999999999999997643221
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||....+...... ......... . .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~~~~--------~---~ 223 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKEVQ--------E---E 223 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhhhhh--------h---h
Confidence 12234689999999999999999999999999999999999999975432211111 111111100 0 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPT-----MREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs-----~~ev~~~ 956 (1010)
.+......+.+++.+|++.||++||| ++|++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11122345778999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.43 Aligned_cols=265 Identities=21% Similarity=0.253 Sum_probs=199.1
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|+..+.||+|+||.||+|... +|..||||+++...........+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 667789999999999999964 6889999998754443334456888999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCC-CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 765 PNGSLGEVLHGKK-GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 765 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+ ++|.+++.... +..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-- 155 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence 6 68888886433 367899999999999999999999776 9999999999999999999999999997653221
Q ss_pred ceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc-------------
Q 001816 844 ECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK------------- 909 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------- 909 (1010)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.||.............+......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 112234578999999988754 578999999999999999999999975332222222111111000
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.....................++.+++.+|++.||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000011123456789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.29 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=203.5
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-CccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH-ETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e 762 (1010)
.|++.+.||+|+||.||++..+ +++.||+|++..........+.+.+|++++++++|||++++++.+... ...|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3777889999999999999854 578999999875444334455688899999999999999999987643 45789999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++.......+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999997655567899999999999999999999777 9999999999999999999999999998664322
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......|++.|+|||+..+..++.++||||+|+++|||++|+.||.... .......... ..++
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~~~~~~~~~~-----------~~~~ 220 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRIIE-----------GKLP 220 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHh-----------cCCC
Confidence 22334568999999999999999999999999999999999999986432 1112111111 1112
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+......+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2233344578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.80 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=203.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCC----EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
+.|+..++||+|+||+||+|.+ .+|+ .||+|+++.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 4567778999999999999984 3454 489998864322 2234568889999999999999999999875 4578
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
++|||+++|+|.++++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999998643 356899999999999999999999766 9999999999999999999999999998764
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
............+++.|+|||...+..++.++|||||||++|||++ |..||..... .....++.. .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~---~--------- 227 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPDLLEK---G--------- 227 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHC---C---------
Confidence 3322222222345678999999999999999999999999999998 8999864321 112222111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~ 964 (1010)
..+..+......+.+++.+||+.||++||++.|+++.++++...+
T Consensus 228 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 --ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011112233456788999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=323.87 Aligned_cols=265 Identities=27% Similarity=0.310 Sum_probs=205.5
Q ss_pred ccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-C-----cccceeeeeEe
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-H-----RHIVRLLGFCS 752 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~ 752 (1010)
+.+.-+|++.++||+|+||.|-||. .++++.||||+++.... ...+-..|+.++..++ | -|+|+++++|.
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 3344588999999999999999998 45699999999976332 2334567999999996 4 39999999999
Q ss_pred cCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC--CceEEee
Q 001816 753 NHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG--FEAHVAD 830 (1010)
Q Consensus 753 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~--~~~kl~D 830 (1010)
..++.|||+|.+ ..+|+++++..+-..++...++.++.||+.||.+||+.+ |||+||||+|||+.+. ..+||+|
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEe
Confidence 999999999999 679999998887778999999999999999999999887 9999999999999653 3699999
Q ss_pred ccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc
Q 001816 831 FGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK 910 (1010)
Q Consensus 831 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 910 (1010)
||.|......- . .+..+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+..+.+.+..++ ++.....
T Consensus 335 FGSSc~~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~-e~lG~Pp 408 (586)
T KOG0667|consen 335 FGSSCFESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII-EVLGLPP 408 (586)
T ss_pred cccccccCCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH-HHhCCCC
Confidence 99998754321 1 5667889999999999999999999999999999999988887644333333222 2110000
Q ss_pred c-----------ccc------------------------c-----ccCCCCC----C----CCHHHHHHHHHHHHhcccc
Q 001816 911 E-----------GVL------------------------K-----ILDPRLP----S----VPLHEVMHVFYVAMLCVEE 942 (1010)
Q Consensus 911 ~-----------~~~------------------------~-----~~~~~~~----~----~~~~~~~~~~~li~~cl~~ 942 (1010)
. -+. + ..+...| + .+..+-..+.+++++|+..
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 0 000 0 0011111 0 0112234578899999999
Q ss_pred CCCCCCCHHHHHHHH
Q 001816 943 QAVERPTMREVVQIL 957 (1010)
Q Consensus 943 ~P~~RPs~~ev~~~L 957 (1010)
||.+|+|+.|++++-
T Consensus 489 dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 489 DPAERITPAQALNHP 503 (586)
T ss_pred CchhcCCHHHHhcCc
Confidence 999999999999853
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.63 Aligned_cols=266 Identities=18% Similarity=0.204 Sum_probs=196.9
Q ss_pred cCCeEeec--CcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 688 EDNIIGKG--GAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 688 ~~~~lG~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
+.++||+| +||+||++.. .+|+.||+|+++...........+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34689999 7899999985 57899999999765443334456778999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+......+...
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999996544456899999999999999999999777 9999999999999999999999998765432211110
Q ss_pred -----eeeeecccccccChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh-------cc
Q 001816 845 -----CMSAIAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS-------KK 910 (1010)
Q Consensus 845 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-------~~ 910 (1010)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.................+. ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 1122356788999999876 468999999999999999999999997543222111111000000 00
Q ss_pred cccc-----cccCC----------CC--------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 911 EGVL-----KILDP----------RL--------PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 911 ~~~~-----~~~~~----------~~--------~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+... ...+. .. ..........+.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 00000 00 00111223467889999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=316.34 Aligned_cols=254 Identities=25% Similarity=0.441 Sum_probs=204.9
Q ss_pred cccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.++|+..+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++++++|+||+++++++.+ ...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 46788889999999999999998778889999886422 224568899999999999999999999887 77899999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++.......+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999997655667889999999999999999999776 99999999999999999999999999976543221
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.......++..|+|||++....++.++|||||||++|++++ |+.||..... .+..++ .... ..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~~---~~~~-----------~~ 221 (260)
T cd05073 158 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRA---LERG-----------YR 221 (260)
T ss_pred -ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HHHHHH---HhCC-----------CC
Confidence 12223346678999999998889999999999999999999 8999965322 111111 1110 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.+.+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122344568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.48 Aligned_cols=250 Identities=31% Similarity=0.440 Sum_probs=203.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.|+..+.||+|+||.||+|.. .|+.||+|.++.... ....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4677788999999999999987 488999999975432 345688999999999999999999999988999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.......+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999997555457999999999999999999999777 99999999999999999999999999986532211
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
...++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+.. ...... . ..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~---~~~~~~--------~---~~ 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVV---PHVEKG--------Y---RM 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HHHH---HHHhcC--------C---CC
Confidence 2235668999999998889999999999999999997 9999865321 1111 111110 0 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
..+...+..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11222345678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=315.44 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=198.9
Q ss_pred CeEeecCcEEEEEEEecC--CC--EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecC
Q 001816 690 NIIGKGGAGIVYKGLMPN--GD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~--g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
++||+|+||.||+|.+.+ ++ .||||.+...... ...+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998643 33 6999998764433 335568899999999999999999999988 88899999999
Q ss_pred CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc-c
Q 001816 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS-E 844 (1010)
Q Consensus 766 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~ 844 (1010)
+++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999997544357899999999999999999999776 999999999999999999999999999876543221 1
Q ss_pred eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+........ .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~----------~~~~~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKIDKE----------GERLE 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhc----------CCcCC
Confidence 1223457789999999999999999999999999999998 9999864321 1122211110 00111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
.+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12223457888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=317.68 Aligned_cols=254 Identities=27% Similarity=0.461 Sum_probs=202.3
Q ss_pred cCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCC----CcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGS----SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.|+..+.||+|+||+||+|...+|+.+|||.++...... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999998889999999986533221 1124578899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++++|.+++.+ ...+++..+..++.|++.|++|||+.+ |+|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999999953 356889999999999999999999777 999999999999999999999999999765321
Q ss_pred CC----cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 841 GT----SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 841 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.. ........|+..|+|||+..+..++.++||||||+++|||++|+.||............ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~-------- 223 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI----GAH-------- 223 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh----hhc--------
Confidence 11 11223356899999999999989999999999999999999999999653221111110 000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+..+......+..++.+|++.+|++||++.|++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 224 -RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011122233345567889999999999999999999753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=328.94 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=204.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEec--------CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP--------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH 754 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 754 (1010)
.+|++.+.||+|+||.||+|... .+..||+|.++.... ....+.+.+|+++++++ +||||+++++++..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 45788899999999999999742 123689998864322 22345688999999999 799999999999999
Q ss_pred CccEEEEEecCCCCHHhhhccCC--------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL 820 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill 820 (1010)
+..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999986432 235788899999999999999999777 9999999999999
Q ss_pred cCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHH
Q 001816 821 DSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIV 899 (1010)
Q Consensus 821 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~ 899 (1010)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~ 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VE 243 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----HH
Confidence 9999999999999986543222222222334578999999999999999999999999999998 888886432 22
Q ss_pred HHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 001816 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964 (1010)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~ 964 (1010)
.+...+... .....+......+.+++.+|++.+|++||++.|+++.|+.+....
T Consensus 244 ~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ELFKLLKEG-----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHcC-----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 222222111 111122233456788999999999999999999999999886433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=325.16 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=199.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC-CC--EEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-GD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 759 (1010)
+.|++.++||+|+||.||+|..++ |. .+|+|.++.... ....+.+.+|+++++++ +||||+++++++...+..|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 567888899999999999998643 43 478888764222 22234588899999999 79999999999999999999
Q ss_pred EEEecCCCCHHhhhccCC--------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCc
Q 001816 760 VYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE 825 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~ 825 (1010)
||||+++++|.+++.... ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999986422 135888999999999999999999776 999999999999999999
Q ss_pred eEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHH
Q 001816 826 AHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 826 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 904 (1010)
+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||..... .+....
T Consensus 158 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~~~~~ 230 (297)
T cd05089 158 SKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AELYEK 230 (297)
T ss_pred EEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Confidence 999999998643211 01111223567999999998889999999999999999997 9999965321 112222
Q ss_pred HhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
.... ..+..+......+.+++.+|++.+|.+||+++++++.|+.+..
T Consensus 231 ~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 LPQG-----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HhcC-----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 0111122234567889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.66 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=197.5
Q ss_pred CeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
++||+|+||.||+|...++..||+|.++.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999988889999999864332 22234588899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeee
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
.+++... ...+++..+..++.|++.|+.|+|+.+ ++||||||+||+++.++.+||+|||++....... .......
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~ 154 (250)
T cd05085 80 LSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLK 154 (250)
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCC
Confidence 9998643 346889999999999999999999776 9999999999999999999999999997543221 1111222
Q ss_pred cccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHH
Q 001816 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHE 928 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1010)
.+++.|+|||+..+..++.++||||||+++||+++ |..||...... ......... .....+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~~~~~-----------~~~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQVEKG-----------YRMSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHHcC-----------CCCCCCCCC
Confidence 34678999999998899999999999999999998 99999653211 111111110 011112233
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 929 VMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 929 ~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
+..+.+++.+|++.+|++||++.|+.+.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 457888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.62 Aligned_cols=255 Identities=31% Similarity=0.454 Sum_probs=200.2
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|+..+.||+|+||+||++... +++.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 556789999999999999965 4668999999765433222223345999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
++++|.+++. ....+++.++..++.|+++||++||+.+ |+||||||+||++++++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred cccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccc
Confidence 9999999996 4467899999999999999999999877 9999999999999999999999999997641 1223
Q ss_pred eeeeecccccccChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 845 CMSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......+++.|+|||++. +..++.++||||+|+++|+|++|..||..... .+............ .... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~---~~~~----~~- 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLEIIEKILKRP---LPSS----SQ- 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHHHHHHHHHTH---HHHH----TT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-hhhhhhhhhccccc---cccc----cc-
Confidence 344567899999999998 88899999999999999999999999976411 11111111111100 0000 00
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
........+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112578899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=326.57 Aligned_cols=258 Identities=29% Similarity=0.475 Sum_probs=212.1
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCC----EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+..++||+|+||+||||.| ++|+ +||+|++.... ..+...++..|+-+|.+++|||++++++++.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34567999999999999984 4555 68999886433 3344567999999999999999999999998765 7899
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
++|++.|+|.++++..+ ..+.....+.|..|||+||.|||++. ++||||..+||||.+-..+||.|||+|+.....
T Consensus 776 tq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999998543 56888899999999999999999766 999999999999999999999999999988776
Q ss_pred CCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
+.........-.+.|||-|.++...|+.++|||||||++||++| |..|+..... .++...++ ++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle--------------~g 916 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLE--------------KG 916 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHh--------------cc
Confidence 66555555556789999999999999999999999999999999 9999976431 11111111 12
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~ 964 (1010)
+.-+.|+-+...++.++.+||..|++.||+++++...+.++.+.+
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 223445667788999999999999999999999999887765443
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.71 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=202.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-C---CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-N---GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
++|++.+.||+|+||.||+|... + +..||+|.++.... ......+.+|+.++++++||||+++++++..++..|+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46777889999999999999853 2 33799998864322 2234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++++|.+++... .+.+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||++.....
T Consensus 83 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 83 VTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999643 356899999999999999999999776 99999999999999999999999999987643
Q ss_pred CCCcc-eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 840 SGTSE-CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 840 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
..... ......++..|+|||++.+..++.++||||||+++||+++ |..||...... +... .+... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~---~~~~~--------~ 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIK---AIEEG--------Y 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHH---HHhCC--------C
Confidence 32211 1112223568999999998899999999999999999887 99999654321 1111 11111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
. .+.+...+..+.+++.+|++.+|.+||++.++++.|.++
T Consensus 227 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 R---LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred c---CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 111222345678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.89 Aligned_cols=265 Identities=19% Similarity=0.266 Sum_probs=198.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|...+.||+|+||.||+|..+ +++.||+|+++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56888899999999999999854 678899999875432 2223457789999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|++ ++|.+++... +..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 85 YLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 996 5888887533 345888999999999999999999776 9999999999999999999999999997643221
Q ss_pred cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc-----
Q 001816 843 SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI----- 916 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 916 (1010)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.............+.......+....+
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 12233468899999998865 46889999999999999999999999754332222222111110000000000
Q ss_pred -cCCCCCC--------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 -LDPRLPS--------VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 -~~~~~~~--------~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+...+. ..........+++.+|++.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.75 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=205.4
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|+||.||++.. .+|+.||+|++............+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477788999999999999984 4688999999875433333445688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.......+++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999987555556889999999999999999999776 9999999999999999999999999997654321
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
.......|++.|+|||+..+..++.++|||||||++|+|++|+.||.... ....+.... ....+.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~-----------~~~~~~ 220 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKII-----------RGSYPP 220 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----HHHHHHHHh-----------cCCCCC
Confidence 11223468899999999998899999999999999999999999986422 111221111 111222
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+......+.+++.+|++.+|++||++.||+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 233445578889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.12 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=198.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCC--EEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 759 (1010)
+.|++.+.||+|+||.||+|.++ +|. .+|+|.++... .......+.+|++++.++ +||||+++++++..++..|+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46777889999999999999864 454 45777765322 222345688899999999 89999999999999999999
Q ss_pred EEEecCCCCHHhhhccCC--------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCc
Q 001816 760 VYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE 825 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~ 825 (1010)
||||+++++|.++++... ...+++.+++.++.|++.|++|||+.+ |+||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999986432 235789999999999999999999776 999999999999999999
Q ss_pred eEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHH
Q 001816 826 AHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 826 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 904 (1010)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... . +....
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~---~~~~~ 235 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-A---ELYEK 235 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-H---HHHHH
Confidence 999999998642211 11111234678999999988889999999999999999998 9999964321 1 11121
Q ss_pred HhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
+... .....+......+.+++.+|++.+|++||+++++++.++++..
T Consensus 236 ~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 236 LPQG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HhcC-----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1110 0111112233467889999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=328.78 Aligned_cols=242 Identities=22% Similarity=0.281 Sum_probs=191.3
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccC-CcccceeeeeEecCCccEEEEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 762 (1010)
|+..+.||+|+||+||+|.. .+|+.||+|+++.... .......+..|++++..+. |++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 55668899999999999985 4688999999874322 1222345677888888885 5788899999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++|+|.+++. +.+.+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 82 YVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 999999999985 3456999999999999999999999777 9999999999999999999999999997543221
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... . .....+... ..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~---~~~~~i~~~---------~~--- 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-D---ELFQSIMEH---------NV--- 218 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-H---HHHHHHHhC---------CC---
Confidence 122345699999999999999999999999999999999999999965321 1 112221111 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTM 950 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~ 950 (1010)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122233466789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=317.86 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=200.0
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|++.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.++++++||||+++++++..++..|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35688899999999999999995 5688999999864322 22345788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++++|.++++. ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 86 EYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999999853 356899999999999999999999776 9999999999999999999999999998654321
Q ss_pred CcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 842 TSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.......|++.|+|||.+. ...++.++||||+||++|||++|+.||...........+ .. ..+.
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~----~~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SK----SNFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ec----CCCC
Confidence 1123456889999999874 445788999999999999999999998543211110000 00 0001
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
+.........+..+.+++.+||+.+|++||+++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111111122345678899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.04 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=197.0
Q ss_pred CeEeecCcEEEEEEEecC----CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecC
Q 001816 690 NIIGKGGAGIVYKGLMPN----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
++||+|+||.||+|.+.. +..||+|.++..... ...+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999997432 268999998754332 33456889999999999999999999876 456799999999
Q ss_pred CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce
Q 001816 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 766 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
+|+|.+++... ..+++..+..++.|++.|++|||..+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 79 LGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999999643 47899999999999999999999776 99999999999999999999999999986643322111
Q ss_pred -eeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 846 -MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 846 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
.....++..|+|||...+..++.++||||||+++|||++ |+.||..... .+...++. ... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~~~---~~~-----------~~~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLE---SGE-----------RLP 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHH---cCC-----------cCC
Confidence 111224568999999999999999999999999999998 9999965422 22222221 110 011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
.+...+..+.+++.+|+..+|++||++.++++.|+.+.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 22233457789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=334.55 Aligned_cols=262 Identities=23% Similarity=0.224 Sum_probs=200.1
Q ss_pred cccCCcCCeEeecCcEEEEEEEec---CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP---NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
..+|++.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 356888899999999999999743 3578999987532 235789999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
|||++. ++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 164 v~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 164 VMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999994 78888883 4467999999999999999999999777 99999999999999999999999999986654
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHH---HHHHHHhhhccc-----
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIV---QWVRKMTDSKKE----- 911 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~---~~~~~~~~~~~~----- 911 (1010)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..++.+.....+
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 333333345679999999999999999999999999999999999999996543322111 111111000000
Q ss_pred ------ccccccCCCCCCC--C-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 912 ------GVLKILDPRLPSV--P-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 912 ------~~~~~~~~~~~~~--~-----~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
..........+.. + ......+.+++.+|+..||++||++.|++.+-
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000000 0 11234577899999999999999999998863
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=321.16 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=201.3
Q ss_pred cCCcCCeEeecCcEEEEEEEe-----cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--Ccc
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-----PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETN 757 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 757 (1010)
.|++.+.||+|+||.||++.. .++..||+|.++.... ......+.+|++++++++|||++++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 467788999999999999973 3578899999864432 22345688999999999999999999998775 567
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
++||||+++++|.+++... ...+++.++..++.|++.||+|+|+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 8999999999999998543 246899999999999999999999776 999999999999999999999999999876
Q ss_pred cCCCCc-ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCC-----------CccHHHHHHHH
Q 001816 838 QDSGTS-ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGD-----------GVDIVQWVRKM 905 (1010)
Q Consensus 838 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~-----------~~~~~~~~~~~ 905 (1010)
...... .......++..|+|||+..+..++.++||||||+++|||++++.|+..... ......++...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433221 122234577789999999988999999999999999999998776532100 00011111111
Q ss_pred hhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 906 TDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
. +....+.+...+..+.+++.+|++.+|++||++.++++.++++
T Consensus 240 ~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 E-----------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H-----------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 1111112233456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=316.31 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=201.2
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCC-------cccchHHHHHHHhccCCcccceeeeeEecCCc
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSS-------HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 756 (1010)
+|...+.||+|+||.||+|.. .+++.||+|.+........ ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999985 4588999998865433221 12357889999999999999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
.++||||+++++|.+++.. .+.+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.+||+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999999953 356889999999999999999999777 99999999999999999999999999987
Q ss_pred ccCCCC----cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc
Q 001816 837 LQDSGT----SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912 (1010)
Q Consensus 837 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 912 (1010)
...... ........|+..|+|||.+.+..++.++||||+|+++|||++|+.||....... .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~------ 225 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ----AIFKIG------ 225 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH----HHHHHh------
Confidence 642211 111223458899999999998889999999999999999999999997532211 111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+..+......+.+++.+||+.+|++||++.|++++
T Consensus 226 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 -----ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111122233344577889999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=332.51 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=197.9
Q ss_pred cccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH----- 754 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 754 (1010)
++.++|...+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999985 4688999999865433323344577899999999999999999987543
Q ss_pred -CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 755 -ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 755 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
...|++||++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 789998874 346999999999999999999999777 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 912 (1010)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........+.........+.
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 234578999999999876 5689999999999999999999999965332221111111110000000
Q ss_pred cccc-------cCCCCCCCCH--------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKI-------LDPRLPSVPL--------HEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~-------~~~~~~~~~~--------~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..++ ....++..+. .....+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0001111111 112246789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=318.04 Aligned_cols=252 Identities=29% Similarity=0.405 Sum_probs=187.2
Q ss_pred eEeecCcEEEEEEEecC---CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 691 IIGKGGAGIVYKGLMPN---GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
.||+|+||+||+|...+ ...+|+|.+.... .......+.+|++.++.++||||+++++++...+..|+||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 3467888765322 2223445788999999999999999999999999999999999999
Q ss_pred CHHhhhccCCC---CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 768 SLGEVLHGKKG---GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 768 ~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
+|.+++...+. ...++..+..++.||+.|++|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865332 33567788999999999999999776 9999999999999999999999999987543322211
Q ss_pred eeeeecccccccChhhhcc-------CCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 845 CMSAIAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
......+++.|+|||+... ..++.++|||||||++|||++ |..||....+.......+. +...+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-------~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR-------EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh-------ccCccC
Confidence 1223346778999998753 356789999999999999999 7888865432211111111 111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
..+ ..+......+.+++..|| .||++||+++||++.+
T Consensus 231 ~~~---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 231 PKP---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCC---cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111 122233445667888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=317.17 Aligned_cols=257 Identities=28% Similarity=0.504 Sum_probs=202.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCC---EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGD---QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
+.|+..+.||+|+||.||+|..+ ++. .||+|.++.... ....+.+..|++++++++|||++++.+++...+..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 45667789999999999999864 333 699998864322 2234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++++|.+++... .+.+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999998643 357899999999999999999999776 99999999999999999999999999986643
Q ss_pred CCCcce-eeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 840 SGTSEC-MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 840 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
...... ......++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~~~--------- 226 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAINDG--------- 226 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhcC---------
Confidence 222111 111223457999999998899999999999999999997 9999965322 1222222111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
...+.+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223345678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=320.82 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=205.0
Q ss_pred eeeccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC
Q 001816 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 677 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 755 (1010)
++..+...+|+..+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+|+.+++.++|||++++++.+..+.
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 34456667889999999999999999985 46889999998653322 2455888999999999999999999999999
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
..|+||||+++++|.+++.. ..+++.++..++.|++.|++|||..+ |+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence 99999999999999999853 35789999999999999999999776 9999999999999999999999999987
Q ss_pred cccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccc
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ +... ....
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~~~~-~~~~------ 232 (296)
T cd06654 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---LYLI-ATNG------ 232 (296)
T ss_pred hccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---HHHH-hcCC------
Confidence 653321 112334688999999999988899999999999999999999999965322111 1111 0000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.. ..+......+.+++.+||+.+|++||++.|++++
T Consensus 233 --~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 --TPEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCCC-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000 1122333567789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=317.79 Aligned_cols=257 Identities=27% Similarity=0.497 Sum_probs=200.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CC---CEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NG---DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
..|++.+.||+|+||.||+|... +| ..||||.++... .......|..|+.++++++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 34667889999999999999854 33 369999986532 22234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++++|.+++... .+.+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 83 ITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999998643 356899999999999999999999777 99999999999999999999999999976543
Q ss_pred CCCcceeee-ec--ccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccc
Q 001816 840 SGTSECMSA-IA--GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 840 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
......... .. .+..|+|||++.+..++.++|||||||++||+++ |..||..... .+...++. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~~~~~i~---~~------- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIE---QD------- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HHHHHHHH---cC-------
Confidence 222111111 11 2457999999999999999999999999999886 9999965321 12222211 00
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
. .. ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 228 -~--~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -Y--RL-PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -C--cC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01 11122345677899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.79 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=199.4
Q ss_pred cccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH---- 754 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~---- 754 (1010)
+..+.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 44567888899999999999999854 58899999986432 2234578899999998 699999999998653
Q ss_pred --CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecc
Q 001816 755 --ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832 (1010)
Q Consensus 755 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFG 832 (1010)
...|+||||+++++|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 35789999999999999997655567899999999999999999999776 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhh
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD 907 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 907 (1010)
++....... .......|++.|+|||++. +..++.++||||+||++|||++|+.||........ ... ...
T Consensus 157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---~~~-~~~ 230 (272)
T cd06637 157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFL-IPR 230 (272)
T ss_pred Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---HHH-Hhc
Confidence 998653321 2233456899999999986 34688899999999999999999999965322111 110 000
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 908 SKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.. .+.. .+...+..+.+++.+||+.+|.+|||+.|++++
T Consensus 231 ---~~-----~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 ---NP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---CC-----CCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0001 111233467889999999999999999999764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=320.37 Aligned_cols=266 Identities=29% Similarity=0.412 Sum_probs=199.7
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-----cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec--CCc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-----PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN--HET 756 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 756 (1010)
++|++.+.||+|+||.||++.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4677888999999999999974 357899999986432 2224568899999999999999999998754 346
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 78999999999999998643 346899999999999999999999777 99999999999999999999999999987
Q ss_pred ccCCCCccee-eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc-----
Q 001816 837 LQDSGTSECM-SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK----- 910 (1010)
Q Consensus 837 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----- 910 (1010)
.......... ....++..|+|||+..+..++.++|||||||++|||++|..|+..... . +.+.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~ 232 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--E---FMRMMGNDKQGQMIV 232 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--h---hhhhcccccccccch
Confidence 6443221111 112244569999999988999999999999999999998877643211 1 1111000000
Q ss_pred ccccccc-CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 911 EGVLKIL-DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 911 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
....+.+ +......+...+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000 0111112223345688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=333.51 Aligned_cols=261 Identities=21% Similarity=0.244 Sum_probs=196.1
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
...|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|||||++++++..++..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 346888899999999999999964 47889999532 223678999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|++ .++|.+++... ...+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 240 e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 240 PKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred Ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 999 57888888532 346999999999999999999999777 9999999999999999999999999998654332
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCC-------ccHHHHHHHHhhhcccc--
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG-------VDIVQWVRKMTDSKKEG-- 912 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~-------~~~~~~~~~~~~~~~~~-- 912 (1010)
.........||+.|+|||++.+..++.++|||||||++|||++|..|+...... ..+.+.++.......+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 222223457999999999999999999999999999999999988765322111 11222222211000000
Q ss_pred ---------cccc-cCCCCCCCCH-------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 ---------VLKI-LDPRLPSVPL-------HEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ---------~~~~-~~~~~~~~~~-------~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.... .....+.... .....+.+++.+|++.||.+|||+.|++++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 0000000000 112256789999999999999999999876
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=353.04 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=214.2
Q ss_pred eccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
...+.-+|.....||.|.||.||-|. ..+|+..|+|.++.............+|..++..++|||+|+++|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 44555677778899999999999999 56799999999976555555566788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
+|.||||++|+|.+.+. .++-.++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|+.+
T Consensus 1310 ~IFMEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999999994 4445677777788999999999999888 999999999999999999999999999887
Q ss_pred cCCCC--cceeeeecccccccChhhhccCC---CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc
Q 001816 838 QDSGT--SECMSAIAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912 (1010)
Q Consensus 838 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 912 (1010)
..... ........||+.|||||++.+.. ...++||||+|||+.||+||+.||..++.+-.+...+..
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-------- 1456 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-------- 1456 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--------
Confidence 65421 11223568999999999998643 567899999999999999999999887655433322211
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...|.+|......-.+++..|+..||+.|.++.|++++
T Consensus 1457 ------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 ------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 23345555667778889999999999999998888775
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.70 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=197.0
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|+..++||+|+||.||+|.. .+++.||+|++..... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 567778999999999999984 5688999999864322 22334588899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|..+. .+++..+..++.|++.|++|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997653 4678889999999999999999777 999999999999999999999999999765332
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccH---HHHHHHHhhhcccccccccCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDI---VQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ..+....... ..+.
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 219 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------DPPV 219 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------CCCC
Confidence 123457899999999999989999999999999999999999999653322211 1111111100 0111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+ .......+.+++.+|++.+|++||+++|++++
T Consensus 220 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11 11223467789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=312.11 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=198.0
Q ss_pred CeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
++||+|+||.||+|...+++.||+|.+...... .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999999767999999988654332 2345688999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeee
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
.+++... ...+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||.+...............
T Consensus 80 ~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9998643 346788999999999999999999777 999999999999999999999999999765422111111122
Q ss_pred cccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHH
Q 001816 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHE 928 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1010)
.++..|+|||.+.+..++.++||||||+++|||++ |..||...... .... ..... .....+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~---~~~~~-----------~~~~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRE---RIESG-----------YRMPAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHH---HHhcC-----------CCCCCCccC
Confidence 34567999999998899999999999999999999 88888654321 1111 11100 001112233
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 929 VMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 929 ~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
+..+.+++.+|+..+|++||++.|+++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 457888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.01 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=202.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
++|+..+.||+|+||.||+|..+ +|+.||+|++..........+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788889999999999999965 58999999986543333334557899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|++++++..+.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999998888774 3346899999999999999999999776 99999999999999999999999999987644321
Q ss_pred cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc---------cc
Q 001816 843 SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK---------EG 912 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------~~ 912 (1010)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....+................ ..
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1223457889999999876 55789999999999999999999999764433222222211111000 00
Q ss_pred cccccCCCCCCC-C-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKILDPRLPSV-P-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~~~~~~~-~-----~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
......+..... + ......+.+++.+|++.+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000110000 0 1123467789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.18 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=203.7
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCC----EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
.+|+..+.||+|+||.||+|.++ +|+ .||+|.++.... ......+.+|+.++++++||||+++++++.. +..+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 45777889999999999999854 343 589998764332 2234568889999999999999999999987 7889
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+++|+|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++...
T Consensus 85 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999999643 345899999999999999999999766 9999999999999999999999999998765
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
............++..|+|||......++.++||||||+++||+++ |+.||.... ..+ +...+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~---~~~~~~~~--------- 227 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVE---IPDLLEKG--------- 227 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-HHH---HHHHHhCC---------
Confidence 3322222222234678999999988899999999999999999998 999996532 112 22211111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (1010)
.....+......+.+++.+||..+|.+||++.++++.+.++.+.
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 228 --ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111222345678899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.71 Aligned_cols=250 Identities=25% Similarity=0.475 Sum_probs=200.2
Q ss_pred cCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
.|+..+.||+|+||.||+|.+.+++.+|+|.++.... ....+.+|++++++++||+++++++++......++||||+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4666788999999999999987788999998864322 2346889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
++++|.+++... .+.++++.+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+........ .
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 156 (256)
T cd05112 82 EHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T 156 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence 999999998643 346889999999999999999999777 99999999999999999999999999976533211 1
Q ss_pred eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......++.+|+|||+..+..++.++||||||+++|||++ |+.||..... .......... . ....
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~----~-~~~~----- 222 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVETINAG----F-RLYK----- 222 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHhCC----C-CCCC-----
Confidence 1122335678999999998899999999999999999998 9999864321 1122221110 0 1111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
+...+..+.+++.+||+.+|++||++.|+++.|
T Consensus 223 -~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 -PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111235688899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.91 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=192.8
Q ss_pred CeEeecCcEEEEEEEecC-CC--EEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecC
Q 001816 690 NIIGKGGAGIVYKGLMPN-GD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
++||+|+||.||+|..++ |. .+|+|.++... .......+.+|+++++++ +||||+++++++...+..|+||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999643 44 46888876422 122334688899999999 79999999999999999999999999
Q ss_pred CCCHHhhhccCC--------------CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeec
Q 001816 766 NGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 766 ~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
+|+|.+++.... ...+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999986432 134788999999999999999999776 999999999999999999999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcc
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 910 (1010)
|++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||..... ......+...
T Consensus 157 gl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~~~~~-- 227 (270)
T cd05047 157 GLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKLPQG-- 227 (270)
T ss_pred CCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HHHHHHHhCC--
Confidence 998632211 11111234567999999998899999999999999999997 9999964321 1112221111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.....+......+.+++.+|++.+|.+||++.|+++.|.++
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00111122334678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.68 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=203.1
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|+||.||++.. .+++.||||++............+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467788999999999999985 4688999999876544444456788999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC-CceEEeeccccccccCCCC
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DFGla~~~~~~~~ 842 (1010)
+++++|.+++.......+++..+..++.|++.|++|||+.+ |+||||||+||+++.+ +.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999997655566899999999999999999999776 9999999999999865 468999999998764322
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
......|+..|+|||...+..++.++||||||+++|+|++|+.||...... ........ ....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~~-----------~~~~ 219 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKIMS-----------GTFA 219 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHHHh-----------cCCC
Confidence 122356889999999999888999999999999999999999999653221 11111111 1111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+......+.+++.+||+.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1222234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=316.49 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=197.1
Q ss_pred CeEeecCcEEEEEEEecC-------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 690 NIIGKGGAGIVYKGLMPN-------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.||+|+||.||+|...+ +..||||.+..... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998642 25799998754321 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCC-----CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-----ceEEeecc
Q 001816 763 YMPNGSLGEVLHGKK-----GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-----EAHVADFG 832 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-----~~kl~DFG 832 (1010)
|+++++|.+++.... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999986432 234788999999999999999999766 99999999999999877 89999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....+ . +....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-~---~~~~~~~~---- 228 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-Q---EVLQHVTA---- 228 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-H---HHHHHHhc----
Confidence 9976543322222223356789999999999999999999999999999998 9999864321 1 11111111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 912 GVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
......+...+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 229 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 -------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01111223344577899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.21 Aligned_cols=266 Identities=26% Similarity=0.370 Sum_probs=202.1
Q ss_pred ccccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhc--cCCcccceeeeeEecC----C
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGR--IRHRHIVRLLGFCSNH----E 755 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~----~ 755 (1010)
+.......+.||+|.||+||+|.| .|+.||||+|... .++.+.+|.++++. ++|+||..|++.-..+ .
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 345566778999999999999999 7899999999642 23446677777764 5999999999875443 2
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-----cCCCceEeecCCCCcEEEcCCCceEEee
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-----DCSPLIVHRDVKSNNILLDSGFEAHVAD 830 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~i~HrDlkp~Nill~~~~~~kl~D 830 (1010)
..|+|++|.+.|+|+|||.+ ..++.+..++++..+|.||++||. +|.+.|.|||||+.||||..++.+.|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 56999999999999999954 568999999999999999999994 4678899999999999999999999999
Q ss_pred ccccccccCCCCc--ceeeeecccccccChhhhccCC------CCccCceehhhHHHHHHHhC----------CCCCCCC
Q 001816 831 FGLAKFLQDSGTS--ECMSAIAGSYGYIAPEYAYTLK------VDEKSDVYSFGVVLLELITG----------RKPVGEF 892 (1010)
Q Consensus 831 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg----------~~P~~~~ 892 (1010)
+|+|......... ......+||.+|||||++...- .-..+||||||.|+||+..+ +.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999876544221 1224568999999999986432 12468999999999999862 5677665
Q ss_pred CCCccHHHHHHHHhhhcccccccccCCCCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 893 GDGVDIVQWVRKMTDSKKEGVLKILDPRLPS--VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
.+.+...+-++++.- .+.+.|..|. ...+....+.++++.||..+|..|-|+-.+.+.+.++..
T Consensus 440 Vp~DPs~eeMrkVVC------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVC------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhccee------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 444332222222211 0111222222 134556678899999999999999999999888877653
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.12 Aligned_cols=242 Identities=26% Similarity=0.246 Sum_probs=185.6
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhcc---CCcccceeeeeEecCCccEEEEEecCC
Q 001816 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRI---RHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
||+|+||+||+|+.. +|+.||||++..... .......+..|..++... +||||+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999854 689999999854221 111223345566666655 699999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.+++. +.+.+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 99999885 3467899999999999999999999777 9999999999999999999999999997532221 223
Q ss_pred eeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCC
Q 001816 847 SAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (1010)
....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+..+.+... +..++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~----~~~~~~~i~~~---------~~~~~~-- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED----TQQMYRNIAFG---------KVRFPK-- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC----HHHHHHHHHcC---------CCCCCC--
Confidence 345799999999998764 48999999999999999999999996422 11222222111 011111
Q ss_pred HHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 001816 926 LHEVMHVFYVAMLCVEEQAVERP----TMREVVQ 955 (1010)
Q Consensus 926 ~~~~~~~~~li~~cl~~~P~~RP----s~~ev~~ 955 (1010)
......+.+++.+|++.+|++|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11233567899999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.51 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=199.4
Q ss_pred CCcCCeEeecCcEEEEEEEec----CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC------
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP----NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE------ 755 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 755 (1010)
|++.++||+|+||.||+|.+. +|+.||||+++.........+.+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 4678999999765444444556889999999999999999999886532
Q ss_pred ccEEEEEecCCCCHHhhhccC----CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeec
Q 001816 756 TNLLVYEYMPNGSLGEVLHGK----KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
..++++||+++|+|.+++... ....+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 237899999999999887432 1235788899999999999999999776 999999999999999999999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcc
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 910 (1010)
|+++...............+++.|++||...+..++.++||||||+++|||++ |+.||..... .+...++. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~---~~-- 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLI---KG-- 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHH---cC--
Confidence 99986543222222223346678999999998899999999999999999999 8888864321 11111111 10
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.....+...+..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 232 ---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 ---------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111123345788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=318.24 Aligned_cols=255 Identities=28% Similarity=0.374 Sum_probs=203.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|++.+.||+|+||+||+|... +|..||+|++..... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46777889999999999999954 588999998864322 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|+++++|.+++.. .+.+++..+..++.+++.|+.|||+ .+ ++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 84 FMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred cCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999999853 4568999999999999999999996 35 9999999999999999999999999986543221
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCcc-------HHHHHHHHhhhcccccc
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD-------IVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 914 (1010)
.....|+..|+|||++.+..++.++|||||||++||+++|+.||.......+ ...+.....
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 226 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-------- 226 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh--------
Confidence 1235689999999999888999999999999999999999999975433211 111121111
Q ss_pred cccCCCCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 915 KILDPRLPSVPL-HEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 915 ~~~~~~~~~~~~-~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
....+..+. ..+..+.+++.+|++.+|++||++.|++++..-
T Consensus 227 ---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 227 ---QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred ---hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 111111111 134567889999999999999999999886433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.89 Aligned_cols=257 Identities=27% Similarity=0.431 Sum_probs=205.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|++.+.||.|+||+||+|.. .++..||+|++....... ....+.+|+++++.++|+|++++++.+..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4678889999999999999995 468899999986533322 45668899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCC-CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 763 YMPNGSLGEVLHGKKG-GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|+++++|.++++.... ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999965432 56899999999999999999999776 9999999999999999999999999998765433
Q ss_pred Ccc--eeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 842 TSE--CMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 842 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
... ......|+..|+|||++... .++.++|+|||||++|||++|+.||............... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~------------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN------------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC------------CC
Confidence 221 22344689999999998877 7899999999999999999999999754332221111111 01
Q ss_pred CCCCCCC--HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVP--LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~--~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+..+... ...+..+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111 1234567889999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=318.65 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=201.3
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|+..+.||+|+||.||+|+.. +|+.||||+++...........+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 677889999999999999854 6899999998754444444456889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
. ++|.+++.......+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.+||+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 155 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--R 155 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--c
Confidence 5 68999887656677899999999999999999999776 9999999999999999999999999987653321 1
Q ss_pred eeeeecccccccChhhhccCC-CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc-------------
Q 001816 845 CMSAIAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK------------- 910 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------- 910 (1010)
......+++.|+|||+..+.. ++.++||||||+++|||+||+.||....+.....+..+.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 122335788999999887654 688999999999999999999999754333333332222111100
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+..................+.+++.+|++.||++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000001112346789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.55 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=201.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|++.+.||+|+||.||++... +|..||+|.++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 35778889999999999999854 688899998864322 2223457889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|+++++|.+++.. .+.+++..+..++.|+++||.|||+ .+ ++||||||+||+++.++.+||+|||++......
T Consensus 80 y~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 80 HMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred ccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999953 3568999999999999999999996 35 999999999999999999999999998755322
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc-----------
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK----------- 910 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 910 (1010)
......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ......+.........
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCC
Confidence 1234568999999999988889999999999999999999999986432 1111111110000000
Q ss_pred -----------cccccccCCCCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 911 -----------EGVLKILDPRLPSVPL-HEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 911 -----------~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
+..........+..+. .....+.+++.+|++.+|++||++.|++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000011111111 1234578999999999999999999998863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=318.65 Aligned_cols=261 Identities=29% Similarity=0.424 Sum_probs=203.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-----CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec--CCc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-----NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN--HET 756 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 756 (1010)
+.|+..+.||+|+||.||+|.+. ++..||||+++..... .....+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45667789999999999999853 3678999998754332 235568999999999999999999999877 557
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 899999999999999996432 36899999999999999999999777 99999999999999999999999999987
Q ss_pred ccCCCCcc-eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc-----------cHHHHHHH
Q 001816 837 LQDSGTSE-CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV-----------DIVQWVRK 904 (1010)
Q Consensus 837 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~-----------~~~~~~~~ 904 (1010)
........ ......++..|+|||...+..++.++||||||+++|||++|+.|+....... ....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322211 1112345567999999998899999999999999999999999985422111 01111111
Q ss_pred HhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
+.. ......+...+.++.+++.+|++.+|++||++.|++++|+.+
T Consensus 239 ~~~-----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKE-----------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHc-----------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 110 001111223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.11 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=199.1
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|+..+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.+++.++||||+++++++..++..|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35677888999999999999985 4688999999865322 22345778999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++++|.+++. ..+.+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06645 86 EFCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT- 159 (267)
T ss_pred eccCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-
Confidence 9999999999985 3457899999999999999999999777 999999999999999999999999998765432
Q ss_pred CcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 842 TSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
........|++.|+|||++. ...++.++||||+||++|||++|+.||............ ... ...
T Consensus 160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~~~-------~~~ 227 (267)
T cd06645 160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----TKS-------NFQ 227 (267)
T ss_pred -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----hcc-------CCC
Confidence 12223457899999999875 456889999999999999999999998643321111110 000 000
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+.........+..+.+++.+|++.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 10000011123457789999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.08 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=198.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++|||++++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4577888999999999999975 67889999986422 234688999999999999999999998764 57999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.......+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 99999999997655556899999999999999999999776 9999999999999999999999999997543211
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||..... .......... . .+
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~----~-------~~ 216 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEVKECVEKG----Y-------RM 216 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHHHHHHhCC----C-------CC
Confidence 12234578999999998899999999999999999998 9999865321 1111111110 0 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
..+...+..+.+++.+||+.+|++||+++++++.+++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122334567889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.81 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=198.9
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999964 689999999976444444455678899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
++ ++|.+++... .+.+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 96 5888877532 356899999999999999999999777 9999999999999999999999999998653321
Q ss_pred ceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc----ccccccC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE----GVLKILD 918 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 918 (1010)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.|+....+.......+.+......+ ......+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 122334578999999998765 47899999999999999999999865433322222221111100000 0000000
Q ss_pred -CCCCC---------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 -PRLPS---------VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 -~~~~~---------~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+. ........+.+++.+|++.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 011123466789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.27 Aligned_cols=369 Identities=26% Similarity=0.397 Sum_probs=216.4
Q ss_pred cEEEEEcCCCCcc-cccCcccCCCCCCCEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceecc
Q 001816 63 HVTSLDLSGLNLS-GALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDL 141 (1010)
Q Consensus 63 ~v~~L~l~~~~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 141 (1010)
-|+.+|+++|.++ +..|.++..++.++.|.|...++. .+|+.++.|.+|++|.+++|++. .+...++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3555556665555 234444445555555555544444 44555555555555555555544 34444444455555555
Q ss_pred cCcccCC-CCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCC
Q 001816 142 YNNNMTG-DLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYT 220 (1010)
Q Consensus 142 s~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~ 220 (1010)
.+|++.. -+|..+..|..|..||||+|+++ ..|..+..-+++-.|+||+|+|. .+|..
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~------------------- 144 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNS------------------- 144 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCch-------------------
Confidence 5554432 23444444445555555555544 44444444444444444444444 22211
Q ss_pred CCCCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCcccc
Q 001816 221 GGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFA 300 (1010)
Q Consensus 221 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 300 (1010)
-+-+++.|-+||||+|++. .+|..+.++..|++|.|++|.+....-.. +.
T Consensus 145 -----lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQ------------------------LP 194 (1255)
T KOG0444|consen 145 -----LFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQ------------------------LP 194 (1255)
T ss_pred -----HHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhc------------------------Cc
Confidence 1122334444555555554 34444445555555555555444332233 33
Q ss_pred ccCCCCEEecCCcccc-CCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCcchh
Q 001816 301 ELKNLTLLNLFRNKLH-GAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQT 379 (1010)
Q Consensus 301 ~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 379 (1010)
.+++|+.|.+++.+-+ ..+|..+..+.+|..+|++.|.+. .+|+.+-.+.+|+.|+||+|+|+.
T Consensus 195 smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-------------- 259 (1255)
T KOG0444|consen 195 SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-------------- 259 (1255)
T ss_pred cchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee--------------
Confidence 3444444555444322 134555555566666666666665 556666666666666666666652
Q ss_pred hhccccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccccceEeccCccc
Q 001816 380 LITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQL 459 (1010)
Q Consensus 380 L~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l 459 (1010)
+.-+.+.+.+|++|+|++|+++ .+|.+++.+++|+.|++.+|+++ |
T Consensus 260 -----------L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~----------------------F 305 (1255)
T KOG0444|consen 260 -----------LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT----------------------F 305 (1255)
T ss_pred -----------eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc----------------------c
Confidence 1223444556666677777776 67888888888888888888775 2
Q ss_pred cCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccc
Q 001816 460 SGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIP 536 (1010)
Q Consensus 460 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 536 (1010)
. -+|..+|++.+|+.+.+++|++. .+|+.++.+.+|+.|.|++|++. .+|.++--++.|+.|||..|.---.+|
T Consensus 306 e-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 306 E-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred c-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 2 57888999999999999999998 88999999999999999999998 789999999999999999987552444
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.16 Aligned_cols=252 Identities=28% Similarity=0.450 Sum_probs=195.0
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC---CcccchHHHHHHHhccCCcccceeeeeEecC--CccE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS---SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETNL 758 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 758 (1010)
.|+..+.||+|+||.||+|.. .+|..||+|++....... .....+.+|+.++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 577889999999999999985 468899999986543221 1234578899999999999999999988653 5678
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
++|||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 83 l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 99999999999999853 346889999999999999999999766 9999999999999999999999999997653
Q ss_pred CCCC-cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGT-SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
.... ........++..|+|||++.+..++.++||||+||++|||++|+.||....... .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~~~~~~---------- 223 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AIFKIAT---------- 223 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HHHHHhc----------
Confidence 2111 111223458899999999999889999999999999999999999997542211 1111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+..+..+......+..++ .||..+|++||+++|++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 224 QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111222333334455566 6888999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.70 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=197.5
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++.++|||++++++++..++..|+||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3567788999999999999964 47788999885422 22345588899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 84 ~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~ 157 (282)
T cd06643 84 CAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 157 (282)
T ss_pred cCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--c
Confidence 999999988753 2356899999999999999999999776 999999999999999999999999999764322 1
Q ss_pred ceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 844 ECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.......|++.|+|||++. +..++.++|||||||++|||++|+.||........ ........ .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~~--------~ 225 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV----LLKIAKSE--------P 225 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH----HHHHhhcC--------C
Confidence 2223456899999999874 45578899999999999999999999865332111 11111110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+.. ..+...+..+.+++.+||+.+|.+||++.+++++
T Consensus 226 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 PTL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 1122334567899999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.37 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=202.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+..+.||+|+||.||+|...+ ++.||+|.++.... ...+.+|++++++++||||+++++++..++..|++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 568888999999999999999764 78999999864322 4568999999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++.. ....+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 79 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 79 YCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred cCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999999853 2357899999999999999999999777 99999999999999999999999999987643321
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........... ... . .....
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~----~~~--------~-~~~~~ 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM----IPN--------K-PPPTL 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh----hcc--------C-CCCCC
Confidence 22334588999999999999999999999999999999999999975322111100 000 0 00011
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+......+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1122334567889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=319.63 Aligned_cols=196 Identities=21% Similarity=0.348 Sum_probs=159.5
Q ss_pred CCeEeecCcEEEEEEEec---CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec--CCccEEEEEe
Q 001816 689 DNIIGKGGAGIVYKGLMP---NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN--HETNLLVYEY 763 (1010)
Q Consensus 689 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~ 763 (1010)
.++||+|+||+||+|..+ +++.||+|.++... ....+.+|++++++++||||+++++++.. +...|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 357999999999999854 46789999986432 23347889999999999999999998854 4567899999
Q ss_pred cCCCCHHhhhccC-------CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE----cCCCceEEeecc
Q 001816 764 MPNGSLGEVLHGK-------KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL----DSGFEAHVADFG 832 (1010)
Q Consensus 764 ~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill----~~~~~~kl~DFG 832 (1010)
+. ++|.+++... +...+++..+..++.|++.||+|||+.+ |+||||||+||++ +..+.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 84 6888776421 2235889999999999999999999777 9999999999999 456789999999
Q ss_pred ccccccCCCC-cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCC
Q 001816 833 LAKFLQDSGT-SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEF 892 (1010)
Q Consensus 833 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~ 892 (1010)
+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9987643221 122334678999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=311.05 Aligned_cols=257 Identities=29% Similarity=0.455 Sum_probs=198.5
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCc--------ccchHHHHHHHhccCCcccceeeeeEecCC
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSH--------DHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 755 (1010)
+|...+.||+|+||.||+|.. .+|+.||+|.++........ .+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366778999999999999985 46899999988643221111 234778999999999999999999999999
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
..++||||+++++|.+++... +.+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++++|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999543 57899999999999999999999776 9999999999999999999999999997
Q ss_pred cccCCCCcceeeeecccccccChhhhccCC--CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccc
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
...............|+..|+|||...... ++.++||||||+++||+++|..||..... .... ...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~-~~~~~~---~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAM-FKLGNK---RS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHH-HHhhcc---cc
Confidence 654322222233456889999999987654 88999999999999999999999854221 1111 111100 00
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 LKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+.. ......+..+.+++.+|++.+|++||++++++++
T Consensus 230 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000111 1111234567789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.77 Aligned_cols=260 Identities=30% Similarity=0.486 Sum_probs=200.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCC----EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
+.|+..+.||+|+||.||+|.+. +|+ .||+|.+..... ......+.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 45677789999999999999853 454 478888754322 22233578899999999999999999998754 567
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999998643 346889999999999999999999776 9999999999999999999999999998764
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
............++..|+|||++.+..++.++||||||+++|||++ |+.||.... ......++. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~~~---~~--------- 227 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDLLE---KG--------- 227 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH---CC---------
Confidence 3322222223346779999999999999999999999999999997 899986532 111111111 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCCC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~~ 964 (1010)
... ..+......+..++.+||..+|++||+++++++.++++...+
T Consensus 228 -~~~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 228 -ERL-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -CCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 001 111223356788999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.33 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=186.7
Q ss_pred eEeecCcEEEEEEEecCCC---EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 691 IIGKGGAGIVYKGLMPNGD---QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~~~g~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
.||+|+||.||+|...++. .+++|.++.... ......+.+|+.+++.++||||+++++++......|+||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5899999999999854433 456666543222 223456889999999999999999999999999999999999999
Q ss_pred CHHhhhccCC--CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce
Q 001816 768 SLGEVLHGKK--GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 768 ~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
+|.++++... ....++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999996432 234566778899999999999999776 99999999999999999999999999864322111112
Q ss_pred eeeecccccccChhhhcc-------CCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 846 MSAIAGSYGYIAPEYAYT-------LKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
.....|+..|+|||+... ..++.++|||||||++|||++ |..||....+.. ....... +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~---~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE----VLNHVIK---DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHh---hcccccC
Confidence 234568899999998753 345789999999999999997 567875433211 1121111 1111222
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
++..+. .....+.+++..|| .+|++||+++|+++.|.
T Consensus 231 ~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 332221 23345677888999 67999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=317.60 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=200.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+..+.||+|+||.||+|... +|+.||+|.++.... ......+.+|++++++++||||+++++++..+...|+|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 45666778999999999999854 578899998864332 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++++|||++.......
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 9999999998843 46899999999999999999999776 9999999999999999999999999997654322
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ... ... ....+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~---~~~-----------~~~~~ 219 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VLF---LIP-----------KNSPP 219 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HHh---hhh-----------cCCCC
Confidence 12223468899999999999899999999999999999999999986432211 111 110 01111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+...+..+.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2222344567889999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.34 Aligned_cols=252 Identities=29% Similarity=0.415 Sum_probs=191.3
Q ss_pred CeEeecCcEEEEEEEec----CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEe-cCCccEEEEEec
Q 001816 690 NIIGKGGAGIVYKGLMP----NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCS-NHETNLLVYEYM 764 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~ 764 (1010)
+.||+|+||.||+|.+. ++..||+|++.... .......+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999853 23479999875322 1222446788999999999999999999775 455689999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc-
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS- 843 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~- 843 (1010)
++|+|.+++... ....++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 80 KHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999998643 344677888899999999999999776 999999999999999999999999999765332211
Q ss_pred -ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhC-CCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 844 -ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG-RKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 844 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.......+++.|+|||.+.+..++.++|||||||++|||++| .+||... +. ......+... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~---~~~~~~~~~~-----------~~ 220 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DS---FDITVYLLQG-----------RR 220 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CH---HHHHHHHhcC-----------CC
Confidence 111233467789999999988999999999999999999995 5566432 11 1122221111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
+..+...+..+.+++.+||+.+|++||++.|+++.++++.
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1112223346788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=315.95 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=199.4
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC---CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG---SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
+|+..+.||+|+||.||+|... +|+.||||+++..... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667788999999999999954 6899999999754433 22234467899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||..+ |+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999996432 47999999999999999999999777 999999999999999999999999999876443
Q ss_pred CCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc------c
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG------V 913 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------~ 913 (1010)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....+.................. .
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 21 2223456889999998865 4678999999999999999999888765333222111111110000000 0
Q ss_pred ccccC-CCCCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 LKILD-PRLPS-----VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..... ...+. ........+.+++.+|++.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 00001 112224567889999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=318.19 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=198.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 56888899999999999999854 6889999998653322 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|++ ++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 85 YLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 996 6898888643 346889999999999999999999776 9999999999999999999999999997543221
Q ss_pred cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc-ccccccc---
Q 001816 843 SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK-EGVLKIL--- 917 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--- 917 (1010)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+........ .......
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhccc
Confidence 12223457899999998875 4578899999999999999999999975322 111111111111000 0000000
Q ss_pred ---CCCCCC--------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 ---DPRLPS--------VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ---~~~~~~--------~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+. ........+.+++.+|++.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000111 011123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.88 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=201.2
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC---CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG---SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
+|+..+.||+|+||.||+|... +++.||+|.+...... .+..+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999965 7899999998653322 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++++|.+++.. ...+++..+..++.|++.|++|||+.+ |+||||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999953 346889999999999999999999777 999999999999999999999999999765432
Q ss_pred CCcceeeeecccccccChhhhccCC-CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
. ......|++.|+|||.+.... ++.++|+||||+++|+|++|+.||...... ......... .
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~----------~ 218 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----AAVFKIGRS----------K 218 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----HHHHHHHhc----------c
Confidence 2 233456899999999987766 899999999999999999999999754311 111111110 1
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+..+......+.+++.+||+.+|++||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1122222334567789999999999999999999763
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.10 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=204.4
Q ss_pred eccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
..+..++|+..+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 455668899999999999999999995 5799999999864332 2245578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
|+||||+++++|.+++.+ ..+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 999999999999999853 35788999999999999999999776 999999999999999999999999999765
Q ss_pred cCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
..... ......|++.|+|||...+..++.++|||||||++|++++|+.||........... .. ..
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~--------~~- 230 (297)
T cd06656 166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IA--------TN- 230 (297)
T ss_pred cCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----ec--------cC-
Confidence 43221 12345688999999999998899999999999999999999999965322111000 00 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.......+......+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 231 GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011122333457789999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=309.58 Aligned_cols=254 Identities=26% Similarity=0.323 Sum_probs=203.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+..+.||+|+||.||+|... +++.+|+|.+...... ....+.+|++++++++||||+++++++...+..|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 56778889999999999999864 5788999999754332 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 81 YCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999988643 256899999999999999999999777 9999999999999999999999999997654321
Q ss_pred cceeeeecccccccChhhhccC---CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||........... ... . .+.+
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~----~~~---~----~~~~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL----ISK---S----NFPP 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHh---c----cCCC
Confidence 122345688999999998776 889999999999999999999999965432111111 000 0 0111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.....+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111223345678899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.62 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=202.4
Q ss_pred cccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
+...+|+..+.||.|+||.||+|.. .+|+.||+|.+..... .....+.+|+.+++.++|||++++++++...+..|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 3446688888999999999999984 5789999999864322 234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++++|.+++.. ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999998853 35899999999999999999999776 99999999999999999999999999876543
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ........ +
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~----~~~~~~~~--------~ 233 (296)
T cd06655 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YLIATNGT--------P 233 (296)
T ss_pred ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCC--------c
Confidence 221 122346889999999999888999999999999999999999999653321111 11110000 0
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+......+.+++.+||..+|++||++.+++++
T Consensus 234 -~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 -ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 001122233467789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.72 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=200.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCC----CEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNG----DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
+.|...+.||+|+||.||+|.+.+. ..||||....... ....+.+.+|++++++++||||+++++++.+ +..|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3466778999999999999985432 4689998764332 2234568899999999999999999998875 56789
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||+++|+|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999999643 345899999999999999999999776 99999999999999999999999999986543
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
... .......++..|+|||.+....++.++||||||+++||+++ |..||...... +....+ ...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~---~~~---------- 224 (270)
T cd05056 160 ESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRI---ENG---------- 224 (270)
T ss_pred ccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH---HcC----------
Confidence 321 11122234568999999988889999999999999999986 99999654322 111111 110
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
.....+...+..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 225 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 -ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111122334578889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=338.51 Aligned_cols=260 Identities=17% Similarity=0.211 Sum_probs=191.0
Q ss_pred ccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCC------cccceeeeeEecC
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH------RHIVRLLGFCSNH 754 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~ 754 (1010)
..++|++.++||+|+||+||+|.. ..++.||||+++... .....+..|+++++.++| ++++++++++..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 357899999999999999999985 457889999986422 123345667777777754 4588899988764
Q ss_pred -CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCC--------
Q 001816 755 -ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGF-------- 824 (1010)
Q Consensus 755 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~-------- 824 (1010)
+..++|||++ +++|.+++.. .+.+++..+..++.||+.||+|||. .+ |+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 4678999988 7889888853 3579999999999999999999996 36 99999999999998765
Q ss_pred --------ceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc
Q 001816 825 --------EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV 896 (1010)
Q Consensus 825 --------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~ 896 (1010)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~- 351 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL- 351 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 499999998864321 223567999999999999999999999999999999999999999754332
Q ss_pred cHHHHHHHHhhhcccc---------cccccC------CCCC------------CCCHHHHHHHHHHHHhccccCCCCCCC
Q 001816 897 DIVQWVRKMTDSKKEG---------VLKILD------PRLP------------SVPLHEVMHVFYVAMLCVEEQAVERPT 949 (1010)
Q Consensus 897 ~~~~~~~~~~~~~~~~---------~~~~~~------~~~~------------~~~~~~~~~~~~li~~cl~~~P~~RPs 949 (1010)
+....+.......... ..++++ +... .........+.+++.+|++.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 2222221111000000 000000 0000 000011234678999999999999999
Q ss_pred HHHHHHH
Q 001816 950 MREVVQI 956 (1010)
Q Consensus 950 ~~ev~~~ 956 (1010)
++|++++
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999985
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.75 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=202.1
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
++|+..+.||.|+||.||+|... +|+.||+|.+..... ......+.+|++++++++|||++++++++.++...|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 35778889999999999999954 688999999865332 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 80 YCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 99999999998532 7899999999999999999999776 9999999999999999999999999998765432
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||..... . ......... ..+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-~---~~~~~~~~~--------~~~~-- 217 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-M---RVLFLIPKN--------NPPS-- 217 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-H---HHHHHhhhc--------CCCC--
Confidence 222345688999999999988899999999999999999999999965331 1 111111111 0111
Q ss_pred CCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~-~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.. ....+.+++.+|+..+|++||++++++++
T Consensus 218 -~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 -LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 34467789999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.85 Aligned_cols=239 Identities=23% Similarity=0.373 Sum_probs=185.4
Q ss_pred CeEeecCcEEEEEEEecC-------------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc
Q 001816 690 NIIGKGGAGIVYKGLMPN-------------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 756 (1010)
+.||+|+||.||+|.+.. ...||+|.+..... .....+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999998432 22588898754322 234457889999999999999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCc-------eEEe
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE-------AHVA 829 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~-------~kl~ 829 (1010)
.++||||+++|+|..++.. ....+++..++.++.||++|++|||+.+ |+||||||+||+++.++. ++++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999988863 3356899999999999999999999766 999999999999986654 8999
Q ss_pred eccccccccCCCCcceeeeecccccccChhhhc-cCCCCccCceehhhHHHHHHH-hCCCCCCCCCCCccHHHHHHHHhh
Q 001816 830 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELI-TGRKPVGEFGDGVDIVQWVRKMTD 907 (1010)
Q Consensus 830 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell-tg~~P~~~~~~~~~~~~~~~~~~~ 907 (1010)
|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.||..... .+ . .....
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~---~-~~~~~ 223 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AE---K-ERFYE 223 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-hH---H-HHHHh
Confidence 99998754321 2345788999999887 567899999999999999998 58888754211 11 0 01100
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 908 SKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
. ... ........+.+++.+||+.||++||++.++++.+
T Consensus 224 ~-----------~~~-~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 G-----------QCM-LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c-----------Ccc-CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 000 0111234577899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.79 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=196.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.+.....||+|+||.||+|.. .++..||+|.++.... ...+.+.+|++++++++|+||+++++++..++..++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34444556899999999999985 4678899998864322 23446889999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCC--ChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-CCceEEeecccccccc
Q 001816 762 EYMPNGSLGEVLHGKKGGHL--HWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DFGla~~~~ 838 (1010)
||+++++|.+++.... ..+ ++..+..++.|++.|++|||+.+ |+||||||+||+++. ++.++|+|||.+....
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999986432 334 78888899999999999999776 999999999999976 6789999999997653
Q ss_pred CCCCcceeeeecccccccChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
... .......|++.|+|||++.+. .++.++||||||+++|+|++|+.||......... .+...
T Consensus 161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-~~~~~------------ 225 (268)
T cd06624 161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-MFKVG------------ 225 (268)
T ss_pred cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-Hhhhh------------
Confidence 221 122234689999999998654 3788999999999999999999999653321111 01000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.....+..+......+..++.+||+.+|++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0011122233344567889999999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=315.67 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=199.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 66888999999999999999964 58899999986432 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|..++... ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 90 FCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 99999998887532 356899999999999999999999776 999999999999999999999999998754322
Q ss_pred cceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 843 SECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
........+++.|+|||++. ...++.++|||||||++|||++|+.||...... ......... .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~--------~ 231 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKS--------E 231 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHHHHHhcC--------C
Confidence 12223456889999999875 345788999999999999999999998653211 111111111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.. ..+......+.+++.+||+.+|++||++.|++++
T Consensus 232 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 PPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111 1122334567889999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.70 Aligned_cols=253 Identities=27% Similarity=0.365 Sum_probs=200.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+..+.||+|+||.||+|... +|..||+|.++... .......+.+|++++++++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 35778889999999999999965 78999999886432 22223568889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCC-CCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 763 YMPNGSLGEVLHGKK-GGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|+++++|..++.... ...+++..+..++.|++.|+.|||+ .+ |+||||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999886421 2468999999999999999999996 35 999999999999999999999999999765322
Q ss_pred CCcceeeeecccccccChhhhccC------CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTL------KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
......|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~---------- 221 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-ANIFAQLSA---------- 221 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-hhHHHHHHH----------
Confidence 12234588899999998654 357899999999999999999999965321 111111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+.+...+..+......+.+++.+|++.+|++||++++++..
T Consensus 222 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 -IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11222233344455678889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=308.40 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=199.8
Q ss_pred CcCCeEeecCcEEEEEEEecC-----CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 687 KEDNIIGKGGAGIVYKGLMPN-----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 687 ~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.+.||+|+||.||++...+ +..||+|+++..... .....+..|+++++.++||||+++++++.+.+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456789999999999999653 378999998643321 13556889999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++++|.+++.......+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999996544333899999999999999999999776 9999999999999999999999999998765432
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
.... ....+++.|+|||...+..++.++||||+|+++|||++ |+.||.... ........... .
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~~~~-----------~ 221 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS----NEEVLEYLKKG-----------Y 221 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHhcC-----------C
Confidence 2211 12337789999999988889999999999999999998 788886421 11222222111 1
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
....+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112222455788899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=308.53 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=197.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC---CcccchHHHHHHHhccCCcccceeeeeEecC--Ccc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS---SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 757 (1010)
..|++.+.||+|+||.||+|.. .+|+.||||.+....... .....+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4577888999999999999985 458999999886432221 1234578899999999999999999988664 457
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 899999999999999853 345788999999999999999999776 999999999999999999999999999765
Q ss_pred cCCCC-cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 838 QDSGT-SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 838 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
..... ........|+..|+|||++.+..++.++||||||+++|||++|+.||....... .. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~-~~~~---------- 222 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AI-FKIA---------- 222 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HH-HHHh----------
Confidence 32111 111233468899999999998889999999999999999999999996532111 11 1111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+..+..+......+..++.+|+. +|++||+++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1111223344455567788889985 89999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.55 Aligned_cols=258 Identities=29% Similarity=0.398 Sum_probs=199.2
Q ss_pred eccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEe----
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCS---- 752 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~---- 752 (1010)
..+..++|++.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 345678999999999999999999985 458899999875421 1234578899999999 6999999999874
Q ss_pred -cCCccEEEEEecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEe
Q 001816 753 -NHETNLLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVA 829 (1010)
Q Consensus 753 -~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~ 829 (1010)
.++..++||||+++++|.+++.. .....+++..+..++.|+++|+.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 34568999999999999998753 23456889999999999999999999776 9999999999999999999999
Q ss_pred eccccccccCCCCcceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 001816 830 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 830 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~ 904 (1010)
|||+++...... .......|++.|+|||++. +..++.++||||+||++|||++|+.||.......... .
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~----~ 240 (286)
T cd06638 167 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF----K 240 (286)
T ss_pred cCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh----h
Confidence 999998654321 1223446899999999875 3457889999999999999999999996543211111 1
Q ss_pred HhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
.... ..+.. ..+......+..++.+||+.+|++|||+.|++++.
T Consensus 241 ~~~~--------~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPRN--------PPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccc--------CCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 00000 01111234677899999999999999999998763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.59 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=203.0
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|+||.||+|..+ +|..||+|.+..........+.+.+|++++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3667789999999999999964 588999999876433334455688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-ceEEeeccccccccCCCC
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~DFGla~~~~~~~~ 842 (1010)
+++++|.+++.......+++..+..++.|++.|++|||+.+ ++||||||+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997655556899999999999999999999777 99999999999998875 46999999997654322
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+++...... ..+
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-----------~~~ 220 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKICQG-----------YFA 220 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcc-----------cCC
Confidence 12233468999999999988889999999999999999999999986432 22222221111 111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+......+.+++.+|++.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1122233467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=314.89 Aligned_cols=266 Identities=22% Similarity=0.296 Sum_probs=202.8
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|+||.||+|..+ +++.||||+++...........+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778889999999999999965 588999999876544444456789999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
++++.+..+.. +...+++.++..++.|++.|++|||+.+ ++||||+|+||++++++.+||+|||.+........
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 99877776653 3355899999999999999999999777 99999999999999999999999999987654322
Q ss_pred ceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc--------cccc
Q 001816 844 ECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK--------EGVL 914 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 914 (1010)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||..................... ....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 122345688999999999888 8899999999999999999999999754322211111110000000 0000
Q ss_pred ---cccCCCCC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 915 ---KILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ---~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+...+ ..+...+..+.+++.+||+.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 0111124668899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=322.14 Aligned_cols=190 Identities=25% Similarity=0.325 Sum_probs=162.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
..|++.+.||+|+||.||+|... +++.||+|+... .....|+.++++++||||+++++++...+..++|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 35788889999999999999964 577899997432 124579999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+ .++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 138 HY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred cc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 99 5688888753 3457899999999999999999999777 999999999999999999999999999753221
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPV 889 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~ 889 (1010)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456999999999999999999999999999999999865554
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.29 Aligned_cols=265 Identities=21% Similarity=0.268 Sum_probs=200.7
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|+..+.||+|++|.||+|... +|..||+|++............+.+|++++++++|||++++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999854 7999999998755433333456888999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
+ ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence 4 69999986554457899999999999999999999776 9999999999999999999999999997653221 1
Q ss_pred eeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc-------------
Q 001816 845 CMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK------------- 910 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------- 910 (1010)
......+++.|+|||++.+. .++.++||||||+++|||++|+.||....+........+.......
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11233568899999987654 5789999999999999999999999754332222222221110000
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+................+.+++.+|++.+|++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000001111112223467789999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.11 Aligned_cols=204 Identities=32% Similarity=0.465 Sum_probs=174.6
Q ss_pred CCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC------CccE
Q 001816 686 LKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------ETNL 758 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~ 758 (1010)
|...+.||+|+||.||+|+ ..+|+.||||.++.... ....+...+|++++++++|||||++++.-++. +...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4456789999999999999 66899999999976542 33455678899999999999999999876543 3568
Q ss_pred EEEEecCCCCHHhhhccCC-CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE--cCCCc--eEEeeccc
Q 001816 759 LVYEYMPNGSLGEVLHGKK-GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL--DSGFE--AHVADFGL 833 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill--~~~~~--~kl~DFGl 833 (1010)
+|||||.||+|..++.+.. ...+++.+.+.+..+++.||.|||+++ |+||||||.||++ .++|+ -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999997643 345999999999999999999999888 9999999999998 34444 69999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV 896 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~ 896 (1010)
|+.+++.. .....+||+.|.+||... ...|+..+|.|||||++|+++||..||.......
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 99876543 567889999999999998 4889999999999999999999999998766654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.58 Aligned_cols=265 Identities=22% Similarity=0.320 Sum_probs=200.5
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+..+.||+|+||.||+|..+ +|+.||+|++............+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777889999999999999975 58899999986544333334568889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|++++++.++... ...+++.++..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 9999999887742 345899999999999999999999776 9999999999999999999999999998654322
Q ss_pred cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc----
Q 001816 843 SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL---- 917 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 917 (1010)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||............. .......+...+..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII-KCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-HHhCCCchhhHHHhccch
Confidence 22234568899999999875 457889999999999999999999986432211111111 10000000000000
Q ss_pred ------CCCCCC------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 ------DPRLPS------VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ------~~~~~~------~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.... ........+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000 011224568889999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.33 Aligned_cols=252 Identities=31% Similarity=0.422 Sum_probs=203.7
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|+..+.||+|+||.||++..+ +++.||+|++..... ......+.+|++++++++||||+++++++..+...++||||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4677789999999999999965 688999999875432 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
+++++|.+++...+ ..+++..+..++.|++.|++|+|+ .+ ++||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999996433 678999999999999999999997 55 99999999999999999999999999876532211
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCC-ccHHHHHHHHhhhcccccccccCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG-VDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
....++..|+|||...+..++.++||||||+++|+|++|+.||...... ....+.++... ....
T Consensus 157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~ 221 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-----------NEPP 221 (265)
T ss_pred ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-----------cCCC
Confidence 1256889999999999999999999999999999999999999654221 22222222221 1112
Q ss_pred CCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 922 PSVPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 922 ~~~~~~-~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+..+.. ....+.+++.+|+..+|++|||+.+++.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 222222 44567889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=314.16 Aligned_cols=266 Identities=25% Similarity=0.316 Sum_probs=202.3
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 467788999999999999996 4689999999976544344455688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+ +++|.+++.... ..+++.+++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999986433 56899999999999999999999776 99999999999999999999999999987643321
Q ss_pred ceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc---c------cc
Q 001816 844 ECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK---E------GV 913 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~------~~ 913 (1010)
.......|+..|+|||++.+. .++.++||||+|+++|||++|++||....+................ . ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 122345689999999988654 4689999999999999999998888653322211111111100000 0 00
Q ss_pred ccccCCCCCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 LKILDPRLPS-----VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.....+.... ........+.+++.+|++.+|++||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 011223678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.86 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=200.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+.|++.+.||+|+||.||+|... ++..||+|.++... ......+.+|++++++++||||+++++++..++..|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 56888899999999999999964 68899999986432 2223458889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++... ...+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 83 FCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 99999999998642 346899999999999999999999777 999999999999999999999999998764322
Q ss_pred cceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 843 SECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
........|++.|+|||++. +..++.++||||||+++|||++|+.||...... +....+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-------- 224 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKILKSE-------- 224 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHhcCC--------
Confidence 12233456899999999875 345778999999999999999999999754221 1111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.. ..+......+.+++.+||+.+|++||++.+++++
T Consensus 225 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PPTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011 1122234467789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.33 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=202.2
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC----CcccchHHHHHHHhccCCcccceeeeeEecCCccEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS----SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 759 (1010)
.|+..+.||+|+||.||+|.. .+|+.||+|+++...... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367778999999999999984 578999999986433221 123468889999999999999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-ceEEeecccccccc
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAKFLQ 838 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~DFGla~~~~ 838 (1010)
||||+++++|.+++.+ .+.+++..+..++.|++.|++|||+.+ ++||||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 9999999999999853 356889999999999999999999776 99999999999998776 59999999998765
Q ss_pred CCCCc--ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 839 DSGTS--ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 839 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
..... .......|+..|+|||...+..++.++||||+|+++|+|++|+.||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-------- 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-NHLALIFKIASA-------- 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-chHHHHHHHhcc--------
Confidence 43211 1122346889999999999888999999999999999999999999643221 111111111100
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+..+......+.+++.+|++.+|++||++.|++++
T Consensus 227 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 --TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11123334455678889999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.25 Aligned_cols=238 Identities=25% Similarity=0.433 Sum_probs=188.0
Q ss_pred CeEeecCcEEEEEEEecCCC-----------EEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 690 NIIGKGGAGIVYKGLMPNGD-----------QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
+.||+|+||.||+|...+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36899999999999975433 4778876543221 5668899999999999999999999988 7789
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-------ceEEeec
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-------EAHVADF 831 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-------~~kl~DF 831 (1010)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999996432 36899999999999999999999766 99999999999999887 7999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhccC--CCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhh
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
|++..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||.... ......+.. ..
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~---~~ 222 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQ---DQ 222 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHh---cC
Confidence 99986532 1234577889999998876 78999999999999999999 577776542 111111111 00
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
...+. .....+.+++.+||+.+|.+||++.|+++.|+
T Consensus 223 ----------~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 ----------HRLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----------CCCCC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 11157788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=287.41 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=196.3
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+..+...-||.|.-|.||+++.+ +|..+|||.+..... .++..++...++++.+. ++|+||+.+|||..+...++.|
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 34455667999999999999954 588999999975433 33445577777777666 4899999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|.| ..-.+.+++ +..+++++.-+-++...+..||.||.+.+ +|+|||+||+|||+|+.|++|+||||++.++.++.
T Consensus 171 elM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 998 334445444 34567888888899999999999998744 49999999999999999999999999998876543
Q ss_pred CcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 842 TSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
. .....|.+.|||||.+. ...|+.++|||||||+++|+.||+.||..-..+.+....+ ++
T Consensus 247 A---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv--------------ln 309 (391)
T KOG0983|consen 247 A---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV--------------LN 309 (391)
T ss_pred c---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH--------------Hh
Confidence 3 23457999999999876 4579999999999999999999999997644443333222 12
Q ss_pred CCCCCCCH--HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPL--HEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~--~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.|..+. ..+..+.+++..|+.+|+.+||.+.+++++
T Consensus 310 ~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11122221 135678899999999999999999999875
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=310.62 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=202.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
..|+..+.||+|+||.||+|... +++.||+|.++.... ......+.+|++++++++||||+++++++.++...|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45667788999999999999864 588999999864322 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++.. +.+++.++..++.|++.|++|+|+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 83 YLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 9999999999853 45889999999999999999999766 9999999999999999999999999997654322
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......++..|+|||++.+..++.++|||||||++|||++|..||....... ..... .....+
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~-----------~~~~~~ 219 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLI-----------PKNNPP 219 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhhhh-----------hcCCCC
Confidence 12233468889999999998899999999999999999999999996532111 11100 011122
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3344566778899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=307.24 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=202.3
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|+||.||+|.. .+++.||+|.++.........+.+..|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477788999999999999985 4688999999876544333456788999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.. ...+++..+..++.|++.|++|||+.+ |+||||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999953 345889999999999999999999777 999999999999999999999999999876543221
Q ss_pred ce--eeeecccccccChhhhccCC---CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 844 EC--MSAIAGSYGYIAPEYAYTLK---VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 844 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.. .....+++.|+|||++.+.. ++.++||||||+++||+++|+.||....+.... ....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~---~~~~~~~--------~~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFHVGAG--------HK 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH---HHHHhcC--------CC
Confidence 11 12356889999999988766 889999999999999999999999654322111 1111100 01
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+..+.. ......+.+++.+|++.+|++||++.|++..
T Consensus 225 ~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111 1124456789999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.69 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=203.4
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec--CCccEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN--HETNLLVY 761 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~ 761 (1010)
+|++.+.||.|+||.||+|.. .+|+.||+|+++.........+.+..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 367778999999999999984 468899999987544444445568889999999999999999998754 34578999
Q ss_pred EecCCCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhcC--CCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 762 EYMPNGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHDC--SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
||+++++|.+++... ....+++..++.++.|++.|++|+|..+ +.+++||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998642 2467899999999999999999999332 333999999999999999999999999999876
Q ss_pred cCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .. .....+.
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~---~~~~~~~----------- 223 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QL---QLASKIK----------- 223 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HH---HHHHHHh-----------
Confidence 43321 1234568999999999998889999999999999999999999997532 11 1222111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+..+......+.+++.+|++.+|++||++.+|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112223334455678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.78 Aligned_cols=255 Identities=23% Similarity=0.270 Sum_probs=201.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
++|+..+.||+|+||.||+|... +++.||+|.+....... ...+.+..|+++++.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 35777889999999999999965 48999999997543321 23445888999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++++|.+++....+..+++..+..++.|++.||+|||..+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999997655677999999999999999999999776 9999999999999999999999999987543221
Q ss_pred Ccc---------------------------eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCC
Q 001816 842 TSE---------------------------CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGD 894 (1010)
Q Consensus 842 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~ 894 (1010)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 11124688999999999998999999999999999999999999965432
Q ss_pred CccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 001816 895 GVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPT----MREVVQ 955 (1010)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs----~~ev~~ 955 (1010)
.... ..+... +...+. .......+.+++.+|++.+|++||+ ++|+++
T Consensus 238 ~~~~----~~~~~~---------~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETF----SNILKK---------EVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHH----HHHhcC---------CccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2111 111110 001111 1113457889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=316.93 Aligned_cols=194 Identities=22% Similarity=0.358 Sum_probs=157.9
Q ss_pred CeEeecCcEEEEEEEec---CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec--CCccEEEEEec
Q 001816 690 NIIGKGGAGIVYKGLMP---NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN--HETNLLVYEYM 764 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~ 764 (1010)
.+||+|+||+||+|..+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 57999999999999864 35689999886432 23357889999999999999999998854 45678999998
Q ss_pred CCCCHHhhhccC-------CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE----cCCCceEEeeccc
Q 001816 765 PNGSLGEVLHGK-------KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL----DSGFEAHVADFGL 833 (1010)
Q Consensus 765 ~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill----~~~~~~kl~DFGl 833 (1010)
+ ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 5 5777776421 2235888999999999999999999776 9999999999999 5567899999999
Q ss_pred cccccCCCC-cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCC
Q 001816 834 AKFLQDSGT-SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGE 891 (1010)
Q Consensus 834 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~ 891 (1010)
++....... ........||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 987643322 112234578999999999876 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=309.77 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=200.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec------CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
+.|+..+.||+|+||.||+|..+ +...||+|.+..... ......+.+|++++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 45777889999999999999854 245799998754221 22345689999999999999999999999998999
Q ss_pred EEEEEecCCCCHHhhhccCCC-------CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEee
Q 001816 758 LLVYEYMPNGSLGEVLHGKKG-------GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVAD 830 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~D 830 (1010)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999965431 26899999999999999999999777 99999999999999999999999
Q ss_pred ccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhc
Q 001816 831 FGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSK 909 (1010)
Q Consensus 831 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 909 (1010)
||++....... ........++..|+|||.+.+..++.++||||||+++||+++ |..||....+. . .+.......
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~---~~~~~~~~~ 235 (275)
T cd05046 161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-E---VLNRLQAGK 235 (275)
T ss_pred cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-H---HHHHHHcCC
Confidence 99987543221 112223456788999999998889999999999999999999 78898653221 1 111111100
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
... ..+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 236 ----~~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 ----LEL------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----cCC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 011223346888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.42 Aligned_cols=256 Identities=28% Similarity=0.370 Sum_probs=199.1
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC---
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH--- 754 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--- 754 (1010)
.+..+.|.+.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 45578899999999999999999995 468899999985422 2234577899999998 799999999998654
Q ss_pred --CccEEEEEecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEee
Q 001816 755 --ETNLLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVAD 830 (1010)
Q Consensus 755 --~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~D 830 (1010)
+..|+||||+++++|.++++. .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEee
Confidence 357999999999999998853 23456899999999999999999999776 99999999999999999999999
Q ss_pred ccccccccCCCCcceeeeecccccccChhhhccC-----CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHH
Q 001816 831 FGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL-----KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKM 905 (1010)
Q Consensus 831 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~ 905 (1010)
||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||........... .
T Consensus 172 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~----~ 245 (291)
T cd06639 172 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK----I 245 (291)
T ss_pred cccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH----H
Confidence 999986543221 12234688999999987643 368899999999999999999999975432222111 1
Q ss_pred hhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 906 TDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..... +.. ..+......+.+++.+|++.+|++||++.|++++
T Consensus 246 ~~~~~--------~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNPP--------PTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCCC--------CCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11100 000 1122233467889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=309.40 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=199.0
Q ss_pred CCcCCeEeecCcEEEEEEEecC--CCEEEEEEeccCCCC--------CCcccchHHHHHHHhc-cCCcccceeeeeEecC
Q 001816 686 LKEDNIIGKGGAGIVYKGLMPN--GDQVAVKRLPAMSRG--------SSHDHGFNAEIQTLGR-IRHRHIVRLLGFCSNH 754 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~ 754 (1010)
|++.+.||+|+||.||+|..+. ++.+|+|.+...... ......+.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 6777899999999999999654 678999988543211 1122346678887765 6999999999999999
Q ss_pred CccEEEEEecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeec
Q 001816 755 ETNLLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
+..++||||+++++|.+++.. .....+++..++.++.|++.|+.|||. .+ ++||||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998743 234568999999999999999999995 45 999999999999999999999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
|.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||.... ...........
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~--- 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----MLSLATKIVEA--- 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC----HHHHHHHHhhc---
Confidence 9998754332 2344568999999999999889999999999999999999999986422 11111111111
Q ss_pred ccccccCCCCCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 912 GVLKILDPRLPSV-PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 912 ~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
...+. .......+.+++.+||+.||++||++.|+.+++++
T Consensus 229 --------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 --------VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred --------cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 01111 11223467889999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=292.91 Aligned_cols=249 Identities=23% Similarity=0.249 Sum_probs=202.4
Q ss_pred ccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|+..+++|+|.||.|-.++ ..+|+.+|+|++++...- ....+.-..|-++++..+||.+..+-..|...++.++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 567778899999999999998 557999999999764332 233445678999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+.||.|.-.+. +...++++..+.+..+|..||.|||+.+ ||.||+|.+|.++|.+|++||+|||+++.- ..
T Consensus 248 eyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IK 320 (516)
T ss_pred EEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--cc
Confidence 9999999998884 4567999999999999999999999665 999999999999999999999999999863 33
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
....+++.+|||.|.|||++....|+.++|.|.+||++|||++|+.||...+. ..+...+.. -|-.+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~------------ed~kF 387 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILM------------EDLKF 387 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHh------------hhccC
Confidence 44567889999999999999999999999999999999999999999965322 222221110 01222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQ 955 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~ 955 (1010)
| .....+...++.-.+.+||.+|. .+.||.+
T Consensus 388 P---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 388 P---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred C---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 2 22233455677888999999993 5777765
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.85 Aligned_cols=240 Identities=21% Similarity=0.379 Sum_probs=186.4
Q ss_pred CeEeecCcEEEEEEEecC--------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 690 NIIGKGGAGIVYKGLMPN--------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999998532 2348888775322 222345788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCc--------eEEeeccc
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE--------AHVADFGL 833 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~--------~kl~DFGl 833 (1010)
||+++|+|.++++... ..+++..+..++.||+.|++|||+.+ |+||||||+||+++.++. ++++|||.
T Consensus 79 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 79 EYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred ecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999996433 46899999999999999999999776 999999999999987765 69999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCC-CCCCCCCCCccHHHHHHHHhhhccc
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGR-KPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
+...... ....+++.|+|||++.+ ..++.++||||||+++|||++|. .||..... ...... ...
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~----~~~--- 220 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQF----YED--- 220 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHH----HHc---
Confidence 8654321 23468889999999886 45789999999999999999985 55543211 111110 000
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 912 GVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122223356789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.31 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=197.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|+..+.||+|+||.||+|..+ +|+.||||.+...... .....+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 367888899999999999999965 6889999998654322 22344678999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||++ ++|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 83 EYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred ecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9997 59999886433 46889999999999999999999776 9999999999999999999999999987542211
Q ss_pred CcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc-ccccc-----
Q 001816 842 TSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK-KEGVL----- 914 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~----- 914 (1010)
. ......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.......+....+....... .+...
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 1122346889999999875 4588999999999999999999999965432222111111110000 00000
Q ss_pred ----cccCCCCCCC-------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 915 ----KILDPRLPSV-------PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ----~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+..... .......+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 01112466789999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=319.33 Aligned_cols=246 Identities=27% Similarity=0.445 Sum_probs=198.9
Q ss_pred cCCeEeecCcEEEEEEEe-cCCCEEEEEEe--ccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc--cEEEEE
Q 001816 688 EDNIIGKGGAGIVYKGLM-PNGDQVAVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET--NLLVYE 762 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~--~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~lv~e 762 (1010)
...+||+|+|-+||||.+ .+|..||--.+ ......+...++|..|+++++.++||||+++|+++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346899999999999995 35777764333 2233334445779999999999999999999999987655 679999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-CCceEEeeccccccccCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DFGla~~~~~~~ 841 (1010)
.+..|+|..|+.+ -++.....+..|++||++||.|||.+ .++|||||||-+||+|+. .|.|||+|.|+|.......
T Consensus 124 L~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999954 45688889999999999999999988 688999999999999975 6899999999998765432
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc-cccccccCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK-EGVLKILDPR 920 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 920 (1010)
.....|||.|||||+.. ..|++.+||||||+.+.||+|+..||.+-.. .+++.+++....+ ..+.++-||
T Consensus 201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---~AQIYKKV~SGiKP~sl~kV~dP- 271 (632)
T KOG0584|consen 201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---PAQIYKKVTSGIKPAALSKVKDP- 271 (632)
T ss_pred ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---HHHHHHHHHcCCCHHHhhccCCH-
Confidence 23468999999999776 7899999999999999999999999976444 3445555544432 233333333
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
++.++|.+|+.. ..+|||+.|+++.
T Consensus 272 ----------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 ----------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 677899999999 8999999999873
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=313.10 Aligned_cols=247 Identities=24% Similarity=0.303 Sum_probs=199.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|+..+.||+|+||.||++... +++.||+|+++.... .......+.+|++++++++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35777889999999999999954 689999999864322 1223456888999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+++++|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 99999999999953 367899999999999999999999776 999999999999999999999999999875432
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||..... .......... .
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~---------~--- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEKILEG---------K--- 214 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcC---------C---
Confidence 2244689999999999888899999999999999999999999965321 1111111100 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
...+......+.+++.+|++.+|.+|+ +++|++++
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 112222345677899999999999998 67777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.58 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=211.4
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
...+..|.+.+.||+|.|+.|..|+. .+|..||||.+++..-.....+.+.+|+++|..++|||||+++.+.+.....|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34567788899999999999999984 46999999999877766666666899999999999999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+.+|.+.+++. +.+++.+.++..++.|+.+|++|||..+ |+|||||++||+++.+..+||+|||++..+.
T Consensus 132 lV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999995 5567888999999999999999999766 9999999999999999999999999998875
Q ss_pred CCCCcceeeeecccccccChhhhccCCC-CccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
. .....+.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++.. +....+......
T Consensus 207 ~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------lk~Lr~rvl~gk---- 271 (596)
T KOG0586|consen 207 Y---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------LKELRPRVLRGK---- 271 (596)
T ss_pred c---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------cccccchheeee----
Confidence 3 344567899999999999998876 579999999999999999999997521 111111111100
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
-.++......+.+++++++-.+|.+|++++++++.-
T Consensus 272 ----~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 272 ----YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ----ecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 112333445667789999999999999999997743
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.21 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=205.9
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|++.+.||+|++|.||+|... +|+.||||++...... .....+.+|++.+++++|||++++++++...+..++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 5777889999999999999965 5899999998654332 3355689999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
+++++|.+++... ..+++..+..++.|+++|++|+|+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999543 678999999999999999999997 66 99999999999999999999999999986643222
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
......++..|+|||...+..++.++||||||+++|||++|+.||..... ....+....+. ....+
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~-----------~~~~~ 221 (264)
T cd06623 156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAIC-----------DGPPP 221 (264)
T ss_pred --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHh-----------cCCCC
Confidence 12245688999999999998999999999999999999999999976542 12222222221 11112
Q ss_pred CCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~-~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+.. .+..+.+++.+|++.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22223 45678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=310.56 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=197.9
Q ss_pred ccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEec------
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSN------ 753 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~------ 753 (1010)
..+.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346788889999999999999995 468899999885432 2234578899999998 69999999999853
Q ss_pred CCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 754 HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 754 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
....|+||||+++|+|.+++...+...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcc
Confidence 456799999999999999997656667888899999999999999999777 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
+....... .......|++.|+|||.+. +..++.++|||||||++|||++|+.||........... ....
T Consensus 168 ~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~ 241 (282)
T cd06636 168 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRN 241 (282)
T ss_pred hhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhC
Confidence 87653221 1223456899999999875 35688899999999999999999999965332111110 0000
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+.. .....+..+.+++.+||+.+|.+||++.|++++
T Consensus 242 --------~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 242 --------PPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --------CCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00000 111234568889999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=314.31 Aligned_cols=257 Identities=21% Similarity=0.239 Sum_probs=197.6
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.|+..+.||+|+||.||++... .++.||+|.+...... ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5777889999999999999854 5789999998654321 1223457789999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++.. .+.+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999953 356899999999999999999999776 99999999999999999999999999864211100
Q ss_pred -------------cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc
Q 001816 843 -------------SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909 (1010)
Q Consensus 843 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 909 (1010)
........|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~----~~~~~~~~~~- 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVISD- 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc-
Confidence 0011124578899999999988999999999999999999999999964321 1222211111
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
....+......+..+.+++.+|++.+|++||++.++.+.++.
T Consensus 232 --------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 --------DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --------ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 001111111234467889999999999999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=311.94 Aligned_cols=267 Identities=20% Similarity=0.260 Sum_probs=200.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--CccEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 759 (1010)
.+.|+..+.||+|+||.||+|..+ +++.||+|.++...........+.+|+.++++++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357888899999999999999965 588999999975444333334567899999999999999999998877 88999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999996 59998886432 46899999999999999999999776 99999999999999999999999999987654
Q ss_pred CCCcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc--------
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK-------- 910 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-------- 910 (1010)
.. .......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||.....................
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112334578899999998764 4689999999999999999999999754332211111111100000
Q ss_pred ------cccccccCCCC-CCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 911 ------EGVLKILDPRL-PSVPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 911 ------~~~~~~~~~~~-~~~~~~-~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
........... ...+.. ....+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000 011111 24457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=312.89 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=200.5
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
.+..+.|.....||+|+||.||++.. .++..||||++.... ......+.+|+.+++.++||||+++++.+...+..|
T Consensus 18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 34445566567899999999999985 468899999985422 223445889999999999999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+++++|.+++.. +.+++.++..++.||+.|++|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 96 lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 96 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 99999999999998843 35889999999999999999999776 9999999999999999999999999987653
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
... .......|++.|+|||...+..++.++||||||+++|||++|+.||...... +.+..+.. ...
T Consensus 170 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~--------~~~ 235 (292)
T cd06658 170 KEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRIRD--------NLP 235 (292)
T ss_pred ccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh--------cCC
Confidence 322 1223456899999999999889999999999999999999999999643221 11111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+..+. .......+..++.+|+..+|.+|||++|++++
T Consensus 236 ~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 236 PRVKD-SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred Ccccc-ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111 11223356788999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.14 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=199.8
Q ss_pred ccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCC----
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHE---- 755 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~---- 755 (1010)
..++|++.+.||+|+||.||+|..+ +++.||+|++..... ....+.+|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4578999999999999999999964 578999999865332 245688999999999 7999999999997644
Q ss_pred --ccEEEEEecCCCCHHhhhccCC--CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeec
Q 001816 756 --TNLLVYEYMPNGSLGEVLHGKK--GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 756 --~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
..|+||||+++++|.+++.... +..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 4799999999999999886433 567899999999999999999999776 999999999999999999999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhcc-----CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHh
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT-----LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMT 906 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 906 (1010)
|.+....... .......|++.|+|||++.. ..++.++||||||+++|||++|+.||..........+ +.
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~ 231 (275)
T cd06608 158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK----IP 231 (275)
T ss_pred ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH----hh
Confidence 9997654322 22334568999999998753 3477899999999999999999999964322111111 11
Q ss_pred hhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 907 DSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.. ..+.. ..+......+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~--------~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RN--------PPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cc--------CCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 00011 1122234567889999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=312.10 Aligned_cols=267 Identities=20% Similarity=0.223 Sum_probs=197.4
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCCc-----
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHET----- 756 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~----- 756 (1010)
++|+..+.||+|+||.||+|... +|+.||||+++...........+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35788899999999999999954 6899999998764443334456888999999995 6999999999877665
Q ss_pred cEEEEEecCCCCHHhhhccCC---CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-CCceEEeecc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKK---GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFG 832 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DFG 832 (1010)
.|+||||+++ +|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8888875432 246899999999999999999999776 999999999999998 8899999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||....+................+
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9976533211 1123357889999998865 457899999999999999999999997543322222222211100000
Q ss_pred ccc---ccc----CCCCC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 912 GVL---KIL----DPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 ~~~---~~~----~~~~~-----~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
... ... -+... .........+.+++.+|++.+|.+||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 000 00000 0001234567889999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.41 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=198.3
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
++|+..+.||+|++|.||+|... +|+.||+|.+............+.+|++++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56788889999999999999964 68899999986544333334568889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-CCceEEeeccccccccCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DFGla~~~~~~~ 841 (1010)
|++ +++.+++.......+++..+..++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 58888875444445688888999999999999999776 999999999999985 5579999999997643221
Q ss_pred CcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccc---ccc
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL---KIL 917 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 917 (1010)
.......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||....+.................... ...
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 112234578999999988764 57899999999999999999999997543322222221111100000000 000
Q ss_pred -----CCCCCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 918 -----DPRLPS-----VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 -----~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.... ........+.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011223457789999999999999999999873
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=312.83 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=198.0
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|+....||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++|||++++++++..++..|+||||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 344455799999999999985 4689999999864322 2245578899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.. ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-- 171 (297)
T cd06659 100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-- 171 (297)
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--
Confidence 999999998743 45899999999999999999999777 9999999999999999999999999987553321
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+.... .....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~---~~~~~~~~~---------~~~~~ 238 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-Q---AMKRLRDSP---------PPKLK 238 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H---HHHHHhccC---------CCCcc
Confidence 1223456899999999999989999999999999999999999999643211 1 111111110 00001
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
........+.+++.+|++.+|++||++.|++++
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111223457789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=286.86 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=198.2
Q ss_pred ccccCCcC-CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEec----C
Q 001816 682 VLDCLKED-NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSN----H 754 (1010)
Q Consensus 682 ~~~~~~~~-~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~ 754 (1010)
+++.|.+. ++||-|-.|.|-.... .+|+++|+|++... ....+|++..-.. .|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 44555543 5799999999998874 57999999998642 2356788876665 69999999998754 3
Q ss_pred CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC---CCceEEeec
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS---GFEAHVADF 831 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~---~~~~kl~DF 831 (1010)
....+|||.++||.|...+.++....+++.++..|+.||+.|+.|||..+ |.||||||+|+|... +..+||+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 56689999999999999998888888999999999999999999999776 999999999999964 557999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
|+|+.... .....+.+-||.|+|||++...+|+..+|+||+||++|-|++|.+||..... ..+.. .+....+.
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aisp---gMk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISP---GMKRRIRT 281 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCCh---hHHhHhhc
Confidence 99986432 3445677899999999999999999999999999999999999999965332 11111 11111111
Q ss_pred ccccccCCCCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 912 GVLKILDPRLPSVPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 912 ~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
+ ...+|..... .+....++|+.++..+|.+|.|+.|++.+-
T Consensus 282 g-----qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 282 G-----QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred c-----CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 1 1223322222 234466799999999999999999998853
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.29 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=191.7
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHH-HhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQT-LGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.|++.+.||+|+||.||+|..+ +|+.||+|+++...... ....+..|+.. ++..+||||+++++++..++..|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5777889999999999999964 69999999987543222 22345556554 566689999999999999999999999
Q ss_pred ecCCCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhc-CCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 763 YMPNGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHD-CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
|++ |+|.+++... ....+++..++.++.|++.|++|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 6888777532 335689999999999999999999975 5 99999999999999999999999999986533
Q ss_pred CCCcceeeeecccccccChhhhcc----CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccc
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYT----LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
.. ......|+..|+|||++.+ ..++.++|+||||+++|||++|+.||.......+ ........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~------- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ---QLKQVVEE------- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH---HHHHHHhc-------
Confidence 21 1123468899999998764 4568899999999999999999999965332211 11111100
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+..+. ...+..+.+++.+|++.+|++||++.+++++
T Consensus 224 -~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 -PSPQLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -CCCCCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 1233567889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.70 Aligned_cols=254 Identities=24% Similarity=0.255 Sum_probs=200.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|+.-++||+||||.||-... .+|+.+|.|++.+..... ........|-+++.+++.+.||.+-.+|+..+..++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 3455567899999999998874 469999999885432211 12334578999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
..|.||+|.-.|....+..+++..+..++.+|+.||++||+.+ ||.||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999997766678999999999999999999999777 9999999999999999999999999999876543
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
. ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||......+...+ +.+..-..-
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE------------vdrr~~~~~ 406 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE------------VDRRTLEDP 406 (591)
T ss_pred c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH------------HHHHHhcch
Confidence 2 3455899999999999999999999999999999999999999976433221111 111111111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQ 955 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~ 955 (1010)
...+...+.+...+-...+.+||++|- .++||.+
T Consensus 407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 112333344566677788899999984 5666655
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.63 Aligned_cols=274 Identities=22% Similarity=0.287 Sum_probs=200.3
Q ss_pred eeeccccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC
Q 001816 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 677 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 755 (1010)
+...+..+.|+..+.||+|+||.||+|... +|+.||||++............+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 344556678999999999999999999954 6899999998654433333344678999999999999999999987654
Q ss_pred c--------cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceE
Q 001816 756 T--------NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH 827 (1010)
Q Consensus 756 ~--------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~k 827 (1010)
. .++||||+. +++.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~k 159 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILK 159 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEE
Confidence 3 499999995 588887753 3346899999999999999999999777 99999999999999999999
Q ss_pred EeeccccccccCCCCc--ceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 001816 828 VADFGLAKFLQDSGTS--ECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 828 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~ 904 (1010)
|+|||++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||..... ......+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~ 238 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQ 238 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Confidence 9999999865432211 112234578899999988764 478899999999999999999999965322 222222222
Q ss_pred Hhhhccccccc------ccC-CCCCCC----------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 905 MTDSKKEGVLK------ILD-PRLPSV----------PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 905 ~~~~~~~~~~~------~~~-~~~~~~----------~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+.......... ..+ ...+.. +......+.+++.+|+..+|++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 21110000000 000 000000 00012345689999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.99 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=200.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+-|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4567788999999999999985 4688999998754322 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 9999999999853 46899999999999999999999776 9999999999999999999999999987654321
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......|+..|+|||...+..++.++|||||||++|+|++|..||..... ......+... ..+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-----------~~~ 219 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFLIPKN-----------NPP 219 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHHHhcC-----------CCC
Confidence 112334688899999999988899999999999999999999999965321 1111111111 111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+...+..+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2222334567789999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.71 Aligned_cols=239 Identities=24% Similarity=0.377 Sum_probs=184.5
Q ss_pred eEeecCcEEEEEEEecC-------------------------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccc
Q 001816 691 IIGKGGAGIVYKGLMPN-------------------------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 745 (1010)
.||+|+||.||+|.... ...||+|++..... .....|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999997421 12588898854221 2234578899999999999999
Q ss_pred eeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-
Q 001816 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF- 824 (1010)
Q Consensus 746 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~- 824 (1010)
++++++.+....++||||+++|+|..++.. ..+.+++..+..++.|+++||+|||+.+ |+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 999999999999999999999999999863 2457899999999999999999999766 99999999999997643
Q ss_pred ------ceEEeeccccccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHH-hCCCCCCCCCCCc
Q 001816 825 ------EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELI-TGRKPVGEFGDGV 896 (1010)
Q Consensus 825 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~ell-tg~~P~~~~~~~~ 896 (1010)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 228 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS- 228 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence 3799999988643221 12357888999998875 56899999999999999995 699998653221
Q ss_pred cHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 897 DIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
....+... ....+. .....+.+++.+||+.+|++||++.++++.|.
T Consensus 229 ~~~~~~~~-------------~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKERFYEK-------------KHRLPE---PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHHh-------------ccCCCC---CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111110 001111 11235778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=311.46 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=198.0
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--CccEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 759 (1010)
.+.|++.+.||+|+||.||+|.. .+|+.||+|+++...........+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46788899999999999999995 4689999999875443333334467899999999999999999998765 46799
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||||++ ++|.+++... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+.....
T Consensus 86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 5888887643 356899999999999999999999777 99999999999999999999999999987643
Q ss_pred CCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccc----
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL---- 914 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---- 914 (1010)
... ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||....+.. ....+............
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhh
Confidence 221 1223346788999999875 567899999999999999999999997533222 11111111110000000
Q ss_pred --------cccCCCCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 915 --------KILDPRLPSV---PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 --------~~~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..-....... .......+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 00123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=317.98 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=198.3
Q ss_pred ccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC------
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------ 754 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 754 (1010)
+.++|+..+.||+|+||.||+|.. .+|+.||||++............+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 567889999999999999999995 4789999999865433333344577899999999999999999988643
Q ss_pred CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccc
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla 834 (1010)
...|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||..+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35699999995 588888742 2888999999999999999999777 999999999999999999999999999
Q ss_pred ccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh------
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS------ 908 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~------ 908 (1010)
+...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...............
T Consensus 166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8654321 1233468899999999999999999999999999999999999996543211111111000000
Q ss_pred -----c-------c----cccccccCCCC-C----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 909 -----K-------K----EGVLKILDPRL-P----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 909 -----~-------~----~~~~~~~~~~~-~----~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
. . ..+.+.+.... + ..+......+.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 00000000000 0 0011234567789999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=316.92 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=196.4
Q ss_pred ccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC-----
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE----- 755 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 755 (1010)
+.++|++.+.||+|+||.||+|.. .+|+.||||+++.... ......+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 457788999999999999999984 4689999999864222 223445778999999999999999999876543
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
..|+||||++ +++.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 82 DVYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred eEEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 4799999995 58888774 246899999999999999999999777 9999999999999999999999999997
Q ss_pred cccCCCCc-ceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhh-hcccc
Q 001816 836 FLQDSGTS-ECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD-SKKEG 912 (1010)
Q Consensus 836 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~ 912 (1010)
........ .......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+..... ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTPSQED 233 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHH
Confidence 65432221 12233568999999998754 5688999999999999999999999965321 111111111100 00000
Q ss_pred cccccC----------CCCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 913 VLKILD----------PRLPSVP-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~----------~~~~~~~-----~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+.+ +..+..+ ......+.+++.+|++.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0000111 1123457889999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=306.48 Aligned_cols=249 Identities=23% Similarity=0.242 Sum_probs=201.2
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
+|++.++||.|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3677889999999999999965 58999999997533222 335568899999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++... ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999543 57899999999999999999999777 9999999999999999999999999997654322
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||...... ........... ..+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~------------~~~ 219 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET------------ADV 219 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc------------ccc
Confidence 223456889999999999888999999999999999999999999754322 11111111110 111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTM--REVV 954 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~--~ev~ 954 (1010)
..+...+..+.+++.+||+.+|.+||++ +|+.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1222334678889999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.56 Aligned_cols=259 Identities=26% Similarity=0.359 Sum_probs=199.3
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--CccEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETNLLVY 761 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~ 761 (1010)
.|+..+.||.|++|.||++... +++.||+|.+..... ......+.+|++++++++||||+++++++... +..|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5677789999999999999964 588999999864322 23345688999999999999999999988653 4679999
Q ss_pred EecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 762 EYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 762 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 23456889999999999999999999777 99999999999999999999999999875432
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCC-ccHHHHHHHHhhhcccccccccC
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG-VDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.. .....++..|+|||.+.+..++.++||||+|+++|||++|+.||...... ....+............ +.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE----LK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh----hc
Confidence 21 12345788999999999999999999999999999999999999754221 11112211111110000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+.........+.+++.+|++.+|++|||+.|++++
T Consensus 230 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 -DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0011011234567899999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.45 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=198.3
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC---CcccceeeeeEecCCccEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR---HRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv 760 (1010)
.|+..+.||+|+||.||+|.+ .+|+.||+|.++.... ......+.+|+.++++++ |||++++++++..++..++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467778999999999999995 5789999999864322 233456888999999996 99999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++++|.+++.. +.+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 81 MEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999999853 36899999999999999999999777 999999999999999999999999999876543
Q ss_pred CCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
. .......|+..|+|||...+ ..++.++||||||+++|+|++|+.||..... ........ . .
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~--------~---~ 217 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA----FRAMMLIP--------K---S 217 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh----hhhhhccc--------c---C
Confidence 2 22234568999999998875 4578999999999999999999999965321 11111100 0 0
Q ss_pred CCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 920 RLPSVPL-HEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 920 ~~~~~~~-~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+..+. .....+.+++.+|++.+|++||++.|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111111 134567889999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=300.33 Aligned_cols=253 Identities=30% Similarity=0.463 Sum_probs=206.5
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--CccEEEEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETNLLVYE 762 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 762 (1010)
|+..+.||+|++|.||+|... +|+.|++|++..........+.+.+|++++++++||||+++++.+... +..++|||
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 666789999999999999965 689999999876544334456788999999999999999999999888 88999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|+++++|.+++... ..+++.++..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 82 YVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 99999999999643 37999999999999999999999776 99999999999999999999999999987654332
Q ss_pred cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
........++..|+|||...+..++.++||||||+++|+|++|+.||....+ .......... ....+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~----------~~~~~ 223 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGS----------SGEPP 223 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhccc----------cCCCc
Confidence 1123345688999999999988899999999999999999999999976441 1111111110 11222
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 2333445678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.39 Aligned_cols=264 Identities=24% Similarity=0.268 Sum_probs=198.3
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc---CCcccceeeeeEecCCc-----
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI---RHRHIVRLLGFCSNHET----- 756 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~----- 756 (1010)
|++.+.||+|+||.||+|..+ +|..||+|+++...........+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556788999999999999976 489999999975444333334566788777666 59999999999988776
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
.+++|||+. ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58999886544456899999999999999999999777 99999999999999999999999999977
Q ss_pred ccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccc---
Q 001816 837 LQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV--- 913 (1010)
Q Consensus 837 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--- 913 (1010)
+..... .....++..|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 643221 12335788999999999999999999999999999999999998754332222222221110000000
Q ss_pred ----ccccCCC----CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 ----LKILDPR----LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ----~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+... ...........+.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 011112234567789999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.21 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=206.8
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|+||.||++... ++..||+|++............+.+|+++++.++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3667789999999999999964 688999999976554444556688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCC--CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 764 MPNGSLGEVLHGKK--GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
+++++|.+++.... ...+++.++..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999996543 467999999999999999999999777 9999999999999999999999999998764432
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ..+....... ...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~-----------~~~ 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKILK-----------GQY 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHhc-----------CCC
Confidence 22334578999999999998889999999999999999999999986532 1122222111 112
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+..+......+.+++.+|++.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 22222344567889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=307.48 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=196.3
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|++.+.||+|+||.||+|.. .+|+.||+|+++.... ......+.+|+++++.++|+||+++++++..++..|+||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46788889999999999999985 4688999999865432 222335778999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||++ +++.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 6777776433 345788889999999999999999776 9999999999999999999999999997543221
Q ss_pred CcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc----------
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK---------- 910 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------- 910 (1010)
. ......+++.|+|||++.+. .++.++||||||+++|||++|+.||....+..+.............
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 12234578999999998754 5788999999999999999999999754332111111100000000
Q ss_pred -cccccccCCCCCCC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 911 -EGVLKILDPRLPSV------PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 911 -~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...........+.. .......+.+++.+|++.||.+|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000 01123467789999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.33 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=199.6
Q ss_pred ccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-----C
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH-----E 755 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 755 (1010)
+.++|++.+.||+|+||+||+|.. .+|+.||||.++...........+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 456788899999999999999984 4689999999875433333344577899999999999999999987654 3
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
..|+||||+. ++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred cEEEEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 4799999995 78988885 3457999999999999999999999776 9999999999999999999999999998
Q ss_pred cccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc-ccc
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK-EGV 913 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~ 913 (1010)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ......+........ +..
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDL 233 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHh
Confidence 654322 22234568899999998765 4688999999999999999999999965321 111111111100000 000
Q ss_pred -----------ccc----cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 -----------LKI----LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 -----------~~~----~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+. .++............+.+++.+|++.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000 0000011112234567899999999999999999999886
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=305.41 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=205.1
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
++..+.|+..+.||+|+||.||+|... ++..||+|+++.... ....+.+|++.++.++|+|++++++++...+..|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 456678888899999999999999965 688999999875332 3456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+|+||+++++|.+++.... ..+++..+..++.|++.||+|||..+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999999996533 37999999999999999999999766 9999999999999999999999999987654
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||........ ....... ..
T Consensus 168 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~----~~~~~~~---~~----- 233 (286)
T cd06614 168 KEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA----LFLITTK---GI----- 233 (286)
T ss_pred cchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhc---CC-----
Confidence 3221 22334588999999999988899999999999999999999999864322111 1111110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+... .+......+.+++.+|++.+|.+||++.+++.+
T Consensus 234 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 PPLK-NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCCc-chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0000 111134567889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=314.94 Aligned_cols=267 Identities=22% Similarity=0.325 Sum_probs=200.3
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec----CCcc
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN----HETN 757 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 757 (1010)
.+.|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788889999999999999985 469999999987544333345567789999999999999999998753 3467
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 689998853 456999999999999999999999777 999999999999999999999999999765
Q ss_pred cCCCCc--ceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc----
Q 001816 838 QDSGTS--ECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK---- 910 (1010)
Q Consensus 838 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 910 (1010)
...... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+... ....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhh
Confidence 432221 11234578999999998765 568899999999999999999999996543221 1111111111100
Q ss_pred -----cccccccC--CCCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 911 -----EGVLKILD--PRLPSVP-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 911 -----~~~~~~~~--~~~~~~~-----~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+.+.+..+ +.....+ ......+.+++.+|++.+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 0111111 1234568899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.15 Aligned_cols=246 Identities=25% Similarity=0.282 Sum_probs=194.2
Q ss_pred EeecCcEEEEEEEe-cCCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 692 IGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
||+|+||+||++.. .+|+.||+|.+...... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 46899999998643221 22244567899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeee
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
.+++.......+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+|||.+...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 99997555457899999999999999999999776 999999999999999999999999999765431 122344
Q ss_pred cccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHH
Q 001816 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEV 929 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1010)
.++..|+|||+..+..++.++||||+|+++|+|++|+.||................. ......+....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~ 222 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL------------EMAVEYPDKFS 222 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc------------cccccCCccCC
Confidence 688899999999888899999999999999999999999975433222111111100 01111222234
Q ss_pred HHHHHHHHhccccCCCCCC-----CHHHHHH
Q 001816 930 MHVFYVAMLCVEEQAVERP-----TMREVVQ 955 (1010)
Q Consensus 930 ~~~~~li~~cl~~~P~~RP-----s~~ev~~ 955 (1010)
..+.+++.+||+.+|++|| ++.+++.
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 5678899999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.84 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=202.5
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccE
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 758 (1010)
.+..++|+..+.||+|+||.||++.. .++..||+|.+..... ...+.+.+|+.++++++|||++++++++...+..|
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 44457889999999999999999985 4688999999854322 22455788999999999999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+++++|.+++.. ..+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 93 lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 99999999999999853 35789999999999999999999776 9999999999999999999999999987654
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.... ......|++.|+|||...+..++.++||||||+++||+++|+.||........... ..... .
T Consensus 167 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~~--------~ 232 (293)
T cd06647 167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG--------T 232 (293)
T ss_pred cccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcCC--------C
Confidence 3222 22344688999999999888899999999999999999999999965322111100 00000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+... .+......+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQ-NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 122233467789999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.15 Aligned_cols=244 Identities=25% Similarity=0.268 Sum_probs=187.5
Q ss_pred eEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCc-ccchHHHHHHHhc---cCCcccceeeeeEecCCccEEEEEecC
Q 001816 691 IIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSH-DHGFNAEIQTLGR---IRHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~---l~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
+||+|+||.||++.. .+|+.||+|.+......... ...+.+|..+++. .+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 46889999998654332221 2234445444433 479999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce
Q 001816 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 766 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
+|+|.+++.. .+.+++..+..++.|++.|++|||..+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 9999999853 356999999999999999999999776 9999999999999999999999999997543221
Q ss_pred eeeecccccccChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCC
Q 001816 846 MSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (1010)
.....|++.|+|||... +..++.++||||+||++|||++|+.||........ ..+...... ... ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~--------~~~---~~ 218 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT--------VNV---EL 218 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhc--------CCc---CC
Confidence 12346899999999886 45689999999999999999999999975432211 111111100 011 12
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 925 PLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 925 ~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
+...+..+.+++.+|++.||++|| +++|++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 223345678899999999999999 59888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.21 Aligned_cols=253 Identities=29% Similarity=0.380 Sum_probs=194.0
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.|...+.||+|+||.||++.. .+|+.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 445567899999999999985 46899999998653332 33456888999999996 9999999999999899999999
Q ss_pred ecCCCCHHhh---hccCCCCCCChhhHHHHHHHHHHHhhHHhhc-CCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 763 YMPNGSLGEV---LHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD-CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 763 ~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
|+. +++.++ +.......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 455443 3323346799999999999999999999963 5 9999999999999999999999999997654
Q ss_pred CCCCcceeeeecccccccChhhhccC---CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
.... .....|++.|+|||++.+. .++.++||||+||++|||++|+.||.... .....+......
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~------- 226 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKG------- 226 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCC-------
Confidence 3221 1233588999999998766 68999999999999999999999996532 111111111110
Q ss_pred ccCCCCC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 916 ILDPRLP-SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 916 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+.++ ..+...+..+.+++.+|++.+|++|||++|++++
T Consensus 227 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 -DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111 1122345578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=308.18 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=199.1
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCcc
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 757 (1010)
++..+.|+..+.||+|+||.||+|... +|+.||+|++...... ......+.+|+++++.++||||+++++++.+++..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 445577888999999999999999854 6889999998643322 22234578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
|+||||++ |++.+++... ...+++..+..++.|++.||.|||..+ |+||||+|+||+++.++.++|+|||++...
T Consensus 91 ~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999996 6777766432 346899999999999999999999776 999999999999999999999999998765
Q ss_pred cCCCCcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccc
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
... ....|++.|+|||++. ...++.++||||||+++|||++|+.||....... .......
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~~~~~~~------- 228 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQ------- 228 (307)
T ss_pred CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----HHHHHhc-------
Confidence 322 2346888999999874 4568899999999999999999999986432111 1111100
Q ss_pred cccCCCCCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 915 KILDPRLPSV-PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 915 ~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
...+.. +......+.+++.+||+.+|++||++.+++.+..
T Consensus 229 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 229 ----NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ----CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 011111 1223456888999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=303.21 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=198.6
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|...+.||+|++|.||+|.. .+++.||+|+++.... .....+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 344557899999999999985 4688999998864322 2244578899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++.. ..+++.++..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 999999999854 46899999999999999999999777 9999999999999999999999999887543321
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
.......|++.|+|||...+..++.++||||||+++|||++|+.||.... ............ .+.. .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~~~~~~~~~~~~--------~~~~-~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----PLQAMKRIRDNL--------PPKL-K 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----HHHHHHHHHhcC--------CCCC-c
Confidence 12234568999999999998889999999999999999999999986422 122222221110 0111 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+......+.+++.+|++.+|++||++.+++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111233568889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=307.66 Aligned_cols=270 Identities=23% Similarity=0.271 Sum_probs=199.2
Q ss_pred cccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE---- 755 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 755 (1010)
...+.|++.+.||+|+||.||+|..+ +|+.||+|+++...........+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34577888999999999999999965 5889999999754433333456788999999999999999999987654
Q ss_pred ------ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEe
Q 001816 756 ------TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVA 829 (1010)
Q Consensus 756 ------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~ 829 (1010)
..++||||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 777776533 356899999999999999999999777 9999999999999999999999
Q ss_pred eccccccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh
Q 001816 830 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 830 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
|||.+........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+........+.....
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999986643321 11122346788999998865 457899999999999999999999997533222211111111111
Q ss_pred ccccccccc--------CCCC------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 909 KKEGVLKIL--------DPRL------PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 909 ~~~~~~~~~--------~~~~------~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.......+. ++.. .......+..+.+++.+|++.+|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000 0000 00001123567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=314.06 Aligned_cols=269 Identities=24% Similarity=0.320 Sum_probs=200.2
Q ss_pred cccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC--Cc
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH--ET 756 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~ 756 (1010)
.+.++|++.+.||+|+||.||+|... +|+.||||++............+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45678899999999999999999965 588999999865333333344577899999999 999999999998654 35
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
.|+||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 799999996 5999888532 6888999999999999999999776 99999999999999999999999999986
Q ss_pred ccCCCCc---ceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHh------
Q 001816 837 LQDSGTS---ECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMT------ 906 (1010)
Q Consensus 837 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~------ 906 (1010)
....... .......|++.|+|||++.+ ..++.++||||||+++|||++|+.||.................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 22334568999999998764 5678999999999999999999999965432221111111100
Q ss_pred -----hhcccccc-cccCCC---CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 907 -----DSKKEGVL-KILDPR---LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 907 -----~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
......+. ...... ...........+.+++.+|++.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000 000000 011111134567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=312.45 Aligned_cols=263 Identities=21% Similarity=0.264 Sum_probs=194.1
Q ss_pred eEeec--CcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 691 IIGKG--GAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 691 ~lG~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
.||+| +||+||+|.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999985 47999999998754433333456889999999999999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce--
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC-- 845 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~-- 845 (1010)
++.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+...........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999987554456889999999999999999999776 99999999999999999999999986543322111110
Q ss_pred ---eeeecccccccChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhh-------------
Q 001816 846 ---MSAIAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD------------- 907 (1010)
Q Consensus 846 ---~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~------------- 907 (1010)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||..................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 1112356779999998763 4789999999999999999999999764332222111110000
Q ss_pred h-------c----ccccc------cccCCCC-CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 908 S-------K----KEGVL------KILDPRL-PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 908 ~-------~----~~~~~------~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
. . .+... ...+... ...+......+.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0 00000 0000000 11123345678899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.92 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=201.5
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|+..+.||+|++|.||+|... +|+.+|+|+++...........+.+|++++++++||||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456778999999999999864 6889999998765444334556888999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
+ +++.+++... ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||.+....... .
T Consensus 81 ~-~~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 D-TDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred C-CCHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 6 4888887643 357899999999999999999999777 9999999999999999999999999998764432 1
Q ss_pred eeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC-----
Q 001816 845 CMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD----- 918 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 918 (1010)
......++..|+|||...+. .++.++||||+|+++|+|++|+.||.....................+...+..+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22234688899999998876 789999999999999999999999965433222111111111100000000000
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 ---------PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ---------~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.............+.+++.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00011112334578899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=304.44 Aligned_cols=261 Identities=18% Similarity=0.236 Sum_probs=184.9
Q ss_pred ccccCCcCCeEeecCcEEEEEEEecC----CCEEEEEEeccCCCCCCcc---------cchHHHHHHHhccCCcccceee
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLMPN----GDQVAVKRLPAMSRGSSHD---------HGFNAEIQTLGRIRHRHIVRLL 748 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~~ 748 (1010)
..++|++.++||+|+||.||+|...+ +..+|+|+........... .....+...+..++|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999999654 3456666543221110000 0112233445566899999999
Q ss_pred eeEecCC----ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC
Q 001816 749 GFCSNHE----TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF 824 (1010)
Q Consensus 749 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~ 824 (1010)
+.+.... ..+++||++ ..++.+.+.. ....++..+..++.|++.|++|||+.+ |+||||||+||+++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 9765543 346888887 3466666642 234678888999999999999999766 99999999999999999
Q ss_pred ceEEeeccccccccCCCCc-----ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHH
Q 001816 825 EAHVADFGLAKFLQDSGTS-----ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIV 899 (1010)
Q Consensus 825 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~ 899 (1010)
.++|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432211 11123469999999999999999999999999999999999999998654333322
Q ss_pred HHHH-HHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 900 QWVR-KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 900 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
.... ..... +..+... ....+..+.+++..|++.+|++||+++++.+.+
T Consensus 244 ~~~~~~~~~~-------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKR-------LHEGKIK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHH-------hhhhhhc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111 11111 0001000 011235678899999999999999999999875
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.09 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=204.8
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|++.+.||+|+||.||++.. .+|+.+|+|.+............+.+|++++++++||||+++++++.+....|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 367778999999999999984 4688999999875444334455678899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 764 MPNGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 764 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
+++++|.+++.+. ....+++..++.++.|++.|++|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998642 2356889999999999999999999776 999999999999999999999999999876543
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
......|++.|+|||...+..++.++|+||+|+++|||++|+.||..... ....... .....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~-----------~~~~~ 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLRYKV-----------QRGKY 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH-----------hcCCC
Confidence 22234688999999999999999999999999999999999999965321 1111111 11222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+..+......+..++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 33334555678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=299.43 Aligned_cols=244 Identities=25% Similarity=0.308 Sum_probs=196.6
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 4889999998653322 23345688999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeee
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
.+++.+ ...+++..+..++.|++.||+|+|+.+ ++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 999954 345899999999999999999999766 9999999999999999999999999998764332 22334
Q ss_pred cccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHH
Q 001816 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEV 929 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1010)
.|++.|+|||.+.+..++.++|+||+|+++|||++|..||....+ +.......+... ......+....
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~----------~~~~~~~~~~~ 220 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYNDILKG----------NGKLEFPNYID 220 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHHHHhcc----------CCCCCCCcccC
Confidence 688999999999888899999999999999999999999975432 122222222110 11112222235
Q ss_pred HHHHHHHHhccccCCCCCCC-----HHHHHH
Q 001816 930 MHVFYVAMLCVEEQAVERPT-----MREVVQ 955 (1010)
Q Consensus 930 ~~~~~li~~cl~~~P~~RPs-----~~ev~~ 955 (1010)
..+..++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 57889999999999999999 777766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.01 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=198.3
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|+..+.||+|+||.||+|.. .+|..||+|++...... ......+.+|++++++++|||++++++++.++...|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 34577788999999999999995 46889999998643222 22234588899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||++ |++.+.+.. ....+++.++..++.|++.|+.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 104 ~e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 104 MEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EeCCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99996 577777653 2456899999999999999999999777 999999999999999999999999998754321
Q ss_pred CCcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
....|++.|+|||++. +..++.++|||||||++|||++|+.||...........+. ..
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~--------- 239 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QN--------- 239 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----hc---------
Confidence 2346889999999874 4568899999999999999999999986532111111111 10
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
...+.........+.+++.+|++.+|.+||++.+++++.....
T Consensus 240 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0001111223345788999999999999999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=332.00 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=188.9
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-------
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------- 754 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------- 754 (1010)
...|+..++||+||||.||+++. -+|+.||||+++... .......+.+|+..+++++|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 44566778999999999999994 489999999998765 344455688999999999999999998532110
Q ss_pred --------------------------------------------------------------------------------
Q 001816 755 -------------------------------------------------------------------------------- 754 (1010)
Q Consensus 755 -------------------------------------------------------------------------------- 754 (1010)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh
Q 001816 755 --------------------------------ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802 (1010)
Q Consensus 755 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 802 (1010)
...||-||||+..++.+++++..-.. ....+++++++|++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 11278899999888888885432111 467889999999999999998
Q ss_pred cCCCceEeecCCCCcEEEcCCCceEEeecccccccc----C------------CCCcceeeeecccccccChhhhccCC-
Q 001816 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ----D------------SGTSECMSAIAGSYGYIAPEYAYTLK- 865 (1010)
Q Consensus 803 ~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~~- 865 (1010)
.| ||||||||.||++|+++.|||+|||+|.... . .......+..+||.-|+|||++.+..
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 87 9999999999999999999999999998721 0 01111334578999999999987654
Q ss_pred --CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC---CCCHHHHHHHHHHHHhcc
Q 001816 866 --VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP---SVPLHEVMHVFYVAMLCV 940 (1010)
Q Consensus 866 --~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl 940 (1010)
|+.|+|+||+|||++||+. ||.. ..+-...+..+. ++.+| .+.......-..+|.+++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T---sMERa~iL~~LR-----------~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGT---SMERASILTNLR-----------KGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCc---hHHHHHHHHhcc-----------cCCCCCCcccccccchHHHHHHHHHh
Confidence 9999999999999999984 5643 222222222221 11122 123333345567999999
Q ss_pred ccCCCCCCCHHHHHH
Q 001816 941 EEQAVERPTMREVVQ 955 (1010)
Q Consensus 941 ~~~P~~RPs~~ev~~ 955 (1010)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999976
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=308.21 Aligned_cols=268 Identities=19% Similarity=0.273 Sum_probs=196.0
Q ss_pred cCCcCCeEeecCcEEEEEEEec---CCCEEEEEEeccCC-CCCCcccchHHHHHHHhccCCcccceeeeeEecC--CccE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP---NGDQVAVKRLPAMS-RGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETNL 758 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 758 (1010)
+|++.+.||+|+||.||+|... +|+.||+|.+.... ........+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667788999999999999964 47899999997633 1222344578899999999999999999999888 7899
Q ss_pred EEEEecCCCCHHhhhccC---CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC----CCceEEeec
Q 001816 759 LVYEYMPNGSLGEVLHGK---KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS----GFEAHVADF 831 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~----~~~~kl~DF 831 (1010)
+||||++ +++.+.+... ....+++..++.++.|++.|++|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 4676666422 2246889999999999999999999776 999999999999999 899999999
Q ss_pred cccccccCCCC-cceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCc---------cHHH
Q 001816 832 GLAKFLQDSGT-SECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGV---------DIVQ 900 (1010)
Q Consensus 832 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~---------~~~~ 900 (1010)
|++........ ........+++.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 1122345688999999988764 57899999999999999999999997543322 0111
Q ss_pred HHHHHhhhccc---------cccc---c-cCCCCCCCC------H--HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 901 WVRKMTDSKKE---------GVLK---I-LDPRLPSVP------L--HEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 901 ~~~~~~~~~~~---------~~~~---~-~~~~~~~~~------~--~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+..+...... .... . .....+... . .....+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111000000 0000 0 000011000 0 223457889999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.39 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=197.3
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC---CCCcccchHHHHHHHhccCCcccceeeeeEecC--Ccc
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR---GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETN 757 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 757 (1010)
..|++.+.||+|+||.||+|.. .+|+.||+|.+..... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3577889999999999999985 4689999998753221 122334688899999999999999999998664 457
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
++||||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999999853 345889999999999999999999777 999999999999999999999999999865
Q ss_pred cCCCC-cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 838 QDSGT-SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 838 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
..... ........|+..|+|||+..+..++.++|||||||++||+++|+.||....... . +.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~-~~~~~~--------- 223 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---A-IFKIAT--------- 223 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---H-HHHHHc---------
Confidence 32111 111224568999999999998889999999999999999999999996532111 1 111110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+..+..+......+.+++.+|++ +|.+||++.+++.+
T Consensus 224 -~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 224 -QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111222344445567889999999 57999999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=308.93 Aligned_cols=263 Identities=19% Similarity=0.209 Sum_probs=194.1
Q ss_pred CeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
+.+|.|+++.||++.. +|+.||||+++...........+.+|++++++++||||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3345555555555544 789999999976533444456789999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc-----c
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS-----E 844 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-----~ 844 (1010)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||.+......... .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99997655567899999999999999999999777 999999999999999999999999998755332211 1
Q ss_pred eeeeecccccccChhhhcc--CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh---------ccccc
Q 001816 845 CMSAIAGSYGYIAPEYAYT--LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS---------KKEGV 913 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~---------~~~~~ 913 (1010)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..........+........ .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1223457789999999875 458899999999999999999999997643322221111100000 00000
Q ss_pred cc----ccCCC-----CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 LK----ILDPR-----LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ~~----~~~~~-----~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.. ..++. ...........+.+++.+||+.+|++|||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 00000 001122334567889999999999999999999884
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=303.14 Aligned_cols=260 Identities=23% Similarity=0.261 Sum_probs=194.1
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecC--CccEEEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNH--ETNLLVY 761 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~ 761 (1010)
|+..+.||+|+||.||+|.. .+++.||+|+++....... .....+|+.+++++. |||++++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 55677899999999999985 4688999999875433222 223457888898885 99999999999887 8899999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||++ |++.+.+... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 80 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 80 ELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred ecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9996 5888877543 356899999999999999999999777 999999999999999 999999999998654322
Q ss_pred CcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc----
Q 001816 842 TSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI---- 916 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 916 (1010)
.. ....+++.|+|||++.+ ..++.++||||+||++|||++|..||..... .+...+.........+.....
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhccc
Confidence 21 23457899999997654 5578899999999999999999999965332 222222222111111100000
Q ss_pred --cCCCCC--------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 --LDPRLP--------SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 --~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+...+ ......+..+.+++.+|++.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 0112335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.38 Aligned_cols=249 Identities=31% Similarity=0.455 Sum_probs=201.3
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|+..+.||+|++|.||++... +|+.|++|+++.... .....+.+|++++++++||+++++++++..+...++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 566788999999999999965 688999999865433 23456889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
++++|.+++.... ..+++..+..++.|+++|++|||..+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999986432 57899999999999999999999766 99999999999999999999999999987654321
Q ss_pred eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCC
Q 001816 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (1010)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... +........ .. +..+ .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~---~~-----~~~~-~ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----KALFKIATN---GP-----PGLR-N 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHHhc---CC-----CCcC-c
Confidence 23456889999999999888999999999999999999999999653211 111111100 00 0111 1
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 925 ~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+......+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124568889999999999999999999764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=327.46 Aligned_cols=255 Identities=24% Similarity=0.240 Sum_probs=199.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.++||+|+||.|..++.+ +++.||+|++.+...- ....+-|..|-.+|..-+.+.|++++.+|.++.+.|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 467888999999999999999954 5788999998652111 12244588899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
||||+||+|-.++.+. .+++++.++.++..|.-||..+|+.| +|||||||+|||+|..|++||+|||.+..+...
T Consensus 154 MdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999543 37999999999999999999999888 999999999999999999999999999887654
Q ss_pred CCcceeeeecccccccChhhhc----c-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAY----T-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
+. ......+|||.|++||++. + +.|++.+|.||+||++|||+.|..||... .++.-..++..- ..
T Consensus 229 G~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----slveTY~KIm~h-----k~ 298 (1317)
T KOG0612|consen 229 GT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----SLVETYGKIMNH-----KE 298 (1317)
T ss_pred Cc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----HHHHHHHHHhch-----hh
Confidence 43 4456678999999999986 3 67999999999999999999999999541 111111111110 00
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 001816 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPT---MREVVQI 956 (1010)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs---~~ev~~~ 956 (1010)
.+ .+|. ....+.....+|.+.+. +|+.|-. +.++..+
T Consensus 299 ~l--~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 299 SL--SFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hc--CCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 01 1221 12234455667766554 5777876 8888774
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=258.39 Aligned_cols=265 Identities=23% Similarity=0.306 Sum_probs=204.2
Q ss_pred cCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|+..++||+|.||+||+|+ +.+++.||+|+++....++.......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566789999999999999 66789999999987766666666788999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
| ..+|..+.. .-++.++.+.++.++.|+++|+.++|.++ +.|||+||.|.+|+.+|+.|++|||+|+-+.- ..
T Consensus 83 c-dqdlkkyfd-slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi--pv 155 (292)
T KOG0662|consen 83 C-DQDLKKYFD-SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI--PV 155 (292)
T ss_pred h-hHHHHHHHH-hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC--ce
Confidence 9 568888875 34578999999999999999999999776 99999999999999999999999999987643 33
Q ss_pred ceeeeecccccccChhhhccCC-CCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcc---cccccccC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK---EGVLKILD 918 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 918 (1010)
.+....+-|.+|.+|.++.+.. |+...|+||.|||+.|+.. |++-|.+.+-.+++..+.+......+ ..+.+..|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 4566677899999999998765 8899999999999999997 66666553323333333333222111 12222222
Q ss_pred CCC-CCCC---------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRL-PSVP---------LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~-~~~~---------~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
... |..| +.-...-.+++...+.-+|..|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 1111 1111223456677777899999999988765
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.04 Aligned_cols=249 Identities=27% Similarity=0.452 Sum_probs=202.5
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|++|.||+|... +++.||+|.+............+.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3677889999999999999854 678999999976544333455688999999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 9999999998533 67899999999999999999999776 99999999999999999999999999987654322
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
......++..|+|||...+..++.++||||+|+++|+|++|+.||........ ... ... ...+.
T Consensus 155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~---~~~-~~~-----------~~~~~ 218 (254)
T cd06627 155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA---LFR-IVQ-----------DDHPP 218 (254)
T ss_pred -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH---HHH-Hhc-----------cCCCC
Confidence 12345688999999999888899999999999999999999999975432111 111 110 01111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
.+......+..++.+|+..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 22233456778999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=328.85 Aligned_cols=272 Identities=18% Similarity=0.265 Sum_probs=188.3
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEecC--CCEEEEEEec---------------cCCCCCCcccchHHHHHHHhccCCc
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLMPN--GDQVAVKRLP---------------AMSRGSSHDHGFNAEIQTLGRIRHR 742 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~---------------~~~~~~~~~~~~~~E~~~l~~l~hp 742 (1010)
+.+.++|++.+.||+|+||+||++..+. ++.+++|.+. ...........+.+|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456789999999999999999987432 2223322111 1111112234578999999999999
Q ss_pred ccceeeeeEecCCccEEEEEecCCCCHHhhhccCC---CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEE
Q 001816 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK---GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNIL 819 (1010)
Q Consensus 743 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nil 819 (1010)
||+++++++...+..|+|||++ ++++.+++.... .......++..++.|++.||+|||+.+ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999999999999999998 467777764321 122345677889999999999999776 999999999999
Q ss_pred EcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCcc--
Q 001816 820 LDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD-- 897 (1010)
Q Consensus 820 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~-- 897 (1010)
++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..++........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999987643222 122345799999999999999999999999999999999998764332222111
Q ss_pred -HHHHHHHHhhhccc------ccccccCC-CCC----CCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 898 -IVQWVRKMTDSKKE------GVLKILDP-RLP----SVP-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 898 -~~~~~~~~~~~~~~------~~~~~~~~-~~~----~~~-----~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+.+.+..+.....+ .+...++. ... ..+ ......+.+++.+|++.||++|||+.|++++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111111000000 00000000 000 000 0012245667889999999999999999875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=280.75 Aligned_cols=205 Identities=24% Similarity=0.372 Sum_probs=172.8
Q ss_pred cccCCcCCeEeecCcEEEEEEEecC-----CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec-CCc
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN-----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-HET 756 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 756 (1010)
...|+....||+|.||.||+|..++ ...+|+|+++.............+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4678888999999999999996332 2268999998766655556667899999999999999999998876 778
Q ss_pred cEEEEEecCCCCHHhhhccC---CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC----CceEEe
Q 001816 757 NLLVYEYMPNGSLGEVLHGK---KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG----FEAHVA 829 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~----~~~kl~ 829 (1010)
.++++||.+ -+|.++++.. +...++...+..++.||+.|+.|||++. |+|||+||+||++..+ |.|||+
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 899999996 5888888542 3456889999999999999999999988 9999999999999877 899999
Q ss_pred eccccccccCCCCc-ceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCC
Q 001816 830 DFGLAKFLQDSGTS-ECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGE 891 (1010)
Q Consensus 830 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~ 891 (1010)
|||+|+.+...-.. ......+-|.+|.|||.+.+. -|+.+.||||.|||+.||+|-++-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999987654322 233456789999999999876 489999999999999999998888754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.03 Aligned_cols=262 Identities=27% Similarity=0.361 Sum_probs=200.2
Q ss_pred ccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCC-----cccchHHHHHHHhccCCcccceeeeeEec-C
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSS-----HDHGFNAEIQTLGRIRHRHIVRLLGFCSN-H 754 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 754 (1010)
+.++|-..++||+|||+.||+|. ....+.||||+-.......+ ..+...+|.++.+.++||.||++|+|+.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 35678888999999999999998 45678899997643222111 12335689999999999999999999865 4
Q ss_pred CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEc---CCCceEEeec
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD---SGFEAHVADF 831 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~---~~~~~kl~DF 831 (1010)
+.++-|+|||+|.+|+-|++ ....+++++++.|+.||+.||.||.+. +++|||=||||.|||+- .-|.+||.||
T Consensus 541 dsFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 56789999999999999995 345799999999999999999999987 68899999999999994 3578999999
Q ss_pred cccccccCCCCcc-----eeeeecccccccChhhhccC----CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHH
Q 001816 832 GLAKFLQDSGTSE-----CMSAIAGSYGYIAPEYAYTL----KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWV 902 (1010)
Q Consensus 832 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~ 902 (1010)
|+++.+.+..... ......||++|++||++.-+ .++.|+||||.|||+|.++.|+.||+......++++.-
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 9999987654432 23446799999999987633 47889999999999999999999998644333333321
Q ss_pred HHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.+.-.-.+|.-|. ...+...+|++|++..-++|....++...
T Consensus 698 ---------TIlkAtEVqFP~KPv-VsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 698 ---------TILKATEVQFPPKPV-VSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ---------chhcceeccCCCCCc-cCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 111111112222221 12345679999999999999887777543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.74 Aligned_cols=265 Identities=23% Similarity=0.298 Sum_probs=198.6
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC--CccEEEEE
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH--ETNLLVYE 762 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 762 (1010)
|++.+.||+|+||.||+|... +|+.||+|+++...........+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999965 588999999986543333445688899999999999999999999888 78999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
|++ ++|.+++... ...+++..+..++.|+++|++|||+.+ ++|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 5898888543 257899999999999999999999777 99999999999999999999999999987654322
Q ss_pred cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc---cccc--
Q 001816 843 SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG---VLKI-- 916 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 916 (1010)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....................... ..+.
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 11223457889999998765 4578999999999999999999999975432221111111110000000 0000
Q ss_pred ---cCCCC--C----CC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 ---LDPRL--P----SV-PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ---~~~~~--~----~~-~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+.. + .. ...++..+.+++.+|++.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 0 00 00024567889999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.69 Aligned_cols=244 Identities=24% Similarity=0.246 Sum_probs=187.2
Q ss_pred eEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCc-ccchHHHHH---HHhccCCcccceeeeeEecCCccEEEEEecC
Q 001816 691 IIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSH-DHGFNAEIQ---TLGRIRHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~-~~~~~~E~~---~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
+||+|+||.||+|.. .+|+.||+|.+......... ...+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 46889999998653322111 122334443 3444579999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce
Q 001816 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 766 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
||+|.+++. ..+.+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999999885 3457999999999999999999999776 9999999999999999999999999997653221
Q ss_pred eeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCC
Q 001816 846 MSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (1010)
.....|+..|+|||++.+. .++.++||||+||++|||++|+.||........ ...... .. ...+. .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~-~~--------~~~~~---~ 218 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRM-TL--------TMAVE---L 218 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHH-hh--------ccCCC---C
Confidence 1234689999999998754 689999999999999999999999975422111 111100 00 01111 2
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 925 PLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 925 ~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
+...+..+.+++.+|+..+|.+|| ++.|+.++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 222345788899999999999999 99999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.21 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=198.2
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+|+..+.||+|++|.||+|... +|+.||||+++..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 3677889999999999999964 6889999998754332 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHhhhccCC-CCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 764 MPNGSLGEVLHGKK-GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++++|||++.......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 80 MD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred CC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 97 48888875432 346899999999999999999999776 9999999999999999999999999997553221
Q ss_pred cceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccc-----cc
Q 001816 843 SECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL-----KI 916 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 916 (1010)
.......+++.|+|||++.+. .++.++||||||+++|||++|+.||.............+.......+... ..
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 112234578899999988654 57889999999999999999999997543322222211111100000000 00
Q ss_pred cCCCCCCC--------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLPSV--------PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~--------~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+....+.. .......+.+++.+|++.+|.+||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00111110 11223457789999999999999999999753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.15 Aligned_cols=269 Identities=21% Similarity=0.248 Sum_probs=196.0
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC------
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE------ 755 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 755 (1010)
.++|++.+.||+|+||.||+|... +|+.||||++............+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578888999999999999999954 6889999998654433333445788999999999999999999875443
Q ss_pred --ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 756 --TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 756 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
..++||||++ +++...+.. ....+++.++..++.|+++||+|||..+ |+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 4599999995 477776653 3457999999999999999999999776 99999999999999999999999999
Q ss_pred cccccCCCCcc---------eeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHH
Q 001816 834 AKFLQDSGTSE---------CMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903 (1010)
Q Consensus 834 a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~ 903 (1010)
++......... ......|++.|+|||.+.+. .++.++|||||||++|||++|++||....+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 97654322111 11234578899999987654 588999999999999999999999965333221111111
Q ss_pred HHhhhccc------cccc----ccCCCCCCCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 904 KMTDSKKE------GVLK----ILDPRLPSVP----LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 904 ~~~~~~~~------~~~~----~~~~~~~~~~----~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
........ .+.. ......+... ......+.+++.+|++.+|++|||+.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11000000 0000 0000111000 1112457789999999999999999999754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.12 Aligned_cols=256 Identities=25% Similarity=0.267 Sum_probs=198.9
Q ss_pred CCcCCeEeecCcEEEEEEEe----cCCCEEEEEEeccCCC--CCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccE
Q 001816 686 LKEDNIIGKGGAGIVYKGLM----PNGDQVAVKRLPAMSR--GSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 758 (1010)
|++.+.||+|+||.||++.. .+++.||||+++.... .......+..|+++++++ +||+|+++++.+..++..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678899999999999874 3578899999864322 122234578899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||..+ ++||||||+||+++.++.++|+|||+++...
T Consensus 82 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 82 LILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999853 356889999999999999999999766 9999999999999999999999999987654
Q ss_pred CCCCcceeeeecccccccChhhhccCC--CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLK--VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.... .......|+..|+|||...+.. .+.++||||||+++|||++|..||...........+.+.....
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-------- 227 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--------
Confidence 3321 1222346899999999987665 7889999999999999999999996432222222222211110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
.+..+......+.+++.+|++.+|++|||+.++.+.++.
T Consensus 228 ----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111222233467789999999999999999888776655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.49 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=199.8
Q ss_pred CCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 689 DNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 689 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
.+++|+|.||+||-|+ .++|+.||||++.+..........+.+|+.+++.+.||.||.+.--|+..+..++|||-+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 4789999999999998 467999999999887777777778999999999999999999999999999999999999 56
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC---CceEEeeccccccccCCCCcc
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG---FEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~---~~~kl~DFGla~~~~~~~~~~ 844 (1010)
+..+.+-....+++++.....+..||+.||.|||..+ |+|+|+||+|||+.+. -++||||||.|+.+... .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---s 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---S 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---h
Confidence 7767666567789999999999999999999999776 9999999999999653 36999999999987653 3
Q ss_pred eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCC
Q 001816 845 CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (1010)
.....+|||.|.|||+++...|...-|+||.|||+|--++|..||.+.++-.+ .++.. .+ ..|..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---QIQNA---------aF---MyPp~ 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---QIQNA---------AF---MYPPN 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH---Hhhcc---------cc---ccCCC
Confidence 34567899999999999999999999999999999999999999976433222 22110 01 11222
Q ss_pred CH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 925 PL-HEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 925 ~~-~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
|. +......++|...++..-.+|-+.+..+.
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 22 22344667888888888888887776544
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=307.95 Aligned_cols=272 Identities=23% Similarity=0.298 Sum_probs=204.3
Q ss_pred cCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC-----ccE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE-----TNL 758 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~ 758 (1010)
+|++.+.||+|+||.||+|... +|+.||||++..........+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999964 5899999999765443444566889999999999999999999987765 789
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 589988853 347999999999999999999999777 9999999999999999999999999998765
Q ss_pred CCCC-cceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc-----
Q 001816 839 DSGT-SECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE----- 911 (1010)
Q Consensus 839 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----- 911 (1010)
.... ........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.....................+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 0122345688999999999887 88999999999999999999999997543221111111110000000
Q ss_pred ---ccccccC--CCCC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCCC
Q 001816 912 ---GVLKILD--PRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI--LTELPK 962 (1010)
Q Consensus 912 ---~~~~~~~--~~~~-----~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~--L~~~~~ 962 (1010)
...+.+. +... ......+..+.+++.+||+.+|++||++.+++++ ++....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000 0000 0011134567889999999999999999999984 554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=299.88 Aligned_cols=253 Identities=24% Similarity=0.278 Sum_probs=196.7
Q ss_pred CCcCCeEeecCcEEEEEEEe----cCCCEEEEEEeccCCC--CCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccE
Q 001816 686 LKEDNIIGKGGAGIVYKGLM----PNGDQVAVKRLPAMSR--GSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 758 (1010)
|++.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+.+|+++++++ +|++|+++++.+..+...|
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 66778999999999999985 3688999999865322 122234578899999999 5999999999999988999
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 82 LILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999853 356889999999999999999999776 9999999999999999999999999998654
Q ss_pred CCCCcceeeeecccccccChhhhccC--CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.... .......|+..|+|||...+. .++.++||||||+++|+|++|+.||...........+.......
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------- 227 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--------
Confidence 3221 122245689999999998753 46789999999999999999999996433322222222221111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~ev~~~ 956 (1010)
.+..+......+.+++.+|++.+|++|| ++.++..+
T Consensus 228 ----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1112223345677899999999999997 66776553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.42 Aligned_cols=266 Identities=21% Similarity=0.328 Sum_probs=196.0
Q ss_pred ccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC-----
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE----- 755 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 755 (1010)
+.++|...+.||+|+||.||+|.. .+|+.||||+++...........+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 346778888999999999999995 46899999998754333333445789999999999999999999986543
Q ss_pred -ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccc
Q 001816 756 -TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 756 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla 834 (1010)
..++||||+. .++.++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred ceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4589999995 47776652 35899999999999999999999777 999999999999999999999999999
Q ss_pred ccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccc
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
+..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||............+ ..........
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL-KVTGVPGPEF 238 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HhcCCCCHHH
Confidence 764321 123467889999999876 468899999999999999999999997532211111111 1000000000
Q ss_pred cc---------ccC--CCCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCC
Q 001816 914 LK---------ILD--PRLPSV-----PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI--LTELP 961 (1010)
Q Consensus 914 ~~---------~~~--~~~~~~-----~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~--L~~~~ 961 (1010)
.+ ... +..+.. .......+.+++.+|++.||++||+++|++.+ ++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 000 000100 01123457789999999999999999999864 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=308.90 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=196.6
Q ss_pred ccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCC---
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE--- 755 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 755 (1010)
..+.++|++.+.||+|+||.||+|. ..+|..||||+++...........+.+|++++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3456788889999999999999998 457899999998643332223345778999999999999999999887654
Q ss_pred ---ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecc
Q 001816 756 ---TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832 (1010)
Q Consensus 756 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFG 832 (1010)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 348999999 7899988843 46899999999999999999999777 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
++...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||.............. .......
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK-VTGTPSK 237 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hcCCCCH
Confidence 99765322 123467899999998876 4588999999999999999999999975332111111111 0000000
Q ss_pred cccccc----------------CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 912 GVLKIL----------------DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 912 ~~~~~~----------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
.+.+.+ ...+..........+.+++.+|++.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000011122335778999999999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.94 Aligned_cols=269 Identities=21% Similarity=0.275 Sum_probs=197.4
Q ss_pred ccccCCc-CCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCC------------cccchHHHHHHHhccCCccccee
Q 001816 682 VLDCLKE-DNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSS------------HDHGFNAEIQTLGRIRHRHIVRL 747 (1010)
Q Consensus 682 ~~~~~~~-~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~hpniv~~ 747 (1010)
+.++|.. .+.||+|+||+||+|... +|+.||||+++....... ....+.+|++++++++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3456654 577999999999999954 689999999865332210 11246789999999999999999
Q ss_pred eeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceE
Q 001816 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH 827 (1010)
Q Consensus 748 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~k 827 (1010)
++++..++..++||||++ |+|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 999999999999999996 69999885 3356899999999999999999999776 99999999999999999999
Q ss_pred EeeccccccccCCC------------CcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCC
Q 001816 828 VADFGLAKFLQDSG------------TSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGD 894 (1010)
Q Consensus 828 l~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~ 894 (1010)
|+|||.+....... .........+++.|+|||++.+. .++.++||||+||++|||++|+.||....+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654111 01111233468899999998764 468999999999999999999999975443
Q ss_pred CccHHHHHHHHhhhcccccccc--------cCCCCC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 895 GVDIVQWVRKMTDSKKEGVLKI--------LDPRLP----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...................... .....+ .........+.+++.+|++.+|++||+++|++.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 2222111111110000000000 000000 1111224567789999999999999999999874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=300.09 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=197.0
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCCccEEEEEe
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
|++.+.||+|+||+||+|... +++.||||++...... .......+|+..+++++ |||++++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 556788999999999999965 5789999998654332 22233567999999998 99999999999999999999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+ +|+|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 9 889999887554457899999999999999999999777 99999999999999999999999999986543221
Q ss_pred ceeeeecccccccChhhhc-cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc------ccccc
Q 001816 844 ECMSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE------GVLKI 916 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 916 (1010)
.....++..|+|||++. ...++.++|+||||+++|||++|+.||.....................+ .....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22346888999999875 4557899999999999999999999996543222211111100000000 00000
Q ss_pred cCCCCC--------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLP--------SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+...+ .........+.+++.+|++.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 010111 0011113568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=307.04 Aligned_cols=266 Identities=20% Similarity=0.254 Sum_probs=193.2
Q ss_pred cCCcCCeEeecCcEEEEEEEec-C--CCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC----Cc
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-N--GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH----ET 756 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~----~~ 756 (1010)
+|++.+.||+|+||.||++... . +..||+|++............+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667788999999999999954 3 77899999865433333345578899999999 599999999875432 45
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
.|++|||+. ++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 688999885 78999884 3456899999999999999999999777 99999999999999999999999999986
Q ss_pred ccCCCCc--ceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccc
Q 001816 837 LQDSGTS--ECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 837 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
....... .......|++.|+|||+..+ ..++.++||||+||++|+|++|+.||............+........+..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 11233568999999998765 56899999999999999999999999754321111111111100000000
Q ss_pred c-----------ccc----CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 L-----------KIL----DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ~-----------~~~----~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
. ... ...+..........+.+++.+|++.+|++|||+.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000 000111111123467889999999999999999999763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=307.73 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=197.0
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC----
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH---- 754 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 754 (1010)
..+.++|.+.+.||+|+||.||+|.. .+|+.||+|+++...........+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 34567888899999999999999984 5789999999875433333345577899999999999999999987543
Q ss_pred --CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecc
Q 001816 755 --ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832 (1010)
Q Consensus 755 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFG 832 (1010)
...|++++++ +++|.+++.. ..+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccc
Confidence 3467888877 8899888743 35899999999999999999999777 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
++...... .....|++.|+|||...+ ..++.++|||||||++|||++|+.||.............+.......+
T Consensus 166 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 166 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99764321 234568899999998866 568899999999999999999999996533221111111111000000
Q ss_pred c-----------cccccCCCCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 912 G-----------VLKILDPRLPSV-----PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 ~-----------~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
. ....+ +..+.. .......+.+++.+|++.+|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHh-cccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00000 001110 01123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=283.80 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=193.6
Q ss_pred CCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEe
Q 001816 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
.+....||.|+||+|+|-.+ +.|+.+|||++..... .....++..|.+...+- +.||||++||++..++..|+.||+
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34456799999999999884 5799999999986554 33345577777765554 799999999999999999999999
Q ss_pred cCCCCHHhh---hccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 764 MPNGSLGEV---LHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 764 ~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
| ..+++.+ ....+...+++.-.-.|..-...||.||.+.. .|||||+||+|||+|..|.+||||||++..+.++
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 9 4566543 34445567888888888888999999998743 4999999999999999999999999999876432
Q ss_pred CCcceeeeecccccccChhhhc--cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAY--TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
...+.-+|...|||||.+. +..|+.++||||+|+++||+.||+.|+..+.+..+ .+..+... |
T Consensus 222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe---ql~~Vv~g---------d 286 (361)
T KOG1006|consen 222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE---QLCQVVIG---------D 286 (361)
T ss_pred ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH---HHHHHHcC---------C
Confidence 2233456899999999886 34599999999999999999999999976543211 11111111 1
Q ss_pred CCCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSV---PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~---~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+..-.. ..+....+..++.-|+.+|-..||.+.++.++
T Consensus 287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111 23456778899999999999999999998763
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=279.47 Aligned_cols=257 Identities=21% Similarity=0.331 Sum_probs=193.4
Q ss_pred CeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecCCC
Q 001816 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
+.||+|+||.|--++ ..+|..||||++.+.. .....+..+|++++... .|+||+++++||++++..|+|||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 579999999999887 7789999999997652 23355678899999998 5999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC---ceEEeeccccccccCCC---
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF---EAHVADFGLAKFLQDSG--- 841 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~---~~kl~DFGla~~~~~~~--- 841 (1010)
+|...+++ ...+++.++.++.++|+.||.|||..| |.|||+||+|||-.... -+|||||.+..-+....
T Consensus 162 plLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 162 PLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred hHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99999964 457999999999999999999999777 99999999999986543 48999998875432211
Q ss_pred --CcceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHH-HHhhhccccc
Q 001816 842 --TSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR-KMTDSKKEGV 913 (1010)
Q Consensus 842 --~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~ 913 (1010)
......+.+|+..|||||++. ...|+.++|.||||||+|-|++|.+||.+.-..+- -|-+ +......+.+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--GWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--GWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--CccCCCccHHHHHHH
Confidence 122334568999999999864 34589999999999999999999999976432110 0100 0000001111
Q ss_pred ccccCCCCCCCCHHHH----HHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 914 LKILDPRLPSVPLHEV----MHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 914 ~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
.+.+....-++|..++ ....+++...+..|+..|-++.+++.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1122222223333333 33456777888899999999999877
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=324.76 Aligned_cols=256 Identities=29% Similarity=0.442 Sum_probs=207.3
Q ss_pred CCcCCeEeecCcEEEEEEEec----C----CCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCc
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP----N----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 756 (1010)
..+.+.+|+|.||.||+|... . ...||||.++..... ...+.+..|+++|+.+ +||||+.++|+|...+.
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 345568999999999999732 1 346999999865554 5667799999999999 69999999999999999
Q ss_pred cEEEEEecCCCCHHhhhccCC------------C--CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC
Q 001816 757 NLLVYEYMPNGSLGEVLHGKK------------G--GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS 822 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~ 822 (1010)
.++|+||++.|+|.++++..+ . ..++....+.++.|||.|++||++.. ++|||+.++|||+.+
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecC
Confidence 999999999999999997544 0 13888899999999999999999554 999999999999999
Q ss_pred CCceEEeeccccccccCCCCcceeeeecc--cccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHH
Q 001816 823 GFEAHVADFGLAKFLQDSGTSECMSAIAG--SYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIV 899 (1010)
Q Consensus 823 ~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~ 899 (1010)
+..+||+|||+|+........... .-.| ...|||||.+....|+.++|||||||++||+++ |..||.+.....++.
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 999999999999965544333211 1122 346999999999999999999999999999999 899997643233333
Q ss_pred HHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
++++. ....+.|..+..+++.+++.||+.+|++||++.|+++.++..
T Consensus 533 ~~l~~--------------G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 533 EFLKE--------------GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHhc--------------CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 32221 222334556677889999999999999999999999998884
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.15 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=194.6
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
||+|+||.||++... +|+.||+|+++..... ......+.+|++++++++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999975 4899999998653321 22345688899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC------c
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT------S 843 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~------~ 843 (1010)
.+++... +.+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999643 47899999999999999999999777 99999999999999999999999999876433211 1
Q ss_pred ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCC
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
.......++..|+|||...+..++.++||||||+++||+++|+.||..... .......... ....+.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~---------~~~~~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIFQNILNG---------KIEWPE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcC---------CcCCCc
Confidence 122345688899999999988899999999999999999999999965321 1112111110 001111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 924 ~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
. ......+..++.+|++.+|++|||+.++.+.++
T Consensus 223 ~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 D-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 012456788999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=301.25 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=196.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|...+.||+|+||.||+|+.. +++.||+|.+...... ......+.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344666788999999999999954 6789999988643221 22234577899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+. |++.+++... ...+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 99996 6887776432 346889999999999999999999776 999999999999999999999999998765321
Q ss_pred CCcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
....|++.|+|||++. ...++.++|||||||++|||++|+.||...........+. .. .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~---~----- 230 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QN---E----- 230 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh----hc---C-----
Confidence 2346889999999875 3567889999999999999999999986532211111111 00 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
.+.. ........+.+++.+||+.+|++||++.+++.+.....
T Consensus 231 ~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 231 SPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0111 11233456778999999999999999999998754443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=310.57 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=199.2
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCc--
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET-- 756 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-- 756 (1010)
.++.++|+..+.||+|+||.||+|... +++.||||++............+.+|+.++++++|||++++.+++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 345678889999999999999999964 58899999986543333334557789999999999999999998866554
Q ss_pred ----cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecc
Q 001816 757 ----NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832 (1010)
Q Consensus 757 ----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFG 832 (1010)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 79999998 6799998853 46899999999999999999999777 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
++...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...+........+
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~ 237 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDE 237 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCH
Confidence 99865322 234468889999998865 4678999999999999999999999965332111 1111111100000
Q ss_pred cc---------ccc---c----CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 912 GV---------LKI---L----DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 ~~---------~~~---~----~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.. ... . .+.+..........+.+++.+|++.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 000 0 000001111124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=304.84 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=198.0
Q ss_pred cccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec-CCccE
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-HETNL 758 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 758 (1010)
.+.++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|++++++++||||+++++++.. ....|
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4577899999999999999999984 478999999986543333345567889999999999999999998865 55789
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||+|+||+++.++.++|+|||.+....
T Consensus 87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 999998 6789888842 45788888999999999999999776 9999999999999999999999999997543
Q ss_pred CCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccc----
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV---- 913 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---- 913 (1010)
.. .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+.+......+..
T Consensus 160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhc
Confidence 21 123467889999998765 56899999999999999999999999653321 11111111110000000
Q ss_pred -----ccccC--CCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 914 -----LKILD--PRLPSVPL-----HEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 -----~~~~~--~~~~~~~~-----~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.+. +.....+. .....+.+++.+|++.+|++||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00001111 123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=292.40 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=187.5
Q ss_pred ccCCcCCe--EeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEE
Q 001816 684 DCLKEDNI--IGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~--lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 759 (1010)
+.|++.+. +|+|+||.||++.. .+|+.+|+|.++..... ..|+.....+ +||||+++++++...+..|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-------hhhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34455444 49999999999984 46889999998643221 1133333323 79999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-ceEEeecccccccc
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAKFLQ 838 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~DFGla~~~~ 838 (1010)
||||+++++|.+++... ..+++.++..++.|+++|++|||+.+ ++||||||+||+++.++ .++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999543 47999999999999999999999777 99999999999999988 99999999987653
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc-cHHHHHHHHhhhccccccccc
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV-DIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
.. ....|+..|+|||++.+..++.++||||+|+++|||++|+.||....+.. ....+.... .
T Consensus 162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~---------- 224 (267)
T PHA03390 162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q---------- 224 (267)
T ss_pred CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c----------
Confidence 22 12368899999999999899999999999999999999999997432221 112222111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPT-MREVVQI 956 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-~~ev~~~ 956 (1010)
.....+......+.+++.+|++.+|.+||+ ++|++++
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 --KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 011112234457888999999999999996 6888753
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=295.61 Aligned_cols=243 Identities=22% Similarity=0.256 Sum_probs=186.3
Q ss_pred CeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC-CcccchHHHHHHH-hccCCcccceeeeeEecCCccEEEEEecCC
Q 001816 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS-SHDHGFNAEIQTL-GRIRHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
+.||+|+||.||+|.. .+|+.||||+++...... .....+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 468899999986432211 1122344555444 345899999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 999999853 356899999999999999999999776 99999999999999999999999999875432 2
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
....|++.|+|||...+..++.++||||+|+++|||++|..||..... ............ . .. .....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~----~-~~---~~~~~ 218 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNILSRRI----N-WP---EEVKE 218 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhccc----C-CC---Ccccc
Confidence 234688999999999888899999999999999999999999964322 111221111100 0 00 01112
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 927 ~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
..+..+.+++.+|++.+|++||++.++.+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 23456889999999999999997754444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=299.66 Aligned_cols=245 Identities=20% Similarity=0.331 Sum_probs=194.5
Q ss_pred CCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCC
Q 001816 689 DNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 689 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
..+||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++|||++++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999986 478999999875422 223455888999999999999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceee
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 847 (1010)
+|.+++.. ..+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||.+....... ....
T Consensus 103 ~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 103 ALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 99998742 35889999999999999999999776 9999999999999999999999999987654321 1223
Q ss_pred eecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHH
Q 001816 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927 (1010)
Q Consensus 848 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (1010)
...|++.|+|||...+..++.++|+||+|+++|||++|..||..... .. ......... .+.... ...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-~~---~~~~~~~~~--------~~~~~~-~~~ 241 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LK---AMKMIRDNL--------PPKLKN-LHK 241 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HH---HHHHHHhhC--------CcccCC-ccc
Confidence 45689999999999888899999999999999999999999864221 11 111111110 111111 111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 928 EVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 928 ~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
....+.+++.+|++.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23356788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=295.43 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=197.5
Q ss_pred cCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCC---CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRG---SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
+|.+.+.||+|+||.||++.... +..+++|.++..... ......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999998543 455667766543221 22233467799999999999999999999999999999
Q ss_pred EEecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc
Q 001816 761 YEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
|||+++++|.+++.. .....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998853 23457899999999999999999999777 999999999999975 569999999997654
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
... .......|++.|+|||...+..++.++|+||||+++|+|++|..||.... ........ ..
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~~-----------~~ 219 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRI-----------VE 219 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHH-----------Hc
Confidence 322 12234568899999999988889999999999999999999999985421 11221111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+..+......+.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 22233344455678889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=299.96 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=201.6
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCC-CCCcccchHHHHHHHhccC-CcccceeeeeEecCCccEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 760 (1010)
++|...+.||+|+||.||+|... +|..||+|++..... .......+..|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 35778889999999999999954 789999999865322 2223456788999999998 99999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 999999999999953 347999999999999999999999777 999999999999999999999999999866433
Q ss_pred CCc------------------ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHH
Q 001816 841 GTS------------------ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWV 902 (1010)
Q Consensus 841 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~ 902 (1010)
... .......|+..|+|||+..+..++.++||||||+++|++++|+.||..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~ 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTF 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHHH
Confidence 211 222334578999999999988899999999999999999999999975431 1111
Q ss_pred HHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 001816 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTM----REVVQI 956 (1010)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~----~ev~~~ 956 (1010)
+..... ....+......+.+++.+|++.+|++||++ .+++++
T Consensus 232 ~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 QKILKL------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHhc------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111110 011122234567889999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=299.35 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=194.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||.||+|.+.. |+.||||+++..... .....+..|+.++.+. .||||+++++++.++...|+|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4668888999999999999999764 889999998753322 2234466677767666 499999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
|||++ +++.++... ....+++..+..++.|++.|++|||+ .+ |+||||+|+||++++++.+||+|||++..+..
T Consensus 93 ~e~~~-~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99984 577776643 23478999999999999999999996 35 99999999999999999999999999976543
Q ss_pred CCCcceeeeecccccccChhhhccCC----CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccc
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLK----VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
... .....+++.|+|||++.+.. ++.++||||||+++|||++|+.||.......+ .........
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~------ 235 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEE------ 235 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH---HHHHHhcCC------
Confidence 222 12335788999999987554 78999999999999999999999965322211 111111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
.+..+. .......+.+++.+|++.+|++||++.+++++-
T Consensus 236 --~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 --PPSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --CCCCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 011111 112345678899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=306.04 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=208.7
Q ss_pred ccccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEec----
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSN---- 753 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---- 753 (1010)
.+-.+.|++.++||.|.+|.||+++ .++|+.+|||+..... ...++++.|.++++.. .|||++.++|++..
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3445778888999999999999999 5678999999876432 3355678899999888 69999999999854
Q ss_pred -CCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecc
Q 001816 754 -HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832 (1010)
Q Consensus 754 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFG 832 (1010)
++..|+|||||.||+..|+++...+.++.|+.+..|++.+++|+.+||++. ++|||||-.|||++.++.||++|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 468899999999999999998877889999999999999999999999877 9999999999999999999999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhh
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD 907 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 907 (1010)
++..++. +.....+..|||.|||||++. ...|+.++|+||+|++..||..|.+|+.++..- +.
T Consensus 169 vSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------ra--- 236 (953)
T KOG0587|consen 169 VSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------RA--- 236 (953)
T ss_pred eeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------hh---
Confidence 9987654 334455678999999999876 345788999999999999999999999765321 11
Q ss_pred hccccccccc-CCCCC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 908 SKKEGVLKIL-DPRLP-SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 908 ~~~~~~~~~~-~~~~~-~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+..+. +|... .-+.....++.++|..|+.+|-++||++.+++++
T Consensus 237 -----LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -----LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 11111 1255666788899999999999999999998763
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=295.80 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=199.2
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|+..+.||+|+||.||+|... +++.||+|+++...........+..|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999965 5899999999765433334456788999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
+ ++|.+++.... ..+++..+..++.|++.|++|||+.+ |+||||+|+||++++++.+||+|||.+........
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 59999996432 46899999999999999999999877 99999999999999999999999999986543221
Q ss_pred eeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccc---cccc--cC
Q 001816 845 CMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG---VLKI--LD 918 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~~ 918 (1010)
......++..|+|||.+.+. .++.++||||||+++||+++|+.||....................... .... .+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12234567889999998766 889999999999999999999999965332111111111110000000 0000 01
Q ss_pred CCCCC---C-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPS---V-----PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~---~-----~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...+. . .......+.+++.+|++.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 01110 0 01114568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=298.60 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=192.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCC-CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.|...+.||+|+||+||+|.. .+|+.||+|++....... .....+.+|+++++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3356667899999999999985 468899999986533322 22345788999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
||+. |++.+++.. ....+++.++..++.|++.|++|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 101 e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 101 EYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred ecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 9995 677777753 3356899999999999999999999777 99999999999999999999999999864321
Q ss_pred CcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 842 TSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.....|+..|+|||++. ...++.++|||||||++|||++|..||....... ........ . .
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~~---~-----~ 237 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQN---D-----S 237 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhc---C-----C
Confidence 12346889999999974 4568889999999999999999999986532211 11111110 0 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+... .......+.+++.+|++.+|.+||++.+++.+
T Consensus 238 ~~~~--~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTLQ--SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 11122357789999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=301.75 Aligned_cols=265 Identities=19% Similarity=0.286 Sum_probs=192.8
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-------
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------- 754 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------- 754 (1010)
..+|...+.||+|+||.||+|.. .+|..||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 46788889999999999999985 4689999999865433 3345578899999999999999999876543
Q ss_pred -------CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-CCce
Q 001816 755 -------ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEA 826 (1010)
Q Consensus 755 -------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~ 826 (1010)
...|+||||++ ++|.+++. ...+++..+..++.||+.|++|||+.+ |+||||||+||+++. ++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 34689999996 68988874 246899999999999999999999777 999999999999974 5578
Q ss_pred EEeeccccccccCCCCcc-eeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 001816 827 HVADFGLAKFLQDSGTSE-CMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 827 kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~ 904 (1010)
|++|||.+.......... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999997653321111 1122357889999998654 56888999999999999999999999654332222211111
Q ss_pred Hhhhcc---ccc----ccc-c-CCCCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 905 MTDSKK---EGV----LKI-L-DPRLPSVP-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 905 ~~~~~~---~~~----~~~-~-~~~~~~~~-----~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...... ... ... . ....+..+ ......+.+++.+|++.||++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 100000 000 000 0 00001111 1123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=322.07 Aligned_cols=148 Identities=30% Similarity=0.370 Sum_probs=130.0
Q ss_pred cccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
.+.|.+.+.||+|+||.||+|... +++.||||+++..... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367888899999999999999965 6899999998653221 22235688899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccc
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~ 835 (1010)
|||+++++|.+++.. .+.+++..++.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999953 346889999999999999999999776 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=298.28 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=195.1
Q ss_pred ccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEE
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 759 (1010)
..+.|+....+|.|+|+.|-++. ..++...+||++..... .-.+|+.++... +||||++..+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 35667777789999999999887 45688899999965422 235677666666 79999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE-cCCCceEEeecccccccc
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL-DSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill-~~~~~~kl~DFGla~~~~ 838 (1010)
|||++.|+-+.+.+...+ .+. .++..|+.+|+.|+.|||.+| |||||+||+|||+ ++.++++|+|||.++...
T Consensus 394 v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999998888775332 233 677789999999999999877 9999999999999 689999999999998765
Q ss_pred CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccC
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.. ..+.+-|..|.|||+....+|++++|+||||+++|+|++|+.||.......++...+..
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~-------------- 528 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM-------------- 528 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC--------------
Confidence 43 23445688999999999999999999999999999999999999876554332221111
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959 (1010)
Q Consensus 919 ~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~ 959 (1010)
+......+....+++.+|++.||.+||+|+++..+-+-
T Consensus 529 ---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 ---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---CccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11112333466789999999999999999999876443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=279.87 Aligned_cols=241 Identities=24% Similarity=0.270 Sum_probs=191.2
Q ss_pred ccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCc-ccchHHHHHHHhcc-CCcccceeeeeEecCCccEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSH-DHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 760 (1010)
..|....+||+|+||.|-.|..+ +.+.+|||++++...-... .+--..|-+++..- +-|.+++++..+..-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 45667789999999999999854 4567999999764432221 22234566666655 578999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
|||+.||+|-..+ +.-+++.+..+..++.+||-||-+||+.| |+.||||..||++|.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-- 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 501 (683)
T ss_pred EEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc--
Confidence 9999999998887 45578999999999999999999999666 9999999999999999999999999998532
Q ss_pred CCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCC
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
-......+.+|||.|+|||++...+|+.++|.||+||++|||+.|++||++. ++.++.+.+.....
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-DE~elF~aI~ehnv------------- 567 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-DEDELFQAIMEHNV------------- 567 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHccC-------------
Confidence 2234556889999999999999999999999999999999999999999763 33333333322111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCC
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVER 947 (1010)
Q Consensus 921 ~~~~~~~~~~~~~~li~~cl~~~P~~R 947 (1010)
..|...+.+...+.+..+.+.|.+|
T Consensus 568 --syPKslSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 568 --SYPKSLSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred --cCcccccHHHHHHHHHHhhcCCccc
Confidence 1233344455567777788899998
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=285.21 Aligned_cols=238 Identities=28% Similarity=0.312 Sum_probs=191.9
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCH
Q 001816 692 IGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 769 (1010)
||+|+||.||++... +++.||+|++...... ......+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999964 5899999998654322 12344688899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeee
Q 001816 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 770 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
.+++.. ...+++..+..++.|++.|+.|+|+.+ ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 999953 346899999999999999999999776 9999999999999999999999999997654321 123345
Q ss_pred cccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHH
Q 001816 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEV 929 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (1010)
.++..|+|||...+...+.++|+||||+++||+++|+.||...+. .+..+..... . ...+...+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~---------~---~~~~~~~~ 217 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKD---------P---LRFPEFLS 217 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcC---------C---CCCCCCCC
Confidence 688999999999988899999999999999999999999965322 1112221110 0 11222224
Q ss_pred HHHHHHHHhccccCCCCCCCHHH
Q 001816 930 MHVFYVAMLCVEEQAVERPTMRE 952 (1010)
Q Consensus 930 ~~~~~li~~cl~~~P~~RPs~~e 952 (1010)
..+.+++.+|+..||++||++++
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 56788999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=265.62 Aligned_cols=274 Identities=20% Similarity=0.272 Sum_probs=200.7
Q ss_pred cccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH----- 754 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 754 (1010)
+....|+...+||+|.||.||+|+.+ .|+.||+|++-.....+.......+|++++..++|+|++.+++.|...
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 34567788889999999999999954 577899987643322222333457899999999999999999887542
Q ss_pred ---CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeec
Q 001816 755 ---ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 755 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
...|+||.+|+ .+|...+.. ...+++..++.+++.++..||.|+|... |+|||+||+|+||+.+|.+||+||
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 34699999995 588888863 3467999999999999999999999776 999999999999999999999999
Q ss_pred cccccccCCCC--cceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh
Q 001816 832 GLAKFLQDSGT--SECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 832 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
|+|+.+..... .......+-|.+|.+||.+.+ ..|+++.|||+.|||+.||+||.+-+.... +....+.++.+...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-eqqql~~Is~LcGs 247 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-EQQQLHLISQLCGS 247 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh-HHHHHHHHHHHhcc
Confidence 99976643332 223445667999999998876 469999999999999999999998886532 23333334333222
Q ss_pred cccc----cc-----cccC-CCCCCCC----HHH------HHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 909 KKEG----VL-----KILD-PRLPSVP----LHE------VMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 909 ~~~~----~~-----~~~~-~~~~~~~----~~~------~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.... +. +.+. +.++.-. ... -....+++..++..||.+|+++++++.+-.-.
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 1110 00 0010 0011000 000 11356788899999999999999998864443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=285.76 Aligned_cols=253 Identities=22% Similarity=0.252 Sum_probs=203.9
Q ss_pred ccCCcCCeEeecCcEEEEEEEecCCC-EEEEEEeccCC-CCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGD-QVAVKRLPAMS-RGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
..++....||-|+||.|-.+..++.. .+|+|.+++.- .+.........|-++|...+.|.||++|.-|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 44566678999999999998875544 38888886432 22333445778999999999999999999999999999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|-|-||.+...++ ..+.++..++..++.-+.+|++|||..+ ||.|||||+|.++|.+|-+||.|||.|+.+...
T Consensus 500 EaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 500 EACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred HhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999999995 5578999999999999999999999777 999999999999999999999999999987643
Q ss_pred CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCC
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
..+-+.+|||.|+|||++.....+.++|.||+|+++||+++|.+||...+.-...-.+++.+ .+
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi--------d~------ 637 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI--------DK------ 637 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh--------hh------
Confidence 34457899999999999999999999999999999999999999998643322222222111 11
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHHh
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPT-----MREVVQILT 958 (1010)
Q Consensus 922 ~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~ev~~~L~ 958 (1010)
...|........+++++.+..+|.+|.- +.++.++-+
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 1233444455667889999999999964 777776543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=275.43 Aligned_cols=271 Identities=21% Similarity=0.277 Sum_probs=208.6
Q ss_pred ceeeeee-ccccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-C-c----cc
Q 001816 673 QRLDFTC-DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-H-R----HI 744 (1010)
Q Consensus 673 ~~~~~~~-~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p----ni 744 (1010)
..+.+.. +.+..+|.+...+|+|.||.|-+..+ ..+..||||+++....- .+...-|+++++++. + | -+
T Consensus 77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY---reAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY---REAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH---hhHHHHHHHHHHHHHhcCCCCceEE
Confidence 3355554 44589999999999999999999874 34789999999764332 333566999999993 2 2 47
Q ss_pred ceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC--
Q 001816 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-- 822 (1010)
Q Consensus 745 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-- 822 (1010)
|++.+||+..++.+||+|.+ |-++.+++......+++.+.+..+++|++++++|||..+ ++|-||||+|||+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE 229 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence 88889999999999999998 669999998877788999999999999999999999776 999999999999831
Q ss_pred ------------------CCceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh
Q 001816 823 ------------------GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT 884 (1010)
Q Consensus 823 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 884 (1010)
...++++|||.|+..... ...++.|..|.|||++.+-.++.++||||+|||++|+++
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 234899999999864322 256789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccHHHHHHHHhhhcccc--------------------------cccccCCCCC-----CCCHHHHHHHH
Q 001816 885 GRKPVGEFGDGVDIVQWVRKMTDSKKEG--------------------------VLKILDPRLP-----SVPLHEVMHVF 933 (1010)
Q Consensus 885 g~~P~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~-----~~~~~~~~~~~ 933 (1010)
|..-|...++.+.+ ..++.+....... .....++..| .....+...++
T Consensus 305 G~~LFqtHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 305 GETLFQTHENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred cceecccCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 99999876543322 2222221111000 0111111111 11334456799
Q ss_pred HHHHhccccCCCCCCCHHHHHHH
Q 001816 934 YVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 934 ~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+++..|+..||.+|+|+.|++++
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHccCccccccHHHHhcC
Confidence 99999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=278.51 Aligned_cols=220 Identities=23% Similarity=0.201 Sum_probs=175.9
Q ss_pred cCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCHHhhh
Q 001816 695 GGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL 773 (1010)
Q Consensus 695 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 773 (1010)
|.||.||++.. .+|+.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999995 468899999986532 2345555566667999999999999999999999999999999998
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeecccc
Q 001816 774 HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY 853 (1010)
Q Consensus 774 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 853 (1010)
.. ...+++..+..++.|+++||+|+|+.+ |+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 77 ~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 77 SK--FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred HH--hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 53 345899999999999999999999776 999999999999999999999999988655332 12334677
Q ss_pred cccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHH
Q 001816 854 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVF 933 (1010)
Q Consensus 854 ~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (1010)
.|+|||+..+..++.++||||+|+++|||++|+.|+....... . ..... ..+......+.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~---~~~~~---~~~~~~~~~~~ 206 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------N---THTTL---NIPEWVSEEAR 206 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------c---ccccc---CCcccCCHHHH
Confidence 8999999988889999999999999999999998875321100 0 00000 11222345677
Q ss_pred HHHHhccccCCCCCCCHH
Q 001816 934 YVAMLCVEEQAVERPTMR 951 (1010)
Q Consensus 934 ~li~~cl~~~P~~RPs~~ 951 (1010)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=267.06 Aligned_cols=248 Identities=21% Similarity=0.279 Sum_probs=196.4
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCc-ccchHHHHHHHhcc-CCcccceeeeeEecCCccEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSH-DHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~-~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 759 (1010)
.+.|+..++||+|+|+.|-.++. ++.+.+|+|++++.-....+ ..=.+.|-.+..+. +||.+|-+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 45678889999999999999985 45778999999865443322 33356787777776 69999999999999999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
|.||++||+|--.+ ++...++++.++.+..+|+-||.|||+.| ||.||+|..|||+|.+|++|+.|+|+++.--
T Consensus 329 vieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l- 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL- 402 (593)
T ss_pred EEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-
Confidence 99999999997666 45567999999999999999999999776 9999999999999999999999999998643
Q ss_pred CCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCC--CC-ccHHHHHHHHhhhcccccccc
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFG--DG-VDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.....+++.+|||.|.|||++++.+|++.+|.|++||+++||+.|+.||+-.+ +. .....++-.+.-
T Consensus 403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil--------- 472 (593)
T KOG0695|consen 403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL--------- 472 (593)
T ss_pred -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh---------
Confidence 23445678899999999999999999999999999999999999999996422 11 111111111110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERP 948 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RP 948 (1010)
.....+|...+.+...+++.-+++||.+|.
T Consensus 473 --ekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 --EKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --hhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 011123344444556688889999999983
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=251.45 Aligned_cols=205 Identities=30% Similarity=0.426 Sum_probs=168.2
Q ss_pred cCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.......||+|+||.|-+.+ ..+|...|+|+++.... ....++..+|+.+..+. .+|.+|.+||.+...+..|+.||
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 33445679999999998877 45899999999975443 33445567788776655 79999999999999999999999
Q ss_pred ecCCCCHHhhhcc--CCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 763 YMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 763 ~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
.| ..+|+.+-.+ .+++.+++...-+|+..+.+||.|||+.- .|+|||+||+|||++.+|++|+||||++..+.++
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99 5688765432 46788999999999999999999999854 3999999999999999999999999999887543
Q ss_pred CCcceeeeecccccccChhhhc----cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAY----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV 896 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~ 896 (1010)
- ..+...|...|||||.+. ...|+-++||||+|+++.||.+++.||+.+..+.
T Consensus 203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred h---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 2 122346889999999875 3479999999999999999999999998765443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=269.61 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=204.3
Q ss_pred cCCcCCeEeecCcEEEEEEEecC------CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec-CCcc
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPN------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-HETN 757 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 757 (1010)
+++...++-+|.||.||+|.|.+ .+.|.||.++.... +.....+..|.-.+....|||+..+.+++.+ .+.+
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 45555678999999999997643 34577888765433 2234457888888888999999999998765 4577
Q ss_pred EEEEEecCCCCHHhhhcc-----C-CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeec
Q 001816 758 LLVYEYMPNGSLGEVLHG-----K-KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~-----~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DF 831 (1010)
+.++.++.-|+|..++.. . ..+.++..+...++.|++.|++|||+++ |||.||..+|.+||+..++||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccc
Confidence 899999988999999962 1 1234667778889999999999999877 999999999999999999999999
Q ss_pred cccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhhcc
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910 (1010)
Q Consensus 832 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 910 (1010)
.+++.+-+.+.............||+||.+.+..|+.++|||||||++|||+| |+.|+.+.+ +.+...+++
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-PfEm~~ylk------- 512 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-PFEMEHYLK------- 512 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-HHHHHHHHh-------
Confidence 99998766554433334456679999999999999999999999999999999 999997653 233333222
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
|.-.-..|..++.+++.++..||+..|++||++++++.-|.++
T Consensus 513 -------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 513 -------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2222234666778999999999999999999999999988764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=300.52 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=168.0
Q ss_pred ccccCCcCCeEeecCcEEEEEEEec-C----CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeee------
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLMP-N----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF------ 750 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~------ 750 (1010)
..+.|+..+.||+|+||.||+|... + +..||||++..... ......| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 3567888999999999999999964 4 68999998753211 1111111 1112122233322221
Q ss_pred EecCCccEEEEEecCCCCHHhhhccCCC------------------CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeec
Q 001816 751 CSNHETNLLVYEYMPNGSLGEVLHGKKG------------------GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRD 812 (1010)
Q Consensus 751 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrD 812 (1010)
...+...++||||+++++|.+++..... .......+..++.|++.||+|||+.+ |+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCc
Confidence 2455678999999999999998864321 01122345679999999999999776 99999
Q ss_pred CCCCcEEEcC-CCceEEeeccccccccCCCCcceeeeecccccccChhhhccC----------------------CCCcc
Q 001816 813 VKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL----------------------KVDEK 869 (1010)
Q Consensus 813 lkp~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 869 (1010)
|||+|||++. ++.+||+|||+|+...... ........|++.|+|||.+... .++.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999986 5799999999998654322 2233456789999999965422 23456
Q ss_pred CceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc--cccccccCCCCC-------CCCHHHHHHHHHHHHhcc
Q 001816 870 SDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK--EGVLKILDPRLP-------SVPLHEVMHVFYVAMLCV 940 (1010)
Q Consensus 870 ~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl 940 (1010)
+||||+||++|||+++..|+.. ...++.+.+..... ........+... +.........++++.+|+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 7999999999999997766432 11111111111000 000011111100 000011123457999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 001816 941 EEQAVERPTMREVVQI 956 (1010)
Q Consensus 941 ~~~P~~RPs~~ev~~~ 956 (1010)
+.||++|||++|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999886
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-31 Score=295.82 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=185.4
Q ss_pred cCCeEeecCcEE-EEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEEEecC
Q 001816 688 EDNIIGKGGAGI-VYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 688 ~~~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
-.+++|.|+-|+ ||+|.. .|+.||||++-.. .....++|++.++.- +|||||++++.-.+.+..||+.|.|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 346789999876 899998 7899999998432 123467899999988 5999999999888889999999999
Q ss_pred CCCHHhhhccC--CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC---C--CceEEeecccccccc
Q 001816 766 NGSLGEVLHGK--KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS---G--FEAHVADFGLAKFLQ 838 (1010)
Q Consensus 766 ~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~---~--~~~kl~DFGla~~~~ 838 (1010)
..+|.+++... .......-..+.+..|++.|+++||..+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 57999999752 1111111345788999999999999666 999999999999965 3 479999999999886
Q ss_pred CCCC-cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhC-CCCCCCCCCCccHHHHHHHHhhhcccccccc
Q 001816 839 DSGT-SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG-RKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 839 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
.... .....+..||-+|+|||++....-+.++||||+||++|+.++| .+||++.-+ .... +..... .+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~N----Il~~~~-~L~-- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQAN----ILTGNY-TLV-- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhh----hhcCcc-cee--
Confidence 5433 2335567899999999999999989999999999999999995 899976311 1011 111100 000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+.+.+ ++ ...++|.+|++.+|..||++.+|+.+
T Consensus 734 ---~L~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 ---HLEPLP-DC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---eeccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 011111 11 56689999999999999999999764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.44 Aligned_cols=239 Identities=29% Similarity=0.407 Sum_probs=192.2
Q ss_pred CcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCHHhhhc
Q 001816 696 GAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLH 774 (1010)
Q Consensus 696 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 774 (1010)
+||.||+|... +|+.||+|++........ ...+.+|++.+++++|+|++++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999975 489999999875433221 4678999999999999999999999999899999999999999999986
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeeccccc
Q 001816 775 GKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG 854 (1010)
Q Consensus 775 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 854 (1010)
... .+++..+..++.++++++.|||+.+ ++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 80 ~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 80 KRG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred hcc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 432 3889999999999999999999776 9999999999999999999999999998765432 2334568899
Q ss_pred ccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHH
Q 001816 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFY 934 (1010)
Q Consensus 855 y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (1010)
|++||...+..++.++||||+|+++|++++|..||....+.....++... ... ............+.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---~~~---------~~~~~~~~~~~~~~~ 219 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---PKP---------PFPPPEWKISPEAKD 219 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---cCC---------CCccccccCCHHHHH
Confidence 99999999888999999999999999999999999654333222222211 100 000000003357888
Q ss_pred HHHhccccCCCCCCCHHHHHH
Q 001816 935 VAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 935 li~~cl~~~P~~RPs~~ev~~ 955 (1010)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=287.00 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=179.2
Q ss_pred cccCCcCCeEeecCcEEEEEEEe-----------------cCCCEEEEEEeccCCCCC------------CcccchHHHH
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-----------------PNGDQVAVKRLPAMSRGS------------SHDHGFNAEI 733 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~------------~~~~~~~~E~ 733 (1010)
.+.|++.++||+|+||+||+|.. .+++.||||+++...... ...+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56789999999999999999963 245689999986432210 1122344577
Q ss_pred HHHhccCCcc-----cceeeeeEec--------CCccEEEEEecCCCCHHhhhccCC----------------------C
Q 001816 734 QTLGRIRHRH-----IVRLLGFCSN--------HETNLLVYEYMPNGSLGEVLHGKK----------------------G 778 (1010)
Q Consensus 734 ~~l~~l~hpn-----iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------~ 778 (1010)
.++.+++|.+ +++++++|.. ++..++||||+++++|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 7777776654 4677777653 356799999999999999986421 1
Q ss_pred CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeecccccccCh
Q 001816 779 GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 858 (1010)
Q Consensus 779 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 858 (1010)
..+++..+..++.|+++||.|+|+.+ |+||||||+||+++.++.+||+|||+++....... .......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 23456788899999999999999776 99999999999999999999999999976533211 111123358999999
Q ss_pred hhhccCC--------------------C--CccCceehhhHHHHHHHhCCC-CCCCCCCCc--------cHHHHHHHHhh
Q 001816 859 EYAYTLK--------------------V--DEKSDVYSFGVVLLELITGRK-PVGEFGDGV--------DIVQWVRKMTD 907 (1010)
Q Consensus 859 E~~~~~~--------------------~--~~~~Dv~slG~il~elltg~~-P~~~~~~~~--------~~~~~~~~~~~ 907 (1010)
|.+.... + ..+.||||+||++|||++|.. ||....... +...|. ....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-~~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-MYKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-hhcc
Confidence 9875432 1 134799999999999999875 664321100 011111 0000
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHhccccCC---CCCCCHHHHHHHH
Q 001816 908 SKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQA---VERPTMREVVQIL 957 (1010)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P---~~RPs~~ev~~~L 957 (1010)
. ...++ .........++++.+++..+| .+|+|++|++++-
T Consensus 459 -------~--~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 459 -------Q--KYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred -------c--CCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0 01111 111223457789999998765 6899999998863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-31 Score=260.10 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=196.9
Q ss_pred cCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC-----CccEEEE
Q 001816 688 EDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH-----ETNLLVY 761 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~ 761 (1010)
-.+.||-|+||+||...+ ++|+.||+|++......-...+++-+|++++..++|.|+...++...-. .+.|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 456899999999999885 4799999999976544434456688999999999999999988876433 3568899
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|++ ..+|.+++ .....++.+.+.-+.+||++||+|||+.+ |.||||||.|.|++++..+||||||+|+......
T Consensus 137 ELm-QSDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 137 ELM-QSDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-Hhhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 999 56898888 45678999999999999999999999666 9999999999999999999999999998754433
Q ss_pred CcceeeeecccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhc---------cc
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK---------KE 911 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------~~ 911 (1010)
...+...+-|..|.|||++++. .|+.+.||||.|||+.|++.++.-|..-+ ..+..+.+..+.... +.
T Consensus 211 -~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 211 -RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-PIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred -hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-hHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 3344555678999999999976 58999999999999999999988886533 333333333221111 11
Q ss_pred cccccc-----CCCCC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 001816 912 GVLKIL-----DPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 912 ~~~~~~-----~~~~~-----~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~ 958 (1010)
....++ .|.++ ..+.+.......+.+.++..||++|.+.++.++++.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 100111 11111 111122233455777889999999999999887653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=278.45 Aligned_cols=205 Identities=25% Similarity=0.330 Sum_probs=170.7
Q ss_pred cCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCC-CCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.|...+.||-|+||+|..++. .+...||.|.+.+... ..........|..|+...+.+.||++|..|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 345567899999999999984 3456799998865322 12234457889999999999999999999999999999999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc---C
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ---D 839 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~---~ 839 (1010)
|++||++-.+|. +-+-|.++.++.++.+++.|+++.|..| +|||||||+|||||.+|++||.|||++.-+. +
T Consensus 710 YIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 999999999885 3467999999999999999999999888 9999999999999999999999999985421 0
Q ss_pred -----CCCcce--------------------------------eeeecccccccChhhhccCCCCccCceehhhHHHHHH
Q 001816 840 -----SGTSEC--------------------------------MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 882 (1010)
Q Consensus 840 -----~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el 882 (1010)
.+...+ ....+||+.|+|||++....|+..+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 000000 0134699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCC
Q 001816 883 ITGRKPVGEFGD 894 (1010)
Q Consensus 883 ltg~~P~~~~~~ 894 (1010)
+.|+.||-....
T Consensus 865 ~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 865 LVGQPPFLADTP 876 (1034)
T ss_pred hhCCCCccCCCC
Confidence 999999975433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=275.52 Aligned_cols=254 Identities=26% Similarity=0.319 Sum_probs=203.8
Q ss_pred ccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEE
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 760 (1010)
-.+.|+...++|.|.||.||||+ ..+++..|||+++....+. ....++|+-+++..+|||||.+++.|...+..|++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 34678888999999999999999 4579999999998654432 44578899999999999999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 840 (1010)
||||.||+|.+.-+ -.+.+++.++..+.++..+|++|+|..+ -+|||||-.||++++.|.+|+.|||.+..+..
T Consensus 91 MEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred EEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh-
Confidence 99999999999774 4578999999999999999999999776 89999999999999999999999999976643
Q ss_pred CCcceeeeecccccccChhhhc---cCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 841 GTSECMSAIAGSYGYIAPEYAY---TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
.-.......||+.|||||+.. .+.|...+|||+.|+...|+-.-++|..+... .+...-+... .+
T Consensus 165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~l~LmTkS-------~~ 232 (829)
T KOG0576|consen 165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRALFLMTKS-------GF 232 (829)
T ss_pred -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHHHHHhhcc-------CC
Confidence 333445678999999999764 67799999999999999999888888543211 1111111111 12
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
+|.....+......+-++++.|+.++|++||+++.+++
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 23222223344455678999999999999999987754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=238.30 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=196.2
Q ss_pred cccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecC--CccE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNH--ETNL 758 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~ 758 (1010)
.+.|++.+++|+|.|+.||.|. ..+.++++||+++... .+.+.+|+.+++.++ ||||+++++...+. ..+.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 4678999999999999999998 5678899999997543 345899999999996 99999999998764 4678
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC-CceEEeeccccccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGLAKFL 837 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DFGla~~~ 837 (1010)
+|+||+.+.+....- ..++...+..++.+++.||.|+|+.| |+|||+||.|+++|.. ..++|+|+|+|.++
T Consensus 112 LiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999998877665 35788889999999999999999777 9999999999999864 46999999999987
Q ss_pred cCCCCcceeeeecccccccChhhhcc-CCCCccCceehhhHHHHHHHhCCCCCCCCCCCcc-HHHHHHHHhhhccc----
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD-IVQWVRKMTDSKKE---- 911 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~---- 911 (1010)
.+... ....+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-...+.-+ ++...+-+......
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 65433 334567778899998764 5689999999999999999999999876554433 33322211110000
Q ss_pred ccccccCCCCCC----------------CCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 912 GVLKILDPRLPS----------------VPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 ~~~~~~~~~~~~----------------~~~~-~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
...--+||.+.. ...+ ...+..+++...+..|-.+|+|++|.+.+
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000011221110 0001 12456788899999999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=259.65 Aligned_cols=296 Identities=23% Similarity=0.206 Sum_probs=192.1
Q ss_pred EEEcCCCCcccccCcccCCCCCCCEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceecccC-c
Q 001816 66 SLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYN-N 144 (1010)
Q Consensus 66 ~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~-N 144 (1010)
.+|.++.+|+ .+|.++.. .-..++|..|+|+.+.|++|+.+++||.||||+|+|+.+-|++|.+|.+|.+|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 4455566665 34443332 456677777777766677777777777777777777777777777777766665555 7
Q ss_pred ccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCC----
Q 001816 145 NMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYT---- 220 (1010)
Q Consensus 145 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~---- 220 (1010)
+|+.....+|.+|..|+.|.+.-|++.-...+.|..+++|..|.+.+|.+..+-...|..+..++.+.+..|..+.
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 7775555667777777777777777776666677777777777777777774444467777777777766443211
Q ss_pred -------CCCCccccCCCCCcEEEccCCCCCCCcCccccCC-CCCC-EEEeccccCCCCccccccccCcCCEEEccCCcC
Q 001816 221 -------GGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRL-QNLD-TLFLQVNALSGPLTTELGYLKSLKSMDLSNNIF 291 (1010)
Q Consensus 221 -------~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l-~~L~-~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l 291 (1010)
...|..++..+-..-..+.++++..+-+..|... ..+. .+....+.........|..+++|+.|+|++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 1122333333333334444444443333333211 1221 112222233323334577888888888888888
Q ss_pred ccccCccccccCCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccc
Q 001816 292 TGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364 (1010)
Q Consensus 292 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (1010)
+.+-+.+|.++..+++|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|..+..|..|+|-.|.+.
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 8877888888888888888888887666677788888888888888888778888888888888888888764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=236.65 Aligned_cols=254 Identities=19% Similarity=0.328 Sum_probs=184.9
Q ss_pred eeccccccCCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeee-EecC
Q 001816 678 TCDDVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGF-CSNH 754 (1010)
Q Consensus 678 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~-~~~~ 754 (1010)
..-++.+.|.+.+.+|+|.||.+-.+.++ +.+.+++|.++.... ..++|.+|..---.+ .|.||+..|+. |+..
T Consensus 18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 33456788999999999999999999854 577899999875433 366789998766666 58999998875 6777
Q ss_pred CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEE-cC-CCceEEeecc
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL-DS-GFEAHVADFG 832 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill-~~-~~~~kl~DFG 832 (1010)
+.++++|||++.|+|..-+.. ..+.+....+++.|++.|+.|+|+.. +||||||.+|||| +. ..++|+||||
T Consensus 95 d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred ceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence 888899999999999998853 45788889999999999999999555 9999999999999 33 3479999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhccC-----CCCccCceehhhHHHHHHHhCCCCCCCCC-CCccHHHHHHHHh
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL-----KVDEKSDVYSFGVVLLELITGRKPVGEFG-DGVDIVQWVRKMT 906 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~P~~~~~-~~~~~~~~~~~~~ 906 (1010)
..+..+.. .....-+..|.|||..... ...+.+|||.||+++|.++||+.||.... .....+.|.+-..
T Consensus 169 ~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~ 243 (378)
T KOG1345|consen 169 LTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK 243 (378)
T ss_pred cccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc
Confidence 98754321 1223346679999976432 35678999999999999999999997421 1222333333221
Q ss_pred hhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 001816 907 DSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954 (1010)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~ 954 (1010)
.. .+..|..=.........+.++-+.++|++|-...++.
T Consensus 244 rk---------~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 244 RK---------NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred cc---------CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 11 1122211111223455677788899999994444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=260.68 Aligned_cols=197 Identities=23% Similarity=0.309 Sum_probs=166.6
Q ss_pred cCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCC------CCcccchHHHHHHHhccC---CcccceeeeeEecC
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRG------SSHDHGFNAEIQTLGRIR---HRHIVRLLGFCSNH 754 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~ 754 (1010)
.|...+.+|+|+||.|+.|.++. ...|+||.+.+...- ....-....||++|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 47788999999999999999765 456899988653221 111223567999999997 99999999999999
Q ss_pred CccEEEEEec-CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 755 ETNLLVYEYM-PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 755 ~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
+.+|++||-- +|-+|.+++.. ...+++.++..|++|++-|+++||..+ |||||||-+||.++.+|.+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 9999999975 45599999954 457999999999999999999999777 99999999999999999999999999
Q ss_pred cccccCCCCcceeeeecccccccChhhhccCCC-CccCceehhhHHHHHHHhCCCCCC
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRKPVG 890 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~P~~ 890 (1010)
|...... .....+||.+|.|||++.+..| +..-|||++|+++|.++....||.
T Consensus 717 aa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9765432 2346789999999999999887 456899999999999999988874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=243.17 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=198.7
Q ss_pred ccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecC------
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------ 754 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 754 (1010)
+..+|-..+.+|.|.- .|..|. .-.+++||+|+...........++..+|..++..+.|+||++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4466777888999998 566665 34688999999876655556667788999999999999999999998554
Q ss_pred CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccc
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla 834 (1010)
.+.|+||||| .++|...++ -.++-++...+..|++.|++|+|+.+ |+||||||+||++..++.+||.|||+|
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 3569999999 679988886 24677889999999999999999777 999999999999999999999999999
Q ss_pred ccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHh--------
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMT-------- 906 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~-------- 906 (1010)
+.... .-.++.++.|..|.|||++.+..|.+.+||||.||++.||++|+.-|.+. ..+.+|.+-..
T Consensus 166 r~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~---d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 166 RTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK---DHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc---hHHHHHHHHHHHhcCCCHH
Confidence 85332 23566788999999999999888999999999999999999999998742 22333322110
Q ss_pred ------hhc-------cc----cccc-ccCCCCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 907 ------DSK-------KE----GVLK-ILDPRLPS---VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 907 ------~~~-------~~----~~~~-~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+.. .+ .+.+ +.|..++. .+.........++.+|+-.+|++|-++++++++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000 00 0000 01111111 122223346678899999999999999999885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=239.08 Aligned_cols=211 Identities=35% Similarity=0.560 Sum_probs=181.0
Q ss_pred EeecCcEEEEEEEecC-CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCHH
Q 001816 692 IGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLG 770 (1010)
Q Consensus 692 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 770 (1010)
||+|.+|.||++.... |+.+++|++....... ....+.+|++.++.++|++++++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999754 8999999987543321 2356899999999999999999999999989999999999999999
Q ss_pred hhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-CCceEEeeccccccccCCCCcceeeee
Q 001816 771 EVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAI 849 (1010)
Q Consensus 771 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 849 (1010)
+++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 9986432 46889999999999999999999776 999999999999999 89999999999986543321 12334
Q ss_pred cccccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHH
Q 001816 850 AGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHE 928 (1010)
Q Consensus 850 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (1010)
.+...|++||..... .++.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 888999999999999999
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 929 VMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 929 ~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 256678999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-28 Score=248.34 Aligned_cols=388 Identities=21% Similarity=0.214 Sum_probs=238.3
Q ss_pred CcEEEEEcCCCCcccccCcccCCCCCCCEEEccccccCCCCCcccccccccceecccc-ccccCCCCccccccCccceec
Q 001816 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSN-NVFNGSFPPQLSQLASLQVLD 140 (1010)
Q Consensus 62 ~~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~ 140 (1010)
...++++|..|+|+.+.+.+|+.+++|+.|||++|+|+.+-|++|.+|.+|..|-+-+ |+|+......|++|..|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 3689999999999988888999999999999999999999999999999988877766 999977777899999999999
Q ss_pred ccCcccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccc------------cccccccccCcchh
Q 001816 141 LYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL------------GGKIPGEIGNLTKL 208 (1010)
Q Consensus 141 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l------------~~~~~~~~~~l~~L 208 (1010)
+.-|++.-....+|..|++|..|.|.+|.+...-...|..+..++.+.+..|.+ ....|-.++..+-.
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 999999988899999999999999999999855555899999999999999982 22334444443333
Q ss_pred hHHhhccc------------------------cCCCCCCC-ccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEec
Q 001816 209 QQLYIGYY------------------------NSYTGGLP-PEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQ 263 (1010)
Q Consensus 209 ~~L~l~~~------------------------~~~~~~~p-~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~ 263 (1010)
.-..+.+. ....+..| ..|..+++|+.|+|++|+|+++-+.+|.++..+++|+|.
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 22222211 00111111 234555555555555555555555555555555555555
Q ss_pred cccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCccccCCCccccc--ccccCcccc
Q 001816 264 VNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVL--QLWENNFTG 341 (1010)
Q Consensus 264 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L--~L~~N~l~~ 341 (1010)
.|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|..|+|-.|.+... -.|..| +|..+.-.|
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn--------C~l~wl~~Wlr~~~~~~ 378 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN--------CRLAWLGEWLRKKSVVG 378 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc--------cchHHHHHHHhhCCCCC
Confidence 5555554445555555555555555555555555555555555555555544310 001111 112222111
Q ss_pred cCCcCCCCCCCccEEEccCccccc---CCCcccCCCCcchhhhccccccccccccccccCCCCceE-EcCCCcccCCCcc
Q 001816 342 SIPQRLGSNGKLRILDLSSNKLTG---TLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRM-RMGENFLNGSIPK 417 (1010)
Q Consensus 342 ~~~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~~~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L-~l~~N~l~~~~p~ 417 (1010)
..| -+.-..++.++++.+.+.. ..|++.+.. -.+ .+-..++-+.+. +.+++.+ ..+|.
T Consensus 379 ~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~------------~s~---~cP~~c~c~~tVvRcSnk~l-k~lp~ 440 (498)
T KOG4237|consen 379 NPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCL------------TSS---PCPPPCTCLDTVVRCSNKLL-KLLPR 440 (498)
T ss_pred CCC--CCCCchhccccchhccccccccCCccccCCC------------CCC---CCCCCcchhhhhHhhcccch-hhcCC
Confidence 111 1222345666666665431 122221110 001 111222222222 2222222 24444
Q ss_pred ccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCccCceEEecCCC
Q 001816 418 GLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGN 481 (1010)
Q Consensus 418 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 481 (1010)
.+- ....+|++.+|.++.+... .+.+| .+|||+|+++..-.-.|.++++|.+|.|++|
T Consensus 441 ~iP--~d~telyl~gn~~~~vp~~---~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 441 GIP--VDVTELYLDGNAITSVPDE---LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CCC--chhHHHhcccchhcccCHH---HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 332 2455666677776643332 45556 6777777777555566777788888877765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=237.47 Aligned_cols=200 Identities=34% Similarity=0.476 Sum_probs=170.3
Q ss_pred CCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 686 LKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
|+..+.||+|++|.||++...+ ++.+|+|.+...... .....+.+|++.+++++|+|++++++++...+..++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4556789999999999999765 889999998753322 13556889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 844 (1010)
++++|.+++..... .+++..+..++.++++++.++|+.+ ++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 80 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 80 EGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 99999999864332 1789999999999999999999776 99999999999999999999999999987654321 1
Q ss_pred eeeeecccccccChhhh-ccCCCCccCceehhhHHHHHHHhCCCCCCC
Q 001816 845 CMSAIAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVLLELITGRKPVGE 891 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~P~~~ 891 (1010)
......++..|++||.. ....++.++|||+||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345688899999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=241.06 Aligned_cols=132 Identities=24% Similarity=0.346 Sum_probs=111.9
Q ss_pred ccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-----C---cccceeeeeEec-
Q 001816 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-----H---RHIVRLLGFCSN- 753 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~~~~~~~~- 753 (1010)
.+|.+.++||-|.|++||.+. ....+.||+|+.+.... ..+....||+++++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh---YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH---YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH---HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 688899999999999999998 45678899999875322 2333567999999983 2 489999999865
Q ss_pred ---CCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEc
Q 001816 754 ---HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD 821 (1010)
Q Consensus 754 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~ 821 (1010)
+.+.+||+|++ |.+|..+|.....+.++...+.+|++||+.||.|||+.+ +|||-||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45789999999 889999998777778999999999999999999999855 599999999999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=246.18 Aligned_cols=270 Identities=22% Similarity=0.240 Sum_probs=203.2
Q ss_pred eeeeecc-ccccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC------Ccccce
Q 001816 675 LDFTCDD-VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR------HRHIVR 746 (1010)
Q Consensus 675 ~~~~~~~-~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~ 746 (1010)
+.+.+.+ +-.+|.+....|+|-|++|.+|.. ..|..||||++.....- ...=.+|+++++++. --|+++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3444444 446788888899999999999995 45889999999653221 122357999999994 358999
Q ss_pred eeeeEecCCccEEEEEecCCCCHHhhhccC-CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-
Q 001816 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF- 824 (1010)
Q Consensus 747 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~- 824 (1010)
++..|....+++||+|-+ .-+|.+++... ++..+....+..++.|+.-||..|...+ |+|.||||.|||+++..
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcc
Confidence 999999999999999988 57999998642 3345788899999999999999999776 99999999999998754
Q ss_pred ceEEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 001816 825 EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 825 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~ 904 (1010)
.+||||||.|........ +.+.-+..|.|||++.+.+|+...|+||.||.+||+.||+.-|++..+. +++.+...
T Consensus 575 iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN-~MLrl~me 649 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN-QMLRLFME 649 (752)
T ss_pred eeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH-HHHHHHHH
Confidence 589999999987654322 2334566899999999999999999999999999999999999865433 33333322
Q ss_pred Hhhhc---------------------------------ccccccccC------------CCCCCCCHHHHHHHHHHHHhc
Q 001816 905 MTDSK---------------------------------KEGVLKILD------------PRLPSVPLHEVMHVFYVAMLC 939 (1010)
Q Consensus 905 ~~~~~---------------------------------~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~c 939 (1010)
+.... ...+...+. +.++........++..++..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 21110 001111111 123333344456688899999
Q ss_pred cccCCCCCCCHHHHHHH
Q 001816 940 VEEQAVERPTMREVVQI 956 (1010)
Q Consensus 940 l~~~P~~RPs~~ev~~~ 956 (1010)
+..||++|-|..+++++
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999998875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=238.51 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=196.2
Q ss_pred ccccccCCcCCeEeecCcEEEEEEEec----CCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecC
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLMP----NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH 754 (1010)
Q Consensus 680 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 754 (1010)
..+.+.|...++||+|.|++||+|... ..+.||+|.+..... ...+..|++++..+ .+.||+++.+++...
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 445677888999999999999999843 467899999865433 44588999999999 589999999999999
Q ss_pred CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-CCceEEeeccc
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGL 833 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-~~~~kl~DFGl 833 (1010)
+...+|+||++..+..++.. .++..++..+++.+..||+++|..| ||||||||+|++.+. .+.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999988873 3678899999999999999999777 999999999999975 56789999999
Q ss_pred cccccCCC------------------------------------------CcceeeeecccccccChhhhcc-CCCCccC
Q 001816 834 AKFLQDSG------------------------------------------TSECMSAIAGSYGYIAPEYAYT-LKVDEKS 870 (1010)
Q Consensus 834 a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 870 (1010)
|....... .........||++|.|||++.. ...+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98321100 0000113459999999999875 4578899
Q ss_pred ceehhhHHHHHHHhCCCCCCCCCCCcc-HHHHHH--------HH---hhh--ccc------------ccccc----cCC-
Q 001816 871 DVYSFGVVLLELITGRKPVGEFGDGVD-IVQWVR--------KM---TDS--KKE------------GVLKI----LDP- 919 (1010)
Q Consensus 871 Dv~slG~il~elltg~~P~~~~~~~~~-~~~~~~--------~~---~~~--~~~------------~~~~~----~~~- 919 (1010)
||||.|||+.-+++++.||-...+..+ +.+.+. +. ... ..+ .+..+ +.+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999965444433 222221 10 000 000 00000 000
Q ss_pred C---CCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 920 R---LPS--VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 920 ~---~~~--~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+ ... .....+...++++.+|+..+|.+|-|++|.+++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 000 011112357789999999999999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=224.50 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=200.4
Q ss_pred CCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecC
Q 001816 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
.....+|.+...|+.|+|+|+ |..+++|+++.........++|..|.-.++-+.||||..+++.|....+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 334557899999999999994 5566779888766667777889999999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce
Q 001816 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 766 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
.|+|+..+++..+-..+..++.+++.++|+|++|||+.. +-|..--+....|++|++.+++|+ ++-+++ .-+
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kf------sfq 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKF------SFQ 342 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-ccccee------eee
Confidence 999999999888778899999999999999999999763 334445688999999999998875 111111 111
Q ss_pred eeeecccccccChhhhccCCCC---ccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCC
Q 001816 846 MSAIAGSYGYIAPEYAYTLKVD---EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.....-.|.||+||.+...+.+ .++|+|||++++||+.|...||.+...-+-- ..-.++....
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------------mkialeglrv 408 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------------MKIALEGLRV 408 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------hhhhhccccc
Confidence 1223457899999999876543 5799999999999999999999875432110 0011222334
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 923 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
.+|+....++.+++.-|+++||.+||.++.++-.|+++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 456666778889999999999999999999999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=210.21 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=200.8
Q ss_pred ccccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCC-cccceeeeeEecCCccEE
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH-RHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 759 (1010)
+..+|+..++||.|+||.+|.|. ..+|+.||||+-..... ...+..|.++.+.++| ..|..+..|..+..+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 45789999999999999999998 67899999998755433 3457889999999974 788888888899999999
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC---CCceEEeecccccc
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS---GFEAHVADFGLAKF 836 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~---~~~~kl~DFGla~~ 836 (1010)
||+.+ |-+|.+... -....++.++++-++.|++.-++|+|..+ ++||||||+|+|..- ...+.++|||+|+.
T Consensus 89 VMdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 99998 889998775 23467999999999999999999999887 999999999999954 34689999999998
Q ss_pred ccCCCCcc-----eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccc
Q 001816 837 LQDSGTSE-----CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 837 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
+.+..+.. ......||.+|.+-....+.+.+.+.|+-|+|.++.++-.|..||.+..... ..|...++.+....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t-k~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT-KKQKYEKISEKKMS 242 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh-HHHHHHHHHHhhcC
Confidence 87654432 2345679999999998888899999999999999999999999998753322 12222222222111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 912 GVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
...+.+-. ..| .++...+..|-..--++-|....+.+.++-+
T Consensus 243 ~~ie~LC~---G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 243 TPIEVLCK---GFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred CCHHHHhC---CCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 11111111 222 3455567778777777889888887766544
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=269.16 Aligned_cols=338 Identities=20% Similarity=0.271 Sum_probs=235.8
Q ss_pred CccccCCCCCcEEEccCCC------CCCCcCccccCCC-CCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccC
Q 001816 224 PPEIGNLSSLVRFDAANCG------LSGEIPTDIGRLQ-NLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIP 296 (1010)
Q Consensus 224 p~~l~~l~~L~~L~l~~n~------l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 296 (1010)
+.+|.++.+|+.|.+..+. +...+|..+..++ +|+.|++.+|.++ .+|..| ...+|+.|+|++|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3456777777777776543 2234566666553 5788888887776 345555 3577888888888877 566
Q ss_pred ccccccCCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCc
Q 001816 297 ASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNC 376 (1010)
Q Consensus 297 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 376 (1010)
..+..+++|+.|+|++|.....+|. ++.+++|+.|+|++|.....+|..+..+++|+.|++++|..-+.+|..+ .+.+
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 6677788888888877654445664 6677888888888876666777778888888888888765555666654 6777
Q ss_pred chhhhccccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCcccc-------ccccCCccccccc
Q 001816 377 LQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLT-------GQFPVSDSISVNL 449 (1010)
Q Consensus 377 L~~L~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~~~~~L 449 (1010)
|+.|++.+|...+.+|.. ..+|++|++++|.+. .+|..+ .+++|++|++.++... ...+..+...++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 888888887766666643 356788888888876 566554 5677887777764321 1122223344678
Q ss_pred ceEeccCccccCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCc
Q 001816 450 GQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRN 529 (1010)
Q Consensus 450 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 529 (1010)
+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|+|++|.....+|.. ..+|+.|+|++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 888888887776788888888888888888765444677665 6788888888887554444432 357888888888
Q ss_pred ccccccchhcccccccceEEecC-ccccCCchhhhhcccccceeccCCC
Q 001816 530 ELSGEIPNQLTGMRILNYLNLSR-NHLVGSIPASIASMQSLTSVDFSYN 577 (1010)
Q Consensus 530 ~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~l~ls~N 577 (1010)
.|+ .+|.++..+++|++|+|++ |+|. .+|..+..+++|+.++++++
T Consensus 857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 887 6777888888888888887 4454 56767777888888888776
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-25 Score=273.12 Aligned_cols=197 Identities=18% Similarity=0.188 Sum_probs=140.3
Q ss_pred ccCC-cccceeeeeE-------ecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceE
Q 001816 738 RIRH-RHIVRLLGFC-------SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809 (1010)
Q Consensus 738 ~l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 809 (1010)
.++| +||+++++++ ...+..+.+|||+ +++|.+++... ...+++.+++.++.||++||+|||+.+ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 4456 6888888877 2334667889987 67999999632 456999999999999999999999776 99
Q ss_pred eecCCCCcEEEcC-------------------CCceEEeeccccccccCCCC--------------cceeeeeccccccc
Q 001816 810 HRDVKSNNILLDS-------------------GFEAHVADFGLAKFLQDSGT--------------SECMSAIAGSYGYI 856 (1010)
Q Consensus 810 HrDlkp~Nill~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 856 (1010)
||||||+|||++. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566667776654211000 00011245889999
Q ss_pred ChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHH
Q 001816 857 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVA 936 (1010)
Q Consensus 857 aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 936 (1010)
|||++.+..++.++|||||||++|||++|..|+.... ..+...... ...+. ..........++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~-------~~~~~----~~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR-------VLPPQ----ILLNWPKEASFC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh-------hcChh----hhhcCHHHHHHH
Confidence 9999999999999999999999999999988864311 111111100 01111 111223455778
Q ss_pred HhccccCCCCCCCHHHHHHH
Q 001816 937 MLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 937 ~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.+|++++|.+||++.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 89999999999999999763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=213.65 Aligned_cols=202 Identities=23% Similarity=0.361 Sum_probs=174.7
Q ss_pred ccCCcCCeEeecCcEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
-.|++.++||+|+||+.+.|. .-+++.||||.-+.... ..++..|.+..+.+ ..++|..++.|..++.+-.+||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 468899999999999999998 66899999998654333 44577899999988 4799999999999988999999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC-----CceEEeecccccc
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG-----FEAHVADFGLAKF 836 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-----~~~kl~DFGla~~ 836 (1010)
|++ |-+|.|+.. -.+.+|+.+++..+|.|++.-++|+|++. .|.|||||+|+||... ..+.++|||+|+.
T Consensus 104 dLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 104 DLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 999 788888764 35678999999999999999999999777 9999999999999643 3589999999999
Q ss_pred ccCCCCcc-----eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCC
Q 001816 837 LQDSGTSE-----CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGD 894 (1010)
Q Consensus 837 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~ 894 (1010)
+.+..+.. ..+...||.+||+-....+.+.+.+.|+-|+|-|+.+.+.|..||.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 98766543 23456799999999999999999999999999999999999999987543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-23 Score=264.34 Aligned_cols=345 Identities=23% Similarity=0.263 Sum_probs=170.6
Q ss_pred ccccccCccceecccCcc------cCCCCCcchhccc-cccceecccccCCCCCCCCCCCcccCceeEeccccccccccc
Q 001816 128 PQLSQLASLQVLDLYNNN------MTGDLPLAVTQLR-NLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPG 200 (1010)
Q Consensus 128 ~~l~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 200 (1010)
.+|.++.+|+.|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..| ...+|++|++.+|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345556666666665442 2223455555442 4666666666555 445544 3455666666666554 3343
Q ss_pred cccCcchhhHHhhccccCCCCCCCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCc
Q 001816 201 EIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKS 280 (1010)
Q Consensus 201 ~~~~l~~L~~L~l~~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 280 (1010)
.+..+ ++|+.|++++|.....+|. ++.+++|++|+|++|.....+|..+.++++
T Consensus 629 ~~~~l-------------------------~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~ 682 (1153)
T PLN03210 629 GVHSL-------------------------TGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNK 682 (1153)
T ss_pred ccccC-------------------------CCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCC
Confidence 34444 4444444444332223332 444444555555444333344444445555
Q ss_pred CCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccC
Q 001816 281 LKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSS 360 (1010)
Q Consensus 281 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 360 (1010)
|+.|++++|..-..+|..+ ++++|+.|++++|.....+|.. ..+|++|++++|.+. .+|..+ .+++|++|++.+
T Consensus 683 L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~ 756 (1153)
T PLN03210 683 LEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCE 756 (1153)
T ss_pred CCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccc
Confidence 5555555443222333332 4455555555555433333321 234555555555554 344333 344555555544
Q ss_pred cccccCCCcccCCCCcchhhhccccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCcccccccc
Q 001816 361 NKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFP 440 (1010)
Q Consensus 361 N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 440 (1010)
+.... +...+. ...+......++|+.|++++|...+.+|..+.++++|+.|++++|..-+.+|
T Consensus 757 ~~~~~-l~~~~~----------------~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP 819 (1153)
T PLN03210 757 MKSEK-LWERVQ----------------PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819 (1153)
T ss_pred cchhh-cccccc----------------ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence 33210 000000 0001111122345555555554444555555555555555555543222333
Q ss_pred CCcccccccceEeccCccccCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecC-CccCCCCchhhccCC
Q 001816 441 VSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSH-NKFSGRIAPEISQCK 519 (1010)
Q Consensus 441 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~ 519 (1010)
... .+++|+.|+|++|..-..+|.. ..+|+.|+|++|.++ .+|..+..+++|++|+|++ |+++ .+|..+..++
T Consensus 820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~ 893 (1153)
T PLN03210 820 TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLK 893 (1153)
T ss_pred CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCccccccc
Confidence 332 3455566666655433344432 246777777777777 6777777777777777776 4554 4666677777
Q ss_pred cccEEEccCcc
Q 001816 520 LLTFVDLSRNE 530 (1010)
Q Consensus 520 ~L~~L~Ls~N~ 530 (1010)
.|+.|+++++.
T Consensus 894 ~L~~L~l~~C~ 904 (1153)
T PLN03210 894 HLETVDFSDCG 904 (1153)
T ss_pred CCCeeecCCCc
Confidence 77777777663
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=247.41 Aligned_cols=263 Identities=27% Similarity=0.372 Sum_probs=147.0
Q ss_pred CCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEec
Q 001816 231 SSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNL 310 (1010)
Q Consensus 231 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 310 (1010)
..-..|++++|+++ .+|..+. ++|+.|++.+|+++. +|. .+++|++|+|++|+|+. +|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 34567888888888 5777665 378888888888885 333 24678888888888873 4532 356777888
Q ss_pred CCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCcchhhhccccccccc
Q 001816 311 FRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGP 390 (1010)
Q Consensus 311 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~ 390 (1010)
++|.++ .+|.. +.+|+.|++++|+++ .+|.. .++|+.|+|++|++++ +|..
T Consensus 270 s~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l-------------------- 320 (788)
T PRK15387 270 FSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL-------------------- 320 (788)
T ss_pred cCCchh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC--------------------
Confidence 888777 34432 245777777777777 34432 3567777777777763 2210
Q ss_pred cccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCc
Q 001816 391 IPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKF 470 (1010)
Q Consensus 391 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 470 (1010)
| .+|+.|++++|.+++ +|.. .++|++|+|++|+|++ +|.. .
T Consensus 321 -p------~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-------------------------LP~l---p 361 (788)
T PRK15387 321 -P------SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-------------------------LPTL---P 361 (788)
T ss_pred -c------ccccccccccCcccc-cccc---ccccceEecCCCccCC-------------------------CCCC---C
Confidence 0 124445555555542 3321 1244555555555543 3321 1
Q ss_pred cCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcccccccceEEe
Q 001816 471 SGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNL 550 (1010)
Q Consensus 471 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 550 (1010)
.+|+.|++++|+|+ .+|... .+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|+|
T Consensus 362 ~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~L 429 (788)
T PRK15387 362 SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSV 429 (788)
T ss_pred cccceehhhccccc-cCcccc---cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhh
Confidence 23444455555554 233321 345555555555552 3322 2345555555555552 34322 24555666
Q ss_pred cCccccCCchhhhhcccccceeccCCCcccCCCCC
Q 001816 551 SRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPG 585 (1010)
Q Consensus 551 s~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 585 (1010)
++|+|+ .+|..+.+++.|+.|+|++|+|++.+|.
T Consensus 430 s~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 430 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred ccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 666665 4555566666666666666666655443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=211.86 Aligned_cols=167 Identities=22% Similarity=0.233 Sum_probs=126.0
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCccee
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 846 (1010)
|+|.++++.. +..+++.+++.++.|+++||+|||+.+ ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6899999632 456999999999999999999999654 999999999999999 99998654321
Q ss_pred eeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCH
Q 001816 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926 (1010)
Q Consensus 847 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 926 (1010)
..||+.|||||++.+..++.++|||||||++|||++|+.||............+.. .... .++.....+.
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~~~~ 133 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN---GMPA-----DDPRDRSNLE 133 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH---Hhcc-----CCccccccHH
Confidence 25899999999999999999999999999999999999999653322222211111 1000 0011011111
Q ss_pred HHHH--HHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 001816 927 HEVM--HVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 927 ~~~~--~~~~li~~cl~~~P~~RPs~~ev~~~L~~~ 960 (1010)
.... .+.+++.+|++.+|++||++.|+++++...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2222 588999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=225.38 Aligned_cols=261 Identities=20% Similarity=0.263 Sum_probs=195.2
Q ss_pred cCCcCCeEeecCcEEEEEEEecCC--CEEEEEEeccCCCCCCcccchHHHHHHHhccCC----cccceeeeeE-ecCCcc
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPNG--DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH----RHIVRLLGFC-SNHETN 757 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~-~~~~~~ 757 (1010)
+|++.+.||+|+||.||.+..... ..+|+|......... ...+..|+.++..+.. +++.++++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 789999999999999999996543 478988876533322 1157889999998863 6999999999 577788
Q ss_pred EEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC-----CceEEeecc
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG-----FEAHVADFG 832 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-----~~~kl~DFG 832 (1010)
|+||+.+ |.+|.++......+.++..++.+++.|++.+|+++|+.| ++||||||+|+.+... ..+.+.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999988 889999886555688999999999999999999999777 9999999999999754 469999999
Q ss_pred ccc--cccCCCCc----c-e-eeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHH
Q 001816 833 LAK--FLQDSGTS----E-C-MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 833 la~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~ 904 (1010)
+|+ .+...... . . .....||..|+++++..+.+.+++.|+||++.++.|+..|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33222211 1 1 22355999999999999999999999999999999999999999765433332222111
Q ss_pred HhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCC
Q 001816 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~ 962 (1010)
.... .... +...... .+.++...+-..+..++|....+...+++...
T Consensus 253 ~~~~-------~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 253 PRKL-------LTDR-FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhhh-------cccc-ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1111 0000 1112222 33344444555788899999999998766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=227.95 Aligned_cols=168 Identities=22% Similarity=0.189 Sum_probs=129.6
Q ss_pred cccccCCcCCeEeecCcEEEEEEEec--CCCEEEEEEeccCCC---CCCcccchHHHHHHHhccCCcccceeeeeEecCC
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLMP--NGDQVAVKRLPAMSR---GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 681 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 755 (1010)
.+.+.|...+.||+|+||+||+|... +|+.||||++..... .......|.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 45678999999999999999999854 577789998753211 11224458999999999999999853322 24
Q ss_pred ccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecC-CCCcEEEcCCCceEEeecccc
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDV-KSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDl-kp~Nill~~~~~~kl~DFGla 834 (1010)
..|+||||++|++|... . .. ....++.|+++||+|||+.+ |+|||| ||+||+++.++.+||+|||+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~--~~------~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R--PH------GDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-C--cc------chHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 67999999999999732 1 10 11467899999999999777 999999 999999999999999999999
Q ss_pred ccccCCCCcce------eeeecccccccChhhhcc
Q 001816 835 KFLQDSGTSEC------MSAIAGSYGYIAPEYAYT 863 (1010)
Q Consensus 835 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 863 (1010)
+.+........ .....+++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 97765442222 135568889999998763
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=244.15 Aligned_cols=257 Identities=27% Similarity=0.332 Sum_probs=161.7
Q ss_pred CCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccC
Q 001816 281 LKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSS 360 (1010)
Q Consensus 281 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 360 (1010)
-..|+|++|.++ .+|..+. ++|+.|++++|+++ .+|. .+++|++|++++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 334444554444 3343332 24455555555554 2332 1345555555555555 23322 23555566666
Q ss_pred cccccCCCcccCCCCcchhhhccccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCcccccccc
Q 001816 361 NKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFP 440 (1010)
Q Consensus 361 N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 440 (1010)
|+++. +| .. ..+|+.|++++|+++ .+|.. .++|+.|+|++|+|++..+
T Consensus 272 N~L~~-Lp------------------------~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~ 319 (788)
T PRK15387 272 NPLTH-LP------------------------AL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPA 319 (788)
T ss_pred Cchhh-hh------------------------hc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCccccCCC
Confidence 65542 11 11 123445555566555 23331 3567777777777765322
Q ss_pred CCcccccccceEeccCccccCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCc
Q 001816 441 VSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKL 520 (1010)
Q Consensus 441 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 520 (1010)
...+|..|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|++ +|.. ..+
T Consensus 320 ----lp~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~ 383 (788)
T PRK15387 320 ----LPSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL---PSG 383 (788)
T ss_pred ----CcccccccccccCccc-ccccc---ccccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cccc---ccc
Confidence 1235777888888887 45642 247999999999999 566543 578899999999994 6653 357
Q ss_pred ccEEEccCcccccccchhcccccccceEEecCccccCCchhhhhcccccceeccCCCcccCCCCCCccccCCcccccCCC
Q 001816 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGN 600 (1010)
Q Consensus 521 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n 600 (1010)
|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|++++|+|+..+.....+..+..+.+.+|
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGN 455 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCC
Confidence 9999999999994 5644 3679999999999995 67543 4678899999999976544456677777788888
Q ss_pred ccCcC
Q 001816 601 SELCG 605 (1010)
Q Consensus 601 ~~~~g 605 (1010)
+ ++|
T Consensus 456 ~-Ls~ 459 (788)
T PRK15387 456 P-LSE 459 (788)
T ss_pred C-CCc
Confidence 6 444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=238.35 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=187.2
Q ss_pred cCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCC-CCC---CcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEE
Q 001816 688 EDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMS-RGS---SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
..+++|.|++|.|+.+.. ...+..+.|.+.... ... .....+..|+-+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456899999998887763 334445555443110 111 111125567777888899999999988877777777799
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 842 (1010)
||++ +|...+. +.+.+...++..++.|+..|++|+|..| |.|||+|++|++++..|.+||+|||.+....-...
T Consensus 402 ~~~~-Dlf~~~~--~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVM--SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHh--cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999984 3457899999999999999999999887 99999999999999999999999999976543333
Q ss_pred c--ceeeeecccccccChhhhccCCCCc-cCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCC
Q 001816 843 S--ECMSAIAGSYGYIAPEYAYTLKVDE-KSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 843 ~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
. ......+|+..|+|||...+.+|++ ..||||.|++++.|.+|+.||-.....++... .. ...... .. ..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~--~~~~~~-~~-~~ 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TN--NYSDQR-NI-FE 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hh--cccccc-cc-cc
Confidence 3 5566788999999999999999986 57999999999999999999965333222110 00 000000 00 00
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 920 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
....+....+.+...++.++++.+|.+|-|+++|++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111122333456677899999999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-20 Score=209.14 Aligned_cols=263 Identities=29% Similarity=0.386 Sum_probs=197.7
Q ss_pred CCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCC-cccchHHHHHHHhccCCc-ccceeeeeEecCCccEEEEEe
Q 001816 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS-HDHGFNAEIQTLGRIRHR-HIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~ 763 (1010)
|...+.||.|+||.||++... ..+|+|.+........ ....+.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999976 7899999976554432 466789999999999988 799999999777778999999
Q ss_pred cCCCCHHhhhccCCC-CCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC-ceEEeeccccccccCCC
Q 001816 764 MPNGSLGEVLHGKKG-GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~-~~kl~DFGla~~~~~~~ 841 (1010)
+.++++.+++..... ..+.......++.|++.+++|+|..+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977743221 26889999999999999999999777 99999999999999988 79999999998654433
Q ss_pred Ccc----eeeeecccccccChhhhcc---CCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccc
Q 001816 842 TSE----CMSAIAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 842 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
... ......|+..|+|||...+ ..+....|+||+|++++++++|..||..........+....+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 221 3456789999999999987 678899999999999999999999976543210111111111111100000
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
..... .........+..++..|+..+|..|.++.+....
T Consensus 237 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSP---SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCc---cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000 0001222456778999999999999998887664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.2e-21 Score=192.56 Aligned_cols=141 Identities=18% Similarity=0.199 Sum_probs=109.1
Q ss_pred CCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCc-------ccch-----------------HHHHHHHhccCCccc
Q 001816 689 DNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSH-------DHGF-----------------NAEIQTLGRIRHRHI 744 (1010)
Q Consensus 689 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-------~~~~-----------------~~E~~~l~~l~hpni 744 (1010)
...||+|+||.||+|...+|+.||||+++........ ...| ..|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999878999999999754221111 1122 349999999988877
Q ss_pred ceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHH-hhcCCCceEeecCCCCcEEEcCC
Q 001816 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL-HHDCSPLIVHRDVKSNNILLDSG 823 (1010)
Q Consensus 745 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~HrDlkp~Nill~~~ 823 (1010)
.....+.. ...++||||++|+++..... ....+++.++..++.|++.+|+|+ |..+ |+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 44333322 23489999999887765432 235688999999999999999999 6666 99999999999998 4
Q ss_pred CceEEeeccccccc
Q 001816 824 FEAHVADFGLAKFL 837 (1010)
Q Consensus 824 ~~~kl~DFGla~~~ 837 (1010)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.4e-21 Score=227.54 Aligned_cols=265 Identities=24% Similarity=0.413 Sum_probs=154.3
Q ss_pred CCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEecC
Q 001816 232 SLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLF 311 (1010)
Q Consensus 232 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 311 (1010)
+...|++++++++ .+|..+. ++|+.|+|++|.++. +|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4567888888887 4666553 468888888888885 344332 47888888888887 4555443 467888888
Q ss_pred CccccCCCCccccCCCcccccccccCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCcchhhhcccccccccc
Q 001816 312 RNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPI 391 (1010)
Q Consensus 312 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~ 391 (1010)
+|++. .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|+|++|++++ +|..+.
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp------------------- 303 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP------------------- 303 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch-------------------
Confidence 88877 5565443 46777777777777 4555443 367777777777763 232110
Q ss_pred ccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCcc
Q 001816 392 PESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFS 471 (1010)
Q Consensus 392 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 471 (1010)
++|+.|++++|.++. +|..+. ++|+. |++++|.|+ .+|..+. +
T Consensus 304 -------~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~------------------------L~Ls~N~Lt-~LP~~l~--~ 346 (754)
T PRK15370 304 -------SGITHLNVQSNSLTA-LPETLP--PGLKT------------------------LEAGENALT-SLPASLP--P 346 (754)
T ss_pred -------hhHHHHHhcCCcccc-CCcccc--cccee------------------------ccccCCccc-cCChhhc--C
Confidence 123344444444431 222221 23444 444444444 2343332 4
Q ss_pred CceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccch----hcccccccce
Q 001816 472 GVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPN----QLTGMRILNY 547 (1010)
Q Consensus 472 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~ 547 (1010)
+|+.|++++|+|+ .+|..+. +.|++|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|. .++.++.+..
T Consensus 347 sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~ 419 (754)
T PRK15370 347 ELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTR 419 (754)
T ss_pred cccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccE
Confidence 5666666666665 4554442 46677777777766 3455443 25677777777776 3343 3344567778
Q ss_pred EEecCccccCCchhhhhcccccceeccCCCcccCC
Q 001816 548 LNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGL 582 (1010)
Q Consensus 548 L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 582 (1010)
|+|.+|+++. ..+..|+.+ ++.|.+.|.
T Consensus 420 L~L~~Npls~------~tl~~L~~L-l~s~~~~gp 447 (754)
T PRK15370 420 IIVEYNPFSE------RTIQNMQRL-MSSVGYQGP 447 (754)
T ss_pred EEeeCCCccH------HHHHHHHHh-hhcccccCC
Confidence 8888888762 233444444 344555554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=225.42 Aligned_cols=247 Identities=26% Similarity=0.447 Sum_probs=164.7
Q ss_pred CCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCccccCCCcccccccc
Q 001816 256 NLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLW 335 (1010)
Q Consensus 256 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 335 (1010)
+...|+++++.++. +|..+. +.|+.|+|++|+|+ .+|..+. ++|+.|++++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 45678888887774 444332 46777777777777 3444433 46777777777766 3444322 345555555
Q ss_pred cCcccccCCcCCCCCCCccEEEccCcccccCCCcccCCCCcchhhhccccccccccccccccCCCCceEEcCCCcccCCC
Q 001816 336 ENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSI 415 (1010)
Q Consensus 336 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 415 (1010)
+|++. .+|..+. .+|+.|+|++|+++ .+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-------------------------------------------------~L 277 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-------------------------------------------------CL 277 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-------------------------------------------------cc
Confidence 55555 3443332 24555555555444 23
Q ss_pred ccccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCccCceEEecCCCcccCCCcccccccc
Q 001816 416 PKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQ 495 (1010)
Q Consensus 416 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 495 (1010)
|..+. ++|+.|++++|+|++. |..+ ..+|+.|++++|+|+ .+|..+. ++|+.|++++|.++ .+|..+. +
T Consensus 278 P~~l~--~sL~~L~Ls~N~Lt~L-P~~l--p~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~ 346 (754)
T PRK15370 278 PENLP--EELRYLSVYDNSIRTL-PAHL--PSGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP--P 346 (754)
T ss_pred ccccC--CCCcEEECCCCccccC-cccc--hhhHHHHHhcCCccc-cCCcccc--ccceeccccCCccc-cCChhhc--C
Confidence 33332 3455666666655542 2211 236777888888887 4565443 68999999999999 5777664 7
Q ss_pred CccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccccCCchhhhhc----ccccce
Q 001816 496 QLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIAS----MQSLTS 571 (1010)
Q Consensus 496 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----l~~L~~ 571 (1010)
+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+.+ ++.+..
T Consensus 347 sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~ 419 (754)
T PRK15370 347 ELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTR 419 (754)
T ss_pred cccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccE
Confidence 9999999999998 5776663 68999999999999 5566554 37999999999998 56665544 478899
Q ss_pred eccCCCcccC
Q 001816 572 VDFSYNNLSG 581 (1010)
Q Consensus 572 l~ls~N~l~~ 581 (1010)
|+|.+|+++.
T Consensus 420 L~L~~Npls~ 429 (754)
T PRK15370 420 IIVEYNPFSE 429 (754)
T ss_pred EEeeCCCccH
Confidence 9999999984
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.6e-21 Score=193.07 Aligned_cols=173 Identities=13% Similarity=0.137 Sum_probs=134.1
Q ss_pred ccccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCC-cccc------hHHHHHHHhccCCcccceeeeeEecC
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS-HDHG------FNAEIQTLGRIRHRHIVRLLGFCSNH 754 (1010)
Q Consensus 682 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~hpniv~~~~~~~~~ 754 (1010)
+.++|+..+++|.|+||.||.+.. ++..+|||.+........ .... +++|++.+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999766 577899999965433221 1112 68899999999999999999986543
Q ss_pred --------CccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCce
Q 001816 755 --------ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEA 826 (1010)
Q Consensus 755 --------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~ 826 (1010)
+..++||||++|.+|.++.. +++ ....+++.++..+|+.| ++|||+||+||+++.+| +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999988741 222 34569999999999887 99999999999999988 9
Q ss_pred EEeeccccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHH
Q 001816 827 HVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 883 (1010)
Q Consensus 827 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 883 (1010)
+++|||........... ..+.....++.++|+|+||+++....
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988754321110 11444556778999999999887664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=184.90 Aligned_cols=142 Identities=19% Similarity=0.176 Sum_probs=110.8
Q ss_pred CCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCc------------------------ccchHHHHHHHhccCCccc
Q 001816 689 DNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSH------------------------DHGFNAEIQTLGRIRHRHI 744 (1010)
Q Consensus 689 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~hpni 744 (1010)
...||+|+||.||+|...+|+.||||+++........ ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998754221100 1113578999999999987
Q ss_pred ceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcCC
Q 001816 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSG 823 (1010)
Q Consensus 745 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~~ 823 (1010)
.....+... ..|+||||++|+++..... ....++..++..++.|++.++.++|+ .| |+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence 554444332 3489999998886544321 22457788999999999999999997 77 99999999999999 7
Q ss_pred CceEEeecccccccc
Q 001816 824 FEAHVADFGLAKFLQ 838 (1010)
Q Consensus 824 ~~~kl~DFGla~~~~ 838 (1010)
+.++|+|||+|+...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=180.27 Aligned_cols=187 Identities=16% Similarity=0.069 Sum_probs=141.2
Q ss_pred cCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCC--cccchHHHHHHHhccC-CcccceeeeeEecCCccEEEEEec
Q 001816 688 EDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS--HDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
....|++|+||+||.+.. .+.+++.+.+........ ....+.+|+++++++. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 356899999999997766 678888887765433211 1124789999999995 5889999886 3469999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecC-CCCcEEEcCCCceEEeeccccccccCCCCc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDV-KSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDl-kp~Nill~~~~~~kl~DFGla~~~~~~~~~ 843 (1010)
+|.+|.+.... ....++.|++++++++|+.| |+|||| ||+||+++.++.++|+|||+|.........
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999765411 12357789999999999887 999999 799999999999999999999865433211
Q ss_pred c---e--------eeeecccccccChhhhccC-CCC-ccCceehhhHHHHHHHhCCCCCCC
Q 001816 844 E---C--------MSAIAGSYGYIAPEYAYTL-KVD-EKSDVYSFGVVLLELITGRKPVGE 891 (1010)
Q Consensus 844 ~---~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slG~il~elltg~~P~~~ 891 (1010)
. . ..-...++.|++|+...-. ..+ .+.+.++-|..+|.++||+.++..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 0112367888999865532 233 567999999999999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-20 Score=205.05 Aligned_cols=227 Identities=24% Similarity=0.249 Sum_probs=180.8
Q ss_pred eEeecCcEEEEEEE----ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCCccEEEEEecC
Q 001816 691 IIGKGGAGIVYKGL----MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLVYEYMP 765 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~ 765 (1010)
++|+|.||.|+... ...|.-+|.|+.++.............|..++...+ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36999999999764 234677999988765544443445667888888886 9999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcce
Q 001816 766 NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845 (1010)
Q Consensus 766 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 845 (1010)
||++...+. ....+++.....+...++-|++++|+.+ |+|||+|++||+++.+|++++.|||+++..-+...
T Consensus 81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999988884 3456777788888899999999999777 99999999999999999999999999987644322
Q ss_pred eeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCC
Q 001816 846 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (1010)
.+||..|||||++. ....++|.||||++++||+||..||.. +. .+.+.. .-...|
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~---~~~Il~------------~~~~~p 207 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DT---MKRILK------------AELEMP 207 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HH---HHHHhh------------hccCCc
Confidence 28999999999998 677899999999999999999999965 11 111111 112345
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCH
Q 001816 926 LHEVMHVFYVAMLCVEEQAVERPTM 950 (1010)
Q Consensus 926 ~~~~~~~~~li~~cl~~~P~~RPs~ 950 (1010)
.........++..+...+|..|--.
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 5555666678888888899888543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-19 Score=196.64 Aligned_cols=220 Identities=23% Similarity=0.404 Sum_probs=164.8
Q ss_pred HhccCCcccceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCC
Q 001816 736 LGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKS 815 (1010)
Q Consensus 736 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp 815 (1010)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++.....++++|+.||+|+|.. +-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence 3567899999999999999999999999999999999974 456789999999999999999999963 3339999999
Q ss_pred CcEEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccCC-------CCccCceehhhHHHHHHHhCCCC
Q 001816 816 NNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK-------VDEKSDVYSFGVVLLELITGRKP 888 (1010)
Q Consensus 816 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slG~il~elltg~~P 888 (1010)
.|.++|....+|++|||+.................-..-|.|||.++... .+.++||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987764311111112223456899999988642 46679999999999999999999
Q ss_pred CCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCCCC
Q 001816 889 VGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~~~ 963 (1010)
|.......+..+.+..+... ....+-|...... .....+..++..||.++|++||+++.+...++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~----~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKG----GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhc----CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 98754444322333222221 1111112222111 2223578899999999999999999999888776543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.1e-20 Score=212.49 Aligned_cols=254 Identities=19% Similarity=0.178 Sum_probs=179.6
Q ss_pred cCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHH--HhccCCcccceeeeeEecCCccEEEEE
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQT--LGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 685 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~~~~~~~~~~~~~lv~e 762 (1010)
.+...+.+|.+.|=.|.+|++..|. |+||++-..... ...+.|.++++- ...++|||.+++.-+...+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~-~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPT-ISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCC-CCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4455678999999999999998887 899998543322 223345544333 445589999999988888888899999
Q ss_pred ecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccccc-CCC
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ-DSG 841 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~-~~~ 841 (1010)
|+ ..+|+|.+..+ ..+...+.+-|+.|++.|+..+|+.| |+|||||.+||||+.=.-+.|+||..-+..- +.+
T Consensus 102 yv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 99 46999999533 45677788889999999999999888 9999999999999998889999998765321 111
Q ss_pred Cccee----eeecccccccChhhhccC-----------CCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHH
Q 001816 842 TSECM----SAIAGSYGYIAPEYAYTL-----------KVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKM 905 (1010)
Q Consensus 842 ~~~~~----~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 905 (1010)
+.... .+...-..|.|||.+... ..+++-||||+||+++|+++ |++||.- .++..+.+.-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC
Confidence 11111 222234589999987531 15678899999999999998 7888852 1111111100
Q ss_pred hhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCC
Q 001816 906 TDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L~~~~ 961 (1010)
.......+.++-|. .+..++..|++.||++|-++++.++.-+...
T Consensus 252 ~~~~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred ccCHHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 00000111111111 4567899999999999999999988755543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=205.06 Aligned_cols=195 Identities=19% Similarity=0.202 Sum_probs=162.1
Q ss_pred cccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccC---CcccceeeeeEecCCccEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR---HRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~l 759 (1010)
-+.|.+.+.||+|+||+||+|...+|+.||+|+-+....- +|.--.+++.+++ -+-|..+..++...+.-++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3567788899999999999999878999999987654332 2333445566665 3566677777777788899
Q ss_pred EEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-------CCceEEeecc
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-------GFEAHVADFG 832 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-------~~~~kl~DFG 832 (1010)
|+||.+.|+|.+++. ..+.++|.-+..+..|+++.+++||..+ ||||||||+|+++.. ...++|+|||
T Consensus 772 v~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 999999999999995 5567999999999999999999999888 999999999999942 3358999999
Q ss_pred ccccccCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCC
Q 001816 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRK 887 (1010)
Q Consensus 833 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~ 887 (1010)
.+..+..-.........++|-.+-.+|+..+..+++.+|.|.++.+++-|+.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9976654444455677889999999999999999999999999999999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.3e-19 Score=182.34 Aligned_cols=195 Identities=25% Similarity=0.320 Sum_probs=141.0
Q ss_pred CCcccceeeeeEec---------------------------CCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHH
Q 001816 740 RHRHIVRLLGFCSN---------------------------HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVE 792 (1010)
Q Consensus 740 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ 792 (1010)
+|||||++.++|.+ ....|+||.-+ ..+|.+++.. ...+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHH
Confidence 59999999987644 22458999988 4699999853 34566777888999
Q ss_pred HHHHhhHHhhcCCCceEeecCCCCcEEE--cCCC--ceEEeeccccccccCCC----CcceeeeecccccccChhhhccC
Q 001816 793 AAKGLCYLHHDCSPLIVHRDVKSNNILL--DSGF--EAHVADFGLAKFLQDSG----TSECMSAIAGSYGYIAPEYAYTL 864 (1010)
Q Consensus 793 i~~~l~~LH~~~~~~i~HrDlkp~Nill--~~~~--~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~ 864 (1010)
+++|+.|||++| |.|||+|++|||+ |+|+ .+.|+|||++---...+ .........|...-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999888 9999999999998 4444 47889999885322211 11112234577889999998743
Q ss_pred C------CCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHh
Q 001816 865 K------VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAML 938 (1010)
Q Consensus 865 ~------~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 938 (1010)
+ .-.|+|.|+.|.+.||+++...||...++ ..... + ..-+..+|..|...+..+.+++..
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~-r-----------~Yqe~qLPalp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDT-R-----------TYQESQLPALPSRVPPVARQLVFD 492 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heech-h-----------hhhhhhCCCCcccCChHHHHHHHH
Confidence 2 12589999999999999999999965221 11100 0 011234566666777778899999
Q ss_pred ccccCCCCCCCHHHHHH
Q 001816 939 CVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 939 cl~~~P~~RPs~~ev~~ 955 (1010)
.++.||.+|++..-...
T Consensus 493 lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HhcCCccccCCccHHHh
Confidence 99999999998654443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=182.97 Aligned_cols=233 Identities=20% Similarity=0.297 Sum_probs=145.4
Q ss_pred CCcCCeEeecCcEEEEEEEec-CCCEEEEEEeccCCCC-CCcccchHHHHHHHhccCC----------cccceeeeeEe-
Q 001816 686 LKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRH----------RHIVRLLGFCS- 752 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h----------pniv~~~~~~~- 752 (1010)
+...+.||.|+++.||.+.+. +|+.+|||++...... ....+.+.+|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999964 5899999998654432 2234456666655544322 12222222221
Q ss_pred --------cC---C-----ccEEEEEecCCCCHHhhhcc---CCC--CCCChhhHHHHHHHHHHHhhHHhhcCCCceEee
Q 001816 753 --------NH---E-----TNLLVYEYMPNGSLGEVLHG---KKG--GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHR 811 (1010)
Q Consensus 753 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~Hr 811 (1010)
.. . ..+++|+-+ .++|.+.+.. ... ..+....+..+..|+.+.+++||..| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 226788877 5788877532 111 12333344566789999999999888 9999
Q ss_pred cCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhcc--------CCCCccCceehhhHHHHHHH
Q 001816 812 DVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT--------LKVDEKSDVYSFGVVLLELI 883 (1010)
Q Consensus 812 Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ell 883 (1010)
||||+|++++.+|.++|+||+.....+.. ......+..|.+||.... ..++++.|.|++|+++|.++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999988754321 111345578999997643 35788999999999999999
Q ss_pred hCCCCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCC
Q 001816 884 TGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVER 947 (1010)
Q Consensus 884 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R 947 (1010)
+|+.||+........ .| .+.... +.+..+..+|..+++.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~-~~------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP-EW------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS-GG------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc-cc------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999754221110 00 122223 455678889999999999987
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-20 Score=168.95 Aligned_cols=168 Identities=26% Similarity=0.414 Sum_probs=144.4
Q ss_pred ccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCccCceEEecCCCcccCCCccccccccCc
Q 001816 418 GLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQL 497 (1010)
Q Consensus 418 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 497 (1010)
+++++..++.|.|++|+++. .|..+..+.+|+.|++++|+|. .+|.++..+++|+.|+++-|++. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 45566777777788888774 3445667778888888888888 88999999999999999999998 899999999999
Q ss_pred cEEEecCCccCC-CCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccccCCchhhhhcccccceeccCC
Q 001816 498 SKMDFSHNKFSG-RIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSY 576 (1010)
Q Consensus 498 ~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~ 576 (1010)
+.|||++|++.. ..|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+..|.+. .+|..++.++.|+.|.+.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 999999999874 47888888999999999999998 88999999999999999999998 7899999999999999999
Q ss_pred CcccCCCCCCcccc
Q 001816 577 NNLSGLVPGTGQFS 590 (1010)
Q Consensus 577 N~l~~~~p~~~~~~ 590 (1010)
|+|+-.+|..+++.
T Consensus 183 nrl~vlppel~~l~ 196 (264)
T KOG0617|consen 183 NRLTVLPPELANLD 196 (264)
T ss_pred ceeeecChhhhhhh
Confidence 99999998875543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-19 Score=202.37 Aligned_cols=281 Identities=20% Similarity=0.214 Sum_probs=158.5
Q ss_pred EEEeccccCC-CCccccccccCcCCEEEccCCcCccc----cCccccccCCCCEEecCCccccC------CCCccccCCC
Q 001816 259 TLFLQVNALS-GPLTTELGYLKSLKSMDLSNNIFTGE----IPASFAELKNLTLLNLFRNKLHG------AIPEFIGVMP 327 (1010)
Q Consensus 259 ~L~L~~N~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~ 327 (1010)
.|+|..+.++ ......+..+..|+.|+++++.++.. ++..+...++|+.|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777776 33444556667788888888887532 34445566677888887777652 1223444555
Q ss_pred cccccccccCcccccCCcCCCCCCC---ccEEEccCcccccCCCcccCCCCcchhhhccccccccccccccccC-CCCce
Q 001816 328 RLEVLQLWENNFTGSIPQRLGSNGK---LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKC-DSLSR 403 (1010)
Q Consensus 328 ~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~p~~l~~l-~~L~~ 403 (1010)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++.+... ..+...+..+ ++|++
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence 6666666666665433333333333 6666666665542100 1122233344 55556
Q ss_pred EEcCCCcccCC----CccccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCccCceEEecC
Q 001816 404 MRMGENFLNGS----IPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLD 479 (1010)
Q Consensus 404 L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 479 (1010)
|++++|.+++. ++..+..+++|++|++++|.+++... ..++..+..+++|+.|+++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~--------------------~~l~~~l~~~~~L~~L~L~ 201 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGI--------------------RALAEGLKANCNLEVLDLN 201 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHH--------------------HHHHHHHHhCCCCCEEecc
Confidence 66666555522 12223333444444444444432000 0122223344567777777
Q ss_pred CCcccCC----CccccccccCccEEEecCCccCCCCchhhcc-----CCcccEEEccCccccc----ccchhcccccccc
Q 001816 480 GNKFSGQ----IPAEIGKLQQLSKMDFSHNKFSGRIAPEISQ-----CKLLTFVDLSRNELSG----EIPNQLTGMRILN 546 (1010)
Q Consensus 480 ~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~ 546 (1010)
+|.+++. ++..+..+++|++|++++|++++.....+.. .+.|+.|++++|.+++ .+...+..+++|+
T Consensus 202 ~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~ 281 (319)
T cd00116 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLL 281 (319)
T ss_pred CCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCcc
Confidence 7766532 3344556777888888888877533333322 3678888888888862 3445566667888
Q ss_pred eEEecCccccCC----chhhhhcc-cccceeccCCCcc
Q 001816 547 YLNLSRNHLVGS----IPASIASM-QSLTSVDFSYNNL 579 (1010)
Q Consensus 547 ~L~Ls~N~l~~~----~p~~~~~l-~~L~~l~ls~N~l 579 (1010)
++++++|+++.. +...+... +.|+.+|+.+|++
T Consensus 282 ~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 282 ELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 888888888855 33334444 5788888887764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-19 Score=202.93 Aligned_cols=280 Identities=21% Similarity=0.224 Sum_probs=153.9
Q ss_pred EEccCCCCC-CCcCccccCCCCCCEEEeccccCCCC----ccccccccCcCCEEEccCCcCcc------ccCccccccCC
Q 001816 236 FDAANCGLS-GEIPTDIGRLQNLDTLFLQVNALSGP----LTTELGYLKSLKSMDLSNNIFTG------EIPASFAELKN 304 (1010)
Q Consensus 236 L~l~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~~ 304 (1010)
|+|.++.++ ......+..+.+|++|+++++.++.. ++..+...++|+.|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 344444443 22233334444555555555555321 23334444555666666555541 12334555666
Q ss_pred CCEEecCCccccCCCCccccCCCc---ccccccccCcccc----cCCcCCCCC-CCccEEEccCcccccCCCcccCCCCc
Q 001816 305 LTLLNLFRNKLHGAIPEFIGVMPR---LEVLQLWENNFTG----SIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNC 376 (1010)
Q Consensus 305 L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~~ 376 (1010)
|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++....
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~------- 155 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE------- 155 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH-------
Confidence 666666666665544444444444 7777777776652 222234445 6777777777777632111
Q ss_pred chhhhccccccccccccccccCCCCceEEcCCCcccCC----CccccCCCCCCCeEEecCccccccccCCcccccccceE
Q 001816 377 LQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGS----IPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQI 452 (1010)
Q Consensus 377 L~~L~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L 452 (1010)
.++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++....
T Consensus 156 -------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~----------- 211 (319)
T cd00116 156 -------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS----------- 211 (319)
T ss_pred -------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH-----------
Confidence 2234455666777777777777632 233344556777777777766532111
Q ss_pred eccCccccCCCCCCCCCccCceEEecCCCcccCCCcccccc-----ccCccEEEecCCccCC----CCchhhccCCcccE
Q 001816 453 CLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGK-----LQQLSKMDFSHNKFSG----RIAPEISQCKLLTF 523 (1010)
Q Consensus 453 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~ 523 (1010)
.+...+..+++|+.|++++|++++.....+.. .+.|+.|++++|.+++ .+...+..+++|++
T Consensus 212 ---------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~ 282 (319)
T cd00116 212 ---------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLE 282 (319)
T ss_pred ---------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccE
Confidence 11223344556666666666665322222221 3677788888887762 22344555677888
Q ss_pred EEccCcccccc----cchhcccc-cccceEEecCccc
Q 001816 524 VDLSRNELSGE----IPNQLTGM-RILNYLNLSRNHL 555 (1010)
Q Consensus 524 L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l 555 (1010)
+++++|.++.. ....+... +.|++|++.+|.+
T Consensus 283 l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 283 LDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 88888888854 44555555 6788888887764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=170.06 Aligned_cols=136 Identities=19% Similarity=0.202 Sum_probs=104.0
Q ss_pred CcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-----CCcccceeeeeEecCC---ccE
Q 001816 687 KEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-----RHRHIVRLLGFCSNHE---TNL 758 (1010)
Q Consensus 687 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~---~~~ 758 (1010)
...+.||+|+||.||. .-.++.. +||++..... ...+.+.+|+++++.+ +||||++++|++.++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999996 3234444 6898865322 2345689999999999 5799999999998863 333
Q ss_pred -EEEEe--cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHh-hHHhhcCCCceEeecCCCCcEEEcC----CCceEEee
Q 001816 759 -LVYEY--MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGL-CYLHHDCSPLIVHRDVKSNNILLDS----GFEAHVAD 830 (1010)
Q Consensus 759 -lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~HrDlkp~Nill~~----~~~~kl~D 830 (1010)
+|||| +++|+|.+++.+ +.+++. ..++.|++.++ +|||+++ |+||||||+||+++. ++.++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 557999999953 235555 35678888887 9999887 999999999999974 34799999
Q ss_pred cccc
Q 001816 831 FGLA 834 (1010)
Q Consensus 831 FGla 834 (1010)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=171.40 Aligned_cols=143 Identities=19% Similarity=0.192 Sum_probs=109.2
Q ss_pred CCcCCeEeecCcEEEEEEE--ecCCCEEEEEEeccCCCCCC----------------------cccchHHHHHHHhccCC
Q 001816 686 LKEDNIIGKGGAGIVYKGL--MPNGDQVAVKRLPAMSRGSS----------------------HDHGFNAEIQTLGRIRH 741 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~~----------------------~~~~~~~E~~~l~~l~h 741 (1010)
|.+.+.||+|+||.||+|. ..+|+.||||+++....... ....+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5567789999999999998 56899999999875322100 01125689999999975
Q ss_pred c--ccceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCc-eEeecCCCCcE
Q 001816 742 R--HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL-IVHRDVKSNNI 818 (1010)
Q Consensus 742 p--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~HrDlkp~Ni 818 (1010)
. .+++++++ ...++||||++|+++..... ........++..++.|++.+++++| ..+ |+||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 3 34444443 23589999999988876542 2234566677899999999999999 445 99999999999
Q ss_pred EEcCCCceEEeecccccccc
Q 001816 819 LLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 819 ll~~~~~~kl~DFGla~~~~ 838 (1010)
+++ ++.++|+|||.|....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.9e-19 Score=162.98 Aligned_cols=157 Identities=33% Similarity=0.589 Sum_probs=106.9
Q ss_pred cccccccceeccccccccCCCCccccccCccceecccCcccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCc
Q 001816 106 ISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLE 185 (1010)
Q Consensus 106 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 185 (1010)
+..+++++.|.||+|+++ .+|..+..|.+|+.|++++|+|+ .+|..+..+++|++|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445778888999999998 77778899999999999999998 78888999999999999988887 7788888888888
Q ss_pred eeEeccccccc-cccccccCcchhhHHhhccccCCCCCCCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEecc
Q 001816 186 YLAVSGNELGG-KIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQV 264 (1010)
Q Consensus 186 ~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~ 264 (1010)
.|||+.|.+.. ..|+.|..++.|+-|+|+.|. -..+|..++++++|+.|.+..|.+. .+|..++.+..|++|.+++
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dnd--fe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDND--FEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCC--cccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 88888887763 456666667777777665321 1234444444444444444444443 3333333333333333333
Q ss_pred ccCC
Q 001816 265 NALS 268 (1010)
Q Consensus 265 N~l~ 268 (1010)
|+++
T Consensus 183 nrl~ 186 (264)
T KOG0617|consen 183 NRLT 186 (264)
T ss_pred ceee
Confidence 3333
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=164.81 Aligned_cols=138 Identities=20% Similarity=0.207 Sum_probs=108.1
Q ss_pred CCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCC--------------------cccchHHHHHHHhccCCc--c
Q 001816 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS--------------------HDHGFNAEIQTLGRIRHR--H 743 (1010)
Q Consensus 686 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--------------------~~~~~~~E~~~l~~l~hp--n 743 (1010)
|...+.||+|+||.||++..++|+.||||+++....... ....+..|+.++.++.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 556688999999999999988899999998764321100 011256788889888777 4
Q ss_pred cceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC
Q 001816 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG 823 (1010)
Q Consensus 744 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~ 823 (1010)
+++.++ ....++||||++|++|.+... ......++.+++.++.++|+.+ |+||||||+||+++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 444443 245699999999999877542 1345678899999999999777 9999999999999999
Q ss_pred CceEEeecccccccc
Q 001816 824 FEAHVADFGLAKFLQ 838 (1010)
Q Consensus 824 ~~~kl~DFGla~~~~ 838 (1010)
+.++|+|||.+....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=165.66 Aligned_cols=136 Identities=21% Similarity=0.355 Sum_probs=113.3
Q ss_pred CeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCC------cccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS------HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.||+|++|.||+|.+ .|..|+||+......... ....+.+|++++..+.|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 778899998754322111 113477899999999999988877777777888999999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
++|++|.+++... .+ ++..++.+++.++.++|..+ ++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998532 12 78899999999999999777 99999999999999 78899999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.7e-16 Score=185.18 Aligned_cols=140 Identities=24% Similarity=0.317 Sum_probs=112.3
Q ss_pred cccCCcCCeEeecCcEEEEEEEecCCCEEEEEEe-ccCCCCC-----CcccchHHHHHHHhccCCcccceeeeeEecCCc
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRL-PAMSRGS-----SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~-~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 756 (1010)
...|...+.||+|+||+||+|.+... .+++|+. ....... .....+.+|++++++++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556788999999999999987443 4444443 2211111 112457889999999999999988888877778
Q ss_pred cEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
.++||||++|++|.+++. ....++.++++++.|||+.+ ++|||+||+||++ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999883 45788999999999999777 9999999999999 577999999999975
Q ss_pred c
Q 001816 837 L 837 (1010)
Q Consensus 837 ~ 837 (1010)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=164.31 Aligned_cols=132 Identities=24% Similarity=0.370 Sum_probs=106.8
Q ss_pred eEeecCcEEEEEEEecCCCEEEEEEeccCCCCCC------cccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEec
Q 001816 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS------HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 764 (1010)
.||+|+||.||+|.+ +|..|++|+......... ....+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999986 678999998654322111 1244678999999999887666555666667789999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
+|++|.+.+.... ..++.+++.++.++|+.+ ++|||++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999874321 078999999999999777 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-17 Score=180.10 Aligned_cols=176 Identities=21% Similarity=0.328 Sum_probs=131.9
Q ss_pred CccEEEEEecCCCCHHhhhccC-CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccc
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGK-KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGl 833 (1010)
.+.||.|++|+..+|.+|+.++ .....++.....++.|++.|++| .+ .+|||+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999643 34567788899999999999999 55 89999999999999999999999999
Q ss_pred cccccCCC----CcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHh-CCCCCCCCCCCccHHHHHHHHhhh
Q 001816 834 AKFLQDSG----TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 834 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
........ ........+||..||+||++.+..|+.++||||||++++|++. -..+++. +..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t---- 468 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IAT---- 468 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHh----
Confidence 98765443 1234456789999999999999999999999999999999997 3333321 111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 001816 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954 (1010)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~ 954 (1010)
..++-|..+|+.-......-..++.+++...|.+||++.++.
T Consensus 469 ----~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 469 ----LTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ----hhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHh
Confidence 111112222211111112334678899999999999665553
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=180.68 Aligned_cols=152 Identities=32% Similarity=0.566 Sum_probs=121.9
Q ss_pred CCChhHHHHHHHHHHhcCCCCCCCCCCcCCCCCC---CCCCceEeCCC-----CcEEEEEcCCCCcccccCcccCCCCCC
Q 001816 17 SRTVPEYKALLSIKSSITDDPQSSLAAWNATTSH---CTWPGVTCDSR-----RHVTSLDLSGLNLSGALSPDVAHLRFL 88 (1010)
Q Consensus 17 ~~~~~~~~all~~~~~~~~~~~~~~~~w~~~~~~---c~w~gv~c~~~-----~~v~~L~l~~~~l~~~~~~~l~~l~~L 88 (1010)
++...|..||+++|+++.. +. ..+|++++|+ |.|.||.|... ..|+.|+|++|++.|.+|..+..+++|
T Consensus 368 ~t~~~~~~aL~~~k~~~~~-~~--~~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGL-PL--RFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred ccCchHHHHHHHHHHhcCC-cc--cCCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 3456799999999999863 32 2479764321 37999999532 258889999999998888888888889
Q ss_pred CEEEccccccCCCCCcccccccccceeccccccccCCCCccccccCccceecccCcccCCCCCcchhcc-ccccceeccc
Q 001816 89 QNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQL-RNLRHLHLGG 167 (1010)
Q Consensus 89 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~ 167 (1010)
+.|+|++|.+.|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|..+..+ .++..+++.+
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~ 524 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence 999999888888888888888888888888888888888888888888888888888888888887764 4566777777
Q ss_pred ccCC
Q 001816 168 NFFS 171 (1010)
Q Consensus 168 N~l~ 171 (1010)
|...
T Consensus 525 N~~l 528 (623)
T PLN03150 525 NAGL 528 (623)
T ss_pred Cccc
Confidence 7644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.2e-16 Score=181.24 Aligned_cols=208 Identities=23% Similarity=0.224 Sum_probs=137.7
Q ss_pred cccCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
...|+..+.|-.|+||.||..+++. .+++|+|+=+. .. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch-------hhhc--cccccCCccee----------------
Confidence 3567778899999999999998653 56788853221 11 1110 22222333333
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCC
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 841 (1010)
|+-...++ .-+.++.+. +.+++|+|+.+ |+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 -----gDc~tllk--~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -----GDCATLLK--NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -----chhhhhcc--cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 44444442 223444433 67899999665 9999999999999999999999999987532111
Q ss_pred Cc-------------ceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhh
Q 001816 842 TS-------------ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 842 ~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
.. -..+..+|||.|.|||++....|+..+|.|++|+|+||.+.|+.||.+.-.++-+.+.+.....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~- 276 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE- 276 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc-
Confidence 00 1123458999999999999999999999999999999999999999653222222222221111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCC
Q 001816 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVER 947 (1010)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R 947 (1010)
.++-......+...++.+.++++|.+|
T Consensus 277 ------------wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 277 ------------WPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred ------------ccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 111111122356678889999999999
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-15 Score=151.98 Aligned_cols=138 Identities=21% Similarity=0.284 Sum_probs=98.1
Q ss_pred CCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccch----------------------HHHHHHHhccCCc--cc
Q 001816 689 DNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGF----------------------NAEIQTLGRIRHR--HI 744 (1010)
Q Consensus 689 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~----------------------~~E~~~l~~l~hp--ni 744 (1010)
.+.||+|+||.||+|...+|+.||||+++...........+ ..|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999986532221111111 3455556555433 24
Q ss_pred ceeeeeEecCCccEEEEEecCCCCHHhh-hccCCCCCCChhhHHHHHHHHHHHhhHHhh-cCCCceEeecCCCCcEEEcC
Q 001816 745 VRLLGFCSNHETNLLVYEYMPNGSLGEV-LHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDS 822 (1010)
Q Consensus 745 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~HrDlkp~Nill~~ 822 (1010)
.+.++. ...++||||++++++... +.... . ..++..++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 346899999998543221 11100 1 16678999999999999997 65 99999999999999
Q ss_pred CCceEEeecccccccc
Q 001816 823 GFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 823 ~~~~kl~DFGla~~~~ 838 (1010)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-14 Score=141.36 Aligned_cols=134 Identities=21% Similarity=0.260 Sum_probs=112.8
Q ss_pred CCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCC--cccceeeeeEecCCccEEEEEecCC
Q 001816 689 DNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH--RHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 689 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..+++|||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4679999999999999744 7899998854322 3468899999999976 5999999988888889999999988
Q ss_pred CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
+.+..+ +......++.+++++++++|....++++|||++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 776543 4466678899999999999975445699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.6e-16 Score=182.91 Aligned_cols=258 Identities=22% Similarity=0.252 Sum_probs=190.8
Q ss_pred ccCCcCCeEeecCcEEEEEEEecC--CCEEEEEEeccCCCCCCcccchHHHHHHHhccC-CcccceeeeeEecCCccEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN--GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 760 (1010)
..|...+.||+|+|+.|-...... ...+|+|.+...............|..+-..+. |+|++++++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 356667779999999998876432 345777776554433333344556777777776 99999999999999999999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHh-hcCCCceEeecCCCCcEEEcCCC-ceEEeecccccccc
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH-HDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAKFLQ 838 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~HrDlkp~Nill~~~~-~~kl~DFGla~~~~ 838 (1010)
+||..|+++.+.+........+...+..++.|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999998883222225667778889999999999999 777 99999999999999999 99999999998877
Q ss_pred C-CCCcceeeeecc-cccccChhhhccC-CCCccCceehhhHHHHHHHhCCCCCCCCCCCcc-HHHHHHHHhhhcccccc
Q 001816 839 D-SGTSECMSAIAG-SYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVD-IVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 839 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~ 914 (1010)
. .+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ...|...-
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~--------- 247 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK--------- 247 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---------
Confidence 6 555555566788 9999999998885 456789999999999999999999875433221 11111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
+................+..+++..+|..|.+.+++...
T Consensus 248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 000000111112234456778888999999998888653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.1e-14 Score=149.56 Aligned_cols=138 Identities=16% Similarity=0.188 Sum_probs=105.7
Q ss_pred CCeEe-ecCcEEEEEEEecCCCEEEEEEeccCC------C-----CCCcccchHHHHHHHhccCCccc--ceeeeeEecC
Q 001816 689 DNIIG-KGGAGIVYKGLMPNGDQVAVKRLPAMS------R-----GSSHDHGFNAEIQTLGRIRHRHI--VRLLGFCSNH 754 (1010)
Q Consensus 689 ~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~------~-----~~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~~ 754 (1010)
..+|| .|+.|+||++.. .+..++||.+.... . .......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 999999999987 47889999885311 1 11223457889999999998775 6777764432
Q ss_pred C-c---cEEEEEecCC-CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEe
Q 001816 755 E-T---NLLVYEYMPN-GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVA 829 (1010)
Q Consensus 755 ~-~---~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~ 829 (1010)
. . .++||||++| .+|.+++.. ..++.. .+.+++.++.+||+.| |+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2 2599999997 699988843 234433 3578999999999877 9999999999999998899999
Q ss_pred eccccccc
Q 001816 830 DFGLAKFL 837 (1010)
Q Consensus 830 DFGla~~~ 837 (1010)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=3e-14 Score=170.54 Aligned_cols=116 Identities=32% Similarity=0.508 Sum_probs=81.0
Q ss_pred ccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccccCCchhhhhcccccceeccCC
Q 001816 497 LSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSY 576 (1010)
Q Consensus 497 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~ 576 (1010)
++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56667777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CcccCCCCCCc--cccCCcccccCCCccCcCCC-CCCCC
Q 001816 577 NNLSGLVPGTG--QFSYFNYTSFLGNSELCGPY-LGPCK 612 (1010)
Q Consensus 577 N~l~~~~p~~~--~~~~~~~~~~~~n~~~~g~~-~~~c~ 612 (1010)
|+++|.+|..- .+..+....+.+|+.+||.+ ..+|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 77777776531 11233455688999999965 46774
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.7e-15 Score=159.27 Aligned_cols=182 Identities=31% Similarity=0.506 Sum_probs=123.9
Q ss_pred CCCccEEEccCcccccCCCcccCCCCcchhhhccccccccccccccccCCCCceEEcCCCcccCCCccccCCCCCCCeEE
Q 001816 350 NGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVE 429 (1010)
Q Consensus 350 l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 429 (1010)
+..-...||+.|++. ++|..+|.+-.|+.+.+..|.+ ..+|+.+..+..|+.|+++.|+++ ..|..+|.+| |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~-r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCI-RTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccc-eecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 334456777888876 6777888887888887777765 467888888888888888888887 7788887765 56666
Q ss_pred ecCccccccccCCcccccccceEeccCccccCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCC
Q 001816 430 LQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSG 509 (1010)
Q Consensus 430 L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 509 (1010)
+++|+++ .+|..++.+..|..||.+.|.+. .+|+.++++..|+.|.+..|++.
T Consensus 150 ~sNNkl~-------------------------~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~- 202 (722)
T KOG0532|consen 150 VSNNKLT-------------------------SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE- 202 (722)
T ss_pred EecCccc-------------------------cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-
Confidence 6666555 55555555556666666666665 55666666666666666666665
Q ss_pred CCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccccCCchhhhhc
Q 001816 510 RIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIAS 565 (1010)
Q Consensus 510 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 565 (1010)
.+|.+++ .-.|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|. ..|+.++.
T Consensus 203 ~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~ 255 (722)
T KOG0532|consen 203 DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE 255 (722)
T ss_pred hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence 4555555 334666666666666 66777777777777777777776 55665544
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.8e-15 Score=163.02 Aligned_cols=181 Identities=24% Similarity=0.375 Sum_probs=160.5
Q ss_pred ccCCCCceEEcCCCcccCCCccccCCCCCCCeEEecCccccccccCCcccccccceEeccCccccCCCCCCCCCccCceE
Q 001816 396 GKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQK 475 (1010)
Q Consensus 396 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 475 (1010)
..+..-...+++.|++. .+|..++.+-.|+.+.|..|.+. .+|.....+..|++|||+.|+++ .+|..++.++ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34455566788888887 78888888888888888888887 67788888899999999999999 8898888775 899
Q ss_pred EecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccc
Q 001816 476 LLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL 555 (1010)
Q Consensus 476 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 555 (1010)
|.+++|+++ .+|..++.++.|..||.|.|.+. .+|..++.+.+|+.|++..|++. .+|.++..++ |..||+|.|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCce
Confidence 999999998 89999999999999999999998 78999999999999999999999 6777888555 89999999999
Q ss_pred cCCchhhhhcccccceeccCCCcccCCCCC
Q 001816 556 VGSIPASIASMQSLTSVDFSYNNLSGLVPG 585 (1010)
Q Consensus 556 ~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 585 (1010)
+ .+|..|.+|..|++|-|.+|+|+..+..
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 9 8999999999999999999999987544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-13 Score=155.68 Aligned_cols=153 Identities=17% Similarity=0.228 Sum_probs=105.7
Q ss_pred eccccccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCC----------------------C------------
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGS----------------------S------------ 724 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------~------------ 724 (1010)
.+++...|+ .+.||.|++|.||+|+.++|+.||||+.+...... .
T Consensus 113 ~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 113 LEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred HHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 344445555 36899999999999999999999999985421100 0
Q ss_pred ----cccchHHHHHHHhccC----CcccceeeeeE-ecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHH
Q 001816 725 ----HDHGFNAEIQTLGRIR----HRHIVRLLGFC-SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK 795 (1010)
Q Consensus 725 ----~~~~~~~E~~~l~~l~----hpniv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~ 795 (1010)
.+-+|.+|++.+.+++ |.+-+.+-..+ ...+..++||||++|++|.++...... .. ....++.++++
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~ 267 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLAR 267 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHH
Confidence 0113556666666652 22223332222 234567999999999999887642211 11 24456666666
Q ss_pred -HhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 796 -GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 796 -~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
.+..+|..| ++|+|+||.||+++.+++++++|||++..+.+
T Consensus 268 ~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 467889777 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=150.36 Aligned_cols=102 Identities=38% Similarity=0.530 Sum_probs=57.1
Q ss_pred EEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccC-CCCEEecCCccccCCCCccccCCCcccccccccC
Q 001816 259 TLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELK-NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWEN 337 (1010)
Q Consensus 259 ~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 337 (1010)
.+++..|.+... ...+..++.++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 455555555321 222333455666666666666 4444444443 6666666666666 44445566666666666666
Q ss_pred cccccCCcCCCCCCCccEEEccCcccc
Q 001816 338 NFTGSIPQRLGSNGKLRILDLSSNKLT 364 (1010)
Q Consensus 338 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (1010)
+++ .+|...+.++.|+.|++++|++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~ 199 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS 199 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc
Confidence 666 34444445556666666666665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.4e-13 Score=151.14 Aligned_cols=195 Identities=33% Similarity=0.488 Sum_probs=123.7
Q ss_pred EEEccccccCCCCCcccccccccceeccccccccCCCCccccccC-ccceecccCcccCCCCCcchhccccccceecccc
Q 001816 90 NLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLA-SLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGN 168 (1010)
Q Consensus 90 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 168 (1010)
.+++..|.+. .....+..++.++.|++.+|.++ .++.....+. +|++|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4666776664 23344555677888888888888 6666677774 8888888888888 56667788888888888888
Q ss_pred cCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhccccCCCCCCCccccCCCCCcEEEccCCCCCCCcC
Q 001816 169 FFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIP 248 (1010)
Q Consensus 169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p 248 (1010)
+++ .+|...+..+.|+.|++++|++. .+|..+..+..|++|.++.|. .-..+..+.++.++..+.+.+|++. ..+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~--~~~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS--IIELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc--ceecchhhhhcccccccccCCceee-ecc
Confidence 887 55665557778888888888887 666665566667777766432 1223444555555555555555555 224
Q ss_pred ccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccc
Q 001816 249 TDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGE 294 (1010)
Q Consensus 249 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 294 (1010)
..++.+.++++|++++|.++.... +..+.+++.|++++|.+...
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCcccccc
Confidence 444555555555555555553222 44555555555555555433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.8e-12 Score=143.49 Aligned_cols=249 Identities=21% Similarity=0.191 Sum_probs=182.6
Q ss_pred cCCcCCeEee--cCcEEEEEEEe---cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccE
Q 001816 685 CLKEDNIIGK--GGAGIVYKGLM---PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 685 ~~~~~~~lG~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 758 (1010)
.+...+.+|+ |.+|.||.+.. .++..+|+|+-+...........=.+|+.....+ .|++.++.+..+.+.+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4455677899 99999999875 4678899998665555444444445677777777 4999999999999999999
Q ss_pred EEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHH----HhhHHhhcCCCceEeecCCCCcEEEcCC-CceEEeeccc
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK----GLCYLHHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGL 833 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DFGl 833 (1010)
+-+|++ +.++.++.+. ....++....+....+... |+.++|... ++|-|+||.||+...+ ...+++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 999998 5788888763 3345788888888889888 999999555 9999999999999998 8899999999
Q ss_pred cccccCCCCcc---eeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhcc
Q 001816 834 AKFLQDSGTSE---CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK 910 (1010)
Q Consensus 834 a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 910 (1010)
...+.+..... ......|...|++||...+ .++.++|+|++|.++.+..++..++...- ... |.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~-~~~---W~-------- 336 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK-NSS---WS-------- 336 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-CCC---cc--------
Confidence 98876654222 1122368889999997654 57789999999999999999877653310 000 11
Q ss_pred ccccccc-CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 001816 911 EGVLKIL-DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955 (1010)
Q Consensus 911 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~ 955 (1010)
...... ..+..+ .....+...+..+++.+|..|++.+++..
T Consensus 337 -~~r~~~ip~e~~~---~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -QLRQGYIPLEFCE---GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccccCchhhhc---CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 001111 001110 11123444788999999999999888765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.7e-13 Score=153.48 Aligned_cols=150 Identities=16% Similarity=0.178 Sum_probs=99.0
Q ss_pred eccccccCCcCCeEeecCcEEEEEEEecC-CCEEEEEEeccCCCC---------------------C-----------C-
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRG---------------------S-----------S- 724 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---------------------~-----------~- 724 (1010)
.+++...|+. +.||+|++|.||+|+.++ |+.||||+.+..... . +
T Consensus 115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 4556667776 789999999999999877 999999998643100 0 0
Q ss_pred -----cccchHHHHHHHhccC----CcccceeeeeEec-CCccEEEEEecCCCCHHhhhccCCCC----CCChhhHHHHH
Q 001816 725 -----HDHGFNAEIQTLGRIR----HRHIVRLLGFCSN-HETNLLVYEYMPNGSLGEVLHGKKGG----HLHWDTRYKIA 790 (1010)
Q Consensus 725 -----~~~~~~~E~~~l~~l~----hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~l~~~~~~~i~ 790 (1010)
.+-+|.+|+..+.+++ +...+.+-..+.+ ....++||||++|+.+.++-.-...+ .+....+..++
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 0112455555555552 3333333333322 45678999999999998743111111 12233333334
Q ss_pred HHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC----ceEEeeccccccccC
Q 001816 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF----EAHVADFGLAKFLQD 839 (1010)
Q Consensus 791 ~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~----~~kl~DFGla~~~~~ 839 (1010)
.|+ +..| ++|+|+||.||+++.++ +++++|||++..+..
T Consensus 274 ~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 444 3456 99999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=123.29 Aligned_cols=130 Identities=19% Similarity=0.117 Sum_probs=96.6
Q ss_pred CeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCccc-ceeeeeEecCCccEEEEEecCCCC
Q 001816 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI-VRLLGFCSNHETNLLVYEYMPNGS 768 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~g~ 768 (1010)
+.++.|.++.||++... |+.|++|....... ....+.+|+++++.+.+.++ ++++.+. .+..++||||++|.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 46899999999999874 78899998754321 23347889999999865554 4455443 334689999999988
Q ss_pred HHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcC--CCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 769 LGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC--SPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 769 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
+.+.- .....++.+++++++.||..+ ...++|||++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 75430 112345679999999999765 22359999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=4e-11 Score=119.84 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=100.0
Q ss_pred CeEeecCcEEEEEEEecC-------CCEEEEEEeccCCCC----------C----------CcccchH----HHHHHHhc
Q 001816 690 NIIGKGGAGIVYKGLMPN-------GDQVAVKRLPAMSRG----------S----------SHDHGFN----AEIQTLGR 738 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~----------~----------~~~~~~~----~E~~~l~~ 738 (1010)
..||.|--+.||.|...+ +..+|||+.+..... . .....+. +|++.+++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998543 479999987532110 0 0011233 79999999
Q ss_pred cC--CcccceeeeeEecCCccEEEEEecCCCCHHh-hhccCCCCCCChhhHHHHHHHHHHHhhHH-hhcCCCceEeecCC
Q 001816 739 IR--HRHIVRLLGFCSNHETNLLVYEYMPNGSLGE-VLHGKKGGHLHWDTRYKIAVEAAKGLCYL-HHDCSPLIVHRDVK 814 (1010)
Q Consensus 739 l~--hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~HrDlk 814 (1010)
+. .-++++.+++ ...++||||+.++.+.. .+. ...++.++...+..+++.++..+ |+.+ ++|||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 84 3567777765 45689999997654322 221 12345566778889999999999 7666 9999999
Q ss_pred CCcEEEcCCCceEEeecccccccc
Q 001816 815 SNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 815 p~Nill~~~~~~kl~DFGla~~~~ 838 (1010)
+.||+++ ++.++++|||.|....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.2e-13 Score=142.60 Aligned_cols=136 Identities=24% Similarity=0.265 Sum_probs=106.3
Q ss_pred CCCCCcEEEccCCCCCCCcC----ccccCCCCCCEEEeccccCCCC----ccccccccCcCCEEEccCCcCccc----cC
Q 001816 229 NLSSLVRFDAANCGLSGEIP----TDIGRLQNLDTLFLQVNALSGP----LTTELGYLKSLKSMDLSNNIFTGE----IP 296 (1010)
Q Consensus 229 ~l~~L~~L~l~~n~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~~ 296 (1010)
.-+.|+++...+|++..... ..|...+.|+++.++.|.|... ....|.++++|++|||.+|.++.. +.
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 34679999999999875433 3455678999999999998742 334688899999999999999843 34
Q ss_pred ccccccCCCCEEecCCccccCCCCccc-----cCCCcccccccccCcccc----cCCcCCCCCCCccEEEccCcccc
Q 001816 297 ASFAELKNLTLLNLFRNKLHGAIPEFI-----GVMPRLEVLQLWENNFTG----SIPQRLGSNGKLRILDLSSNKLT 364 (1010)
Q Consensus 297 ~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~ 364 (1010)
..+..+++|+.|++++|.+.......+ ...|+|++|.|.+|.|+. .+...+...+.|..|+|++|++.
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 567788999999999999987655444 357899999999999973 23334566889999999999993
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.3e-12 Score=128.49 Aligned_cols=202 Identities=21% Similarity=0.309 Sum_probs=137.6
Q ss_pred HhccCCcccceeeeeEecCC-----ccEEEEEecCCCCHHhhhccCC--CCCCChhhHHHHHHHHHHHhhHHhhcCCCce
Q 001816 736 LGRIRHRHIVRLLGFCSNHE-----TNLLVYEYMPNGSLGEVLHGKK--GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808 (1010)
Q Consensus 736 l~~l~hpniv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 808 (1010)
+-++.|-|+|+++.|+.+.. ...+++||+.-|++..+|++.+ ...+......+|+.||..||.|||.. .++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 44557999999999986543 4689999999999999997533 34577777889999999999999976 6889
Q ss_pred EeecCCCCcEEEcCCCceEEeecccccccc--CCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCC
Q 001816 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQ--DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 886 (1010)
Q Consensus 809 ~HrDlkp~Nill~~~~~~kl~DFGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~ 886 (1010)
+|+++.-+-|++..+|-+|++--.-..... ..........-.+-++|.|||.-.....+.++|||+||.-..||..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999988888875211100000 000011112234678999999988888889999999999999998876
Q ss_pred CCCCCCCCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 001816 887 KPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 887 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~ 956 (1010)
.--...........-+... +.-.-++ + -..++..|++..|..||+|.+++.+
T Consensus 280 iq~tnseS~~~~ee~ia~~-------i~~len~-l----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANV-------IIGLENG-L----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eccCCCcceeehhhhhhhh-------eeeccCc-c----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 5422111111100000000 0000011 0 1135678999999999999998654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-12 Score=135.22 Aligned_cols=241 Identities=21% Similarity=0.254 Sum_probs=147.4
Q ss_pred CcEEEEEcCCCCccc----ccCcccCCCCCCCEEEcccc---ccCCCCCcccccccccceeccccccccCCCCccccccC
Q 001816 62 RHVTSLDLSGLNLSG----ALSPDVAHLRFLQNLSVAAN---QLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLA 134 (1010)
Q Consensus 62 ~~v~~L~l~~~~l~~----~~~~~l~~l~~L~~L~L~~n---~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~ 134 (1010)
..++.|+|+||.+.. .+.+.+...+.|+..++++- ++...+|+++.-| .+++...+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l-----------------~~aL~~~~ 92 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKML-----------------SKALLGCP 92 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHH-----------------HHHHhcCC
Confidence 356777777777642 33445555666666666553 2222333222110 01223334
Q ss_pred ccceecccCcccCCCCCcchh----ccccccceecccccCCCCCC-------------CCCCCcccCceeEecccccccc
Q 001816 135 SLQVLDLYNNNMTGDLPLAVT----QLRNLRHLHLGGNFFSGQIP-------------PEYGIWEFLEYLAVSGNELGGK 197 (1010)
Q Consensus 135 ~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~L~~N~l~~~~p-------------~~~~~l~~L~~L~L~~N~l~~~ 197 (1010)
+|++||||+|.+.-..+..|. .+..|++|.|++|.+.-.-. .-.+.-+.|+++..++|++...
T Consensus 93 ~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred ceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccc
Confidence 555555555555433333322 23555555555555441111 1123446788999999888632
Q ss_pred ccccccCcchhhHHhhccccCCCCCCCccccCCCCCcEEEccCCCCCCC----cCccccCCCCCCEEEeccccCCCC---
Q 001816 198 IPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGE----IPTDIGRLQNLDTLFLQVNALSGP--- 270 (1010)
Q Consensus 198 ~~~~~~~l~~L~~L~l~~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~--- 270 (1010)
.... +...|...+.|+.+.++.|.|... +...+..+++|+.|||..|.++..
T Consensus 173 ga~~---------------------~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~ 231 (382)
T KOG1909|consen 173 GATA---------------------LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV 231 (382)
T ss_pred cHHH---------------------HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH
Confidence 2211 123344456788888888887632 234567889999999999998743
Q ss_pred -ccccccccCcCCEEEccCCcCccccCcccc-----ccCCCCEEecCCccccCC----CCccccCCCcccccccccCccc
Q 001816 271 -LTTELGYLKSLKSMDLSNNIFTGEIPASFA-----ELKNLTLLNLFRNKLHGA----IPEFIGVMPRLEVLQLWENNFT 340 (1010)
Q Consensus 271 -~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 340 (1010)
+...++.++.|+.|++++|.++.....+|. ..++|+.|.|.+|.|+.. +...+...+.|..|+|++|++.
T Consensus 232 ~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 232 ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 445677888999999999999865544432 268899999999999752 2334456889999999999994
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.1e-12 Score=127.19 Aligned_cols=134 Identities=21% Similarity=0.275 Sum_probs=106.4
Q ss_pred cccccceEeccCccccCCCCCCCCCccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhhccCCcccEE
Q 001816 445 ISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFV 524 (1010)
Q Consensus 445 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 524 (1010)
....|+++|||+|.|+ .+.+++.-.+.++.|++++|.|. .+. .+..+++|+.||||+|.++ .+-.+-..+.+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3457888999999988 77777877888999999999987 443 3888889999999999887 556666678889999
Q ss_pred EccCcccccccchhcccccccceEEecCccccCCc-hhhhhcccccceeccCCCcccCCCC
Q 001816 525 DLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSI-PASIASMQSLTSVDFSYNNLSGLVP 584 (1010)
Q Consensus 525 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~~~~p 584 (1010)
.|+.|.|.. -..++.+-+|.+||+++|+|.... ...+++|+-|+.+.|.+|++++.+.
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 999998863 245677788899999999987432 2468888889999999999988753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.2e-11 Score=135.03 Aligned_cols=245 Identities=20% Similarity=0.148 Sum_probs=174.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEe--cCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeeeEecCCccEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM--PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 760 (1010)
..|.....||.|.|+.||+... .++..|++|.+.........+..-..|+.+...+ .|.++++.+..+...+..|+-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 4566677899999999998773 3577899998876544433333334566666666 599999998888888888999
Q ss_pred EEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCC-CceEEeeccccccccC
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGLAKFLQD 839 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~-~~~kl~DFGla~~~~~ 839 (1010)
-|||++++..... .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||++..+.-
T Consensus 345 ~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 345 LEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred hhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccce
Confidence 9999999887665 23345788899999999999999999555 9999999999999875 7889999999864321
Q ss_pred CCCcceeeeeccccccc--ChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCCCCCccHHHHHHHHhhhccccccccc
Q 001816 840 SGTSECMSAIAGSYGYI--APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
.. ....+.-+++ +++......+..+.|+||||..++|..++..--+... +|. .+.
T Consensus 420 ~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------~~~------------~i~ 476 (524)
T KOG0601|consen 420 SS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------QSL------------TIR 476 (524)
T ss_pred ec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc------cce------------eee
Confidence 11 1112333444 5556667788899999999999999998865322111 111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev~~~L 957 (1010)
....+..+.. ...+..+.+.+..+++..||.+.++..+.
T Consensus 477 ~~~~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 477 SGDTPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred cccccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 1112222221 24455677778899999999988886653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.2e-10 Score=129.28 Aligned_cols=166 Identities=19% Similarity=0.228 Sum_probs=124.1
Q ss_pred ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChh
Q 001816 705 MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD 784 (1010)
Q Consensus 705 ~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~ 784 (1010)
..++.+|.|++.+.... .......+-++.++.++||+|+++++.++.++..|+|+|-+ ..|..++.+ +...
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHH
Confidence 55788999988865433 33344677888999999999999999999999999999998 467777743 3356
Q ss_pred hHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCCCCcceeeeecccccccChhhhccC
Q 001816 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864 (1010)
Q Consensus 785 ~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 864 (1010)
...--+.||+.||.|||+.+ .++|++|...-|+++..|..||++|.++........ ......---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 66677899999999998644 499999999999999999999999998865432211 01111112245556643322
Q ss_pred CCCccCceehhhHHHHHHHhC
Q 001816 865 KVDEKSDVYSFGVVLLELITG 885 (1010)
Q Consensus 865 ~~~~~~Dv~slG~il~elltg 885 (1010)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 246999999999999998
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.2e-11 Score=124.51 Aligned_cols=128 Identities=28% Similarity=0.273 Sum_probs=63.2
Q ss_pred CCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCccccCCCcccccccc
Q 001816 256 NLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLW 335 (1010)
Q Consensus 256 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 335 (1010)
.|+++||++|.|+ .+.....-+++++.|++|+|.|... ..++.+.+|+.||||+|.++ .+..+-..+.+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 3455555555554 2333444445555555555555422 22455555555555555554 334444445555555555
Q ss_pred cCcccccCCcCCCCCCCccEEEccCcccccCC-CcccCCCCcchhhhcccccccc
Q 001816 336 ENNFTGSIPQRLGSNGKLRILDLSSNKLTGTL-PPDMCAGNCLQTLITLGNFLFG 389 (1010)
Q Consensus 336 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~~~L~~L~l~~n~~~~ 389 (1010)
+|.|.. -..++.+-+|.+||+++|+|.... ...+++++||+++.+.+|.+.+
T Consensus 361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 555531 122334445555555555554221 2345556666666666665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.4e-10 Score=117.38 Aligned_cols=143 Identities=22% Similarity=0.296 Sum_probs=110.4
Q ss_pred CeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCC--cccceeeeeEecC---CccEEEEEec
Q 001816 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH--RHIVRLLGFCSNH---ETNLLVYEYM 764 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~---~~~~lv~e~~ 764 (1010)
+.+|.|.++.||++...+|+.+++|........ .....+.+|+++++.+++ ..+++++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 468999999999999877789999987543321 234568999999999965 4467777776654 3678999999
Q ss_pred CCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcC----------------------------------------
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC---------------------------------------- 804 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 804 (1010)
+|.++.+.+.. ..++......++.++++++.+||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988776521 34677777888888888888888521
Q ss_pred -------------CCceEeecCCCCcEEEcC--CCceEEeecccccc
Q 001816 805 -------------SPLIVHRDVKSNNILLDS--GFEAHVADFGLAKF 836 (1010)
Q Consensus 805 -------------~~~i~HrDlkp~Nill~~--~~~~kl~DFGla~~ 836 (1010)
...++|+|++|.||+++. ++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.1e-10 Score=106.62 Aligned_cols=133 Identities=26% Similarity=0.379 Sum_probs=100.5
Q ss_pred CeEeecCcEEEEEEEecCCCEEEEEEec-cCCCCCCcc-----cchHHHHHHHhccCCcccceeeeeEecCCccEEEEEe
Q 001816 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLP-AMSRGSSHD-----HGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 690 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~-~~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 763 (1010)
..+++|+-+.+|.+.+ -|..+.+|.-. +....+.-. ....+|++++.+++--.|.-.+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3588999999999987 45556666543 222222222 2356799999998765665555566677788899999
Q ss_pred cCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccccc
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~ 836 (1010)
++|..|.+.+... ...++..+-+-+.-||..+ |+|+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888532 2566677777788899888 99999999999998764 99999999974
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-10 Score=114.08 Aligned_cols=121 Identities=25% Similarity=0.362 Sum_probs=43.9
Q ss_pred ccceEeccCccccCCCCCCCC-CccCceEEecCCCcccCCCccccccccCccEEEecCCccCCCCchhh-ccCCcccEEE
Q 001816 448 NLGQICLSNNQLSGSLPASIG-KFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVD 525 (1010)
Q Consensus 448 ~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~ 525 (1010)
.+++|+|++|+|+ .+ +.++ .+.+|+.|+|++|+|+ .++ .+..++.|++|++++|+|+. +...+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 4455555555555 22 2344 4567777777777776 333 46667777777888887773 43333 3577777788
Q ss_pred ccCcccccccc-hhcccccccceEEecCccccCCchh----hhhcccccceecc
Q 001816 526 LSRNELSGEIP-NQLTGMRILNYLNLSRNHLVGSIPA----SIASMQSLTSVDF 574 (1010)
Q Consensus 526 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~l~l 574 (1010)
|++|+|...-- ..+..+++|+.|+|.+|+++.. +. .+..+++|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 87777764221 4556778888888888888743 32 3566788888774
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1e-10 Score=142.71 Aligned_cols=291 Identities=22% Similarity=0.209 Sum_probs=177.5
Q ss_pred cEEEEEcCCCCcccccCcccCCCCCCCEEEccccc--cCCCCCcccccccccceeccccccccCCCCccccccCccceec
Q 001816 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQ--LSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLD 140 (1010)
Q Consensus 63 ~v~~L~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 140 (1010)
.++.+.+-+|.+.- ++... ..+.|++|-+..|. +.....+.|..++.|++|||++|.--+.+|..+++|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~~-~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIEH-IAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchhh-ccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 45556666665542 22222 22368888888886 5544555578899999999998876668899999999999999
Q ss_pred ccCcccCCCCCcchhccccccceecccccCCCCCCCCCCCcccCceeEeccccc--cccccccccCcchhhHHhhccccC
Q 001816 141 LYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL--GGKIPGEIGNLTKLQQLYIGYYNS 218 (1010)
Q Consensus 141 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l--~~~~~~~~~~l~~L~~L~l~~~~~ 218 (1010)
|++..++ .+|..+.+|+.|.+||+..+.-...+|.....+++|++|.+..-.. ....-..+.+|.+|+.+....
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~--- 677 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI--- 677 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec---
Confidence 9999998 7899999999999999998876656677777788999988876542 222233344555555544421
Q ss_pred CCCCCCccccCCCCCc----EEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccc------cCcCCEEEccC
Q 001816 219 YTGGLPPEIGNLSSLV----RFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGY------LKSLKSMDLSN 288 (1010)
Q Consensus 219 ~~~~~p~~l~~l~~L~----~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~------l~~L~~L~Ls~ 288 (1010)
....+-..+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+.......... ++++..+...+
T Consensus 678 ~s~~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~ 756 (889)
T KOG4658|consen 678 SSVLLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILN 756 (889)
T ss_pred chhHhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhc
Confidence 1111112222233332 2333333333 45556777888888888888876433322211 11222222222
Q ss_pred CcCccccCccccccCCCCEEecCCccccCCCCccccCCCcccccccccCccccc-CCcCCCCCCCccEEEccCc
Q 001816 289 NIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGS-IPQRLGSNGKLRILDLSSN 361 (1010)
Q Consensus 289 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N 361 (1010)
+..- ..+.+..-.++|+.|++..+.....+.+....+..+..+.+..+.+.+. .-...+.++++..+.+++=
T Consensus 757 ~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~~ 829 (889)
T KOG4658|consen 757 CHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSFL 829 (889)
T ss_pred cccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCcc
Confidence 2111 1223333457888888888877666666666777777766777777654 3444555555555555443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-11 Score=141.42 Aligned_cols=106 Identities=31% Similarity=0.383 Sum_probs=54.3
Q ss_pred CCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCccccCCCccccc
Q 001816 253 RLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVL 332 (1010)
Q Consensus 253 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 332 (1010)
.+..++.+++..|.+.. +...+..+++|+.|++.+|+|.. +...+..+.+|++|+|++|+|+...+ +..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence 34455555566666553 22335555566666666666653 22224555556666666666553221 3344445555
Q ss_pred ccccCcccccCCcCCCCCCCccEEEccCcccc
Q 001816 333 QLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364 (1010)
Q Consensus 333 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (1010)
++++|.|+. ...+..++.|+.+++++|+++
T Consensus 146 ~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~ 175 (414)
T KOG0531|consen 146 NLSGNLISD--ISGLESLKSLKLLDLSYNRIV 175 (414)
T ss_pred eeccCcchh--ccCCccchhhhcccCCcchhh
Confidence 555555542 123344555555555555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-11 Score=141.34 Aligned_cols=104 Identities=29% Similarity=0.394 Sum_probs=46.6
Q ss_pred CCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCccccccCCCCEEecCCccccCCCCccccCCCcccccccc
Q 001816 256 NLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLW 335 (1010)
Q Consensus 256 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 335 (1010)
.++.++..++.+...... ...+..++.+++..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+++
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecc
Confidence 344455555444321111 1334455555566665552 22334455555555555555552 22223444555555555
Q ss_pred cCcccccCCcCCCCCCCccEEEccCcccc
Q 001816 336 ENNFTGSIPQRLGSNGKLRILDLSSNKLT 364 (1010)
Q Consensus 336 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 364 (1010)
+|.|+.. ..+..++.|+.|++++|.++
T Consensus 127 ~N~I~~i--~~l~~l~~L~~L~l~~N~i~ 153 (414)
T KOG0531|consen 127 FNKITKL--EGLSTLTLLKELNLSGNLIS 153 (414)
T ss_pred ccccccc--cchhhccchhhheeccCcch
Confidence 5555422 12233333444444444443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=103.01 Aligned_cols=145 Identities=19% Similarity=0.230 Sum_probs=105.9
Q ss_pred cCCeEeecCcEEEEEEEecCCCEEEEEEecc-CCCCCC-----cccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 688 EDNIIGKGGAGIVYKGLMPNGDQVAVKRLPA-MSRGSS-----HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~-~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
...++-+|+-+.|+++.+ .|+...||.-.. ..+.+. ..++..+|++.+.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999998 688878875432 222221 2345678999999986555544444566666678999
Q ss_pred EecCC-CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCC---ceEEeecccccc
Q 001816 762 EYMPN-GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF---EAHVADFGLAKF 836 (1010)
Q Consensus 762 e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~---~~kl~DFGla~~ 836 (1010)
||++| .++.+++...-...........++..|-+.+.-||..+ |+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 37888876433333333334788999999999999877 99999999999996554 458999999854
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-11 Score=130.36 Aligned_cols=207 Identities=22% Similarity=0.198 Sum_probs=133.2
Q ss_pred ccccccceeccccccccCCCC--ccccccCccceecccCcccCCC--CCcchhccccccceecccccCCCCCCCCC-CCc
Q 001816 107 SALSSLRLLNLSNNVFNGSFP--PQLSQLASLQVLDLYNNNMTGD--LPLAVTQLRNLRHLHLGGNFFSGQIPPEY-GIW 181 (1010)
Q Consensus 107 ~~l~~L~~L~Ls~n~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l 181 (1010)
.++++|+...|.+..+. ..+ .....+++++.||||+|-+..- +-.-...|++|+.|+|+.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 34677777777777765 333 2456677777888887776631 22234567778888888887763322221 245
Q ss_pred ccCceeEecccccccccc-ccccCcchhhHHhhccccCCCCCCCccccCCCCCcEEEccCCCCCCCcC--ccccCCCCCC
Q 001816 182 EFLEYLAVSGNELGGKIP-GEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIP--TDIGRLQNLD 258 (1010)
Q Consensus 182 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p--~~l~~l~~L~ 258 (1010)
+.|+.|.|+.|.++...- .....+++|+.|+|.+|+ ....-......+..|+.|||++|++.. .+ ...+.++.|+
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~-~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANE-IILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLN 274 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccc-ccceecchhhhhhHHhhccccCCcccc-cccccccccccchh
Confidence 677888888887774322 234466788888887664 222222333446778888888888773 33 3456778888
Q ss_pred EEEeccccCCCCc-ccc-----ccccCcCCEEEccCCcCccccC--ccccccCCCCEEecCCccccC
Q 001816 259 TLFLQVNALSGPL-TTE-----LGYLKSLKSMDLSNNIFTGEIP--ASFAELKNLTLLNLFRNKLHG 317 (1010)
Q Consensus 259 ~L~L~~N~l~~~~-~~~-----l~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~ 317 (1010)
.|+++.+.+..+- |+. ....++|++|+++.|+|.. .+ ..+..+.+|+.|....|.+..
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhccchhhhhhcccccccc
Confidence 8888888887532 222 3556889999999998862 22 234556777888888888874
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.02 E-value=7e-11 Score=125.70 Aligned_cols=210 Identities=22% Similarity=0.168 Sum_probs=144.9
Q ss_pred cccCccceecccCcccCCCCC--cchhccccccceecccccCCCC--CCCCCCCcccCceeEeccccccccccccc-cCc
Q 001816 131 SQLASLQVLDLYNNNMTGDLP--LAVTQLRNLRHLHLGGNFFSGQ--IPPEYGIWEFLEYLAVSGNELGGKIPGEI-GNL 205 (1010)
Q Consensus 131 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l 205 (1010)
.++.+|++..|.+..... .+ .....|++++.|||+.|-|... +-.....+++|+.|+|+.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 467788888888888773 33 3566788888899988877632 22334567888888999888874443332 256
Q ss_pred chhhHHhhccccCCCCCCCccccCCCCCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCC-ccccccccCcCCEE
Q 001816 206 TKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGP-LTTELGYLKSLKSM 284 (1010)
Q Consensus 206 ~~L~~L~l~~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L 284 (1010)
+.|+.|.|+.|+.-...+...+...++|+.|+|..|...........-++.|++|+|++|.+-.. .....+.++.|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 77888888776655544555556678888888888853334444455567888889988877632 23456778888888
Q ss_pred EccCCcCccc-cCcc-----ccccCCCCEEecCCccccCC-CCccccCCCcccccccccCcccc
Q 001816 285 DLSNNIFTGE-IPAS-----FAELKNLTLLNLFRNKLHGA-IPEFIGVMPRLEVLQLWENNFTG 341 (1010)
Q Consensus 285 ~Ls~N~l~~~-~~~~-----~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~ 341 (1010)
+++.+.++.+ .|+. ...+++|++|++..|+|... .-..+..+++|+.|.+..|.++.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 8888888743 2332 34568888889988888631 22345566778888888888863
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-10 Score=141.44 Aligned_cols=154 Identities=27% Similarity=0.290 Sum_probs=106.5
Q ss_pred cCCCCCCCEEEccccccCCCCCcccccccccceecccccc--ccCCCCccccccCccceecccCcccCCCCCcchhcccc
Q 001816 82 VAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV--FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRN 159 (1010)
Q Consensus 82 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 159 (1010)
..+....+...+-+|.+. .++..... ++|+.|-+.+|. +.....+.|..++.|++|||++|.=-+.+|..++.|-+
T Consensus 519 ~~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH 596 (889)
T ss_pred ccchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence 344466778888888776 34444433 368888888885 55344455777888888888887766688888888888
Q ss_pred ccceecccccCCCCCCCCCCCcccCceeEeccccccccccccccCcchhhHHhhcccc-CCCCCCCccccCCCCCcEEEc
Q 001816 160 LRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYN-SYTGGLPPEIGNLSSLVRFDA 238 (1010)
Q Consensus 160 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~-~~~~~~p~~l~~l~~L~~L~l 238 (1010)
||+|+|++..++ .+|..++++..|.+|++..+.-...+|..+..|++|++|.+.... ......-..+.++.+|+.+..
T Consensus 597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 888888888888 788888888888888888877665666777778888887775322 222223333344444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.6e-10 Score=109.97 Aligned_cols=111 Identities=25% Similarity=0.362 Sum_probs=44.0
Q ss_pred CCCccCceEEecCCCcccCCCccccc-cccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhc-ccccc
Q 001816 467 IGKFSGVQKLLLDGNKFSGQIPAEIG-KLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQL-TGMRI 544 (1010)
Q Consensus 467 ~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 544 (1010)
+.+..++++|+|++|+|+ .+ +.++ .+.+|+.||||+|.|+. + ..+..++.|+.|++++|+|+. +.+.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~-l-~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITK-L-EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcc-c-cCccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 345557899999999998 45 3565 58899999999999984 3 357889999999999999995 44444 57899
Q ss_pred cceEEecCccccCCch-hhhhcccccceeccCCCcccCC
Q 001816 545 LNYLNLSRNHLVGSIP-ASIASMQSLTSVDFSYNNLSGL 582 (1010)
Q Consensus 545 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~~~ 582 (1010)
|++|+|++|+|...-- ..+..+++|+.|+|.+|+++..
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~ 128 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK 128 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence 9999999999975322 5677899999999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.9e-10 Score=132.46 Aligned_cols=250 Identities=20% Similarity=0.222 Sum_probs=164.0
Q ss_pred ccCCcCCeEeecCcEEEEEEEe-cCCCEEEEEEeccCCCCCC-cccchHHHHHHHhccCCcccceeeeeEecCCccEEEE
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSS-HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 761 (1010)
+.+.+.+-+-+|.+|.++-+.- ..|...++|+......-.. ..+....+-.+.-..+||.+++...-+.-....++||
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 4455666788899999998762 2354445554432111110 1111222222222234566666555555567789999
Q ss_pred EecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccCC-
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS- 840 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~~- 840 (1010)
+|+.+++|...++.. +..+.+.+......+..+.+|||... +.|||++|.|.+...++..++.|||........
T Consensus 884 ~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred HHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccccc
Confidence 999999999998643 35666667777788889999999544 899999999999999999999999844322100
Q ss_pred --------------------CC--------cceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCCCCCCC
Q 001816 841 --------------------GT--------SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEF 892 (1010)
Q Consensus 841 --------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~P~~~~ 892 (1010)
.. ........||+.|.+||...+......+|.|+.|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 00 01122456999999999999999999999999999999999999999653
Q ss_pred CCCccHHHHHHHHhhhcccccccccCCCCCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 001816 893 GDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMR 951 (1010)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ 951 (1010)
... +.++.+... +...+..+.........++...+..+|.+|-.|.
T Consensus 1039 tpq----~~f~ni~~~---------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQ----QIFENILNR---------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chh----hhhhccccC---------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 211 111111110 1122223333344556677778888888886655
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.7e-08 Score=107.22 Aligned_cols=142 Identities=15% Similarity=0.125 Sum_probs=99.9
Q ss_pred eEeecCcEEEEEEEecCCCEEEEEEeccCCCC---------CCcccchHHHHHHHhccC--CcccceeeeeEec-----C
Q 001816 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRG---------SSHDHGFNAEIQTLGRIR--HRHIVRLLGFCSN-----H 754 (1010)
Q Consensus 691 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~-----~ 754 (1010)
++-+.....|++..+ +|+.|.||+....... ......+.+|.+.+.++. .-.+++.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344333445667666 6788999976432210 011124788999998884 3334455555543 2
Q ss_pred CccEEEEEecCCC-CHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcC-------CCce
Q 001816 755 ETNLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-------GFEA 826 (1010)
Q Consensus 755 ~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~-------~~~~ 826 (1010)
...++|||++++. +|.+++........+......++.+++..+.-||..| |+|+|++++|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3468999999876 8998874322234556677899999999999999888 999999999999975 4679
Q ss_pred EEeecccccc
Q 001816 827 HVADFGLAKF 836 (1010)
Q Consensus 827 kl~DFGla~~ 836 (1010)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=101.14 Aligned_cols=128 Identities=26% Similarity=0.345 Sum_probs=84.1
Q ss_pred EEEEEEecCCCEEEEEEeccCCC-----------CCC--------c-----ccchHHHHHHHhccCCc--ccceeeeeEe
Q 001816 699 IVYKGLMPNGDQVAVKRLPAMSR-----------GSS--------H-----DHGFNAEIQTLGRIRHR--HIVRLLGFCS 752 (1010)
Q Consensus 699 ~Vy~~~~~~g~~vavK~~~~~~~-----------~~~--------~-----~~~~~~E~~~l~~l~hp--niv~~~~~~~ 752 (1010)
.||.|...+|+.+|||+.+.... ... . .....+|++.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999998753211 000 0 11256799999999654 567776553
Q ss_pred cCCccEEEEEecC--CCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhH-HhhcCCCceEeecCCCCcEEEcCCCceEEe
Q 001816 753 NHETNLLVYEYMP--NGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY-LHHDCSPLIVHRDVKSNNILLDSGFEAHVA 829 (1010)
Q Consensus 753 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~HrDlkp~Nill~~~~~~kl~ 829 (1010)
..++||||++ |..+..+.. ..++.+....++.+++..+.. +|..| |+|+|+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~----~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD----VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH----CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHh----ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 4589999998 555544332 112245677788888886665 57666 9999999999999887 99999
Q ss_pred ecccccccc
Q 001816 830 DFGLAKFLQ 838 (1010)
Q Consensus 830 DFGla~~~~ 838 (1010)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.7e-09 Score=85.12 Aligned_cols=60 Identities=33% Similarity=0.488 Sum_probs=32.8
Q ss_pred CccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccc
Q 001816 496 QLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL 555 (1010)
Q Consensus 496 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 555 (1010)
+|++|++++|+|+...+..|..+++|++|++++|+|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544444555555555555555555555555555555555555555543
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.3e-07 Score=98.86 Aligned_cols=258 Identities=19% Similarity=0.216 Sum_probs=153.1
Q ss_pred cCCeEeecCcEEEEEEEecCCCEEEEEEeccCCCCCCcccchHHHHHHHhcc-CCcccceeeee------E-ecCCccEE
Q 001816 688 EDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGF------C-SNHETNLL 759 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~------~-~~~~~~~l 759 (1010)
..+.+|+|+-+.+|-.-- -+..|| |+.+...... -.+-+..|... .||-+-.-+.+ . .......+
T Consensus 15 ~gr~LgqGgea~ly~l~e-~~d~VA-KIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-VRDQVA-KIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecch-hhchhh-eeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 356799999999995431 122344 6665432211 11223333333 56644432221 1 11223568
Q ss_pred EEEecCCC-CHHhhhc----cCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeecccc
Q 001816 760 VYEYMPNG-SLGEVLH----GKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 760 v~e~~~~g-~L~~~l~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla 834 (1010)
.|..+++. .+..+.. ++.-....|+...++++.+|.+.+.||+.| .+-+|+.++|+|+.+++.+.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 88888764 2222221 123345789999999999999999999888 889999999999999999999875433
Q ss_pred ccccCCCCcceeeeecccccccChhhhc-----cCCCCccCceehhhHHHHHHHhC-CCCCCCCCCCcc----HHHHHHH
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITG-RKPVGEFGDGVD----IVQWVRK 904 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg-~~P~~~~~~~~~----~~~~~~~ 904 (1010)
... .......-.+|.+.|.+||... +...+...|.|.+|+++++++.| ++||.+.....+ ....+..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 222 1222334457899999999754 55677889999999999999986 999976321110 1001100
Q ss_pred --HhhhcccccccccCCCCCCCCHHH-HHHHHHHHHhcccc--CCCCCCCHHHHHHHHhcC
Q 001816 905 --MTDSKKEGVLKILDPRLPSVPLHE-VMHVFYVAMLCVEE--QAVERPTMREVVQILTEL 960 (1010)
Q Consensus 905 --~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~--~P~~RPs~~ev~~~L~~~ 960 (1010)
+....... .-..+...+.|... +..+..+..+|+.. .+.-|||++..+..|..+
T Consensus 242 g~f~ya~~~~--~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 242 GRFAYASDQR--RGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred ceeeechhcc--CCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 00000000 00111111122221 12345566677764 356899998887766544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.3e-09 Score=84.75 Aligned_cols=61 Identities=33% Similarity=0.472 Sum_probs=57.4
Q ss_pred CcccEEEccCcccccccchhcccccccceEEecCccccCCchhhhhcccccceeccCCCcc
Q 001816 519 KLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNL 579 (1010)
Q Consensus 519 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l 579 (1010)
++|++|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999987778999999999999999999988888999999999999999986
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.8e-08 Score=100.18 Aligned_cols=136 Identities=23% Similarity=0.243 Sum_probs=98.8
Q ss_pred cCCeEeecCcEEEEEEEecCCCEEEEEEeccCCC----------------CCC----cccchHHHHHHHhccCCc--ccc
Q 001816 688 EDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSR----------------GSS----HDHGFNAEIQTLGRIRHR--HIV 745 (1010)
Q Consensus 688 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------~~~----~~~~~~~E~~~l~~l~hp--niv 745 (1010)
+.+.||.|--+.||.|..++|.++|||.=+.... ..+ .....++|.++|.++... .++
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 4578999999999999999999999995432100 000 112357899999998543 677
Q ss_pred eeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCc
Q 001816 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE 825 (1010)
Q Consensus 746 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~ 825 (1010)
+.+++ +...+||||++|-.|...- ++.+....++..|++-+.-+-..| |||+|+.+-||+++++|.
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 77664 4558999999987665432 233444555566666666555566 999999999999999999
Q ss_pred eEEeeccccccc
Q 001816 826 AHVADFGLAKFL 837 (1010)
Q Consensus 826 ~kl~DFGla~~~ 837 (1010)
+.++||--+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999877643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.3e-10 Score=127.09 Aligned_cols=183 Identities=26% Similarity=0.358 Sum_probs=117.0
Q ss_pred ccccCCCCCCCeEEecCccccccccCCcccccccceEeccCcccc----------CCCCCCCCCccCceEEecCCCcccC
Q 001816 416 PKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLS----------GSLPASIGKFSGVQKLLLDGNKFSG 485 (1010)
Q Consensus 416 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~----------~~~p~~~~~l~~L~~L~L~~N~l~~ 485 (1010)
|-.++.+.+|+.|.|.++.|.. .......-..|+.|-. .|.++ |.+..++ ....|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh-hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH-
Confidence 5566777788888888777753 1111111112222211 11111 0111111 0135667788888887
Q ss_pred CCccccccccCccEEEecCCccCCCCchhhccCCcccEEEccCcccccccchhcccccccceEEecCccccCCchhhhhc
Q 001816 486 QIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIAS 565 (1010)
Q Consensus 486 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 565 (1010)
.+..++.-++.|+.||||+|+++. ...+..++.|++|||++|.|+...--...++. |+.|+|+||.++. + ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~--v~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~t-L-~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTK--VDNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTT-L-RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhh--hHHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHh-h-hhHHh
Confidence 667777778888888888888874 33777888888888888888844433444555 8888888888873 2 34778
Q ss_pred ccccceeccCCCcccCC--CCCCccccCCcccccCCCccCcCCC
Q 001816 566 MQSLTSVDFSYNNLSGL--VPGTGQFSYFNYTSFLGNSELCGPY 607 (1010)
Q Consensus 566 l~~L~~l~ls~N~l~~~--~p~~~~~~~~~~~~~~~n~~~~g~~ 607 (1010)
|.+|+.|||++|-|++- .-..+.++.+....++|||--|.|.
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 88888889998888774 2223456666777788888777543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2e-08 Score=73.78 Aligned_cols=40 Identities=43% Similarity=0.988 Sum_probs=31.5
Q ss_pred hhHHHHHHHHHHhcCCCCCCCCCCcCCC--CCCCCCCceEeC
Q 001816 20 VPEYKALLSIKSSITDDPQSSLAAWNAT--TSHCTWPGVTCD 59 (1010)
Q Consensus 20 ~~~~~all~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~ 59 (1010)
..|++||++||+++..+|...+.+|+.. .++|+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999999998888899999987 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.5e-07 Score=90.79 Aligned_cols=139 Identities=16% Similarity=0.087 Sum_probs=102.7
Q ss_pred eecCcEEEEEEEecCCCEEEEEEeccCCC-C---CCcccchHHHHHHHhccC--CcccceeeeeEe-cC----CccEEEE
Q 001816 693 GKGGAGIVYKGLMPNGDQVAVKRLPAMSR-G---SSHDHGFNAEIQTLGRIR--HRHIVRLLGFCS-NH----ETNLLVY 761 (1010)
Q Consensus 693 G~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~---~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~-~~----~~~~lv~ 761 (1010)
|+||.+-|++... +|..+-+|+-..... . +-....|.+|+..+.++. .-.+.+.. ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 7788888998776 455788887642111 1 223556999999999985 33355555 332 11 2347999
Q ss_pred EecCC-CCHHhhhccCCCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCc--eEEeecccccc
Q 001816 762 EYMPN-GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE--AHVADFGLAKF 836 (1010)
Q Consensus 762 e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~--~kl~DFGla~~ 836 (1010)
|-++| -+|.+++....-.+.+......+..+++..+.-||..| +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 48999885443345677788899999999999999877 999999999999986666 99999987764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.2e-09 Score=96.36 Aligned_cols=132 Identities=18% Similarity=0.240 Sum_probs=74.4
Q ss_pred ceEeccCccccCCCCCCC---CCccCceEEecCCCcccCCCcccc-ccccCccEEEecCCccCCCCchhhccCCcccEEE
Q 001816 450 GQICLSNNQLSGSLPASI---GKFSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVD 525 (1010)
Q Consensus 450 ~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 525 (1010)
..+||++++|- .+++.. .....|+..+|++|.+. .+|+.| ...+.++.|+|++|+|+ .+|.++..++.|+.|+
T Consensus 30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 34445554443 333322 23345555677777776 334333 33456777777777776 5666677777777777
Q ss_pred ccCcccccccchhcccccccceEEecCccccCCchhhhhcccccceeccCCCcccCCCCCC
Q 001816 526 LSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586 (1010)
Q Consensus 526 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 586 (1010)
++.|.|. ..|..+..+.+|-+||..+|.+. .+|-.+-.-+.....++.+|+|.+..|..
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 7777776 55555656777777777777665 33332222233334455666666655543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.3e-07 Score=97.44 Aligned_cols=167 Identities=19% Similarity=0.332 Sum_probs=124.9
Q ss_pred cEEEEEEE-ecCCCEEEEEEeccCCCCCCcccchHHHHHHHhccCCcccceeeeeEec----CCccEEEEEecCC-CCHH
Q 001816 697 AGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN----HETNLLVYEYMPN-GSLG 770 (1010)
Q Consensus 697 ~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~~~-g~L~ 770 (1010)
-.+.||+. ..+|..|++|+++...... ...-..-+++++++.|+|+|++.+++.. +-..++||+|+++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 35789998 4589999999995322211 1112446888999999999999998863 3356899999986 4777
Q ss_pred hhhccC-------------CCCCCChhhHHHHHHHHHHHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccc
Q 001816 771 EVLHGK-------------KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 771 ~~l~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~ 837 (1010)
++-... .+...++...|.++.|++.||.++|+.| ..-+-+.+.+|+++.+.+++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 654321 2345778899999999999999999877 889999999999999989999988877655
Q ss_pred cCCCCcceeeeecccccccChhhhccCCCCccCceehhhHHHHHHHhCCC
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRK 887 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~ 887 (1010)
...... | + +-..+-|.-.||.++..|.||..
T Consensus 444 ~~d~~~--------------~--l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPTE--------------P--L---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCCc--------------c--h---hHHhhhhHHHHHHHHHHHhhccc
Confidence 432200 0 0 11246788999999999999864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.2e-08 Score=111.25 Aligned_cols=155 Identities=19% Similarity=0.250 Sum_probs=100.5
Q ss_pred eeccccccCCcCCeEeecCcEEEEEEEecCCCEEEEEEeccCCC---------------------CC-C-----------
Q 001816 678 TCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSR---------------------GS-S----------- 724 (1010)
Q Consensus 678 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------------------~~-~----------- 724 (1010)
..+++...|+. +.|+.++-|.||+|++++|+.||||+.+.... .. .
T Consensus 120 ~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~ 198 (517)
T COG0661 120 PIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEF 198 (517)
T ss_pred CHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHH
Confidence 34555556653 68999999999999999999999998753211 00 0
Q ss_pred -----cccchHHHHHHHhccC-----CcccceeeeeEecCCccEEEEEecCCCCHHhhhccCCCCCCChhhHHHHHHHHH
Q 001816 725 -----HDHGFNAEIQTLGRIR-----HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAA 794 (1010)
Q Consensus 725 -----~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~ 794 (1010)
.+-++.+|+.-+.+++ .|.+.-..=|++..+..+++|||++|-.+.+...-.. ...+.+.+.....++.
T Consensus 199 ~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f 277 (517)
T COG0661 199 EKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF 277 (517)
T ss_pred HHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 0112455666665552 2333222222334567799999999998888753222 3344333333222222
Q ss_pred HHhhHHhhcCCCceEeecCCCCcEEEcCCCceEEeeccccccccC
Q 001816 795 KGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 795 ~~l~~LH~~~~~~i~HrDlkp~Nill~~~~~~kl~DFGla~~~~~ 839 (1010)
+..+-..| ++|.|.+|.||+++.+|++.+.|||+...+.+
T Consensus 278 --~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 --LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 23333355 99999999999999999999999999987654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.2e-09 Score=122.66 Aligned_cols=126 Identities=29% Similarity=0.271 Sum_probs=75.1
Q ss_pred CCcEEEccCCCCCCCcCccccCCCCCCEEEeccccCCCCccccccccCcCCEEEccCCcCccccCc-cccccCCCCEEec
Q 001816 232 SLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPA-SFAELKNLTLLNL 310 (1010)
Q Consensus 232 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L 310 (1010)
.|...+.++|.+. .+..++.-++.|+.|+|++|++... +.+..+++|++|||++|.+. .+|. ....++ |..|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4555666666666 4555566666677777777777642 36666777777777777776 3332 233333 677777
Q ss_pred CCccccCCCCccccCCCcccccccccCcccccC-CcCCCCCCCccEEEccCcccc
Q 001816 311 FRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI-PQRLGSNGKLRILDLSSNKLT 364 (1010)
Q Consensus 311 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~ 364 (1010)
++|.++. . ..+.++.+|+.||+++|-|.+.- -..++.+..|+.|+|.||.+.
T Consensus 240 rnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7776652 1 22456666777777777665321 112345556667777777664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.5e-07 Score=92.73 Aligned_cols=107 Identities=21% Similarity=0.298 Sum_probs=84.4
Q ss_pred ccchHHHHHHHhccC--CcccceeeeeEecCC----ccEEEEEecCCC-CHHhhhccCCCCCCChhhHHHHHHHHHHHhh
Q 001816 726 DHGFNAEIQTLGRIR--HRHIVRLLGFCSNHE----TNLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798 (1010)
Q Consensus 726 ~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~ 798 (1010)
.....+|.+.+.++. .=.+++.+++..... ..++|||++++. +|.+++.... ..+......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 345788988888884 344566677665532 348999999884 8999885422 2566778899999999999
Q ss_pred HHhhcCCCceEeecCCCCcEEEcCCC---ceEEeeccccccc
Q 001816 799 YLHHDCSPLIVHRDVKSNNILLDSGF---EAHVADFGLAKFL 837 (1010)
Q Consensus 799 ~LH~~~~~~i~HrDlkp~Nill~~~~---~~kl~DFGla~~~ 837 (1010)
-||..| |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999888 99999999999998877 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.52 E-value=7e-09 Score=103.71 Aligned_cols=134 Identities=22% Similarity=0.153 Sum_probs=88.7
Q ss_pred CCCCcEEEccCCCCCCCcCcc-----ccCCCCCCEEEeccccCCCCcc-----ccccccCcCCEEEccCCcCcccc----
Q 001816 230 LSSLVRFDAANCGLSGEIPTD-----IGRLQNLDTLFLQVNALSGPLT-----TELGYLKSLKSMDLSNNIFTGEI---- 295 (1010)
Q Consensus 230 l~~L~~L~l~~n~l~~~~p~~-----l~~l~~L~~L~L~~N~l~~~~~-----~~l~~l~~L~~L~Ls~N~l~~~~---- 295 (1010)
-+.|+..++..|++.. .+.. +..-.+|+++.+..|.|.-... ..+..+.+|+.|||.+|.++...
T Consensus 156 kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~L 234 (388)
T COG5238 156 KPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYL 234 (388)
T ss_pred CCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHH
Confidence 3667888888888763 2221 2222478888888888873321 23456778888888888887433
Q ss_pred CccccccCCCCEEecCCccccCCCCccc------cCCCcccccccccCcccccCCcC-------CCCCCCccEEEccCcc
Q 001816 296 PASFAELKNLTLLNLFRNKLHGAIPEFI------GVMPRLEVLQLWENNFTGSIPQR-------LGSNGKLRILDLSSNK 362 (1010)
Q Consensus 296 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~~~~~~~-------~~~l~~L~~L~Ls~N~ 362 (1010)
..++..++.|+.|.+..|-++......+ ...|+|..|-..+|.+.+.+-.. =..++-|..|.+.+|+
T Consensus 235 a~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr 314 (388)
T COG5238 235 ADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNR 314 (388)
T ss_pred HHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCc
Confidence 3345667778888888888876554433 24578888888888876432222 1346678888888888
Q ss_pred cc
Q 001816 363 LT 364 (1010)
Q Consensus 363 l~ 364 (1010)
+.
T Consensus 315 ~~ 316 (388)
T COG5238 315 IK 316 (388)
T ss_pred ch
Confidence 86
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1010 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-54 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-52 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-37 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-25 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-25 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-15 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-06 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 8e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 2e-05 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 591 bits (1525), Expect = 0.0
Identities = 186/572 (32%), Positives = 277/572 (48%), Gaps = 16/572 (2%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
++ LD+S N S + P + LQ+L ++ N+LSG IS + L+LLN+S+N
Sbjct: 200 VNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVT-QLRNLRHLHLGGNFFSGQIPPEYGI 180
F G PP L SLQ L L N TG++P ++ L L L GN F G +PP +G
Sbjct: 259 FVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
Query: 181 WEFLEYLAVSGNELGGKIPGE-IGNLTKLQQLYIGYYNSYTGGLPPEIGNLS-SLVRFDA 238
LE LA+S N G++P + + + L+ L + + N ++G LP + NLS SL+ D
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF-NEFSGELPESLTNLSASLLTLDL 375
Query: 239 ANCGLSGEIPTDIGR--LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIP 296
++ SG I ++ + L L+LQ N +G + L L S+ LS N +G IP
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 297 ASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRIL 356
+S L L L L+ N L G IP+ + + LE L L N+ TG IP L + L +
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 357 DLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIP 416
LS+N+LTG +P + L L N G IP LG C SL + + N NG+IP
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 417 KGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNN--QLSGSLPASIGKFSGVQ 474
+F + N++ G+ V + + N + G + + S
Sbjct: 556 AAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611
Query: 475 KLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGE 534
+ + G + +D S+N SG I EI L ++L N++SG
Sbjct: 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671
Query: 535 IPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNY 594
IP+++ +R LN L+LS N L G IP +++++ LT +D S NNLSG +P GQF F
Sbjct: 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPP 731
Query: 595 TSFLGNSELCGPYLGPCKDGVANGTHQPHVKG 626
FL N LCG L C A+G + H +
Sbjct: 732 AKFLNNPGLCGYPLPRCDPSNADG-YAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 488 bits (1258), Expect = e-159
Identities = 175/597 (29%), Positives = 267/597 (44%), Gaps = 48/597 (8%)
Query: 22 EYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPD 81
E L+S K + D ++ L W++ + CT+ GVTC VTS+DLS L+
Sbjct: 13 EIHQLISFKDVLPD--KNLLPDWSSNKNPCTFDGVTCRDD-KVTSIDLSSKPLNVGF--- 66
Query: 82 VAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDL 141
+ + +L+ L L LSN+ NGS ASL LDL
Sbjct: 67 ------------------SAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDL 107
Query: 142 YNNNMTGDLPLAVT--QLRNLRHLHLGGNFFSGQIPPEYGI-WEFLEYLAVSGNELGGKI 198
N+++G + + L+ L++ N G+ LE L +S N + G
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 199 PGEI---GNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQ 255
+L+ L I N +G + + +L D ++ S IP +G
Sbjct: 168 VVGWVLSDGCGELKHLAIS-GNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCS 223
Query: 256 NLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKL 315
L L + N LSG + + LK +++S+N F G IP LK+L L+L NK
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281
Query: 316 HGAIPEFI-GVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAG 374
G IP+F+ G L L L N+F G++P GS L L LSSN +G LP D
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL-L 340
Query: 375 NC--LQTLITLGNFLFGPIPESLGKC-DSLSRMRMGENFLNGSIPKGLFG--LPSLSQVE 429
L+ L N G +PESL SL + + N +G I L +L ++
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 430 LQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPA 489
LQ+N TG+ P + S L + LS N LSG++P+S+G S ++ L L N G+IP
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 490 EIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLN 549
E+ ++ L + N +G I +S C L ++ LS N L+GEIP + + L L
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 550 LSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGP 606
LS N G+IPA + +SL +D + N +G +P + F + + + + G
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA----AMFKQSGKIAANFIAGK 573
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 4e-82
Identities = 102/337 (30%), Positives = 161/337 (47%), Gaps = 7/337 (2%)
Query: 60 SRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSN 119
+ + L L +G + P +++ L +L ++ N LSG IP + +LS LR L L
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 120 NVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYG 179
N+ G P +L + +L+ L L N++TG++P ++ NL + L N +G+IP G
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 180 IWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAA 239
E L L +S N G IP E+G+ L L + N + G +P + S + +
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN-TNLFNGTIPAAMFKQSGKIAANF- 569
Query: 240 NCGLSGEIPTDIGRLQNLDTLFLQVNA--LSGPLTTELGYLKSLKSMDLSNNIFTGEIPA 297
++G+ I N G + +L L + ++++ ++ G
Sbjct: 570 ---IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626
Query: 298 SFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILD 357
+F ++ L++ N L G IP+ IG MP L +L L N+ +GSIP +G L ILD
Sbjct: 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 686
Query: 358 LSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPES 394
LSSNKL G +P M A L + N L GPIPE
Sbjct: 687 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-117
Identities = 117/278 (42%), Positives = 160/278 (57%), Gaps = 11/278 (3%)
Query: 688 EDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
NI+G+GG G VYKG + +G VAVKRL + F E++ + HR+++RL
Sbjct: 34 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH--LHWDTRYKIAVEAAKGLCYLHHDCS 805
GFC LLVY YM NGS+ L + L W R +IA+ +A+GL YLH C
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
P I+HRDVK+ NILLD FEA V DFGLAK L D + +A+ G+ G+IAPEY T K
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211
Query: 866 VDEKSDVYSFGVVLLELITGRKPV----GEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
EK+DV+ +GV+LLELITG++ D V ++ WV+ + KK + ++D L
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK--LEALVDVDL 269
Query: 922 PS-VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958
EV + VA+LC + +ERP M EVV++L
Sbjct: 270 QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-115
Identities = 101/614 (16%), Positives = 196/614 (31%), Gaps = 63/614 (10%)
Query: 16 QSRTVPEYKALLSIKSSITDDPQS-------SLAAWNATTSHCTW---PGVTCDSRRHVT 65
+ + +Y AL I ++ S A WN W PGV+ +S VT
Sbjct: 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVT 84
Query: 66 SLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGP----IPPEISALSSLRLLNLSNNV 121
L L G SG + + L L+ L++ ++ P ISA S
Sbjct: 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144
Query: 122 FNGSFPPQLS--QLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYG 179
+ +F + L + ++ + + + N + +
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVM 203
Query: 180 IWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAA 239
L + + + E + Y + NL L +
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSE------YAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 240 NCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLT--------TELGYLKSLKSMDLS-NNI 290
NC ++PT + L + + + N + + ++ + + NN+
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 291 FTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN 350
T + S ++K L +L N+L G +P F G +L L L N T G
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITEIPANFCGFT 376
Query: 351 GKLRILDLSSNKLTGTLPPDMCAGNC--LQTLI-------TLGNFLFGPIPESLGKCDSL 401
++ L + NKL +P A + + + ++ F P+ + K ++
Sbjct: 377 EQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 402 SRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTG-----QFPVSDSIS--VNLGQICL 454
S + + N ++ + LS + L N LT +++ L I L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 455 SNNQLSGSLPASI--GKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKM------DFSHNK 506
N+L+ L + + L N FS P + L D N+
Sbjct: 496 RFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553
Query: 507 FSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASM 566
I+ C LT + + N++ + ++ ++ L++ N + + +
Sbjct: 554 TLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPY 610
Query: 567 QSLTSVDFSYNNLS 580
Y+
Sbjct: 611 IEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 1e-77
Identities = 74/512 (14%), Positives = 147/512 (28%), Gaps = 85/512 (16%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
T + N++ +S V L L+ + + E N
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA-----WENENSEYAQQYK 239
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFF--------SGQIPP 176
+ + L L +++YN LP + L ++ +++ N Q
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 177 EYGIWEFLEYLAVSGNEL-GGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVR 235
+ + E ++ + + N L + + + KL L YN G P G+ L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC-LYNQLEG-KLPAFGSEIKLAS 357
Query: 236 FDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSG-PLTTELGYLKSLKSMDLSNNIFTG- 293
+ A ++ G + ++ L N L P + + + ++D S N
Sbjct: 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSV 417
Query: 294 ------EIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTG------ 341
+ + + N++ +NL N++ E L + L N T
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477
Query: 342 -SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDS 400
+ + L +DL NKLT L D A
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP----------------------Y 514
Query: 401 LSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLS 460
L + + N + P +L +++ N+
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD------------------AQGNRTL 555
Query: 461 GSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKL 520
P I + +L + N + +I +S +D N +
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSR 552
L ++ +I + L++ R
Sbjct: 613 AGMYMLFYDKTQ-DIRG-------CDALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-51
Identities = 45/323 (13%), Positives = 105/323 (32%), Gaps = 22/323 (6%)
Query: 283 SMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTG- 341
+ + +++ + S +T L+L G +P+ IG + LEVL L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 342 ---SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNC--LQTLITLGNFLFGPIPESLG 396
P+ + +N T + L + I +S
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 397 KCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSN 456
+++ N + + K + L L Q + ++ + + N
Sbjct: 181 ITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EY 234
Query: 457 NQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKF--------S 508
Q + + + + ++P + L ++ ++ + N+
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 509 GRIAPEISQCKLLTFVDLSRNEL-SGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQ 567
+ + + + + + N L + + L M+ L L N L G +P + S
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353
Query: 568 SLTSVDFSYNNLSGLVPGTGQFS 590
L S++ +YN ++ + F+
Sbjct: 354 KLASLNLAYNQITEIPANFCGFT 376
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-32
Identities = 29/260 (11%), Positives = 79/260 (30%), Gaps = 36/260 (13%)
Query: 347 LGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRM 406
L SNG++ L L +G +P+++G+ L + +
Sbjct: 77 LNSNGRVTGLSLEGFGASGR------------------------VPDAIGQLTELEVLAL 112
Query: 407 GENFLNG----SIPKGLFGLPSLSQVELQDNYLTGQFP--VSDSISVNLGQICLSNNQLS 460
G + PKG+ S Q + + F +L + C++++
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 461 GSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKL 520
S+ S ++ N + + + +L +L + ++ F E + +
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLS 580
+ + + ++ L + + + +P + ++ + ++ + N
Sbjct: 232 SEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
Query: 581 GLVPGTGQFSYFNYTSFLGN 600
+
Sbjct: 287 SGEQLKDDWQALADAPVGEK 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-111
Identities = 98/278 (35%), Positives = 152/278 (54%), Gaps = 14/278 (5%)
Query: 688 EDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSH-DHGFNAEIQTLGRIRHRHIVR 746
+IG G G VYKG++ +G +VA+KR + SS F EI+TL RH H+V
Sbjct: 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRR---TPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG--GHLHWDTRYKIAVEAAKGLCYLHHDC 804
L+GFC +L+Y+YM NG+L L+G + W+ R +I + AA+GL YLH
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
I+HRDVKS NILLD F + DFG++K + + + + G+ GYI PEY
Sbjct: 160 ---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG 216
Query: 865 KVDEKSDVYSFGVVLLELITGRKPV--GEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922
++ EKSDVYSFGVVL E++ R + + V++ +W + ++ + + +I+DP L
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ--LEQIVDPNLA 274
Query: 923 S-VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTE 959
+ + A+ C+ + +RP+M +V+ L
Sbjct: 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-108
Identities = 105/277 (37%), Positives = 158/277 (57%), Gaps = 9/277 (3%)
Query: 687 KEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSH--DHGFNAEIQTLGRIRHRHI 744
N +G+GG G+VYKG + N VAVK+L AM ++ F+ EI+ + + +H ++
Sbjct: 34 VGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG-HLHWDTRYKIAVEAAKGLCYLHHD 803
V LLGF S+ + LVY YMPNGSL + L G L W R KIA AA G+ +LH +
Sbjct: 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
+HRD+KS NILLD F A ++DFGLA+ + + S I G+ Y+APE
Sbjct: 153 H---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LR 208
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
++ KSD+YSFGVVLLE+ITG V E + ++ ++ D +K + +D ++
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK-TIEDYIDKKMND 267
Query: 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
V ++ VA C+ E+ +RP +++V Q+L E+
Sbjct: 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = 4e-95
Identities = 105/331 (31%), Positives = 155/331 (46%), Gaps = 37/331 (11%)
Query: 22 EYKALLSIKSSITDDPQSSLAAWNATTSHC--TWPGVTCDSRRH---VTSLDLSGLNLSG 76
+ +ALL IK + + ++L++W TT C TW GV CD+ V +LDLSGLNL
Sbjct: 7 DKQALLQIKKDLGNP--TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 77 --ALSPDVAHLRFLQNLSVA-ANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQL 133
+ +A+L +L L + N L GPIPP I+ L+ L L +++ +G+ P LSQ+
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNE 193
+L LD N ++G LP +++ L NL + GN SG IP
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS---------------- 168
Query: 194 LGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGR 253
G+ +KL N TG +PP NL +L D + L G+ G
Sbjct: 169 --------YGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGS 219
Query: 254 LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRN 313
+N + L N+L+ L ++G K+L +DL NN G +P +LK L LN+ N
Sbjct: 220 DKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 314 KLHGAIPEFIGVMPRLEVLQLWENNFTGSIP 344
L G IP+ G + R +V N P
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-85
Identities = 77/333 (23%), Positives = 137/333 (41%), Gaps = 54/333 (16%)
Query: 283 SMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG--AIPEFIGVMPRLEVLQLW-ENNF 339
+ D N + G + + + + L+L L IP + +P L L + NN
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 340 TGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCD 399
G IP + +L L ++ ++G IP+ L +
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSG------------------------AIPDFLSQIK 125
Query: 400 SLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQL 459
+L + N L+G++P + LP NL I N++
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLP------------------------NLVGITFDGNRI 161
Query: 460 SGSLPASIGKFSG-VQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQC 518
SG++P S G FS + + N+ +G+IP L L+ +D S N G +
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSD 220
Query: 519 KLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNN 578
K + L++N L+ ++ ++ + LN L+L N + G++P + ++ L S++ S+NN
Sbjct: 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 579 LSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPC 611
L G +P G F+ +++ N LCG L C
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-67
Identities = 79/308 (25%), Positives = 122/308 (39%), Gaps = 32/308 (10%)
Query: 163 LHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG--KIPGEIGNLTKLQQLYIGYYNSYT 220
+ G + + L +SG L IP + NL L LYIG N+
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 221 GGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKS 280
G +PP I L+ L + +SG IP + +++ L TL NALSG L + L +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 281 LKSMDLSNNIFTGEIPASFAELKNL-TLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNF 339
L + N +G IP S+ L T + + RN+L G IP + L + L N
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209
Query: 340 TGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCD 399
G GS+ + + L+ N L L +G
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-------------------------KVGLSK 244
Query: 400 SLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLS-NNQ 458
+L+ + + N + G++P+GL L L + + N L G+ P ++ + N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ-RFDVSAYANNKC 303
Query: 459 LSGS-LPA 465
L GS LPA
Sbjct: 304 LCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 8/179 (4%)
Query: 414 SIPKGLFGLPSLS----QVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGS--LPASI 467
I K L +LS + + G +D+ + + + LS L +P+S+
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 468 GKFSGVQKL-LLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDL 526
+ L + N G IP I KL QL + +H SG I +SQ K L +D
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 527 SRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSL-TSVDFSYNNLSGLVP 584
S N LSG +P ++ + L + N + G+IP S S L TS+ S N L+G +P
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 309 bits (792), Expect = 5e-91
Identities = 103/615 (16%), Positives = 191/615 (31%), Gaps = 70/615 (11%)
Query: 19 TVPEYKALLSIKS----------SITDDPQSSLAAWNATTSHCTW---PGVTCDSRRHVT 65
+ +YKAL +I S T + WN W PGV D+ VT
Sbjct: 267 YIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVT 326
Query: 66 SLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGS 125
L L+G G + + L L+ LS + + + + +
Sbjct: 327 GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386
Query: 126 FPP-QLSQLASLQVLDLYNNNMTGDL---PLAVTQLRNLRHLHLGG-NFFSGQIPPEYGI 180
+ L L + DL + + + P+ +L+ +G I
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQR 446
Query: 181 WEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAAN 240
L+ + + + Y NL L + N
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSD------YAKQYENEELSWSNLKDLTDVELYN 500
Query: 241 CGLSGEIPTDIGRLQNLDTLFLQVNALSGP---------LTTELGYLKSLKSMDLSNNIF 291
C ++P + L L +L + N L + ++ + N
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560
Query: 292 TGEIPAS--FAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGS 349
E PAS ++ L LL+ NK+ + F G +L L+L N IP+ +
Sbjct: 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIE-EIPEDFCA 616
Query: 350 N-GKLRILDLSSNKLTGTLPPDMCAGNC--LQTLITLGNFLFGPIPESLG------KCDS 400
++ L S NKL +P A + + ++ G ++ K +
Sbjct: 617 FTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD-FSYNKIGSEGRNISCSMDDYKGIN 674
Query: 401 LSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLT-------GQFPVSDSISVNLGQIC 453
S + + N + + +S + L +N +T + + L I
Sbjct: 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTID 734
Query: 454 LSNNQLSGSLPASI--GKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSH------N 505
L N+L+ SL + + + N FS P + QL H N
Sbjct: 735 LRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN 792
Query: 506 KFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIAS 565
+ + I+ C L + + N++ ++ +L L L+++ N + S+
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCP 849
Query: 566 MQSLTSVDFSYNNLS 580
Y+
Sbjct: 850 YIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 7e-49
Identities = 66/383 (17%), Positives = 121/383 (31%), Gaps = 37/383 (9%)
Query: 216 YNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSG-PLTTE 274
+ + ++ N + A G G +P IG+L L L ++ +
Sbjct: 308 LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367
Query: 275 LGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMP----RLE 330
L S + + I + L L +L ++ ++ PE + L+
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLK 426
Query: 331 VLQLWE-NNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFG 389
Q+ N I + + KL+I+ +++ T + + + +
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-DNIAVD----WEDANSDYAKQYE 481
Query: 390 PIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNL 449
S L+ + + +P L+ LP L + + N + +
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT--- 538
Query: 450 GQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAE--IGKLQQLSKMDFSHNKF 507
L +Q + N PA + K+ +L +D HNK
Sbjct: 539 ------------RLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV 585
Query: 508 SGRIAPEISQCKLLTFVDLSRNELSGEIPNQL-TGMRILNYLNLSRNHLVGSIP--ASIA 564
LT + L N++ EIP + L S N L IP +
Sbjct: 586 R--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAK 641
Query: 565 SMQSLTSVDFSYNNLSGLVPGTG 587
S+ + SVDFSYN +
Sbjct: 642 SVYVMGSVDFSYNKIGSEGRNIS 664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-42
Identities = 46/368 (12%), Positives = 105/368 (28%), Gaps = 27/368 (7%)
Query: 237 DAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIP 296
D N + N + +++ +L + + L+ G +P
Sbjct: 282 DGKNWRYYSGTINNTIHSLNWNFN-KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340
Query: 297 ASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQR-LGSNGKLRI 355
+ +L L +L+ + + F ++ + ++ + L + +L +
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400
Query: 356 LDLSSNKLT-----GTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENF 410
DL + + + D + T I I +++ + L + +
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRI-SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSP 459
Query: 411 LNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKF 470
+S S +L + L N LP +
Sbjct: 460 FTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514
Query: 471 SGVQKLLLDGNKFSG---------QIPAEIGKLQQLSKMDFSHNKFSGRIAP-EISQCKL 520
+Q L + N+ ++ + ++ +N A + +
Sbjct: 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK 574
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNL 579
L +D N++ + L L L N + IP A + + FS+N L
Sbjct: 575 LGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKL 631
Query: 580 SGLVPGTG 587
+
Sbjct: 632 KYIPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-28
Identities = 42/417 (10%), Positives = 118/417 (28%), Gaps = 61/417 (14%)
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGL 243
L+ + V+ E + K + + +S LP + + + +
Sbjct: 173 LKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVW-LPAGTYQVVAYTTYSQSGIKR 231
Query: 244 S----GEIPTDI-----GRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGE 294
S + + +L + +Q+ + + +++D N +
Sbjct: 232 SELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSG 291
Query: 295 IPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLR 354
+ N N + + R+ L L G +P +G +L+
Sbjct: 292 TINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELK 350
Query: 355 ILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPE-SLGKCDSLSRMRMGENFLNG 413
+L ++ T + + + + L L+ + ++ +N
Sbjct: 351 VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410
Query: 414 SIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGV 473
+ + + S++ L+D + N+++
Sbjct: 411 N--PEMKPIKKDSRISLKDTQIG-----------------NLTNRITF------------ 439
Query: 474 QKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSG 533
I I +L +L + F+++ F+ + + +
Sbjct: 440 -------------ISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYE 481
Query: 534 EIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFS 590
+ ++ L + L + +P + + L S++ + N ++
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 2e-89
Identities = 114/550 (20%), Positives = 205/550 (37%), Gaps = 33/550 (6%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
D S L L+ + D+ + L++ NQL + S L L++ N +
Sbjct: 7 EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFL 184
P +L L+VL+L +N ++ NL LHL N + + L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 185 EYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIG--NLSSLVRFDAANCG 242
L +S N L G L LQ+L + N E+ SSL + + ++
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLL-SNNKIQALKSEELDIFANSSLKKLELSSNQ 182
Query: 243 LSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGY---LKSLKSMDLSNNIFTGEIPASF 299
+ P + L LFL L LT +L S++++ LSN+ + +F
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 300 AELK--NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILD 357
LK NLT+L+L N L+ + +P+LE L NN L +R L+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 358 LSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPK 417
L + ++ L S L + M +N + G
Sbjct: 303 LKRSFTKQSIS---------------LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
Query: 418 GLFGLPSLSQVELQDNYLTGQFPVSDS----ISVNLGQICLSNNQLSGSLPASIGKFSGV 473
GL +L + L +++ + + +++ L + L+ N++S + +
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407
Query: 474 QKLLLDGNKFSGQIPA-EIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELS 532
+ L L N+ ++ E L+ + ++ S+NK+ + L + L R L
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 533 G--EIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFS 590
P+ +R L L+LS N++ + ++ L +D +NNL+ L
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 591 YFNYTSFLGN 600
+ L +
Sbjct: 528 PIYFLKGLSH 537
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 9e-87
Identities = 103/556 (18%), Positives = 183/556 (32%), Gaps = 56/556 (10%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
+ L+L LS A L L + +N + +L L+LS+N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTG--DLPLAVTQLRNLRHLHLGGNFFSGQIPPEYG 179
+ + QL +LQ L L NN + L + +L+ L L
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL-------------- 178
Query: 180 IWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIG---NLSSLVRF 236
S N++ PG + +L L++ L ++ +S+
Sbjct: 179 ----------SSNQIKEFSPGCFHAIGRLFGLFLN-NVQLGPSLTEKLCLELANTSIRNL 227
Query: 237 DAANCGLSGEIPTDIGRLQ--NLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGE 294
+N LS T L+ NL L L N L+ +L L+ L N
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287
Query: 295 IPASFAELKNLTLLNLFRN---------KLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQ 345
S L N+ LNL R+ L + LE L + +N+ G
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
Query: 346 RLGSNGKLRILDLSSNKLT-GTLPPDMCAGNCLQTLITL---GNFLFGPIPESLGKCDSL 401
L+ L LS++ + TL + L L N + ++ L
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407
Query: 402 SRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLS 460
+ +G N + + + GL ++ ++ L N S ++ +L ++ L L
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 461 G--SLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFS--------GR 510
S P+ + L L N + + L++L +D HN + G
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 511 IAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLT 570
+ L ++L N + L ++L N+L + + SL
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587
Query: 571 SVDFSYNNLSGLVPGT 586
S++ N ++ +
Sbjct: 588 SLNLQKNLITSVEKKV 603
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 9e-84
Identities = 103/578 (17%), Positives = 183/578 (31%), Gaps = 55/578 (9%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
++T L L ++ + + L L ++ N LS L +L+ L LSNN
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 122 FNGSFPPQLS--QLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYG 179
+L +SL+ L+L +N + P + L L L + +
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216
Query: 180 IWEF---LEYLAVSGNELGGKIPGEIGNL--TKLQQLYIGYYNSYTGGLPPEIGNLSSLV 234
+ + L++S ++L L T L L + YN+ L L
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL-SYNNLNVVGNDSFAWLPQLE 275
Query: 235 RFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTT---------ELGYLKSLKSMD 285
F + + L N+ L L+ + ++ +LK L+ ++
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 286 LSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE---FIG-VMPRLEVLQLWENNFTG 341
+ +N G F L NL L+L + F+ L +L L +N +
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 342 SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSL 401
G L +LDL N++ L +++
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQ-----------------------EWRGLENI 432
Query: 402 SRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS--VNLGQICLSNNQL 459
+ + N +PSL ++ L+ L NL + LSNN +
Sbjct: 433 FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492
Query: 460 SGSLPASIGKFSGVQKLLLDGNKFS--------GQIPAEIGKLQQLSKMDFSHNKFSGRI 511
+ + ++ L L N + G + L L ++ N F
Sbjct: 493 ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552
Query: 512 APEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIA-SMQSLT 570
L +DL N L+ + L LNL +N + + ++LT
Sbjct: 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT 612
Query: 571 SVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYL 608
+D +N F + + EL YL
Sbjct: 613 ELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 9e-76
Identities = 87/465 (18%), Positives = 159/465 (34%), Gaps = 33/465 (7%)
Query: 135 SLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL 194
S +V D + +T +P + N+ L+L N + + L L V N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 195 GGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRL 254
P L L+ L + +N + ++L + + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQ-HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 255 QNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKN--LTLLNLFR 312
+NL TL L N LS L++L+ + LSNN N L L L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 313 NKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLG---SNGKLRILDLSSNKLTGTLPP 369
N++ P + RL L L S+ ++L +N +R L LS+++L+
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-TSN 239
Query: 370 DMCAGNCLQTLITL---GNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLS 426
G L L N L +S L + N + L GL ++
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
Query: 427 QVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQ 486
+ L+ ++ +S L S ++ L ++ N G
Sbjct: 300 YLNLKRSFTKQS---------------ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344
Query: 487 IPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKL----LTFVDLSRNELSGEIPNQLTGM 542
L L + S++ S R + L L ++L++N++S + + +
Sbjct: 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404
Query: 543 RILNYLNLSRNHLVGSIPAS-IASMQSLTSVDFSYNNLSGLVPGT 586
L L+L N + + ++++ + SYN L +
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-58
Identities = 85/528 (16%), Positives = 153/528 (28%), Gaps = 102/528 (19%)
Query: 60 SRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISAL--SSLRLLNL 117
+ + +L LS +QLS L ++L +L+L
Sbjct: 220 ANTSIRNLSLSN------------------------SQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 118 SNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPE 177
S N N + L L+ L NN+ ++ L N+R+L+L +F I
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI--- 312
Query: 178 YGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFD 237
S L L L+ L + N G L +L
Sbjct: 313 ------------SLASLPKIDDFSFQWLKCLEHLNM-EDNDIPGIKSNMFTGLINLKYLS 359
Query: 238 AANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPA 297
+N S T+ +L L ++L+ N +
Sbjct: 360 LSNSFTSLRTLTN-ETFVSL-------------------AHSPLHILNLTKNKISKIESD 399
Query: 298 SFAELKNLTLLNLFRNKLHGAIP-EFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRIL 356
+F+ L +L +L+L N++ + + + + + L N + L+ L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 357 DLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIP 416
L L P +L+ + + N +
Sbjct: 460 MLRRVALKN----------------------VDSSPSPFQPLRNLTILDLSNNNIANIND 497
Query: 417 KGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKL 476
L GL L ++LQ N L L + G + S + L
Sbjct: 498 DMLEGLEKLEILDLQHNNLA----------------RLWKHANPGGPIYFLKGLSHLHIL 541
Query: 477 LLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIP 536
L+ N F L +L +D N + A + L ++L +N ++
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 537 NQL-TGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLV 583
R L L++ N + + + + + LS
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-49
Identities = 69/326 (21%), Positives = 124/326 (38%), Gaps = 17/326 (5%)
Query: 59 DSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLS 118
+ +R T +S +L L+ L++L++ N + G + L +L+ L+LS
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 119 NNVFNGSFPPQLS----QLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQI 174
N+ + + + L +L+L N ++ A + L +L L LG N ++
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 175 PP-EYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG--GLPPEIGNLS 231
E+ E + + +S N+ + LQ+L + + P L
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML-RRVALKNVDSSPSPFQPLR 480
Query: 232 SLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALS--------GPLTTELGYLKSLKS 283
+L D +N ++ + L+ L+ L LQ N L+ G L L L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 284 MDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI 343
++L +N F F +L L +++L N L+ L+ L L +N T
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 344 PQRLGSN-GKLRILDLSSNKLTGTLP 368
+ G L LD+ N T
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-26
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 5/173 (2%)
Query: 424 SLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKF 483
S + LT V D + N+ + L++NQL A+ ++S + L + N
Sbjct: 5 SHEVADCSHLKLTQ---VPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543
S P KL L ++ HN+ S + C LT + L N + N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTS 596
L L+LS N L + + +++L + S N + L F +S
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE--LDIFANSS 172
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 1e-84
Identities = 103/538 (19%), Positives = 190/538 (35%), Gaps = 26/538 (4%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
+LDLS L S LQ L ++ ++ +LS L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFF-SGQIPPEYGI 180
S L+SLQ L N+ + L+ L+ L++ N S ++P +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 181 WEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYT--GGLPPEIGNLSSLVRFDA 238
LE+L +S N++ ++ L ++ L + S + P L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 239 ANCGLSGEIPTD-IGRLQNLDTLFLQVNALSG---PLTTELGYLKSLKSMDLSNN----- 289
N S + I L L+ L + + L+ L ++ +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 290 -IFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLG 348
+ +I F L N++ +L + + +F + L+L F +L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSY-NFGWQHLELVNCKFGQFPTLKLK 325
Query: 349 SNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFL--FGPIPESLGKCDSLSRMRM 406
S L+ L +SNK L+ L N L G +S SL + +
Sbjct: 326 S---LKRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 407 GENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISV-NLGQICLSNNQLSGSLPA 465
N + + GL L ++ Q + L S +S+ NL + +S+ +
Sbjct: 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 466 SIGKFSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFV 524
S ++ L + GN F +I +L+ L+ +D S + + L +
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 525 DLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASM-QSLTSVDFSYNNLSG 581
++S N + L L+ S NH++ S + SL ++ + N+ +
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-74
Identities = 93/543 (17%), Positives = 166/543 (30%), Gaps = 32/543 (5%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
LDLS + L L L + N + S LSSL+ L
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 125 SFPPQLSQLASLQVLDLYNNNMTG-DLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
+ L +L+ L++ +N + LP + L NL HL L N + +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 184 LEYLAV----SGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPE-IGNLSSLVRFDA 238
+ L + S N + PG + +L +L + N + + I L+ L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL-RNNFDSLNVMKTCIQGLAGLEVHRL 232
Query: 239 ANCGLSGEI---PTDIGRLQNLDTLFLQVNALS------GPLTTELGYLKSLKSMDLSNN 289
E D L+ L L ++ L+ + L ++ S L +
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292
Query: 290 IFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGS 349
S+ L L K + + RL + G
Sbjct: 293 TIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVD 345
Query: 350 NGKLRILDLSSNKLTGTLPPDMCAGNC--LQTLITLGNFLFGPIPESLGKCDSLSRMRMG 407
L LDLS N L+ L+ L N + + + + L +
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQ 404
Query: 408 ENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSL-PA 465
+ L +F L +L +++ + F + +L + ++ N + P
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 466 SIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVD 525
+ + L L + P L L ++ SHN F L +D
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524
Query: 526 LSRNELSGEIPNQLTGM-RILNYLNLSRNHLVGSIPAS--IASMQSLTSVDFSYNNLSGL 582
S N + +L L +LNL++N + + ++ + +
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584
Query: 583 VPG 585
P
Sbjct: 585 TPS 587
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-50
Identities = 67/385 (17%), Positives = 116/385 (30%), Gaps = 27/385 (7%)
Query: 223 LPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLK 282
+P + S D + L L L L + L L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 283 SMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTG- 341
++ L+ N +F+ L +L L L IG + L+ L + N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 342 SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL----GNFLFGPIPESLGK 397
+P+ + L LDLSSNK+ D+ + + L N + P + +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 398 CDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQIC--- 453
L ++ + NF + ++ K GL L L + + L +C
Sbjct: 200 I-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 454 LSNNQLS------GSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKF 507
+ +L+ + + V L ++ + KF
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 508 SGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL--VGSIPASIAS 565
KL + L+ G + L +L+LSRN L G S
Sbjct: 317 GQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 566 MQSLTSVDFSYNNLSGLVPGTGQFS 590
SL +D S+N + +
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFLGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-44
Identities = 65/324 (20%), Positives = 101/324 (31%), Gaps = 31/324 (9%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLS-------------------GPI 102
+V+S L + + D ++ Q+L + + G
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 103 PPEISALSSLRLLNLSNN--VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNL 160
L SL L+LS N F G SL+ LDL N + + L L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 398
Query: 161 RHLHLGGNFFSGQIPPEY-GIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSY 219
HL + L YL +S G L+ L+ L + NS+
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG-NSF 457
Query: 220 TGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYL 278
P+I L +L D + C L PT L +L L + N T L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 517
Query: 279 KSLKSMDLSNNIFTGEIPASFAEL-KNLTLLNLFRNKLHGAIP--EFIGVMPRLEVLQLW 335
SL+ +D S N +L LNL +N F+ + L +
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 577
Query: 336 ENNFTGSIPQRLGSNGKLRILDLS 359
+ P + L+++
Sbjct: 578 VERMECATPSDK-QGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 55/308 (17%), Positives = 101/308 (32%), Gaps = 28/308 (9%)
Query: 302 LKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSN 361
+ N+T + N IP+ + + L L N S +L++LDLS
Sbjct: 7 VPNITYQCMELN--FYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 362 KLTGTLPPDMCAGNCLQTLITL---GNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKG 418
++ + L L TL GN + + SL ++ E L
Sbjct: 63 EIQT-IEDGAYQS--LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 419 LFGLPSLSQVELQDNYLTGQFPVSDSIS--VNLGQICLSNNQLSGSLPASIGKFSGVQ-- 474
+ L +L ++ + N + F + + S NL + LS+N++ + +
Sbjct: 120 IGHLKTLKELNVAHNLIQS-FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 475 --KLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPE-ISQCKLLTFVDLSRNEL 531
L L N + I K +L K+ +N S + I L L E
Sbjct: 179 NLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 532 SGE------IPNQLTGMRILNYLNLSRNHL---VGSIPASIASMQSLTSVDFSYNNLSGL 582
E + L G+ L +L + I + +++S + +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 583 VPGTGQFS 590
+ F
Sbjct: 298 KDFSYNFG 305
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 37/193 (19%), Positives = 69/193 (35%), Gaps = 7/193 (3%)
Query: 414 SIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGV 473
IP L S ++L N L S L + LS ++ + S +
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 474 QKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNEL-S 532
L+L GN L L K+ + I K L ++++ N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 533 GEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLT----SVDFSYNNLSGLVPGTGQ 588
++P + + L +L+LS N + + + + S+D S N ++ + PG +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 589 FSYFNYTSFLGNS 601
+ + N
Sbjct: 199 EIRLHKLTLRNNF 211
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 1e-84
Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 30/300 (10%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
L+ + +G G V+K + VAVK P + S E+ +L ++H +I+
Sbjct: 26 LQLLEVKARGRFGCVWKA-QLLNEYVAVKIFPIQDKQSWQ---NEYEVYSLPGMKHENIL 81
Query: 746 RLLGFCSNHETN----LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+ +G + L+ + GSL + L + W+ IA A+GL YLH
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLH 138
Query: 802 HD-------CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG 854
D P I HRD+KS N+LL + A +ADFGLA + ++ G+
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 855 YIAPEYA-----YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG-----VDIVQWVRK 904
Y+APE + + D+Y+ G+VL EL + D + +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 905 MTDSKKEGVLKILDPRLP-SVPLHEVMHVFY-VAMLCVEEQAVERPTMREVVQILTELPK 962
+ D ++ V K P L H M + C + A R + V + +T++ +
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-79
Identities = 98/534 (18%), Positives = 177/534 (33%), Gaps = 19/534 (3%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
L+ S L + + L L L + Q+ + L L L+ N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIW 181
LS +L+ L ++ + + + L L+LG N S P+
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 182 EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANC 241
E L+ L N + ++ +L + L + + G+ P + + +
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
Query: 242 GLSGEIP-----TDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIP 296
I + I L + +S + L + S++S++L + F
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISS 271
Query: 297 ASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRIL 356
+F L L+L L +P + + L+ L L N F + L L
Sbjct: 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 357 DLSSNKLTGTLPPDMCAGNCLQTLITL---GNFL--FGPIPESLGKCDSLSRMRMGENFL 411
+ N L L+ L L + + L L + + N
Sbjct: 331 SIKGNTKRLELGTGCLEN--LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 412 NGSIPKGLFGLPSLSQVELQDNYLTGQFPVSD-SISVNLGQICLSNNQLSGSLPASIGKF 470
+ P L ++L L + S L + LS++ L S
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448
Query: 471 SGVQKLLLDGNKFSGQIPAEIGKLQQLSKM---DFSHNKFSGRIAPEISQCKLLTFVDLS 527
+Q L L GN F + LQ L ++ S S + K++ VDLS
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 528 RNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSG 581
N L+ L+ ++ + YLNL+ NH+ +P+ + + +++ N L
Sbjct: 509 HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 8e-52
Identities = 80/406 (19%), Positives = 130/406 (32%), Gaps = 15/406 (3%)
Query: 190 SGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPT 249
L +IPG + + L +N L +L D C +
Sbjct: 20 ENLGLN-EIPGTL--PNSTECLEF-SFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 250 DIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLN 309
LDTL L N L T L K+LK + + K L L
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 310 LFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRI--LDLSSNKLTGTL 367
L N + +L+VL N + + S + L+L+ N + +
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GI 194
Query: 368 PPDMCAGNCLQTLITLGNFLFGPIPESLGKCD--SLSRMRMGENFLNGSIPKGLFGLPSL 425
P Q+L G I + L SL + P GL +
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
Query: 426 SQVEL--QDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKF 483
S + Q +Y + L ++ L+ LS LP+ + S ++KL+L NKF
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPE-ISQCKLLTFVDLSRNEL--SGEIPNQLT 540
L+ + N + + + L +DLS +++ S QL
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 541 GMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
+ L LNLS N + + L +D ++ L +
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-49
Identities = 79/414 (19%), Positives = 144/414 (34%), Gaps = 17/414 (4%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQN--LSVAANQLSGPIPPEISALSSLRLLNLSN 119
+ LD + D++ L+ N L++ N ++G I P + + LN
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGG 211
Query: 120 NVFNGSFPPQLS--QLASLQVLDLYNNNMTGDLPLAVTQLR--NLRHLHLGGNFFSGQIP 175
L + SL + + + P L ++ ++L ++F
Sbjct: 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
Query: 176 PEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVR 235
+ + L+ L ++ L ++P + L+ L++L + N + N SL
Sbjct: 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL-SANKFENLCQISASNFPSLTH 329
Query: 236 FDAANCGLSGEIPTD-IGRLQNLDTLFLQVNAL--SGPLTTELGYLKSLKSMDLSNNIFT 292
E+ T + L+NL L L + + S +L L L+S++LS N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 293 GEIPASFAELKNLTLLNLFRNKLHGAIPE-FIGVMPRLEVLQLWENNFTGSIPQRLGSNG 351
+F E L LL+L +L + + L+VL L + S Q
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 352 KLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFLFGPIPESLGKCDSLSRMRMGE 408
L+ L+L N + L L L L + ++ + +
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 409 NFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGS 462
N L S + L L + + L N+++ P I I L N L +
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-48
Identities = 57/363 (15%), Positives = 110/363 (30%), Gaps = 14/363 (3%)
Query: 236 FDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEI 295
++ N GL+ EIP + + + L N L T L +L +DL+
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 296 PASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRI 355
+F L L L N L + L+ L + + L + L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 356 LDLSSNKLTGTLPPDMCAG-NCLQTLITLGNFLFGPIPESLGKCDSLSRM--RMGENFLN 412
L L SN ++ + L+ L N + E + + + + N +
Sbjct: 134 LYLGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI- 191
Query: 413 GSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS--VNLGQICLSNNQLSGSLPASIGKF 470
I G F + S +L + PA
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 471 SG--VQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSR 528
V+ + L + F L ++D + S + + L + LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 529 NELSGEIPNQLTGMRILNYLNLSRNHLVGSI-PASIASMQSLTSVDFSYNNLSGLVPGTG 587
N+ + L +L++ N + + ++++L +D S++++
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 588 QFS 590
Q
Sbjct: 371 QLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-44
Identities = 71/315 (22%), Positives = 112/315 (35%), Gaps = 12/315 (3%)
Query: 60 SRRHVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLS 118
V S++L +S + LQ L + A LS +P + LS+L+ L LS
Sbjct: 252 CEMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLS 309
Query: 119 NNVFNGSFPPQLSQLASLQVLDLYNNNMTGDL-PLAVTQLRNLRHLHLGGNFFSGQIPPE 177
N F S SL L + N +L + L NLR L L +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 178 YGIW--EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI-GNLSSLV 234
+ L+ L +S NE +L+ L + + NL L
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL-AFTRLKVKDAQSPFQNLHLLK 428
Query: 235 RFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSG---PLTTELGYLKSLKSMDLSNNIF 291
+ ++ L L L L LQ N T L L L+ + LS
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 292 TGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNG 351
+ +F LK + ++L N+L + E + + + L L N+ + +P L
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547
Query: 352 KLRILDLSSNKLTGT 366
+ R ++L N L T
Sbjct: 548 QQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-20
Identities = 32/237 (13%), Positives = 67/237 (28%), Gaps = 5/237 (2%)
Query: 369 PDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQV 428
C + N IP +L S + N L L +L+ +
Sbjct: 5 DQKCIEKEVNKTYNCENLGLNEIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 429 ELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIP 488
+L + + L + L+ N L ++ ++ L S
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122
Query: 489 AEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILN-- 546
+ + L + N S P+ + L +D N + ++ ++
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182
Query: 547 YLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSEL 603
LNL+ N + I S++F ++ + S ++
Sbjct: 183 SLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-67
Identities = 89/302 (29%), Positives = 136/302 (45%), Gaps = 39/302 (12%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
++ + ++G+G G+V K VA+K++ S F E++ L R+ H +IV
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIV 64
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG-GHLHWDTRYKIAVEAAKGLCYLHHDC 804
+L G C N LV EY GSL VLHG + + ++ ++G+ YLH
Sbjct: 65 KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 805 SPLIVHRDVKSNNILLDSGFE-AHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
++HRD+K N+LL +G + DFG A +Q M+ GS ++APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEG 177
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
EK DV+S+G++L E+IT RKP E G + W V P L
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA----------VHNGTRPPLIK 227
Query: 924 ---VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL------PKPPTSKQGEESLP 974
P+ +M C + +RP+M E+V+I+T L P + SLP
Sbjct: 228 NLPKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281
Query: 975 PS 976
P
Sbjct: 282 PG 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-67
Identities = 85/292 (29%), Positives = 132/292 (45%), Gaps = 25/292 (8%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
L IG G G V++ +G VAVK L + + F E+ + R+RH +IV
Sbjct: 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG-HLHWDTRYKIAVEAAKGLCYLHHDC 804
+G + +V EY+ GSL +LH L R +A + AKG+ YLH+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
+P IVHR++KS N+L+D + V DFGL++ + S + AG+ ++APE
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDE 214
Query: 865 KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS- 923
+EKSDVYSFGV+L EL T ++P G + +V V K +P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAV----------GFKCKRLEIPRN 263
Query: 924 --VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESL 973
+ ++ C + +RP+ ++ +L L K L
Sbjct: 264 LNPQVAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-64
Identities = 85/288 (29%), Positives = 126/288 (43%), Gaps = 38/288 (13%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRH 743
L + IIG GG G VY+ GD+VAVK S E + ++H +
Sbjct: 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
I+ L G C LV E+ G L VL GK+ + D AV+ A+G+ YLH +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDE 124
Query: 804 CSPLIVHRDVKSNNILLDSGFEAH--------VADFGLAKFLQDSGTSECMSAIAGSYGY 855
I+HRD+KS+NIL+ E + DFGLA+ + + AG+Y +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAW 180
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
+APE + SDV+S+GV+L EL+TG P DG+ + V +
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGV----------AMN 229
Query: 916 ILDPRLPS---VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
L +PS P ++M C RP+ ++ LT +
Sbjct: 230 KLALPIPSTCPEPFAKLM------EDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-64
Identities = 92/542 (16%), Positives = 171/542 (31%), Gaps = 38/542 (7%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
++DLS L S ++ LQ L ++ ++ L L L L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIW 181
P S L SL+ L + + QL L+ L++ NF P Y
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY--- 148
Query: 182 EF-----LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYT--GGLPPEIGNLSSLV 234
F L ++ +S N + ++ L + Q+ + S + + L
Sbjct: 149 -FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLH 207
Query: 235 RFDAANCGLSGEIPTDIGR-LQNLDTLFLQVNALSG--PLTT-ELGYLKSLKSM-----D 285
S I + L L L + L E ++ L +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 286 LSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQ 345
L+ + F L N++ ++L + + + + + L +
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPK-HFKWQSLSIIRCQLKQFPTL 325
Query: 346 RLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFL--FGPIPESLGKCDS 400
L L+ L L+ NK + + L +L L N L G S +S
Sbjct: 326 DLPF---LKSLTLTMNKGSISFK-----KVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377
Query: 401 LSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSD-SISVNLGQICLSNNQL 459
L + + N + GL L ++ Q + L S L + +S
Sbjct: 378 LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
Query: 460 SGSLPASIGKFSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQC 518
+ + L + GN F + + L+ +D S +
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 519 KLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNN 578
L +++S N L + + L+ L+ S N + S +SL + + N+
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 579 LS 580
++
Sbjct: 557 VA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-41
Identities = 64/385 (16%), Positives = 120/385 (31%), Gaps = 30/385 (7%)
Query: 221 GGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKS 280
G L P I + ++ + + LS ++P DI + + L N L +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 281 LKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFT 340
L+ +DLS ++ L +L+ L L N + P + LE L E
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 341 GSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFLFGPIPESL-- 395
+G L+ L+++ N + P + L L+ + N++ L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN--LTNLVHVDLSYNYIQTITVNDLQF 175
Query: 396 --GKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFP-------VSDSIS 446
+ M N ++ I F L ++ L+ N+ + +
Sbjct: 176 LRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234
Query: 447 VNLGQICLSNNQLSGSLPASIGKFSGVQKLLLD--GNKFSGQIPAEIGKLQQLSKMDFSH 504
+ L P+ + V + L +S M +
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294
Query: 505 NKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIA 564
++ + + + R +L L L L L+ N SI
Sbjct: 295 VSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKG--SISFKKV 347
Query: 565 SMQSLTSVDFSYNNLSGLVPGTGQF 589
++ SL+ +D S N LS +
Sbjct: 348 ALPSLSYLDLSRNALSFSGCCSYSD 372
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-63
Identities = 83/292 (28%), Positives = 136/292 (46%), Gaps = 42/292 (14%)
Query: 686 LKEDNIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHG-----FNAEIQTLGRI 739
++ + IGKGG G+V+KG L+ + VA+K L + F E+ + +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
H +IV+L G N +V E++P G L L K + W + ++ ++ A G+ Y
Sbjct: 81 NHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDIALGIEY 137
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFE-----AHVADFGLAKFLQDSGTSECMSAIAGSYG 854
+ + +P IVHRD++S NI L S E A VADFGL++ S +S + G++
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQ 191
Query: 855 YIAPE--YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEF-GDGVDIVQWVRKMTDSKKE 911
++APE A EK+D YSF ++L ++TG P E+ + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI--------- 242
Query: 912 GVLKILDPRLPSV---PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+ L P +P L V+ LC +RP +V+ L+EL
Sbjct: 243 -REEGLRPTIPEDCPPRLRNVI------ELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 9e-63
Identities = 73/341 (21%), Positives = 129/341 (37%), Gaps = 51/341 (14%)
Query: 675 LDFTCDDV---LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNA 731
++ + LD LK +IG+G G VYKG + + VAVK ++ F
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS-----FANRQNFIN 54
Query: 732 E--IQTLGRIRHRHIVRLLGFC----SNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD 784
E I + + H +I R + ++ LV EY PNGSL + L W
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWV 111
Query: 785 TRYKIAVEAAKGLCYLHHD------CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838
+ ++A +GL YLH + P I HRD+ S N+L+ + ++DFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 839 DSGTSE------CMSAIAGSYGYIAPEYA-------YTLKVDEKSDVYSFGVVLLELITG 885
+ + G+ Y+APE ++ D+Y+ G++ E+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 886 RKPVGEFGDG-------VDIVQWVRKMTDSKKEGVLKILDPRLP-SVPLHEVMHVFYVAM 937
+ V D + + P+ P + + +
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 938 L--CVEEQAVERPTMREVVQILTELPKPPTSKQGEESLPPS 976
+ C ++ A R T + + + EL + +S+ P+
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMM---IWERNKSVSPT 329
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-62
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
L + + +G ++KG G+ + VK L + FN E L H +++
Sbjct: 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 746 RLLGFCSNHETNLL--VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+LG C + + +MP GSL VLH + K A++ A+G+ +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT- 129
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE---Y 860
PLI + S ++++D A ++ + Q G + ++APE
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEALQK 182
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920
+D++SF V+L EL+T P F + ++ K+ L+ L P
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVP---F-ADLSNMEIGMKV-------ALEGLRPT 231
Query: 921 LP---SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+P S + ++M +C+ E +RP +V IL ++
Sbjct: 232 IPPGISPHVSKLMK------ICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 81/284 (28%), Positives = 128/284 (45%), Gaps = 28/284 (9%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+ IG G G VYKG +GD VAVK L + F E+ L + RH +I+
Sbjct: 26 ITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 746 RLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
+G+ + L +V ++ SL LH IA + A+G+ YLH
Sbjct: 84 LFMGYSTAP--QLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE---YA 861
+ I+HRD+KSNNI L + DFGLA S ++GS ++APE
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
+ +SDVY+FG+VL EL+TG+ P + I++ V + G L ++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR-------GSLSPDLSKV 250
Query: 922 PS---VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
S + +M C++++ ERP+ ++ + EL +
Sbjct: 251 RSNCPKRMKRLM------AECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-60
Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 41/293 (13%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
L+ +IGKG G VY G +G+ VA++ + F E+ + RH ++V
Sbjct: 35 LEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
+G C + ++ +L V+ K L + +IA E KG+ YLH +
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---A 148
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKF---LQDSGTSECMSAIAGSYGYIAPE--- 859
I+H+D+KS N+ D+G + + DFGL LQ + + G ++APE
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 860 ------YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913
L + SDV++ G + EL P F + +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---F-KTQPAEAII--------WQM 255
Query: 914 LKILDPRLPSV----PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
+ P L + + +++ + C + ERPT +++ +L +LPK
Sbjct: 256 GTGMKPNLSQIGMGKEISDIL------LFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-58
Identities = 71/300 (23%), Positives = 118/300 (39%), Gaps = 34/300 (11%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAE--IQTLGRIRHRH 743
+ +GKG G V++G G+ VAVK S + + E + +RH +
Sbjct: 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFS-----SRDEKSWFRETELYNTVMLRHEN 63
Query: 744 IVRLLGFC---SNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
I+ + + T L L+ Y GSL + L L + +I + A GL +
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAH 120
Query: 800 LHHD-----CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE--CMSAIAGS 852
LH + P I HRD+KS NIL+ + +AD GLA S + G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 853 YGYIAPE------YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV----DIVQWV 902
Y+APE ++ D+++FG+VL E+ G D D+V
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAML--CVEEQAVERPTMREVVQILTEL 960
D +K + P +P+ + ++ C + R T + + LT++
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-58
Identities = 75/305 (24%), Positives = 117/305 (38%), Gaps = 30/305 (9%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
++ IGKG G V+ G G++VAVK S EI +RH +I+
Sbjct: 39 IQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF---RETEIYQTVLMRHENIL 94
Query: 746 RLLGFC---SNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+ + T L L+ +Y NGSL + L L + K+A + GLC+LH
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLH 151
Query: 802 -----HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE--CMSAIAGSYG 854
P I HRD+KS NIL+ +AD GLA + G+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 855 YIAPE------YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG----VDIVQWVRK 904
Y+ PE + +D+YSFG++L E+ G + D+V
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAML--CVEEQAVERPTMREVVQILTELPK 962
D ++ +K L P P+ + ++ C R T V + L ++ +
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 963 PPTSK 967
K
Sbjct: 332 SQDIK 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-57
Identities = 68/314 (21%), Positives = 114/314 (36%), Gaps = 38/314 (12%)
Query: 684 DCLKEDNIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR 742
L ++GKG G K G+ + +K L + F E++ + + H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHP 67
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
++++ +G + + EY+ G+L ++ W R A + A G+ YLH
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLH- 125
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS------------ECMSAIA 850
S I+HRD+ S+N L+ VADFGLA+ + D T + +
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 851 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK 910
G+ ++APE DEK DV+SFG+VL E+I ++ T
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL----------PRTMDFG 233
Query: 911 EGVLKILDPRLPS---VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSK 967
V LD P + + C + +RP+ ++ L L
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPIT------VRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 968 QGEESLPPSGTTSL 981
Sbjct: 288 LPLGPQLEQLDRGF 301
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 9e-57
Identities = 105/474 (22%), Positives = 177/474 (37%), Gaps = 38/474 (8%)
Query: 117 LSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPP 176
+ N F + LA L N+T + L + L +
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL--GIKSID 62
Query: 177 EYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRF 236
L + S N+L P + NLTKL + + N + NL++L
Sbjct: 63 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM-NNNQIAD--ITPLANLTNLTGL 117
Query: 237 DAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIP 296
N ++ P + L NL+ L L N +S + L L SL+ + N +
Sbjct: 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFGNQVTD---L 170
Query: 297 ASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRIL 356
A L L L++ NK+ + + LE L N + P LG L L
Sbjct: 171 KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 226
Query: 357 DLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIP 416
L+ N+L + + L L N + P L L+ +++G N ++ P
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282
Query: 417 KGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKL 476
L GL +L+ +EL +N L P+S+ NL + L N +S P + + +Q+L
Sbjct: 283 --LAGLTALTNLELNENQLEDISPISNLK--NLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 477 LLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIP 536
NK S + + L ++ + HN+ S ++ +T + L+ +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPV 392
Query: 537 NQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFS 590
N + I N + L+ PA+I+ S T D ++N S + FS
Sbjct: 393 NYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFS 444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-45
Identities = 91/427 (21%), Positives = 159/427 (37%), Gaps = 33/427 (7%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
++T ++ S L+ + +L L ++ + NQ++ P ++ L++L L L NN
Sbjct: 68 NNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQ 123
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIW 181
P L L +L L+L +N ++ L+ L +L+ L G + P +
Sbjct: 124 ITDIDP--LKNLTNLNRLELSSNTISDISALS--GLTSLQQLSFGNQVTD--LKPLANL- 176
Query: 182 EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANC 241
LE L +S N++ + LT L+ L N + +G L++L
Sbjct: 177 TTLERLDISSNKV--SDISVLAKLTNLESLIA-TNNQISD--ITPLGILTNLDELSLNGN 231
Query: 242 GLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAE 301
L + L NL L L N +S L L L + L N + P A
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISP--LAG 285
Query: 302 LKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSN 361
L LT L L N+L P I + L L L+ NN + P + S KL+ L +N
Sbjct: 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 362 KLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFG 421
K++ + + L N + P L ++++ + + +
Sbjct: 342 KVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 422 LPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGN 481
+ + V+ L +SD + + ++ N S FS +
Sbjct: 398 VSIPNTVKNVTGALIAPATISDGG--SYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTT 454
Query: 482 KFSGQIP 488
FSG +
Sbjct: 455 TFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-30
Identities = 75/331 (22%), Positives = 126/331 (38%), Gaps = 46/331 (13%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
LD+S +S +S +A L L++L NQ+S P + L++L L+L+ N
Sbjct: 180 ERLDISSNKVSD-ISV-LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFL 184
L+ L +L LDL NN ++ PL+ L L L LG N S I P G+ L
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN-ISPLAGLTA-L 289
Query: 185 EYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLS 244
L ++ N+L P I NL L L + Y+N+ + + +L+ L R N +S
Sbjct: 290 TNLELNENQLEDISP--ISNLKNLTYLTL-YFNNISD--ISPVSSLTKLQRLFFYNNKVS 344
Query: 245 GEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
+ + L N++ L N +S T L L + + L++ +T N
Sbjct: 345 D--VSSLANLTNINWLSAGHNQISDL--TPLANLTRITQLGLNDQAWTNAPVNYK---AN 397
Query: 305 LTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364
+++ N +N P + G D++ N +
Sbjct: 398 VSIPNTVKN-----------------------VTGALIAPATISDGGSYTEPDITWNLPS 434
Query: 365 GTLPPDMCAGNCLQTLITLGNFLFGPIPESL 395
+ T+ G + + L
Sbjct: 435 Y-TNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-55
Identities = 73/307 (23%), Positives = 125/307 (40%), Gaps = 34/307 (11%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAE--IQTLGRIRHRH 743
+ IGKG G V++G G++VAVK S + + E I +RH +
Sbjct: 44 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS-----SREERSWFREAEIYQTVMLRHEN 97
Query: 744 IVRLLGFC---SNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
I+ + + T L LV +Y +GSL + L+ + + K+A+ A GL +
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 154
Query: 800 LHHD-----CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC--MSAIAGS 852
LH + P I HRD+KS NIL+ +AD GLA + + + G+
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 853 YGYIAPE------YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV----DIVQWV 902
Y+APE + +++D+Y+ G+V E+ G D D+V
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAML--CVEEQAVERPTMREVVQILTEL 960
+ + +K + L P +P+ ++ C R T + + L++L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 961 PKPPTSK 967
+ K
Sbjct: 335 SQQEGIK 341
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-50
Identities = 110/541 (20%), Positives = 191/541 (35%), Gaps = 59/541 (10%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
+LDLS L S LQ L ++ ++ +LS L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFF-SGQIPPEYGI 180
S L+SLQ L N+ + L+ L+ L++ N S ++P +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 181 WEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIG---YYNSYTGGLPPEIGNLSSLVRFD 237
LE+L +S N++ ++ L ++ L + N + P L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 238 AANCGLSGEIPTD-IGRLQNLDTLFLQVNALSGP---LTTELGYLKSLKSMDLS------ 287
N S + I L L+ L + + L+ L ++ +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 288 NNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRL 347
+ + +I F L N++ +L + + +F + L+L F +L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSY-NFGWQHLELVNCKFGQFPTLKL 324
Query: 348 GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFL--FGPIPESLGKCDSLS 402
S L+ L +SNK + L +L L N L G +S SL
Sbjct: 325 KS---LKRLTFTSNKGGNAF-----SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 403 RMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS-VNLGQICLSNNQLSG 461
+ + N + ++ GL L ++ Q + L S +S NL + +S+
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR- 434
Query: 462 SLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI-SQCKL 520
I F+G L L + + N F P+I ++ +
Sbjct: 435 VAFNGI--FNG---------------------LSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNL 579
LTF+DLS+ +L P + L LN++ N L S+P I + SL + N
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530
Query: 580 S 580
Sbjct: 531 D 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 54/360 (15%), Positives = 109/360 (30%), Gaps = 25/360 (6%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
+IP ++ + L L N L + L+ +DLS ++ L +L
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 306 TLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTG 365
+ L L N + + L+ L E N +G L+ L+++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 366 TLPPDMCAG-NCLQTLITLGNFLFGPIPESLGKCDSLSRMR----MGENFLNGSIPKGLF 420
P+ + L+ L N + L + + + N +N I G F
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 421 GLPSLSQVELQDNYLTGQFP-------VSDSISVNLGQICLSNNQLSGSLPASIGKFSGV 473
L ++ L++N+ + + + + L +++ +
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 474 QKLLLDGNK---FSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNE 530
+ I L +S + S ++L +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315
Query: 531 LSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFS 590
+L L L + N G+ + + + SL +D S N LS +
Sbjct: 316 FGQFPTLKLKS---LKRLTFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDF 370
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-26
Identities = 59/309 (19%), Positives = 98/309 (31%), Gaps = 34/309 (11%)
Query: 63 HVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
+ L+ L+ D+ L + + S+ + + + S + L L N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCK 315
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIW 181
F FP +L SL+ L +N L +L L L N S +
Sbjct: 316 FG-QFPTL--KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFK-------- 362
Query: 182 EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANC 241
G T L+ L + + N + L L D +
Sbjct: 363 --------------GCCSQSDFGTTSLKYLDLSF-NGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 242 GLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPA-SF 299
L + L+NL L + L SL+ + ++ N F F
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 300 AELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLS 359
EL+NLT L+L + +L P + L+VL + N L+ + L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526
Query: 360 SNKLTGTLP 368
+N + P
Sbjct: 527 TNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-12
Identities = 17/133 (12%), Positives = 39/133 (29%), Gaps = 3/133 (2%)
Query: 454 LSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAP 513
+P ++ + L L N +L +D S +
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 514 EISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVD 573
L+ + L+ N + +G+ L L +L I +++L ++
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 574 FSYNNLSGLVPGT 586
++N +
Sbjct: 131 VAHNLIQSFKLPE 143
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 3/93 (3%)
Query: 62 RHVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSN 119
+ L ++G + PD+ LR L L ++ QL + P ++LSSL++LN+++
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMAS 503
Query: 120 NVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPL 152
N +L SLQ + L+ N P
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-49
Identities = 93/497 (18%), Positives = 168/497 (33%), Gaps = 80/497 (16%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLR--- 158
I P + + L+ ++ P + + S + + P + R
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 159 ----------NLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKL 208
L L S +P LE L S N L ++P +L L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELPQSLKSL 116
Query: 209 QQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALS 268
N+ L L L +N L ++P ++ L + + N+L
Sbjct: 117 LVD----NNNLK-ALSDLPPLLEYL---GVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL- 165
Query: 269 GPLTTEL-GYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMP 327
+L SL+ + NN E+P L LT + N L +P+
Sbjct: 166 ----KKLPDLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPL--- 215
Query: 328 RLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFL 387
LE + N +P+ L + L + +N L TLP + L+ L N+L
Sbjct: 216 SLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYL 269
Query: 388 FGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISV 447
+PE SL+ + + EN + + + P+L + N + + D
Sbjct: 270 TD-LPELPQ---SLTFLDVSENIFS-GLSE---LPPNLYYLNASSNEIRS---LCDLPP- 317
Query: 448 NLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKF 507
+L ++ +SNN+L LPA + +++L+ N + ++P L+QL +N
Sbjct: 318 SLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLKQL---HVEYNPL 369
Query: 508 SGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQ 567
+ L ++ E+ N L L++ N L P S++
Sbjct: 370 R-EFPDIPESVEDLR-MNSHLAEVPELPQN-------LKQLHVETNPLR-EFPDIPESVE 419
Query: 568 SLTSVDFSYNNLSGLVP 584
L + +
Sbjct: 420 DL---RMNSERVVDPYE 433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-47
Identities = 103/448 (22%), Positives = 170/448 (37%), Gaps = 66/448 (14%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
R L+L+ L LS +L HL ++L + N L+ +P +L SL + N +
Sbjct: 71 RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLK- 124
Query: 122 FNGSFPPQLSQL-ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGI 180
LS L L+ L + NN + LP + L+ + + N ++P
Sbjct: 125 -------ALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP- 173
Query: 181 WEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAAN 240
LE++A N+L ++P E+ NL L +Y NS LP +L S+ A N
Sbjct: 174 --SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYA-DNNSLKK-LPDLPLSLESI---VAGN 224
Query: 241 CGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFA 300
L ++ L L T++ N L L SL+++++ +N T ++P
Sbjct: 225 NILE--ELPELQNLPFLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYLT-DLPELPQ 277
Query: 301 ELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSS 360
L L + + L E P L L N S+ S L L++S+
Sbjct: 278 SLTFLDVSENIFSGL----SELP---PNLYYLNASSNEIR-SLCDLPPS---LEELNVSN 326
Query: 361 NKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF 420
NKL LP L+ LI N L +PE +L ++ + N L P
Sbjct: 327 NKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPE 377
Query: 421 GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDG 480
+ L +++L + P + NL Q+ + N L P V+ L ++
Sbjct: 378 SVEDLRM----NSHLA-EVP---ELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNS 425
Query: 481 NKFSGQIPAEIGKLQQLSKMDFSHNKFS 508
+ +L F H+
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-47
Identities = 89/521 (17%), Positives = 169/521 (32%), Gaps = 76/521 (14%)
Query: 60 SRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSN 119
S + NL+ + + +++ A ++ PP + + L +
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 120 NVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYG 179
+ L+L N ++ LP +L L N + ++P
Sbjct: 68 CLDR-----------QAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQ 111
Query: 180 IWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAA 239
+ L + L P L+ L + N PE+ N S L D
Sbjct: 112 SLKSLLVDNNNLKALSDLPP-------LLEYLGV-SNNQLEK--LPELQNSSFLKIIDVD 161
Query: 240 NCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASF 299
N L ++P L+ + Q+ L EL L L ++ NN +
Sbjct: 162 NNSLK-KLPDLPPSLEFIAAGNNQLEELP-----ELQNLPFLTAIYADNN----SLKKLP 211
Query: 300 AELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLS 359
+L + N L +PE + +P L + N ++P S L L++
Sbjct: 212 DLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVR 265
Query: 360 SNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGL 419
N LT LP L L N + E +L + N + S+
Sbjct: 266 DNYLT-DLPELPQ---SLTFLDVSENIF-SGLSELPP---NLYYLNASSNEIR-SLCD-- 314
Query: 420 FGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLD 479
PSL ++ + +N L + P L ++ S N L+ +P +++L ++
Sbjct: 315 -LPPSLEELNVSNNKLI-ELP--ALPP-RLERLIASFNHLA-EVPELPQN---LKQLHVE 365
Query: 480 GNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQL 539
N + P ++ L ++ + + K L + N L E P+
Sbjct: 366 YNPLR-EFPDIPESVEDLR----MNSHLA-EVPELPQNLKQL---HVETNPLR-EFPDIP 415
Query: 540 TGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLS 580
+ L ++ +V + + L F +++
Sbjct: 416 ES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-46
Identities = 107/577 (18%), Positives = 186/577 (32%), Gaps = 73/577 (12%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNN 120
L LS + + L LQ L + + I E L +LR+L+L ++
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 121 VFNGSFPPQ-LSQLASLQVLDLYNNNMTGDL--PLAVTQLRNLRHLHLGGNFFSG-QIPP 176
P L L L LY ++ + L+ L L L N + P
Sbjct: 84 KIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 177 EYGIWEFLEYLAVSGNELGGKIPGEIGNLT--KLQQLYIGYYNSYTGGLPPEI------- 227
+G L+ + S N++ E+ L L + NS + +
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA-ANSLYSRVSVDWGKCMNPF 201
Query: 228 -----------GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELG 276
GN ++ + +S + ++ + + P
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 277 YLK--SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQL 334
L S++ +DLS+ F LK+L +LNL NK++ E + L+VL L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 335 WENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPES 394
N K+ +DL N + + L+ L TL
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKF--LEKLQTL----------- 367
Query: 395 LGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICL 454
L + + +PS+ + L N L I++ I L
Sbjct: 368 -----DLRDNALTT----------IHFIPSIPDIFLSGNKLV----TLPKINLTANLIHL 408
Query: 455 SNNQLSG-SLPASIGKFSGVQKLLLDGNKFSG-QIPAEIGKLQQLSKMDFSHNKFSGRIA 512
S N+L + + + +Q L+L+ N+FS + L ++ N
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468
Query: 513 PEISQCKL-----LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQ 567
E+ L + L+ N L+ P + + L L+L+ N L + +
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLP-A 526
Query: 568 SLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELC 604
+L +D S N L P F + N +C
Sbjct: 527 NLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-40
Identities = 98/536 (18%), Positives = 184/536 (34%), Gaps = 58/536 (10%)
Query: 65 TSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNNVF 122
L+L + + +L L+ L + ++++ + P+ L L L L
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF-LHPDAFQGLFHLFELRLYFCGL 109
Query: 123 NGSFPPQ--LSQLASLQVLDLYNNNMTG-DLPLAVTQLRNLRHLHLGGNFFSGQIPPEYG 179
+ + L +L LDL N + L + +L +L+ + N +
Sbjct: 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEH-- 166
Query: 180 IWEF-------LEYLAVSGNELGGKIPGEIGNLTK------LQQLYIGY----------- 215
E L + +++ N L ++ + G L+ L +
Sbjct: 167 --ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF 224
Query: 216 YNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQ--NLDTLFLQVNALSGPLTT 273
N+ + + ++ + L ++ L L + +
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284
Query: 274 ELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQ 333
LK LK ++L+ N +F L NL +LNL N L +P++ +
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID 344
Query: 334 LWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPE 393
L +N+ Q KL+ LDL N LT + + + GN L
Sbjct: 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKI 399
Query: 394 SLGKCDSLSRMRMGENFLNG-SIPKGLFGLPSLSQVELQDNYLTG-QFPVSDSISVNLGQ 451
+L + + + + EN L I L +P L + L N + + S + +L Q
Sbjct: 400 NL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQ 455
Query: 452 ICLSNNQLSGSLPASI--GKFSG---VQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNK 506
+ L N L + + F G +Q L L+ N + P L L + + N+
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515
Query: 507 FSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPAS 562
+ L +D+SRN+L P+ L+ L+++ N + S
Sbjct: 516 LTV--LSHNDLPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-35
Identities = 88/506 (17%), Positives = 160/506 (31%), Gaps = 44/506 (8%)
Query: 110 SSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNF 169
R+ P L+ + + L L N + + L L+ L LG +
Sbjct: 4 FDGRIAFYRFCNLT-QVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQY 59
Query: 170 FSGQIPPE-YGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI- 227
I E + L L + +++ P L L +L + + L
Sbjct: 60 TPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 228 GNLSSLVRFDAANCGLSG-EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYL--KSLKSM 284
NL +L R D + + + G+L +L ++ N + EL L K+L
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179
Query: 285 DLSNNIFTGEIPASFAELKN------LTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENN 338
L+ N + + + N L +L++ N +++ + N
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT------------VDITGNFSNA 227
Query: 339 FTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFLFGPIPESL 395
+ S L + + + + AG ++ L F+F
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286
Query: 396 GKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICL 454
L + + N +N I F GL +L + L N L + + + I L
Sbjct: 287 ETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPE 514
N ++ + +Q L L N + I + + + S NK
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKIN 400
Query: 515 ISQCKLLTFVDLSRNELSG-EIPNQLTGMRILNYLNLSRNHLVG-SIPASIASMQSLTSV 572
++ + LS N L +I L + L L L++N S + + SL +
Sbjct: 401 LT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456
Query: 573 DFSYNNLSGLVPGTGQFSYFNYTSFL 598
N L + F S L
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHL 482
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 32/149 (21%), Positives = 57/149 (38%), Gaps = 16/149 (10%)
Query: 54 PGVTCDSRRHVTSLDLSGLNLSGALSPDV-----AHLRFLQNLSVAANQLSGPIPPEI-S 107
T + L L L A ++ L LQ L + N L+ +PP + S
Sbjct: 443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS-LPPGVFS 501
Query: 108 ALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGG 167
L++LR L+L++N + A+L++LD+ N + +L L +
Sbjct: 502 HLTALRGLSLNSNRL--TVLSHNDLPANLEILDISRNQLLA---PNPDVFVSLSVLDITH 556
Query: 168 NFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
N F + F+ +L + + G
Sbjct: 557 NKFICECELS----TFINWLNHTNVTIAG 581
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-46
Identities = 78/514 (15%), Positives = 166/514 (32%), Gaps = 49/514 (9%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
++ +L AL+ ++ L ++ N LS +++ + L LLNLS+NV
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFL 184
L L++L+ LDL NN + + ++ LH N S ++ +
Sbjct: 73 --TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGK 122
Query: 185 EYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLS 244
+ + ++ N++ + G +++Q L + N + ++
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDL-KLN-----------EIDTV----------- 159
Query: 245 GEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
L+ L LQ N + + ++ LK++DLS+N + F
Sbjct: 160 -NFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 305 LTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364
+T ++L NKL I + + LE L N F + S R+ ++ +
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN-QRVQTVAKQTVK 273
Query: 365 GTLPPDMCAGNCLQTLITLGNFLFGPIPES-LGKCDSLSRMRMGENFLNGS----IPKGL 419
L + TL G + +P + +L R GS +
Sbjct: 274 -KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECER 332
Query: 420 FGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLD 479
+++ + L + + + L
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQ 392
Query: 480 GNKFSG--QIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPN 537
E LQ L + + + + + Q + D+ +++ +
Sbjct: 393 AVGQIELQHATEEQSPLQLLRAIVKRYEEMY--VEQQSVQNNAIRDWDMYQHKETQLAEE 450
Query: 538 QLTGMRILNYLNLSRNHLVGSIPASIASMQSLTS 571
++ +L+ ++ + Q+L S
Sbjct: 451 NARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-38
Identities = 65/431 (15%), Positives = 126/431 (29%), Gaps = 45/431 (10%)
Query: 157 LRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYY 216
+ + + + ++ L +SGN L ++ TKL+ L +
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL-SS 67
Query: 217 NSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELG 276
N ++ +LS+L D N + ++ +++TL N +S
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS---RVSCS 117
Query: 277 YLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG-AIPEFIGVMPRLEVLQLW 335
+ K++ L+NN T + L+L N++ E LE L L
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 336 ENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESL 395
N + ++ KL+ LDLSSNKL +
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-------------------------MGPEF 210
Query: 396 GKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLS 455
++ + + N L I K L +L +L+ N + D S N ++
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG-TLRDFFSKNQRVQTVA 268
Query: 456 NNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSG----RI 511
+ + + + +L L + + + G R+
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERL 328
Query: 512 APEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTS 571
E +D + + I + L + L + + L
Sbjct: 329 ECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388
Query: 572 VDFSYNNLSGL 582
L
Sbjct: 389 TLQQAVGQIEL 399
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 58/376 (15%), Positives = 113/376 (30%), Gaps = 32/376 (8%)
Query: 222 GLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSL 281
+ N + + L + + N+ L L N LS +L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 282 KSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTG 341
+ ++LS+N+ E L L L+L N + + + V P +E L NN +
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 342 SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFLFG-PIPESLGK 397
+ G + + L++NK+T L + L N + E
Sbjct: 113 RVSCSRGQG--KKNIYLANNKIT-MLRDLDEGC--RSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 398 CDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS--VNLGQICLS 455
D+L + + NF+ + + L ++L N L + + I L
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF---MGPEFQSAAGVTWISLR 222
Query: 456 NNQLSGSLPASIGKFSGVQKLLLDGNKFS-GQIPAEIGKLQQLSKMDFSHNKFSGRIAPE 514
NN+L + ++ ++ L GN F G + K Q++ +
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVKKLTGQN 279
Query: 515 ISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL----VGSIPASIASMQSLT 570
+C + T + L + + +
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339
Query: 571 SVDFSYNNLSGLVPGT 586
+D ++
Sbjct: 340 EIDALKEQYRTVIDQV 355
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-34
Identities = 54/352 (15%), Positives = 104/352 (29%), Gaps = 18/352 (5%)
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLT 306
I + ++L L + ++K +DLS N + A A L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 307 LLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGT 366
LLNL N L+ + + L L L N L + L ++N ++
Sbjct: 62 LLNLSSNVLYE-TLDLES-LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 367 LPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFG-LPSL 425
+ G + + N + G + + + N ++ L +L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 426 SQVELQDNYLTGQFPVSDSIS-VNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFS 484
+ LQ N++ V + L + LS+N+L+ + +GV + L NK
Sbjct: 172 EHLNLQYNFIYD---VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 485 GQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRI 544
I + Q L D N F K +++ + +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 545 LNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTS 596
+ + +L + + + G + N
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 22/127 (17%), Positives = 51/127 (40%), Gaps = 7/127 (5%)
Query: 462 SLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLL 521
++ + + + + + + + ++D S N S A +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 522 TFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSG 581
++LS N L E + L + L L+L+ N++ + S+ ++ + NN+S
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 582 LVPGTGQ 588
+ GQ
Sbjct: 114 VSCSRGQ 120
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-44
Identities = 75/418 (17%), Positives = 137/418 (32%), Gaps = 76/418 (18%)
Query: 115 LNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQI 174
L N FP + LA L ++T + +L ++ L + G +
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA--- 57
Query: 175 PPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLV 234
I G I LT L+ L + N T + NL L
Sbjct: 58 ----------------------SIQG-IEYLTNLEYLNL-NGNQITD--ISPLSNLVKLT 91
Query: 235 RFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGE 294
++ + + L NL L+L + +S + L L + S++L N +
Sbjct: 92 NLYIGTNKIT--DISALQNLTNLRELYLNEDNISDI--SPLANLTKMYSLNLGANHNLSD 147
Query: 295 IPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLR 354
+ + + L L + +K+ P I + L L L N P L S L
Sbjct: 148 LSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLH 202
Query: 355 ILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGS 414
N++T + L+ +++G N +
Sbjct: 203 YFTAYVNQITD--------------------------ITPVANMTRLNSLKIGNNKITDL 236
Query: 415 IPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQ 474
P L L L+ +E+ N ++ V D L + + +NQ+S + + S +
Sbjct: 237 SP--LANLSQLTWLEIGTNQISDINAVKD--LTKLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 475 KLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELS 532
L L+ N+ + IG L L+ + S N + ++ + D + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-44
Identities = 79/394 (20%), Positives = 144/394 (36%), Gaps = 52/394 (13%)
Query: 187 LAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGE 246
LA + P +L + + + S T L S+ + A ++
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVL-QKASVTD--VVTQEELESITKLVVAGEKVA-S 58
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLT 306
I I L NL+ L L N ++ + L L L ++ + N T ++ L NL
Sbjct: 59 IQ-GIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKIT--DISALQNLTNLR 113
Query: 307 LLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGT 366
L L + + P + + ++ L L N+ S L + L L ++ +K+
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD- 169
Query: 367 LPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLS 426
+ L + + N + P L L SL
Sbjct: 170 -------------------------VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLH 202
Query: 427 QVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQ 486
N +T PV++ L + + NN+++ P + S + L + N+ S
Sbjct: 203 YFTAYVNQITDITPVANMT--RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD- 257
Query: 487 IPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILN 546
I A + L +L ++ N+ S ++ L + L+ N+L E + G+ L
Sbjct: 258 INA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314
Query: 547 YLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLS 580
L LS+NH+ P +AS+ + S DF+ +
Sbjct: 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-44
Identities = 66/377 (17%), Positives = 140/377 (37%), Gaps = 36/377 (9%)
Query: 88 LQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMT 147
L+ ++ P + L+ L +L S+ L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 148 GDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF--LEYLAVSGNELGGKIPGEIGNL 205
+ + L NL +L+L GN + P + L L + N++ + NL
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP----LSNLVKLTNLYIGTNKI--TDISALQNL 109
Query: 206 TKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVN 265
T L++LY+ ++ + + NL+ + + ++ + + L+ L + +
Sbjct: 110 TNLRELYL-NEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTES 165
Query: 266 ALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGV 325
+ T + L L S+ L+ N P A L +L + N++ P +
Sbjct: 166 KVKDV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VAN 219
Query: 326 MPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNC--LQTLITL 383
M RL L++ N T P L + +L L++ +N+++ + + L+ L
Sbjct: 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DINA---VKDLTKLKMLNVG 273
Query: 384 GNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSD 443
N + L L+ + + N L + + GL +L+ + L N++T P++
Sbjct: 274 SNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS 331
Query: 444 SISVNLGQICLSNNQLS 460
+ +N +
Sbjct: 332 LS--KMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 69/377 (18%), Positives = 140/377 (37%), Gaps = 50/377 (13%)
Query: 208 LQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNAL 267
L + + P +L+ +R ++ + L+++ L + +
Sbjct: 2 AATLAT--LPAPINQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 268 SGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMP 327
+ + YL +L+ ++L+ N T P + L LT L + NK+ + +
Sbjct: 57 ASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLT 110
Query: 328 RLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFL 387
L L L E+N + P L + K+ L+L +N
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS---------------------- 146
Query: 388 FGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISV 447
L L+ + + E+ + P + L L + L N + P++
Sbjct: 147 ---DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASL--T 199
Query: 448 NLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKF 507
+L NQ++ P + + + L + NK + P + L QL+ ++ N+
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
Query: 508 SGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQ 567
S + L +++ N++S +I L + LN L L+ N L I +
Sbjct: 256 SD--INAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 568 SLTSVDFSYNNLSGLVP 584
+LT++ S N+++ + P
Sbjct: 312 NLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-35
Identities = 63/281 (22%), Positives = 106/281 (37%), Gaps = 24/281 (8%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
+T+L + ++ + +L L+ L + + +S P ++ L+ + LNL N
Sbjct: 88 VKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGAN- 142
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIW 181
N S LS + L L + + + P+A L +L L L N P +
Sbjct: 143 HNLSDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSLNYNQIEDISP----LA 196
Query: 182 EF--LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAA 239
L Y N++ P + N+T+L L I N T + NLS L +
Sbjct: 197 SLTSLHYFTAYVNQITDITP--VANMTRLNSLKI-GNNKITD--LSPLANLSQLTWLEIG 251
Query: 240 NCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASF 299
+S + L L L + N +S + L L L S+ L+NN E
Sbjct: 252 TNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 300 AELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFT 340
L NLT L L +N + P + + +++
Sbjct: 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 64/336 (19%), Positives = 128/336 (38%), Gaps = 34/336 (10%)
Query: 254 LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRN 313
L TL +N + L L T + EL+++T L +
Sbjct: 2 AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 314 KLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCA 373
K+ + I + LE L L N T P L + KL L + +NK+T D+ A
Sbjct: 55 KVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-----DISA 105
Query: 374 GNCLQTLITL---GNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVEL 430
L L L + + P L + + +G N S L + L+ + +
Sbjct: 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTV 162
Query: 431 QDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAE 490
++ + P+++ +L + L+ NQ+ P + + + N+ + P
Sbjct: 163 TESKVKDVTPIANLT--DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-- 216
Query: 491 IGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNL 550
+ + +L+ + +NK + ++ LT++++ N++S I + + L LN+
Sbjct: 217 VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD-INA-VKDLTKLKMLNV 272
Query: 551 SRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
N + S + + ++ L S+ + N L
Sbjct: 273 GSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 61/353 (17%), Positives = 110/353 (31%), Gaps = 30/353 (8%)
Query: 76 GALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLAS 135
G+ H +NL + P +S + + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 136 LQVLDLYNNNMTGDLPLAVTQLR--NLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNE 193
Q+ + + L L Q P + L+++ +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 194 LGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGR 253
L ++P + L+ L + N LP I +L+ L C E+P +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLAR-NPLRA-LPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 254 LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRN 313
E L +L+S+ L +PAS A L+NL L + +
Sbjct: 173 TDASG---------------EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 314 KLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSS-NKLTGTLPPDMC 372
L A+ I +P+LE L L + P G L+ L L + L TLP D+
Sbjct: 217 PLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH 274
Query: 373 AGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSL 425
L+ L G +P + + + + + + P+
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 56/321 (17%), Positives = 107/321 (33%), Gaps = 27/321 (8%)
Query: 59 DSRRHVTSL---DLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLL 115
H + G ++ + N + ++ ++
Sbjct: 6 HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIE 61
Query: 116 NLSNNVFNGSFPPQLSQLAS--LQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQ 173
+ + L L+L + + P +L +L+H+ + +
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 174 IPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGN---- 229
+P + LE L ++ N L +P I +L +L++L I T LP + +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE-LPEPLASTDAS 176
Query: 230 -----LSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSM 284
L +L G+ +P I LQNL +L ++ + LS L + +L L+ +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234
Query: 285 DLSNNIFTGEIPASFAELKNLTLLNLF-RNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI 343
DL P F L L L + L +P I + +LE L L +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 344 PQRLGSNGKLRILDLSSNKLT 364
P + I+ + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 49/343 (14%), Positives = 109/343 (31%), Gaps = 30/343 (8%)
Query: 201 EIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTL 260
+ + + LY + + D N
Sbjct: 7 HHHHSSGRENLYFQGSTALRP-YHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIE 61
Query: 261 FLQVNALSG-PLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAI 319
AL E +++L + + P L +L + + L +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 320 PEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQT 379
P+ + LE L L N ++P + S +LR L + + LP + + +
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD---- 174
Query: 380 LITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQF 439
+L +R+ + S+P + L +L ++++++ L+
Sbjct: 175 -----------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-AL 221
Query: 440 PVSDSIS--VNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQL 497
+I L ++ L + P G + +++L+L +P +I +L QL
Sbjct: 222 G--PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279
Query: 498 SKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLT 540
K+D R+ I+Q + + + + ++
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 47/366 (12%), Positives = 86/366 (23%), Gaps = 75/366 (20%)
Query: 221 GGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKS 280
G + S + + Q + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSA----WRQANSNN 57
Query: 281 LKSMDLSNNIFTGEIPASFAELK--NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENN 338
+ + + L L L P+ + L+ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 339 FTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKC 398
+P + L L L+ N L LP + + N L+ L +PE L
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 399 DSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQ 458
GL +L + L+ +
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR---------------------- 196
Query: 459 LSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQC 518
SLPASI ++ L + + S + I L +L ++D P
Sbjct: 197 ---SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 519 KLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNN 578
L + L + L ++P I + L +D
Sbjct: 253 APLKRLILKDC-------SNLL-----------------TLPLDIHRLTQLEKLDLRGCV 288
Query: 579 LSGLVP 584
+P
Sbjct: 289 NLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 26/111 (23%), Positives = 42/111 (37%), Gaps = 1/111 (0%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
SL + LS AL P + HL L+ L + PP + L+ L L +
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIP 175
+ P + +L L+ LDL LP + QL + + + +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 10/72 (13%), Positives = 24/72 (33%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
L L + L D+ L L+ L + +P I+ L + ++ + ++
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 125 SFPPQLSQLASL 136
+ +
Sbjct: 316 LDQHRPVARPAE 327
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-44
Identities = 92/545 (16%), Positives = 197/545 (36%), Gaps = 68/545 (12%)
Query: 56 VTCDSRRHVTSLDLSGLNLS---GALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSL 112
++CD+ D + + L+ +++L ++ N+++ ++ A ++L
Sbjct: 2 LSCDAS---GVCDGRSRSFTSIPSGLTAA------MKSLDLSFNKITYIGHGDLRACANL 52
Query: 113 RLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSG 172
++L L ++ N L SL+ LDL +N+++ L +L++L+L GN +
Sbjct: 53 QVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ- 111
Query: 173 QIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSS 232
+ NLT LQ L IG +++ + L+S
Sbjct: 112 TLGV----------------------TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149
Query: 233 LVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFT 292
L + L + ++++ L L ++ + L L S++ ++L +
Sbjct: 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209
Query: 293 GEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLE--VLQLWENNFTGSIPQRLGSN 350
+ + + + + E + +L +L+L E F LG
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269
Query: 351 GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENF 410
+S T+ ++ L +LF + + + R+ + +
Sbjct: 270 NPSESDVVSELGKVETVT--------IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 411 LNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSIS---VNLGQICLSNNQLSGSLPAS 466
+ +P L SL ++L +N + ++ + + +L + LS N L S+ +
Sbjct: 322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKT 379
Query: 467 IGKFSGVQKLL---LDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKL--L 521
++ L + N F +P +++ ++ S + C L
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-----VVKTCIPQTL 433
Query: 522 TFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSG 581
+D+S N L L L L +SRN L ++P + + L + S N L
Sbjct: 434 EVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKS 487
Query: 582 LVPGT 586
+ G
Sbjct: 488 VPDGI 492
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-37
Identities = 81/510 (15%), Positives = 163/510 (31%), Gaps = 64/510 (12%)
Query: 62 RHVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPE-ISALSSLRLLNLSN 119
++ L L + + D L L++L ++ N LS + LSSL+ LNL
Sbjct: 50 ANLQVLILKS-SRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMG 107
Query: 120 NVFNG-SFPPQLSQLASLQVLDLYNNNMTGDLP-LAVTQLRNLRHLHLGGNFFSGQIPPE 177
N + L +LQ L + N ++ + L +L L + +
Sbjct: 108 NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQ 166
Query: 178 YGIWEF-----LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGY--YNSYTGGLPPEIGNL 230
+ +L + +E + L+ ++ L + + P
Sbjct: 167 ----SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 231 SSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNI 290
S + + L+ L L L+++ + D + +
Sbjct: 223 SPMKKLAFRGSVLT---DESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSE 273
Query: 291 FTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN 350
E + L++ + L + ++ +++ + + + +P +
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQH 332
Query: 351 -GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGEN 409
L LDLS N + + +L TL LS+ N
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL----------------VLSQ-----N 371
Query: 410 FLNGSIPK--GLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPAS 466
L S+ K + L +L+ +++ N P S + + LS+ + +
Sbjct: 372 HLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTC 428
Query: 467 IGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDL 526
I ++ L + N + +LQ+L S NK P+ S +L + +
Sbjct: 429 I--PQTLEVLDVSNNNLD-SFSLFLPRLQEL---YISRNKLK--TLPDASLFPVLLVMKI 480
Query: 527 SRNELSGEIPNQLTGMRILNYLNLSRNHLV 556
SRN+L + L + L N
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 6e-32
Identities = 55/387 (14%), Positives = 134/387 (34%), Gaps = 30/387 (7%)
Query: 229 NLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSN 288
+ + D + + IP+ + + +L L N ++ +L +L+ + L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 289 NIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQR-- 346
+ +F L +L L+L N L + G + L+ L L N + ++
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSL 118
Query: 347 LGSNGKLRILDLSSNKLTGTLPPDMCAG-NCLQTLITLGNFLFGPIPESLGKCDSLSRMR 405
+ L+ L + + + + AG L L L +SL + +
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 406 MGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLP 464
+ + + + L S+ +EL+D L + + + S
Sbjct: 179 LHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 465 ASIGKFSGVQKLLLDGNKFS----------------GQIPAEIGKLQ--QLSKMDFSHNK 506
S + + + +L+ ++ + +E+GK++ + ++
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY 297
Query: 507 FSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSI---PASI 563
++ S + + + + +++ + ++ L +L+LS N +V A
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 564 ASMQSLTSVDFSYNNLSGLVPGTGQFS 590
+ SL ++ S N+L +
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILL 384
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-12
Identities = 46/280 (16%), Positives = 93/280 (33%), Gaps = 31/280 (11%)
Query: 327 PRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNF 386
V +FT SIP L + ++ LDLS NK+T +
Sbjct: 5 DASGVCDGRSRSFT-SIPSGLTAA--MKSLDLSFNKIT-YIGHG---------------- 44
Query: 387 LFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSI 445
L C +L + + + +N +I F L SL ++L DN+L+
Sbjct: 45 -------DLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96
Query: 446 SVNLGQICLSNNQLSG-SLPASIGKFSGVQKLLLDGNKFSGQIPAE-IGKLQQLSKMDFS 503
+L + L N + + + +Q L + + +I L L++++
Sbjct: 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 504 HNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI 563
+ + + + + L +E + + + + YL L +L + +
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 564 ASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSEL 603
+ + + S L + L SE+
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-43
Identities = 70/294 (23%), Positives = 116/294 (39%), Gaps = 44/294 (14%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD-QVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRH 741
+ L IG+G G V+ G + + VAVK + F E + L + H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK--FLQEARILKQYSH 171
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+IVRL+G C+ + +V E + G L +G L T ++ +AA G+ YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI----- 856
S +HRD+ + N L+ ++DFG+++ D + A +G +
Sbjct: 231 ---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG-----VYAASGGLRQVPVKWT 282
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
APE + +SDV+SFG++L E + G P ++V K
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEK----------- 330
Query: 916 ILDPRLPS-----VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
RLP + +M C + +RP+ + Q L + K
Sbjct: 331 --GGRLPCPELCPDAVFRLM------EQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 29/274 (10%)
Query: 686 LKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
LK D IG+G VYKGL +VA L S F E + L ++H +I
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 745 VRLLGFC---SNHETNLLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
VR + +++ E M +G+L L K+ + + KGL +L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 801 HHDCSPLIVHRDVKSNNILLD--SGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 858
H +P I+HRD+K +NI + +G + D GLA + S + G+ ++AP
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRASFAKAVI----GTPEFMAP 199
Query: 859 EYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918
E Y K DE DVY+FG+ +LE+ T P E + Q R++T K
Sbjct: 200 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKPASF---- 251
Query: 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMRE 952
++ + E++ C+ + ER ++++
Sbjct: 252 DKVAIPEVKEII------EGCIRQNKDERYSIKD 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-41
Identities = 73/341 (21%), Positives = 125/341 (36%), Gaps = 42/341 (12%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH--RHIVRL 747
IG GG+ V++ L A+K + + + EI L +++ I+RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH-HDCSP 806
+ + +V E N L L KK + R + + +H H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE------- 859
IVH D+K N L+ G + DFG+A +Q TS + G+ Y+ PE
Sbjct: 176 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 860 ----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
K+ KSDV+S G +L + G+ P F ++ + + + D E
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAIIDPNHE---- 286
Query: 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMRE------VVQILTELPKPPTSKQG 969
I P +P L +V+ L + + +R ++ E V + +
Sbjct: 287 IEFPDIPEKDLQDVLK----CCLKRDPK--QRISIPELLAHPYVQIQTHPVNQMAKGTTE 340
Query: 970 EESLPPSGTTSLDSPNASNKDQKD-HQRPAPPQSPPPDLLS 1009
E L+SPN+ K K ++ + +S
Sbjct: 341 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSK 381
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 70/332 (21%), Positives = 121/332 (36%), Gaps = 38/332 (11%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH--RHIVRL 747
IG GG+ V++ L A+K + + + EI L +++ I+RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH-HDCSP 806
+ + +V E N L L KK + R + + +H H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE------- 859
IVH D+K N L+ G + DFG+A +Q TS + G+ Y+ PE
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 860 ----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
K+ KSDV+S G +L + G+ P F ++ + + + D E
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAIIDPNHE---- 239
Query: 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ---ILTELPKPPTSKQGEES 972
I P +P L +V+ L + + +R ++ E++ + + +G
Sbjct: 240 IEFPDIPEKDLQDVLK----CCLKRDPK--QRISIPELLAHPYVQIQTHPVNQMAKGTTE 293
Query: 973 LPPSGTTSLDSPNASNKDQKDHQRPAPPQSPP 1004
L N+ N K + S
Sbjct: 294 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 325
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 35/280 (12%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH--RHIVRL 747
IG GG+ V++ L A+K + + + EI L +++ I+RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH-HDCSP 806
+ + +V E N L L KK + R + + +H H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE------- 859
IVH D+K N L+ G + DFG+A +Q TS + G+ Y+ PE
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 860 ----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
K+ KSDV+S G +L + G+ P F ++ + + + D E
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAIIDPNHE---- 258
Query: 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
I P +P L +V+ L + + +R ++ E++
Sbjct: 259 IEFPDIPEKDLQDVLK----CCLKRDPK--QRISIPELLA 292
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-40
Identities = 71/304 (23%), Positives = 123/304 (40%), Gaps = 37/304 (12%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR 742
+ + +G G G VY+G+ VAVK L + F E + I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 276
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
++V+LLG C+ ++ E+M G+L + L + +A + + + YL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG-TSECMSAIAGSYGYIAPEYA 861
+HR++ + N L+ VADFGL++ + T+ + + APE
Sbjct: 336 --KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESL 391
Query: 862 YTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920
K KSDV++FGV+L E+ T G P D + + + K D R
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEK-------------DYR 437
Query: 921 LP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL-PKPPTSKQGEESLP 974
+ ++E+M C + +RP+ E+ Q + + S + E+ L
Sbjct: 438 MERPEGCPEKVYELM------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 491
Query: 975 PSGT 978
GT
Sbjct: 492 KRGT 495
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 89/321 (27%), Positives = 148/321 (46%), Gaps = 53/321 (16%)
Query: 684 DCLKEDNIIGKGGAGIVYKGL--MPNGDQ---VAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
C+ +IG G G VYKG+ +G + VA+K L A F E +G+
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQ 102
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
H +I+RL G S ++ +++ EYM NG+L + L +K G + A G+
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMK 161
Query: 799 YL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
YL + VHRD+ + NIL++S V+DFGL++ L+D + + S G I
Sbjct: 162 YLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEATYTTSGGKI 212
Query: 857 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
APE K SDV+SFG+V+ E++T G +P + + +++ +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---YWE----------LSNHE- 258
Query: 911 EGVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963
V+K ++ RLP ++++M M C +++ RP ++V IL +L +
Sbjct: 259 --VMKAINDGFRLPTPMDCPSAIYQLM------MQCWQQERARRPKFADIVSILDKLIRA 310
Query: 964 PTSKQGEESLPPSGTTSLDSP 984
P S + P + L S
Sbjct: 311 PDSLKTLADFDPRVSIRLPST 331
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-40
Identities = 83/324 (25%), Positives = 136/324 (41%), Gaps = 52/324 (16%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ D ++G G G V G + + VA+K L F E +G+
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQF 103
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
H +I+RL G + + ++V EYM NGSL L K + A G+ Y
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKY 162
Query: 800 L--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI- 856
L VHRD+ + NIL++S V+DFGL + L+D + +A G I
Sbjct: 163 LSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED----DPEAAYTTRGGKIP 213
Query: 857 ----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKE 911
+PE K SDV+S+G+VL E+++ G +P + + M++
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWE----------MSNQD-- 258
Query: 912 GVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
V+K +D RLP L+++M + C ++ RP ++V IL +L + P
Sbjct: 259 -VIKAVDEGYRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILDKLIRNP 311
Query: 965 TSKQGEESLPPSGTTSLDSPNASN 988
S + S + L + +
Sbjct: 312 GSLKIITSAAARPSNLLLDQSNVD 335
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 88/316 (27%), Positives = 122/316 (38%), Gaps = 41/316 (12%)
Query: 684 DCLKEDNIIGKGGAGIVYKG-LMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
LK + +GKG G V P GD VAVK+L G F EIQ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKA 80
Query: 739 IRHRHIVRLLGFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
+ IV+ G LV EY+P+G L + L + L + + KG
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKG 139
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
+ YL S VHRD+ + NIL++S +ADFGLAK L + + G
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDY--YVVREPGQS 192
Query: 857 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKP-VGEFGDGVDIVQWVRKMTDSK 909
APE +SDV+SFGVVL EL T K + S+
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 910 KEGVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL-P 961
+L++L+ RLP +HE+M LC +RP+ + L L
Sbjct: 253 ---LLELLEEGQRLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQLDMLWS 303
Query: 962 KPPTSKQGEESLPPSG 977
+ + P G
Sbjct: 304 GSRGCETHAFTAHPEG 319
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 82/298 (27%), Positives = 128/298 (42%), Gaps = 39/298 (13%)
Query: 684 DCLKEDNIIGKGGAGIVYKG-LMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
LK +G+G G V P GD VAVK L S G +H EI+ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRN 79
Query: 739 IRHRHIVRLLGFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
+ H +IV+ G C+ N L+ E++P+GSL E L K ++ + K AV+ KG
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKG 138
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
+ YL S VHRD+ + N+L++S + + DFGL K ++ +
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET----DKEYYTVKDDRDS 191
Query: 857 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQ-WVRKMTDSK 909
APE K SDV+SFGV L EL+T + ++ +MT ++
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 910 KEGVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++ L RLP ++++M C E Q R + + +++ L
Sbjct: 252 ---LVNTLKEGKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-39
Identities = 82/286 (28%), Positives = 128/286 (44%), Gaps = 40/286 (13%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ L+ + +G+G G V+ G +VA+K L G+ F E Q + ++RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 240
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+V+L S E +V EYM GSL + L G+ G +L +A + A G+ Y+
Sbjct: 241 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 297
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS---GTSECMSAIAGSYGYIAPEY 860
VHRD+++ NIL+ VADFGLA+ ++D+ I + APE
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEA 352
Query: 861 AYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
A + KSDV+SFG++L EL T GR P +++ V + G
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVER-------GY------ 398
Query: 920 RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
R+P LH++M C ++ ERPT + L +
Sbjct: 399 RMPCPPECPESLHDLM------CQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 53/302 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKG-LMPNGD----QVAVKRL-PAMSRGSSHDHGFNAEIQTLG 737
K+ ++G G G VYKG +P G+ VA+K L A S ++ + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMA 72
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGL 797
+ + H+ RLLG C T L+ + MP G L + + + ++ V+ AKG+
Sbjct: 73 SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGM 130
Query: 798 CYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 855
YL +VHRD+ + N+L+ + + DFGLAK L G
Sbjct: 131 NYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGK 180
Query: 856 I-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSK 909
+ A E +SDV+S+GV + EL+T G KP +I + K
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEK----- 234
Query: 910 KEGVLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
G RLP ++ ++ +M C A RP RE++ +++ + P
Sbjct: 235 --GE------RLPQPPICTIDVYMIM------RKCWMIDADSRPKFRELIIEFSKMARDP 280
Query: 965 TS 966
Sbjct: 281 QR 282
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 72/308 (23%), Positives = 123/308 (39%), Gaps = 45/308 (14%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR 742
+ + +G G G VY+G+ VAVK L + F E + I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 69
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
++V+LLG C+ ++ E+M G+L + L + +A + + + YL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 128
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-----A 857
+HRD+ + N L+ VADFGL++ + + A + A
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTA 180
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
PE K KSDV++FGV+L E+ T G P D + + + K
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEK------------ 227
Query: 917 LDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT-SKQGE 970
D R+ ++E+M C + +RP+ E+ Q + + + S + E
Sbjct: 228 -DYRMERPEGCPEKVYELM------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 280
Query: 971 ESLPPSGT 978
+ L GT
Sbjct: 281 KELGKRGT 288
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 83/334 (24%), Positives = 134/334 (40%), Gaps = 51/334 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKG-LMPNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
L++ ++G G G V+KG +P G+ V +K + S G + +G
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGS 71
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
+ H HIVRLLG C + LV +Y+P GSL + + + G L V+ AKG+
Sbjct: 72 LDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMY 129
Query: 799 YL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
YL H +VHR++ + N+LL S + VADFG+A L + S
Sbjct: 130 YLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEAKT 179
Query: 857 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
A E + K +SDV+S+GV + EL+T G +P ++ + K
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEK------ 232
Query: 911 EGVLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT 965
RL ++ ++ VM + C RPT +E+ T + + P
Sbjct: 233 -------GERLAQPQICTIDVYMVM------VKCWMIDENIRPTFKELANEFTRMARDPP 279
Query: 966 SKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAP 999
+ G P+ + + P
Sbjct: 280 RYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEP 313
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 59/317 (18%), Positives = 117/317 (36%), Gaps = 67/317 (21%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD--------QVAVKRLPAMSRGSSHDHGFNAEIQT 735
+ L + +G+G ++KG+ +V +K L R S F
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASM 65
Query: 736 LGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK 795
+ ++ H+H+V G C + N+LV E++ GSL L K ++ + ++A + A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAA 124
Query: 796 GLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAH--------VADFGLAKFLQDSGTSEC 845
+ +L + ++H +V + NILL + ++D G++ +
Sbjct: 125 AMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----- 174
Query: 846 MSAIAGSYGYI-----APE-YAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDI 898
PE ++ +D +SFG L E+ + G KP+ D
Sbjct: 175 ------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DSQRK 227
Query: 899 VQWVRK---MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+Q+ + P + L ++ C++ + RP+ R +++
Sbjct: 228 LQFYEDRHQL-------------PAPKAAELANLI------NNCMDYEPDHRPSFRAIIR 268
Query: 956 ILTELPKPPTSKQGEES 972
L L P +G
Sbjct: 269 DLNSLFTPDLVPRGSHH 285
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 82/309 (26%), Positives = 131/309 (42%), Gaps = 52/309 (16%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ + IIG G +G V G + VA+K L A F +E +G+
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQF 107
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
H +I+RL G + ++V EYM NGSL L G + G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRY 166
Query: 800 L--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI- 856
L VHRD+ + N+L+DS V+DFGL++ L+D + +A + G I
Sbjct: 167 LSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED----DPDAAYTTTGGKIP 217
Query: 857 ----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKE 911
APE SDV+SFGVV+ E++ G +P + + MT+
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YWN----------MTNRD-- 262
Query: 912 GVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
V+ ++ RLP LH++M + C + +RP ++V +L L + P
Sbjct: 263 -VISSVEEGYRLPAPMGCPHALHQLM------LDCWHKDRAQRPRFSQIVSVLDALIRSP 315
Query: 965 TSKQGEESL 973
S + ++
Sbjct: 316 ESLRATATV 324
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 68/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
L IG G G+V+ G N D+VA+K + G+ + F E + + ++ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPK 64
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL--H 801
+V+L G C LV E+M +G L + L + G +T + ++ +G+ YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI---AP 858
++HRD+ + N L+ V+DFG+ +F+ D + ++ G+ + +P
Sbjct: 124 C-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWASP 174
Query: 859 EYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917
E + KSDV+SFGV++ E+ + G+ P ++V+ +
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDIST------------- 220
Query: 918 DPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
RL S ++++M C E+ +RP +++ L E+ +
Sbjct: 221 GFRLYKPRLASTHVYQIM------NHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 48/301 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ LK +G G G V+ G +VAVK L GS F AE + +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQR 69
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+VRL + E ++ EYM NGSL + L G L + +A + A+G+ ++
Sbjct: 70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-----AP 858
+HRD+++ NIL+ +ADFGLA+ ++D+ A AP
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN------EYTAREGAKFPIKWTAP 179
Query: 859 EYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917
E KSDV+SFG++L E++T GR P MT+ + V++ L
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------------MTNPE---VIQNL 223
Query: 918 DP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGE 970
+ R+ L+++M LC +E+ +RPT + +L + +
Sbjct: 224 ERGYRMVRPDNCPEELYQLM------RLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
Query: 971 E 971
+
Sbjct: 278 Q 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-38
Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 40/286 (13%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ LK + +G G G V+ +VAVK + GS F AE + ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQHDK 244
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+V+L + E ++ E+M GSL + L +G + + A+G+ ++
Sbjct: 245 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-- 301
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI---APEY 860
+HRD+++ NIL+ + +ADFGLA+ ++D+ +A G+ I APE
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEA 356
Query: 861 AYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
KSDV+SFG++L+E++T GR P ++++ + + G
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALER-------GY------ 402
Query: 920 RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
R+P L+ +M M C + + ERPT + +L +
Sbjct: 403 RMPRPENCPEELYNIM------MRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 68/290 (23%), Positives = 121/290 (41%), Gaps = 48/290 (16%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ + +G G G+V G VAVK + GS + F E QT+ ++ H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMKLSHPK 64
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL--H 801
+V+ G CS +V EY+ NG L L G L ++ + +G+ +L H
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI----- 856
+HRD+ + N L+D V+DFG+ +++ D ++
Sbjct: 124 Q-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSVGTKFPVKWS 172
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
APE + K KSDV++FG+++ E+ + G+ P + ++V V +
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQ----------- 220
Query: 916 ILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
RL S ++++M C E +RPT ++++ + L
Sbjct: 221 --GHRLYRPHLASDTIYQIM------YSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 71/305 (23%), Positives = 124/305 (40%), Gaps = 53/305 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRL-PAMSRGSSHDHGFNAEIQTLGR 738
+ + + I+G+G G VY+G+ N VAVK + + F +E +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FMSEAVIMKN 69
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
+ H HIV+L+G E ++ E P G LG L + L T +++ K +
Sbjct: 70 LDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMA 127
Query: 799 YL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
YL + VHRD+ NIL+ S + DFGL+++++D S +
Sbjct: 128 YLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRL 176
Query: 857 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
+PE + SDV+ F V + E+++ G++P + D++ + K
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEK------ 229
Query: 911 EGVLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT 965
G RLP L+ +M C + +RP E+V L+++ +
Sbjct: 230 -GD------RLPKPDLCPPVLYTLM------TRCWDYDPSDRPRFTELVCSLSDVYQMEK 276
Query: 966 SKQGE 970
E
Sbjct: 277 DIAME 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 48/297 (16%)
Query: 688 EDNIIGKGGAGIVYKGLMPNGD---QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
D +G G G V +G+ VA+K L + + + E Q + ++ + +I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYI 72
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL--HH 802
VRL+G C E +LV E G L + L K + ++ + + G+ YL +
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-----A 857
VHRD+ + N+LL + A ++DFGL+K L +A + G A
Sbjct: 131 -----FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSA--GKWPLKWYA 181
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
PE K +SDV+S+GV + E ++ G+KP + G +++ ++ +
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQ------------ 228
Query: 917 LDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQ 968
R+ L+ +M C + +RP V Q + SK
Sbjct: 229 -GKRMECPPECPPELYALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-38
Identities = 79/296 (26%), Positives = 123/296 (41%), Gaps = 52/296 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
LK IGKG G V G G++VAVK + + + F AE + ++RH +
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 247
Query: 744 IVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL-H 801
+V+LLG + L +V EYM GSL + L + L D K +++ + + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI----- 856
++ VHRD+ + N+L+ A V+DFGL K + G +
Sbjct: 308 NNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEA----------SSTQDTGKLPVKWT 353
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
APE K KSDV+SFG++L E+ + GR P D+V V K
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEK----------- 401
Query: 916 ILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTS 966
++ +++VM C A RPT ++ + L +
Sbjct: 402 --GYKMDAPDGCPPAVYDVM------KNCWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-38
Identities = 82/284 (28%), Positives = 130/284 (45%), Gaps = 36/284 (12%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ L+ + +G+G G V+ G +VA+K L G+ F E Q + ++RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 323
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+V+L S E +V EYM GSL + L G+ G +L +A + A G+ Y+
Sbjct: 324 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 380
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG-TSECMSAIAGSYGYIAPEYAY 862
VHRD+++ NIL+ VADFGLA+ ++D+ T+ + + APE A
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAAL 437
Query: 863 TLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
+ KSDV+SFG++L EL T GR P +++ V + G R+
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVER-------GY------RM 483
Query: 922 P-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
P LH++M C ++ ERPT + L +
Sbjct: 484 PCPPECPESLHDLM------CQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-38
Identities = 83/297 (27%), Positives = 129/297 (43%), Gaps = 39/297 (13%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPN-----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
LK+ +G+G G V G+ VAVK L A + G H G+ EI L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRT 89
Query: 739 IRHRHIVRLLGFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
+ H HI++ G C + LV EY+P GSL + L + A + +G
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEG 146
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS---- 852
+ YLH + +HRD+ + N+LLD+ + DFGLAK + + + S
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 853 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVR-KMTDSKK 910
Y APE K SDV+SFGV L EL+T ++++ + +MT +
Sbjct: 204 Y---APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR- 259
Query: 911 EGVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+ ++L+ RLP ++ +M C E +A RPT ++ IL +
Sbjct: 260 --LTELLERGERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILKTV 308
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 82/303 (27%), Positives = 125/303 (41%), Gaps = 46/303 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGL--MPNGD--QVAVKRL-PAMSRGSSHDHGFNAEIQTLGR 738
L+ +G G G+V +G P+G VAVK L P + F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
+ HR+++RL G +V E P GSL + L K GH T + AV+ A+G+
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMG 135
Query: 799 YL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS---Y 853
YL +HRD+ + N+LL + + DFGL + L + + +
Sbjct: 136 YLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKVPF 188
Query: 854 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
+ APE T SD + FGV L E+ T G++P +G I+ + KEG
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKI------DKEG 241
Query: 913 VLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSK 967
RLP ++ VM + C + +RPT + L E PT
Sbjct: 242 E------RLPRPEDCPQDIYNVM------VQCWAHKPEDRPTFVALRDFLLEA--QPTDM 287
Query: 968 QGE 970
+ E
Sbjct: 288 RAE 290
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 73/294 (24%), Positives = 119/294 (40%), Gaps = 44/294 (14%)
Query: 688 EDNIIGKGGAGIVYKGLMPNGD---QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
ED +G G G V KG VAVK L + + AE + ++ + +I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL--HH 802
VR++G C E+ +LV E G L + L ++ H+ ++ + + G+ YL +
Sbjct: 81 VRMIGICEA-ESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS---YGYIAPE 859
VHRD+ + N+LL + A ++DFGL+K L+ A + APE
Sbjct: 138 -----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 190
Query: 860 YAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918
K KSDV+SFGV++ E + G+KP G ++ + K G
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEK-------GE----- 237
Query: 919 PRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSK 967
R+ ++++M LC RP V L ++
Sbjct: 238 -RMGCPAGCPREMYDLM------NLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 52/290 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
LK IGKG G V G G++VAVK + + + F AE + ++RH +
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSN 75
Query: 744 IVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
+V+LLG + L +V EYM GSL + L + L D K +++ + + YL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 134
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG------YI 856
VHRD+ + N+L+ A V+DFGL K + +
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----------QDTGKLPVKWT 181
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
APE K KSDV+SFG++L E+ + GR P D+V V K
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEK----------- 229
Query: 916 ILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++ ++EVM C A RP+ ++ + L +
Sbjct: 230 --GYKMDAPDGCPPAVYEVM------KNCWHLDAAMRPSFLQLREQLEHI 271
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 63/333 (18%), Positives = 122/333 (36%), Gaps = 40/333 (12%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
++ +L AL+ ++ L ++ N LS +++ + L LLNLS+NV
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFL 184
L L++L+ LDL NN + +L ++ LH N S ++ +
Sbjct: 73 --TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVSCS--RGQGK 122
Query: 185 EYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLS 244
+ + ++ N++ + G +++Q L + N + ++
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDL-KLN-----------EIDTV----------- 159
Query: 245 GEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
L+ L LQ N + + ++ LK++DLS+N + F
Sbjct: 160 -NFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 305 LTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364
+T ++L NKL I + + LE L N F R + R+ ++ +
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK 273
Query: 365 GTLPPDMCAGNCLQTLITLGNFLFGPIPESLGK 397
L + TL G + +P
Sbjct: 274 -KLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 61/405 (15%), Positives = 115/405 (28%), Gaps = 91/405 (22%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
I + ++ ++++ + +++ LDL N ++ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG 221
L+L N + + +L+ L+ L + N
Sbjct: 62 LLNLSSNVLY-ETLD-------------------------LESLSTLRTLDL-NNN---- 90
Query: 222 GLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSL 281
+ + +++TL N +S +
Sbjct: 91 -------YVQE------------------LLVGPSIETLHAANNNIS---RVSCSRGQGK 122
Query: 282 KSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG-AIPEFIGVMPRLEVLQLWENNFT 340
K++ L+NN T + L+L N++ E LE L L N
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 341 GSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDS 400
+ ++ KL+ LDLSSNKL +
Sbjct: 183 -DVKGQV-VFAKLKTLDLSSNKLAF-------------------------MGPEFQSAAG 215
Query: 401 LSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLS 460
++ + + N L I K L +L +L+ N + D S N ++ +
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK 273
Query: 461 GSLPASIGKFSGVQKLLLDGNKFSGQIPAEIG-KLQQLSKMDFSH 504
L + V L G +PA +L L H
Sbjct: 274 -KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 54/311 (17%), Positives = 95/311 (30%), Gaps = 63/311 (20%)
Query: 271 LTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLE 330
+ K ++++ + + N+ L+L N L + +LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 331 VLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGP 390
+L L N L S LR LDL++N + L
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV--------------------- 97
Query: 391 IPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLG 450
PS+ + +N ++ VS S
Sbjct: 98 -------------------------------GPSIETLHAANNNISR---VSCSRGQGKK 123
Query: 451 QICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSG-QIPAEIGKLQQLSKMDFSHNKFSG 509
I L+NN+++ G S VQ L L N+ L ++ +N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 510 RIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSL 569
+ L +DLS N+L+ + + + +++L N LV I ++ Q+L
Sbjct: 183 DV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 570 TSVDFSYNNLS 580
D N
Sbjct: 240 EHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 57/340 (16%), Positives = 106/340 (31%), Gaps = 31/340 (9%)
Query: 222 GLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSL 281
+ N + + L + + N+ L L N LS +L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 282 KSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTG 341
+ ++LS+N+ E L L L+L N + + + V P +E L NN +
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 342 SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFLFG-PIPESLGK 397
+ G + + L++NK+T L + L N + E
Sbjct: 113 RVSCSRGQG--KKNIYLANNKIT-MLRDLDEGC--RSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 398 CDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS--VNLGQICLS 455
D+L + + NF+ + + L ++L N L + + I L
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF---MGPEFQSAAGVTWISLR 222
Query: 456 NNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI 515
NN+L + ++ ++ L GN F + +
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280
Query: 516 SQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL 555
+C + T E R+ + L +H
Sbjct: 281 EECTVPTL--GHYGAYCCEDLPAPFADRL---IALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 23/124 (18%), Positives = 39/124 (31%), Gaps = 25/124 (20%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
+LDLS L+ + P+ + +S+ N+L I + +L +L N F+
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251
Query: 125 SFPPQL----------------------SQLASLQVLDLYNNNMTGDLP-LAVTQLRNLR 161
+ ++ L Y DLP +L L
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
Query: 162 HLHL 165
H H
Sbjct: 312 HHHH 315
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 64/288 (22%), Positives = 119/288 (41%), Gaps = 44/288 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
L +G G G+V G VA+K + GS + F E + + + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEK 80
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL--H 801
+V+L G C+ ++ EYM NG L L + ++ + + + YL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI---AP 858
+HRD+ + N L++ V+DFGL++++ D + ++ GS + P
Sbjct: 140 Q-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPP 190
Query: 859 EYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917
E K KSD+++FGV++ E+ + G+ P F + + + +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQ------------- 236
Query: 918 DPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
RL S ++ +M C E+A ERPT + ++ + ++
Sbjct: 237 GLRLYRPHLASEKVYTIM------YSCWHEKADERPTFKILLSNILDV 278
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 81/344 (23%), Positives = 133/344 (38%), Gaps = 54/344 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKG-LMPNGD----QVAVKRL-PAMSRGSSHDHGFNAEIQTLG 737
K+ ++G G G VYKG +P G+ VA+K L A S ++ + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMA 72
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGL 797
+ + H+ RLLG C T L+ + MP G L + + + ++ V+ AKG+
Sbjct: 73 SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGM 130
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI- 856
YL +VHRD+ + N+L+ + + DFGLAK L G +
Sbjct: 131 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVP 182
Query: 857 ----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKE 911
A E +SDV+S+GV + EL+T G KP +I + K
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEK------- 234
Query: 912 GVLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP-- 964
RLP ++ ++ +M + C A RP RE++ +++ + P
Sbjct: 235 ------GERLPQPPICTIDVYMIM------VKCWMIDADSRPKFRELIIEFSKMARDPQR 282
Query: 965 ---TSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPP 1005
LP ++ +D D P
Sbjct: 283 YLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQ 326
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 83/293 (28%), Positives = 126/293 (43%), Gaps = 44/293 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ + +IG+G G VY G + + D AVK L ++ F E +
Sbjct: 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDF 83
Query: 740 RHRHIVRLLGFCSNHETNLL-VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
H +++ LLG C E + L V YM +G L + + + ++ AKG+
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMK 142
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-- 856
YL S VHRD+ + N +LD F VADFGLA+ + D E S + +
Sbjct: 143 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD---KEYYSVHNKTGAKLPV 196
Query: 857 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
A E T K KSDV+SFGV+L EL+T G P + + DI ++ +
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQ-------- 247
Query: 913 VLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
RL PL+EVM + C +A RP+ E+V ++ +
Sbjct: 248 -----GRRLLQPEYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRISAI 289
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 76/296 (25%), Positives = 117/296 (39%), Gaps = 35/296 (11%)
Query: 684 DCLKEDNIIGKGGAGIVYKG-LMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
LK +GKG G V P D VAVK+L + H F EI+ L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKS 67
Query: 739 IRHRHIVRLLGFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
++H +IV+ G C + L+ EY+P GSL + L K + + + KG
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKG 126
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
+ YL + +HRD+ + NIL+++ + DFGL K L G
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----FFKVKEPGES 179
Query: 857 -----APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911
APE K SDV+SFGVVL EL T + + K
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 912 GVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++++L RLP ++ +M C +RP+ R++ + ++
Sbjct: 240 HLIELLKNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQI 289
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 80/309 (25%), Positives = 124/309 (40%), Gaps = 49/309 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
D +IGKG G+VY G + Q A+K L ++ + F E + +
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGL 79
Query: 740 RHRHIVRLLGFCSNHE-TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
H +++ L+G E ++ YM +G L + + + ++ A+G+
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGME 138
Query: 799 YL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
YL VHRD+ + N +LD F VADFGLA+ + D E S + +
Sbjct: 139 YLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILD---REYYSVQQHRHARL 190
Query: 857 -----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKK 910
A E T + KSDV+SFGV+L EL+T G P D D+ ++
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLA------- 242
Query: 911 EGVLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT 965
+G RLP L++VM C E RPT R +V + ++
Sbjct: 243 QGR------RLPQPEYCPDSLYQVM------QQCWEADPAVRPTFRVLVGEVEQIVS-AL 289
Query: 966 SKQGEESLP 974
LP
Sbjct: 290 LGDHYVQLP 298
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-37
Identities = 70/303 (23%), Positives = 124/303 (40%), Gaps = 44/303 (14%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD---QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR 740
+ L D +G G G V +G+ VA+K L + + + E Q + ++
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLD 394
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
+ +IVRL+G C E +LV E G L + L K + ++ + + G+ YL
Sbjct: 395 NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL 452
Query: 801 --HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-- 856
+ VHR++ + N+LL + A ++DFGL+K L +A + +
Sbjct: 453 EEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKW 505
Query: 857 -APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914
APE K +SDV+S+GV + E ++ G+KP + G +++ ++ +
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQ---------- 554
Query: 915 KILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQG 969
R+ L+ +M C + +RP V Q + SK
Sbjct: 555 ---GKRMECPPECPPELYALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605
Query: 970 EES 972
S
Sbjct: 606 GGS 608
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-37
Identities = 76/296 (25%), Positives = 117/296 (39%), Gaps = 35/296 (11%)
Query: 684 DCLKEDNIIGKGGAGIVYKG-LMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
LK +GKG G V P D VAVK+L + H F EI+ L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKS 98
Query: 739 IRHRHIVRLLGFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
++H +IV+ G C + L+ EY+P GSL + L K + + + KG
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKG 157
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI 856
+ YL + +HRD+ + NIL+++ + DFGL K L G
Sbjct: 158 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE----YYKVKEPGES 210
Query: 857 -----APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911
APE K SDV+SFGVVL EL T + + K
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 912 GVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++++L RLP ++ +M C +RP+ R++ + ++
Sbjct: 271 HLIELLKNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQI 320
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 44/299 (14%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ + +IG+G G VY G + + D AVK L ++ F E +
Sbjct: 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDF 147
Query: 740 RHRHIVRLLGFCSNHETNLL-VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
H +++ LLG C E + L V YM +G L + + + ++ AKG+
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMK 206
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-- 856
+L S VHRD+ + N +LD F VADFGLA+ + D E S + +
Sbjct: 207 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD---KEFDSVHNKTGAKLPV 260
Query: 857 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
A E T K KSDV+SFGV+L EL+T G P + + DI ++ +
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQ-------- 311
Query: 913 VLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTS 966
RL PL+EVM + C +A RP+ E+V ++ +
Sbjct: 312 -----GRRLLQPEYCPDPLYEVM------LKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 53/302 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ ++ IG+G G V++G+ + + VA+K + S F E T+ +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQF 73
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
H HIV+L+G + ++ E G L L + L + A + + L Y
Sbjct: 74 DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAY 131
Query: 800 L-HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-- 856
L VHRD+ + N+L+ S + DFGL+++++DS + S G +
Sbjct: 132 LESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPI 181
Query: 857 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
APE + SDV+ FGV + E++ G KP F + ++
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQG----------VKNND--- 225
Query: 913 VLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPT 965
V+ ++ RLP L+ +M C RP E+ L+ + +
Sbjct: 226 VIGRIENGERLPMPPNCPPTLYSLM------TKCWAYDPSRRPRFTELKAQLSTILEEEK 279
Query: 966 SK 967
++
Sbjct: 280 AQ 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 73/335 (21%), Positives = 124/335 (37%), Gaps = 44/335 (13%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
IG+G G +G Q +K + S E+ L ++H +IV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ + +V +Y G L + ++ +KG D V+ L ++H I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEK 869
HRD+KS NI L + DFG+A+ L + T E A G+ Y++PE + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 870 SDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP---SVPL 926
SD+++ G VL EL T + F + + V K+ P + S L
Sbjct: 206 SDIWALGCVLYELCTLKHA---F-EAGSMKNLVLKIISGSF--------PPVSLHYSYDL 253
Query: 927 HEVMHVFYVAMLCVEEQAVERPTMREV----------------VQILTELPKPPTSKQGE 970
++ + + +RP++ + I E SK G
Sbjct: 254 RSLVS----QLFKRNPR--DRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGS 307
Query: 971 ESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPP 1005
+ +P S + + QK +PA P
Sbjct: 308 QPIPAKRPASGQNSISVMPAQK-ITKPAAKYGIPL 341
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 65/316 (20%), Positives = 112/316 (35%), Gaps = 57/316 (18%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
++GKG G V + + D VAVK L A SS F E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 740 RHRHIVRLLGFCSNHETN------LLVYEYMPNGSLGEVL----HGKKGGHLHWDTRYKI 789
H H+ +L+G +++ +M +G L L G+ +L T +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 790 AVEAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847
V+ A G+ YL + +HRD+ + N +L VADFGL++ +
Sbjct: 143 MVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--- 194
Query: 848 AIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQW 901
G + A E SDV++FGV + E++T G+ P + +I +
Sbjct: 195 --QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNY 251
Query: 902 VRKMTDSKKEGVLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956
+ G RL ++++M C +RP+ +
Sbjct: 252 L-------IGGN------RLKQPPECMEEVYDLM------YQCWSADPKQRPSFTCLRME 292
Query: 957 LTELPKPPTSKQGEES 972
L + + +
Sbjct: 293 LENILGHLSVLSTSQD 308
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+G GG VY +VA+K + F E+ ++ H++IV ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ LV EY+ +L E + G L DT + G+ + H IV
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDMR---IV 133
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEK 869
HRD+K NIL+DS + DFG+AK L ++ ++ + + G+ Y +PE A DE
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDEC 192
Query: 870 SDVYSFGVVLLELITGRKP 888
+D+YS G+VL E++ G P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 70/303 (23%), Positives = 113/303 (37%), Gaps = 56/303 (18%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ L I+G+G G V +G + D +VAVK + + F +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 740 RHRHIVRLLGFCSNHETN-----LLVYEYMPNGSLGEVL----HGKKGGHLHWDTRYKIA 790
H +++RLLG C + +++ +M G L L H+ T K
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 791 VEAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA 848
V+ A G+ YL + +HRD+ + N +L VADFGL+K +
Sbjct: 154 VDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---- 204
Query: 849 IAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWV 902
G + A E KSDV++FGV + E+ T G P ++ ++
Sbjct: 205 -QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYL 262
Query: 903 RKMTDSKKEGVLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957
G RL L+E+M C ++RPT + L
Sbjct: 263 -------LHGH------RLKQPEDCLDELYEIM------YSCWRTDPLDRPTFSVLRLQL 303
Query: 958 TEL 960
+L
Sbjct: 304 EKL 306
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-35
Identities = 62/343 (18%), Positives = 126/343 (36%), Gaps = 21/343 (6%)
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLT 306
I +++ + + + E L + K + N+ A + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 307 LLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNKLTG 365
LLNL ++ ++ L + N +P + N L +L L N L+
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 366 TLPPDMCAGNC-LQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPS 424
+LP + L TL N L ++ SL +++ N L + L PS
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI--PS 187
Query: 425 LSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFS 484
L + N L+ + +I + + ++ S+N ++ + + + L L N +
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT 239
Query: 485 GQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSRNELSGEIPNQLTGMR 543
+ L ++D S+N+ +I + + L + +S N L + +
Sbjct: 240 -DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
L L+LS NHL+ + + L ++ +N++ L T
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLST 337
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-35
Identities = 66/414 (15%), Positives = 135/414 (32%), Gaps = 63/414 (15%)
Query: 88 LQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQ-LSQLASLQVLDLYNNNM 146
++ + E L++ +++ N+ P L +++L+L + +
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 81
Query: 147 TGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF-----LEYLAVSGNELGGKIPGE 201
A ++ L++G N +PP F L L + N+L +P
Sbjct: 82 EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV----FQNVPLLTVLVLERNDL-SSLPRG 135
Query: 202 I-GNLTKLQQLYIGYYNSYTGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDT 259
I N KL L + N+ + + +SL ++ L+ + + + +L
Sbjct: 136 IFHNTPKLTTLSM-SNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFH 190
Query: 260 LFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAI 319
+ N L + L +++ +D S+N + LT+L L N L
Sbjct: 191 ANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DT 241
Query: 320 PEFIGVMPRLEVLQLWENNFTGSIPQR-LGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQ 378
+ P L + L N I +L L +S+N+L
Sbjct: 242 AWLLN-YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA------------- 286
Query: 379 TLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQ 438
+ +L + + N L + + L + L N +
Sbjct: 287 ------------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-- 331
Query: 439 FPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIG 492
+ S L + LS+N + ++ F V + +D +I ++
Sbjct: 332 -TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-33
Identities = 71/364 (19%), Positives = 128/364 (35%), Gaps = 31/364 (8%)
Query: 198 IPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDI-GRLQN 256
I + ++I + E L++ N + ++P + +
Sbjct: 13 IDSNLQYDCVFYDVHIDM-QTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 257 LDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLH 316
++ L L + T Y +++ + + N P F + LT+L L RN L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 317 GAIPEFI-GVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAG 374
++P I P+L L + NN I L+ L LSSN+LT + +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 187
Query: 375 NCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNY 434
L N L +L ++ + N +N + + L+ ++LQ N
Sbjct: 188 --LFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNN 237
Query: 435 LTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGV---QKLLLDGNKFSGQIPAEI 491
LT + L ++ LS N+L + F + ++L + N+ +
Sbjct: 238 LT-DTAWLLNYP-GLVEVDLSYNELE-KIMYHP--FVKMQRLERLYISNNRLV-ALNLYG 291
Query: 492 GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLS 551
+ L +D SHN + Q L + L N + + L+ L L LS
Sbjct: 292 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLS 347
Query: 552 RNHL 555
N
Sbjct: 348 HNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 60/413 (14%), Positives = 121/413 (29%), Gaps = 58/413 (14%)
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFL 184
L + + L N + + + ++P
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP--------- 61
Query: 185 EYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI-GNLSSLVRFDAANCGL 243
+ + +++ L + + ++ + +
Sbjct: 62 --------------AALLDSFRQVELLNLN-DLQIE-EIDTYAFAYAHTIQKLYMGFNAI 105
Query: 244 SGEIPTDIGR-LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPAS-FAE 301
+P + + + L L L+ N LS L ++ +SNN I F
Sbjct: 106 R-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 163
Query: 302 LKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSN 361
+L L L N+L + + ++P L + N + L + LD S N
Sbjct: 164 TTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 215
Query: 362 KLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF- 420
+ + + L L N L L L + + N L I F
Sbjct: 216 SIN-VVRGPVNVE--LTILKLQHNNL-TDTA-WLLNYPGLVEVDLSYNELE-KIMYHPFV 269
Query: 421 GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDG 480
+ L ++ + +N L + L + LS+N L + + +F ++ L LD
Sbjct: 270 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 327
Query: 481 NKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSG 533
N + + L + SHN + F +++R +
Sbjct: 328 NSIV-TLK--LSTHHTLKNLTLSHNDWD-------CNSLRALFRNVARPAVDD 370
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 23/227 (10%)
Query: 65 TSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFN 123
T+L +S NL + D LQNL +++N+L+ + S + SL N+S N+ +
Sbjct: 144 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDL--SLIPSLFHANVSYNLLS 199
Query: 124 GSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
L+ +++ LD +N++ + L L L N + +
Sbjct: 200 -----TLAIPIAVEELDASHNSINV---VRGPVNVELTILKLQHNNLT-DTAWLLN-YPG 249
Query: 184 LEYLAVSGNELGGKIPGEI-GNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCG 242
L + +S NEL KI + +L++LYI N L + +L D ++
Sbjct: 250 LVEVDLSYNEL-EKIMYHPFVKMQRLERLYI-SNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 243 LSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNN 289
L + + + L+ L+L N++ T +L +LK++ LS+N
Sbjct: 307 LL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 46/283 (16%), Positives = 98/283 (34%), Gaps = 29/283 (10%)
Query: 312 RNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDM 371
R + I + + + + +I+ ++ + LP +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64
Query: 372 CAG-NCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVE 429
++ L + + ++ ++ MG N + +P +F +P L+ +
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 123
Query: 430 LQDNYLTGQFPVSDSISVNLGQ---ICLSNNQLSGSLPASIGKFSGV---QKLLLDGNKF 483
L+ N L+ + I N + + +SNN L + F Q L L N+
Sbjct: 124 LERNDLSS---LPRGIFHNTPKLTTLSMSNNNLE-RIEDDT--FQATTSLQNLQLSSNRL 177
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543
+ + + + L + S+N S ++ + +D S N ++ + +
Sbjct: 178 T-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NV 226
Query: 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
L L L N+L + + L VD SYN L ++
Sbjct: 227 ELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHP 267
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 26/152 (17%), Positives = 54/152 (35%), Gaps = 12/152 (7%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
+ ++S LS +A ++ L + N ++ + L +L L +N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNN 237
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIW 181
+ L L +DL N + + +++ L L++ N +
Sbjct: 238 L--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 182 EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYI 213
L+ L +S N L + +L+ LY+
Sbjct: 295 PTLKVLDLSHNHL-LHVERNQPQFDRLENLYL 325
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 12/69 (17%), Positives = 22/69 (31%), Gaps = 2/69 (2%)
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNL 579
V + + L R + LNL+ + I A ++ + +N +
Sbjct: 47 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI 105
Query: 580 SGLVPGTGQ 588
L P Q
Sbjct: 106 RYLPPHVFQ 114
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 687 KEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G+G G V++ G Q AVK++ E+ + IV
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIV 113
Query: 746 RLLGFCSNHETNLLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
L G + ++ E + GSLG+++ K+ G L D +A +GL YLH
Sbjct: 114 PLYG-AVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 805 SPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSA---IAGSYGYIAPEY 860
I+H DVK++N+LL S G A + DFG A LQ G + + I G+ ++APE
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP 888
D K D++S ++L ++ G P
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 692 IGKGGAGIVYKGLMPNGD-QVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
+G+GG G VY+ + VA+K + S D F E +T GR++ H+V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSE---TLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
+ F + + L +L ++ G L I + L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAAG-- 154
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
HRDVK NIL+ + A++ DFG+A D ++ + + G+ Y+APE
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHA 212
Query: 867 DEKSDVYSFGVVLLELITGRKP 888
++D+Y+ VL E +TG P
Sbjct: 213 TYRADIYALTCVLYECLTGSPP 234
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 58/299 (19%), Positives = 118/299 (39%), Gaps = 55/299 (18%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+IG GG G V+K +G +KR+ + + E++ L ++ H +IV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAER-----EVKALAKLDHVNIVHYN 70
Query: 749 GF-------------CSNHETNLLVY---EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVE 792
G S+ ++ E+ G+L + + ++G L ++ +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGS 852
KG+ Y+H S +++RD+K +NI L + + DFGL L++ G + G+
Sbjct: 131 ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGT 184
Query: 853 YGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
Y++PE + ++ D+Y+ G++L EL+ +
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFT------------ 229
Query: 913 VLKILDPRLP---SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQ 968
+ D + ++ +L + + +RP E+++ LT K P +
Sbjct: 230 --DLRDGIISDIFDKKEKTLLQ----KLLSKKPE--DRPNTSEILRTLTVWKKSPEKNE 280
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 59/286 (20%), Positives = 116/286 (40%), Gaps = 23/286 (8%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRHIVRLLG 749
IG+G VY+ + +G VA+K++ + EI L ++ H ++++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 750 FCSNHETNLLVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+V E G L ++ K+ + T +K V+ L ++H S
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
++HRD+K N+ + + + D GL +F S + ++ G+ Y++PE + +
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 868 EKSDVYSFGVVLLELITGRKPVGEF-GDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926
KSD++S G +L E+ + P F GD +++ +K+ P LPS
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCDY--------PPLPSDHY 263
Query: 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEES 972
E + + + + +RP + V + + S
Sbjct: 264 SEELRQLVNMCINPDPE--KRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 76/311 (24%), Positives = 125/311 (40%), Gaps = 56/311 (18%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
+ +G+G G V+ N VAVK L S + D F E + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLT 98
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL-------------HGKKGGHLHWD 784
++H+HIVR G C+ L+V+EYM +G L L G L
Sbjct: 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 785 TRYKIAVEAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842
+A + A G+ YL H VHRD+ + N L+ G + DFG+++ + +
Sbjct: 159 QLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 843 SECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGV 896
G + PE K +SDV+SFGVVL E+ T G++P +
Sbjct: 214 YR-----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-SNT 267
Query: 897 DIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+ + + +G + L+ PR ++ +M C + + +R ++++V
Sbjct: 268 EAIDCIT-------QG--RELERPRACPPEVYAIM------RGCWQREPQQRHSIKDVHA 312
Query: 956 ILTELPKPPTS 966
L L + P
Sbjct: 313 RLQALAQAPPV 323
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 91/499 (18%), Positives = 167/499 (33%), Gaps = 52/499 (10%)
Query: 96 NQLSGPIPPEISAL---SSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPL 152
N L + + + + QLA+L LD +N+++T D+
Sbjct: 1 NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT- 58
Query: 153 AVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLY 212
+ +L L L N + + L YLA N+L + + LTKL L
Sbjct: 59 GIEKLTGLTKLICTSNNIT-TLDL--SQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLN 112
Query: 213 IGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLT 272
N T L + L + A L+ EI D+ L L +N L
Sbjct: 113 C-DTNKLT-KLD--VSQNPLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKITKL- 164
Query: 273 TELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVL 332
++ L ++D S N T E+ ++ K L LN N + + + +L L
Sbjct: 165 -DVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFL 217
Query: 333 QLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIP 392
N T I + +L D S N LT L + L TL + L +
Sbjct: 218 DCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSK--LTTLHCIQTDL---LE 268
Query: 393 ESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQI 452
L L + + + L ++ Q +T + +S + L +
Sbjct: 269 IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDLSQNP--KLVYL 323
Query: 453 CLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIA 512
L+N +L+ L + + ++ L +GK+ L+ + + +
Sbjct: 324 YLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMP 377
Query: 513 PEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSV 572
E LT +L + N + + + + S + +V
Sbjct: 378 KETLTNNSLTI--AVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDN----PAV 431
Query: 573 DFSYNNLSGLVPGTGQFSY 591
+++ + +G + GT +
Sbjct: 432 TYTFTSENGAIVGTVTTPF 450
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 71/436 (16%), Positives = 138/436 (31%), Gaps = 91/436 (20%)
Query: 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVF 122
+TSLD +++ + L L L +N ++ ++S ++L L +N
Sbjct: 43 TLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKL 97
Query: 123 NGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWE 182
+ ++ L L L+ N +T L V+Q L +L+ N +
Sbjct: 98 T-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT----------- 140
Query: 183 FLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCG 242
E+ ++ + T+L +L T ++ + L D +
Sbjct: 141 ----------EI------DVSHNTQLTELDCHLNKKIT---KLDVTPQTQLTTLDCSFNK 181
Query: 243 LSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL 302
++ D+ + + L+ L N ++ +L L +D S+N T EI L
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 303 KNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNK 362
LT + N L + + + +L L + + I L N +L +
Sbjct: 233 TQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCR 286
Query: 363 LTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGL 422
L + L + + + L
Sbjct: 287 KIKELD--------------------------VTHNTQLYLLDCQAAGIT-ELD--LSQN 317
Query: 423 PSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNK 482
P L + L + LT + VS + L + N + S+GK + +
Sbjct: 318 PKLVYLYLNNTELT-ELDVSH--NTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQ 372
Query: 483 FSGQIPAEIGKLQQLS 498
+P E L+
Sbjct: 373 TI-TMPKETLTNNSLT 387
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 62/322 (19%), Positives = 108/322 (33%), Gaps = 35/322 (10%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
T L+ L+ DV+ L L+ A N L+ ++S + L L+ N
Sbjct: 109 TYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLN--KK 160
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFL 184
++ L LD N +T L V+Q + L L+ N + ++ L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLDLNQ--NIQL 214
Query: 185 EYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLS 244
+L S N+L +I + LT+L N T L + LS L L
Sbjct: 215 TFLDCSSNKL-TEID--VTPLTQLTYFDC-SVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267
Query: 245 GEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
EI D+ L + L ++ + L +D T E+ ++
Sbjct: 268 -EI--DLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPK 319
Query: 305 LTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364
L L L +L + + +L+ L + +G L + +
Sbjct: 320 LVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI 374
Query: 365 GTLPPDMCAGNCLQTLITLGNF 386
T+P + N L ++
Sbjct: 375 -TMPKETLTNNSLTIAVSPDLL 395
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 30/275 (10%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
IG G G K +G + K L S + +E+ L ++H +IVR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 750 FCSNHETNLL--VYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGLCYLH--HD 803
+ L V EY G L V+ K+ +L + ++ + L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
++HRD+K N+ LD + DFGLA+ L + + G+ Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP- 922
+ +EKSD++S G +L EL P F + K + + R+P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP---F-TAFSQKELAGK--------IREGKFRRIPY 238
Query: 923 --SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
S L+E++ ML +++ RP++ E+++
Sbjct: 239 RYSDELNEIIT----RMLNLKDY--HRPSVEEILE 267
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 6e-34
Identities = 69/390 (17%), Positives = 121/390 (31%), Gaps = 71/390 (18%)
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGL 243
L V + L +P + + L I N+ T LP L +L + + L
Sbjct: 42 NAVLNVGESGLT-TLPDCLP--AHITTLVI-PDNNLTS-LPALPPELRTL---EVSGNQL 93
Query: 244 SGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELK 303
+ +P L L + L + L + + N T +P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPV---LPP 141
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKL 363
L L++ N+L ++P L L + N T S+P L+ L +S N+L
Sbjct: 142 GLQELSVSDNQL-ASLPALPS---ELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQL 193
Query: 364 TGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLP 423
+LP L L N L +P
Sbjct: 194 A-SLPTLPSE---LYKLWAYNNRL-TSLPALPS--------------------------- 221
Query: 424 SLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKF 483
L ++ + N LT + S L ++ +S N+L+ SLP G+ L + N+
Sbjct: 222 GLKELIVSGNRLTS---LPVLPS-ELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQL 273
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543
+ ++P + L + ++ N S R + + + R
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETR 332
Query: 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVD 573
L + + LV + A
Sbjct: 333 AL--HLAAADWLVPAREGEPAPADRWHMFG 360
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 7e-34
Identities = 72/306 (23%), Positives = 121/306 (39%), Gaps = 44/306 (14%)
Query: 277 YLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWE 336
+++ + T +P ++T L + N L ++P L L++
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSG 90
Query: 337 NNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
N T S+P +L I L LP L L GN L +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSG------LCKLWIFGNQLTS-LPVLPP 141
Query: 397 KCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSN 456
L + + +N L S+P L L +N LT + S L ++ +S+
Sbjct: 142 ---GLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLTS---LPMLPS-GLQELSVSD 190
Query: 457 NQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEIS 516
NQL+ SLP + + KL N+ + +PA L++L S N+ + + S
Sbjct: 191 NQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLT-SLPVLPS 241
Query: 517 QCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSY 576
+ L + +S N L+ +P +G L L++ RN L +P S+ + S T+V+
Sbjct: 242 E---LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 577 NNLSGL 582
N LS
Sbjct: 294 NPLSER 299
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-33
Identities = 78/373 (20%), Positives = 129/373 (34%), Gaps = 50/373 (13%)
Query: 109 LSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGN 168
+ +LN+ + + P L A + L + +NN+T LP LR L + GN
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLP---ALPPELRTLEVSGN 91
Query: 169 FFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIG 228
+ +P L + L P L KL + N T LP
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLWI----FGNQLT-SLPVLPP 141
Query: 229 NLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSN 288
L L ++ L+ +P L L Q+ +L L+ L +S+
Sbjct: 142 GLQEL---SVSDNQLA-SLPALPSELCKLWAYNNQLTSLP----MLPSGLQEL---SVSD 190
Query: 289 NIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLG 348
N +P +EL L N N+L ++P L+ L + N T S+P
Sbjct: 191 NQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPS 241
Query: 349 SNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGE 408
L+ L +S N+LT +LP L +L N L +PESL S + + +
Sbjct: 242 E---LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQL-TRLPESLIHLSSETTVNLEG 293
Query: 409 NFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIG 468
N L+ ++ + S + L+ +PA G
Sbjct: 294 NPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW--LVPAREG 348
Query: 469 KFSGVQKLLLDGN 481
+ + + + G
Sbjct: 349 EPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-33
Identities = 68/348 (19%), Positives = 115/348 (33%), Gaps = 46/348 (13%)
Query: 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVF 122
H+T+L + NL+ +L L+ L V+ NQL+ +P L L + +
Sbjct: 62 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLT-- 114
Query: 123 NGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWE 182
P S L L ++ N +T LP L+ L + N + +P
Sbjct: 115 --HLPALPS---GLCKLWIFGNQLT-SLP---VLPPGLQELSVSDNQLA-SLPALPS--- 161
Query: 183 FLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCG 242
L L N+L +P L + L + N LP L L A N
Sbjct: 162 ELCKLWAYNNQL-TSLPMLPSGLQE---LSVS-DNQLA-SLPTLPSELYKL---WAYNNR 212
Query: 243 LSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL 302
L+ +P L+ L + N L+ L LK L +S N T +P
Sbjct: 213 LT-SLPALPSGLKELI---VSGNRLTS-LPVLPSELKEL---MVSGNRLT-SLP---MLP 260
Query: 303 KNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNK 362
L L+++RN+L +PE + + + L N + + ++ S
Sbjct: 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQA--LREITSAPGYSGP 316
Query: 363 LT-GTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGEN 409
+ + + ++L D +N
Sbjct: 317 IIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-15
Identities = 25/141 (17%), Positives = 48/141 (34%), Gaps = 19/141 (13%)
Query: 448 NLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKF 507
+ + + L+ +LP + + L++ N + +PA +L+ L + S N+
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTL---EVSGNQL 93
Query: 508 SGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQ 567
+ + L+ L L L + N L S+P +Q
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQL-TSLPVLPPGLQ 144
Query: 568 SLTSVDFSYNNLSGLVPGTGQ 588
L S N L+ L +
Sbjct: 145 EL---SVSDNQLASLPALPSE 162
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 2e-13
Identities = 39/191 (20%), Positives = 71/191 (37%), Gaps = 27/191 (14%)
Query: 398 CDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNN 457
+ + + +GE+ L ++P L ++ + + DN LT + L + +S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS---LPALPP-ELRTLEVSGN 91
Query: 458 QLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQ 517
QL+ SLP + +PA L +L N+ + +
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKL---WIFGNQLT-SLPVLPPG 142
Query: 518 CKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYN 577
L + +S N+L+ +P + L L N L S+P + +Q L S N
Sbjct: 143 ---LQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQEL---SVSDN 191
Query: 578 NLSGLVPGTGQ 588
L+ L +
Sbjct: 192 QLASLPTLPSE 202
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 43/207 (20%), Positives = 71/207 (34%), Gaps = 37/207 (17%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
L L+ +L A L+ L V+ N+L+ +P S L+ L +S N
Sbjct: 204 YKLWAYNNRLT-SLP---ALPSGLKELIVSGNRLTS-LPVLPS---ELKELMVSGNRLT- 254
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFL 184
S P S L L +Y N +T LP ++ L + ++L GN S +
Sbjct: 255 SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 185 EYLA---VSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANC 241
+ + + G P E L ++ +P G + R+
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADWL---------VPAREGEPAPADRWHM--- 358
Query: 242 GLSGEIPTDIGRLQNLDTLFLQVNALS 268
G+ N D L ++ LS
Sbjct: 359 ---------FGQEDNADAFSLFLDRLS 376
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-34
Identities = 68/299 (22%), Positives = 120/299 (40%), Gaps = 53/299 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ ++ IG+G G V++G+ + + VA+K + S + F E T+ +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQF 448
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
H HIV+L+G + ++ E G L L + L + A + + L Y
Sbjct: 449 DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAY 506
Query: 800 LH-HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYI-- 856
L VHRD+ + N+L+ S + DFGL+++++DS + S G +
Sbjct: 507 LESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPI 556
Query: 857 ---APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
APE + SDV+ FGV + E++ G KP F + ++
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP---FQG----------VKNND--- 600
Query: 913 VLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
V+ ++ RLP L+ +M C RP E+ L+ + +
Sbjct: 601 VIGRIENGERLPMPPNCPPTLYSLM------TKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 74/310 (23%), Positives = 135/310 (43%), Gaps = 57/310 (18%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
+ +G+G G V+ N VAVK L + + D F E + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLT 72
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--------------HGKKGGHLHW 783
++H HIV+ G C + + ++V+EYM +G L + L + G L
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 784 DTRYKIAVEAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841
IA + A G+ YL H VHRD+ + N L+ + + DFG+++ + +
Sbjct: 133 SQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 842 TSECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDG 895
G + + PE K +SDV+SFGV+L E+ T G++P + +
Sbjct: 188 YYR-----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN- 241
Query: 896 VDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVV 954
++++ + +G ++L+ PR+ +++VM + C + + +R ++E+
Sbjct: 242 TEVIECIT-------QG--RVLERPRVCPKEVYDVM------LGCWQREPQQRLNIKEIY 286
Query: 955 QILTELPKPP 964
+IL L K
Sbjct: 287 KILHALGKAT 296
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 692 IGKGGAGIVYKGLMPNGD-----QVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G GG V+ D VAVK L ++R S F E Q + H IV
Sbjct: 20 LGFGGMSEVHLAR----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 746 RLL--GFCSNHETNL--LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+ G L +V EY+ +L +++H G + ++ +A + L + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH 133
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM-SAIAGSYGYIAPEY 860
+ I+HRDVK NI++ + V DFG+A+ + DSG S +A+ G+ Y++PE
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP 888
A VD +SDVYS G VL E++TG P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 68/304 (22%), Positives = 114/304 (37%), Gaps = 50/304 (16%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
+ +G G G VY+G + QVAVK LP + S D F E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALII 87
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL-----HGKKGGHLHWDTRYKIAV 791
+ H++IVR +G ++ E M G L L + L +A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 792 EAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHV---ADFGLAKFLQDSGTSECM 846
+ A G YL +H +HRD+ + N LL V DFG+A+ + +
Sbjct: 148 DIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-- 200
Query: 847 SAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQ 900
G + PE K+D +SFGV+L E+ + G P ++++
Sbjct: 201 ---KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLE 256
Query: 901 WVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+V G + P+ P++ +M C + Q +RP +++ +
Sbjct: 257 FVT------SGGRMDP--PKNCPGPVYRIM------TQCWQHQPEDRPNFAIILERIEYC 302
Query: 961 PKPP 964
+ P
Sbjct: 303 TQDP 306
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 60/296 (20%), Positives = 106/296 (35%), Gaps = 40/296 (13%)
Query: 689 DNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+I+G+G V++G GD A+K E + L ++ H++IV+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 748 LGFCSNHETNL--LVYEYMPNGSLGEVLHGK-KGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
T L+ E+ P GSL VL L + + G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 805 SPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTSECMSAIAGSYGYIAPE- 859
IVHR++K NI+ G + + DFG A+ L+D E ++ G+ Y+ P+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDM 186
Query: 860 -------YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912
+ K D++S GV TG P F + + K+ K G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 913 VLKIL---------------DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREV 953
+ + S L ++ +L +++ + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE--KCWGFDQF 300
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
++GKG GIVY G + N ++A+K +P S + EI ++H++IV+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP--LHEEIALHKHLKHKNIVQYLG 86
Query: 750 FCSNHETNLLVY-EYMPNGSLGEVLHGKKGGHLHWDTRYK-IAVEAAKGLCYLHHDCSPL 807
+ + ++ E +P GSL +L K G + + +GL YLH +
Sbjct: 87 -SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 808 IVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPE------ 859
IVHRD+K +N+L+++ + + +DFG +K L +G + C G+ Y+APE
Sbjct: 143 IVHRDIKGDNVLINT-YSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV 896
Y +D++S G ++E+ TG+ P E G+
Sbjct: 200 RGYGK----AADIWSLGCTIIEMATGKPPFYELGEPQ 232
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 57/302 (18%), Positives = 111/302 (36%), Gaps = 53/302 (17%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G+GG G+V++ + A+KR+ + E++ L ++ H IVR
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 751 ---------CSNHETNLLVY---EYMPNGSLGEVLHGKKGGH-LHWDTRYKIAVEAAKGL 797
+ +Y + +L + ++G+ I ++ A+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG----------TSECMS 847
+LH S ++HRD+K +NI V DFGL + +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD 907
G+ Y++PE + K D++S G++L EL+ P F T
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P---FS------------TQ 230
Query: 908 SKKEGVL-KILDPRLPSVPLH--EVMHVFYVAMLCVEEQAVERPTMREVVQ--ILTELPK 962
++ L + + + P + +V ML +ERP +++ + +L
Sbjct: 231 MERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPS--PMERPEAINIIENAVFEDLDF 288
Query: 963 PP 964
P
Sbjct: 289 PG 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 61/310 (19%), Positives = 114/310 (36%), Gaps = 70/310 (22%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
++ +G+ G VYKG + VA+K L + F E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLR 66
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--------------HGKKGGHLH 782
R++H ++V LLG + + +++ Y +G L E L L
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 783 WDTRYKIAVEAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840
+ + A G+ YL HH +VH+D+ + N+L+ ++D GL + + +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 841 GTSECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGD 894
+ + APE K SD++S+GVVL E+ + G +P
Sbjct: 182 DYYK-----LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG--- 233
Query: 895 GVDIVQWVRKMTDSKKEGVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVER 947
++ + V++++ LP ++ +M + C E R
Sbjct: 234 ----------YSN---QDVVEMIRNRQVLPCPDDCPAWVYALM------IECWNEFPSRR 274
Query: 948 PTMREVVQIL 957
P +++ L
Sbjct: 275 PRFKDIHSRL 284
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 72/399 (18%), Positives = 139/399 (34%), Gaps = 35/399 (8%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
I + +++ + F + L + +++ N+ M + R +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 162 HLHLGGNFFSGQIPPE-YGIWEFLEYLAVSGNELGGKIPGEI-GNLTKLQQLYIGYYNSY 219
L+L +I + ++ L + N + +P + N+ L L + N
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVL-ERNDL 135
Query: 220 TGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDIGR-LQNLDTLFLQVNALSGPLTTELGY 277
+ LP I N L +N L I D + +L L L N L+ +L
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT---HVDLSL 190
Query: 278 LKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWEN 337
+ SL ++S N+ + + A + L+ N ++ + V L +L+L N
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHN 242
Query: 338 NFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFLFGPIPES 394
N T L + L +DLS N+L + +Q L L N L +
Sbjct: 243 NLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK--MQRLERLYISNNRLVA-LNLY 296
Query: 395 LGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICL 454
+L + + N L + + L + L N + + S L + L
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTL 352
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGK 493
S+N + ++ F V + +D +I ++
Sbjct: 353 SHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 63/345 (18%), Positives = 130/345 (37%), Gaps = 23/345 (6%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPAS-FAELKN 304
I +++ + + + E L + K + N+ ++PA+ +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 305 LTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNKL 363
+ LLNL ++ ++ L + N +P + N L +L L N L
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 364 TGTLPPDMCAGNC-LQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGL 422
+ +LP + L TL N L ++ SL +++ N L + L
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI-- 191
Query: 423 PSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNK 482
PSL + N L+ + +I + + ++ S+N ++ + + + L L N
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNN 243
Query: 483 FSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSRNELSGEIPNQLTG 541
+ + L ++D S+N+ +I + + L + +S N L +
Sbjct: 244 LT-DTAWLLN-YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
Query: 542 MRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
+ L L+LS NHL+ + + L ++ +N++ L T
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLST 343
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 58/388 (14%), Positives = 115/388 (29%), Gaps = 51/388 (13%)
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFL 184
L + + L N + + + ++P
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP--------- 67
Query: 185 EYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI-GNLSSLVRFDAANCGL 243
+ + +++ L + + ++ + +
Sbjct: 68 --------------AALLDSFRQVELLNLN-DLQIE-EIDTYAFAYAHTIQKLYMGFNAI 111
Query: 244 SGEIPTDIGR-LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPAS-FAE 301
+P + + + L L L+ N LS L ++ +SNN I F
Sbjct: 112 R-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169
Query: 302 LKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSN 361
+L L L N+L + + ++P L + N + L + LD S N
Sbjct: 170 TTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221
Query: 362 KLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF- 420
+ + + L L N L L L + + N L I F
Sbjct: 222 SIN-VVRGPVNVE--LTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFV 275
Query: 421 GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDG 480
+ L ++ + +N L + L + LS+N L + + +F ++ L LD
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 333
Query: 481 NKFSGQIPAEIGKLQQLSKMDFSHNKFS 508
N + + L + SHN +
Sbjct: 334 NSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-21
Identities = 84/524 (16%), Positives = 169/524 (32%), Gaps = 87/524 (16%)
Query: 65 TSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFN 123
T+L +S NL + D LQNL +++N+L+ + S + SL N+S N+ +
Sbjct: 150 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDL--SLIPSLFHANVSYNLLS 205
Query: 124 GSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
L+ +++ LD +N++ + V L L L N +
Sbjct: 206 -----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD----------- 246
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGL 243
+ N L ++ + YN
Sbjct: 247 ---------------TAWLLNYPGLVEVDLS-YNELE----------------------- 267
Query: 244 SGEIPTDI-GRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL 302
+I ++Q L+ L++ N L L + +LK +DLS+N + + +
Sbjct: 268 --KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 323
Query: 303 KNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSN 361
L L L N + + + L+ L L N++ + + L N + + D +
Sbjct: 324 DRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
Query: 362 KLTG-TLPPDMCAGNCLQTLITLGNF------LFGPIPESLGKCDSLSRMRMGENFLNGS 414
L +C + + + + + G+C + + ++ +
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYI 440
Query: 415 IPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQ 474
+G L Q+E + N L + L + QL L A I
Sbjct: 441 TQQGGVPLQGNEQLEAEVNELRAEVQ-------QLTNEQIQQEQLLQGLHAEIDTNLRRY 493
Query: 475 KLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGE 534
+L DG S ++ + + F + R ++ K ++ L +
Sbjct: 494 RLPKDGLARSSDNLNKVFTHLK-ERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQ 552
Query: 535 IPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNN 578
+ N+ L + V + A V +++
Sbjct: 553 LDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHH 596
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 4e-15
Identities = 41/311 (13%), Positives = 86/311 (27%), Gaps = 48/311 (15%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV 121
+ ++S LS +A ++ L + N ++ + L +L L +N
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNN 243
Query: 122 FNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIW 181
+ L L +DL N + + +++ L L++ N +
Sbjct: 244 L--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 182 EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANC 241
L+ L +S N L + +L+ LY+ +N ++ +L
Sbjct: 301 PTLKVLDLSHNHL-LHVERNQPQFDRLENLYL-DHN-----------SIVTL-------- 339
Query: 242 GLSGEIPTDIGRLQNLDTLFLQVNALSG-PLTTELGYLKSLKSMDLSNNIFTGEI----- 295
+ L L L N L + D +
Sbjct: 340 --------KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGL 391
Query: 296 --PASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKL 353
S + L + + + G + + ++ Q
Sbjct: 392 CCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGN 451
Query: 354 RILDLSSNKLT 364
L+ N+L
Sbjct: 452 EQLEAEVNELR 462
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-33
Identities = 60/304 (19%), Positives = 110/304 (36%), Gaps = 42/304 (13%)
Query: 689 DNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+I+G+G V++G GD A+K E + L ++ H++IV+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 748 LGFCSNHETNL--LVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
T L+ E+ P GSL VL G + + + G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLR-- 129
Query: 804 CSPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
IVHR++K NI+ G + + DFG A+ L+D E ++ G+ Y+ P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPD 185
Query: 860 --------YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911
+ K D++S GV TG P F + + K+ K
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 912 GVL---------------KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956
G + + S L ++ +L +++ + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE--KCWGFDQFFAE 303
Query: 957 LTEL 960
+++
Sbjct: 304 TSDI 307
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 76/322 (23%), Positives = 128/322 (39%), Gaps = 49/322 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
+ + +G+G G+VY+G+ +VA+K + + S + F E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVM 82
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--------K 788
H+VRLLG S + L++ E M G L L + + +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 789 IAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA 848
+A E A G+ YL+ + VHRD+ + N ++ F + DFG+ + + ++
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---- 195
Query: 849 IAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWV 902
G G + +PE SDV+SFGVVL E+ T +P G+ Q +
Sbjct: 196 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ----GLSNEQVL 250
Query: 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
R + + G+L P L E+M +C + RP+ E++ + E +
Sbjct: 251 RFVMEG---GLLDK--PDNCPDMLFELM------RMCWQYNPKMRPSFLEIISSIKEEME 299
Query: 963 PPTSKQGEESLPPSGTTSLDSP 984
P E S S L P
Sbjct: 300 PGFR---EVSFYYSEENKLPEP 318
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 69/304 (22%), Positives = 115/304 (37%), Gaps = 50/304 (16%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
+ +G G G VY+G + QVAVK LP + S D F E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALII 128
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL-----HGKKGGHLHWDTRYKIAV 791
+ H++IVR +G ++ E M G L L + L +A
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 792 EAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHV---ADFGLAKFLQDSGTSECM 846
+ A G YL +H +HRD+ + N LL V DFG+A+ + +G
Sbjct: 189 DIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-- 241
Query: 847 SAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQ 900
G + PE K+D +SFGV+L E+ + G P ++++
Sbjct: 242 ---KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLE 297
Query: 901 WVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+V G + P+ P++ +M C + Q +RP +++ +
Sbjct: 298 FVT------SGGRMDP--PKNCPGPVYRIM------TQCWQHQPEDRPNFAIILERIEYC 343
Query: 961 PKPP 964
+ P
Sbjct: 344 TQDP 347
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-32
Identities = 66/283 (23%), Positives = 110/283 (38%), Gaps = 44/283 (15%)
Query: 689 DNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRL 747
+++G G G + M + VAVKR+ + E+Q L H +++R
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRESDEHPNVIRY 83
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+ + + E +L E + K HL + + + GL +LH S
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SLN 138
Query: 808 IVHRDVKSNNILL-----DSGFEAHVADFGLAKFLQ-DSGTSECMSAIAGSYGYIAPEY- 860
IVHRD+K +NIL+ +A ++DFGL K L + S + G+ G+IAPE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 861 --AYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918
D++S G V +I+ FG + IL
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH--PFGK--------------SLQRQANILL 242
Query: 919 PRLPSVPLHEVMHVFYVA------MLCVEEQAVERPTMREVVQ 955
LH H +A M+ ++ Q +RP+ + V++
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQ--KRPSAKHVLK 283
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 74/335 (22%), Positives = 131/335 (39%), Gaps = 71/335 (21%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ---VAVKRLPAMSRGSSHDHG-FNAEIQTLGRI 739
+ +K ++IG+G G V K + A+KR+ + S DH F E++ L ++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKL 82
Query: 740 -RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--------------HGKKGGHLHWD 784
H +I+ LLG C + L EY P+G+L + L L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
A + A+G+ YL +HRD+ + NIL+ + A +ADFGL++
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEV-- 194
Query: 845 CMSAIAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGD 894
+ + G + A E YT SDV+S+GV+L E+++ G P
Sbjct: 195 ---YVKKTMGRLPVRWMAIESLNYSVYT----TNSDVWSYGVLLWEIVSLGGTPYC---- 243
Query: 895 GVDIVQWVRKMTDSKKEGVLKILDPRLP-----SVPLHEVMHVFYVAMLCVEEQAVERPT 949
G+ ++ + +G RL ++++M C E+ ERP+
Sbjct: 244 GMT----CAELYEKLPQGY------RLEKPLNCDDEVYDLM------RQCWREKPYERPS 287
Query: 950 MREVVQILTELPKPPTSKQGEESLPPSGTTSLDSP 984
+++ L + + + +D
Sbjct: 288 FAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 322
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-31
Identities = 77/332 (23%), Positives = 110/332 (33%), Gaps = 51/332 (15%)
Query: 692 IGKGGAGIVYKG--LMPNGDQVAVKRLPAMSRGSSHDHG----FNAEIQTLGRIRHRHIV 745
I GG G +Y NG V +K L S D AE Q L + H IV
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVH-----SGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 746 RLLGF-----CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
++ F +V EY+ SL G L +E L YL
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYL 198
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H +V+ D+K NI+L + + D G + G + G+ G+ APE
Sbjct: 199 HSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYGTPGFQAPEI 248
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP-VGEFGDGVDIVQWVRKMTDSKKEGVLKIL-- 917
T +D+Y+ G L L G + DG+ V K DS + + +
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDP 307
Query: 918 DP--RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESLPP 975
DP R + M + +REVV T +P+P S S
Sbjct: 308 DPRQRFTTAE----------EMS----AQLTG-VLREVVAQDTGVPRPGLSTIFSPSRST 352
Query: 976 SGTTSLDSPNASNKDQKDHQRPAPPQSPPPDL 1007
G L + D + H L
Sbjct: 353 FGVDLLVAHTDVYLDGQVHAEKLTANEIVTAL 384
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 43/303 (14%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G+GG V + +G A+KR+ + + E H +I+RL+ +
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE--AQREADMHRLFNHPNILRLVAY 94
Query: 751 CSNHETN----LLVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
C L+ + G+L + KG L D + + +GL +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL-------QDSGTSECMSAIAGSYGYIA 857
+ HRD+K NILL + + D G + + T + +A + Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 858 PE----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913
PE ++ +DE++DV+S G VL ++ G P + M K + V
Sbjct: 212 PELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGP---Y-----------DMVFQKGDSV 256
Query: 914 LKIL--DPRLPSVPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGE 970
+ +P P H + +M+ V +RP + ++ L L P +
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTV--DPHQRPHIPLLLSQLEALQPPAPGQHTT 314
Query: 971 ESL 973
+ L
Sbjct: 315 QIL 317
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 72/334 (21%), Positives = 121/334 (36%), Gaps = 29/334 (8%)
Query: 50 HCTWPG--VTCDSRR----------HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQ 97
C+ V C +R LDL + + A L+ L + N
Sbjct: 8 ECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 98 LSGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQ-LSQLASLQVLDLYNNNMTGDLPLAVT 155
+S + P + L +LR L L +N P + L++L LD+ N + L
Sbjct: 68 VSA-VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 156 QLRNLRHLHLGGNFFSGQIPPE--YGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYI 213
L NL+ L +G N I G LE L + L + +L L L +
Sbjct: 126 DLYNLKSLEVGDNDLV-YISHRAFSG-LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183
Query: 214 GYYNSYTGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLT 272
+ + + L L + ++ + + NL +L + L+
Sbjct: 184 -RHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241
Query: 273 TELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLE 330
+ +L L+ ++LS N + + EL L + L +L + F G + L
Sbjct: 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRG-LNYLR 299
Query: 331 VLQLWENNFTGSIPQRL-GSNGKLRILDLSSNKL 363
VL + N T ++ + + S G L L L SN L
Sbjct: 300 VLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-29
Identities = 67/343 (19%), Positives = 122/343 (35%), Gaps = 42/343 (12%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPA-SFAELKN 304
+P I L L N + E L+ ++L+ NI + + +F L N
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81
Query: 305 LTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWENNFTGSIPQRL-GSNGKLRILDLSSN 361
L L L N+L IP F G + L L + EN + + L+ L++ N
Sbjct: 82 LRTLGLRSNRLK-LIPLGVFTG-LSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN 138
Query: 362 KLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF- 420
L + L +SL ++ + + L SIP
Sbjct: 139 DLV-YISH-----RAFSGL------------------NSLEQLTLEKCNLT-SIPTEALS 173
Query: 421 GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDG 480
L L + L+ + S L + +S+ ++ + + L +
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233
Query: 481 NKFSGQIPAE-IGKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSRNELSGEIPNQ 538
+ +P + L L ++ S+N S I + + L + L +L+ P
Sbjct: 234 CNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYA 291
Query: 539 LTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNLS 580
G+ L LN+S N L ++ S+ S+ +L ++ N L+
Sbjct: 292 FRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 74/339 (21%), Positives = 121/339 (35%), Gaps = 37/339 (10%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
+P I + RLL+L N + + L+ L+L N ++ P A L NLR
Sbjct: 26 VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83
Query: 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG 221
L L N IP G L+ L +L I N
Sbjct: 84 TLGLRSNRLK-LIPL-----------------------GVFTGLSNLTKLDI-SENKIVI 118
Query: 222 GLPPEI-GNLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTTELGYLK 279
L + +L +L + + L I L +L+ L L+ L+ T L +L
Sbjct: 119 -LLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH 176
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNF 339
L + L + SF L L +L + + L L + N
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
Query: 340 TGSIPQR-LGSNGKLRILDLSSNKLTGTLPPDMCAGNC-LQTLITLGNFLFGPIPESLGK 397
T ++P + LR L+LS N ++ T+ M LQ + +G L P +
Sbjct: 237 T-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294
Query: 398 CDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYL 435
+ L + + N L ++ + +F + +L + L N L
Sbjct: 295 LNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-25
Identities = 63/319 (19%), Positives = 119/319 (37%), Gaps = 51/319 (15%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNF 339
+++ F +P LL+L +N++ + P LE L+L EN
Sbjct: 12 QDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 340 TGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKC 398
+ ++ +N LR L L SN+L +P + G
Sbjct: 69 S-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGL----------------------- 103
Query: 399 DSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISV-------NLG 450
+L+++ + EN + + +F L +L +E+ DN L IS +L
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-------YISHRAFSGLNSLE 155
Query: 451 QICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSG 509
Q+ L L+ ++ G+ L L + I +L +L ++ SH +
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 510 RIAPEISQCKLLTFVDLSRNELSGEIP-NQLTGMRILNYLNLSRNHLVGSIPASI-ASMQ 567
+ P LT + ++ L+ +P + + L +LNLS N + +I S+ +
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELL 272
Query: 568 SLTSVDFSYNNLSGLVPGT 586
L + L+ + P
Sbjct: 273 RLQEIQLVGGQLAVVEPYA 291
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 6e-13
Identities = 47/254 (18%), Positives = 80/254 (31%), Gaps = 77/254 (30%)
Query: 65 TSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNNVF 122
L L NL+ ++ + +HL L L + ++ I L L++L +S+ +
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPY 212
Query: 123 NGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWE 182
+ P +L L + + N+T LAV L LR L+L N S I
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIE------- 264
Query: 183 FLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCG 242
+ L +LQ++ + L+
Sbjct: 265 ----------------GSMLHELLRLQEIQL-VGG-----------QLAV---------- 286
Query: 243 LSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL 302
++ A G L L+ +++S N T + F +
Sbjct: 287 -------------------VEPYAFRG--------LNYLRVLNVSGNQLTTLEESVFHSV 319
Query: 303 KNLTLLNLFRNKLH 316
NL L L N L
Sbjct: 320 GNLETLILDSNPLA 333
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 19/303 (6%)
Query: 655 ARSLKKAS--ESRAWKLTAF-QRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQ 710
+ L++ E + +L AF + + D ++ + +G G G+V+K P+G
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 711 VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG-FCSNHETNLLVYEYMPNGSL 769
+A K + + + + E+Q L +IV G F S+ E ++ E+M GSL
Sbjct: 61 MARKLIH-LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSL 118
Query: 770 GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVA 829
+VL KK G + K+++ KGL YL I+HRDVK +NIL++S E +
Sbjct: 119 DQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 174
Query: 830 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPV 889
DFG++ L DS ++ G+ Y++PE +SD++S G+ L+E+ GR P+
Sbjct: 175 DFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
Query: 890 GEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP----LHEVMHVFYVAMLCVEEQAV 945
+ + ++ E + P P M +F + V E
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290
Query: 946 ERP 948
+ P
Sbjct: 291 KLP 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 63/292 (21%), Positives = 121/292 (41%), Gaps = 48/292 (16%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
++G+G G V K + A+K+ + +E+ L + H+++VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKK---IRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 750 F----------CSNHETNLLVY---EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKG 796
+ + ++ EY NG+L +++H + + D +++ + +
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEA 128
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS------------GTSE 844
L Y+H S I+HRD+K NI +D + DFGLAK + S G+S+
Sbjct: 129 LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 845 CMSAIAGSYGYIAPE-YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903
+++ G+ Y+A E T +EK D+YS G++ E+I F G++ V ++
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------FSTGMERVNILK 239
Query: 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
K+ E P +V ++ + +RP R ++
Sbjct: 240 KLRSVSIE-----FPPDFDD-NKMKVEKKIIRLLIDHDPN--KRPGARTLLN 283
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 69/307 (22%), Positives = 120/307 (39%), Gaps = 54/307 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
+ L +G G G V + VAVK L + + + +E++ L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLS 81
Query: 738 RI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--------- 787
+ H +IV LLG C+ L++ EY G L L K+ + T
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 788 -------KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840
+ + AKG+ +L S +HRD+ + NILL G + DFGLA+ +++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 841 GTSECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGD 894
+ APE + +SDV+S+G+ L EL + G P
Sbjct: 199 SNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 895 GVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREV 953
+ + KEG + P ++++M C + ++RPT +++
Sbjct: 254 DSKFYKMI-------KEG--FRMLSPEHAPAEMYDIM------KTCWDADPLKRPTFKQI 298
Query: 954 VQILTEL 960
VQ++ +
Sbjct: 299 VQLIEKQ 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 75/341 (21%), Positives = 122/341 (35%), Gaps = 66/341 (19%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLG 749
+ +GG VY+ + +G + A+KRL + + E+ + ++ H +IV+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA--IIQEVCFMKKLSGHPNIVQFCS 93
Query: 750 FCSNHETN--------LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
S + LL+ E + + + G L DT KI + + + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL----------QDSGTSECMSAIAG 851
P I+HRD+K N+LL + + DFG A + Q E
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 852 SYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD 907
+ Y PE Y+ + EK D+++ G +L L + P F DG
Sbjct: 213 TPMYRTPEIIDLYSN-FPIGEKQDIWALGCILYLLCFRQHP---FEDG------------ 256
Query: 908 SKKEGVLKIL--DPRLPSVPLH-EVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964
L+I+ +P V H AML + ER ++ EVV L E+
Sbjct: 257 ----AKLRIVNGKYSIPPHDTQYTVFHSLIRAML--QVNPEERLSIAEVVHQLQEIAAAR 310
Query: 965 TSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPP 1005
P S T L N + S P
Sbjct: 311 ------NVNPKSPITELLEQNGG--------YGSATLSRGP 337
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-30
Identities = 65/275 (23%), Positives = 106/275 (38%), Gaps = 26/275 (9%)
Query: 689 DNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+G GG G V + + G+QVA+K+ + + EIQ + ++ H ++V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSA 77
Query: 748 L------GFCSNHETNLLVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGLCY 799
+ ++ LL EY G L + L G L + + + L Y
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISSALRY 136
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYI 856
LH I+HRD+K NI+L G + + D G AK L E + G+ Y+
Sbjct: 137 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYL 190
Query: 857 APEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916
APE K D +SFG + E ITG +P F VQW K+ +++ I
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRP---FLPNWQPVQWHGKV---REKSNEHI 244
Query: 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMR 951
+ + + + L ++
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 57/308 (18%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD--------QVAVKRLPAMSRGSSHDHG-FNAEIQ 734
D L +G+G G V D VAVK L + + D +E++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEME 92
Query: 735 TLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--------------HGKKGG 779
+ I +H++I+ LLG C+ ++ EY G+L E L +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 780 HLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839
+ + + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ + +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
Query: 840 SGTSECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFG 893
+ + G + APE + +SDV+SFGV++ E+ T G P
Sbjct: 210 IDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP--- 261
Query: 894 DGVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMRE 952
G+ V ++ KEG +D P + L+ +M C +RPT ++
Sbjct: 262 -GIP----VEELFKLLKEG--HRMDKPANCTNELYMMM------RDCWHAVPSQRPTFKQ 308
Query: 953 VVQILTEL 960
+V+ L +
Sbjct: 309 LVEDLDRI 316
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 32/304 (10%), Positives = 73/304 (24%), Gaps = 49/304 (16%)
Query: 686 LKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRH 743
LK + G +V+ + + A+K + S + + R+
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 744 IVRLLGFC-----------------------SNHETNLLVYEYMP--NGSLGEVL----- 773
+ MP + L +
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 774 HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833
G + + + + L +VH +N+ + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 834 AKFLQDSGTSECMSAIAGSYGYIAPEY--AYTLKVDEKSDVYSFGVVLLELITGRKPVGE 891
+ G + Y E+ A T + + G+ + + P
Sbjct: 241 LWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--- 292
Query: 892 FGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMR 951
FG ++ K + G + +P + + L + + R
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP--DFVKTLIGRFLNFDRR--RRLLPL 348
Query: 952 EVVQ 955
E ++
Sbjct: 349 EAME 352
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 65/310 (20%), Positives = 121/310 (39%), Gaps = 64/310 (20%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
+ L+ +G G G V + +VAVK L + + + + +E++ +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIM 103
Query: 737 GRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY-------- 787
+ +H +IV LLG C++ L++ EY G L L K
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 788 ----KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843
+ + A+G+ +L S +HRDV + N+LL +G A + DFGLA+ + +
Sbjct: 164 RDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 844 ECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVD 897
+ APE + +SDV+S+G++L E+ + G P
Sbjct: 221 I-----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--------- 266
Query: 898 IVQWVRKMTDSKKEGVLKILDP--RLP-----SVPLHEVMHVFYVAMLCVEEQAVERPTM 950
+ + +SK K++ ++ ++ +M C + RPT
Sbjct: 267 ---YPGILVNSK---FYKLVKDGYQMAQPAFAPKNIYSIM------QACWALEPTHRPTF 314
Query: 951 REVVQILTEL 960
+++ L E
Sbjct: 315 QQICSFLQEQ 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 83/336 (24%), Positives = 132/336 (39%), Gaps = 58/336 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD--------QVAVKRLPAMSRGSSHDHG-FNAEIQ 734
D L +G+G G V D +VAVK L + + + D +E++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEME 126
Query: 735 TLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--------------HGKKGG 779
+ I +H++I+ LLG C+ ++ EY G+L E L
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 780 HLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839
L A + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 840 SGTSECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFG 893
+ + G + APE + +SDV+SFGV+L E+ T G P
Sbjct: 244 IDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--- 295
Query: 894 DGVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMRE 952
GV V ++ KEG +D P + L+ +M C +RPT ++
Sbjct: 296 -GVP----VEELFKLLKEG--HRMDKPSNCTNELYMMM------RDCWHAVPSQRPTFKQ 342
Query: 953 VVQILTELPKPPTSKQGEESLPPSGTTSLDSPNASN 988
+V+ L + TS Q D P N
Sbjct: 343 LVEDLDRI-VALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-30
Identities = 73/321 (22%), Positives = 126/321 (39%), Gaps = 66/321 (20%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
+ ++ IG+G G V++ P VAVK L + S+ F E +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 104
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--------- 787
+ +IV+LLG C+ + L++EYM G L E L + +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 788 -------------KIAVEAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832
IA + A G+ YL VHRD+ + N L+ +ADFG
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFG 219
Query: 833 LAKFLQDSGTSECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GR 886
L++ + + + A I PE + + +SDV+++GVVL E+ + G
Sbjct: 220 LSRNIYSADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 887 KPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAV 945
+P +++ +VR +G IL P + L+ +M LC +
Sbjct: 275 QPYYGM-AHEEVIYYVR-------DG--NILACPENCPLELYNLM------RLCWSKLPA 318
Query: 946 ERPTMREVVQILTELPKPPTS 966
+RP+ + +IL + +
Sbjct: 319 DRPSFCSIHRILQRMCERAEG 339
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 75/312 (24%), Positives = 127/312 (40%), Gaps = 65/312 (20%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD--------QVAVKRLPAMSRGSSHDHG-FNAEIQ 734
D L +G+G G V D VAVK L + + D +E++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEME 138
Query: 735 TLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--------------HGKKGG 779
+ I +H++I+ LLG C+ ++ EY G+L E L +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 780 HLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839
+ + + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ + +
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 840 SGTSECMSAIAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELIT-GRKPV 889
+ + G + APE YT +SDV+SFGV++ E+ T G P
Sbjct: 256 IDYYK-----KTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIFTLGGSPY 306
Query: 890 GEFGDGVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVERP 948
G+ V ++ KEG +D P + L+ +M C +RP
Sbjct: 307 P----GIP----VEELFKLLKEG--HRMDKPANCTNELYMMM------RDCWHAVPSQRP 350
Query: 949 TMREVVQILTEL 960
T +++V+ L +
Sbjct: 351 TFKQLVEDLDRI 362
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 55/307 (17%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
D LK +G+G G V + D VAVK L + + +H +E++ L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKIL 84
Query: 737 GRI-RHRHIVRLLGFCSNHET-NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY------- 787
I H ++V LLG C+ +++ E+ G+L L K+ + +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 788 -------KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840
+ + AKG+ +L S +HRD+ + NILL + DFGLA+ +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 841 GTSECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGD 894
+ APE + +SDV+SFGV+L E+ + G P
Sbjct: 202 PDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 895 GVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREV 953
+ + + KEG + P + +++ M + C + +RPT E+
Sbjct: 257 DEEFCRRL-------KEG--TRMRAPDYTTPEMYQTM------LDCWHGEPSQRPTFSEL 301
Query: 954 VQILTEL 960
V+ L L
Sbjct: 302 VEHLGNL 308
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 74/319 (23%), Positives = 126/319 (39%), Gaps = 74/319 (23%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
L +G+G G V K + VAVK L + S + +E L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVL 80
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL----------------------H 774
++ H H+++L G CS LL+ EY GSL L
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 775 GKKGGHLHWDTRYKIAVEAAKGLCYL--HHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832
L A + ++G+ YL +VHRD+ + NIL+ G + ++DFG
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFG 195
Query: 833 LAKFLQDSGTSECMSAIAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELI 883
L++ + + + S G I A E + YT +SDV+SFGV+L E++
Sbjct: 196 LSRDVYEEDSYV-----KRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWEIV 246
Query: 884 T-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVE 941
T G P G+ + + K G ++ P S ++ +M + C +
Sbjct: 247 TLGGNPYP----GIPPERLFNLL----KTG--HRMERPDNCSEEMYRLM------LQCWK 290
Query: 942 EQAVERPTMREVVQILTEL 960
++ +RP ++ + L ++
Sbjct: 291 QEPDKRPVFADISKDLEKM 309
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 68/317 (21%), Positives = 116/317 (36%), Gaps = 69/317 (21%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGD------QVAVKRLPAMSRGSSHDHG-FNAEIQTL 736
+ L+ ++G G G V QVAVK L + S + +E++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 102
Query: 737 GRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY-------- 787
++ H +IV LLG C+ L++EY G L L K+ + Y
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 788 -------------KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834
A + AKG+ +L VHRD+ + N+L+ G + DFGLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 835 KFLQDSGTSECMSAIAGSYGYI-----APE----YAYTLKVDEKSDVYSFGVVLLELIT- 884
+ + + APE YT KSDV+S+G++L E+ +
Sbjct: 220 RDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYT----IKSDVWSYGILLWEIFSL 270
Query: 885 GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQ 943
G P + + + + G +D P + ++ +M C
Sbjct: 271 GVNPYPGIPVDANFYKLI-------QNG--FKMDQPFYATEEIYIIM------QSCWAFD 315
Query: 944 AVERPTMREVVQILTEL 960
+ +RP+ + L
Sbjct: 316 SRKRPSFPNLTSFLGCQ 332
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 692 IGKGGAGIVYKG-LMPNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+GKGG ++ + A K +P + + + + EI + H+H+V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLH-WDTRYKIAVEAAKGLCYLHHDCSPL 807
GF +++ +V E SL E+ K+ L + RY + + G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYL-RQIVLGCQYLH---RNR 135
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
++HRD+K N+ L+ E + DFGLA ++ G E + G+ YIAPE
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 868 EKSDVYSFGVVLLELITGRKP 888
+ DV+S G ++ L+ G+ P
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPP 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-29
Identities = 51/352 (14%), Positives = 91/352 (25%), Gaps = 74/352 (21%)
Query: 686 LKEDNIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRH 743
L ++G+ + G+ V R S+ E+ L +R
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 744 ----------------IVRLLGFCSNHE----------TNLLVYEYMPNGSLGEVL---- 773
+V+ + +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 774 -HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFG 832
H L R ++ ++ + L LHH +VH ++ +I+LD + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 833 LAKFLQDSGTSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRK 887
S S A + D ++ G+ + +
Sbjct: 257 HLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 888 PVGEFGDGVDIVQWVRKMTDSKKEGVLKIL--DPRLPSVPLHEVMHVFYVAMLCVE---- 941
P D D+ G I +P P+ ++ L
Sbjct: 316 P---NTD------------DAALGGSEWIFRSCKNIPQ-PVRALLE----GFLRYPKEDR 355
Query: 942 ---EQAVERPT---MREVVQILTELPKPPTSKQGEESLPPSGTTSLDSPNAS 987
QA+E P +R + L + E PPSGT+ D A+
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAA 407
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-29
Identities = 58/301 (19%), Positives = 112/301 (37%), Gaps = 59/301 (19%)
Query: 689 DNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRL 747
+ I+G G +G V G VAVKR+ EI+ L H +++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-------GLCYL 800
+ + E N +L +++ + + + + G+ +L
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLV--ESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAH-------------VADFGLAKFLQDSGTSEC-- 845
H S I+HRD+K NIL+ + ++DFGL K L +S
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 846 MSAIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVD 897
++ +G+ G+ APE ++ D++S G V +++ G+ P FGD
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDKYS 245
Query: 898 IVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHV---FYVAMLCVEEQAVERPTMREVV 954
+ + G+ + + + ++ M+ + +RPT +V+
Sbjct: 246 RESNIIR-------GIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPL--KRPTAMKVL 294
Query: 955 Q 955
+
Sbjct: 295 R 295
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 29/231 (12%)
Query: 662 SESRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKG-LMPNGDQVAVKRLP--A 718
S+ R W L F+ +GKG G VY + +A+K L
Sbjct: 1 SKKRQWALEDFEIG--------------RPLGKGKFGNVYLAREKQSKFILALKVLFKAQ 46
Query: 719 MSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG 778
+ + E++ +RH +I+RL G+ + L+ EY P G++ L +K
Sbjct: 47 LEKAGVEHQ-LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKL 103
Query: 779 GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838
E A L Y H S ++HRD+K N+LL S E +ADFG +
Sbjct: 104 SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 839 DSGTSE-CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
S ++ C G+ Y+ PE DEK D++S GV+ E + G+ P
Sbjct: 161 SSRRTDLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 692 IGKGGAGIVYKG-LMPNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+GKGG ++ + A K +P + + + + EI + H+H+V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLH-WDTRYKIAVEAAKGLCYLHHDCSPL 807
GF +++ +V E SL E+ K+ L + RY + + G YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYL-RQIVLGCQYLHRNR--- 161
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
++HRD+K N+ L+ E + DFGLA ++ G E + G+ YIAPE
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 868 EKSDVYSFGVVLLELITGRKP 888
+ DV+S G ++ L+ G+ P
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPP 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG G +V P ++VA+KR+ + + + EIQ + + H +IV
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQTSMDELLKEIQAMSQCHHPNIVSYYT- 80
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYK---IAV---EAAKGLCYLHHD 803
+ L LV + + GS+ +++ H IA E +GL YLH +
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA---IAGSYGYIAPE- 859
+HRDVK+ NILL +ADFG++ FL G G+ ++APE
Sbjct: 141 G---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 860 ----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y D K+D++SFG+ +EL TG P
Sbjct: 198 MEQVRGY----DFKADIWSFGITAIELATGAAP 226
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 85/470 (18%), Positives = 160/470 (34%), Gaps = 34/470 (7%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNN 120
+ T L++S +S + D+ L L+ L ++ N++ + + L L+LS+N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHN 79
Query: 121 VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVT--QLRNLRHLHLGGNFFSGQIPPEY 178
+L+ LDL N LP+ + L+ L L
Sbjct: 80 KLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 179 GIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGY--YNSYTGGLPPEIGNLSSLVRF 236
+ L V G G K E + L+I + + L + +++L
Sbjct: 136 AHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 237 D------AANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELG---YLKSLKSMDLS 287
+ C I + L L L + + + ++ +S
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 288 NNIFTG-----EIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGS 342
N G + S LK L++ + + + + + +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 343 IPQRLGSNGKLRILDLSSNKLTGTLPPDMCAG-NCLQTLITLGNFL--FGPIPESLGKCD 399
LD S+N LT + C L+TLI N L I E +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 400 SLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQ 458
SL ++ + +N ++ KG SL + + N LT + + + + L +N+
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD--TIFRCLPPRIKVLDLHSNK 432
Query: 459 LSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKF 507
+ S+P + K +Q+L + N+ +P I +L L K+ N +
Sbjct: 433 IK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 84/503 (16%), Positives = 167/503 (33%), Gaps = 66/503 (13%)
Query: 88 LQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMT 147
L+++ N +S +I +LS LR+L +S+N L+ LDL +N +
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 148 GDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTK 207
+ NL+HL L N F +P E GN+++
Sbjct: 83 K-ISC--HPTVNLKHLDLSFNAFD-ALPI----------------------CKEFGNMSQ 116
Query: 208 LQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNAL 267
L+ L + I +L+ + D LQ+ +T L +
Sbjct: 117 LKFLGL-STTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIV-- 171
Query: 268 SGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMP 327
+N F + S + NL L N+ F+ ++
Sbjct: 172 -----------------FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214
Query: 328 RLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFL 387
+L+ N + + S ++ + + + G
Sbjct: 215 KLQTNPKLSNL----------TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264
Query: 388 FGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISV 447
F S +LS ++ + +++ + + S
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 448 NLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIG---KLQQLSKMDFSH 504
+ SNN L+ ++ + G + ++ L+L N+ ++ +++ L ++D S
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQ 383
Query: 505 NKFSGRIAPEI-SQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI 563
N S S K L +++S N L+ I L + L+L N + SIP +
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQV 440
Query: 564 ASMQSLTSVDFSYNNLSGLVPGT 586
+++L ++ + N L + G
Sbjct: 441 VKLEALQELNVASNQLKSVPDGI 463
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 73/481 (15%), Positives = 137/481 (28%), Gaps = 76/481 (15%)
Query: 114 LLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQ 173
L++ S N P LS +L++ N ++ + L LR L + N
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 174 IPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSL 233
+ +L+ L + +N L +
Sbjct: 60 LDI-----------------------SVFKFNQELEYLDL-SHN-----------KLVKI 84
Query: 234 VRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNAL-SGPLTTELGYLKSLKSMDLSNNIFT 292
NL L L NA + P+ E G + LK + LS
Sbjct: 85 ----------------SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 293 GEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGK 352
A L +L + E + L T +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 353 LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLN 412
+ +L + + L + C+ + L +L+ + N
Sbjct: 187 KTVANLELSNIKCVLEDNKCS--------YFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 413 GSIPKGLFGLPSLSQVELQDNYLTGQ--FPVSDSISVNLGQIC---LSNNQLSGSLPASI 467
+ L ++ + + L GQ F D +L + + ++
Sbjct: 239 RILQ--LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 468 GKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLS 527
FS + + K+ +DFS+N + + L + L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 528 RNELS--GEIPNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNLSGLVP 584
N+L +I T M+ L L++S+N + + +SL S++ S N L+ +
Sbjct: 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 585 G 585
Sbjct: 417 R 417
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 5e-19
Identities = 62/362 (17%), Positives = 124/362 (34%), Gaps = 25/362 (6%)
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLT 306
+P D+ + L + N +S T+++ L L+ + +S+N + F + L
Sbjct: 15 VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 307 LLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQ--RLGSNGKLRILDLSSNKLT 364
L+L NKL I L+ L L N F ++P G+ +L+ L LS+ L
Sbjct: 73 YLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 365 GTLPPDMCAGNCLQTLITLGNFLFGPI-PESLGKCD--SLSRMRMGENFLNGSIPKGLFG 421
+ + N + L+ LG PE L + SL + + + +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 422 LPSLSQVELQDNYLTGQFPVSDSISVNLGQ------ICLSNNQLSGSLPASIGKF---SG 472
+ +L ++ + SI L + L+N + + + I + +
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 473 VQKLLLDGNKFSGQIPAEIG-----KLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLS 527
V + K GQ+ L+ LS + F + + + +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 528 RNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTG 587
+ + + +L+ S N L ++ + + L ++ N L L
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368
Query: 588 QF 589
Sbjct: 369 MT 370
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 46/324 (14%), Positives = 112/324 (34%), Gaps = 18/324 (5%)
Query: 4 LLLLLLLLLHISQSRTVPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRH 63
L ++ + + + +++ + S+ +
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSN---IKCVLEDNKCSYFLSILAKLQTNPK 221
Query: 64 VTSLDLSGLNLSGALSPDVAHL---RFLQNLSVAANQLSGPIPPEI-----SALSSLRLL 115
+++L L+ + + + L + S++ +L G + ++L +L +
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281
Query: 116 NLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIP 175
+ ++VF +++ + + + L +++ HL N + +
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341
Query: 176 PEYGIWEFLEYLAVSGNELG--GKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI-GNLSS 232
G LE L + N+L KI + LQQL I NS + S
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDI-SQNSVSYDEKKGDCSWTKS 400
Query: 233 LVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFT 292
L+ + ++ L+ I + + L L N + + ++ L++L+ +++++N
Sbjct: 401 LLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK 457
Query: 293 GEIPASFAELKNLTLLNLFRNKLH 316
F L +L + L N
Sbjct: 458 SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 29/156 (18%), Positives = 51/156 (32%), Gaps = 9/156 (5%)
Query: 454 LSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAP 513
S N L +P + L + N S ++I L +L + SHN+
Sbjct: 7 RSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 514 EISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIP--ASIASMQSLTS 571
+ L ++DLS N+L + L +L+LS N ++P +M L
Sbjct: 64 VFKFNQELEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAF-DALPICKEFGNMSQLKF 119
Query: 572 VDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPY 607
+ S +L + +
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 50/216 (23%), Positives = 82/216 (37%), Gaps = 31/216 (14%)
Query: 692 IGKGGA--GIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IGKG V P G+ V V+R+ + + E+ H +IV
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 749 G-FCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHD 803
F +++E L +V +M GS +++ + IA K L Y+HH
Sbjct: 93 ATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGM---NELAIAYILQGVLKALDYIHHM 147
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT-----SECMSAIAGSYGYIAP 858
VHR VK+++IL+ + +++ + G + +++P
Sbjct: 148 G---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 859 E------YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
E Y D KSD+YS G+ EL G P
Sbjct: 205 EVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 64/283 (22%), Positives = 96/283 (33%), Gaps = 44/283 (15%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-R 740
+ + +G G G V+K +G AVKR + RG AE+ + ++ +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
H VRL L E SL + G L + + L +L
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHL 173
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE- 859
H S +VH DVK NI L + DFGL L GT+ G Y+APE
Sbjct: 174 H---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL---GTAGAGEVQEGDPRYMAPEL 227
Query: 860 ----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
Y +DV+S G+ +LE+ + + Q
Sbjct: 228 LQGSY------GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--------------G 267
Query: 916 ILDPRLP---SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
L P S L V+ ++ +E R T ++
Sbjct: 268 YLPPEFTAGLSSELRSVL------VMMLEPDPKLRATAEALLA 304
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 34/287 (11%)
Query: 675 LDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEI 733
++ DD L+ + E +G+G G+V K +P+G +AVKR+ + S ++
Sbjct: 2 MEVKADD-LEPIME---LGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDL 56
Query: 734 QTLGR-IRHRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHG--KKGGHLHWDTRYKI 789
R + V G + + E M + SL + KG + D KI
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDV-WICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
AV K L +LH S ++HRDVK +N+L+++ + + DFG++ +L D
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDID 169
Query: 850 AGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKM 905
AG Y+APE KSD++S G+ ++EL R P +G ++
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ---- 225
Query: 906 TDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMRE 952
V++ P+LP+ F + C+++ + ERPT E
Sbjct: 226 -------VVEEPSPQLPADKFSAEFVDF-TS-QCLKKNSKERPTYPE 263
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLP-AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+GKG VY+ + G +VA+K + + E++ +++H I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLH-WDTRYKIAVEAAKGLCYLHHDCSPLI 808
+ + LV E NG + L + + R+ + + G+ YLH S I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMH-QIITGMLYLH---SHGI 133
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG----TSECMSAIAGSYGYIAPEYAYTL 864
+HRD+ +N+LL +ADFGLA L+ T C G+ YI+PE A
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-C-----GTPNYISPEIATRS 187
Query: 865 KVDEKSDVYSFGVVLLELITGRKP 888
+SDV+S G + L+ GR P
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 22/234 (9%)
Query: 669 LTAFQRLDFTCDDVLDCLKED----NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGS 723
+ + +L + + D ED IG+G G V K + P+G +AVKR+ +
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDE 61
Query: 724 SHDHGFNAEIQTLGR-IRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVL---HGKKG 778
++ + R +IV+ G E + + E M + S + +
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYG-ALFREGDCWICMELM-STSFDKFYKYVYSVLD 119
Query: 779 GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838
+ + KI + K L +L + I+HRD+K +NILLD + DFG++ L
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 839 DSGTSECMSAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
DS + AG Y+APE A D +SDV+S G+ L EL TGR P
Sbjct: 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 54/304 (17%), Positives = 104/304 (34%), Gaps = 65/304 (21%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-R 740
E IG G G V+K + +G A+KR GS + E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 741 HRHIVRLLGFCSNHETNLLVY-EYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGL 797
H H+VR + ++L+ EY GSL + + + + + + ++ +GL
Sbjct: 70 HSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 798 CYLHHDCSPLIVHRDVKSNNILLD-------------------SGFEAHVADFGLAKFLQ 838
Y+H S +VH D+K +NI + + + D G +
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 839 DSGTSECMSAIAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFG 893
E G ++A E Y + K+D+++ + ++
Sbjct: 186 SPQVEE------GDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL---PR 232
Query: 894 DGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH--EVMHVFYVAMLCVEEQAVERPTMR 951
+G + +I RLP +P + M+ + RP+
Sbjct: 233 NG---------------DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPD--PERRPSAM 275
Query: 952 EVVQ 955
+V+
Sbjct: 276 ALVK 279
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IGKG G V+KG+ VA+K + + EI L + ++ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG- 87
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDCSP 806
+T L ++ EY+ GS ++L IA E KGL YLH +
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ------IATILREILKGLDYLHSEK-- 139
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS--------GTSECMSAIAGSYGYIAP 858
+HRD+K+ N+LL E +ADFG+A L D+ GT M AP
Sbjct: 140 -KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM----------AP 188
Query: 859 EYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
E D K+D++S G+ +EL G P
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-26
Identities = 67/326 (20%), Positives = 109/326 (33%), Gaps = 57/326 (17%)
Query: 227 IGNLSSLVRFDAAN--CGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSM 284
I N SL + N G + + + + N L L + +
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSEL 64
Query: 285 DLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIP 344
L+ + +P + +T+L + +N L ++PE LE L +N + ++P
Sbjct: 65 QLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLP 116
Query: 345 QRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRM 404
+ S L+ LD+ +N+LT LP L+ + N L +PE SL +
Sbjct: 117 ELPAS---LKHLDVDNNQLT-MLPELPAL---LEYINADNNQL-TMLPELPT---SLEVL 165
Query: 405 RMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLP 464
+ N L +P+ L +L +S N L SLP
Sbjct: 166 SVRNNQLT-FLPELPESLEALD---------------------------VSTNLLE-SLP 196
Query: 465 ASIGKFSGVQKLL----LDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKL 520
A + ++ N+ + IP I L + N S RI +SQ
Sbjct: 197 AVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILN 546
R S Q T R L
Sbjct: 256 QPDYHGPRIYFSMSDGQQNTLHRPLA 281
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 70/468 (14%), Positives = 133/468 (28%), Gaps = 96/468 (20%)
Query: 109 LSSLRLLNLSNNVFN-------GSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
L +LS N F + + + N L +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC--LINQFS 62
Query: 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG 221
L L S +P + + L ++ N L +P +L L N +
Sbjct: 63 ELQLNRLNLS-SLPDN--LPPQITVLEITQNALI-SLPELPASLEYLDACD----NRLST 114
Query: 222 GLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSL 281
LP +L L D N L+ +P L+ ++ N L+ L L+ L
Sbjct: 115 -LPELPASLKHL---DVDNNQLT-MLPELPALLEYIN---ADNNQLTM-LPELPTSLEVL 165
Query: 282 KSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTG 341
+ NN T +P ++L L++ N L ++P E +++
Sbjct: 166 ---SVRNNQLT-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIF------ 211
Query: 342 SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSL 401
N++T IPE++ D
Sbjct: 212 --------------FRCRENRITH-------------------------IPENILSLDPT 232
Query: 402 SRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQIC---LSNNQ 458
+ + +N L+ I + L + Y + +++ L N+
Sbjct: 233 CTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENK 292
Query: 459 LS---------GSLPASIGKFSGVQKLLLDGN-----KFSGQIPAEIGKLQQLSKMDFSH 504
S + + + +L + F Q+ A + KL +++
Sbjct: 293 QSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQS 352
Query: 505 NKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSR 552
+ LT+ +L + L + L L+L R
Sbjct: 353 FAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGR 400
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 56/284 (19%), Positives = 103/284 (36%), Gaps = 33/284 (11%)
Query: 278 LKSLKSMDLSNNIFT--GEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLW 335
SL N I + +++ + + L RN+ + E + + + LQL
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLN 67
Query: 336 ENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESL 395
N + S+P L + +L+++ N L +LP L+ L N L +PE
Sbjct: 68 RLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPA---SLEYLDACDNRL-STLPELP 119
Query: 396 GKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLS 455
SL + + N L +P+ L ++ +N LT + + + +L + +
Sbjct: 120 A---SLKHLDVDNNQLT-MLPELPALLEYIN---ADNNQLTM---LPELPT-SLEVLSVR 168
Query: 456 NNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKM----DFSHNKFSGRI 511
NNQL+ LP ++ L + N +PA + + N+ + I
Sbjct: 169 NNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HI 222
Query: 512 APEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL 555
I + L N LS I L+ + R +
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 5e-25
Identities = 82/499 (16%), Positives = 142/499 (28%), Gaps = 96/499 (19%)
Query: 96 NQLSGPIPPEI-SALSSLRLLNLSNNVFNGSFP-PQLSQLASLQVLDLYNNNMTGDLPLA 153
N +SG + SA L N + + + L L N++ LP
Sbjct: 20 NTISG-TYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDN 77
Query: 154 VTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYI 213
+ + L + N +P LEYL N L +P +L L
Sbjct: 78 LPP--QITVLEITQNALI-SLPELPA---SLEYLDACDNRL-STLPELPASLKHLDV--- 127
Query: 214 GYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTT 273
N T LP L + +A N L+ +P L+ L
Sbjct: 128 -DNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPTSLEVL---------------- 165
Query: 274 ELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLE--- 330
+ NN T +P ++L L++ N L ++P E
Sbjct: 166 -----------SVRNNQLT-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETE 209
Query: 331 -VLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFG 389
+ EN T IP+ + S + L N L+ + + + Q F
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFS 267
Query: 390 PIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNL 449
+ + + + + E N + F S +V+
Sbjct: 268 MSDGQQNTL-HRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSA 325
Query: 450 GQICLSNNQLSGSLPASIG-------------------------KFSGVQKLLLDGNKFS 484
Q++ L ++ ++K LL
Sbjct: 326 RNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASE 385
Query: 485 GQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLS------RNELSG--EIP 536
G + G L L + F IA + + + L FVD + L+ ++
Sbjct: 386 GLFDNDTGALLSLGREMFRLEIL-EDIARD--KVRTLHFVDEIEVYLAFQTMLAEKLQLS 442
Query: 537 NQLTGMRILNYLNLSRNHL 555
+ MR ++ N L
Sbjct: 443 TAVKEMRFYGVSGVTANDL 461
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 67/387 (17%), Positives = 120/387 (31%), Gaps = 64/387 (16%)
Query: 65 TSLDLSGLNLSGALS-PDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFN 123
L G N + A+S + L + LS +P + + +L ++ N
Sbjct: 37 EKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNAL- 92
Query: 124 GSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
S P + L + LD +N ++ LP +L+HL + N + +P +
Sbjct: 93 ISLPELPASL---EYLDACDNRLS-TLP---ELPASLKHLDVDNNQLT-MLPELPAL--- 141
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKL-----------------QQLYIGYYNSYTGGLPPE 226
LEY+ N+L +P +L L + L + N LP
Sbjct: 142 LEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVST-NLLES-LPAV 198
Query: 227 IGNLSSL----VRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLK 282
+ F ++ IP +I L T+ L+ N LS + L +
Sbjct: 199 PVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257
Query: 283 SMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGS 342
F+ N L A+ + + +V Q+W
Sbjct: 258 DYHGPRIYFSMSDGQ----------QNTLHRPLADAVTAWFPENKQSDVSQIWHA----- 302
Query: 343 IPQRLGSNGKLRILDLSSNKLTGTLPPDMCAG-----NCLQTLITLGNFLFGPIPESLGK 397
+N LD S+ ++ L L F ++
Sbjct: 303 FEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATES 362
Query: 398 CD---SLSRMRMGENFLNGSIPKGLFG 421
C+ +L+ + + L +GLF
Sbjct: 363 CEDRVALTWNNLRKTLLVHQASEGLFD 389
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 8e-16
Identities = 38/202 (18%), Positives = 76/202 (37%), Gaps = 29/202 (14%)
Query: 391 IPESLGKC-DSLSRMRMGENFLN---GSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS 446
D + + N + + L + S+++L L+ P D++
Sbjct: 25 TYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLP--DNLP 79
Query: 447 VNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNK 506
+ + ++ N L SLP ++ L N+ S +P L+ L D +N+
Sbjct: 80 PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKHL---DVDNNQ 131
Query: 507 FSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASM 566
+ + + L +++ N+L+ +P T L L++ N L +P S+
Sbjct: 132 LT-MLPELPAL---LEYINADNNQLT-MLPELPTS---LEVLSVRNNQL-TFLPELPESL 182
Query: 567 QSLTSVDFSYNNLSGLVPGTGQ 588
++L D S N L L +
Sbjct: 183 EAL---DVSTNLLESLPAVPVR 201
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 77/457 (16%), Positives = 141/457 (30%), Gaps = 90/457 (19%)
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNE 193
A + +DL N++ + ++L++L+ L + I
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR------------------ 71
Query: 194 LGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI-GNLSSLVRFDAANCGL-SGEIPTDI 251
L+ L L + YN + L L++L C L + +
Sbjct: 72 -----NNTFRGLSSLIILKL-DYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 252 -GRLQNLDTLFLQVNALSG-PLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL--KNLTL 307
L +L+ L L+ N + + ++ +DL+ N K+ TL
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL 184
Query: 308 LNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTL 367
L L L M + N N + LDLS N ++
Sbjct: 185 LRLSSITLQD--------MNEYWLGWEKCGNPFK--------NTSITTLDLSGNGFKESM 228
Query: 368 PPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQ 427
+ +L + S G + + +
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN-------------------FKDPDNFTF 269
Query: 428 VELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASI-GKFSGVQKLLLDGNKFSGQ 486
L+ + + LS +++ +L S+ F+ +++L L N+ + +
Sbjct: 270 KGLEASGVK--------------TCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-K 313
Query: 487 IPAEI-GKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSRNELSGEIPNQL-TGMR 543
I L L K++ S N I + L +DLS N + + +Q G+
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLP 371
Query: 544 ILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNL 579
L L L N L S+P I + SL + N
Sbjct: 372 NLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 80/441 (18%), Positives = 140/441 (31%), Gaps = 68/441 (15%)
Query: 65 TSLDLSGLNLSG--ALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVF 122
+ L L V ++ N ++ S L L+ L +
Sbjct: 13 YNAICINRGLHQVPELPAHVNYVDLSLN------SIAELNETSFSRLQDLQFLKVEQQTP 66
Query: 123 NGSFPPQL-SQLASLQVLDLYNNNMTGDLPLAV-TQLRNLRHLHLGGN-FFSGQIPPEYG 179
L+SL +L L N L L NL L L + +
Sbjct: 67 GLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF- 124
Query: 180 IWEF-----LEYLAVSGNELGGKIPGEI-GNLTKLQQLYIGYYNSYTGGLPPEIGNLSSL 233
F LE L + N + P N+ + L + +N + E
Sbjct: 125 ---FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL-TFNKVK-SICEED------ 173
Query: 234 VRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTG 293
G+ T + RL ++ + L S+ ++DLS N F
Sbjct: 174 --LL----NFQGKHFTLL-RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 294 EIPASFAELKNLT-LLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGK 352
+ F + T + +L + + F F G
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSF----GHTNFKDPDNFTFKGL------EASG 276
Query: 353 LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPE-SLGKCDSLSRMRMGENFL 411
++ DLS +K+ L + + +TL I + + L ++ + +NFL
Sbjct: 277 VKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335
Query: 412 NGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSIS-------VNLGQICLSNNQLSGSL 463
GSI +F L L ++L N++ ++ NL ++ L NQL S+
Sbjct: 336 -GSIDSRMFENLDKLEVLDLSYNHIR-------ALGDQSFLGLPNLKELALDTNQLK-SV 386
Query: 464 PASI-GKFSGVQKLLLDGNKF 483
P I + + +QK+ L N +
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 62/342 (18%), Positives = 107/342 (31%), Gaps = 47/342 (13%)
Query: 57 TCDSRRHVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQL-SGPIPPEI-SALSSLR 113
T + L L L L L+ L++ L + L+SL
Sbjct: 74 TFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132
Query: 114 LLNLSNN-----VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQL--RNLRHLHLG 166
+L L +N F + VLDL N + + ++ L L
Sbjct: 133 MLVLRDNNIKKIQPASFF----LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188
Query: 167 GNFFSGQIPPEYGIWEF---------LEYLAVSGNELGGKIPGEI---GNLTKLQQLYIG 214
+ + WE + L +SGN + TK+Q L +
Sbjct: 189 SITLQ-DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 215 YYNSYTGGLPP-EIGNLSSLVRFDAANCGLS---------GEIPTDI-GRLQNLDTLFLQ 263
+ + + G+ + + +L+ L L
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLA 307
Query: 264 VNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPA-SFAELKNLTLLNLFRNKLHGAIPE- 321
N ++ L L ++LS N I + F L L +L+L N + A+ +
Sbjct: 308 QNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365
Query: 322 -FIGVMPRLEVLQLWENNFTGSIPQR-LGSNGKLRILDLSSN 361
F+G +P L+ L L N S+P L+ + L +N
Sbjct: 366 SFLG-LPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 56/338 (16%), Positives = 104/338 (30%), Gaps = 57/338 (16%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWEN 337
+ +DLS N SF+ L++L L + + I F G + L +L+L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG-LSSLIILKLDYN 89
Query: 338 NFTGSIPQR-LGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
F + L +L L+ L G + N + L
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSG----NFFKPL---------------- 128
Query: 397 KCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLT-------GQFPVSDSISVN 448
SL + + +N + P F + ++L N + F +
Sbjct: 129 --TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 449 LGQICL---SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHN 505
L I L + L + K + + L L GN F + +K+
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 506 KFSGRIAPEISQCKL---------------LTFVDLSRNELSGEIPNQL-TGMRILNYLN 549
S + + DLS++++ + + + L L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 550 LSRNHLVGSIPASI-ASMQSLTSVDFSYNNLSGLVPGT 586
L++N + I + + L ++ S N L +
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRM 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 48/287 (16%), Positives = 95/287 (33%), Gaps = 39/287 (13%)
Query: 62 RHVTSLDLSGLNLSGALSPDVA--HLRFLQNLSVAANQLSGPIPPEI-----------SA 108
+ L L N+ + P ++R L + N++ I E
Sbjct: 129 TSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLR 186
Query: 109 LSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRN---LRHLHL 165
LSS+ L +++ + S+ LDL N + ++ L L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 166 GGNFFSG--------QIPPEYGIWEF----LEYLAVSGNELGGKIPGEI-GNLTKLQQLY 212
++ G + P + ++ +S +++ + + + T L+QL
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 213 IGYYNSYTGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGP 270
+ N + L+ L++ + + L I + + L L+ L L N +
Sbjct: 306 L-AQNEINK-IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRAL 362
Query: 271 LTTELGYLKSLKSMDLSNNIFTGEIPAS-FAELKNLTLLNLFRNKLH 316
L +LK + L N +P F L +L + L N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 47/268 (17%), Positives = 85/268 (31%), Gaps = 49/268 (18%)
Query: 353 LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLN 412
+ +DLS N + L S + L +++ +
Sbjct: 32 VNYVDLSLNSIA-ELNET-----------------------SFSRLQDLQFLKVEQQTPG 67
Query: 413 GSIPKGLF-GLPSLSQVELQDNYLT----GQFPVSDSISVNLGQICLSNNQL-SGSLPAS 466
I F GL SL ++L N G F + ++ NL + L+ L L +
Sbjct: 68 LVIRNNTFRGLSSLIILKLDYNQFLQLETGAF---NGLA-NLEVLTLTQCNLDGAVLSGN 123
Query: 467 I-GKFSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNK--------FSGRIAPEIS 516
+ ++ L+L N PA +++ +D + NK +
Sbjct: 124 FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183
Query: 517 QCKL--LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSV-- 572
+L +T D++ L E + L+LS N S+ + T +
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243
Query: 573 -DFSYNNLSGLVPGTGQFSYFNYTSFLG 599
S + G G F + +F G
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 37/202 (18%), Positives = 64/202 (31%), Gaps = 20/202 (9%)
Query: 417 KGLFGLPSLS----QVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSG 472
+GL +P L V+L N + S S +L + + + F G
Sbjct: 20 RGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRG 77
Query: 473 ---VQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQCKL--LTFVDL 526
+ L LD N+F Q+ L L + + G + L L + L
Sbjct: 78 LSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 527 SRNELSGEIPNQL-TGMRILNYLNLSRNHLVGSIPASI---ASMQSLTSVDFSYNNLSGL 582
N + P MR + L+L+ N + SI + T + S L +
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDM 195
Query: 583 VPGTGQFSYFNYTSFLGNSELC 604
+ + N+ +
Sbjct: 196 --NEYWLGWEKCGNPFKNTSIT 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 29/220 (13%), Positives = 70/220 (31%), Gaps = 21/220 (9%)
Query: 687 KEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAM----SRGSSHDHGFNAEIQTLGRIRHR 742
+++G+G VY+ + + K+ + + ++ L
Sbjct: 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQH 127
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK---GGHLHWDTRYKIAVEAAKGLCY 799
++ ++LV E G+L ++ K + A+ +
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAH-----------VADFGLAKFLQDSGTSECMSA 848
+H I+H D+K +N +L +GF + D G + ++ +A
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 849 IAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ G+ E + + D + + ++ G
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 673 QRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA 731
QR +D L+ L E +G G G V+K G +AVK++ S +
Sbjct: 18 QRYQAEIND-LENLGE---MGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILM 72
Query: 732 EIQTLGR-IRHRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI 789
++ + + +IV+ G F +N + + E M + L + G + K+
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFI-AMELMGTCAE--KLKKRMQGPIPERILGKM 129
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
V K L YL ++HRDVK +NILLD + + DFG++ L D
Sbjct: 130 TVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRS 184
Query: 850 AGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
AG Y+APE D ++DV+S G+ L+EL TG+ P
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/201 (26%), Positives = 84/201 (41%), Gaps = 15/201 (7%)
Query: 692 IGKGGAGIVYKG-LMPNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+GKG G VY N +A+K L + + EI+ +RH +I+R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMY 80
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
+ + + L+ E+ P G L + L +K G E A L Y H +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH---ERKV 135
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS-ECMSAIAGSYGYIAPEYAYTLKVD 867
+HRD+K N+L+ E +ADFG + C G+ Y+ PE D
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-----GTLDYLPPEMIEGKTHD 190
Query: 868 EKSDVYSFGVVLLELITGRKP 888
EK D++ GV+ E + G P
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPP 211
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 13/213 (6%)
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
+ + + +G G G V + A+K + S +S + E+ L
Sbjct: 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
+ H +I++L F + LV E G L + + + I + G+
Sbjct: 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVT 150
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGY 855
YLH IVHRD+K N+LL+S + + DFGL+ ++ + M G+ Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKERLGTAYY 204
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
IAPE K DEK DV+S GV+L L+ G P
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 47/230 (20%), Positives = 88/230 (38%), Gaps = 50/230 (21%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRL---------------PAMSRGSSHDHGFNAEIQTL 736
+ +G + + A+K+ S F E+Q +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 737 GRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK 795
I++ + + G +N + ++YEYM N S+ + + L + I ++ K
Sbjct: 98 TDIKNEYCLTCEGIITN-YDEVYIIYEYMENDSILKFD--EYFFVLDKNYTCFIPIQVIK 154
Query: 796 --------GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS--GTSEC 845
Y+H++ + I HRDVK +NIL+D ++DFG ++++ D S
Sbjct: 155 CIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS-R 211
Query: 846 MSAIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+Y ++ PE Y K D++S G+ L + P
Sbjct: 212 -----GTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVVP 251
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 63/335 (18%), Positives = 105/335 (31%), Gaps = 56/335 (16%)
Query: 50 HCTWPGVTCDSRR----------HVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQL 98
C V C LDL ++ + +L+ L L + N++
Sbjct: 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKI 88
Query: 99 SGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQL 157
S I P + L L L LS N P ++ +LQ L ++ N +T L
Sbjct: 89 SK-ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGL 144
Query: 158 RNLRHLHLGGN-FFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYY 216
+ + LG N S I G + KL + I
Sbjct: 145 NQMIVVELGTNPLKSSGIE-----------------------NGAFQGMKKLSYIRI-AD 180
Query: 217 NSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTTEL 275
+ T +P G SL ++ ++ L NL L L N++S L
Sbjct: 181 TNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 276 GYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG------AIPEFIGVMPRL 329
L+ + L+NN ++P A+ K + ++ L N + P +
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295
Query: 330 EVLQLWENNFT-GSIPQRLGSN-GKLRILDLSSNK 362
+ L+ N I + L + K
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 65/313 (20%), Positives = 117/313 (37%), Gaps = 30/313 (9%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWEN 337
L+ + S+ ++P + LL+L NK+ I + F + L L L N
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKIT-EIKDGDFKN-LKNLHTLILINN 86
Query: 338 NFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
+ I + KL L LS N+L LP M LQ L N +
Sbjct: 87 KIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT--LQELRVHENEITKVRKSVFN 142
Query: 397 KCDSLSRMRMGENFL-NGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICL 454
+ + + +G N L + I G F G+ LS + + D +T + + +L ++ L
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHL 199
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAP 513
N+++ AS+ + + KL L N S + L ++ ++NK ++
Sbjct: 200 DGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPG 257
Query: 514 EISQCKLLTFVDLSRNELSGEIPNQ-------LTGMRILNYLNLSRNHL-VGSIPASI-A 564
++ K + V L N +S I + T + ++L N + I S
Sbjct: 258 GLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
Query: 565 SMQSLTSVDFSYN 577
+ +V
Sbjct: 317 CVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 68/325 (20%), Positives = 130/325 (40%), Gaps = 57/325 (17%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
++P D+ + L LQ N ++ + LK+L ++ L NN + P +FA L L
Sbjct: 45 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 306 TLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNKLT 364
L L +N+L +PE + L+ L++ EN T + + + + ++ +++L +N L
Sbjct: 103 ERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 365 -GTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLP 423
+ G LS +R+ + + +IP+GL P
Sbjct: 159 SSGIENGAFQG-----------------------MKKLSYIRIADTNIT-TIPQGLP--P 192
Query: 424 SLSQVELQDNYLTGQFPVSDSIS-------VNLGQICLSNNQLSGSLPASIGKFSGVQKL 476
SL+++ L N +T + NL ++ LS N +S S+ +++L
Sbjct: 193 SLTELHLDGNKIT-------KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245
Query: 477 LLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFS----GRIAPEISQCKL--LTFVDLSRNE 530
L+ NK ++P + + + + +N S P K + V L N
Sbjct: 246 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304
Query: 531 LS-GEI-PNQLTGMRILNYLNLSRN 553
+ EI P+ + + + L
Sbjct: 305 VQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 14/219 (6%)
Query: 675 LDFTCDDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHD-HGFNAE 732
+ + D K ++GKG G V G + AVK + D E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 733 IQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVE 792
+Q L ++ H +I++L F + LV E G L + + +I +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQ 134
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDS---GFEAHVADFGLAKFLQDSGTSECMSAI 849
G+ Y+H + IVHRD+K N+LL+S + DFGL+ + S+ M
Sbjct: 135 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDK 188
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ YIAPE DEK DV+S GV+L L++G P
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLG 749
+G G G VYKG + G A+K + + EI L + HR+I G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 750 -----FCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYL 800
+ L LV E+ GS+ +++ KG L IA E +GL +L
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEEWIAYICREILRGLSHL 145
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H ++HRD+K N+LL E + DFG++ Q T + G+ ++APE
Sbjct: 146 HQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEV 200
Query: 861 AYTLKV-----DEKSDVYSFGVVLLELITGRKP 888
+ D KSD++S G+ +E+ G P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G +G VY + + G +VA++++ + + + N EI + ++ +IV L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIIN-EILVMRENKNPNIVNYLD- 84
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDCSP 806
L +V EY+ GSL +V+ IA E + L +LH S
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLH---SN 135
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
++HRD+KS+NILL + DFG Q + S + G+ ++APE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 867 DEKSDVYSFGVVLLELITGRKP 888
K D++S G++ +E+I G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 20/238 (8%)
Query: 657 SLKKASESRA-WKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVK 714
SL+ + D + +G+G G VYK + G VA+K
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 715 RLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVL 773
++P S EI + + H+V+ G T+L +V EY GS+ +++
Sbjct: 61 QVPVESDLQE----IIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDII 115
Query: 774 HGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVAD 830
+ T +IA KGL YLH +HRD+K+ NILL++ A +AD
Sbjct: 116 RLRNKTL----TEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLAD 168
Query: 831 FGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
FG+A Q + T + + G+ ++APE + + +D++S G+ +E+ G+ P
Sbjct: 169 FGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 71/335 (21%), Positives = 115/335 (34%), Gaps = 57/335 (17%)
Query: 50 HCTWPGVTCDSRR----------HVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQL 98
HC V C T LDL ++S L D L+ L L + N++
Sbjct: 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 99 SGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQL 157
S I + S L L+ L +S N PP L +SL L +++N + + L
Sbjct: 91 SK-IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGL 146
Query: 158 RNLRHLHLGGN-FFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYY 216
RN+ + +GGN + P L YL +S +L IP L +L++ +
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPK--DLPETLNELHL-DH 202
Query: 217 NSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELG 276
N I + D+ R L L L N + L
Sbjct: 203 NK--------IQAIE----------------LEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 277 YLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE-------FIGVMPRL 329
+L +L+ + L NN + +PA +LK L ++ L N + + F
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 330 EVLQLWENNFT-GSIPQRLGSN-GKLRILDLSSNK 362
+ L+ N + + + K
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 63/313 (20%), Positives = 116/313 (37%), Gaps = 69/313 (22%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWEN 337
L+ + S+ +P + + TLL+L N + + + F G + L L L N
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKG-LQHLYALVLVNN 88
Query: 338 NFTGSIPQR-LGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
+ I ++ KL+ L +S N L +PP+ L
Sbjct: 89 KIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPN----------------LP-------- 122
Query: 397 KCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSI--SVNLGQIC 453
SL +R+ +N + +PKG+F GL +++ +E+ N L + L +
Sbjct: 123 --SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGLKLNYLR 178
Query: 454 LSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAP 513
+S +L+ +P + + +L LD NK +Q + D
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNK-----------IQAIELEDLLR--------- 215
Query: 514 EISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVD 573
L + L N++ L+ + L L+L N L +PA + ++ L V
Sbjct: 216 ----YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270
Query: 574 FSYNNLSGLVPGT 586
NN++ +
Sbjct: 271 LHTNNITKVGVND 283
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 58/268 (21%), Positives = 93/268 (34%), Gaps = 26/268 (9%)
Query: 229 NLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLS 287
L L N +S +I L+ L L++ N L + L SL + +
Sbjct: 76 GLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIH 131
Query: 288 NNIFTGEIPA-SFAELKNLTLLNLFRNKL-HGAIPEFIGVMPRLEVLQLWENNFTGSIPQ 345
+N ++P F+ L+N+ + + N L + +L L++ E T IP+
Sbjct: 132 DNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK 189
Query: 346 RLGSNGKLRILDLSSNKLTGTLPPDMCAG-NCLQTLITLGNFLFGPIPESLGKCDSLSRM 404
L L L L NK+ + + + L L N + SL +L +
Sbjct: 190 DLPET--LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL 246
Query: 405 RMGENFLNGSIPKGLFGLPSLSQVELQDNYLT----GQFP--VSDSISVNLGQICLSNNQ 458
+ N L+ +P GL L L V L N +T F I L NN
Sbjct: 247 HLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305
Query: 459 LS-GSLPASIGKFSGVQKLL---LDGNK 482
+ + + F V L K
Sbjct: 306 VPYWEVQPAT--FRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 33/145 (22%), Positives = 58/145 (40%), Gaps = 10/145 (6%)
Query: 448 NLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKF 507
+L + S+ L ++P I L L N S + LQ L + +NK
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 508 SGRIAPEI-SQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-AS 565
S +I + S + L + +S+N L EIP L L L + N + +P + +
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSG 145
Query: 566 MQSLTSVDFSYNNLSGLVPGTGQFS 590
++++ ++ N L G F
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFD 170
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 32/242 (13%), Positives = 65/242 (26%), Gaps = 53/242 (21%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIR-------- 740
++G+ + G+ V R S+ E+ L +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 741 -----------------HRHIVRLLG-FCSNHETNLLVYEYMPNGSLGEVL-----HGKK 777
+ ++R+ + +L H
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 778 GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837
L R ++ ++ + L LHH +VH ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 838 QDSGTSECMSAIAGSYGYIAPEY-----------AYTLKVDEKSDVYSFGVVLLELITGR 886
S + S G+ PE + D ++ G+V+ +
Sbjct: 257 GARVVS------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 887 KP 888
P
Sbjct: 311 LP 312
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
++GKG G V K + AVK + S + E++ L ++ H +I++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY------KIAVEAAKGLCYLHH 802
+ + +V E G L + + +K R+ +I + G+ Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRK--------RFSEHDAARIIKQVFSGITYMHK 139
Query: 803 DCSPLIVHRDVKSNNILLDS---GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
IVHRD+K NILL+S + + DFGL+ Q + M G+ YIAPE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPE 193
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
DEK DV+S GV+L L++G P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G GIV +G QVAVK + + + + FN E+ + +H ++V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMD-LRKQQRRELLFN-EVVIMRDYQHFNVVEMYK- 109
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDCSP 806
L ++ E++ G+L +++ + IA + L YLH +
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ------IATVCEAVLQALAYLH---AQ 160
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
++HRD+KS++ILL ++DFG Q S ++ G+ ++APE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 867 DEKSDVYSFGVVLLELITGRKP 888
+ D++S G++++E++ G P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 30/214 (14%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLP------AMSRGSSHDHGFNAEIQTLGRIRHRHI 744
+G G G V +VA++ + +R + EI+ L ++ H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
+++ F + + V E M G L + + G L T + + YLH
Sbjct: 203 IKIKNFFDAEDYYI-VLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH--- 256
Query: 805 SPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-- 859
I+HRD+K N+LL S E + DFG +K L + + M + G+ Y+APE
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVL 313
Query: 860 -----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y V D +S GV+L ++G P
Sbjct: 314 VSVGTAGYNRAV----DCWSLGVILFICLSGYPP 343
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 84/474 (17%), Positives = 149/474 (31%), Gaps = 53/474 (11%)
Query: 54 PGVTCDSRRHVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEISALSSL 112
+ L LS + +L V + L+ L V+ N+L I ++SL
Sbjct: 69 MPD-ISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASL 123
Query: 113 RLLNLSNNVFNGSFPP--QLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFF 170
R L+LS N F+ P + L L L L L L +L + L +
Sbjct: 124 RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSY 181
Query: 171 SGQIPPEYGIW----EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLP-- 224
+ + L + + ++ + L LQ I + L
Sbjct: 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241
Query: 225 -PEIGNLSSLVRFDAANCGLSGEIPTDIGRLQ--------NLDTLFLQVNALSGPLTTEL 275
E+ +L+ + + + + + N+ L + T
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301
Query: 276 GYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLW 335
LKSL + N +F A ++ + + L + L
Sbjct: 302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361
Query: 336 ENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESL 395
+N FT S+ Q + +L+ L L N L + +L TL L
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL-------- 412
Query: 396 GKCDSLSRMRMGENFLNGSIPKGLFGLP-SLSQVELQDNYLTGQFPVSDSISVNLGQICL 454
N LN S+ + L N LTG V + + + L
Sbjct: 413 -------------NSLNSHAYDRTCAWAESILVLNLSSNMLTGS--VFRCLPPKVKVLDL 457
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKF 507
NN++ S+P + +Q+L + N+ +P + +L L + N +
Sbjct: 458 HNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 74/470 (15%), Positives = 153/470 (32%), Gaps = 38/470 (8%)
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF---LEYLAVS 190
+ L L N+++ ++ L LR L L N + ++ F LEYL VS
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF--HVFLFNQDLEYLDVS 108
Query: 191 GNELGGKIPGEIGNLTKLQQLYIGYYNSYTG-GLPPEIGNLSSLVRFDAANCGLSGEIPT 249
N L I + L+ L + +N + + E GNL+ L + ++
Sbjct: 109 HNRL-QNIS--CCPMASLRHLDL-SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDL 163
Query: 250 DIGRLQNLDTLFLQVNALSGPLTTE----LGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
+L + L + + + L + N++F+ ++ S L +L
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL 223
Query: 306 TL--LNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLG-----SNGKLRILDL 358
L + L + + +L + + + + + L++
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 359 SSNKLTGTLPPDMC--AGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLN--GS 414
+ +T + + + L++L+ + + M + ++
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 415 IPKGLFGLPS-LSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGV 473
I PS + + N T S L + L N L + +
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 474 QKLLLDGNKF----SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRN 529
L S + + ++ S N +G + + + +DL N
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNN 460
Query: 530 ELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNN 578
+ IP +T ++ L LN++ N L S+P + + SL + N
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 7e-18
Identities = 65/380 (17%), Positives = 125/380 (32%), Gaps = 27/380 (7%)
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPAS-FAELKNL 305
+P D+ L L N++S ++ +L L+ + LS+N + F ++L
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 306 TLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQ--RLGSNGKLRILDLSSNKL 363
L++ N+L I M L L L N+F +P G+ KL L LS+ K
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 364 TGTLPPDMCAGNCLQTLIT--LGNFLFGPIPESL--GKCDSLSRMRMGENFLNGSIPKGL 419
L A L ++ + + G ESL L + + + + +
Sbjct: 159 R-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 420 FGLPSLSQVELQDNYLTGQFPVSDSISVNLG----QICLSNNQLSGSLPASIGKF---SG 472
L L ++ N Q ++ + G + L + + + + +F
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 473 VQKLLLDGNKFSGQIPAEIG-----KLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLS 527
V+ L + + +I E L+ L + F S + LS
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 528 RNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTG 587
++ +LN ++N S+ ++++ L ++ N L
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397
Query: 588 QFSYFNYTSFLGNSELCGPY 607
+ L S
Sbjct: 398 MTKNMSSLETLDVSLNSLNS 417
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 48/302 (15%), Positives = 85/302 (28%), Gaps = 56/302 (18%)
Query: 44 WNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSG-----ALSPDVAHLRFLQNLSVAANQL 98
TT C+ R V L++ L ++ + L+ L V
Sbjct: 258 HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF 317
Query: 99 SGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLR 158
S + + + LS + +S L+ N T + + L+
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLK 377
Query: 159 NLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNS 218
L+ L L N + L +
Sbjct: 378 RLQTLILQRNGLK-------------------------NFFKVALMTKNMSSLE--TLDV 410
Query: 219 YTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYL 278
L S +++ L L N L+G + L
Sbjct: 411 SLNSLN-------------------SHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--P 449
Query: 279 KSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE-FIGVMPRLEVLQLWEN 337
+K +DL NN IP L+ L LN+ N+L ++P+ + L+ + L +N
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
Query: 338 NF 339
+
Sbjct: 508 PW 509
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 691 IIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
++GKG G V K + AVK + S + E++ L ++ H +I++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ + +V E G L + + + +I + G+ Y+H IV
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 810 HRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAPE---YAYT 863
HRD+K NILL+S + + DFGL+ Q + M G+ YIAPE Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRGTYD 200
Query: 864 LKVDEKSDVYSFGVVLLELITGRKP 888
K DV+S GV+L L++G P
Sbjct: 201 EKC----DVWSAGVILYILLSGTPP 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 38/215 (17%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G G G VYK G A K + S D + EI+ L H +IV+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLLG- 83
Query: 751 CSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDCSP 806
H+ L ++ E+ P G++ ++ G T +I V + + L +LH S
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQMLEALNFLH---SK 136
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS--------GTSECMSAIAGSYGYIAP 858
I+HRD+K+ N+L+ + +ADFG++ + GT M AP
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM----------AP 186
Query: 859 EYAYTLKV-----DEKSDVYSFGVVLLELITGRKP 888
E + D K+D++S G+ L+E+ P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 692 IGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G G G V+ +G + +K + R AEI+ L + H +I+++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINK-DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 751 CSNHETNLLVYEYMPNGSLGE--VLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
++ +V E G L E V +G L ++ + L Y H S +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHV 145
Query: 809 VHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAPE---YAY 862
VH+D+K NIL + DFGLA+ + E + AG+ Y+APE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPEVFKRDV 202
Query: 863 TLKVDEKSDVYSFGVVLLELITGRKP 888
K D++S GVV+ L+TG P
Sbjct: 203 ----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 58/310 (18%), Positives = 94/310 (30%), Gaps = 63/310 (20%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVK--RLPAMSRGSSHD-HGFNAEIQTLGRIRHRHIVRL 747
IG+G G+V + A+K + + + D E++ + ++ H +I RL
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---------------- 791
+ + LV E G L + L+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 792 ---------------EAAK-------GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV- 828
+ L YLH + I HRD+K N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 829 -ADFGLAKFLQ--DSGTSECMSAIAGSYGYIAPE--YAYTLKVDEKSDVYSFGVVLLELI 883
DFGL+K ++G M+ AG+ ++APE K D +S GV+L L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 884 TGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQ 943
G P F D L +P + +L
Sbjct: 271 MGAVP---FPGVND-----ADTISQVLNKKLCFENPNYNVLS-PLARD-LLSNLLNRNVD 320
Query: 944 AVERPTMREV 953
ER
Sbjct: 321 --ERFDAMRA 328
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 56/245 (22%), Positives = 87/245 (35%), Gaps = 13/245 (5%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMT--GDLPLAVTQLRN 159
+P I SS L L +N +L L L L +N ++ G + +
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 160 LRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEI-GNLTKLQQLYIGYYNS 218
L++L L N + + E LE+L + L + +L L L I +
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI-SHTH 137
Query: 219 YTGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTTELG 276
I LSSL A DI L+NL L L L T
Sbjct: 138 TRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 277 YLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQL 334
L SL+ +++S+N F + L +L +L+ N + + L L L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNL 255
Query: 335 WENNF 339
+N+F
Sbjct: 256 TQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 52/293 (17%), Positives = 93/293 (31%), Gaps = 68/293 (23%)
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKL 363
+ T + L ++P G+ L+L N +L L LSSN L
Sbjct: 8 SGTEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 364 TGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLP 423
+ + SL + + N + ++ GL
Sbjct: 65 S---------------FKGCCSQSDFGTT-------SLKYLDLSFNGVI-TMSSNFLGLE 101
Query: 424 SLSQVELQDNYLTGQFPVSDSIS--------VNLGQICLSNNQLSGSLPASIGKFSGVQK 475
L ++ Q + L +S NL + +S+ I
Sbjct: 102 QLEHLDFQHSNLK-------QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI-------- 145
Query: 476 LLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSRNELSGE 534
F+G L L + + N F P+I ++ + LTF+DLS+ +L +
Sbjct: 146 -------FNG--------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-Q 189
Query: 535 IPNQ-LTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
+ + L LN+S N+ + SL +D+S N++
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-24
Identities = 56/214 (26%), Positives = 82/214 (38%), Gaps = 24/214 (11%)
Query: 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLP-----------AMSRGSSHDHGFNAEIQTLG 737
+G G G V + A+K + EI L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGL 797
+ H +I++L + + LV E+ G L E + I + G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQILSGI 159
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDS---GFEAHVADFGLAKFLQDSGTSECMSAIAGSYG 854
CYLH IVHRD+K NILL++ + DFGL+ F + G+
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAY 213
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
YIAPE K +EK DV+S GV++ L+ G P
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 32/216 (14%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLP--AMSRGSSHDH-GFNAEIQTLGRIRHRHIVR 746
+IGKG +V + + G Q AVK + + E ++H HIV
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--KIAVEAAK----GLCYL 800
LL S+ +V+E+M L + + Y +A + L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRA----DAGFVYSEAVASHYMRQILEALRYC 146
Query: 801 H-HDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYI 856
H ++ I+HRDVK + +LL S + + FG+A L +SG G+ ++
Sbjct: 147 HDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFM 200
Query: 857 APE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
APE Y + DV+ GV+L L++G P
Sbjct: 201 APEVVKREPY----GKPVDVWGCGVILFILLSGCLP 232
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 36/271 (13%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IGKG V + G +VA+K + + E++ + + H +IV+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
+T L+ EY G + + L G + + + Y H IVH
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVH 137
Query: 811 RDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE------YAYTL 864
RD+K+ N+LLD+ +ADFG + G + A G+ Y APE Y
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYD--- 191
Query: 865 KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924
+ DV+S GV+L L++G P F DG ++ + ++ G +I P S
Sbjct: 192 --GPEVDVWSLGVILYTLVSGSLP---F-DGQNLKELRERV----LRGKYRI--PFYMST 239
Query: 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
++ L + ++R T+ ++++
Sbjct: 240 DCENLLK----RFLVLN--PIKRGTLEQIMK 264
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 45/292 (15%), Positives = 97/292 (33%), Gaps = 41/292 (14%)
Query: 682 VLDCLKEDNIIGKGGAGIV----YKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
L L+ I+ A + + + + S + +I+ +
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLH-WDTRYKIAVEAAKG 796
++ V L S + + +L + ++ + I ++ A+
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG----------TSECM 846
+ +LH S ++HRD+K +NI V DFGL +
Sbjct: 177 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233
Query: 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMT 906
+ G+ Y++PE + K D++S G++L EL T
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL------------------LYSFST 275
Query: 907 DSKKEGVLKIL-DPRLPSVPL--HEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
++ ++ + + + P + + H+ ML ERP ++++
Sbjct: 276 QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT--ERPEATDIIE 325
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 20/197 (10%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+GKG +V + + G + A K + + E + +++H +IVRL
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ LV++ + G L E + + + + + Y H S IV
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIV 127
Query: 810 HRDVKSNNILLDSGFE-AHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----YAY 862
HR++K N+LL S + A V ADFGLA + D SE AG+ GY++PE Y
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 863 TLKVDEKSDVYSFGVVL 879
+ V D+++ GV+L
Sbjct: 185 SKPV----DIWACGVIL 197
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFN--AEIQTLGRIRHRHIVRLL 748
IG G G VY + N + VA+K++ S S++ + E++ L ++RH + ++
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 749 GFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDC 804
G C E LV EY GS ++L K +IA A +GL YLH
Sbjct: 121 G-CYLREHTAWLVMEYCL-GSASDLLEVHKKPL----QEVEIAAVTHGALQGLAYLH--- 171
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
S ++HRDVK+ NILL + DFG A + + + G+ ++APE +
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAM 225
Query: 865 KV---DEKSDVYSFGVVLLELITGRKP 888
D K DV+S G+ +EL + P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 61/242 (25%), Positives = 94/242 (38%), Gaps = 12/242 (4%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
+P IS + RLLNL N L L++L L N++ A L NL
Sbjct: 58 VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115
Query: 162 HLHLGGNFFSGQIPPE--YGIWEFLEYLAVSGNELGGKIPGEI-GNLTKLQQLYIGYYNS 218
L L N + IP + + L+ L + N + IP + L++L +G
Sbjct: 116 TLELFDNRLT-TIPNGAFVYLSK-LKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKR 172
Query: 219 YTGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGY 277
+ + LS+L + A C L EIP + L LD L L N LS
Sbjct: 173 LS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQG 229
Query: 278 LKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWEN 337
L L+ + + + +F L++L +NL N L + + LE + L N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 338 NF 339
+
Sbjct: 290 PW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 61/288 (21%), Positives = 102/288 (35%), Gaps = 30/288 (10%)
Query: 40 SLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLS---GALSPDVAHLRFLQNLSVAAN 96
A + C P V C + + NL +S + + L++ N
Sbjct: 24 GCVAETGSAQTC--PSV-CSCSNQFSKVICVRKNLREVPDGISTN------TRLLNLHEN 74
Query: 97 QLSGPIPPEISALSSLRLLNLSNN----VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPL 152
Q+ L L +L LS N + G+F + LA+L L+L++N +T
Sbjct: 75 QIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAF----NGLANLNTLELFDNRLTTIPNG 130
Query: 153 AVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAV----SGNELGGKIPGEIGNLTKL 208
A L L+ L L N IP + + L L G L+ L
Sbjct: 131 AFVYLSKLKELWLRNNPIE-SIPS--YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL 187
Query: 209 QQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALS 268
+ L + + P + L L D + LS P L +L L++ + +
Sbjct: 188 RYLNL-AMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
Query: 269 GPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLH 316
L+SL ++L++N T F L +L ++L N +
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 62/279 (22%), Positives = 106/279 (37%), Gaps = 59/279 (21%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWEN 337
+ + ++L N SF L++L +L L RN + I F G + L L+L++N
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNG-LANLNTLELFDN 122
Query: 338 NFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
T +IP KL+ L L +N + ++P + +L L LG
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR--IPSLRRL----------DLG 168
Query: 397 KCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLS 455
+ LS I +G F GL +L + L L + P + + + L ++ LS
Sbjct: 169 ELKRLS-----------YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215
Query: 456 NNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPE- 514
N LS ++ G F G L L K+ ++ I
Sbjct: 216 GNHLS-AIRP--GSFQG---------------------LMHLQKLWMIQSQIQ-VIERNA 250
Query: 515 ISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRN 553
+ L ++L+ N L+ + T + L ++L N
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 60/297 (20%), Positives = 101/297 (34%), Gaps = 80/297 (26%)
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNK 362
+ + R L +P+ G+ +L L EN I + L IL LS N
Sbjct: 44 QFSKVICVRKNLR-EVPD--GISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 363 LTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-G 421
+ +I G F G
Sbjct: 100 IR-------------------------------------------------TIEIGAFNG 110
Query: 422 LPSLSQVELQDNYLTGQFPVSDSIS-------VNLGQICLSNNQLSGSLPASIGKFSGVQ 474
L +L+ +EL DN LT +I L ++ L NN + S+P+ F+ +
Sbjct: 111 LANLNTLELFDNRLT-------TIPNGAFVYLSKLKELWLRNNPIE-SIPSYA--FNRIP 160
Query: 475 KL----LLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRN 529
L L + + S I L L ++ + P ++ L +DLS N
Sbjct: 161 SLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGN 217
Query: 530 ELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
LS P G+ L L + ++ + + ++QSL ++ ++NNL+ L
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 48/273 (17%), Positives = 90/273 (32%), Gaps = 78/273 (28%)
Query: 327 PRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNF 386
+ + N +P + +N R+L+L N++ + N + L
Sbjct: 43 NQFSKVICVRKNLR-EVPDGISTN--TRLLNLHENQIQ-IIKV-----NSFKHL------ 87
Query: 387 LFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSI 445
L +++ N + +I G F GL +L+ +EL DN LT +I
Sbjct: 88 ------------RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-------TI 127
Query: 446 S-------VNLGQICLSNNQLSGSLPASIGKFSGVQKL----LLDGNKFSGQIPAEI-GK 493
L ++ L NN + S+P+ F+ + L L + + S I
Sbjct: 128 PNGAFVYLSKLKELWLRNNPIE-SIPSYA--FNRIPSLRRLDLGELKRLS-YISEGAFEG 183
Query: 494 LQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRN 553
L L ++ + ++ L + L+ L+LS N
Sbjct: 184 LSNLRYLNLAMCNLR----------EIPNLTPLIK----------------LDELDLSGN 217
Query: 554 HLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
HL P S + L + + + +
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 63/307 (20%), Positives = 102/307 (33%), Gaps = 20/307 (6%)
Query: 44 WNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDVAH-------LRFLQNLSVAAN 96
W T H TW + + + ++ A S + +
Sbjct: 5 WQVTVHHHTWNAILLPFVYLTAQVWILCAAIAAAASAGPQNCPSVCSCSNQFSKVVCTRR 64
Query: 97 QLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQ 156
LS +P I + + R LNL N L L+VL L N++ A
Sbjct: 65 GLSE-VPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNG 121
Query: 157 LRNLRHLHLGGNFFSGQIPPE--YGIWEFLEYLAVSGNELGGKIPGEI-GNLTKLQQLYI 213
L +L L L N+ + IP + L L + N + IP + L +L +
Sbjct: 122 LASLNTLELFDNWLT-VIPSGAFEYL-SKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDL 178
Query: 214 GYYNSYTGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLT 272
G + L +L + C + ++P L L+ L + N
Sbjct: 179 GELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP-LVGLEELEMSGNHFPEIRP 235
Query: 273 TELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVL 332
L SLK + + N+ + +F L +L LNL N L + + L L
Sbjct: 236 GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295
Query: 333 QLWENNF 339
L N +
Sbjct: 296 HLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 63/289 (21%), Positives = 104/289 (35%), Gaps = 34/289 (11%)
Query: 41 LAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLS---GALSPDVAHLRFLQNLSVAANQ 97
AA +A +C P V C + + + LS + + +L L N
Sbjct: 36 AAAASAGPQNC--PSV-CSCSNQFSKVVCTRRGLSEVPQGIPSNTRYL-NLME-----NN 86
Query: 98 LSGPIPPEI-SALSSLRLLNLSNN----VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPL 152
+ I + L L +L L N + G+F + LASL L+L++N +T
Sbjct: 87 IQM-IQADTFRHLHHLEVLQLGRNSIRQIEVGAF----NGLASLNTLELFDNWLTVIPSG 141
Query: 153 AVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAV----SGNELGGKIPGEIGNLTKL 208
A L LR L L N IP + + L +L G L L
Sbjct: 142 AFEYLSKLRELWLRNNPIE-SIPS--YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL 198
Query: 209 QQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALS 268
+ L + + P + L L + + P L +L L++ + +S
Sbjct: 199 KYLNL-GMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255
Query: 269 GPLTTELGYLKSLKSMDLSNNIFTGEIPAS-FAELKNLTLLNLFRNKLH 316
L SL ++L++N + +P F L+ L L+L N +
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 57/297 (19%), Positives = 93/297 (31%), Gaps = 80/297 (26%)
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNK 362
+ + R L +P+ G+ L L ENN I + L +L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110
Query: 363 LTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-G 421
+ I G F G
Sbjct: 111 IR-------------------------------------------------QIEVGAFNG 121
Query: 422 LPSLSQVELQDNYLTGQFPVSDSIS-------VNLGQICLSNNQLSGSLPASIGKFSGVQ 474
L SL+ +EL DN+LT I L ++ L NN + S+P+ F+ V
Sbjct: 122 LASLNTLELFDNWLT-------VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA--FNRVP 171
Query: 475 KL----LLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRN 529
L L + K I L L ++ + P ++ L +++S N
Sbjct: 172 SLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DM-PNLTPLVGLEELEMSGN 228
Query: 530 ELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
P G+ L L + + + + + SL ++ ++NNLS L
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 60/281 (21%), Positives = 104/281 (37%), Gaps = 63/281 (22%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWEN 337
+ + ++L N +F L +L +L L RN + I F G + L L+L++N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNG-LASLNTLELFDN 133
Query: 338 NFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
T IP KLR L L +N + ++P + +L+ L LG
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR--VPSLMRL----------DLG 179
Query: 397 KCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLS 455
+ L I +G F GL +L + L + P + + V L ++ +S
Sbjct: 180 ELKKLE-----------YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 456 NNQLSGSLPASIGKFSGV---QKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIA 512
N + G F G+ +KL + ++ + + + F
Sbjct: 227 GNHFP-EIRP--GSFHGLSSLKKLWVMNSQ-----------VSLIERNAFDGLA------ 266
Query: 513 PEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRN 553
L ++L+ N LS + T +R L L+L N
Sbjct: 267 -------SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 7e-13
Identities = 51/273 (18%), Positives = 83/273 (30%), Gaps = 78/273 (28%)
Query: 327 PRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNF 386
+ + + +PQ + SN R L+L N + + D
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPSN--TRYLNLMENNIQ-MIQAD---------------- 93
Query: 387 LFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSI 445
+ L +++G N + I G F GL SL+ +EL DN+LT I
Sbjct: 94 -------TFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-------VI 138
Query: 446 S-------VNLGQICLSNNQLSGSLPASIGKFSGVQKL----LLDGNKFSGQIPAEI-GK 493
L ++ L NN + S+P+ F+ V L L + K I
Sbjct: 139 PSGAFEYLSKLRELWLRNNPIE-SIPSYA--FNRVPSLMRLDLGELKKLE-YISEGAFEG 194
Query: 494 LQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRN 553
L L ++ + L L L +S N
Sbjct: 195 LFNLKYLNLGMCNIK----------DMPNLTPLVG----------------LEELEMSGN 228
Query: 554 HLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
H P S + SL + + +S +
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 54/306 (17%), Positives = 86/306 (28%), Gaps = 47/306 (15%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISAL---SSLRLLNLSNNV 121
L D+ L+ L+V A ++ I + S L+ L L N
Sbjct: 47 YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106
Query: 122 FNGSFPPQLSQLASLQVLDLY-NNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGI 180
G+ PP L + + L N + +L+
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG---------------- 150
Query: 181 WEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAAN 240
L+ L+++ ++ L L + N +A
Sbjct: 151 ---LKVLSIAQAHSLNFSCEQVRVFPALSTLDL-SDNP-----------ELGERGLISAL 195
Query: 241 CGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPA-SF 299
C P LQ L + SG + L+ +DLS+N A S
Sbjct: 196 C------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 300 AELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLS 359
L LNL L +P+ + +L VL L N P ++ L L
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSPDELP-QVGNLSLK 304
Query: 360 SNKLTG 365
N
Sbjct: 305 GNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 54/353 (15%), Positives = 92/353 (26%), Gaps = 79/353 (22%)
Query: 95 ANQLSGPIPPEISA--LSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPL 152
A G E+ S LL + + + + SL+ L + + +
Sbjct: 27 AFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILF 86
Query: 153 AVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLY 212
++ + L + L + E+ G P + T
Sbjct: 87 GALRVLGISGL---------------------QELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 213 IGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLT 272
+ N + L + L L +
Sbjct: 126 LNLRNVSWATRDAWLAELQQWL-------------------KPGLKVLSIAQAHSLNFSC 166
Query: 273 TELGYLKSLKSMDLSNNIFTGEI-------PASFAELKNLTLLNLFRNKLHGAIPEFIGV 325
++ +L ++DLS+N GE P F L+ L L N G
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 326 MPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLG 384
+L+ L L N+ + +L L+LS L +P L L
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GLPAKLSVL---- 279
Query: 385 NFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTG 437
LS N L+ P LP + + L+ N
Sbjct: 280 ---------------DLSY-----NRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 59/354 (16%), Positives = 106/354 (29%), Gaps = 76/354 (21%)
Query: 236 FDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLT-TELGYLKSLKSMDLSNNIFTGE 294
A NC + ++ G ++L+ L +V+ + T++ SLK + +
Sbjct: 25 SSAFNCLGAADVELYGG-GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSR 83
Query: 295 IPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLG--SNGK 352
I + ++ L+ L L TG+ P L +
Sbjct: 84 ILFGALRVLGIS---------------------GLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 353 LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLN 412
L IL+L + L+ L + + +
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKP--------------------GLKVLSIAQAHSL 162
Query: 413 GSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISV----NLGQICLSNNQLSGSLPASIG 468
+ + P+LS ++L DN G+ + ++ L + L N +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM--------- 213
Query: 469 KFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQ-CKLLTFVDLS 527
SG A QL +D SHN L ++LS
Sbjct: 214 ------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 528 RNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSG 581
L ++P L L+ L+LS N L P S + + ++ N
Sbjct: 262 FTGLK-QVPKGLP--AKLSVLDLSYNRL-DRNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 44/243 (18%), Positives = 73/243 (30%), Gaps = 40/243 (16%)
Query: 63 HVTSLDLSGLNLSGALSPDVAHLRF--LQNLSVAANQLSG--PIPPEISALS--SLRLLN 116
+ L L L ++G P + L L++ + E+ L++L+
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 117 LSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVT----QLRNLRHLHLGGNFFSG 172
++ Q+ +L LDL +N G+ L + L+ L L
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA---- 211
Query: 173 QIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI-GNLS 231
G +LQ L + +NS S
Sbjct: 212 -----------------GMETPSGVCSALAAARVQLQGLDLS-HNSLRDAAGAPSCDWPS 253
Query: 232 SLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSG-PLTTELGYLKSLKSMDLSNNI 290
L + + GL ++P + L L L N L P EL + +L L N
Sbjct: 254 QLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNL---SLKGNP 307
Query: 291 FTG 293
F
Sbjct: 308 FLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 44/233 (18%), Positives = 81/233 (34%), Gaps = 18/233 (7%)
Query: 374 GNCLQTLITLGNFLFGPIPES-LGKCDSLSRMRMGENFLNGSIPKG---LFGLPSLSQVE 429
G L+ L+ + + + K SL R+ + + I G + G+ L ++
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 430 LQDNYLTGQFPVSDSISV--NLGQICLSNNQLSG--SLPASIGKFS--GVQKLLLDGNKF 483
L++ +TG P + +L + L N + + A + ++ G++ L +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQC----KLLTFVDLSRNE---LSGEIP 536
++ LS +D S N G + C L + L SG
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 537 NQLTGMRILNYLNLSRNHLVGSIPASIAS-MQSLTSVDFSYNNLSGLVPGTGQ 588
L L+LS N L + A L S++ S+ L + G
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA 274
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 40/223 (17%), Positives = 71/223 (31%), Gaps = 20/223 (8%)
Query: 377 LQTLITLGNFLFGPIPESLGKCDSLSRMR---MGENFLNGSIPKGLFGL--PSLSQVELQ 431
L+ L + I + +S ++ + + G+ P L P L+ + L+
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 432 DNYLTGQFP----VSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQI 487
+ + + + L + ++ + F + L L N G+
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 488 PAEI----GKLQQLSKMDFSHNKF---SGRIAPEISQCKLLTFVDLSRNELSGEIPNQL- 539
K L + + SG + + L +DLS N L
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 540 TGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGL 582
LN LNLS L +P + L+ +D SYN L
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN 289
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 48/216 (22%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 678 TCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTL 736
TC + + +GKG +V + + + G + A + + E +
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 737 GRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--KIAVEAA 794
++H +IVRL S + L+++ + G L E + ++ Y A
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--------YYSEADASHCI 116
Query: 795 K----GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMS 847
+ + + H +VHR++K N+LL S + +ADFGLA ++ +
Sbjct: 117 QQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWF 171
Query: 848 AIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVL 879
AG+ GY++PE Y V D+++ GV+L
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPV----DLWACGVIL 203
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 34/217 (15%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLP------AMSRGSSHDHGFNAEIQTLGRIRHRH 743
+G G G V +VA+K + +R + EI+ L ++ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 744 IVRLLGFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
I+++ F + +V E M G L + + G L T + + YLH
Sbjct: 77 IIKIKNF---FDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH 131
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAP 858
I+HRD+K N+LL S E + DFG +K L + + M + G+ Y+AP
Sbjct: 132 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAP 185
Query: 859 E-------YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
E Y V D +S GV+L ++G P
Sbjct: 186 EVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPP 218
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 25/228 (10%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA--EIQTLGRIRHRHIVRLL 748
+G+G G V + + VAVK + + D N EI + H ++V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYK-----IAVEAAKGLCYLHHD 803
G L EY G L + + G D + V YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVV------YLH-- 122
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
I HRD+K N+LLD ++DFGLA + + ++ + G+ Y+APE
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 864 LKVD-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK 910
+ E DV+S G+VL ++ G P + D Q + K
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKT 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVK-------RLPAMSRGSSHDHGFNAEIQTLGRI-RH 741
I+G+G + +V + + P + AVK + E+ L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+I++L + LV++ M G L + L K L KI + +C LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH 141
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-- 859
IVHRD+K NILLD + DFG + L E + + G+ Y+APE
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEII 195
Query: 860 ----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
++ D++S GV++ L+ G P
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 59/290 (20%), Positives = 109/290 (37%), Gaps = 24/290 (8%)
Query: 78 LSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQ 137
+ PD L ++ + ++ + + L + L+ + + L +L
Sbjct: 12 IFPD-PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66
Query: 138 VLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGK 197
L+L +N +T DL + L + L L GN + G+ ++ L ++ ++
Sbjct: 67 GLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSAIAGLQS-IKTLDLTSTQITDV 122
Query: 198 IPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNL 257
P + L+ LQ LY+ N T + P + L++L N +S P + L L
Sbjct: 123 TP--LAGLSNLQVLYLD-LNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKL 175
Query: 258 DTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG 317
TL N +S + L L +L + L NN + P A NL ++ L +
Sbjct: 176 TTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231
Query: 318 AIPEFIGVMPRLEVLQLWENNFTGSI-PQRLGSNGKLRILDLSSNKLTGT 366
+ L V + + I P + NG +L+ N +
Sbjct: 232 QPVFY---NNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 62/330 (18%), Positives = 118/330 (35%), Gaps = 49/330 (14%)
Query: 275 LGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQL 334
L + + + T + A+L +T L+ F + E + + L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 335 WENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPES 394
+N T + L + K+ L+LS N L +
Sbjct: 71 KDNQIT-DLAP-LKNLTKITELELSGNPLK--------------------------NVSA 102
Query: 395 LGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICL 454
+ S+ + + + P L GL +L + L N +T P++ NL + +
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLAGLT--NLQYLSI 158
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPE 514
N Q+S L + S + L D NK S I + L L ++ +N+ S
Sbjct: 159 GNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD--VSP 212
Query: 515 ISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDF 574
++ L V L+ ++ + + + N + + PA+I+ + S +
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNL 270
Query: 575 SYNNLSGLVPGTGQFSY-FNYTSFLGNSEL 603
++N S SY FN + N+ +
Sbjct: 271 TWNLTS----FINNVSYTFNQSVTFKNTTV 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 49/218 (22%), Positives = 82/218 (37%), Gaps = 25/218 (11%)
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
D+ +N IG+G G V + + A K++P F EI+ +
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--KYFVEDVDRFKQEIEIMKS 62
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
+ H +I+RL ++ LV E G L E + +I + +
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVA 120
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGY 855
Y H + HRD+K N L + + DFGLA + + M G+ Y
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYY 174
Query: 856 IAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
++P+ Y + D +S GV++ L+ G P
Sbjct: 175 VSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 28/202 (13%), Positives = 50/202 (24%), Gaps = 44/202 (21%)
Query: 692 IGKGGAGIVYKG----LMPNGDQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
G ++ L QVA+ + P + L RI + R
Sbjct: 39 HGGVPPLQFWQALDTAL---DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
+L L+V E++ GSL EV + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
+ + + + + +A +
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD-------A 179
Query: 867 DEKSDVYSFGVVLLELITGRKP 888
+ + D+ G L L+ R P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP 201
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 32/203 (15%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+GKG +V + + G + A K + + E + +++H +IVRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--KIAVEAAK----GLCYLHHD 803
+ LV++ + G L E + ++ Y A + + Y H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVARE--------FYSEADASHCIQQILESIAYCH-- 145
Query: 804 CSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAPE- 859
S IVHR++K N+LL S + +ADFGLA + D SE AG+ GY++PE
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGYLSPEV 201
Query: 860 ---YAYTLKVDEKSDVYSFGVVL 879
Y+ V D+++ GV+L
Sbjct: 202 LKKDPYSKPV----DIWACGVIL 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 25/228 (10%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA--EIQTLGRIRHRHIVRLL 748
+G+G G V + + VAVK + + D N EI + H ++V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYK-----IAVEAAKGLCYLHHD 803
G L EY G L + + G D + V YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVV------YLH-- 122
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
I HRD+K N+LLD ++DFGLA + + ++ + G+ Y+APE
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 864 LKVD-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK 910
+ E DV+S G+VL ++ G P + D Q + K
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKT 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 51/197 (25%), Positives = 79/197 (40%), Gaps = 23/197 (11%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
++G G V+ G A+K + EI L +I+H +IV L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS--LENEIAVLKKIKHENIVTLED 73
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ LV + + G L + + + G + + + YLH IV
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLH---ENGIV 128
Query: 810 HRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----YAY 862
HRD+K N+L + E + DFGL+K Q+ MS G+ GY+APE Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPY 184
Query: 863 TLKVDEKSDVYSFGVVL 879
+ V D +S GV+
Sbjct: 185 SKAV----DCWSIGVIT 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+G+G G V + L + AVK L + R + + EIQ L R+RH+++++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 749 GFCSNHETN--LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-------GLCY 799
N E +V EY G + E+L +A GL Y
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVC-------QAHGYFCQLIDGLEY 124
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
LH S IVH+D+K N+LL +G ++ G+A+ L + GS + PE
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 860 YAYTLKVDE--KSDVYSFGVVLLELITGRKP 888
A L K D++S GV L + TG P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 60/306 (19%), Positives = 114/306 (37%), Gaps = 56/306 (18%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLP--AMSRGSSHDHGFNA--EIQTLGRIRHR--HI 744
+G GG G VY G+ + + VA+K + +S +G E+ L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGE-----VLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
+RLL + ++ +L+ E + G L + + + + +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPV--QDLFDFITERGA----LQEELARSFFWQVLEAVRH 164
Query: 800 LHHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGLAKFLQDSG--TSECMSAIAGSYGYI 856
H + ++HRD+K NIL+D E + DFG L+D+ G+ Y
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-D-----GTRVYS 215
Query: 857 APEYAYTLKVD-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
PE+ + + V+S G++L +++ G P F +I G +
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEI-----------IRGQVF 261
Query: 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ---ILTELPKPPTSKQGEES 972
+ S ++ L + +RPT E+ + L T++ S
Sbjct: 262 F--RQRVSSECQHLIR----WCLALR--PSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS 313
Query: 973 LPPSGT 978
L P +
Sbjct: 314 LSPGPS 319
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 46/209 (22%), Positives = 83/209 (39%), Gaps = 25/209 (11%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR-HIVRLLG 749
+G+G +V + + G + A K L RG EI L + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-------GLCYLHH 802
N +L+ EY G + + + + + + G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVS-------ENDVIRLIKQILEGVYYLH- 148
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
IVH D+K NILL S + + DFG+++ + + + I G+ Y+APE
Sbjct: 149 --QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPE 203
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ +D+++ G++ L+T P
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD------HGFNAEIQTLGRIR-HR 742
+IG+G + +V + + G + AVK + + S + E L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLH-WDTRYKIAVEAAKGLCYLH 801
HI+ L+ + LV++ M G L + L K L +TR I + + +LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETR-SIMRSLLEAVSFLH 217
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-- 859
+ IVHRD+K NILLD + ++DFG + L+ E + + G+ GY+APE
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGYLAPEIL 271
Query: 860 ----YAYTLKVDEKSDVYSFGVVL 879
++ D+++ GV+L
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 52/215 (24%), Positives = 84/215 (39%), Gaps = 33/215 (15%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLP--AMSRGSSHDHGFNA--EIQTLGRIR----HR 742
+GKGG G V+ G + + QVA+K +P + S E+ L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGE-----VLHGKKGGHLHWDTRYKIAVEAAKGL 797
++RLL + E +LV E + G L + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP----LGEGPSRCFFGQVVAAI 152
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSG-FEAHVADFGLAKFLQDSG--TSECMSAIAGSYG 854
+ H S +VHRD+K NIL+D A + DFG L D G+
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-D-----GTRV 203
Query: 855 YIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRKP 888
Y PE+ + + V+S G++L +++ G P
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 69/342 (20%), Positives = 111/342 (32%), Gaps = 70/342 (20%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLP-------AMSRGSSHDHGFNAEIQTLGRIRHRH 743
+G G G V+ + +V VK + EI L R+ H +
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGE-----VLHGKKGGHLHWDTRYKIAVEAAKGLC 798
I+++L N LV E +G + H + L I + +
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPR----LDEPLASYIFRQLVSAVG 144
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---TSECMSAIAGSYGY 855
YL I+HRD+K NI++ F + DFG A +L+ T C G+ Y
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-C-----GTIEY 195
Query: 856 IAPE------YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909
APE Y + +++S GV L L+ P F + + +
Sbjct: 196 CAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENP---FCE-------LEET---- 236
Query: 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREV-----VQILTELPKPP 964
E + P L S L ++ +L R T+ ++ V L
Sbjct: 237 VEAAIHP--PYLVSKELMSLVS----GLLQPV--PERRTTLEKLVTDPWVTQPVNLADYT 288
Query: 965 TSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPPD 1006
+ + P SG S S N+ D +
Sbjct: 289 WEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGH 330
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 78/343 (22%), Positives = 120/343 (34%), Gaps = 62/343 (18%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG G G+ + VAVK + RG++ D EI +RH +IVR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK---YIERGAAIDENVQREIINHRSLRHPNIVRF--- 81
Query: 751 CSNHE-----TNL-LVYEYMPNGSLGE--VLHGKKGGHLHWDT-RYK-----IAVEAAKG 796
E T+L ++ EY G L E G+ D R+ V
Sbjct: 82 ---KEVILTPTHLAIIMEYASGGELYERICNAGR----FSEDEARFFFQQLLSGVS---- 130
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAH--VADFGLAKFLQDSG---TSECMSAIAG 851
Y H S I HRD+K N LLD + DFG +K ++ G
Sbjct: 131 --YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V-----G 179
Query: 852 SYGYIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK 910
+ YIAPE + D + +DV+S GV L ++ G P F + + + RK
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP---F-EDPEEPRDYRKTIQRIL 235
Query: 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ---ILTELPKPPTSK 967
I P + E H+ + + R ++ E+ L LP ++
Sbjct: 236 SVKYSI--PDDIRIS-PECCHLIS-RIFVAD--PATRISIPEIKTHSWFLKNLPADLMNE 289
Query: 968 QGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
S + S + + + PA D ++
Sbjct: 290 SNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTD 332
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
+G G G V G G +VAVK ++R EIQ L RH HI++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGE--VLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
L S +V EY+ G L + HG+ + ++ + + Y H
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCH--- 128
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---TSECMSAIAGSYGYIAPEYA 861
++VHRD+K N+LLD+ A +ADFGL+ + D TS C GS Y APE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-C-----GSPNYAAPEVI 182
Query: 862 YTLKVD-EKSDVYSFGVVLLELITGRKP 888
+ D++S GV+L L+ G P
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 52/264 (19%), Positives = 86/264 (32%), Gaps = 58/264 (21%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
+P I A + + + L N + +L +L L++N + A T L L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG 221
L L N + P + L +L L++
Sbjct: 84 QLDLSDNAQLRSVDP--ATFH---------------------GLGRLHTLHL-DRC---- 115
Query: 222 GLPPEIGNLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTTELGYLKS 280
L + + L L L+LQ NAL L +
Sbjct: 116 -------GLQE--------------LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154
Query: 281 LKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWENN 338
L + L N + +F L +L L L +N++ + F + RL L L+ NN
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD-LGRLMTLYLFANN 212
Query: 339 FTGSIPQR-LGSNGKLRILDLSSN 361
+ ++P L L+ L L+ N
Sbjct: 213 LS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 51/274 (18%), Positives = 83/274 (30%), Gaps = 64/274 (23%)
Query: 56 VTCDSRR----------HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPE 105
+C + + L G +S + R L L + +N L+ I
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAA 74
Query: 106 I-SALSSLRLLNLSNNVFNGSFPPQ-LSQLASLQVLDLYNNNMTGDLPLAV-TQLRNLRH 162
+ L+ L L+LS+N S P L L L L + +L + L L++
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 163 LHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGG 222
L+L N +P +L L L++ N +
Sbjct: 134 LYLQDNALQ-ALP-----------------------DDTFRDLGNLTHLFLH-GNRIS-S 167
Query: 223 LPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLK 282
+P F L +LD L L N ++ L L
Sbjct: 168 VPERA--------FR---------------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 283 SMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLH 316
++ L N + + A L+ L L L N
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 46/252 (18%), Positives = 87/252 (34%), Gaps = 42/252 (16%)
Query: 336 ENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESL 395
+ ++P + + + + L N+++ +P S
Sbjct: 20 QQGLQ-AVPVGIPAA--SQRIFLHGNRIS-HVPAA-----------------------SF 52
Query: 396 GKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSD-SISVNLGQIC 453
C +L+ + + N L I F GL L Q++L DN + L +
Sbjct: 53 RACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111
Query: 454 LSNNQLSGSLPASIGKFSGV---QKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSG 509
L L L + F G+ Q L L N +P + L L+ + N+ S
Sbjct: 112 LDRCGLQ-ELGPGL--FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS- 166
Query: 510 RIAPEI-SQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQ 567
+ L + L +N ++ P+ + L L L N+L ++P A ++
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLR 225
Query: 568 SLTSVDFSYNNL 579
+L + + N
Sbjct: 226 ALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 33/228 (14%)
Query: 318 AIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAG-N 375
A+P G+ + + L N + +P L IL L SN L + G
Sbjct: 25 AVPV--GIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80
Query: 376 CLQTLITLGNFLFGPIP-ESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDN 433
L+ L N + + L + + L + GLF GL +L + LQDN
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 434 YLTGQFPVSDSIS-------VNLGQICLSNNQLSGSLPASIGKFSG---VQKLLLDGNKF 483
L ++ NL + L N++S S+P F G + +LLL N+
Sbjct: 140 ALQ-------ALPDDTFRDLGNLTHLFLHGNRIS-SVPERA--FRGLHSLDRLLLHQNRV 189
Query: 484 SGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSRN 529
+ + L +L + N S + E + + L ++ L+ N
Sbjct: 190 A-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 39/201 (19%), Positives = 70/201 (34%), Gaps = 27/201 (13%)
Query: 400 SLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSIS-------VNLGQ 451
+ R+ + N ++ +P F +L+ + L N L I L Q
Sbjct: 33 ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-------RIDAAAFTGLALLEQ 84
Query: 452 ICLSNNQLSGSLPASIGKFSGVQKLL---LDGNKFSGQIPAEI-GKLQQLSKMDFSHNKF 507
+ LS+N S+ + F G+ +L LD ++ + L L + N
Sbjct: 85 LDLSDNAQLRSVDPAT--FHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 508 SGRIAPEI-SQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-AS 565
+ + LT + L N +S G+ L+ L L +N + +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
Query: 566 MQSLTSVDFSYNNLSGLVPGT 586
+ L ++ NNLS L
Sbjct: 200 LGRLMTLYLFANNLSALPTEA 220
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 34/180 (18%), Positives = 68/180 (37%), Gaps = 15/180 (8%)
Query: 414 SIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGV 473
++P G+ + ++ L N ++ S NL + L +N L+ + A F+G+
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA--AAFTGL 79
Query: 474 ---QKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSR 528
++L L N + L +L + + P + L ++ L
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQD 138
Query: 529 NELSGEIPNQ-LTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNLSGLVPGT 586
N L +P+ + L +L L N + S+P + SL + N ++ + P
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 27/133 (20%), Positives = 47/133 (35%), Gaps = 28/133 (21%)
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPE 514
L ++P I + Q++ L GN+ + + F
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNR-----------ISHVPAASFRA---------- 54
Query: 515 ISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVD 573
C+ LT + L N L+ TG+ +L L+LS N + S+ + + L ++
Sbjct: 55 ---CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111
Query: 574 FSYNNLSGLVPGT 586
L L PG
Sbjct: 112 LDRCGLQELGPGL 124
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 57/311 (18%), Positives = 91/311 (29%), Gaps = 71/311 (22%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWEN 337
++KS+DLSNN T + NL L L N ++ I E F + LE L L N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSS-LGSLEHLDLSYN 110
Query: 338 NFTGSIPQRL-GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
+ ++ L L+L N TL LF +
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETS---------------LFSHLT---- 149
Query: 397 KCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLS 455
L +R+G I + F GL L ++E+ + L P S N+ + L
Sbjct: 150 ---KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 456 NNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI 515
Q L + ++
Sbjct: 207 MKQHI-LLLE--IFVDV---------------------TSSVECLELRDTDLDT------ 236
Query: 516 SQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFS 575
+ELS N L + ++ L + + + L ++FS
Sbjct: 237 ----------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285
Query: 576 YNNLSGLVPGT 586
N L + G
Sbjct: 286 RNQLKSVPDGI 296
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 56/311 (18%), Positives = 106/311 (34%), Gaps = 45/311 (14%)
Query: 39 SSLAAWNATTSHCTWPG---VTCDSRRH----------VTSLDLSGLNLSGALSPDV-AH 84
S ++ + + S V SLDLS ++ +S
Sbjct: 16 SLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQR 74
Query: 85 LRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNN----VFNGSFPPQLSQLASLQVL 139
LQ L + +N ++ I + S+L SL L+LS N + + F L+SL L
Sbjct: 75 CVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWF----KPLSSLTFL 129
Query: 140 DLYNNNMTGDLPLAV-TQLRNLRHLHLGGNFFSGQIPPEYGIWE---FLEYLAVSGNELG 195
+L N ++ + L L+ L +G +I + FLE L + ++L
Sbjct: 130 NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR--KDFAGLTFLEELEIDASDLQ 187
Query: 196 GKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDI--- 251
P + ++ + L + L SS+ + + L +++
Sbjct: 188 SYEPKSLKSIQNVSHLILHMKQHIL--LLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245
Query: 252 -----GRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPAS-FAELKNL 305
+ + + +L + L + L ++ S N +P F L +L
Sbjct: 246 ETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSL 303
Query: 306 TLLNLFRNKLH 316
+ L N
Sbjct: 304 QKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 64/352 (18%), Positives = 117/352 (33%), Gaps = 53/352 (15%)
Query: 87 FLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNM 146
+ + + + S+ N S P L+ +++ LDL NN +
Sbjct: 8 VWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRI 64
Query: 147 TGDLPLAVTQLRNLRHLHLGGNFFSGQIPPE--YGIWEFLEYLAVSGNELGGKIPGEIGN 204
T + + NL+ L L N + I + + LE+L +S N L
Sbjct: 65 TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS-LEHLDLSYNYLSNLSSSWFKP 122
Query: 205 LTKLQQLYIGYYNSYTGGLPPEI--GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFL 262
L+ L L + N Y L +L+ L N +I
Sbjct: 123 LSSLTFLNL-LGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQ-------------- 166
Query: 263 QVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEF 322
+G L L+ +++ + P S ++N++ L L + + F
Sbjct: 167 -RKDFAG--------LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF 217
Query: 323 IGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLIT 382
+ V +E L+L + + L + + +N L + +
Sbjct: 218 VDVTSSVECLELRDTD--------LDTFHFSELSTGETNSLIKKFT--------FRNVKI 261
Query: 383 LGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDN 433
LF + + L + L + N L S+P G+F L SL ++ L N
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 47/249 (18%), Positives = 93/249 (37%), Gaps = 22/249 (8%)
Query: 367 LPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLS 426
+P + L +I+L ++ CD + LN SIP GL ++
Sbjct: 1 MPHTLWMVWVLGVIISLS--KEESSNQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVK 55
Query: 427 QVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSG---VQKLLLDGNKF 483
++L +N +T VNL + L++N ++ ++ FS ++ L L N
Sbjct: 56 SLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEE--DSFSSLGSLEHLDLSYNYL 112
Query: 484 SGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEI--SQCKLLTFVDLSRNELSGEIPNQ-L 539
S + + L L+ ++ N + + S L + + + +I +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 540 TGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLG 599
G+ L L + + L P S+ S+Q+++ + L+ + TS +
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF-----VDVTSSVE 225
Query: 600 NSELCGPYL 608
EL L
Sbjct: 226 CLELRDTDL 234
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVK----RLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G G IV K G + A K R SR E+ L ++ H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK----GLCYLH 801
L N +L+ E + G L + L K L + A K G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESL----SEEEATSFIKQILDGVNYLH 132
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTSECMSAIAGSYGYIA 857
+ I H D+K NI+L + DFGLA ++D I G+ ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPEFVA 186
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
PE + ++D++S GV+ L++G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 9e-20
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 24/234 (10%)
Query: 664 SRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRG 722
WK Q ++ D VLD +G G G+V++ G+ A K +
Sbjct: 137 FDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES 196
Query: 723 SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLH 782
EIQT+ +RH +V L + +++YE+M G L E + +
Sbjct: 197 DKET--VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---- 250
Query: 783 WDTRY--KIAVEAAK----GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLA 834
+ AVE + GLC++H VH D+K NI+ + + DFGL
Sbjct: 251 ---KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
L + + G+ + APE A V +D++S GV+ L++G P
Sbjct: 305 AHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 39/224 (17%)
Query: 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
D +D +G+G I K + + AVK + + EI L
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-----KRMEANTQKEITALKLC 62
Query: 740 R-HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK--- 795
H +IV+L + LV E + G L E + KK H+ EA+
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK----HFSET-----EASYIMR 113
Query: 796 ----GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSA 848
+ ++H +VHRD+K N+L + + DFG A+ + +
Sbjct: 114 KLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKT 168
Query: 849 IAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ Y APE Y DE D++S GV+L +++G+ P
Sbjct: 169 PCFTLHYAAPELLNQNGY----DESCDLWSLGVILYTMLSGQVP 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
D + D + ++ +G+G IVY+ A+K L + EI L R
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK----TVDKKIVRTEIGVLLR 104
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--KIAVEAAK- 795
+ H +I++L LV E + G L + + K Y + A +A K
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--------YYSERDAADAVKQ 156
Query: 796 ---GLCYLHHDCSPLIVHRDVKSNNILLDSGFE-AHV--ADFGLAKFLQDSGTSECMSAI 849
+ YLH IVHRD+K N+L + A + ADFGL+K ++ M +
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTV 210
Query: 850 AGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ GY APE AY +V D++S G++ L+ G +P
Sbjct: 211 CGTPGYCAPEILRGCAYGPEV----DMWSVGIITYILLCGFEP 249
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 58/225 (25%), Positives = 88/225 (39%), Gaps = 25/225 (11%)
Query: 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVK----RLPAMSRGSSHDHGFNA 731
F V D +G G IV K G + A K R SR
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV 791
E+ L ++ H +I+ L N +L+ E + G L + L K L + A
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESL----SEEEAT 118
Query: 792 EAAK----GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTS 843
K G+ YLH + I H D+K NI+L + DFGLA ++D
Sbjct: 119 SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---G 172
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
I G+ ++APE + ++D++S GV+ L++G P
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLL 748
++G+G V + + + AVK + G F E++ L + + HR+++ L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFR-EVEMLYQCQGHRNVLELI 77
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-------GLCYLH 801
F + LV+E M GS+ +H ++ H++ EA+ L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNEL-----EASVVVQDVASALDFLH 128
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSG-----TSECMSAIAGSY 853
+ I HRD+K NIL + + + DF L ++ +G ++ + GS
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 854 GYIAPE-----YAYTLKVDEKSDVYSFGVVL 879
Y+APE D++ D++S GV+L
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 41/216 (18%)
Query: 690 NIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGR-IRHRHIVRL 747
IG G + + + + AVK + R + EI+ L R +H +I+ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------EIEILLRYGQHPNIITL 81
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-------GLCYL 800
+ + +V E M G L + + +K + R EA+ + YL
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSER-----EASAVLFTITKTVEYL 132
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTSECMSAIAGSYGYI 856
H + +VHRD+K +NIL + DFG AK L+ + + ++
Sbjct: 133 H---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFV 187
Query: 857 APE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
APE Y D++S GV+L ++TG P
Sbjct: 188 APEVLERQGYDAAC----DIWSLGVLLYTMLTGYTP 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 671 AFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFN 730
+ R + +++ ++ +G+G G+VYK G VA+KR+ R + D G
Sbjct: 8 SSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI----RLDAEDEGIP 63
Query: 731 A----EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTR 786
+ EI L + H +IV L+ + LV+E+M L +VL K G L
Sbjct: 64 STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQI 121
Query: 787 YKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---TS 843
+ +G+ + H I+HRD+K N+L++S +ADFGLA+ T
Sbjct: 122 KIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
Query: 844 ECMSAIAGSYGYIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 886
E + + Y AP+ Y+ V D++S G + E+ITG+
Sbjct: 179 EVV-----TLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 686 LKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
+ + I+G G G V+K G ++A K + RG EI + ++ H ++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANL 148
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY--KIAVEAAKGLCYLHH 802
++L + +LV EY+ G L + + + DT K E G+ ++H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMH- 204
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPE- 859
I+H D+K NIL + + DFGLA+ + E + G+ ++APE
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEFLAPEV 259
Query: 860 --YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y + V +D++S GV+ L++G P
Sbjct: 260 VNYDF---VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 25/209 (11%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHI 744
IG+G G V+K + VA+KR+ R D G + EI L ++H++I
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
VRL + + LV+E+ L + G L + + KGL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY---- 860
++HRD+K N+L++ E +A+FGLA+ C SA + Y P+
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGA 176
Query: 861 -AYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y+ + D++S G + EL +P
Sbjct: 177 KLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 65/215 (30%), Positives = 92/215 (42%), Gaps = 41/215 (19%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
+G G G V G G +VAVK ++R EIQ L RH HI++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGE--VLHGKKGGHLHWDTRYKIAVEAAK-------GL 797
L S +V EY+ G L + +G+ L E+ + G+
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEK-------ESRRLFQQILSGV 129
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---TSECMSAIAGSYG 854
Y H ++VHRD+K N+LLD+ A +ADFGL+ + D TS C GS
Sbjct: 130 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-C-----GSPN 180
Query: 855 YIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRKP 888
Y APE + D++S GV+L L+ G P
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 44/207 (21%), Positives = 85/207 (41%), Gaps = 27/207 (13%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G+G GIV++ + + K + +G+ EI L RHR+I+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKK-EISILNIARHRNILHLHES 69
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-------GLCYLHHD 803
+ E ++++E++ + E + L+ E L +LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERI-NTSAFELN-------EREIVSYVHQVCEALQFLH-- 119
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
S I H D++ NI+ + + + +FG A+ L+ + + + Y APE
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVH 175
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKP 888
V +D++S G ++ L++G P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 48/232 (20%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVK--------------RLPAMSRGSSHDHGFNA----- 731
IGKG G+V + A+K R P G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 732 -----EIQTLGRIRHRHIVRL---LGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLH 782
EI L ++ H ++V+L L + E +L +V+E + G V+ L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPN--EDHLYMVFELVNQG---PVMEVPTLKPLS 135
Query: 783 WDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842
D + KG+ YLH I+HRD+K +N+L+ +ADFG++ + S
Sbjct: 136 EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD- 191
Query: 843 SECMSAIAGSYGYIAPEYAYTLKVDEK------SDVYSFGVVLLELITGRKP 888
+S G+ ++APE +L K DV++ GV L + G+ P
Sbjct: 192 -ALLSNTVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-19
Identities = 43/203 (21%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G G G+V++ + G K + + EI + ++ H ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--VKNEISIMNQLHHPKLINLHDA 116
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV---EAAKGLCYLHHDCSPL 807
+ +L+ E++ G L + + + + + ++ +A +GL ++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI-AAEDYKM---SEAEVINYMRQACEGLKHMH---EHS 169
Query: 808 IVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
IVH D+K NI+ ++ + V DFGLA L E + + + APE
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREP 226
Query: 866 VDEKSDVYSFGVVLLELITGRKP 888
V +D+++ GV+ L++G P
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-19
Identities = 53/214 (24%), Positives = 82/214 (38%), Gaps = 37/214 (17%)
Query: 691 IIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLL 748
++G G G V + G + A+K L + E+ + HIV +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCIL 88
Query: 749 GFCSNHETN----LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-------GL 797
N L++ E M G L + + G + R EAA+ +
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQER--GDQAFTER-----EAAEIMRDIGTAI 141
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYG 854
+LH I HRDVK N+L S + + DFG AK + +
Sbjct: 142 QFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPY 194
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y+APE K D+ D++S GV++ L+ G P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 31/213 (14%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVK----RLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVR 746
+G G IV K G + A K R + SR E+ L IRH +I+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-------GLCY 799
L N +L+ E + G L + L K L EA + G+ Y
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEK--ESLT-------EDEATQFLKQILDGVHY 123
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTSECMSAIAGSYGY 855
LH S I H D+K NI+L + + DFG+A ++ I G+ +
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFGTPEF 177
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+APE + ++D++S GV+ L++G P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIV 745
IG+G G+VYK G+ A+K++ R D G + EI L ++H +IV
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI----RLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 746 RLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
+L + + L LV+E++ L ++L +GG L T ++ G+ Y H
Sbjct: 64 KLYDVI-HTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRR 120
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----- 859
++HRD+K N+L++ E +ADFGLA+ + + Y AP+
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGS 175
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y+ + D++S G + E++ G
Sbjct: 176 KKYSTTI----DIWSVGCIFAEMVNGT 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 42/215 (19%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHIVR 746
+G+G G V +VA+K +SR + EI L +RH HI++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGE--VLHGKKGGHLHWDTRYKIAVEAAK-------GL 797
L + ++V EY G L + V + + D E + +
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKKR----MTED-------EGRRFFQQIICAI 121
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---TSECMSAIAGSYG 854
Y H IVHRD+K N+LLD +ADFGL+ + D TS C GS
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-C-----GSPN 172
Query: 855 YIAPEYAYTLKVD-EKSDVYSFGVVLLELITGRKP 888
Y APE + DV+S G+VL ++ GR P
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 26/161 (16%), Positives = 61/161 (37%), Gaps = 9/161 (5%)
Query: 204 NLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQ 263
+G + ++SL AN ++ ++ T I N+ L +
Sbjct: 21 TFKAYLNGLLGQ----SSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTIN 74
Query: 264 VNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFI 323
+ + L +L+ + + T + + + L +LTLL++ + +I I
Sbjct: 75 NIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 324 GVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364
+P++ + L N I L + +L+ L++ + +
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 39/209 (18%), Positives = 68/209 (32%), Gaps = 35/209 (16%)
Query: 107 SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLG 166
S + L + +Q+ SL + L N N+T DL + N++ L +
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTIN 74
Query: 167 GNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPE 226
+ P I L+ L++L I T P
Sbjct: 75 NIHATN-YNP-------------------------ISGLSNLERLRIM-GKDVTSDKIPN 107
Query: 227 IGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDL 286
+ L+SL D ++ I T I L ++++ L N + L L LKS+++
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166
Query: 287 SNNIFTGEIPASFAELKNLTLLNLFRNKL 315
+ + L L F +
Sbjct: 167 QFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 7/153 (4%)
Query: 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVF 122
+T + L+ +N++ L+ + + +++L++ + P IS LS+L L +
Sbjct: 45 SLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
Query: 123 NGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWE 182
P LS L SL +LD+ ++ + + L + + L N I P +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTL-P 159
Query: 183 FLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGY 215
L+ L + + + G I + KL QLY
Sbjct: 160 ELKSLNIQFDGV-HDYRG-IEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 25/137 (18%), Positives = 56/137 (40%), Gaps = 5/137 (3%)
Query: 448 NLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKF 507
+L I L+N ++ L I ++ L ++ + P I L L ++
Sbjct: 45 SLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
Query: 508 SGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQ 567
+ P +S LT +D+S + I ++ + +N ++LS N + I + ++
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLP 159
Query: 568 SLTSVDFSYNNLSGLVP 584
L S++ ++ +
Sbjct: 160 ELKSLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 30/166 (18%), Positives = 62/166 (37%), Gaps = 17/166 (10%)
Query: 422 LPSLSQVELQDNYLTGQFPVSDSIS-----VNLGQICLSNNQLSGSLPASIGKFSGVQKL 476
+ SL+ + L + +T ++ N+ + ++N + P I S +++L
Sbjct: 43 MNSLTYITLANINVT-------DLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERL 93
Query: 477 LLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIP 536
+ G + + L L+ +D SH+ I +I+ + +DLS N +I
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 537 NQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGL 582
L + L LN+ + + I L + + G
Sbjct: 154 P-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 23/141 (16%), Positives = 50/141 (35%), Gaps = 7/141 (4%)
Query: 229 NLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSN 288
+ + + + L + + V L+G + Y ++K + ++N
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 289 NIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLG 348
T P + L NL L + + + + L +L + + SI ++
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 349 SNGKLRILDLSSNKLTGTLPP 369
+ K+ +DLS N + P
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 27/210 (12%), Positives = 61/210 (29%), Gaps = 38/210 (18%)
Query: 278 LKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWEN 337
K+ + L + + A++ +LT + L + I ++ L +
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 338 NFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGK 397
+ T P + L L + +T +L
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSD------------------------KIPNLSG 110
Query: 398 CDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS--VNLGQICLS 455
SL+ + + + + SI + LP ++ ++L N + L + +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI---MPLKTLPELKSLNIQ 167
Query: 456 NNQLSGSLPASIGKFSGVQKLLLDGNKFSG 485
+ + I F + +L G
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 15/84 (17%), Positives = 34/84 (40%), Gaps = 3/84 (3%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
T LD+S ++ + L + ++ ++ N I P + L L+ LN+ + +
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH- 172
Query: 125 SFPPQLSQLASLQVLDLYNNNMTG 148
+ + L L ++ + G
Sbjct: 173 DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 49/219 (22%)
Query: 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGF-NAEIQTLGRIRHRHIVRLLG 749
+IG G G+V++ + D+VA+K++ D F N E+Q + ++H ++V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQ-------DKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 750 F-----CSNHETNL-LVYEYMPNGSLGEVL--HGKKGGHLHWDT----RYKIAVEAAKGL 797
F E L LV EY+P ++ + K + Y++ + L
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSL 154
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHV---ADFGLAKFL--QDSGTSECMSAIAGS 852
Y+H S I HRD+K N+LLD + V DFG AK L + S I
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDP--PSGVLKLIDFGSAKILIAGEPNVSY----ICSR 205
Query: 853 YGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y Y APE YT + D++S G V+ EL+ G+
Sbjct: 206 Y-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 47/221 (21%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVK-----RLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+G G +V K G Q A K R + RG S + E+ L I+H +++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER-EVSILKEIQHPNVI 77
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA-------VEAAK--- 795
L N +L+ E + GG L D +A EA +
Sbjct: 78 TLHEVYENKTDVILILELV------------AGGELF-D---FLAEKESLTEEEATEFLK 121
Query: 796 ----GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTSECMS 847
G+ YLH S I H D+K NI+L + DFGLA +
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFK 175
Query: 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
I G+ ++APE + ++D++S GV+ L++G P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 69/222 (31%), Positives = 99/222 (44%), Gaps = 54/222 (24%)
Query: 691 IIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGF-NAEIQTLGRIRHRHIVRLL 748
+IG G G+VY+ L +G+ VA+K++ D F N E+Q + ++ H +IVRL
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHCNIVRLR 113
Query: 749 G-FCSNHETNL-----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK------- 795
F S+ E LV +Y+P E ++ + + + + V K
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP-----ETVY--RVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 796 -GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV---ADFGLAKFLQDSG--TSECMSAI 849
L Y+H S I HRD+K N+LLD + V DFG AK L S I
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSY----I 217
Query: 850 AGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y Y APE YT + DV+S G VL EL+ G+
Sbjct: 218 CSRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 691 IIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLL 748
++G G G V + ++ A+K L + E++ R + HIVR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIV 121
Query: 749 GFCSNHETN----LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAA-------KGL 797
N L+V E + G L + + G + R EA+ + +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTER-----EASEIMKSIGEAI 174
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYG 854
YLH S I HRDVK N+L S + DFG AK ++ +
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPY 228
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y+APE K D+ D++S GV++ L+ G P
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 7e-18
Identities = 50/254 (19%), Positives = 101/254 (39%), Gaps = 23/254 (9%)
Query: 88 LQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMT 147
+ + + I P A + NL + + ++L S+ + N+++
Sbjct: 1 MGETITVSTPIKQ-IFP-DDAFAETIKDNLKKK--SVTDAVTQNELNSIDQIIANNSDIK 56
Query: 148 GDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF--LEYLAVSGNELGGKIPGEIGNL 205
+ + L N+ L L GN ++ + L +L + N++ + + +L
Sbjct: 57 -SVQ-GIQYLPNVTKLFLNGN----KLTDIKPLTNLKNLGWLFLDENKI-KDLSS-LKDL 108
Query: 206 TKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVN 265
KL+ L + +N + + + +L L N ++ T + RL LDTL L+ N
Sbjct: 109 KKLKSLSLE-HNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDN 163
Query: 266 ALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGV 325
+S L L L+++ LS N + ++ A A LKNL +L LF +
Sbjct: 164 QISD--IVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSN 219
Query: 326 MPRLEVLQLWENNF 339
+ ++ + +
Sbjct: 220 LVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 7e-13
Identities = 45/311 (14%), Positives = 96/311 (30%), Gaps = 76/311 (24%)
Query: 275 LGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQL 334
+L T + EL ++ + + + ++ +Q
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----------SVQGIQ- 62
Query: 335 WENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPES 394
+ L L+ NKLT D+ +
Sbjct: 63 ---YLP-----------NVTKLFLNGNKLT-----DI---------------------KP 82
Query: 395 LGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS-----VNL 449
L +L + + EN + + L L L + L+ N ++ I+ L
Sbjct: 83 LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-------DINGLVHLPQL 133
Query: 450 GQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSG 509
+ L NN+++ + + + + L L+ N+ S I + L +L + S N S
Sbjct: 134 ESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS- 188
Query: 510 RIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSL 569
++ K L ++L E + N + + + N + + L P I+
Sbjct: 189 -DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDY 245
Query: 570 TSVDFSYNNLS 580
+ ++
Sbjct: 246 EKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 3e-11
Identities = 40/182 (21%), Positives = 76/182 (41%), Gaps = 15/182 (8%)
Query: 406 MGENFLNGSIPKGLFGLPSLSQVE---LQDNYLTGQFPVSDSISVNLGQICLSNNQLSGS 462
MGE + K +F + ++ L+ +T ++ ++ QI +N+ + S
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSDIK-S 57
Query: 463 LPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLT 522
+ I V KL L+GNK + I + L+ L + NK ++ + K L
Sbjct: 58 VQG-IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLK 112
Query: 523 FVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGL 582
+ L N +S +I L + L L L N + + ++ + L ++ N +S +
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI 168
Query: 583 VP 584
VP
Sbjct: 169 VP 170
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 6/101 (5%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
SL L ++ ++ ++ L L LS+ NQ+S I P ++ L+ L+ L LS N +
Sbjct: 134 ESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS- 188
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHL 165
L+ L +L VL+L++ + L +
Sbjct: 189 DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 52/222 (23%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHI 744
+ +G+G VYK VA+K++ + S G N EI+ L + H +I
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 745 VRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+ LL H++N+ LV+++M L ++ L + +GL YLH
Sbjct: 75 IGLLDAFG-HKSNISLVFDFMET-DLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG--------- 854
I+HRD+K NN+LLD +ADFGLAK S+G
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAK----------------SFGSPNRAYTHQ 172
Query: 855 -----YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 886
Y APE Y + V D+++ G +L EL+
Sbjct: 173 VVTRWYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 61/215 (28%), Positives = 86/215 (40%), Gaps = 35/215 (16%)
Query: 691 IIGKGGAGIVY----KGLMPNGDQVAVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
+IG+G G V K A+K L M + S F E + +
Sbjct: 76 VIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWV 131
Query: 745 VRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
V+L + + L +V EYMP G L V R+ A E L +H
Sbjct: 132 VQLF-YAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFYTA-EVVLALDAIH-- 185
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-- 859
S +HRDVK +N+LLD H+ ADFG + G C +A+ G+ YI+PE
Sbjct: 186 -SMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241
Query: 860 ------YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y + D +S GV L E++ G P
Sbjct: 242 KSQGGDGYYGREC----DWWSVGVFLYEMLVGDTP 272
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 37/215 (17%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHI 744
+G+G G VYK + + VA+KR+ R + G E+ L ++HR+I
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI----RLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
+ L ++ L++EY N L + + K + + G+ + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCH--- 149
Query: 805 SPLIVHRDVKSNNILLDSGFEAH-----VADFGLAKFLQDSG---TSECMSAIAGSYGYI 856
S +HRD+K N+LL + + DFGLA+ T E + + Y
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-----TLWYR 204
Query: 857 APEY-----AYTLKVDEKSDVYSFGVVLLELITGR 886
PE Y+ V D++S + E++
Sbjct: 205 PPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 691 IIGKGGAGIVY----KGLMPNGDQVAVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
I+G+G V + A+K L + + + + E + R+ H
Sbjct: 37 ILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDHPFF 92
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIAVEAAKGLCYLH-H 802
V+L + E Y NG L + + +K G TR+ A E L YLH
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK 149
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
I+HRD+K NILL+ + H+ DFG AK L ++ G+ Y++PE
Sbjct: 150 G----IIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ SD+++ G ++ +L+ G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 50/223 (22%)
Query: 691 IIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRHI 744
+ G+G G V G G VA+K++ +Q L + H +I
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKV--------IQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 745 VRLL-GFCSNHETNL------LVYEYMPNGSLGEVL--HGKKGGHLHWDT----RYKIAV 791
V+L F + E + +V EY+P+ +L + ++ +++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI- 139
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLD-SGFEAHVADFGLAKFL--QDSGTSECMSA 848
+ + LH S + HRD+K +N+L++ + + DFG AK L + +
Sbjct: 140 ---RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY---- 191
Query: 849 IAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
I Y Y APE YT V D++S G + E++ G
Sbjct: 192 ICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-17
Identities = 65/238 (27%), Positives = 95/238 (39%), Gaps = 42/238 (17%)
Query: 667 WKLTAFQRL---DFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQV-AVKRL--PAMS 720
WK Q + F + ++GKGG G V + ++ A K+L +
Sbjct: 173 WKWLERQPVTKNTF------RQYR---VLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223
Query: 721 RGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGG 779
+ N E Q L ++ R +V L + + L LV M G L H G
Sbjct: 224 KRKGEAMALN-EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL--KFHIYHMG 279
Query: 780 HLHWD---TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLA 834
+ + A E GL LH IV+RD+K NILLD H+ +D GLA
Sbjct: 280 QAGFPEARAVFYAA-EICCGLEDLH---RERIVYRDLKPENILLDD--HGHIRISDLGLA 333
Query: 835 KFLQDSGTSECMSAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ + T G+ GY+APE YT D ++ G +L E+I G+ P
Sbjct: 334 VHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 23/168 (13%)
Query: 730 NAEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLH-WDTRY 787
E+Q + + H +V L + E ++ +V + + G L H ++ H +
Sbjct: 63 FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKL 119
Query: 788 KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847
I E L YL + I+HRD+K +NILLD H+ DF +A L ++
Sbjct: 120 FIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---IT 172
Query: 848 AIAGSYGYIAPE-------YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+AG+ Y+APE Y+ V D +S GV EL+ GR+P
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 691 IIGKGGAGIVYKGLMPNGDQV-AVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+IG+G G V + N D+V A+K L M + + F E L + I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWITTL 139
Query: 748 LGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
+ + NL LV +Y G L +L + R+ +A E + +H
Sbjct: 140 H-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---QL 194
Query: 807 LIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----- 859
VHRD+K +NIL+D H+ ADFG L + GT + A+ G+ YI+PE
Sbjct: 195 HYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAM 251
Query: 860 ----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y + D +S GV + E++ G P
Sbjct: 252 EGGKGRYGPEC----DWWSLGVCMYEMLYGETP 280
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 679 CDDVLDCLKEDNIIGKGGAGIVYKG--LMPNGDQVAVKRLPAMSRGSSHDHGFNA----E 732
C + IG+G G V+K L G VA+KR+ R + + G E
Sbjct: 7 CRAD-QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIRE 61
Query: 733 IQTLGRIR---HRHIVRLL----GFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD 784
+ L + H ++VRL ++ ET L LV+E++ L L + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
T + + +GL +LH +VHRD+K NIL+ S + +ADFGLA+
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-- 175
Query: 845 CMSAIAGSYGYIAPEY----AYTLKVDEKSDVYSFGVVLLELITGR 886
++++ + Y APE +Y V D++S G + E+ +
Sbjct: 176 -LTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 61/212 (28%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 691 IIGKGGAGIVYKGLMPNGDQV-AVKRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+IG+G V M QV A+K + M + F E L R I +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQL 126
Query: 748 LGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIAVEAAKGLCYLHHDCS 805
F E L LV EY G L +L K G + + R+ +A E + +H
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA-EIVMAIDSVH---R 180
Query: 806 PLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
VHRD+K +NILLD H+ ADFG L+ GT + A+ G+ Y++PE
Sbjct: 181 LGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQA 237
Query: 864 LKVDEKSDVY-------SFGVVLLELITGRKP 888
+ + Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 54/218 (24%), Positives = 83/218 (38%), Gaps = 37/218 (16%)
Query: 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNA---------EIQTLGRIRH 741
I G G V G+ G VA+KR+ + + EI+ L H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 742 RHIVRLLG-FCSNHETNL----LVYEYMPNGSLGEVLHGKKGG--HLHWDTRYKIAVEAA 794
+I+ L F E + LV E M L +V+H ++ H +Y
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH--IQY-FMYHIL 144
Query: 795 KGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSA-IAGSY 853
GL LH +VHRD+ NILL + + DF LA+ + + + +
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRW 198
Query: 854 GYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y APE +T V D++S G V+ E+ +
Sbjct: 199 -YRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 33/213 (15%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHI 744
+G G VYKGL G VA+K + + G + EI + ++H +I
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKL-----DSEEGTPSTAIREISLMKELKHENI 65
Query: 745 VRLLGFCSNHETNLLVYEYMPN---GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
VRL LV+E+M N + G L + + +GL + H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---TSECMSAIAGSYGYIAP 858
+ I+HRD+K N+L++ + + DFGLA+ +SE ++ Y AP
Sbjct: 126 ENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT-----LWYRAP 177
Query: 859 EY-----AYTLKVDEKSDVYSFGVVLLELITGR 886
+ Y+ +D ++S G +L E+ITG+
Sbjct: 178 DVLMGSRTYSTSID----IWSCGCILAEMITGK 206
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 42/277 (15%), Positives = 83/277 (29%), Gaps = 47/277 (16%)
Query: 50 HCTWPGVTCDSRR----------HVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQL 98
HC+ C + + L L + + L+ + ++ N +
Sbjct: 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDV 66
Query: 99 SGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQ-LSQLASLQVLDLYNNNMTGDLPLAVTQ 156
I ++ S L L + + P+ L +LQ L + N + +
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
Query: 157 LRNLRHLHLGGNFFSGQIPPE--YGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIG 214
L + N I G+ L ++ N + +I N T+L +L +
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLS 185
Query: 215 YYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTT 273
N+ E+P D+ L + + +
Sbjct: 186 DNNNLE-------------------------ELPNDVFHGASGPVILDISRTRIHSLPSY 220
Query: 274 ELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNL 310
L LK L++ N ++P + +L L +L
Sbjct: 221 GLENLKKLRARSTYNLK---KLP-TLEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 39/281 (13%), Positives = 89/281 (31%), Gaps = 41/281 (14%)
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQR-LGSNGKLRILDLSSNK 362
+ + +K+ IP + L+ I + G L +++S N
Sbjct: 10 SNRVFLCQESKVT-EIPS--DLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65
Query: 363 LTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-G 421
+ + D+ + L L + + K ++L I F
Sbjct: 66 VLEVIEADVFSN--LPKLHEI----------RIEKANNLL-----------YINPEAFQN 102
Query: 422 LPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLL---- 477
LP+L + + + + V S+ + + +N ++ F G+
Sbjct: 103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER--NSFVGLSFESVILW 160
Query: 478 LDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSRNELSGEIP 536
L+ N +I QL +++ S N + ++ +D+SR +
Sbjct: 161 LNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219
Query: 537 NQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYN 577
L ++ L + +P ++ + +L +Y
Sbjct: 220 YGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 46/266 (17%), Positives = 77/266 (28%), Gaps = 41/266 (15%)
Query: 111 SLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFF 170
S R+ + P L + L + A + +L + + N
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 171 SGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI-GN 229
I NL KL ++ I N+ + PE N
Sbjct: 67 LEVIEA-----------------------DVFSNLPKLHEIRIEKANNLLY-INPEAFQN 102
Query: 230 LSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNA--LSGPLTTELGYLKSLKSMDL 286
L +L +N G+ +P L +Q N + + +G + L
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 287 SNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWENNFTGSIP 344
+ N ++F + L N L +P F G +L + S+P
Sbjct: 162 NKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHG-ASGPVILDISRTRIH-SLP 218
Query: 345 QR-LGSNGKLRILDLSSNKLTGTLPP 369
L + KLR + K LP
Sbjct: 219 SYGLENLKKLRARSTYNLK---KLPT 241
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 37/230 (16%), Positives = 68/230 (29%), Gaps = 22/230 (9%)
Query: 368 PPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLS 426
+C +C + IP L + + +R L I KG F G L
Sbjct: 3 HHRIC--HCSNRVFLCQESKVTEIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLE 57
Query: 427 QVELQDNYLTGQFPVS--DSISVNLGQICLSN-NQLSGSLPASIGKFSGV---QKLLLDG 480
++E+ N + ++ L +I + N L + F + Q LL+
Sbjct: 58 KIEISQNDVLEVIEADVFSNLP-KLHEIRIEKANNLL-YINPEA--FQNLPNLQYLLISN 113
Query: 481 NKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQ--CKLLTFVDLSRNELSGEIPN 537
+P Q +D N I + L++N + +
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS 172
Query: 538 QLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNLSGLVPGT 586
G ++ N+L +P + +D S + L
Sbjct: 173 AFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYG 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 44/233 (18%)
Query: 679 CDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EI 733
CD+V ++ IG+G G V+K G +VA+K++ + GF EI
Sbjct: 13 CDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREI 67
Query: 734 QTLGRIRHRHIVRLLGFCSNHETNL--------LVYEYMPNGSLGEVLHGKKGGHLHWDT 785
+ L ++H ++V L+ C + LV+++ + L +L
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS-NVLVKFTLSE 125
Query: 786 RYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC 845
++ GL Y+H + I+HRD+K+ N+L+ +ADFGLA+ + S+
Sbjct: 126 IKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ- 181
Query: 846 MSAIAGSYG-------YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 886
Y Y PE Y + D++ G ++ E+ T
Sbjct: 182 ----PNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLG 737
++ + + +G+G VYKG + VA+K + H+ G E+ L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-----EHEEGAPCTAIREVSLLK 55
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGL 797
++H +IV L ++ LV+EY+ L + L G ++ + +GL
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD-DCGNIINMHNVKLFLFQLLRGL 113
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG---TSECMSAIAGSYG 854
Y H ++HRD+K N+L++ E +ADFGLA+ +E + +
Sbjct: 114 AYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLW 165
Query: 855 YIAPEY-----AYTLKVDEKSDVYSFGVVLLELITGR 886
Y P+ Y+ ++ D++ G + E+ TGR
Sbjct: 166 YRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-16
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 39/238 (16%)
Query: 667 WKLTAFQRL---DFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQV-AVKRL--PAMS 720
WK Q + F + ++G+GG G V+ M ++ A K+L +
Sbjct: 174 WKWLEAQPMGEDWF------LDFR---VLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 721 RGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGG 779
+ + E + L ++ R IV L + +T+L LV M G + ++
Sbjct: 225 KRKGYQGAMV-EKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDED 282
Query: 780 HLHWD---TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLA 834
+ + + A + GL +LH I++RD+K N+LLD + +V +D GLA
Sbjct: 283 NPGFQEPRAIFYTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDD--DGNVRISDLGLA 336
Query: 835 KFLQDSGTSECMSAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ AG+ G++APE Y V D ++ GV L E+I R P
Sbjct: 337 V--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 41/215 (19%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHI 744
++G+G G+V K G VA+K+ S D EI+ L ++RH ++
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 745 VRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
V LL C + LV+E++ + ++ + L G L + K + G+ + H
Sbjct: 87 VNLLEVCK-KKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSH 143
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG-------YI 856
I+HRD+K NIL+ + DFG A+ L G Y Y
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---------EVYDDEVATRWYR 191
Query: 857 APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
APE Y V DV++ G ++ E+ G
Sbjct: 192 APELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 12/190 (6%)
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLT 306
+P D+ ++ L L N L L L ++L T ++ L L
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLG 80
Query: 307 LLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNKLTG 365
L+L N+L ++P +P L VL + N T S+P G+L+ L L N+L
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK- 137
Query: 366 TLPPDMCAG-NCLQTLITLGNFLFGPIPESL-GKCDSLSRMRMGENFLNGSIPKGLFGLP 423
TLPP + L+ L +L N +P L ++L + + EN L +IPKG FG
Sbjct: 138 TLPPGLLTPTPKLEKL-SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 424 SLSQVELQDN 433
L L N
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 49/257 (19%), Positives = 74/257 (28%), Gaps = 64/257 (24%)
Query: 109 LSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGN 168
++S +N + PP L +L L N + + L L+L
Sbjct: 9 VASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 169 FFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIG 228
G L L +S N+L +P L L L + +N T LP
Sbjct: 66 --ELTKLQVDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDV-SFNRLT-SLPLGA- 119
Query: 229 NLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSN 288
L L L+L+ N L
Sbjct: 120 -------LR---------------GLGELQELYLKGNELK-------------------- 137
Query: 289 NIFTGEIPAS-FAELKNLTLLNLFRNKLHGAIPEFIGV---MPRLEVLQLWENNFTGSIP 344
+P L L+L N L +P G+ + L+ L L EN+ +IP
Sbjct: 138 -----TLPPGLLTPTPKLEKLSLANNNLT-ELPA--GLLNGLENLDTLLLQENSLY-TIP 188
Query: 345 QRLGSNGKLRILDLSSN 361
+ + L L N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 56/230 (24%), Positives = 83/230 (36%), Gaps = 42/230 (18%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
++ NL+ AL PD+ + L ++ N L + + L LNL
Sbjct: 13 LEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-- 67
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF- 183
+ L L LDL +N + LPL L L L + N + +P G
Sbjct: 68 TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL--GA--LR 121
Query: 184 ----LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAA 239
L+ L + GNEL PG + KL++L + N+ T LP + +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL-ANNNLT-ELPAGL--------LN-- 169
Query: 240 NCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNN 289
L+NLDTL LQ N+L + L L N
Sbjct: 170 -------------GLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 51/241 (21%), Positives = 86/241 (35%), Gaps = 44/241 (18%)
Query: 296 PA-SFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLR 354
P +++ + +N + L A+P + +L L EN L +L
Sbjct: 2 PICEVSKVASHLEVNCDKRNL-TALP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 355 ILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGS 414
L+L +LT L G +P L + + N L S
Sbjct: 59 QLNLDRAELT-KLQV------------------DGTLP-------VLGTLDLSHNQLQ-S 91
Query: 415 IPKGLFGLPSLSQVELQDNYLT----GQFPVSDSISVNLGQICLSNNQLSGSLPASI-GK 469
+P LP+L+ +++ N LT G + L ++ L N+L +LP +
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTSLPLGAL---RGL-GELQELYLKGNELK-TLPPGLLTP 146
Query: 470 FSGVQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSR 528
++KL L N + ++PA + L+ L + N I LL F L
Sbjct: 147 TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204
Query: 529 N 529
N
Sbjct: 205 N 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 39/167 (23%), Positives = 69/167 (41%), Gaps = 8/167 (4%)
Query: 421 GLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDG 480
+ S +V LT + + + + LS N L A++ ++ + +L LD
Sbjct: 8 KVASHLEVNCDKRNLTA---LPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 481 NKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLT 540
+ + ++ + G L L +D SHN+ + LT +D+S N L+ L
Sbjct: 65 AELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 541 GMRILNYLNLSRNHLVGSIPASI-ASMQSLTSVDFSYNNLSGLVPGT 586
G+ L L L N L ++P + L + + NNL+ L G
Sbjct: 122 GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGL 167
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 35/214 (16%)
Query: 691 IIGKGGAGIVYKGLMPNGDQV-AVKRLP----AMSRGSSHDHGFNAEIQTLGRI---RHR 742
IIG+GG G VY + ++ A+K L M +G + E L +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLSLVSTGDCP 252
Query: 743 HIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
IV + + + L + + M G L L + G D R+ A E GL ++H
Sbjct: 253 FIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAA-EIILGLEHMH 309
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
+ +V+RD+K NILLD HV +D GLA A G++GY+APE
Sbjct: 310 ---NRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKKP----HASVGTHGYMAPE 360
Query: 860 -----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
AY D +S G +L +L+ G P
Sbjct: 361 VLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 60/230 (26%), Positives = 90/230 (39%), Gaps = 61/230 (26%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-------EI---QTLGR 738
IG G G VYK +G VA+K + R + G E+ + L
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 739 IRHRHIVRLL----GFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEA 793
H ++VRL+ ++ E + LV+E++ L L L +T + +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 794 AKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY 853
+GL +LH +C IVHRD+K NIL+ SG +ADFGLA+ Y
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR----------------IY 170
Query: 854 G-------------YIAPEY----AYTLKVDEKSDVYSFGVVLLELITGR 886
Y APE Y V D++S G + E+ +
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 54/215 (25%), Positives = 85/215 (39%), Gaps = 41/215 (19%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRIRHRHI 744
IG+G G+V+K G VA+K+ S D EI+ L +++H ++
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 745 VRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
V LL + L LV+EY + ++ L + G + I + + + + H
Sbjct: 65 VNLLEVFR-RKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQAVNFCHKH 121
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG-------YI 856
+HRDVK NIL+ + DFG A+ L Y Y
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---------DYYDDEVATRWYR 169
Query: 857 APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
+PE Y V DV++ G V EL++G
Sbjct: 170 SPELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 52/263 (19%), Positives = 107/263 (40%), Gaps = 23/263 (8%)
Query: 106 ISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHL 165
A + NL + + ++L S+ + N+++ + + L N+ L L
Sbjct: 20 DDAFAETIKDNLKKK--SVTDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 75
Query: 166 GGNFFSGQIPPEYGIWEF--LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGL 223
GN ++ + L +L + N++ + + +L KL+ L + +N + +
Sbjct: 76 NGN----KLTDIKPLANLKNLGWLFLDENKV-KDLSS-LKDLKKLKSLSLE-HNGIS-DI 127
Query: 224 PPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKS 283
+ +L L N ++ +I T + RL LDTL L+ N +S L L L++
Sbjct: 128 NG-LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQN 182
Query: 284 MDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI 343
+ LS N + ++ A A LKNL +L LF + + ++ + +
Sbjct: 183 LYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT-- 238
Query: 344 PQRLGSNGKLRILDLSSNKLTGT 366
P+ + +G ++ + T
Sbjct: 239 PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 49/312 (15%), Positives = 105/312 (33%), Gaps = 53/312 (16%)
Query: 269 GPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPR 328
GPL +E + + NL + + A+ +
Sbjct: 1 GPLGSET-ITVPTPIKQIFS----------DDAFAETIKDNLKKKSVTDAVT--QNELNS 47
Query: 329 LEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLF 388
++ + ++ S+ Q + + L L+ NKLT D+
Sbjct: 48 IDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-----DI----------------- 83
Query: 389 GPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVN 448
+ L +L + + EN + + L L L + L+ N ++ +
Sbjct: 84 ----KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDINGLVHL--PQ 135
Query: 449 LGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFS 508
L + L NN+++ + + + + L L+ N+ S I + L +L + S N S
Sbjct: 136 LESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191
Query: 509 GRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQS 568
+ ++ K L ++L E + N + + + N + + LV P I+
Sbjct: 192 -DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGD 247
Query: 569 LTSVDFSYNNLS 580
+ ++
Sbjct: 248 YEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 6/99 (6%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
SL L ++ ++ ++ L L LS+ NQ+S I P ++ L+ L+ L LS N +
Sbjct: 137 ESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKN--HI 190
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHL 163
S L+ L +L VL+L++ + L +
Sbjct: 191 SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG G GIV VA+K+L + +H E+ + + H++I+ LL
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 749 G-FCSNHETNL-----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
F +V E M +L +V+ + H Y + + G+ +LH
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-MELDHER--MSY-LLYQMLCGIKHLH- 144
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
S I+HRD+K +NI++ S + DFGLA+ +GTS M+ + Y APE
Sbjct: 145 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 863 TLKVDEKSDVYSFGVVLLELITGR 886
+ E D++S G ++ E+I G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 46/220 (20%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRH 743
+ IG+G G+V N +VA+K++ +H EI+ L R RH +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPF------EHQTYCQRTLREIKILLRFRHEN 86
Query: 744 IVRLLG-FCSNHETNL----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
I+ + + + +V + M L ++L + + H Y + +GL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH--ICY-FLYQILRGLK 142
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL-QDSGTSECMSAIAGSYGYI- 856
Y+H S ++HRD+K +N+LL++ + + DFGLA+ D + ++ Y+
Sbjct: 143 YIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------EYVA 193
Query: 857 -----APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
APE YT + D++S G +L E+++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG- 749
+G G G V + G +VA+K+L + E++ L +RH +++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 750 FCSNHETNL-----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
F + + LV +M LG+++ +K G ++ + + KGL Y+H
Sbjct: 93 FTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDR--IQF-LVYQMLKGLRYIH--- 145
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----- 859
+ I+HRD+K N+ ++ E + DFGLA+ T + + Y APE
Sbjct: 146 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY----VVTRW-YRAPEVILNW 200
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGR 886
YT V D++S G ++ E+ITG+
Sbjct: 201 MRYTQTV----DIWSVGCIMAEMITGK 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 49/171 (28%), Positives = 71/171 (41%), Gaps = 32/171 (18%)
Query: 731 AEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI 789
E + L RH + L + L V EY NG GE+ HL + +
Sbjct: 197 TENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYA-NG--GELFF-----HLSRERVFSE 247
Query: 790 ------AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSG 841
E L YLH + + +V+RD+K N++LD + H+ DFGL K +
Sbjct: 248 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDK--DGHIKITDFGLCK--EGIK 301
Query: 842 TSECMSAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
M G+ Y+APE Y V D + GVV+ E++ GR P
Sbjct: 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRHI 744
++G+G G+V P G+ VA+K++ D A EI+ L +H +I
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPF------DKPLFALRTLREIKILKHFKHENI 71
Query: 745 VRLLG-FCSNHETNL----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
+ + + N ++ E M L V+ + H +Y + + +
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH--IQY-FIYQTLRAVKV 127
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSY--GYI- 856
LH ++HRD+K +N+L++S + V DFGLA+ + +S S ++
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 857 -----APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
APE Y+ + DV+S G +L EL R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 39/214 (18%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRH 743
+G G G V + +G++VA+K+L A E+ L ++H +
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-----FQSEIFAKRAYRELLLLKHMQHEN 84
Query: 744 IVRLLG-FCSNHETNL-----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGL 797
++ LL F LV +M L +++ K +Y + + KGL
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-LKFSEEK--IQY-LVYQMLKGL 139
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 857
Y+H S +VHRD+K N+ ++ E + DFGLA+ T + + Y A
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY----VVTRW-YRA 191
Query: 858 PE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
PE Y V D++S G ++ E++TG+
Sbjct: 192 PEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 42/246 (17%)
Query: 658 LKKASESRAWKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVY----KGLMPNGDQVAV 713
L KA E K + D D +K +G G G V K +G+ A+
Sbjct: 19 LAKAKEDFLKKWETPSQNTAQLDQ-FDRIK---TLGTGSFGRVMLVKHKE---SGNHYAM 71
Query: 714 KRL--PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLG 770
K L + + +H E + L + +V+L + +NL +V EY+ G +
Sbjct: 72 KILDKQKVVKLKQIEH-TLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEM- 128
Query: 771 EVLHGKKGGHLHWDT-RYKIAVEAAKGLCYLH-HDCSPLIVHRDVKSNNILLDSGFEAHV 828
H ++ G R+ A + YLH D +++RD+K N+L+D + ++
Sbjct: 129 -FSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSLD----LIYRDLKPENLLIDQ--QGYI 180
Query: 829 --ADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLEL 882
DFG AK ++ + C G+ +APE Y V D ++ GV++ E+
Sbjct: 181 QVTDFGFAKRVKGRTWTLC-----GTPEALAPEIILSKGYNKAV----DWWALGVLIYEM 231
Query: 883 ITGRKP 888
G P
Sbjct: 232 AAGYPP 237
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 27/200 (13%)
Query: 41 LAAWNATTS-----HCTWPGVTCDSRR----------HVTSLDLSGLNLSGALSPDVA-- 83
LA+ + S C ++C ++ + LDLS NLS L +
Sbjct: 3 LASGRSVVSCPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPT 61
Query: 84 HLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQ-LSQLASLQVLDL 141
L L +L ++ N L+ I E + +LR L+LS+N + + S L +L+VL L
Sbjct: 62 RLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 142 YNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPE----YGIWEFLEYLAVSGNELGGK 197
YNN++ A + L+ L+L N S + P E L L +S N+L
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 198 IPGEIGNLTKLQQLYIGYYN 217
++ L + + +N
Sbjct: 179 PLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 34/167 (20%), Positives = 64/167 (38%), Gaps = 20/167 (11%)
Query: 280 SLKSMDLSNNIFTGEIPA--SFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLW 335
+DLS+N + + A + L NL L L N L+ I F+ +P L L L
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVP-VPNLRYLDLS 96
Query: 336 ENNFTGSIPQR-LGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL---GNFLFGPI 391
N+ ++ + L +L L +N + + + + L L N +
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED--MAQLQKLYLSQNQISRFP 152
Query: 392 PESLGKCDSLSRMRMGENFLN--GSIPKGLF-GLPSLSQ--VELQDN 433
E + + L ++ + + N +P LP+ + + L +N
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 36/137 (26%), Positives = 56/137 (40%), Gaps = 12/137 (8%)
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEI--GKLQQLSKMDFSHNKFSGRIA 512
S QL ++P S+ S L L N S ++ AE +L L + SHN + I+
Sbjct: 26 SKQQLP-NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FIS 80
Query: 513 PEI-SQCKLLTFVDLSRNELSGEIPNQ-LTGMRILNYLNLSRNHLVGSIPASI-ASMQSL 569
E L ++DLS N L + + ++ L L L NH+V + + M L
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQL 138
Query: 570 TSVDFSYNNLSGLVPGT 586
+ S N +S
Sbjct: 139 QKLYLSQNQISRFPVEL 155
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 32/175 (18%), Positives = 62/175 (35%), Gaps = 18/175 (10%)
Query: 414 SIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS-VNLGQICLSNNQLSGSLPASIGKFSG 472
++P+ L + ++L N L+ NL + LS+N L+ + + F
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISS--EAFVP 86
Query: 473 ---VQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLS 527
++ L L N + + LQ L + +N + L + LS
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 528 RNELSGEIPNQ----LTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNN 578
+N++S P + + L L+LS N L + + + +N
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 38/174 (21%), Positives = 64/174 (36%), Gaps = 16/174 (9%)
Query: 174 IPPEYGIWEFLEYLAVSGNELGGKIPGEI--GNLTKLQQLYIGYYNSYTGGLPPEI-GNL 230
+P + + L +S N L ++ E LT L L + +N + E +
Sbjct: 33 VPQ--SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLL-SHNHLNF-ISSEAFVPV 87
Query: 231 SSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNN 289
+L D ++ L + + LQ L+ L L N + + L+ + LS N
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 290 IFTGEIPA----SFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLW-ENN 338
+ P +L L LL+L NKL + +P L+ NN
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 33/171 (19%)
Query: 731 AEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI 789
E + L RH + L + L V EY NG GE+ HL + +
Sbjct: 54 TESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYA-NG--GELFF-----HLSRERVFTE 104
Query: 790 ------AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSG 841
E L YLH S +V+RD+K N++LD + H+ DFGL K +
Sbjct: 105 ERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDK--DGHIKITDFGLCK--EGIS 157
Query: 842 TSECMSAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
M G+ Y+APE Y V D + GVV+ E++ GR P
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 55/314 (17%), Positives = 103/314 (32%), Gaps = 52/314 (16%)
Query: 676 DFTCDDVLDCLKE----------DNIIGKGGAGIVYKG-------LMPNGD-----QVAV 713
T + + E N++ GA G G+ +
Sbjct: 63 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
Query: 714 KRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL 773
+ + + R + + S+ + + + + + E
Sbjct: 123 NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182
Query: 774 HGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833
L + + + AKG+ +L S +HRD+ + NILL + DFGL
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 834 AKFLQDSGTSECMSAIAGSYGYI-----APEYAYTLKVDEKSDVYSFGVVLLELIT-GRK 887
A+ + + APE + +SDV+SFGV+L E+ + G
Sbjct: 240 ARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 294
Query: 888 PVGEFGDGVDIVQWVRKMTDSKKEGVLKILD-PRLPSVPLHEVMHVFYVAMLCVEEQAVE 946
P + + + KEG + P + +++ M + C + +
Sbjct: 295 PYPGVKIDEEFCRRL-------KEG--TRMRAPDYTTPEMYQTM------LDCWHGEPSQ 339
Query: 947 RPTMREVVQILTEL 960
RPT E+V+ L L
Sbjct: 340 RPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 40/171 (23%), Positives = 63/171 (36%), Gaps = 18/171 (10%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ------VAVKRLPAMSRGSSHDHGFNAEIQTLG 737
D LK +G+G G V + D+ VAVK L + S H +E++ L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILI 80
Query: 738 RI-RHRHIVRLLGFCSNH-ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK 795
I H ++V LLG C+ +++ E+ G+L L K R + K
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK---------RNEFVPYKTK 131
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846
G + + D+K + S + + F K L D E
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 46/229 (20%), Positives = 88/229 (38%), Gaps = 48/229 (20%)
Query: 687 KEDNIIGKGGAGIVYKG---LMPNGDQVAVKRLPAMSRGSSHDHGFNA----EIQTLGRI 739
E +G+G G VYK + A+K++ G + EI L +
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLREL 75
Query: 740 RHRHIVRLLGFCSNHETNL--LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAK-- 795
+H +++ L +H L+++Y + L ++ + + ++ K
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN-KKPVQLPRGMVKSL 133
Query: 796 ------GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH----VADFGLAKFLQDSGTSEC 845
G+ YLH + ++HRD+K NIL+ +AD G A+ +
Sbjct: 134 LYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP--LKP 188
Query: 846 MSAIAGS---YGYIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
++ + + Y APE YT + D+++ G + EL+T
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 53/260 (20%), Positives = 83/260 (31%), Gaps = 53/260 (20%)
Query: 51 CTWPGVTCDSRRH----------VTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLS 99
C +LDLS L L LQ L ++ ++
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 100 GPIPPEI-SALSSLRLLNLSNN----VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAV 154
I +LS L L L+ N + G+F S L+SLQ L N+ +
Sbjct: 66 T-IEDGAYQSLSHLSTLILTGNPIQSLALGAF----SGLSSLQKLVAVETNLASLENFPI 120
Query: 155 TQLRNLRHLHLGGNFFSGQIPPEYGIWEF-----LEYLAVSGNELGGKIPGEIGNLTKLQ 209
L+ L+ L++ N PEY F LE+L +S N++ ++ L ++
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEY----FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 210 QLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSG 269
L + S ++ I + L L L N L
Sbjct: 177 LLNLSLDLSLN--------PMNF--------------IQPGAFKEIRLKELALDTNQLKS 214
Query: 270 PLTTELGYLKSLKSMDLSNN 289
L SL+ + L N
Sbjct: 215 VPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 47/237 (19%), Positives = 81/237 (34%), Gaps = 42/237 (17%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWEN 337
S K++DLS N SF L +L+L R ++ I + + + L L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQS-LSHLSTLILTGN 86
Query: 338 NFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
S+ S L+ L L +L +G
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFP-----------------------IG 121
Query: 397 KCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLT----GQFPVSDSISVNLGQ 451
+L + + N + F L +L ++L N + V + +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 452 ICLSNNQLSGSLPASIGKFSGV--QKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHN 505
+ LS N ++ + G F + ++L LD N+ +P I +L L K+ N
Sbjct: 182 LDLSLNPMN-FIQP--GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 43/188 (22%), Positives = 69/188 (36%), Gaps = 25/188 (13%)
Query: 414 SIPKGLF-GLPSLSQVELQDNYLT----GQFPVSDSISVNLGQICLSNNQLSGSLPASIG 468
+ F P L ++L + G + +L + L+ N + SL
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAY----QSLSHLSTLILTGNPIQ-SLALGA- 95
Query: 469 KFSG---VQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEI-SQCKLLTF 523
FSG +QKL+ + + G L+ L +++ +HN PE S L
Sbjct: 96 -FSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 524 VDLSRNELSGEIPNQ----LTGMRILNY-LNLSRNHLVGSIPASIASMQSLTSVDFSYNN 578
+DLS N++ I L M +LN L+LS N + I L + N
Sbjct: 154 LDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQ 211
Query: 579 LSGLVPGT 586
L + G
Sbjct: 212 LKSVPDGI 219
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 28/150 (18%), Positives = 50/150 (33%), Gaps = 15/150 (10%)
Query: 445 ISVNLGQICLSNNQLSGSLPASIGKFSGV---QKLLLDGNKFSGQIPAEI-GKLQQLSKM 500
+ + + LS N L L + F Q L L + I L LS +
Sbjct: 26 LPFSTKNLDLSFNPLR-HLGS--YSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81
Query: 501 DFSHNKFSGRIAPEI-SQCKLLTFVDLSRNELSGEIPNQL-TGMRILNYLNLSRNHLVGS 558
+ N +A S L + L+ + N ++ L LN++ N + S
Sbjct: 82 ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-S 138
Query: 559 IPASIA--SMQSLTSVDFSYNNLSGLVPGT 586
++ +L +D S N + +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG- 749
+G G G V G +VAVK+L + H E++ L ++H +++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 750 FCSNHETNL-----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
F LV M L ++ +K H ++ + + +GL Y+H
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDH--VQF-LIYQILRGLKYIH--- 149
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE----- 859
S I+HRD+K +N+ ++ E + DFGLA+ D T +A + Y APE
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY----VATRW-YRAPEIMLNW 204
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y V D++S G ++ EL+TGR
Sbjct: 205 MHYNQTV----DIWSVGCIMAELLTGR 227
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 38/173 (21%)
Query: 730 NAEIQTLGRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD-TRY 787
N E L + H I+R+ G + + ++ +Y+ G L +K ++
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKF 110
Query: 788 KIAVEAAKGLCYLH-HDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDS---- 840
A E L YLH D I++RD+K NILLD H+ DFG AK++ D
Sbjct: 111 YAA-EVCLALEYLHSKD----IIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTL 163
Query: 841 -GTSECMSAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
GT + YIAPE Y + D +SFG+++ E++ G P
Sbjct: 164 CGTPD----------YIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 54/251 (21%), Positives = 99/251 (39%), Gaps = 80/251 (31%)
Query: 691 IIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL- 748
+G G GIV + + +G + A+K++ R N E+ + + H +I++L+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRELDIMKVLDHVNIIKLVD 67
Query: 749 GFCSNHETNL-------------------------------------LVYEYMPNGSLGE 771
F + + ++ EY+P+ +L +
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126
Query: 772 VL--HGKKGGHLHWDT----RYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE 825
VL + G + + Y++ + + ++H S I HRD+K N+L++S +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIH---SLGICHRDIKPQNLLVNS--K 177
Query: 826 AHV---ADFGLAKFL--QDSGTSECMSAIAGSYGYIAPE-----YAYTLKVDEKSDVYSF 875
+ DFG AK L + + I + Y APE YT + D++S
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAY----ICSRF-YRAPELMLGATEYTPSI----DLWSI 228
Query: 876 GVVLLELITGR 886
G V ELI G+
Sbjct: 229 GCVFGELILGK 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-14
Identities = 64/372 (17%), Positives = 117/372 (31%), Gaps = 66/372 (17%)
Query: 255 QNLDTLFLQVNALSGPLTTELG-YLKSLKSMDLSNNIFTGE----IPASFAELKNLTLLN 309
++ +L +Q LS EL L+ + + L + T I ++ L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 310 LFRNKLHGAIPEFIGVM-----PRLEVLQLWENNFT----GSIPQRLGSNGKLRILDLSS 360
L N+L + +++ L L T G + L + L+ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 361 NKLTGTLPPDMCAG----NC-LQTLITLGNFLFGP-----IPESLGKCDSLSRMRMGENF 410
N L +C G C L+ L L + L + + N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQ-LEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 411 LNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLS----GSLPAS 466
+N + G+ L Q L+D+ L + L + ++ L
Sbjct: 182 INEA------GVRVLCQG-LKDSPCQ------------LEALKLESCGVTSDNCRDLCGI 222
Query: 467 IGKFSGVQKLLLDGNKFSGQ-----IPAEIGKLQQLSKMDFSHNKFSGR----IAPEISQ 517
+ + +++L L NK P + +L + + + + +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 518 CKLLTFVDLSRNELSGEIPNQLTGMRI-----LNYLNLSRNHL----VGSIPASIASMQS 568
+ L + L+ NEL E L + L L + + +A +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 569 LTSVDFSYNNLS 580
L + S N L
Sbjct: 343 LLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 64/358 (17%), Positives = 114/358 (31%), Gaps = 61/358 (17%)
Query: 62 RHVTSLDLSGLNLS-GALSPDVAHLRFLQNLSVAANQLS----GPIPPEISALSSLRLLN 116
+ SLD+ LS + + L+ Q + + L+ I + +L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 117 LSNNVFNGSFPPQLSQL-----ASLQVLDLYNNNMT----GDLPLAVTQLRNLRHLHLGG 167
L +N + Q +Q L L N +T G L + L L+ LHL
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 168 NFFSGQIPPEYGIWEF----------LEYLAVSGNELGGKIPGEIG----NLTKLQQLYI 213
N G+ LE L + L + ++L +
Sbjct: 123 NLLGDA-----GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 177
Query: 214 GYYNSYTGGLPPEIG-----NLSSLVRFDAANCGLSGEIPTDIGRL----QNLDTLFLQV 264
+ G+ + + L +CG++ + D+ + +L L L
Sbjct: 178 SNNDINEAGVR-VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236
Query: 265 NALSGP-----LTTELGYLKSLKSMDLSNNIFTGE----IPASFAELKNLTLLNLFRNKL 315
N L L L+++ + T + + ++L L+L N+L
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
Query: 316 HGAIPEFIGVM-----PRLEVLQLWENNFTG----SIPQRLGSNGKLRILDLSSNKLT 364
+ +LE L + +FT L N L L +S+N+L
Sbjct: 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-11
Identities = 75/407 (18%), Positives = 134/407 (32%), Gaps = 78/407 (19%)
Query: 230 LSSLVRFDAANCGLSGEIPTDIGRL----QNLDTLFLQVNALSGPLTTELGY-LKS---- 280
L +CGL+ DI L L L+ N L + L++
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 281 LKSMDLSNNIFTGE----IPASFAELKNLTLLNLFRNKLHGAIPEFIGVM-----PRLEV 331
++ + L N TG + ++ L L L+L N L A + + RLE
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 332 LQLWENNFT----GSIPQRLGSNGKLRILDLSSNKLTGT----LPPDMCAGNC-LQTLIT 382
LQL + + + L + + L +S+N + L + C L+ L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206
Query: 383 LGNFL----FGPIPESLGKCDSLSRMRMGENFLNGS-----IPKGLFGLPSLSQVELQDN 433
+ + + SL + +G N L P L L + + +
Sbjct: 207 ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266
Query: 434 YLT--GQFPVSDSISVN--LGQICLSNNQLSGSLPASIGKFSGVQKL---LLDGNKFSGQ 486
+T G + + L ++ L+ N+L G + L LL+
Sbjct: 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDE---------GARLLCETLLEPGC---- 313
Query: 487 IPAEIGKLQQLSKMDFSHNKFSGR----IAPEISQCKLLTFVDLSRNELSGEIPNQL--- 539
QL + F+ + ++Q + L + +S N L +L
Sbjct: 314 ---------QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 540 --TGMRILNYLNLSRNHL----VGSIPASIASMQSLTSVDFSYNNLS 580
+L L L+ + S+ A++ + SL +D S N L
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 63/354 (17%), Positives = 109/354 (30%), Gaps = 65/354 (18%)
Query: 62 RHVTSLDLSGLNLSG----ALSPDVAHLRF-LQNLSVAANQLS----GPIPPEISALSSL 112
+ L LS L L + + L+ L + LS P+ + A
Sbjct: 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF 172
Query: 113 RLLNLSNNVFNGSFPPQLSQL-----ASLQVLDLYNNNMTGD----LPLAVTQLRNLRHL 163
+ L +SNN N + L Q L+ L L + +T D L V +LR L
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232
Query: 164 HLGGNFFSGQIPPEYGIWEF----------LEYLAVSGNELGGK----IPGEIGNLTKLQ 209
LG N G+ E L L + + K + + L+
Sbjct: 233 ALGSNKLGDV-----GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLK 287
Query: 210 QLYIGYYNSYTGGLPPEIGNL-----SSLVRFDAANCGLSGEIPTDIG----RLQNLDTL 260
+L + G + L +C + + + + L L
Sbjct: 288 ELSLAGNELGDEGAR-LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346
Query: 261 FLQVNALSGPLTTELG-----YLKSLKSMDLSNNIFTGEIPASFAEL----KNLTLLNLF 311
+ N L EL L+ + L++ + +S A +L L+L
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406
Query: 312 RNKLHG----AIPEFIGVM-PRLEVLQLWENNFT----GSIPQRLGSNGKLRIL 356
N L + E + LE L L++ ++ + LR++
Sbjct: 407 NNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 39/269 (14%), Positives = 90/269 (33%), Gaps = 39/269 (14%)
Query: 350 NGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGP-----IPESLGKCDSLSRM 404
+ ++ LD+ +L+ ++ ++ L + I +L +L+ +
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 405 RMGENFLNGSIPKGLF-GL----PSLSQVELQDNYLT--GQFPVSDSISVN--LGQICLS 455
+ N L + GL + ++ LQ+ LT G +S ++ L ++ LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 456 NNQLSGSLPASIGKF-----SGVQKLLLDGNKFSGQIPAEIGKL----QQLSKMDFSHNK 506
+N L + + + ++KL L+ S + + ++ S+N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 507 FSGRIAPEI------SQCKLLTFVDLSRNELSGE----IPNQLTGMRILNYLNLSRNHLV 556
+ + S C+L L ++ + + + L L L N L
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEAL-KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 557 GS-----IPASIASMQSLTSVDFSYNNLS 580
P + L ++ ++
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGIT 269
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 34/209 (16%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLG 749
+G+G V++ + + N ++V VK L + + EI+ L +R +I+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLAD 98
Query: 750 -FCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
LV+E++ N ++ + R+ + E K L Y H S
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI----RFYM-YEILKALDYCH---SMG 150
Query: 808 IVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE------- 859
I+HRDVK +N+++D + + D+GLA+F + + S + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH---PGQEYNVRVASRYFKGPELLVDYQM 207
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
Y Y+L D++S G +L +I ++P
Sbjct: 208 YDYSL------DMWSLGCMLASMIFRKEP 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 681 DVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQ 734
VL + IG G GIV VA+K+L + +H A E+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-----AKRAYRELV 113
Query: 735 TLGRIRHRHIVRLL------GFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGHLHWDTRY 787
+ + H++I+ LL + LV E M +L +V+ + + + Y
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSY-LLY 171
Query: 788 KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847
++ G+ +LH S I+HRD+K +NI++ S + DFGLA+ +GTS M+
Sbjct: 172 QML----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMT 221
Query: 848 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 886
+ Y APE + E D++S G ++ E++ +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 35/215 (16%), Positives = 74/215 (34%), Gaps = 23/215 (10%)
Query: 280 SLKSMDLSNNIFTGEIPA-SFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWE 336
S +++ L IP+ +F+ L N++ + + + + F + ++ +++
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYN-LSKVTHIEIRN 89
Query: 337 NNFTGSIPQR-LGSNGKLRILDLSSNKLTGTLPPDMCAGNC--LQTLITLGNFLFGPIPE 393
I L L+ L + + L P + L N IP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 394 SL--GKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDN-YLT----GQFPVSDSIS 446
+ G C+ +++ N S+ F L V L N YLT F +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF---GGVY 204
Query: 447 VNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGN 481
+ +S ++ +LP+ +++L+
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 38/239 (15%), Positives = 68/239 (28%), Gaps = 49/239 (20%)
Query: 88 LQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQL-SQLASLQVLDLYNNN 145
Q L + L IP S L ++ + +S +V L+ + +++ N
Sbjct: 33 TQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 146 MTGDLPLAV-TQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGN 204
+ +L L+ L + P + +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK----------------------VYS 128
Query: 205 LTKLQQLYIGYYNSYTGGLPPEI--GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFL 262
L I N Y +P G + + N G + + LD ++L
Sbjct: 129 TDIFFILEIT-DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186
Query: 263 QVN---------ALSGPLTTELGYLKSLKSMDLSNNIFTGEIPA-SFAELKNLTLLNLF 311
N A G + + L D+S T +P+ LK L N +
Sbjct: 187 NKNKYLTVIDKDAFGG-VYSGPSLL------DVSQTSVT-ALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 33/184 (17%), Positives = 63/184 (34%), Gaps = 18/184 (9%)
Query: 254 LQNLDTLFLQVNALSGPLTT-ELG---YLKSLKSMDLSNNIFTGEIPAS-FAELKNLTLL 308
L N+ +++ ++ L E L + +++ N I EL L L
Sbjct: 54 LPNISRIYVSID---VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110
Query: 309 NLFRNKLHGAIPE--FIGVMPRLEVLQLWENNFTGSIPQRL--GSNGKLRILDLSSNKLT 364
+F L P+ + +L++ +N + SIP G + L L +N T
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
Query: 365 GTLPPDMCAGNCLQTLITLGNFLFGPIPESL--GKCDSLSRMRMGENFLNGSIPKGLF-G 421
++ G L + N I + G S + + + + ++P
Sbjct: 170 -SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEH 227
Query: 422 LPSL 425
L L
Sbjct: 228 LKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 36/277 (12%), Positives = 82/277 (29%), Gaps = 64/277 (23%)
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQR-LGSNGKLRILDLSSNK 362
+ + IP + P + L+L E + +IP + + + +S +
Sbjct: 12 QEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV 66
Query: 363 LTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-G 421
L L + + + +L+ I
Sbjct: 67 TLQQLESHSFYN--LSKVTHI----------EIRNTRNLT-----------YIDPDALKE 103
Query: 422 LPSLSQVELQDNYLTGQFPVSDSIS--VNLGQICLSNNQLSGSLPASIGKFSGVQKLL-- 477
LP L + + + L FP + + +++N S+P F G+
Sbjct: 104 LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV--NAFQGLCNETLT 160
Query: 478 --LDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEI 535
L N F+ + +L + + NK+ I + F +
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKD-------AFGGVYSG------ 206
Query: 536 PNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTS 571
+ L++S+ + ++P+ ++ L +
Sbjct: 207 ---------PSLLDVSQTSVT-ALPSKGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 17/165 (10%), Positives = 50/165 (30%), Gaps = 33/165 (20%)
Query: 424 SLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPA-SIGKFSGVQKLLLDGNK 482
+ + + P S+ + + L L ++P+ + + ++ + +
Sbjct: 12 QEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV 66
Query: 483 FSGQIPAEI-GKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTG 541
Q+ + L +++ ++ + + I P+ +L
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPD-------ALKELPL------------- 106
Query: 542 MRILNYLNLSRNHLVGSIPA--SIASMQSLTSVDFSYNNLSGLVP 584
L +L + L P + S ++ + N +P
Sbjct: 107 ---LKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 49/229 (21%), Positives = 89/229 (38%), Gaps = 57/229 (24%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRHI 744
+G GG G+V+ + +VA+K++ + EI+ + R+ H +I
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIV-------LTDPQSVKHALREIKIIRRLDHDNI 70
Query: 745 VRLL----------GFCSNHETNL----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIA 790
V++ T L +V EYM L VL H R
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEH--ARL-FM 126
Query: 791 VEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAKFL-QDSGTSECMSA 848
+ +GL Y+H S ++HRD+K N+ +++ + DFGLA+ + +S
Sbjct: 127 YQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS- 182
Query: 849 IAGSYGYI------APE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
+ +P YT + D+++ G + E++TG+
Sbjct: 183 -----EGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.9 bits (178), Expect = 3e-13
Identities = 35/167 (20%), Positives = 67/167 (40%), Gaps = 10/167 (5%)
Query: 4 LLLLLLLLLHISQSRTVPEYKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRH 63
LL ++LL+ + E S ++ D +++ + + +
Sbjct: 385 LLTIILLMRALDPLLYEKETLQYFSTLKAV-DPMRAAYLDDLRSKFLLENSVLKMEYA-D 442
Query: 64 VTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFN 123
V L L+ +L+ + L + +L ++ N+L +PP ++AL L +L S+N
Sbjct: 443 VRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499
Query: 124 GSFPPQLSQLASLQVLDLYNNNMTGDLP--LAVTQLRNLRHLHLGGN 168
+ ++ L LQ L L NN + + L L+L GN
Sbjct: 500 -NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 5e-12
Identities = 38/295 (12%), Positives = 92/295 (31%), Gaps = 25/295 (8%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
+ + + L ++ G +L L + L++ + + +
Sbjct: 269 SRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQ 328
Query: 306 TLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTG 365
L +++ + +L +L T + L S +L+ L+ +
Sbjct: 329 KECVLLKDRPECWCRD-SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLL 386
Query: 366 TLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSL--SRMRMGENFLNGSIPKGLFGLP 423
T+ M A + L + +L D + + + +
Sbjct: 387 TIILLMRALDPLLYEKETLQYF-----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYA 441
Query: 424 SLSQVELQDNYLTGQFPVSDSIS-----VNLGQICLSNNQLSGSLPASIGKFSGVQKLLL 478
+ + L LT + + + + LS+N+L +LP ++ ++ L
Sbjct: 442 DVRVLHLAHKDLT-------VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQA 493
Query: 479 DGNKFSGQIPAEIGKLQQLSKMDFSHNKFSG-RIAPEISQCKLLTFVDLSRNELS 532
N + + L +L ++ +N+ + C L ++L N L
Sbjct: 494 SDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 1e-10
Identities = 41/306 (13%), Positives = 94/306 (30%), Gaps = 40/306 (13%)
Query: 281 LKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQ----LWE 336
L +D + P ++ L +L L+ +P+ + +
Sbjct: 275 LLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL 334
Query: 337 NNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
+ + ++ +L +LS K T + L
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-------------------------VLQSELE 369
Query: 397 KCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSN 456
C L + E + + + +L + + L + + +
Sbjct: 370 SCKELQEL---EPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR 426
Query: 457 NQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEIS 516
++ +++ V+ L L + + + +L ++ +D SHN+ + P ++
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALA 483
Query: 517 QCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPA--SIASMQSLTSVDF 574
+ L + S N L + + + L L L N L A + S L ++
Sbjct: 484 ALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL-QQSAAIQPLVSCPRLVLLNL 540
Query: 575 SYNNLS 580
N+L
Sbjct: 541 QGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 2e-10
Identities = 50/340 (14%), Positives = 101/340 (29%), Gaps = 40/340 (11%)
Query: 103 PPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVL-DLYNNNMTGDLPLAVTQLRNLR 161
P ++ + +V S++ +L ++ D ++ P + ++
Sbjct: 241 PHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVW 300
Query: 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL----GGKIPGEIGNLTKLQQLYIGYYN 217
L + Q+P + + L + +L + +
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 218 SYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGY 277
S L E+ + L + N + T I ++ LD L + L T +
Sbjct: 361 STV--LQSELESCKELQELEPEN---KWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415
Query: 278 LKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWEN 337
+D + F E E ++ +L+L L + + + + L L N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHN 473
Query: 338 NFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGK 397
++P L + L +L S N L + +
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVDG-------------------------VAN 506
Query: 398 CDSLSRMRMGENFLNG-SIPKGLFGLPSLSQVELQDNYLT 436
L + + N L + + L P L + LQ N L
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 1e-07
Identities = 23/102 (22%), Positives = 42/102 (41%), Gaps = 5/102 (4%)
Query: 481 NKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLT 540
+KF + + + + +H + + + Q L+T +DLS N L +P L
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR-ALPPALA 483
Query: 541 GMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGL 582
+R L L S N L ++ +A++ L + N L
Sbjct: 484 ALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQS 523
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 4e-13
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 684 DCLKEDNIIGKGGAGIVY---KGLMPNGDQV-AVKRL---PAMSRGSSHDHGFNAEIQTL 736
+ L+ ++GKGG G V+ K N ++ A+K L + H AE L
Sbjct: 20 ELLR---VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-TKAERNIL 75
Query: 737 GRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIAVEAA 794
++H IV L+ + L L+ EY+ G L + ++ G D + +A E +
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EIS 131
Query: 795 KGLCYLH-HDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAG 851
L +LH I++RD+K NI+L+ + HV DFGL K + G
Sbjct: 132 MALGHLHQKG----IIYRDLKPENIMLNH--QGHVKLTDFGLCK--ESIHDGTVTHTFCG 183
Query: 852 SYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ Y+APE + V D +S G ++ +++TG P
Sbjct: 184 TIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 684 DCLKEDNIIGKGGAGIVY---KGLMPNGDQV-AVKRL---PAMSRGSSHDHGFNAEIQTL 736
+ LK ++G+G G V+ K + Q+ A+K L R E L
Sbjct: 27 ELLK---VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK---MERDIL 80
Query: 737 GRIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIAVEAA 794
+ H IV+L + E L L+ +++ G L K + ++ +A E A
Sbjct: 81 VEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA-ELA 136
Query: 795 KGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAK-FLQDSGTSECMSAIAG 851
L +LH S I++RD+K NILLD E H+ DFGL+K + + + G
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKA---YSFCG 188
Query: 852 SYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ Y+APE +T D +SFGV++ E++TG P
Sbjct: 189 TVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 33/238 (13%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH-RHIVRLLG 749
IG G G +Y G + G++VA+K ++ E + ++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI----ESKIYKMMQGGVGIPTIRW 72
Query: 750 FCSNHETNLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
+ + N++V E + G SL E L T +A + + Y+H S
Sbjct: 73 CGAEGDYNVMVMELL--GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNF 126
Query: 809 VHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA--YT 863
+HRDVK +N L+ G + + + DFGLAK +D+ T + + YA T
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 186
Query: 864 LKVDEKS---DVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918
E+S D+ S G VL+ G P W +K++ +I +
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGSLP------------WQGLKAATKRQKYERISE 232
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 50/223 (22%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA---EIQTLGRIR------ 740
+G G V+ M N VA+K + R A EI+ L R+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK----IVR--GDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 741 -----HRHIVRLL------GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI 789
HI++LL G H ++V+E + +L ++ + + +I
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHV--VMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH------VADFGLAKFLQDSGTS 843
+ + GL Y+H C I+H D+K N+L++ +AD G A +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----YD 189
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 886
E + + Y +PE +D++S ++ ELITG
Sbjct: 190 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 2e-12
Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 33/162 (20%)
Query: 740 RHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYK------IAVE 792
+ + +L C L V EY+ NG G++++ H+ R+K A E
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYV-NG--GDLMY-----HIQQVGRFKEPHAVFYAAE 450
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIA 850
A GL +L S I++RD+K +N++LDS E H+ ADFG+ K ++
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCK--ENIWDGVTTKTFC 503
Query: 851 GSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ YIAPE Y V D ++FGV+L E++ G+ P
Sbjct: 504 GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 33/143 (23%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYK------IAVEAAKGLCYLHHDCSPLIVHRD 812
V E++ NG G+++ H+ R+ A E L +LH I++RD
Sbjct: 101 FVMEFV-NG--GDLMF-----HIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRD 149
Query: 813 VKSNNILLDSGFEAHV--ADFGLAK-FLQDSGTSECMSAIAGSYGYIAPE----YAYTLK 865
+K +N+LLD E H ADFG+ K + + T+ + G+ YIAPE Y
Sbjct: 150 LKLDNVLLDH--EGHCKLADFGMCKEGICNGVTT---ATFCGTPDYIAPEILQEMLYGPA 204
Query: 866 VDEKSDVYSFGVVLLELITGRKP 888
V D ++ GV+L E++ G P
Sbjct: 205 V----DWWAMGVLLYEMLCGHAP 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 692 IGKGGAGIVY---KGLMPNGDQV-AVKRL---PAMSRGSSHDHGFNAEIQTLGRIRHRH- 743
+G G G V+ K + ++ A+K L + + + +H E Q L IR
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-TRTERQVLEHIRQSPF 120
Query: 744 IVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIAVEAAKGLCYLH 801
+V L + ET L L+ +Y+ G L H + + + E L +LH
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVG-EIVLALEHLH 176
Query: 802 -HDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAP 858
I++RD+K NILLDS HV DFGL+K T G+ Y+AP
Sbjct: 177 KLG----IIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAP 229
Query: 859 E------YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ + V D +S GV++ EL+TG P
Sbjct: 230 DIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 51/244 (20%), Positives = 86/244 (35%), Gaps = 57/244 (23%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRHI 744
+IG+G G VY VA+K++ M + + EI L R++ +I
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-----FEDLIDCKRILREITILNRLKSDYI 87
Query: 745 VRLLG-FCSNHETNL----LVYEYMPNGSLGEVLHGKKGGHL---HWDTRYKIAVEAAKG 796
+RL + +V E + L ++ K L H + I G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF--KTPIFLTEEH--IKT-ILYNLLLG 141
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG-- 854
++H I+HRD+K N LL+ V DFGLA+ + + ++ + +
Sbjct: 142 ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 855 ------------------YIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGRKPVGE 891
Y APE YT + D++S G + EL+ +
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFAELLNMLQSHIN 254
Query: 892 FGDG 895
Sbjct: 255 DPTN 258
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 31/212 (14%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVK---RLPAMSRGSSHDHGFNAEIQTLGRIRHR--- 742
++IGKG G V K + VA+K A + E++ L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-----LNQAQI-EVRLLELMNKHDTE 113
Query: 743 ---HIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGL 797
+IV L LV+E + + +L ++L +G L+ TR K A + L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLN-LTR-KFAQQMCTAL 170
Query: 798 CYLH-HDCSPLIVHRDVKSNNILLDSGFEAH--VADFGLAKFLQDSGTSECMSAIAGSYG 854
+L + S I+H D+K NILL + + + DFG + + + S
Sbjct: 171 LFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ-----LGQRIYQYIQSRF 223
Query: 855 YIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 886
Y +PE + D D++S G +L+E+ TG
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 54/166 (32%), Positives = 76/166 (45%), Gaps = 39/166 (23%)
Query: 739 IRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI------AV 791
++H +V L F L V +Y+ NG GE+ + HL + + A
Sbjct: 96 VKHPFLVGLH-FSFQTADKLYFVLDYI-NG--GELFY-----HLQRERCFLEPRARFYAA 146
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAK-FLQDSGTSE--CM 846
E A L YLH S IV+RD+K NILLDS + H+ DFGL K ++ + T+ C
Sbjct: 147 EIASALGYLH---SLNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTSTFC- 200
Query: 847 SAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ Y+APE Y V D + G VL E++ G P
Sbjct: 201 ----GTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 52/246 (21%)
Query: 674 RLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA- 731
R+D + +K +GKG GIV+K + G+ VAVK++ + S+ A
Sbjct: 2 RVDRHVLRKYELVK---KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD-----AQ 53
Query: 732 ----EIQTLGRIR-HRHIVRLLG-FCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWD 784
EI L + H +IV LL ++++ ++ LV++YM L V+ +H
Sbjct: 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVH-- 110
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844
+Y + + K + YLH S ++HRD+K +NILL++ VADFGL++ +
Sbjct: 111 KQY-VVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 845 CMSAIAGSYG-------------------YIAPE-----YAYTLKVDEKSDVYSFGVVLL 880
++ + Y APE YT + D++S G +L
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG 222
Query: 881 ELITGR 886
E++ G+
Sbjct: 223 EILCGK 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 51/264 (19%), Positives = 90/264 (34%), Gaps = 48/264 (18%)
Query: 106 ISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHL 165
L++ NL + + +L+ +Q + N+N+ L + NL+ LHL
Sbjct: 15 DPGLANAVKQNLGKQ--SVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHL 70
Query: 166 GGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPP 225
N QI + + +LTKL++L + N
Sbjct: 71 SHN----QI---------------------SDLSP-LKDLTKLEELSVN-RNRLK----- 98
Query: 226 EIGNLS--SLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKS 283
+ + L R N L + L+NL+ L ++ N L LG+L L+
Sbjct: 99 NLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEV 154
Query: 284 MDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI 343
+DL N T LK + ++L K + E + P L + ++ I
Sbjct: 155 LDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKC---VNEPVKYQPELYITNTVKDPDGRWI 209
Query: 344 -PQRLGSNGKLRILDLSSNKLTGT 366
P + + G + T
Sbjct: 210 SPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 41/251 (16%), Positives = 77/251 (30%), Gaps = 67/251 (26%)
Query: 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVF 122
+ +L +++ L L +QN + + + + + ++L+ L+LS+N
Sbjct: 20 NAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQS-LAG-MQFFTNLKELHLSHN-- 73
Query: 123 NGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWE 182
S L L L+ L + N + + L L L N ++
Sbjct: 74 QISDLSPLKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFLDNN----ELR------- 119
Query: 183 FLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCG 242
+ +L L+ L I N L S+
Sbjct: 120 --------------DTDS-LIHLKNLEILSIR-NN-----------KLKSI--------- 143
Query: 243 LSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL 302
+G L L+ L L N ++ L LK + +DL+ E
Sbjct: 144 ------VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE---PVKYQ 192
Query: 303 KNLTLLNLFRN 313
L + N ++
Sbjct: 193 PELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 33/210 (15%), Positives = 69/210 (32%), Gaps = 39/210 (18%)
Query: 227 IGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDL 286
L++ V+ + ++ + L + + + + + +LK + L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHL 70
Query: 287 SNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQR 346
S+N + ++ +L L L++ RN+L + L L L N +
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFLDNNELRDTDS-- 123
Query: 347 LGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRM 406
L L IL + +NKL ++ LG L + +
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-------------------------LGFLSKLEVLDL 157
Query: 407 GENFLNGSIPKGLFGLPSLSQVELQDNYLT 436
N + + GL L ++ ++L
Sbjct: 158 HGNEIT-NT-GGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 38/252 (15%), Positives = 82/252 (32%), Gaps = 30/252 (11%)
Query: 352 KLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIP--ESLGKCDSLSRMRMGEN 409
+L +T D+ + L + N I + +L + + N
Sbjct: 20 NAVKQNLGKQSVT-----DLVSQKELSGVQNF-NGDNSNIQSLAGMQFFTNLKELHLSHN 73
Query: 410 FLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGK 469
++ + L L L ++ + N L ++ S L ++ L NN+L S+
Sbjct: 74 QIS-DL-SPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLIH 126
Query: 470 FSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRN 529
++ L + NK I +G L +L +D N+ + +++ K + ++DL+
Sbjct: 127 LKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQ 182
Query: 530 ELSGEIPNQLTGMRILNYL-----------NLSRNHLVGSIPASIASMQSLTSVDFSYNN 578
+ E + I N + +S V + ++
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSE 242
Query: 579 LSGLVPGTGQFS 590
+ F
Sbjct: 243 YINVGETEAIFD 254
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 33/143 (23%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI------AVEAAKGLCYLHHDCSPLIVHRD 812
V EY+ NG G+++ H+ + + E + L YLH I++RD
Sbjct: 87 FVIEYV-NG--GDLMF-----HMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRD 135
Query: 813 VKSNNILLDSGFEAHV--ADFGLAK-FLQDSGTSECMSAIAGSYGYIAPE----YAYTLK 865
+K +N+LLDS E H+ D+G+ K L+ T+ S G+ YIAPE Y
Sbjct: 136 LKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFS 190
Query: 866 VDEKSDVYSFGVVLLELITGRKP 888
V D ++ GV++ E++ GR P
Sbjct: 191 V----DWWALGVLMFEMMAGRSP 209
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 46/213 (21%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWEN 337
K +DL +N + +F L L LL L NKL +P F + LE L + +N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKE-LKNLETLWVTDN 95
Query: 338 NFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG 396
++P + L L L N+L +LPP + +SL
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPR--------------------VFDSLT 133
Query: 397 KCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDNYLT----GQFPVSDSISVNLGQ 451
K L+ + +G N L S+PKG+F L SL ++ L +N L G F D ++ L
Sbjct: 134 K---LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAF---DKLT-ELKT 185
Query: 452 ICLSNNQLSGSLPASIGKFSGVQKLL---LDGN 481
+ L NNQL +P G F ++KL L N
Sbjct: 186 LKLDNNQLK-RVPE--GAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 55/217 (25%), Positives = 86/217 (39%), Gaps = 37/217 (17%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAV-TQLRNL 160
IP I A + L+L +N + +L L++L L +N + LP + +L+NL
Sbjct: 31 IPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 161 RHLHLGGNFFSGQIPPEYGIWEF---LEYLAVSGNELGGKIPGEI-GNLTKLQQLYIGYY 216
L + N +P G+++ L L + N+L +P + +LTKL L + Y
Sbjct: 88 ETLWVTDNKLQ-ALPI--GVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSL-GY 142
Query: 217 NSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELG 276
N LP + FD +L +L L L N L
Sbjct: 143 NELQ-SLPKGV--------FD---------------KLTSLKELRLYNNQLKRVPEGAFD 178
Query: 277 YLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRN 313
L LK++ L NN +F L+ L +L L N
Sbjct: 179 KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 38/185 (20%), Positives = 67/185 (36%), Gaps = 41/185 (22%)
Query: 414 SIPKGLF-GLPSLSQVELQDNYLTGQFPVSDSIS-------VNLGQICLSNNQLSGSLPA 465
S+P F L L + L DN L ++ NL + +++N+L +LP
Sbjct: 51 SLPSKAFHRLTKLRLLYLNDNKLQ-------TLPAGIFKELKNLETLWVTDNKLQ-ALPI 102
Query: 466 SIGKFSG---VQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNK--------FSGRIAP 513
+ F + +L LD N+ +P + L +L+ + +N+ F +
Sbjct: 103 GV--FDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTS- 158
Query: 514 EISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI-ASMQSLTSV 572
L + L N+L + L L L N L +P S++ L +
Sbjct: 159 -------LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210
Query: 573 DFSYN 577
N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 34/136 (25%), Positives = 50/136 (36%), Gaps = 28/136 (20%)
Query: 59 DSRRHVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLN 116
+ L L+ L L + L+ L+ L V N+L +P + L +L L
Sbjct: 58 HRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELR 115
Query: 117 LSNN--------VFNG---------------SFPPQL-SQLASLQVLDLYNNNMTGDLPL 152
L N VF+ S P + +L SL+ L LYNN +
Sbjct: 116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175
Query: 153 AVTQLRNLRHLHLGGN 168
A +L L+ L L N
Sbjct: 176 AFDKLTELKTLKLDNN 191
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 35/110 (31%), Positives = 47/110 (42%), Gaps = 12/110 (10%)
Query: 65 TSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNN-- 120
L L L +L P V L L LS+ N+L +P + L+SL+ L L NN
Sbjct: 112 AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQL 169
Query: 121 --VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGN 168
V G+F +L L+ L L NN + A L L+ L L N
Sbjct: 170 KRVPEGAF----DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 39/166 (23%)
Query: 739 IRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKI------AV 791
H + + + NL V EY+ NG G++++ H+ ++ + A
Sbjct: 75 WEHPFLTHMF-CTFQTKENLFFVMEYL-NG--GDLMY-----HIQSCHKFDLSRATFYAA 125
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAK-FLQDSGTSE--CM 846
E GL +LH S IV+RD+K +NILLD + H+ ADFG+ K + + C
Sbjct: 126 EIILGLQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNTFC- 179
Query: 847 SAIAGSYGYIAPE----YAYTLKVDEKSDVYSFGVVLLELITGRKP 888
G+ YIAPE Y V D +SFGV+L E++ G+ P
Sbjct: 180 ----GTPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 50/145 (34%), Positives = 76/145 (52%), Gaps = 37/145 (25%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYK------IAVEAAKGLCYLHHDCSPLIVHRD 812
V EY+ NG G++++ H+ R+K A E A GL +L S I++RD
Sbjct: 98 FVMEYV-NG--GDLMY-----HIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRD 146
Query: 813 VKSNNILLDSGFEAHV--ADFGLAK-FLQDSGTSE--CMSAIAGSYGYIAPE----YAYT 863
+K +N++LDS E H+ ADFG+ K + D T++ C G+ YIAPE Y
Sbjct: 147 LKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKTFC-----GTPDYIAPEIIAYQPYG 199
Query: 864 LKVDEKSDVYSFGVVLLELITGRKP 888
V D ++FGV+L E++ G+ P
Sbjct: 200 KSV----DWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 46/138 (33%), Positives = 70/138 (50%), Gaps = 23/138 (16%)
Query: 759 LVYEYMPNGSLGEVLHGKKGGHLHWD-TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNN 817
V EY+ G L + H ++ L + R+ A E + L YLH I++RD+K +N
Sbjct: 130 FVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDN 183
Query: 818 ILLDSGFEAHV--ADFGLAK-FLQDSGTSECMSAIAGSYGYIAPE----YAYTLKVDEKS 870
+LLDS E H+ D+G+ K L+ T+ S G+ YIAPE Y V
Sbjct: 184 VLLDS--EGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFSV---- 234
Query: 871 DVYSFGVVLLELITGRKP 888
D ++ GV++ E++ GR P
Sbjct: 235 DWWALGVLMFEMMAGRSP 252
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 60/253 (23%), Positives = 90/253 (35%), Gaps = 61/253 (24%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH-RHIVRLLG 749
IG G G + G + + VA+K P SR + E + ++ I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGSGDGIPQVYY 72
Query: 750 FCSNHETNLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
F + N +V E + G SL E L T IA++ + Y+H S +
Sbjct: 73 FGPCGKYNAMVLELL--GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNL 126
Query: 809 VHRDVKSNNILLDSGFEA-----HVADFGLAKFLQDS---------------GTSECMSA 848
++RDVK N L+ H+ DF LAK D GT+ MS
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS- 185
Query: 849 IAGSYGYIAPEYAYTLKVDEKS---DVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKM 905
I G E+S D+ + G + + + G P W
Sbjct: 186 INTHLGK------------EQSRRDDLEALGHMFMYFLRGSLP------------WQGLK 221
Query: 906 TDSKKEGVLKILD 918
D+ KE KI D
Sbjct: 222 ADTLKERYQKIGD 234
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 3e-11
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 21/208 (10%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLG 749
IG G G +Y G + ++VA+K ++ + E + ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKIYRILQGGTGIPNVRW 70
Query: 750 FCSNHETNLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
F + N+LV + + G SL E L L T +A + + ++H S
Sbjct: 71 FGVEGDYNVLVMDLL--GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSF 124
Query: 809 VHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA--YT 863
+HRD+K +N L+ G A+ + DFGLAK +D+ T + + YA T
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT 184
Query: 864 LKVDEKS---DVYSFGVVLLELITGRKP 888
E+S D+ S G VL+ + G P
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 57/253 (22%), Positives = 91/253 (35%), Gaps = 61/253 (24%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH-RHIVRLLG 749
IG+G G++++G + N QVA+K P S E +T + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD----EYRTYKLLAGCTGIPNVYY 73
Query: 750 FCSNHETNLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
F N+LV + + G SL E L G T A + + +H +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 127
Query: 809 VHRDVKSNNILLDSGFEA-----HVADFGLAKFLQDS---------------GTSECMSA 848
V+RD+K +N L+ +V DFG+ KF +D GT+ MS
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS- 186
Query: 849 IAGSYGYIAPEYAYTLKVDEKS---DVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKM 905
I G E+S D+ + G V + + G P W
Sbjct: 187 INTHLGR------------EQSRRDDLEALGHVFMYFLRGSLP------------WQGLK 222
Query: 906 TDSKKEGVLKILD 918
+ K+ +I +
Sbjct: 223 AATNKQKYERIGE 235
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 51/242 (21%), Positives = 84/242 (34%), Gaps = 62/242 (25%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA-----EIQTLGRIRHRHI 744
+IG G G V + VA+K++ + + + EI L R+ H H+
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-----EDLIDCKRILREIAILNRLNHDHV 114
Query: 745 VRLLG-FCSNHETNL----LVYEYMPNGSLGEVLHGKKGGHL---HWDTRYKIAVEAAKG 796
V++L +V E + ++ + +L H + + G
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF--RTPVYLTELH--IKT-LLYNLLVG 168
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG-- 854
+ Y+H S I+HRD+K N L++ V DFGLA+ + I+
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 855 -----------------------YIAPE-----YAYTLKVDEKSDVYSFGVVLLELITGR 886
Y APE YT + DV+S G + EL+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIGCIFAELLNMI 281
Query: 887 KP 888
K
Sbjct: 282 KE 283
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 51/265 (19%), Positives = 85/265 (32%), Gaps = 67/265 (25%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHG----------FNAEIQTLGRIRH 741
IG+GG G +Y M + + V + D+G A+ + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 742 RHIVRLLGFCS-----NHETNLLVYEYMPNGSLG---EVLHGKKGGHLHWDTRYKIAVEA 793
++ LG H+ N Y +M G + ++ T ++++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 794 AKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDS----------- 840
L Y+H VH D+K++N+LL+ V D+GLA
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 841 ----GTSECMSAIAGSYGYIAPEYAYTLKVDEKS---DVYSFGVVLLELITGRKPVGEFG 893
GT E S I G S D+ G +++ +TG P
Sbjct: 219 RCHDGTIEFTS-IDAHNGV------------APSRRGDLEILGYCMIQWLTGHLP----- 260
Query: 894 DGVDIVQWVRKMTDSKKEGVLKILD 918
W + D K KI
Sbjct: 261 -------WEDNLKDPKYVRDSKIRY 278
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 12/110 (10%)
Query: 65 TSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNN-- 120
+DLS +S L+PD LR L +L + N+++ +P + L SL+LL L+ N
Sbjct: 59 RRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKI 116
Query: 121 --VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGN 168
+ +F L +L +L LY+N + + LR ++ +HL N
Sbjct: 117 NCLRVDAF----QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 33/159 (20%), Positives = 62/159 (38%), Gaps = 34/159 (21%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGV---MPRLEVLQLWE 336
++ + L N P +F+ K L ++L N++ + + L L L+
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQGLRSLNSLVLYG 89
Query: 337 NNFTGSIPQRL-GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESL 395
N T +P+ L L++L L++NK+ L D F +
Sbjct: 90 NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVD----------------AFQDLH--- 128
Query: 396 GKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDN 433
+L+ + + +N L +I KG F L ++ + L N
Sbjct: 129 ----NLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 33/163 (20%), Positives = 55/163 (33%), Gaps = 39/163 (23%)
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF-----LEYLA 188
++ + L N + P A + + LR + L N S ++ P F L L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DA--FQGLRSLNSLV 86
Query: 189 VSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVR--FDAANCGLSGE 246
+ GN++ L LQ L + N ++ L F
Sbjct: 87 LYGNKITELPKSLFEGLFSLQLLLL-NAN-----------KINCLRVDAFQ--------- 125
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNN 289
L NL+ L L N L L+++++M L+ N
Sbjct: 126 ------DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 6/128 (4%)
Query: 215 YYNSYTGGLPPEI-GNLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLT 272
N+ +PP L R D +N +S E+ D L++L++L L N ++
Sbjct: 40 EQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPK 97
Query: 273 TELGYLKSLKSMDLSNNIFTGEIPA-SFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEV 331
+ L SL+ + L+ N + +F +L NL LL+L+ NKL + ++
Sbjct: 98 SLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156
Query: 332 LQLWENNF 339
+ L +N F
Sbjct: 157 MHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 43/176 (24%), Positives = 68/176 (38%), Gaps = 38/176 (21%)
Query: 312 RNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNKLTGTLPPD 370
R K IP + + ++L +N IP S KLR +DLS+N+++ L PD
Sbjct: 19 RGKGLTEIP--TNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 371 MCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVE 429
G L++L +L + N + +PK LF GL SL +
Sbjct: 75 AFQG--LRSLNSL---------------------VLYGNKIT-ELPKSLFEGLFSLQLLL 110
Query: 430 LQDNYLT----GQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGN 481
L N + F + NL + L +N+L + +Q + L N
Sbjct: 111 LNANKINCLRVDAF---QDLH-NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 49/215 (22%), Positives = 78/215 (36%), Gaps = 59/215 (27%)
Query: 691 IIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLL 748
++G G G V + ++ A+K L + E++ R + HIVR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIV 77
Query: 749 GFCSNHETN----LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAA-------KGL 797
N L+V E + G L + + G + R EA+ + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTER-----EASEIMKSIGEAI 130
Query: 798 CYLH-HDCSPLIVHRDVKSNNILLDSGFEAH---VADFGLAKFLQDSGTSECMSAIAGSY 853
YLH + I HRDVK N+L S + DFG AK Y
Sbjct: 131 QYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-----------TGEKY 175
Query: 854 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
D+ D++S GV++ L+ G P
Sbjct: 176 -------------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 37/213 (17%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRL---PAMSRGSSHDHGFNAEIQTLGRIRHR---- 742
+IGKG G V K VA+K + H EI+ L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-----HRQAAE-EIRILEHLRKQDKDN 157
Query: 743 --HIVRLLGF--CSNHETNL-LVYEYMPNGSLGEVLHGKKGGH--LHWDTRYKIAVEAAK 795
+++ +L NH + + +E + + +L E++ KK K A +
Sbjct: 158 TMNVIHMLENFTFRNH---ICMTFELL-SMNLYELI--KKNKFQGFSLPLVRKFAHSILQ 211
Query: 796 GLCYLHHDCSPLIVHRDVKSNNILLDSGFEAH--VADFGLAKFLQDSGTSECMSAIAGSY 853
L LH I+H D+K NILL + V DFG + + + + S
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE-----HQRVYTYIQSR 263
Query: 854 GYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 886
Y APE + D++S G +L EL+TG
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 46/266 (17%), Positives = 80/266 (30%), Gaps = 69/266 (25%)
Query: 692 IGKGGAGIVYKGL---------MPNGDQVAVKRLPAMSRGSSHDHGFN--------AEIQ 734
+ GI+Y+ P + ++K R + + F + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 735 TLGRIRHRHIVRLLGFCSNHET-NLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVE 792
L I +GF + + LV + G SL L L + ++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 793 AAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDS---------- 840
L +LH VH +V + NI +D ++ V A +G A S
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 841 -----GTSECMSAIAGSYGYIAPEYAYTLKVDEKS---DVYSFGVVLLELITGRKPVGEF 892
G E +S + G S D+ S G +L+ + G P
Sbjct: 225 RSPHEGDLEFIS-MDLHKGC------------GPSRRSDLQSLGYCMLKWLYGFLP---- 267
Query: 893 GDGVDIVQWVRKMTDSKKEGVLKILD 918
W + +++ K
Sbjct: 268 --------WTNCLPNTEDIMKQKQKF 285
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 32/129 (24%), Positives = 50/129 (38%), Gaps = 10/129 (7%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSG-PLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
+IP I Q L L N + T L L+ ++ SNN T +F
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 305 LTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSN 361
+ + L N+L + F G + L+ L L N T + +R+L L N
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKG-LESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 362 KLTGTLPPD 370
++T T+ P
Sbjct: 140 QIT-TVAPG 147
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 35/155 (22%), Positives = 57/155 (36%), Gaps = 35/155 (22%)
Query: 285 DLSNNIFTG-EIPASFAELKNLTLLNLFRNKLHGAIPEFIGV---MPRLEVLQLWENNFT 340
L+NN FT E F +L L +N NK+ I E G + + L N
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE--GAFEGASGVNEILLTSNRLE 94
Query: 341 GSIPQRLGSN-GKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCD 399
++ ++ L+ L L SN++T + D S
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRIT-CVGND-----------------------SFIGLS 129
Query: 400 SLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDN 433
S+ + + +N + ++ G F L SLS + L N
Sbjct: 130 SVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 12/113 (10%)
Query: 62 RHVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSN 119
+ ++ S ++ + + + + +N+L + ++ L SL+ L L +
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRS 114
Query: 120 N----VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGN 168
N V N SF L+S+++L LY+N +T P A L +L L+L N
Sbjct: 115 NRITCVGNDSF----IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 33/181 (18%), Positives = 59/181 (32%), Gaps = 50/181 (27%)
Query: 134 ASLQVLDLYNNNMTGDLPLAV-TQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGN 192
L L NN T + +L LR ++ N +I +E
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN----KI-------TDIE------- 73
Query: 193 ELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIG 252
G + + ++ + N + ++ F
Sbjct: 74 ------EGAFEGASGVNEILL-TSNRLEN-VQHKM--------FK--------------- 102
Query: 253 RLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFR 312
L++L TL L+ N ++ L S++ + L +N T P +F L +L+ LNL
Sbjct: 103 GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA 162
Query: 313 N 313
N
Sbjct: 163 N 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 32/175 (18%), Positives = 54/175 (30%), Gaps = 44/175 (25%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQ--LSQLASLQVLDLYNNNMTGDLPLAVTQLRN 159
IP I L L+NN F +L L+ ++ NN +T A
Sbjct: 26 IPEHIPQ--YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 160 LRHLHLGGNFFSGQIPPEYGIWEF-----LEYLAVSGNELGGKIPGEIGNLTKLQQLYIG 214
+ + L N + + F L+ L + N + L+ ++ L +
Sbjct: 83 VNEILLTSNRLEN-VQH--KM--FKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL- 136
Query: 215 YYNSYTGGLPPEIGNLSSLVR--FDAANCGLSGEIPTDIGRLQNLDTLFLQVNAL 267
Y N ++++ FD L +L TL L N
Sbjct: 137 YDN-----------QITTVAPGAFD---------------TLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 8/115 (6%)
Query: 229 NLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLS 287
L L + + +N ++ +I ++ + L N L L+SLK++ L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113
Query: 288 NNIFTGEIPA-SFAELKNLTLLNLFRNKLHGAIPE--FIGVMPRLEVLQLWENNF 339
+N T + SF L ++ LL+L+ N++ + F + L L L N F
Sbjct: 114 SNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT-LHSLSTLNLLANPF 165
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 1e-09
Identities = 78/526 (14%), Positives = 165/526 (31%), Gaps = 75/526 (14%)
Query: 53 WPGVTCDSRRHVTSLDLSGLNLSGALS--PDVAHL-----RFLQNLSVAANQLSGPIPPE 105
W + RR V + ++ + + P V + + ++ + G + P
Sbjct: 37 WYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPW 96
Query: 106 ISALSS----LRLLNLSNNVFNGSFPPQLSQ-LASLQVLDLYNNNMTGDLPLA--VTQLR 158
I A+SS L + L V +++ + +VL L + LA R
Sbjct: 97 IEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCR 156
Query: 159 NLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNS 218
NL+ L L + +L + T L L I S
Sbjct: 157 NLKELDLRESDVDDVSG------HWLSHFP--------------DTYTSLVSLNISCLAS 196
Query: 219 YTG--GLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQV------NALSGP 270
L + +L ++ T + R L+ L +
Sbjct: 197 EVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG 256
Query: 271 LTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNL-FRNKLHGAIPEFIGVMPRL 329
L+ L K L+ + + +PA ++ LT LNL + + + + P+L
Sbjct: 257 LSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKL 316
Query: 330 EVLQLWENNFTGSIPQRLGSNGK-LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLF 388
+ L + + + + L S K LR L + ++ + Q L+++
Sbjct: 317 QRLWV-LDYIEDAGLEVLASTCKDLRELRVFPSE---PFVMEPNVALTEQGLVSVSMGCP 372
Query: 389 GPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVN 448
+ L C ++ N ++ P++++ L I
Sbjct: 373 K-LESVLYFCRQMT---------NAALITIARNRPNMTRFRL-------------CIIEP 409
Query: 449 LGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGK-LQQLSKMDFSHNKF 507
L+ L A + +++L L G + ++ IG +++ + +
Sbjct: 410 KAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL-LTDKVFEYIGTYAKKMEMLSVAFAGD 468
Query: 508 SGRIAPEISQ-CKLLTFVDLSRNELSGE-IPNQLTGMRILNYLNLS 551
S + C L +++ + + + + + L +S
Sbjct: 469 SDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMS 514
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 54/361 (14%), Positives = 105/361 (29%), Gaps = 54/361 (14%)
Query: 27 LSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLS-GALSPDVAHL 85
L K D +L W S + + L + ++ L
Sbjct: 73 LKGKPHFAD---FNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSF 129
Query: 86 RFLQNLSVAA-NQLSGPIPPEISA-LSSLRLLNLSNNVFNGSFPPQLSQLA----SLQVL 139
+ + L +++ S I+A +L+ L+L + + LS SL L
Sbjct: 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189
Query: 140 DL--YNNNMT-GDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
++ + ++ L VT+ NL+ L L + + L
Sbjct: 190 NISCLASEVSFSALERLVTRCPNLKSLKLNRAV---------PLEKLATLLQ-------- 232
Query: 197 KIPGEIGNLTKLQQLYIGYYNSYTG-----GLPPEIGNLSSLVRFDAANCGLSGEIPTDI 251
+L++L G Y + GL + L + +P
Sbjct: 233 -------RAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVY 285
Query: 252 GRLQNLDTLFLQVNALSGP-LTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNL 310
L TL L + L L L+ + + + I + + K+L L +
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRV 345
Query: 311 FRNKLHG----------AIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLS 359
F ++ + P+LE + + T + + N + L
Sbjct: 346 FPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC 405
Query: 360 S 360
Sbjct: 406 I 406
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 1e-09
Identities = 89/632 (14%), Positives = 169/632 (26%), Gaps = 168/632 (26%)
Query: 20 VPEYKALLSIKSSITDDPQSSLAAWNATTSH-CTWPGVTCDSRRHVTSLDLSGLN----- 73
+ K + D P+S L+ H + R +L
Sbjct: 26 EDAFVDNFDCKD-VQDMPKSILS--KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF 82
Query: 74 LSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQL 133
+ L + L + + Q S I RL N N VF +L
Sbjct: 83 VEEVLRINYKFL--MSPIKTEQRQPSMMTRMYIEQRD--RLYN-DNQVFAKYNVSRLQPY 137
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRH-----LH-LGGNFFSGQIPPEYGIWEFLEYL 187
L+ L LR + + G SG+ ++
Sbjct: 138 LKLR-----------------QALLELRPAKNVLIDGVLG---SGK--------TWVALD 169
Query: 188 AVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFD-AANCGLSGE 246
++ K+ +I L + NS + + L + + + S
Sbjct: 170 VCLSYKVQCKMDFKIFWLN------LKNCNS-PETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLT 306
I I +Q L+ Y L + N+ + +F L
Sbjct: 223 IKLRIHSIQAELRRLLK----------SKPYENCLLVLL---NVQNAKAWNAF-NLSCKI 268
Query: 307 LLNLFRNKLHGAIPEFIGVMPRLEV-LQLWENNFTGSIPQRLGSNGKLRILDLSSNKL-- 363
LL R K + +F+ + L T + L L
Sbjct: 269 LL-TTRFK---QVTDFLSAATTTHISLDHHSMTLT-----------PDEVKSLLLKYLDC 313
Query: 364 -TGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG------------KCDSLSRMRMGENF 410
LP ++ N +++ I ES+ CD L+ + E+
Sbjct: 314 RPQDLPREVLTTNPR--RLSI-------IAESIRDGLATWDNWKHVNCDKLTTII--ESS 362
Query: 411 LNGSIPKGLFGLPSLSQVELQDNYLT-GQFPVSDSISVNLGQICLSNNQLSGSLPASI-G 468
LN L E + + FP S I L + L + S +
Sbjct: 363 LN-----------VLEPAEYRKMFDRLSVFPPSAHIPTIL--LSLIWFDVIKSDVMVVVN 409
Query: 469 KFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFS-----HNKFSGRIAPEISQCKLLTF 523
K + L++ I I + K+ H ++
Sbjct: 410 KL--HKYSLVEKQPKESTI--SIPSIYLELKVKLENEYALHR-------------SIVDH 452
Query: 524 VDLSRN-ELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSY------ 576
++ + + IP L +++ +HL ++ + +DF +
Sbjct: 453 YNIPKTFDSDDLIPPYLDQY-FYSHIG---HHLKNIEHPERMTLFRMVFLDFRFLEQKIR 508
Query: 577 ------NNLSGLVPGTGQFSYFNYTSFLGNSE 602
N ++ Q + Y ++ +++
Sbjct: 509 HDSTAWNASGSILNTLQQLKF--YKPYICDND 538
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 4e-08
Identities = 60/349 (17%), Positives = 99/349 (28%), Gaps = 120/349 (34%)
Query: 669 LTAFQRLDFTCDDVLDCLKE-------DNIIGKG----------------GAGIVYK--- 702
AF +F C DV D K D+II +V K
Sbjct: 26 EDAFVD-NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE 84
Query: 703 -GLMPNGDQVAVK-----RLPAMSRG---SSHDHGFNAEIQTLGRI---RHRHIVRLLGF 750
L N + R P+M D +N + Q + R + ++L
Sbjct: 85 EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN-DNQVFAKYNVSRLQPYLKL--- 140
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKG---------------------GHLHWDT--RY 787
L E P ++ ++ G G + W
Sbjct: 141 -----RQAL-LELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC 192
Query: 788 KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847
+ L L + P R S+NI L H L + L+
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL----RIHSIQAELRRLLKS-------- 240
Query: 848 AIAGSYGYIAPEYAYTLKV-DEKSDVYS------FGV---VLLELITGRKPVGEFGDG-- 895
Y L V +V + F + +L L T K V +F
Sbjct: 241 ----------KPYENCLLVLL---NVQNAKAWNAFNLSCKIL--LTTRFKQVTDFLSAAT 285
Query: 896 ---VDIVQWVRKMTDSKKEGVL-KILDPRLPSVPLHEVM--HVFYVAML 938
+ + +T + + +L K LD R +P EV+ + ++++
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP-REVLTTNPRRLSII 333
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 4e-04
Identities = 103/721 (14%), Positives = 198/721 (27%), Gaps = 239/721 (33%)
Query: 285 DLSNNIFTGE-----IPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQ-----L 334
D+ +I + E I + A L L +K + +F+ EVL+ L
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE-----EVLRINYKFL 94
Query: 335 WENNFTGSIPQRLGSNGKLRILDLSS---NKLTGTLPPDMCAGNCLQTLITLGNF--LFG 389
P + + + ++L F
Sbjct: 95 MS-------PIKTEQRQPSMMTRMYIEQRDRLYNDNQV----------------FAKYNV 131
Query: 390 PIPESLGKC-DSLSRMRMGEN-FLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS- 446
+ K +L +R +N ++G G G ++ + + I
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDG--VLG-SGKTWVALDVCLSYKVQCKMD--FKIFW 186
Query: 447 VNLGQICLSNNQLSGSLPASIGKFSGVQKLL--LDGN-----KFSGQIPAEIGKLQQLSK 499
+NL C S + L QKLL +D N S I I +Q +
Sbjct: 187 LNLKN-CNSPETVLEML----------QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 500 MDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSI 559
+ C LL +++ + N NLS L+ +
Sbjct: 236 RLLKSKPYE--------NC-LLVLLNVQNAK-------------AWNAFNLSCKILLTTR 273
Query: 560 PASIA-SMQSLTSVDFSYNNLS-GLVPGTGQFSYFNYTSFLGNSELCGPYLG-PCKDGVA 616
+ + + T+ S ++ S L P + L YL +D
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVK-------------SLLLKYLDCRPQD--- 317
Query: 617 NGTHQPHVKGPLSASVKLLLVVGLLVCSIAFAVAAIIKARSLKKASESRAWKLTAFQRLD 676
L V SI +A I+ + WK +L
Sbjct: 318 -----------LPREVLT---TNPRRLSI---IAESIR----DGLATWDNWKHVNCDKLT 356
Query: 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEI--Q 734
+ L+ L+ + ++ L +V P +A I
Sbjct: 357 TIIESSLNVLEPAEY--RK----MFDRL-------SV--FPP-----------SAHIPTI 390
Query: 735 TLGRI-------RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRY 787
L I +V L LV + ++ + ++ + +
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKL------HKYSLVEKQPKESTIS--IP-----SIYLELKV 437
Query: 788 KIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS 847
K+ E A +HR ++D + F D +
Sbjct: 438 KLENEYA--------------LHR------SIVDH-YNIP------KTFDSDDLIPPYLD 470
Query: 848 AIAGSYGYIAPEYAYTLKVDEKSDVYS-FGVVLLEL-ITGRK------PVGEFGDGVDIV 899
Y + LK E + + F +V L+ +K G ++ +
Sbjct: 471 ------QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 900 QWVRK----MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
Q ++ + D+ DP+ ++ ++ F + +EE + +++
Sbjct: 525 QQLKFYKPYICDN---------DPK-YERLVNAILD-F---LPKIEENLICSKYTD-LLR 569
Query: 956 I 956
I
Sbjct: 570 I 570
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 46/173 (26%), Positives = 65/173 (37%), Gaps = 22/173 (12%)
Query: 56 VTCDSRRH----------VTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPE 105
V C + LDL L+ L L L++ NQL +
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAG 77
Query: 106 I-SALSSLRLLNLSNNVFNGSFPPQL-SQLASLQVLDLYNNNMTGDLPLAV-TQLRNLRH 162
+ L+ L L L+NN S P + L L L L N + LP V +L L+
Sbjct: 78 VFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKE 135
Query: 163 LHLGGNFFSGQIPPEYGIWEFL---EYLAVSGNELGGKIPGEIGNLTKLQQLY 212
L L N IP G ++ L + L++S N+L G L KLQ +
Sbjct: 136 LRLNTNQLQ-SIPA--GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 51/196 (26%), Positives = 75/196 (38%), Gaps = 48/196 (24%)
Query: 247 IPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPAS-FAELKNL 305
IP D +L LQ L+ L L ++L N + A F +L L
Sbjct: 33 IPADTEKLD------LQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTEL 85
Query: 306 TLLNLFRNKLHGAIPEFIGV---MPRLEVLQLWENNFTGSIPQ----RLGSNGKLRILDL 358
L L N+L ++P GV + +L+ L L N S+P RL KL+ L L
Sbjct: 86 GTLGLANNQLA-SLPL--GVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL---TKLKELRL 138
Query: 359 SSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKG 418
++N+L ++P G F + L L + + N L S+P G
Sbjct: 139 NTNQLQ-SIPA--------------GAF------DKLTN---LQTLSLSTNQLQ-SVPHG 173
Query: 419 LF-GLPSLSQVELQDN 433
F L L + L N
Sbjct: 174 AFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 43/183 (23%), Positives = 65/183 (35%), Gaps = 31/183 (16%)
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF---LEYLAVS 190
A + LDL + + L L L+L N + G+++ L L ++
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSA--GVFDDLTELGTLGLA 91
Query: 191 GNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTD 250
N+L G +LT+L +LY+ N LP + FD
Sbjct: 92 NNQLASLPLGVFDHLTQLDKLYL-GGNQLK-SLPSGV--------FD------------- 128
Query: 251 IGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNL 310
RL L L L N L L +L+++ LS N +F L L + L
Sbjct: 129 --RLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186
Query: 311 FRN 313
F N
Sbjct: 187 FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 49/203 (24%), Positives = 68/203 (33%), Gaps = 53/203 (26%)
Query: 89 QNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQL-SQLASLQVLDLYNNNMT 147
+ L + + L+ L+ L LNL N + + L L L L NN +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 148 GDLPLAV-TQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLT 206
LPL V L L L+LGGN Q+ + L G LT
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGN----QL-------KSLP-------------SGVFDRLT 131
Query: 207 KLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNA 266
KL++L + N +P FD +L NL TL L N
Sbjct: 132 KLKELRL-NTNQLQ-SIPAGA--------FD---------------KLTNLQTLSLSTNQ 166
Query: 267 LSGPLTTELGYLKSLKSMDLSNN 289
L L L+++ L N
Sbjct: 167 LQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 43/173 (24%), Positives = 60/173 (34%), Gaps = 33/173 (19%)
Query: 23 YKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDV 82
K+L S+ S I D + + T +T L+L L LS V
Sbjct: 23 GKSLDSVPSGIPADTEKLDLQSTGLAT---LSDATFRGLTKLTWLNLDYNQLQ-TLSAGV 78
Query: 83 -AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNNVFNGSFPP------------ 128
L L L +A NQL+ +P + L+ L L L N S P
Sbjct: 79 FDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL 136
Query: 129 -----QLS--------QLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGN 168
QL +L +LQ L L N + A +L L+ + L GN
Sbjct: 137 RLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 50/279 (17%), Positives = 92/279 (32%), Gaps = 51/279 (18%)
Query: 111 SLRLLNLSNNVFNG----SFPPQLSQLASLQVLDLYNNNMTGD----LPLAVTQLRNLRH 162
S+ +L + S L + S++ + L N + + L + ++L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 163 LHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG- 221
F+G++ E I E L L + KL + + N++
Sbjct: 65 AEFSDI-FTGRVKDE--IPEALRLLL-----------QALLKCPKLHTVRLS-DNAFGPT 109
Query: 222 ---GLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYL 278
L + + L N GL + I R LQ A++ +
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-------LQELAVN----KKAKNA 158
Query: 279 KSLKSMDLSNNIFTGE----IPASFAELKNLTLLNLFRNKLH-----GAIPEFIGVMPRL 329
L+S+ N +F + L + + +N + + E + L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218
Query: 330 EVLQLWENNFTG----SIPQRLGSNGKLRILDLSSNKLT 364
+VL L +N FT ++ L S LR L L+ L+
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 56/371 (15%), Positives = 109/371 (29%), Gaps = 104/371 (28%)
Query: 135 SLQVLDLYNNNMTGD----LPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVS 190
S++ L + +T + + + + +++ + L GN I E E +A
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGN----TIGTE-AARWLSENIA-- 57
Query: 191 GNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIG-NLSSLVRFDAANCGLSGEIPT 249
+ L+ + +TG + EI L L++
Sbjct: 58 -------------SKKDLEIAEFS--DIFTGRVKDEIPEALRLLLQALLKCP-------- 94
Query: 250 DIGRLQNLDTLFLQVNALSG----PLTTELGYLKSLKSMDLSNN-------------IFT 292
L T+ L NA PL L L+ + L NN +
Sbjct: 95 ------KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQE 148
Query: 293 GEIPASFAELKNLTLLNLFRNKLHG----AIPEFIGVMPRLEVLQLWENNFT-----GSI 343
+ L + RN+L + L +++ +N +
Sbjct: 149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL 208
Query: 344 PQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSR 403
+ L +L++LDL N T + + L +L +L
Sbjct: 209 LEGLAYCQELKVLDLQDNTFT-----HLGS-------SALA--------IALKSWPNLRE 248
Query: 404 MRMGENFLNGSIPKGLFGL---------PSLSQVELQDNYLT--GQFPVSDSISVN---L 449
+ + + L+ +G + L + LQ N + + I L
Sbjct: 249 LGLNDCLLS---ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 450 GQICLSNNQLS 460
+ L+ N+ S
Sbjct: 306 LFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 40/286 (13%), Positives = 79/286 (27%), Gaps = 68/286 (23%)
Query: 329 LEVLQLWENNFTG----SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLG 384
+E L + T S+ L + ++ + LS N + +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG----TEAARW---------- 51
Query: 385 NFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDS 444
+ E++ L + F + L L Q L
Sbjct: 52 ------LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA-LLKCP---------- 94
Query: 445 ISVNLGQICLSNNQLSGSLPASIGKF----SGVQKLLLDGNKFS-------------GQI 487
L + LS+N + + F + ++ L L N +
Sbjct: 95 ---KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151
Query: 488 PAEIGKLQQLSKMDFSHNKFSGR----IAPEISQCKLLTFVDLSRNELSGE-----IPNQ 538
+ L + N+ A +LL V + +N + E +
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 539 LTGMRILNYLNLSRNHL----VGSIPASIASMQSLTSVDFSYNNLS 580
L + L L+L N ++ ++ S +L + + LS
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 56/345 (16%), Positives = 107/345 (31%), Gaps = 75/345 (21%)
Query: 279 KSLKSMDLSNNIFTGE----IPASFAELKNLTLLNLFRNKL--HGA--IPEFIGVMPRLE 330
S++ L + T E + A E ++ + L N + A + E I LE
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 331 VLQLWENNFTGSIPQR-----------LGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQT 379
+ + + FTG + L KL + LS N
Sbjct: 64 IAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG-----PTAQE----- 112
Query: 380 LITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQF 439
P+ + L K L + + N L G +++ LQ+ + +
Sbjct: 113 ----------PLIDFLSKHTPLEHLYLHNNGL------GPQAGAKIARA-LQELAVNKKA 155
Query: 440 PVSDSISVNLGQICLSNNQLSG----SLPASIGKFSGVQKLLLDGNKFSGQ-IPAEIGKL 494
+ + I N+L + + + + N + I + +
Sbjct: 156 KNAPPLRS----IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 495 ----QQLSKMDFSHNKFSGR----IAPEISQCKLLTFVDLSRNELSGE----IPNQLTGM 542
Q+L +D N F+ +A + L + L+ LS + + + +
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 543 --RILNYLNLSRNHL----VGSIPASIAS-MQSLTSVDFSYNNLS 580
L L L N + V ++ I M L ++ + N S
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 63/346 (18%), Positives = 114/346 (32%), Gaps = 76/346 (21%)
Query: 62 RHVTSLDLSGLNLSG----ALSPDVAHLRFLQNLSVAANQLSGP---IPPEISALS---- 110
V + LSG + LS ++A + L+ + IP + L
Sbjct: 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALL 91
Query: 111 ---SLRLLNLSNNVFNG----SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQL-RNLRH 162
L + LS+N F LS+ L+ L L+NN + P A ++ R L+
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQE 148
Query: 163 LHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGK----IPGEIGNLTKLQQLYIGYYNS 218
L + + L + N L + L + + N
Sbjct: 149 LAVNKKAKNAPP---------LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM-VQNG 198
Query: 219 YTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGP----LTTE 274
I G+ + + Q L L LQ N + L
Sbjct: 199 --------IR-----------PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 275 LGYLKSLKSMDLSNNIFTGE----IPASFAELKNLTL--LNLFRNKLHG----AIPEFIG 324
L +L+ + L++ + + + +F++L+N+ L L L N++ + I
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299
Query: 325 V-MPRLEVLQLWENNFT------GSIPQRLGSNGKLRILDLSSNKL 363
MP L L+L N F+ I + + G+ + +L +
Sbjct: 300 EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 18/136 (13%), Positives = 43/136 (31%), Gaps = 23/136 (16%)
Query: 467 IGKFSGVQKLLLDGNKFSGQ----IPAEIGKLQQLSKMDFSHNKFSGR----IAPEISQC 518
+ +FS ++ L + + + + A + + + ++ S N ++ I+
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 519 KLLTFVDLSRNELSGEIPNQLTGMRI----------LNYLNLSRNHL----VGSIPASIA 564
K L + S +R+ L+ + LS N + ++
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 565 SMQSLTSVDFSYNNLS 580
L + N L
Sbjct: 120 KHTPLEHLYLHNNGLG 135
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 19/94 (20%), Positives = 32/94 (34%), Gaps = 2/94 (2%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQ-LSQLASLQVLDLYNNNMTGDLPLAVTQLRNL 160
+ +L L + N + L L L+ L + + + P A L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 161 RHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL 194
L+L N + + L+ L +SGN L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 30/152 (19%), Positives = 46/152 (30%), Gaps = 22/152 (14%)
Query: 50 HCTWP-GVTCDSRR------------HVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAA 95
G+ C ++T L + L L L+NL++
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 96 NQLSGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAV 154
+ L + P+ L LNLS N S + Q SLQ L L N +
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS----- 118
Query: 155 TQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEY 186
LR L+ G + + L +
Sbjct: 119 CALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 2/96 (2%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTE-LGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
+ + +NL L+++ L L L L+++ + + P +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 305 LTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFT 340
L+ LNL N L ++ L+ L L N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 19/92 (20%), Positives = 33/92 (35%), Gaps = 6/92 (6%)
Query: 125 SFPPQLSQLASLQVLDLYNNNMTGDLPL-AVTQLRNLRHLHLGGNFFSGQIPPE--YGIW 181
L +L L + N L L + L LR+L + + + P+ +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT- 79
Query: 182 EFLEYLAVSGNELGGKIPGEIGNLTKLQQLYI 213
L L +S N L + + LQ+L +
Sbjct: 80 PRLSRLNLSFNAL-ESLSWKTVQGLSLQELVL 110
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 2/96 (2%)
Query: 342 SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAG-NCLQTLITLGNFLFGPIPESLGKCDS 400
L L L + + + L G L+ L + + L P++
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 401 LSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLT 436
LSR+ + N L S+ SL ++ L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 2/94 (2%)
Query: 487 IPAEIGKLQQLSKMDFSHNKFSGRIAPE-ISQCKLLTFVDLSRNELSGEIPNQLTGMRIL 545
+ + L+++ + + + + L + + ++ L P+ L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 546 NYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNL 579
+ LNLS N L S+ SL + S N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 3/68 (4%)
Query: 521 LTFVDLSRNELSGEIPNQ-LTGMRILNYLNLSRNHLVGSIPASIAS-MQSLTSVDFSYNN 578
LT + + + + + L G+ L L + ++ L + L+ ++ S+N
Sbjct: 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNA 91
Query: 579 LSGLVPGT 586
L L T
Sbjct: 92 LESLSWKT 99
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 40/252 (15%), Positives = 62/252 (24%), Gaps = 63/252 (25%)
Query: 684 DCLKEDNI-----IGKGGAGIVYKGLMPNGDQVAVKRLP------AMSRGSSHDHGFNAE 732
CL + + IG+G G V++ + + VA+K + E
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73
Query: 733 IQTL---------GRIRHRHIVRLLGFC----SNHETNLLVYEYMP--NGSL-------- 769
I R + L S L +++ GS
Sbjct: 74 IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133
Query: 770 -------------GEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSN 816
G L + T I + L HRD+
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191
Query: 817 NILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSD--VYS 874
N+LL + K S G YTL E+ V+
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVVFC 240
Query: 875 FGVVLLELITGR 886
+ +L TG
Sbjct: 241 DVSMDEDLFTGD 252
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 63/344 (18%), Positives = 106/344 (30%), Gaps = 116/344 (33%)
Query: 711 VAVKRLPAMSRGSSHDHGFNAEIQTLGRIR--------HRHIVRLL------GFCSNHET 756
VA+K + + + EI+ L +R +V+LL G H
Sbjct: 65 VAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI- 120
Query: 757 NLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKS 815
+V+E + G L + + L KI + +GL YLH C I+H D+K
Sbjct: 121 -CMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 816 NNILLDSG-------------------------------------------------FEA 826
NILL +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 827 HVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR 886
+AD G A ++ T + + Y + E + +D++S + EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
Query: 887 -----KPVGEFGDGVDIV------------QWVRKMTDSKK----EGVLKILDPRLPSVP 925
E+ D + + + SK+ +G LK +L
Sbjct: 291 YLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK-HITKLKPWG 349
Query: 926 LHEVMH--------------VFYVAMLCVEEQAVERPTMREVVQ 955
L EV+ F + ML + + +R T E ++
Sbjct: 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE--KRATAAECLR 391
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 59/227 (25%), Positives = 89/227 (39%), Gaps = 46/227 (20%)
Query: 215 YYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTE 274
S T + L+S+ + A N + L N+ L L N L +
Sbjct: 27 KKKSVTD-AVTQNE-LNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKL-----HD 77
Query: 275 LG---YLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRL-- 329
+ L +L + L+ N F +L NL L L N+L ++P+ GV +L
Sbjct: 78 ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPD--GVFDKLTN 134
Query: 330 -EVLQLWENNFTGSIPQRL-GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFL 387
L L N S+P+ + L LDLS N+L +LP G F
Sbjct: 135 LTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE--------------GVF- 177
Query: 388 FGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDN 433
+ L + L +R+ +N L S+P G+F L SL + L DN
Sbjct: 178 -----DKLTQ---LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 53/236 (22%), Positives = 87/236 (36%), Gaps = 53/236 (22%)
Query: 89 QNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTG 148
++ ++ + L+S+ + +N+ + L +++ L L N +
Sbjct: 22 IKANLKKKSVTD-AVTQNE-LNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH- 76
Query: 149 DLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF---LEYLAVSGNELGGKIPGEIGNL 205
D+ A+ +L NL +L L GN +P G+++ L+ L + N+L G L
Sbjct: 77 DIS-ALKELTNLTYLILTGNQLQ-SLPN--GVFDKLTNLKELVLVENQLQSLPDGVFDKL 132
Query: 206 TKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVN 265
T L L + +N LP + FD +L NL L L N
Sbjct: 133 TNLTYLNL-AHNQLQ-SLPKGV--------FD---------------KLTNLTELDLSYN 167
Query: 266 AL-SGP------LTTELGYLKSLKSMDLSNNIFTGEIP-ASFAELKNLTLLNLFRN 313
L S P LT LK + L N +P F L +L + L N
Sbjct: 168 QLQSLPEGVFDKLT-------QLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 42/203 (20%), Positives = 77/203 (37%), Gaps = 24/203 (11%)
Query: 312 RNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDM 371
+ P L + + T + N + + +++ +
Sbjct: 6 STPIKQIFP--DDAFAETIKANLKKKSVT-DAVTQNELN-SIDQIIANNSDIKSVQGIQY 61
Query: 372 CAGNCLQTLITLGNFLFGPIPESLGKCDSLS---RMRMGENFLNGSIPKGLF-GLPSLSQ 427
++ L GN L + L+ + + N L S+P G+F L +L +
Sbjct: 62 LPN--VRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKE 113
Query: 428 VELQDNYLTGQFP--VSDSISVNLGQICLSNNQLSGSLPASI-GKFSGVQKLLLDGNKFS 484
+ L +N L P V D + NL + L++NQL SLP + K + + +L L N+
Sbjct: 114 LVLVENQLQ-SLPDGVFDKL-TNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170
Query: 485 GQIPAEI-GKLQQLSKMDFSHNK 506
+P + KL QL + N+
Sbjct: 171 -SLPEGVFDKLTQLKDLRLYQNQ 192
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 18/138 (13%)
Query: 84 HLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQL-SQLASLQVLDL 141
L L L + NQL +P + L++L+ L L N S P + +L +L L+L
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140
Query: 142 YNNNMTGDLPLAV-TQLRNLRHLHLGGNFFSGQIPPEYGIWEF-----LEYLAVSGNELG 195
+N + LP V +L NL L L N +P G+ F L+ L + N+L
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE--GV--FDKLTQLKDLRLYQNQLK 194
Query: 196 GKIP-GEIGNLTKLQQLY 212
+P G LT LQ ++
Sbjct: 195 S-VPDGVFDRLTSLQYIW 211
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 32/171 (18%), Positives = 61/171 (35%), Gaps = 27/171 (15%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHG------FNAEIQTLGRIRHRHI 744
IG GG G++Y ++ A + + + A+ + + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 745 VRLLGF----------CSNHETNLLVYEYMPNG-SLGEVLHGKKGGHLHWDTRYKIAVEA 793
+ LG +V E + G L ++ + G T ++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS--GQNGTFKKSTVLQLGIRM 160
Query: 794 AKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE--AHVADFGLAKFLQDSGT 842
L Y+H + VH D+K+ N+LL ++AD+GL+ +G
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 26/139 (18%), Positives = 50/139 (35%), Gaps = 10/139 (7%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTE-LGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
++ + L+ L L N + L +++L+ + L N+ +I A
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNLIK-KIENLDAVADT 94
Query: 305 LTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIP--QRLGSNGKLRILDLSSNK 362
L L + N++ I + L VL + NN + +L + KL L L+ N
Sbjct: 95 LEELWISYNQIASL--SGIEKLVNLRVLYM-SNNKITNWGEIDKLAALDKLEDLLLAGNP 151
Query: 363 LTGTLPPDMCAGNCLQTLI 381
L + ++
Sbjct: 152 LYNDYKENNATSEYRIEVV 170
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 35/213 (16%), Positives = 67/213 (31%), Gaps = 68/213 (31%)
Query: 133 LASLQVLDLYN--NNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVS 190
+ ++L+ + + ++ L+ +HL L N
Sbjct: 22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE------------------- 61
Query: 191 GNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTD 250
KI + + L+ L +G N +I NL ++
Sbjct: 62 ------KISS-LSGMENLRILSLG-RNLIK-----KIENLDAV----------------- 91
Query: 251 IGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNN-IFTGEIPASFAELKNLTLLN 309
L+ L++ N ++ + + L +L+ + +SNN I A L L L
Sbjct: 92 ---ADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL 146
Query: 310 LFRNKLHGAIPEF----------IGVMPRLEVL 332
L N L+ E + +P L+ L
Sbjct: 147 LAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 27/132 (20%), Positives = 47/132 (35%), Gaps = 24/132 (18%)
Query: 84 HLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNN---VFNGSFPPQLSQLASLQVLD 140
+ L+ LS+ N + I + +L L +S N +G + +L +L+VL
Sbjct: 68 GMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLY 121
Query: 141 LYNNNMTGDLPLAV-TQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIP 199
+ NN +T + L L L L GN E+ +
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV------------ 169
Query: 200 GEIGNLTKLQQL 211
+ L L++L
Sbjct: 170 --VKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 22/108 (20%), Positives = 43/108 (39%), Gaps = 6/108 (5%)
Query: 475 KLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGE 534
+L + A + L+ + S N +I+ +S + L + L RN + +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-K 84
Query: 535 IPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGL 582
I N L L +S N + S+ + I + +L + S N ++
Sbjct: 85 IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNW 130
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 36/156 (23%), Positives = 57/156 (36%), Gaps = 14/156 (8%)
Query: 299 FAELKNLTLLNLFRNKLHGAIPEF------IGVMPRLEVLQLWENNFTGSIPQRLGSNGK 352
F E K++ + +LHG IP + + + L L NN I L
Sbjct: 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMEN 71
Query: 353 LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLN 412
LRIL L N + + + L+ L N + + K +L + M N +
Sbjct: 72 LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT 128
Query: 413 --GSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSIS 446
G I L L L + L N L + +++ S
Sbjct: 129 NWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 20/129 (15%), Positives = 50/129 (38%), Gaps = 9/129 (6%)
Query: 451 QICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGR 510
++ + + A++ + L L N +I + + ++ L + N +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-K 84
Query: 511 IAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL--VGSIPASIASMQS 568
I + L + +S N+++ + + + L L +S N + G I +A++
Sbjct: 85 IENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDK 141
Query: 569 LTSVDFSYN 577
L + + N
Sbjct: 142 LEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 40/194 (20%), Positives = 66/194 (34%), Gaps = 63/194 (32%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
+ +S L + + L LS N + +++SL + NLR
Sbjct: 40 MDATLSTLKACKHLALSTN--------NIEKISSLS------------------GMENLR 73
Query: 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG 221
L LG N +I + + LE L +S N++ + G I L L+ LY+ N
Sbjct: 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQI-ASLSG-IEKLVNLRVLYMS-NN---- 125
Query: 222 GLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTE------- 274
+I N + + + L L+ L L N L
Sbjct: 126 ----KITNWGEIDK---------------LAALDKLEDLLLAGNPLYNDYKENNATSEYR 166
Query: 275 ---LGYLKSLKSMD 285
+ L +LK +D
Sbjct: 167 IEVVKRLPNLKKLD 180
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 58/362 (16%), Positives = 113/362 (31%), Gaps = 34/362 (9%)
Query: 27 LSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLS--GALSPDVAH 84
L K +L N W ++ R + S+ + +S A
Sbjct: 80 LKGKPRAAM---FNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKAR 136
Query: 85 LRFLQNLSVAA-NQLSGPIPPEISA-LSSLRLLNLSNNVFNGSFPPQLSQLA----SLQV 138
L+ L + + + I ++ L + + F+ L +LA SL+V
Sbjct: 137 ADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEV 196
Query: 139 LDLYNNNMTG----DLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL 194
L+ Y DL R+L + +G + + LE
Sbjct: 197 LNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF-FKAAANLEEFCGGSLNE 255
Query: 195 GGKIPGEIGNLTKLQQL-YIGYYNSYTGGLPPEIGNLSSLVRFDAANC-GLSGEIPTDIG 252
+P + NL ++L +G +P + + + D + + T I
Sbjct: 256 DIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQ 315
Query: 253 RLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFR 312
+ NL+ L + L Y K LK + + + + L+ L +
Sbjct: 316 KCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ 375
Query: 313 NKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGK----LRILDLSSNKLTGTLP 368
LE + ++ ++ T + +G+ K R++ L + LP
Sbjct: 376 G------------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP 423
Query: 369 PD 370
D
Sbjct: 424 LD 425
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 50/325 (15%), Positives = 92/325 (28%), Gaps = 36/325 (11%)
Query: 62 RHVTSLDLSGLNLS--GALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSN 119
R + S+ + + A+L S+ + + L L LS
Sbjct: 220 RSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279
Query: 120 NVFNGSFPPQLSQLASLQVLDL-YNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEY 178
+ P A ++ LDL Y T D + + NL L +
Sbjct: 280 -MGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLA 338
Query: 179 GIWEFLEYLAVSGNELGGKIPGEIGNLT------------KLQQLYIGYYNSYTGGLPPE 226
+ L+ L + + E G ++ +L+ + + + L
Sbjct: 339 QYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESI 398
Query: 227 IGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDL 286
L +L F I TD+ LD + L K L+
Sbjct: 399 GTYLKNLCDFRLVLLDREERI-TDLP----LDNGVRSL----------LIGCKKLRRFAF 443
Query: 287 SNN--IFTGEIPASFAEL-KNLTLLNLFRNKLH-GAIPEFIGVMPRLEVLQLWENNFTGS 342
T + + N+ + L + EF P L+ L++ F+
Sbjct: 444 YLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER 503
Query: 343 IPQRLGSN-GKLRILDLSSNKLTGT 366
+ LR L + + + T
Sbjct: 504 AIAAAVTKLPSLRYLWVQGYRASMT 528
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 4/114 (3%)
Query: 253 RLQNLDTLFLQVNALSGPLTTELG-YLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLF 311
++ L L + + L + L+ + N T I A+ +L L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 312 RNKLHGAIPEFIGVMPRLEVLQLWENNFTG-SIPQRLGSNGKLRILDLSSNKLT 364
N++ G + P L L L N S + L L+ LDL + ++T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 245 GEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
G++ + L+ L L+ L L LK ++LS+N +G + + N
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLTS--IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 305 LTLLNLFRNKLHG-AIPEFIGVMPRLEVLQLWEN 337
LT LNL NK+ + E + + L+ L L+
Sbjct: 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 26/131 (19%), Positives = 47/131 (35%), Gaps = 34/131 (25%)
Query: 88 LQNLSVAANQLS-GPIPPEISALSSLRLLNLSNN----VFNGSFPPQLSQLASLQVLDLY 142
++ L + ++ + G + L L+ N + N L +L L+ L+L
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN------LPKLNKLKKLELS 72
Query: 143 NNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEI 202
+N ++G L + + NL HL+L GN +E L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--------LSTIEPLK-------------- 110
Query: 203 GNLTKLQQLYI 213
L L+ L +
Sbjct: 111 -KLENLKSLDL 120
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 21/97 (21%), Positives = 39/97 (40%), Gaps = 5/97 (5%)
Query: 271 LTTELG--YLKSLKSMDLSNN-IFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMP 327
+ EL +K + L N+ G++ E + L L+ L + +
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLN 64
Query: 328 RLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364
+L+ L+L +N +G + L L+LS NK+
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 29/122 (23%), Positives = 47/122 (38%), Gaps = 9/122 (7%)
Query: 284 MDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI 343
M++ I + +++K L L N N+ G + LE L T SI
Sbjct: 1 MEMGRRIHLELRNRTPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT-SI 57
Query: 344 PQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSR 403
L KL+ L+LS N+++G L L L GN + + L + L +
Sbjct: 58 AN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKK 111
Query: 404 MR 405
+
Sbjct: 112 LE 113
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 3/87 (3%)
Query: 59 DSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLS 118
D + L + L+ +++ ++ L L+ L ++ N++SG + +L LNLS
Sbjct: 39 DEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96
Query: 119 NNVFNG-SFPPQLSQLASLQVLDLYNN 144
N S L +L +L+ LDL+N
Sbjct: 97 GNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 24/114 (21%), Positives = 42/114 (36%), Gaps = 4/114 (3%)
Query: 253 RLQNLDTLFLQVNALSGPLTTELG-YLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLF 311
+ L L + L +L+ + L N + ++ +L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 312 RNKLHGAIPEFIGVMPRLEVLQLWENNFTG-SIPQRLGSNGKLRILDLSSNKLT 364
N++ G + +P L L L N S + L L+ LDL + ++T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 245 GEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKN 304
G+I NL+ L L L + L L LK ++LS N G + +L N
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLIS--VSNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 305 LTLLNLFRNKLHG-AIPEFIGVMPRLEVLQLWEN 337
LT LNL NKL + E + + L+ L L+
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 27/109 (24%), Positives = 49/109 (44%), Gaps = 13/109 (11%)
Query: 70 SGLNLSGALSPDVAHLRF--LQNLSVAANQLS-GPIPPEISALSSLRLLNLSNN----VF 122
SG+++ + ++ + ++ L + + + G I + +L L+L N V
Sbjct: 6 SGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVS 65
Query: 123 NGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFS 171
N L +L L+ L+L N + G L + +L NL HL+L GN
Sbjct: 66 N------LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 30/126 (23%), Positives = 44/126 (34%), Gaps = 9/126 (7%)
Query: 280 SLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNF 339
MD+ I + A ++ L L N N G I LE L L
Sbjct: 4 GSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGL 61
Query: 340 TGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCD 399
S+ L KL+ L+LS N++ G L L L GN L + + +
Sbjct: 62 I-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLE 114
Query: 400 SLSRMR 405
L ++
Sbjct: 115 PLKKLE 120
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 20/82 (24%), Positives = 34/82 (41%), Gaps = 3/82 (3%)
Query: 501 DFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIP 560
D + G+I ++ L F+ L L + N L + L L LS N + G +
Sbjct: 32 DNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLD 88
Query: 561 ASIASMQSLTSVDFSYNNLSGL 582
+ +LT ++ S N L +
Sbjct: 89 MLAEKLPNLTHLNLSGNKLKDI 110
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 6e-07
Identities = 21/153 (13%), Positives = 50/153 (32%), Gaps = 18/153 (11%)
Query: 230 LSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELG--YLKSLKSMDL- 286
L ++ + + + NL +L + L + ++ L +L+ + L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 287 --SNNIFTGEIPASFAEL------KNLTLLNLFRNKLHGAIPEFIG---VMPRLEVLQLW 335
+ F L NL L + + + E ++P+LE + +
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 336 ENNFTGS----IPQRLGSNGKLRILDLSSNKLT 364
T + + L+ +++ N L+
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 7e-05
Identities = 31/194 (15%), Positives = 58/194 (29%), Gaps = 36/194 (18%)
Query: 121 VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGI 180
+ P L + L L + N +L + NL+ L +
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPD-------- 207
Query: 181 WEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEI------GNLSSLV 234
+E + S +P NL KL LY+G + G +L
Sbjct: 208 -SVVEDILGS------DLP----NLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255
Query: 235 RFDAANCGLSGEIPTDIGR---LQNLDTLFLQVNALSG----PLTTELGYLKSLKSMDLS 287
+ + L L+T+ + L+ L + +K LK +++
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 288 NNIFTGEIPASFAE 301
N + E+ +
Sbjct: 316 YNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 8e-05
Identities = 21/152 (13%), Positives = 49/152 (32%), Gaps = 18/152 (11%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEI--SALSSLRLLNLSN 119
+ L+ + + LS L++L + + L + +I S L +L L L
Sbjct: 169 DAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYV 228
Query: 120 NVFNGSFPPQLSQLA---------SLQVLDLYNNNMTGDLPLAV---TQLRNLRHLHLGG 167
V + F ++ +L+ L + + + L L + +
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 168 NFFSG----QIPPEYGIWEFLEYLAVSGNELG 195
+ + + L+++ + N L
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 7e-04
Identities = 28/183 (15%), Positives = 54/183 (29%), Gaps = 18/183 (9%)
Query: 269 GPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPR 328
L+ L + L ++ + LK+L +++ +P
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPD-SVVEDILGSDLPN 220
Query: 329 LEVLQLW---ENNFTGSIPQRL------GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQT 379
LE L L+ E+ L+ L + + + + L
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 380 LITL-------GNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQ 431
L T+ + + + + K L + M N+L+ + K L LP V
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDS 340
Query: 432 DNY 434
Y
Sbjct: 341 QEY 343
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 43/157 (27%), Positives = 62/157 (39%), Gaps = 35/157 (22%)
Query: 282 KSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGV---MPRLEVLQLWENN 338
+ + L +N T P F L NL L L N+L A+P GV + +L VL L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV--GVFDSLTQLTVLDLGTNQ 99
Query: 339 FTGSIPQRL-GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGK 397
T +P + L+ L + NKLT +P + +
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLTE-------------------------LPRGIER 133
Query: 398 CDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDN 433
L+ + + +N L SIP G F L SL+ L N
Sbjct: 134 LTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 38/148 (25%), Positives = 55/148 (37%), Gaps = 8/148 (5%)
Query: 23 YKALLSIKSSITDDPQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDV 82
K S+ + I + Q N T DS ++ L L L AL V
Sbjct: 28 SKRHASVPAGIPTNAQILYLHDNQITK---LEPGVFDSLINLKELYLGSNQLG-ALPVGV 83
Query: 83 -AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLD 140
L L L + NQL+ +P + L L+ L + N P + +L L L
Sbjct: 84 FDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 141 LYNNNMTGDLPLAVTQLRNLRHLHLGGN 168
L N + A +L +L H +L GN
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 38/159 (23%), Positives = 58/159 (36%), Gaps = 32/159 (20%)
Query: 134 ASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF---LEYLAVS 190
+ Q+L L++N +T P L NL+ L+LG N +P G+++ L L +
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV--GVFDSLTQLTVLDLG 96
Query: 191 GNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTD 250
N+L L L++L++ N L+ +P
Sbjct: 97 TNQLTVLPSAVFDRLVHLKELFM-CCN-----------KLTE--------------LPRG 130
Query: 251 IGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNN 289
I RL +L L L N L L SL L N
Sbjct: 131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 12/99 (12%)
Query: 414 SIPKGLF-GLPSLSQVELQDNYLT----GQFPVSDSISVNLGQICLSNNQLSGSLPASI- 467
+ G+F L +L ++ L N L G F DS+ L + L NQL+ LP+++
Sbjct: 54 KLEPGVFDSLINLKELYLGSNQLGALPVGVF---DSL-TQLTVLDLGTNQLT-VLPSAVF 108
Query: 468 GKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNK 506
+ +++L + NK + +P I +L L+ + N+
Sbjct: 109 DRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQ 146
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 38/139 (27%), Positives = 55/139 (39%), Gaps = 25/139 (17%)
Query: 49 SHCTWPG--VTCDSRRH----------VTSLDLSGLNLSGALSPDVA--HLRFLQNLSVA 94
+ C G V C R T L L+ L +S D L L L +
Sbjct: 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELK 62
Query: 95 ANQLSGPIPPEI-SALSSLRLLNLSNN----VFNGSFPPQLSQLASLQVLDLYNNNMTGD 149
NQL+G I P S ++ L L N + N F L L+ L+LY+N ++
Sbjct: 63 RNQLTG-IEPNAFEGASHIQELQLGENKIKEISNKMF----LGLHQLKTLNLYDNQISCV 117
Query: 150 LPLAVTQLRNLRHLHLGGN 168
+P + L +L L+L N
Sbjct: 118 MPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 31/123 (25%), Positives = 47/123 (38%), Gaps = 21/123 (17%)
Query: 247 IPTDIGRLQNLDTLFLQVNALSG-PLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
IP L L N L G L L ++L N TG P +F ++
Sbjct: 27 IPLHT------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 306 TLLNLFRNKLHGAIPEFIGV---MPRLEVLQLWENNFTGSIPQ----RLGSNGKLRILDL 358
L L NK+ I + + +L+ L L++N + + L S L L+L
Sbjct: 81 QELQLGENKIK-EISN--KMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNS---LTSLNL 133
Query: 359 SSN 361
+SN
Sbjct: 134 ASN 136
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 28/116 (24%), Positives = 42/116 (36%), Gaps = 12/116 (10%)
Query: 254 LQNLDTLFLQVNALSGPLTTELG-YLKSLKSMDLSNNIFTGEIP--ASFAELKNLTLLNL 310
L L+ + P+ LG L ++D S+N EI F L+ L L +
Sbjct: 18 AVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLV 71
Query: 311 FRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIP--QRLGSNGKLRILDLSSNKLT 364
N++ +P L L L NN + L S L L + N +T
Sbjct: 72 NNNRICRIGEGLDQALPDLTELIL-TNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 23/133 (17%), Positives = 39/133 (29%), Gaps = 32/133 (24%)
Query: 84 HLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNN---VFNGSFPPQLSQLASLQVLD 140
+ + L + ++ I + L ++ S+N +G L L+ L
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRLKTLL 70
Query: 141 LYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPG 200
+ NN + L +L L L N L+ LA
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVE--------LGDLDPLA------------ 110
Query: 201 EIGNLTKLQQLYI 213
+L L L I
Sbjct: 111 ---SLKSLTYLCI 120
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 17/94 (18%), Positives = 35/94 (37%), Gaps = 3/94 (3%)
Query: 489 AEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYL 548
A+ + ++D K I + +D S NE+ ++ +R L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 549 NLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGL 582
++ N + ++ LT + + N+L L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 65/358 (18%), Positives = 119/358 (33%), Gaps = 81/358 (22%)
Query: 62 RHVTSLDLSGLNLSG----ALSPDVAHLR-FLQNLSVAANQLSGPIPPEISAL-----SS 111
VTSLDLS NL L A+ + +L+++ N L E+ + ++
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 112 LRLLNLSNNVFNGSFPPQLSQL-----ASLQVLDLYNNNMT--GDLPLA---VTQLRNLR 161
+ LNLS N + +L + ++ VLDL N+ + ++
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 162 HLHLGGNFFSGQIPPEYGIWEF----------LEYLAVSGNELGGKIPGEIGNL-----T 206
L+L GN E + L + GN L K E+
Sbjct: 142 SLNLRGNDLG-----IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 207 KLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNA 266
+ L + N +G + L+ + + +L+ L +N
Sbjct: 197 SVTSLDLS-AN--------LLG--------LKSYAELAYIFSSIPNHVVSLN---LCLNC 236
Query: 267 LSGP----LTTELGYLKSLKSMDLSNNIFTG-------EIPASFAELKNLTLLNLFRNKL 315
L GP L LK L+++ L +I + A+F ++ + L++ ++
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
Query: 316 HG----AIPEFIG-VMPRLEVLQLWENNFT-----GSIPQRLGSNGKLRILDLSSNKL 363
H I I + + +V L + + L +LR + L
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 56/371 (15%), Positives = 103/371 (27%), Gaps = 84/371 (22%)
Query: 255 QNLDTLFLQVNALSGPLTTELGYL-----KSLKSMDLSNNIFTGEIPASFAEL-----KN 304
+ +L L +N L T EL S+ S++LS N + ++ N
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 305 LTLLNLFRNKLHG----AIPEFIGVMP-RLEVLQLWENNFTGSIPQRLGS-----NGKLR 354
+T LNL N L + + + +P + VL L N+F+ +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 355 ILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGS 414
L+L N L + L L +++ + + N L
Sbjct: 142 SLNLRGNDLG-----IKSS-------DELIQILAAI-------PANVNSLNLRGNNL--- 179
Query: 415 IPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKF---- 470
L++ L SI ++ + LS N L A +
Sbjct: 180 ---ASKNCAELAKF-LA------------SIPASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 471 -SGVQKLLLDGNKFSGQIPAEIGKL----QQLSKMDFSHNKFSG-------RIAPEISQC 518
+ V L L N G + L + L + ++ +
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI 283
Query: 519 KLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQ----------S 568
+ + VD + E+ ++ + L+ Q
Sbjct: 284 QKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDE 343
Query: 569 LTSVDFSYNNL 579
L + L
Sbjct: 344 LRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 45/335 (13%), Positives = 98/335 (29%), Gaps = 78/335 (23%)
Query: 286 LSNNIFTGEIPASFAEL----KNLTLLNLFRNKLHGAIPEFIGVM-----PRLEVLQLWE 336
++ + E +T L+L N L+ + + L L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 337 NNFTGSIPQRLGS-----NGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPI 391
N+ L + L+LS N L+ ++ L L
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSY------------KSSDELVKTLAAI- 107
Query: 392 PESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQ 451
+++ + +G N + Q + + +
Sbjct: 108 ------PFTITVLDLGWNDFSSK------SSSEFKQA-FSNLPAS------------ITS 142
Query: 452 ICLSNNQLSGSLPASIGKF-----SGVQKLLLDGNKFSGQIPAEIGKL-----QQLSKMD 501
+ L N L + + + V L L GN + + AE+ K ++ +D
Sbjct: 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLD 202
Query: 502 FSHNKFSGRIAPEISQC-----KLLTFVDLSRNELSGE----IPNQLTGMRILNYLNLSR 552
S N + E++ + ++L N L G + ++ L + L
Sbjct: 203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262
Query: 553 NHL-------VGSIPASIASMQSLTSVDFSYNNLS 580
+ + ++ A+ ++Q + VD + +
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 53/304 (17%), Positives = 102/304 (33%), Gaps = 71/304 (23%)
Query: 106 ISALSSLRLLNLSNNVFNGSFPPQLSQL-----ASLQVLDLYNNNMTGDLPLAVTQL--- 157
S + L+LS N +L Q AS+ L+L N++ + Q+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 158 --RNLRHLHLGGNFFSGQIPPEYGIWEF----------LEYLAVSGNELGGKIPGEIGNL 205
N+ L+L GNF S + E + L + N+ K E
Sbjct: 78 IPANVTSLNLSGNFLSYK-----SSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA 132
Query: 206 TKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRL-----QNLDTL 260
+S+ + L + ++ ++ N+++L
Sbjct: 133 FS--------------------NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL 172
Query: 261 FLQVNALSGPLTTELGYL-----KSLKSMDLSNNIFTGEIPASFAEL-----KNLTLLNL 310
L+ N L+ EL S+ S+DLS N+ + A A + ++ LNL
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNL 232
Query: 311 FRNKLHG----AIPEFIGVMPRLEVLQLWENNFTG-------SIPQRLGSNGKLRILDLS 359
N LHG + + L+ + L + ++ + K+ ++D +
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292
Query: 360 SNKL 363
++
Sbjct: 293 GKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 41/248 (16%), Positives = 84/248 (33%), Gaps = 41/248 (16%)
Query: 229 NLSSLVRFDAANCGLSGEIPTDIGRL-----QNLDTLFLQVNALSGPLTTELGYL----- 278
+S+ + + L + ++ ++ N+ +L L N LS + EL
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108
Query: 279 KSLKSMDLSNNIFTGEIPASFAEL-----KNLTLLNLFRNKLHG----AIPEFIGVMP-R 328
++ +DL N F+ + + F + ++T LNL N L + + + +P
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168
Query: 329 LEVLQLWENNFTGSIPQRLGS-----NGKLRILDLSSNKLTGTLPPDMCAG--NCLQTLI 381
+ L L NN L + LDLS+N L ++ + ++
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 382 TL---GNFLFGP----IPESLGKCDSLSRMRMGENFLNGSIPKGLFGL-------PSLSQ 427
+L N L GP + L + + + + + L +
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288
Query: 428 VELQDNYL 435
V+ +
Sbjct: 289 VDKNGKEI 296
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 47/228 (20%), Positives = 78/228 (34%), Gaps = 51/228 (22%)
Query: 691 IIGKGGAGIVYKG--LMPNGDQVAVK---RLPAMSRGSSHDHGFNAEIQTLGRIRHR--- 742
+G+G G V + QVA+K + + EI L +I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR------LEINVLKKIKEKDKE 79
Query: 743 ---HIVRLLGFCSNHETNL-LVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKG 796
V + N ++ + +E + + E L + + L R +A +
Sbjct: 80 NKFLCVLMSD-WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLP-HVR-HMAYQLCHA 135
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVA-------------------DFGLAKFL 837
L +LH + + H D+K NIL + + DFG A F
Sbjct: 136 LRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 191
Query: 838 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 885
E + I + Y PE L + DV+S G +L E G
Sbjct: 192 ----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 62/234 (26%), Positives = 92/234 (39%), Gaps = 59/234 (25%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVK---RLPAMSRGSSHDHGFNAEIQTLGRIRHR---- 742
+G G G V + N AVK + +R + E L +I++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI------EADILKKIQNDDINN 95
Query: 743 -HIVRLLGF--CSNHETNL-LVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKG 796
+IV+ G +H + L++E + SL E++ + G H+ D + +E K
Sbjct: 96 NNIVKYHGKFMYYDH---MCLIFEPL-GPSLYEIITRNNYNGFHIE-DIK-LYCIEILKA 149
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDSGFEAH-------------------------VADF 831
L YL S + H D+K NILLD + + DF
Sbjct: 150 LNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 885
G A F S+ +I + Y APE L D SD++SFG VL EL TG
Sbjct: 207 GCATF-----KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 34/157 (21%)
Query: 282 KSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPR---LEVLQLWENN 338
+DL N F EL +LT L L NKL ++P GV + L L L N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPN--GVFNKLTSLTYLNLSTNQ 87
Query: 339 FTGSIPQRL-GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGK 397
S+P + +L+ L L++N+L +LP G F + L +
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPD--------------GVF------DKLTQ 125
Query: 398 CDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVELQDN 433
L +R+ +N L S+P G+F L SL + L DN
Sbjct: 126 ---LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 37/131 (28%), Positives = 53/131 (40%), Gaps = 14/131 (10%)
Query: 89 QNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQL-SQLASLQVLDLYNNNMT 147
L + N L L+SL L L N S P + ++L SL L+L N +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 148 GDLPLAV-TQLRNLRHLHLGGNFFSGQIPPEYGIWEF-----LEYLAVSGNELGGKIPGE 201
LP V +L L+ L L N +P G+ F L+ L + N+L G
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPD--GV--FDKLTQLKDLRLYQNQLKSVPDGV 143
Query: 202 IGNLTKLQQLY 212
LT LQ ++
Sbjct: 144 FDRLTSLQYIW 154
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 40/135 (29%), Positives = 56/135 (41%), Gaps = 18/135 (13%)
Query: 49 SHCTWPG--VTCDSRRHV----------TSLDLSGLNLSGALSPDVAHLRFLQNLSVAAN 96
S C+ G V C S+ T LDL +L + L L L + N
Sbjct: 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN 62
Query: 97 QLSGPIPPEI-SALSSLRLLNLSNNVFNGSFPPQL-SQLASLQVLDLYNNNMTGDLPLAV 154
+L +P + + L+SL LNLS N S P + +L L+ L L N + LP V
Sbjct: 63 KLQS-LPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGV 119
Query: 155 -TQLRNLRHLHLGGN 168
+L L+ L L N
Sbjct: 120 FDKLTQLKDLRLYQN 134
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 51/227 (22%), Positives = 81/227 (35%), Gaps = 49/227 (21%)
Query: 691 IIGKGGAGIVYKG--LMPNGDQVAVK---RLPAMSRGSSHDHGFNAEIQTLGRIRHR--- 742
+G+G G V + G VAVK + + +EIQ L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA------RSEIQVLEHLNTTDPN 74
Query: 743 ---HIVRLLGFCSNHETNLLVYEYMPNGSLGEVL--HGKKGGHLHWDTRYKIAVEAAKGL 797
V++L + +H +V+E + S + + +G L R K+A + K +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLD-HIR-KMAYQICKSV 131
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVA-------------------DFGLAKFLQ 838
+LH + H D+K NIL DFG A +
Sbjct: 132 NFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 885
E S + + Y APE L + DV+S G +L+E G
Sbjct: 187 ---DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 49/292 (16%), Positives = 97/292 (33%), Gaps = 41/292 (14%)
Query: 52 TWPGVTCDSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSS 111
W + D +LDL+G NL ++ + + + + P+ S
Sbjct: 38 RWYRLASDESLW-QTLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPFRV 95
Query: 112 LRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGG-NFF 170
+ ++ + + LSQ + LQ L L ++ + + + NL L+L G + F
Sbjct: 96 QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155
Query: 171 SGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYT-GGLPPEIG- 228
S L+ L + ++L +L + + +T + +
Sbjct: 156 SE---------FALQTLL--------------SSCSRLDELNLSWCFDFTEKHVQVAVAH 192
Query: 229 NLSSLVRFDAANCGLSGEIPTDIG------RLQNLDTLFL-QVNALSGPLTTELGYLKSL 281
++ + + + + R NL L L L E L L
Sbjct: 193 VSETITQLNLSGYR---KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 249
Query: 282 KSMDLSN--NIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEV 331
+ + LS +I E E+ L L +F G + +P L++
Sbjct: 250 QHLSLSRCYDI-IPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 34/120 (28%), Positives = 50/120 (41%), Gaps = 17/120 (14%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAV-TQLRNL 160
+P I + L L N F P +LS L ++DL NN ++ L + + L
Sbjct: 25 LPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 161 RHLHLGGNFFSGQIPPEYGIWEF-----LEYLAVSGNELGGKIP-GEIGNLTKLQQLYIG 214
L L N IPP F L L++ GN++ +P G +L+ L L IG
Sbjct: 81 LTLILSYNRLR-CIPP--RT--FDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIG 134
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 24/86 (27%), Positives = 36/86 (41%), Gaps = 9/86 (10%)
Query: 282 KSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGV---MPRLEVLQLWENN 338
+ L N FT +P + K+LTL++L N++ + M +L L L N
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSN--QSFSNMTQLLTLILSYNR 89
Query: 339 FTGSIPQRL-GSNGKLRILDLSSNKL 363
IP R LR+L L N +
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 39/154 (25%)
Query: 312 RNKLHGAIPEFIGVMPR-LEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPD 370
NK +P+ I PR + L L N FT +P+ L + L ++DLS+N+++ TL
Sbjct: 18 SNKGLKVLPKGI---PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN- 71
Query: 371 MCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLF-GLPSLSQVE 429
+F ++ + L + + N L IP F GL SL +
Sbjct: 72 -------------QSF------SNMTQ---LLTLILSYNRLR-CIPPRTFDGLKSLRLLS 108
Query: 430 LQDNYLT----GQFPVSDSISVNLGQICLSNNQL 459
L N ++ G F + +S L + + N L
Sbjct: 109 LHGNDISVVPEGAF---NDLS-ALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 12/92 (13%)
Query: 59 DSRRHVTSLDLSGLNLSGALSPDV-AHLRFLQNLSVAANQLSGPIPPEI-SALSSLRLLN 116
+ +H+T +DLS +S LS +++ L L ++ N+L IPP L SLRLL+
Sbjct: 51 SNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLS 108
Query: 117 LSNN----VFNGSFPPQLSQLASLQVLDLYNN 144
L N V G+F + L++L L + N
Sbjct: 109 LHGNDISVVPEGAF----NDLSALSHLAIGAN 136
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 50/341 (14%), Positives = 87/341 (25%), Gaps = 100/341 (29%)
Query: 62 RHVTSLDLSGLNLSGALSPDVAHLRF--------LQNLSVAANQLSGPIPPE-----ISA 108
+ L+L+G+ ++ + L +++A+ QL P +
Sbjct: 72 SSLRQLNLAGVRMTPV---KCTVVAAVLGSGRHALDEVNLASCQLD----PAGLRTLLPV 124
Query: 109 LSSLRLLNLSNNVFNGSFPPQLSQL-----ASLQVLDLYNNNMTGD----LPLAVTQLRN 159
R L L N L L + L L NN +T L + +
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 160 LRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSY 219
+ HL L + G+ L + +LQ+L + Y
Sbjct: 185 VTHLSLLHTGLGDE-----GLELLAAQLDRN---------------RQLQELNVAY---- 220
Query: 220 TGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRL----QNLDTLFLQVNALS------- 268
G + R +L+ L L N LS
Sbjct: 221 ---------------------NGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259
Query: 269 GPLTTELGYLKSLKSMDLSNNIFTGEIPASFAE-LKNLTLLNLFRNKLHGAIPEFIGVMP 327
L + + +E +NL + R + H
Sbjct: 260 RDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRH----------L 309
Query: 328 RLEVLQLWENNFTGSIPQRLG----SNGKLRILDLSSNKLT 364
L + L ++ P R G++R L
Sbjct: 310 ELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 20/128 (15%), Positives = 41/128 (32%), Gaps = 19/128 (14%)
Query: 254 LQNLDTLFLQVNALSGPLTTELGYL-----KSLKSMDLSNNIFTGEIPASFAE-LKNLTL 307
L +L L L ++ T + + +L ++L++ +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 308 LNLFRNKL--HGAIPEFIGVM-----PRLEVLQLWENNFTGS----IPQRLGSNGKLRIL 356
L L N L + + + ++ L+L N T + + + L N + L
Sbjct: 131 LGLQLNSLGPEAC--KDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188
Query: 357 DLSSNKLT 364
L L
Sbjct: 189 SLLHTGLG 196
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 31/207 (14%), Positives = 72/207 (34%), Gaps = 42/207 (20%)
Query: 689 DNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+++IGKG + + + D + +R+ R D +T R+ +V+
Sbjct: 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKS-RTAREARYLALVKDF 399
Query: 749 GFCS------NHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
G + + + ++ Y+ +V+ + IA + + + LH
Sbjct: 400 GIPAPYIFDVDLDNKRIMMSYINGKLAKDVI----------EDNLDIAYKIGEIVGKLHK 449
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF---LQDSGT----------------- 842
+ ++H D+ ++N + D + ++ DFGL K +D
Sbjct: 450 N---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKF 504
Query: 843 SECMSAIAGSYGYIAPEYAYTLKVDEK 869
E Y + + L++ +
Sbjct: 505 DEIWERFLEGYKSVYDRWEIILELMKD 531
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 10/115 (8%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAV-TQLRNL 160
+P I + S L L +N +L L L L N + LP V +L L
Sbjct: 22 VPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 161 RHLHLGGNFFSGQIPPEYGIWE---FLEYLAVSGNELGGKIPGEIGNLTKLQQLY 212
L+L N +P G+++ L+ LA+ N+L G LT LQ+++
Sbjct: 79 TILYLHENKLQ-SLPN--GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1010 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-35 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-34 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-07 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-29 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-16 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 2e-71
Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 20/282 (7%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ IG G G VYKG VAVK L + F E+ L + RH +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
I+ +G+ + + +V ++ SL LH IA + A+G+ YLH
Sbjct: 66 ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
I+HRD+KSNNI L + DFGLA S ++GS ++APE
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 864 LK---VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920
+SDVY+FG+VL EL+TG+ P + I+ V + L P
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------GYLSPD 230
Query: 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962
L V + + + C++++ ERP +++ + L +
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 4e-67
Identities = 72/277 (25%), Positives = 128/277 (46%), Gaps = 22/277 (7%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ LK +G G G V+ G +VAVK L +GS F AE + +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQR 69
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+VRL + E ++ EYM NGSL + L G L + +A + A+G+ ++
Sbjct: 70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
+HRD+++ NIL+ +ADFGLA+ ++D+ + APE
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINY 184
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
KSDV+SFG++L E++T + +++Q + + +++ P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRMVRPDNCP 236
Query: 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
L+++M LC +E+ +RPT + +L +
Sbjct: 237 EELYQLM------RLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 4e-65
Identities = 68/277 (24%), Positives = 127/277 (45%), Gaps = 22/277 (7%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
L IG G G+V+ G N D+VA+K + G+ + F E + + ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPK 61
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+V+L G C LV+E+M +G L + + G +T + ++ +G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
C ++HRD+ + N L+ V+DFG+ +F+ D + + +PE
Sbjct: 121 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSF 176
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
+ KSDV+SFGV++ E+ + K E ++V+ + ++ PRL S
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRLYKPRLAS 228
Query: 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++++M C +E+ +RP +++ L E+
Sbjct: 229 THVYQIM------NHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-63
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 24/290 (8%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH 743
+ L+ + +G+G G V+ G +VA+K L G+ F E Q + ++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+V+L S E +V EYM GSL + L G+ G +L +A + A G+ Y+
Sbjct: 74 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
VHRD+++ NIL+ VADFGLA+ ++D+ + + APE A
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY 188
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
+ KSDV+SFG++L EL T + +++ V +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------------MP 234
Query: 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK--PPTSKQGEE 971
P + + C ++ ERPT + L + P + GE
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-61
Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 30/292 (10%)
Query: 692 IGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 751
IGKG G V++G G++VAVK S AEI +RH +I+ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 752 SNHETNL----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC--- 804
+ LV +Y +GSL + L+ + + K+A+ A GL +LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 805 --SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG--TSECMSAIAGSYGYIAPEY 860
P I HRD+KS NIL+ +AD GLA + + G+ Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 861 AYT------LKVDEKSDVYSFGVVLLELITGRKPVGEFGDG----VDIVQWVRKMTDSKK 910
+ +++D+Y+ G+V E+ G D D+V + + +K
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 911 EGVLKILDPRLPSVPL-HEVMHVFY-VAMLCVEEQAVERPTMREVVQILTEL 960
+ L P +P+ E + V + C R T + + L++L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (532), Expect = 2e-61
Identities = 71/298 (23%), Positives = 131/298 (43%), Gaps = 26/298 (8%)
Query: 676 DFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNA 731
+F + + C+K + +IG G G V G + + VA+K L + F +
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLS 76
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAV 791
E +G+ H +++ L G + +++ E+M NGSL + + G +
Sbjct: 77 EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLR 135
Query: 792 EAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAG 851
A G+ YL VHRD+ + NIL++S V+DFGL++FL+D + ++ G
Sbjct: 136 GIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 852 SYG---YIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS 908
+ APE K SDV+S+G+V+ E+++ + D++ + +
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---- 248
Query: 909 KKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTS 966
D RLP P+ + + + C ++ RP ++V L ++ + P S
Sbjct: 249 ---------DYRLPP-PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-61
Identities = 77/289 (26%), Positives = 128/289 (44%), Gaps = 25/289 (8%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ-----VAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
C+ +IG G G VYKG++ VA+K L A F E +G+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQ 65
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
H +I+RL G S ++ +++ EYM NG+L + +K G + A G+
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 799 YLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT-SECMSAIAGSYGYIA 857
YL + VHRD+ + NIL++S V+DFGL++ L+D + S + A
Sbjct: 125 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917
PE K SDV+SFG+V+ E++T + ++++ I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK--------------AIN 227
Query: 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTS 966
D P+ ++ + M C +++ RP ++V IL +L + P S
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 5e-61
Identities = 61/271 (22%), Positives = 115/271 (42%), Gaps = 22/271 (8%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
+G G G+V G VA+K + GS + F E + + + H +V+L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
C+ ++ EYM NG L L + ++ + + + YL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FL 122
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEK 869
HRD+ + N L++ V+DFGL++++ D + + PE K K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 870 SDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEV 929
SD+++FGV++ E+ + K E + + + + L++ P L S ++ +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ--------GLRLYRPHLASEKVYTI 233
Query: 930 MHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
M C E+A ERPT + ++ + ++
Sbjct: 234 M------YSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 8e-61
Identities = 75/279 (26%), Positives = 118/279 (42%), Gaps = 28/279 (10%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR 742
+ LK IGKG G V G G++VAVK + + + F AE + ++RH
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHS 60
Query: 743 HIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
++V+LLG + L +V EYM GSL + L + L D K +++ + + YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
+ VHRD+ + N+L+ A V+DFGL K + + + APE
Sbjct: 121 GNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEAL 172
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
K KSDV+SFG++L E+ + + D+V V K
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------- 218
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
P V+ V C A RP+ ++ + L +
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-60
Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 15/281 (5%)
Query: 686 LKEDN-----IIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
LK+D+ +G G G+V+K P+G +A K + + + + E+Q L
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ-IIRELQVLHEC 61
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
+IV G + + E+M GSL +VL K G + K+++ KGL Y
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTY 119
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
L I+HRDVK +NIL++S E + DFG++ L DS + + G+ Y++PE
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPE 173
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
+SD++S G+ L+E+ GR P+ + + ++ E + P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
P ++ E P E
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-60
Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 26/279 (9%)
Query: 689 DNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
+ +IG+G G VY G + + D AVK L ++ F E + H ++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 90
Query: 745 VRLLGFCSNHETN-LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+ LLG C E + L+V YM +G L + + ++ AKG+ +L
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG--TSECMSAIAGSYGYIAPEYA 861
VHRD+ + N +LD F VADFGLA+ + D + + ++A E
Sbjct: 150 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
T K KSDV+SFGV+L EL+T P V+ + + ++L P
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGR-----RLLQPEY 258
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
PL+EVM + C +A RP+ E+V ++ +
Sbjct: 259 CPDPLYEVM------LKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 2e-59
Identities = 64/305 (20%), Positives = 118/305 (38%), Gaps = 46/305 (15%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPN------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
+ ++ IG+G G V++ P VAVK L + F E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMA 71
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG------------------- 778
+ +IV+LLG C+ + L++EYM G L E L
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 779 ---GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835
L + IA + A G+ YL VHRD+ + N L+ +ADFGL++
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG 895
+ + + A ++ PE + + +SDV+++GVVL E+ +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 896 VDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+++ + D + + P + + ++ + LC + +RP+ + +
Sbjct: 249 EEVIY--------------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 956 ILTEL 960
IL +
Sbjct: 295 ILQRM 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-59
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 24/274 (8%)
Query: 688 EDNIIGKGGAGIVYKGLMPN---GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
ED +G G G V KG VAVK L + + AE + ++ + +I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
VR++G C E+ +LV E G L + L + H+ ++ + + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ-DSGTSECMSAIAGSYGYIAPEYAYT 863
VHRD+ + N+LL + A ++DFGL+K L+ D + + + APE
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
K KSDV+SFGV++ E + + G ++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--------------MLEKGERMG 230
Query: 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957
P ++ + LC RP V L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 27/276 (9%)
Query: 686 LKEDNIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
LK D IG+G VYKG +VA L S F E + L ++H +I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 745 VRLLGFCSNHETN----LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
VR + +LV E M +G+L L + + + KGL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 801 HHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
H P I+HRD+K +NI + + D GLA + S A+ G+ ++APE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPE 183
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
Y K DE DVY+FG+ +LE+ T P + + + Q R++T +
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTS-------GVKPA 232
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
V + EV + C+ + ER ++++++
Sbjct: 233 SFDKVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-58
Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 24/273 (8%)
Query: 690 NIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG G G K +G + K L S + +E+ L ++H +IVR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 749 GFCSNHETNLL--VYEYMPNGSLGEVLH--GKKGGHLHWDTRYKIAVEAAKGLCYLH--H 802
+ L V EY G L V+ K+ +L + ++ + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
D ++HRD+K N+ LD + DFGLA+ L + A G+ Y++PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMN 187
Query: 863 TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922
+ +EKSD++S G +L EL P S+KE KI + +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTA---------------FSQKELAGKIREGKFR 232
Query: 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+P + + + + RP++ E+++
Sbjct: 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-58
Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 688 EDNIIGKGGAGIVYKGLMPNGDQ---VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI 744
D +G G G V +G+ + VA+K L + + + E Q + ++ + +I
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYI 71
Query: 745 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
VRL+G C +LV E G L + L GK+ + ++ + + G+ YL
Sbjct: 72 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKN 129
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ-DSGTSECMSAIAGSYGYIAPEYAYT 863
VHRD+ + N+LL + A ++DFGL+K L D SA + APE
Sbjct: 130 ---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
K +SDV+S+GV + E ++ + + G +++ I +
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA--------------FIEQGKRME 232
Query: 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQIL 957
P ++ + C + +RP V Q +
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (496), Expect = 1e-56
Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 22/279 (7%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQ-VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH 741
+ + +G G G VY+G+ VAVK L + F E + I+H
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKH 72
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
++V+LLG C+ ++ E+M G+L + L + +A + + + YL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
+HRD+ + N L+ VADFGL++ + T + + APE
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESL 188
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
K KSDV++FGV+L E+ T D + + + K D R+
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-------------DYRM 235
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
P V+ + C + +RP+ E+ Q +
Sbjct: 236 ER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-56
Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 40/306 (13%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLM------PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
+ L +G G G V + VAVK L + + + +E++ L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLS 81
Query: 738 RI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH---------------- 780
+ H +IV LLG C+ L++ EY G L L K+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 781 LHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840
L + + + AKG+ +L +HRD+ + NILL G + DFGLA+ +++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQ 900
++APE + +SDV+S+G+ L EL + G+ +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---PYPGMPVDS 255
Query: 901 WVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
KM ++L P ++++M C + ++RPT +++VQ++ +
Sbjct: 256 KFYKMIKEG----FRMLSPEHAPAEMYDIM------KTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 961 PKPPTS 966
T+
Sbjct: 306 ISESTN 311
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-56
Identities = 76/310 (24%), Positives = 125/310 (40%), Gaps = 28/310 (9%)
Query: 687 KEDNIIGKGGAGIVYKGLMPNGDQ-----VAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH 741
K+ ++G G G VYKGL + VA+K L + ++ E + + +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDN 70
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
H+ RLLG C T L+ + MP G L + + ++ V+ AKG+ YL
Sbjct: 71 PHVCRLLGICL-TSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
+VHRD+ + N+L+ + + DFGLAK L ++A E
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
+SDV+S+GV + EL+T + +I + K RL
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------GERL 232
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPPTSKQGEESLPPSGTTSL 981
P P + V+ + + C A RP RE++ +++ + P Q + L
Sbjct: 233 PQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP---QRYLVIQGDERMHL 288
Query: 982 DSPNASNKDQ 991
SP SN +
Sbjct: 289 PSPTDSNFYR 298
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-55
Identities = 70/332 (21%), Positives = 127/332 (38%), Gaps = 45/332 (13%)
Query: 670 TAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGLMPNGDQ---VAVKRLPAMSRGSSHD 726
T + LD+ + +K ++IG+G G V K + A+KR+ + H
Sbjct: 2 TIYPVLDW------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 727 HGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK--------- 776
F E++ L ++ H +I+ LLG C + L EY P+G+L + L
Sbjct: 56 D-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 777 -----KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831
L A + A+G+ YL +HRD+ + NIL+ + A +ADF
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 171
Query: 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGE 891
GL++ + ++A E SDV+S+GV+L E+++
Sbjct: 172 GLSRGQEVYVKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--- 225
Query: 892 FGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMR 951
G+ + K+ + PL+ V+ + C E+ ERP+
Sbjct: 226 PYCGMTCAELYEKLPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 952 EVVQILTELPKPPTSKQGEESLPPSGTTSLDS 983
+++ L + + + +D
Sbjct: 275 QILVSLNRMLEERKTYVNTTLYEKFTYAGIDC 306
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 66/275 (24%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 683 LDCLKEDNIIGKGGAGIVYKG-LMPNGDQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIR 740
L+ + +GKG G VY + +A+K L A + +H E++ +R
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
H +I+RL G+ + L+ EY P G++ L K E A L Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYC 122
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H S ++HRD+K N+LL S E +ADFG + S + + G+ Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEM 175
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920
DEK D++S GV+ E + G+ P + + ++++ ++ P
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF----EANTYQETYKRISR------VEFTFPD 225
Query: 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+ +++ ++ +RP +REV++
Sbjct: 226 FVTEGARDLI------SRLLKHNPSQRPMLREVLE 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 9e-55
Identities = 62/302 (20%), Positives = 114/302 (37%), Gaps = 45/302 (14%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ------VAVKRLPAMSRGSSHDHGFNAEIQTLG 737
+ L+ ++G G G V + VAVK L + S + +E++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMT 95
Query: 738 RI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG------------------ 778
++ H +IV LLG C+ L++EY G L L K+
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 779 ---GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835
L ++ A + AKG+ +L VHRD+ + N+L+ G + DFGLA+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDG 895
+ ++APE + KSDV+S+G++L E+ + G
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPG 269
Query: 896 VDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+ + K+ + + P + ++ + C + +RP+ +
Sbjct: 270 IPVDANFYKLIQNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 956 IL 957
L
Sbjct: 320 FL 321
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-54
Identities = 68/275 (24%), Positives = 106/275 (38%), Gaps = 24/275 (8%)
Query: 692 IGKGGAGIVYKGLMP----NGDQVAVKRLPAMSRGSSHDHG-FNAEIQTLGRIRHRHIVR 746
+G G G+V +G VAVK L F E+ + + HR+++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
L G +V E P GSL + K GH T + AV+ A+G+ YL
Sbjct: 76 LYGVVLTPP-MKMVTELAPLGSLLD-RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR-- 131
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMS-AIAGSYGYIAPEYAYTLK 865
+HRD+ + N+LL + + DFGL + L + M + + APE T
Sbjct: 132 -FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 866 VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925
SD + FGV L E+ T + +G I+ + K + P
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------EGERLPRP 237
Query: 926 LHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
++ V + C + +RPT + L E
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 191 bits (487), Expect = 1e-54
Identities = 80/349 (22%), Positives = 138/349 (39%), Gaps = 32/349 (9%)
Query: 667 WKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSH 725
WK Q ++ D VLD +G G G+V++ G+ A K + M+ S
Sbjct: 9 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESD 66
Query: 726 DHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDT 785
EIQT+ +RH +V L + +++YE+M G L E + + + D
Sbjct: 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDE 125
Query: 786 RYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTS 843
+ + KGLC++H + VH D+K NI+ + + DFGL L +
Sbjct: 126 AVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903
+ + G+ + APE A V +D++S GV+ L++G P G + + +R
Sbjct: 183 KVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF----GGENDDETLR 235
Query: 904 KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ--ILTELP 961
+ K + D + E F +L + R T+ + ++ LT
Sbjct: 236 NV----KSCDWNMDDSAFSGIS--EDGKDFIRKLLLADPN--TRMTIHQALEHPWLTPGN 287
Query: 962 KPPTSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQSPPPDLLSI 1010
P + +P S T + + D P PP + S+
Sbjct: 288 APGR----DSQIPSSRYTKIRDSIKTKYDA--WPEPLPPLGRISNYSSL 330
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 7e-54
Identities = 66/284 (23%), Positives = 112/284 (39%), Gaps = 30/284 (10%)
Query: 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQ 734
F DD + IG G G VY + N + VA+K++ + S+ E++
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 735 TLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAA 794
L ++RH + ++ G T LV EY + + KK L + A
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGAL 125
Query: 795 KGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYG 854
+GL YLH S ++HRDVK+ NILL + DFG A + + + G+
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPY 176
Query: 855 YIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911
++APE + + D K DV+S G+ +EL + P + + +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIA-----Q 228
Query: 912 GVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
L S + C+++ +RPT +++
Sbjct: 229 NESPALQSGHWSEYFRNFV------DSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 1e-53
Identities = 60/268 (22%), Positives = 100/268 (37%), Gaps = 21/268 (7%)
Query: 690 NIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+G+G G V + VAVK + M R EI + H ++V+
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
G L EY G L + + + + + G+ YLH I
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD- 867
HRD+K N+LLD ++DFGLA + + ++ + G+ Y+APE +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 868 EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927
E DV+S G+VL ++ G P + D Q KE + +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDW----KEKKTYLNPWKKIDSAPL 237
Query: 928 EVMHVFYVAMLCVEEQAVERPTMREVVQ 955
++H +L R T+ ++ +
Sbjct: 238 ALLH----KILVENPS--ARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-53
Identities = 61/294 (20%), Positives = 116/294 (39%), Gaps = 32/294 (10%)
Query: 684 DCLKEDNIIGKGGAGIVYKGL------MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
+ + +G+G G+VY+G+ +VA+K + + F E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMK 78
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH--------LHWDTRYKI 789
H+VRLLG S + L++ E M G L L + ++
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
A E A G+ YL+ + VHRD+ + N ++ F + DFG+ + + ++
Sbjct: 139 AGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909
+++PE SDV+SFGVVL E+ T + + +++
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--------- 246
Query: 910 KEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963
+++ L P + +F + +C + RP+ E++ + E +P
Sbjct: 247 -----FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-52
Identities = 60/281 (21%), Positives = 114/281 (40%), Gaps = 25/281 (8%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQ----VAVKRLPAMSRGSSHDHGFNAEIQTLGRI 739
+ ++ IG+G G V++G+ + + VA+K + S + F E T+ +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 65
Query: 740 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCY 799
H HIV+L+G + + ++ E G L + L + A + + L Y
Sbjct: 66 DHPHIVKLIGVITENPV-WIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 800 LHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE 859
L VHRD+ + N+L+ S + DFGL+++++DS T S ++APE
Sbjct: 124 LESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPE 179
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
+ SDV+ FGV + E++ + D++ +I +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--------------RIENG 225
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+P + ++ + C RP E+ L+ +
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-52
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 27/270 (10%)
Query: 692 IGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G G G VYK A K + S D + EI L H +IV+LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED--YMVEIDILASCDHPNIVKLLDA 77
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
++ E+ G++ V+ + L + + L YLH I+H
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIH 133
Query: 811 RDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL-----K 865
RD+K+ NIL + +ADFG++ + + G+ ++APE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 866 VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP 925
D K+DV+S G+ L+E+ P ++ ++ + K+ K + P S
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPH----HELNPMRVLLKIA---KSEPPTLAQPSRWSSN 244
Query: 926 LHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+ + C+E+ R T +++Q
Sbjct: 245 FKDFL------KKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-49
Identities = 57/265 (21%), Positives = 117/265 (44%), Gaps = 24/265 (9%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG+G +G VY + + G +VA++++ + EI + ++ +IV L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 85
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
+ +V EY+ GSL +V+ + + E + L +LH + ++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 811 RDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS 870
RD+KS+NILL + DFG + + S + G+ ++APE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 871 DVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVM 930
D++S G++ +E+I G P + ++ + + G ++ +P S + +
Sbjct: 198 DIWSLGIMAIEMIEGEPPY----LNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFL 250
Query: 931 HVFYVAMLCVEEQAVERPTMREVVQ 955
+ L ++ + +R + +E++Q
Sbjct: 251 N----RCLDMDVE--KRGSAKELLQ 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (445), Expect = 5e-49
Identities = 62/351 (17%), Positives = 128/351 (36%), Gaps = 38/351 (10%)
Query: 667 WKLTAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSH 725
WK Q ++ V D +G G G+V++ + G K + +
Sbjct: 12 WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLD 69
Query: 726 DHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDT 785
+ EI + ++ H ++ L + +L+ E++ G L + + + +
Sbjct: 70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAE 128
Query: 786 RYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTS 843
+A +GL ++H IVH D+K NI+ ++ + V DFGLA L
Sbjct: 129 VINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185
Query: 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR 903
+ + + + APE V +D+++ GV+ L++G P G D ++ ++
Sbjct: 186 KVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF----AGEDDLETLQ 238
Query: 904 KMTDSKKEGVLKILDPRLPSVP--LHEVMHVFYVAMLCVEEQAVERPTMREVVQ------ 955
+ K + + SV + + +L E + +R T+ + ++
Sbjct: 239 NV----KRCDWEFDEDAFSSVSPEAKDFIK----NLLQKEPR--KRLTVHDALEHPWLKG 288
Query: 956 ----ILTELPKPPTSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQS 1002
+ + +P +K ++ P R PQ
Sbjct: 289 DHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQE 339
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-48
Identities = 57/276 (20%), Positives = 98/276 (35%), Gaps = 23/276 (8%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIRHRHIVRL 747
I+G+G V + + A+K L + E + R+ H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+ E Y NG L + + K G E L YLH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH---GKG 128
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
I+HRD+K NILL+ + DFG AK L ++ G+ Y++PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 868 EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLH 927
+ SD+++ G ++ +L+ G P F G + + + + + L+ P
Sbjct: 189 KSSDLWALGCIIYQLVAGLPP---FRAGNEYLIFQKIIK----------LEYDFPEKFFP 235
Query: 928 EVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963
+ +L ++ +R E+ P
Sbjct: 236 KARD-LVEKLLVLDAT--KRLGCEEMEGYGPLKAHP 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-48
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 41/300 (13%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLMP--------NGDQVAVKRLPAMSRGSSHDHGFNAEIQT 735
D L +G+G G V +VAVK L + + +E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEM 71
Query: 736 LGRI-RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG--------------GH 780
+ I +H++I+ LLG C+ ++ EY G+L E L ++
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 781 LHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840
L A + A+G+ YL S +HRD+ + N+L+ +ADFGLA+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQ 900
+ + ++APE + +SDV+SFGV+L E+ T GV + +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPVEE 245
Query: 901 WVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+ + + P + ++ + C +RPT +++V+ L +
Sbjct: 246 LFK-----------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-47
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 37/298 (12%)
Query: 684 DCLKEDNIIGKGGAGIVYKGLM------PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLG 737
D LK +G+G G V + VAVK L + S H + +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 738 RIRHRHIVRLLGFCSNHETNL-LVYEYMPNGSLGEVLHGKKG--------------GHLH 782
H ++V LLG C+ L ++ E+ G+L L K+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 783 WDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842
+ + + AKG+ +L +HRD+ + NILL + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWV 902
++APE + +SDV+SFGV+L E+ + GV I +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEF 246
Query: 903 RKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
+ ++ + P + ++ + C + +RPT E+V+ L L
Sbjct: 247 CR----------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 6e-46
Identities = 52/329 (15%), Positives = 114/329 (34%), Gaps = 39/329 (11%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G+G GIV++ + + K + EI L RHR+I+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHRNILHLHES 69
Query: 751 CSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVH 810
+ E ++++E++ + E ++ L+ + + L +LH S I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGH 125
Query: 811 RDVKSNNILLDSGFEAHV--ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
D++ NI+ + + + +FG A+ L+ + + + Y APE V
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 869 KSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVP--L 926
+D++S G ++ L++G P Q + + + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPF----LAETNQQIIENI----MNAEYTFDEEAFKEISIEA 234
Query: 927 HEVMHVFYVAMLCVEEQAVERPTMREVVQ----------ILTELPKPPTSKQGEESLPPS 976
+ + +L E + R T E +Q + T++ + ++ +L
Sbjct: 235 MDFVD----RLLVKERK--SRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 977 GTTSLDSPNASNKDQKDHQRPAPPQSPPP 1005
+ S + + +
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGVSVAKVK 317
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 162 bits (411), Expect = 3e-45
Identities = 55/281 (19%), Positives = 104/281 (37%), Gaps = 29/281 (10%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHR-HIVRLLG 749
IG+G G++++G + N QVA+K P S E +T + I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
F N+LV + + G E L G T A + + +H +V
Sbjct: 69 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 810 HRDVKSNNILLDSGFEAH-----VADFGLAKFLQDSGTSEC-----MSAIAGSYGYIAPE 859
+RD+K +N L+ + V DFG+ KF +D T + ++G+ Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 860 YAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919
+ + D+ + G V + + G P + Q ++ + K+ L+ L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
P ++ MH P + + +++
Sbjct: 243 GFPE-EFYKYMH------YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (408), Expect = 6e-45
Identities = 72/275 (26%), Positives = 119/275 (43%), Gaps = 25/275 (9%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
I+G GG V+ + VAVK L ++R S F E Q + H IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 749 GFCSNHETNL----LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
+V EY+ +L +++H G + ++ +A + L + H +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG 131
Query: 805 SPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSEC-MSAIAGSYGYIAPEYAYT 863
I+HRDVK NI++ + V DFG+A+ + DSG S +A+ G+ Y++PE A
Sbjct: 132 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 864 LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923
VD +SDVYS G VL E++TG P F + + + +++ + S
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHV---REDPIPPSARHEGLS 242
Query: 924 VPLHEVMHVFYVAMLCVEEQAVERP-TMREVVQIL 957
L V+ + + + R T E+ L
Sbjct: 243 ADLDAVV------LKALAKNPENRYQTAAEMRADL 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 9e-45
Identities = 54/279 (19%), Positives = 106/279 (37%), Gaps = 27/279 (9%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
IG G G +Y G + G++VA+K + + E + ++ + + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 751 C-SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
C + + N++V E + L T +A + + Y+H S +
Sbjct: 71 CGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 125
Query: 810 HRDVKSNNIL---LDSGFEAHVADFGLAKFLQDSGTSECM-----SAIAGSYGYIAPEYA 861
HRDVK +N L G ++ DFGLAK +D+ T + + + G+ Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
++ + D+ S G VL+ G + Q ++++ K +++L
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960
PS + C + ++P + Q+ L
Sbjct: 245 PS-EFATYL------NFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 2e-44
Identities = 56/280 (20%), Positives = 106/280 (37%), Gaps = 25/280 (8%)
Query: 680 DDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGR 738
+D+ D +++G G V VA+K + + EI L +
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHK 63
Query: 739 IRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLC 798
I+H +IV L + L+ + + G L + + + G ++ + +
Sbjct: 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVK 121
Query: 799 YLHHDCSPLIVHRDVKSNNILL---DSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 855
YLH IVHRD+K N+L D + ++DFGL+K +S G+ GY
Sbjct: 122 YLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGY 175
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915
+APE + D +S GV+ L+ G P + + ++ + +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF----YDENDAKLFEQI----LKAEYE 227
Query: 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
P + + F ++ + + +R T + +Q
Sbjct: 228 FDSPYWDDIS--DSAKDFIRHLMEKDPE--KRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (404), Expect = 2e-44
Identities = 64/281 (22%), Positives = 108/281 (38%), Gaps = 35/281 (12%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-------HGFNAEIQTLGRIR- 740
I+G+G + +V + + P + AVK + GS E+ L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
H +I++L + LV++ M G L + L + L KI + +C L
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICAL 126
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H IVHRD+K NILLD + DFG + L E + + G+ Y+APE
Sbjct: 127 HKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPSYLAPEI 180
Query: 861 AYT------LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914
++ D++S GV++ L+ G P + +R + G
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----WHRKQMLMLRMI----MSGNY 232
Query: 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+ P + + L V+ Q +R T E +
Sbjct: 233 QFGSPEWDDYS--DTVKDLVSRFLVVQPQ--KRYTAEEALA 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (396), Expect = 7e-43
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 690 NIIGKGGAGIVYKG-LMPNGDQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIRHRHIVRL 747
+G G G V+ NG A+K L + N E L + H I+R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 748 LGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
G + + ++ +Y+ G L +L + Y V L + S
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKD 124
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVD 867
I++RD+K NILLD + DFG AK++ D + C G+ YIAPE T +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVSTKPYN 179
Query: 868 EKSDVYSFGVVLLELITGRKP 888
+ D +SFG+++ E++ G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 63/296 (21%), Positives = 109/296 (36%), Gaps = 32/296 (10%)
Query: 690 NIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHG---FNAEIQTLGRIRHRHIV 745
+ +G+G VYK VA+K++ R + D EI+ L + H +I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 746 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
LL + LV+++M V+ L + +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 865
I+HRD+K NN+LLD +ADFGLAK + + Y APE + +
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRWYRAPELLFGAR 176
Query: 866 V-DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL--------KI 916
+ D+++ G +L EL+ + +D + + + + E +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 917 LDPRLPSVPLHEVMHV-------FYVAMLCVEEQAVERPTMREVVQ--ILTELPKP 963
P +PLH + + R T + ++ + P P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC--ARITATQALKMKYFSNRPGP 289
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-42
Identities = 66/313 (21%), Positives = 112/313 (35%), Gaps = 37/313 (11%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLL 748
++G G G V + ++ A+K L + E++ R + HIVR++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIV 71
Query: 749 GFCSNHETN----LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC 804
N L+V E + G L + + +I + + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 805 SPLIVHRDVKSNNILLDSGFE---AHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA 861
S I HRDVK N+L S + DFG AK + + Y+APE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPYYVAPEVL 185
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
K D+ D++S GV++ L+ G P + M + G + +P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPF----YSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ--ILTELPKPPTSKQGEESLPPSGTT 979
V E + + +L E +R T+ E + + + K P + L S
Sbjct: 242 SEVS--EEVKMLIRNLLKTEPT--QRMTITEFMNHPWIMQSTKVP-----QTPLHTSRVL 292
Query: 980 SLDSPNASNKDQK 992
D + ++
Sbjct: 293 KEDKERWEDVKEE 305
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-42
Identities = 73/342 (21%), Positives = 118/342 (34%), Gaps = 42/342 (12%)
Query: 687 KEDNIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV 745
+ +IG G G+VY+ L +G+ VA+K++ N E+Q + ++ H +IV
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIV 76
Query: 746 RLLGFCSNHETN------LLVYEYMPNGSLGEVLH-GKKGGHLHWDTRYKIAVEAAKGLC 798
RL F + LV +Y+P H + L + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 799 YLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 857
Y+H S I HRD+K N+LLD + DFG AK L +S I Y
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAP 191
Query: 858 PEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI- 916
DV+S G VL EL+ G+ +V+ ++ + +E + ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 917 ---LDPRLPSVPLHEVMHVFYV-----------AMLCVEEQAVERPTMREVVQ--ILTEL 960
+ + P + H VF +L R T E EL
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT--ARLTPLEACAHSFFDEL 309
Query: 961 PKPPTSKQGEESLPPSGTTSLDSPNASNKDQKDHQRPAPPQS 1002
P P + + + PP +
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQEL---SSNPPLATILIPPHA 348
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-42
Identities = 59/295 (20%), Positives = 113/295 (38%), Gaps = 34/295 (11%)
Query: 670 TAFQRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHG 728
T F++ + DD D +E +G G +V K G Q A K + SS
Sbjct: 1 TVFRQENV--DDYYDTGEE---LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 729 ----FNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD 784
E+ L I+H +++ L N +L+ E + G L + + L +
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEE 113
Query: 785 TRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS----GFEAHVADFGLAKFLQDS 840
+ + G +++ S I H D+K NI+L + DFGLA +
Sbjct: 114 EATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQ 900
+ + G+ ++APE + ++D++S GV+ L++G P G +
Sbjct: 171 NEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF----LGDTKQE 223
Query: 901 WVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ 955
+ + + D + + F +L + + +R T+++ +Q
Sbjct: 224 TLANV----SAVNYEFEDEYFSNTS--ALAKDFIRRLLVKDPK--KRMTIQDSLQ 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 3e-41
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 15/212 (7%)
Query: 683 LDCLKEDNIIGKGGAGIVYKG-LMPNGDQVAVKRLP----AMSRGSSHDHGFNAEIQTLG 737
++ IIG+GG G VY G A+K L M +G + + +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 738 RIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGL 797
IV + + + + M G L L + G A E GL
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGL 120
Query: 798 CYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIA 857
++H+ +V+RD+K NILLD ++D GLA + G++GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 858 PEYAYT-LKVDEKSDVYSFGVVLLELITGRKP 888
PE + D +D +S G +L +L+ G P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 6e-41
Identities = 62/266 (23%), Positives = 95/266 (35%), Gaps = 26/266 (9%)
Query: 690 NIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGR-IRHRHIVR 746
++GKG G V+ A+K L D E + L H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 747 LLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSP 806
+ E V EY+ G L + A E GL +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKG-- 123
Query: 807 LIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
IV+RD+K +NILLD +ADFG+ K + G+ YIAPE K
Sbjct: 124 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKY 180
Query: 867 DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPL 926
+ D +SFGV+L E++ G+ P D ++ +R PR
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSIRMD---------NPFYPRWLEKEA 230
Query: 927 HEVMHVFYVAMLCVEEQAVERPTMRE 952
+++ + E + +R +R
Sbjct: 231 KDLLV----KLFVREPE--KRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (378), Expect = 7e-41
Identities = 50/279 (17%), Positives = 104/279 (37%), Gaps = 19/279 (6%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
IG+G G+VYK G+ A+K++ EI L ++H +IV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 750 FCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIV 809
+ +LV+E++ + + G L T ++ G+ Y H ++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 810 HRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEK 869
HRD+K N+L++ E +ADFGLA+ + Y + K
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY-RAPDVLMGSKKYSTT 181
Query: 870 SDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD--------PRL 921
D++S G + E++ G + +++ R + + + +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 922 PSVPLHEVMHVFYVAML-----CVEEQAVERPTMREVVQ 955
+P + + + ++ +R T ++ ++
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 57/299 (19%), Positives = 112/299 (37%), Gaps = 25/299 (8%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH 741
++ ++ IG+G G+VYK G+ VA+K++ + EI L + H
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
+IV+LL LV+E++ + L + + + + +GL + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPE-Y 860
++HRD+K N+L+++ +ADFGLA+ + + Y APE
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEIL 174
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL------ 914
D++S G + E++T R +D + + + + E V
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 915 ---KILDPRLPSVPLHEVMHVFYVAML-----CVEEQAVERPTMREVVQ--ILTELPKP 963
K P+ +V+ + +R + + + ++ KP
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-40
Identities = 61/296 (20%), Positives = 116/296 (39%), Gaps = 25/296 (8%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
+ IG+G G+V N +VA+K++ + EI+ L R RH +I+ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR-TLREIKILLRFRHENIIGIN 72
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGK-KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPL 807
+ Y+ +G L+ K HL D + +GL Y+H S
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SAN 129
Query: 808 IVHRDVKSNNILLDSGFEAHVADFGLAKFL-QDSGTSECMSAIAGSYGYIAPEYAYTLKV 866
++HRD+K +N+LL++ + + DFGLA+ D + ++ + Y APE K
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 867 D-EKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD------- 918
+ D++S G +L E+++ R + + + +E + I++
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 919 ---PRLPSVPLHEVMHVFYVAML-----CVEEQAVERPTMREVVQ--ILTELPKPP 964
P VP + + L + +R + + + L + P
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-39
Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 26/286 (9%)
Query: 690 NIIGKGGAGIVYKG--LMPNGDQVAVKRLPAMSRGSSHDHGFNAEI---QTLGRIRHRHI 744
IG+G G V+K L G VA+KR+ + E+ + L H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 745 VRLLGFCSNHETNLLVYEYMPN----GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
VRL C+ T+ + L L + +T + + +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H +VHRD+K NIL+ S + +ADFGLA+ ++++ + Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEV 186
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP------VGEFGDGVDIVQWVRKMTDSKKEGVL 914
D++S G + E+ + V + G +D++ + + +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 915 KILDPRLPSVPLHEVMHVFYVAML-----CVEEQAVERPTMREVVQ 955
+ + P+ + + C+ +R + +
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 5e-39
Identities = 54/291 (18%), Positives = 102/291 (35%), Gaps = 23/291 (7%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG+G G V+K + VA+KR+ EI L ++H++IVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 749 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLI 808
+ + LV+E+ G L + + KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 809 VHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 868
+HRD+K N+L++ E +A+FGLA+ + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYST 181
Query: 869 KSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD--PRLPSVPL 926
D++S G + EL +P+ D D ++ + ++ + E + P P+
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 927 HEVMHVFYVAMLCVEEQAV------------ERPTMREVVQ--ILTELPKP 963
+ + + +R + E +Q ++ P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 54/289 (18%), Positives = 114/289 (39%), Gaps = 41/289 (14%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHG----FNAEIQTLGRIRHRH-- 743
++G GG G VY G+ + + VA+K + + E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 744 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
++RLL + ++ +L+ E + G L + + + + + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 804 CSPLIVHRDVKSNNILLD-SGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY-A 861
++HRD+K NIL+D + E + DFG L+D+ + G+ Y PE+
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIR 182
Query: 862 YTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921
Y + V+S G++L +++ G P F +I++ ++ +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIRG-------------QVFFRQR 226
Query: 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ--ILTELPKPPTSKQ 968
S ++ C+ + +RPT E+ + ++ P + +
Sbjct: 227 VSSECQHLI------RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-38
Identities = 54/306 (17%), Positives = 106/306 (34%), Gaps = 39/306 (12%)
Query: 690 NIIGKGGAGIVYKG-LMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLL 748
IG+G G V+K G +VA+K++ + EI+ L ++H ++V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 749 GFCSNHETN--------LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
C + LV+++ + G + + L R + L L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS--ECMSAIAGSYGYIAP 858
++ I+HRD+K+ N+L+ +ADFGLA+ + S + + Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 859 EYAYTLK-VDEKSDVYSFGVVLLELITGRKP----------------VGEFGDGV--DIV 899
E + D++ G ++ E+ T G V ++
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQ--IL 957
+ +G + + RL + +L ++ +R + +
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA--QRIDSDDALNHDFF 308
Query: 958 TELPKP 963
P P
Sbjct: 309 WSDPMP 314
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 65/346 (18%), Positives = 120/346 (34%), Gaps = 42/346 (12%)
Query: 673 QRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA 731
Q + T +V ++ +G G G V + G +VA+K+L +
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK--KGGHLHWDTRYKI 789
E++ L +RH +++ LL + ET ++ GK K L D +
Sbjct: 67 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126
Query: 790 AVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAI 849
+ KGL Y+H HRD+K N+ ++ E + DFGLA+ T ++
Sbjct: 127 VYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT-- 181
Query: 850 AGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVR------ 903
+ ++ + D++S G ++ E+ITG+ F + Q
Sbjct: 182 --RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL---FKGSDHLDQLKEIMKVTG 236
Query: 904 ----KMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVA----------MLCVEEQAVERPT 949
+ + K LP + + + A ML ++ + +R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE--QRVT 294
Query: 950 MREVVQ--ILTELPKPPTSKQGEESLPPSGTTSLDSPNASNKDQKD 993
E + L +E S D + + + K
Sbjct: 295 AGEALAHPYFESLHDTE-----DEPQVQKYDDSFDDVDRTLDEWKR 335
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 9e-35
Identities = 50/208 (24%), Positives = 75/208 (36%), Gaps = 9/208 (4%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRL-PAMSRGSSHDHGFNAEIQTLGRIR 740
++ ++GKG G V G A+K L + E + L R
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
H + L H+ V EY G L L + + E L
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSAL--- 118
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
+ S +V+RD+K N++LD + DFGL K G + G+ Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP 888
D + GVV+ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 132 bits (331), Expect = 2e-34
Identities = 89/329 (27%), Positives = 134/329 (40%), Gaps = 33/329 (10%)
Query: 22 EYKALLSIKSSITDDPQSSLAAWNATTSHC--TWPGVTCDSR---RHVTSLDLSGLNLSG 76
+ +ALL IK + + ++L++W TT C TW GV CD+ V +LDLSGLNL
Sbjct: 7 DKQALLQIKKDLGNP--TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 77 ALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNV-FNGSFPPQLSQLAS 135
PIP ++ L L L + G PP +++L
Sbjct: 65 ----------------------PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 136 LQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELG 195
L L + + N++G +P ++Q++ L L N SG +PP L + GN +
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 196 GKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQ 255
G IP G+ +KL N TG +PP NL+ + N + +
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM--LEGDASVLFGSD 220
Query: 256 NLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKL 315
++G K+L +DL NN G +P +LK L LN+ N L
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 316 HGAIPEFIGVMPRLEVLQLWENNFTGSIP 344
G IP+ G + R +V N P
Sbjct: 281 CGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 99.4 bits (246), Expect = 3e-23
Identities = 73/288 (25%), Positives = 107/288 (37%), Gaps = 46/288 (15%)
Query: 348 GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMG 407
++ LDLS L P IP SL L+ + +G
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFLYIG 84
Query: 408 EN-FLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPAS 466
L G IP + L L + + ++G P S L + S N LSG+LP S
Sbjct: 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
Query: 467 IGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDL 526
I + + DGN+ SG IP G +L P L FVDL
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204
Query: 527 SRNEL-----------------------SGEIPNQLTGMRILNYLNLSRNHLVGSIPASI 563
SRN L ++ + LN L+L N + G++P +
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 564 ASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPC 611
++ L S++ S+NNL G +P G F+ +++ N LCG L C
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 64.4 bits (155), Expect = 2e-11
Identities = 18/57 (31%), Positives = 24/57 (42%), Gaps = 1/57 (1%)
Query: 96 NQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPL 152
N++ G +P ++ L L LN+S N G PQ L V NN PL
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGE-IPQGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.5 bits (119), Expect = 4e-07
Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 3/140 (2%)
Query: 442 SDSISVNLGQICLSNNQLSG--SLPASIGKFSGVQKLLLDGN-KFSGQIPAEIGKLQQLS 498
+D+ + + + LS L +P+S+ + L + G G IP I KL QL
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 499 KMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGS 558
+ +H SG I +SQ K L +D S N LSG +P ++ + L + N + G+
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 559 IPASIASMQSLTSVDFSYNN 578
IP S S L + N
Sbjct: 165 IPDSYGSFSKLFTSMTISRN 184
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 3e-33
Identities = 66/360 (18%), Positives = 135/360 (37%), Gaps = 45/360 (12%)
Query: 673 QRLDFTCDDVLDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNA 731
Q L+ T +V + + + +G G G V G +VAVK+L + H
Sbjct: 7 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66
Query: 732 EIQTLGRIRHRHIVRLLGFCSNHET-----NLLVYEYMPNGSLGEVLHGKKGGHLHWDTR 786
E++ L ++H +++ LL + + ++ + ++ + + K L D
Sbjct: 67 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKCQKLTDDHV 123
Query: 787 YKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECM 846
+ + +GL Y+H HRD+K +N+ ++ E + DFGLA+ D T
Sbjct: 124 QFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180
Query: 847 SAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMT 906
+ + + ++ D++S G ++ EL+TGR D +D ++ + ++
Sbjct: 181 TR----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLV 235
Query: 907 DSKKEGVLKILD-----------PRLPSVPLHEVMHV-------FYVAMLCVEEQAVERP 948
+ +LK + ++P + V ML ++ +R
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD--KRI 293
Query: 949 TMREVVQ--ILTELPKPPTSKQGEESLPPSGTTSLDSPNASNKDQKDH-QRPAPPQSPPP 1005
T + + + P +E + S +S + + K PPP
Sbjct: 294 TAAQALAHAYFAQYHDPD-----DEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 3e-33
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 12/208 (5%)
Query: 683 LDCLKEDNIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHD-HGFNAEIQTLGRIR 740
LD +G G G V +G+ A+K L E + L +
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 741 HRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYL 800
+V+L ++ +V EY+ G + L + G A + YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 801 HHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY 860
H +++RD+K N+L+D V DFG AK ++ + + G+ +APE
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 861 AYTLKVDEKSDVYSFGVVLLELITGRKP 888
+ ++ D ++ GV++ E+ G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-32
Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 15/229 (6%)
Query: 690 NIIGKGGAGIVYKG----LMPNGDQVAVKRLP--AMSRGSSHDHGFNAEIQTLGRIRHR- 742
++G G G V+ G A+K L + + + E Q L IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 743 HIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH 802
+V L L+ +Y+ G L L ++ H Y + + L H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVLALEH 144
Query: 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAY 862
I++RD+K NILLDS + DFGL+K T E G+ Y+AP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVR 203
Query: 863 TLK--VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909
D+ D +S GV++ EL+TG P G+ + R++ S+
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 9e-32
Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 22/226 (9%)
Query: 690 NIIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRL 747
+G+G V++ + + N ++V VK L + + EI+ L +R +I+ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITL 95
Query: 748 LGFCSNHETNL--LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCS 805
+ + LV+E++ N ++ L E K L Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG- 149
Query: 806 PLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 864
I+HRDVK +N+++D + + D+GLA+F S + PE
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLVDY 204
Query: 865 K-VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909
+ D D++S G +L +I ++P D D + + K+ ++
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-31
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 691 IIGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLG 749
IG G GIV VA+K+L + +H E+ + + H++I+ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 750 FCSNHETN------LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD 803
+ +T LV E M + L + + + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA 138
Query: 804 CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 863
I+HRD+K +NI++ S + DFGLA+ +GTS M+ + Y APE
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILG 192
Query: 864 LKVDEKSDVYSFGVVLLELITGRKP 888
+ E D++S G ++ E++ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 8e-29
Identities = 43/213 (20%), Positives = 77/213 (36%), Gaps = 21/213 (9%)
Query: 692 IGKGGAGIVYKGL-MPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGF 750
+G G V+ M N VA+K + + EI+ L R+ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKI---VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 751 CSNHETNLLVY--EYMPNGSLGEV------------LHGKKGGHLHWDTRYKIAVEAAKG 796
+NH LL + PNG + + + + +I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 797 LCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGLAKFLQDSGTSECMSAIAGSYGY 855
L Y+H C I+H D+K N+L++ ++ +A E + + Y
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 856 IAPEYAYTLKVDEKSDVYSFGVVLLELITGRKP 888
+PE +D++S ++ ELITG
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 101 bits (251), Expect = 2e-23
Identities = 75/423 (17%), Positives = 138/423 (32%), Gaps = 58/423 (13%)
Query: 107 SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLG 166
+AL+ L + L + L + + V L NL ++
Sbjct: 19 TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFS 74
Query: 167 GNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPE 226
N + P + NLTKL + +
Sbjct: 75 NNQLTDITP--------------------------LKNLTKLVDILMNNNQIADITPLAN 108
Query: 227 IGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDL 286
+ NL+ L F+ + L + + ++ L L S+
Sbjct: 109 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS----------DISALSGLTSLQQ 158
Query: 287 SNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQR 346
+ A L L L++ NK+ + + LE L N + P
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITPLG 216
Query: 347 LGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRM 406
+ +N L L L+ N+L + + L L N + P L L+ +++
Sbjct: 217 ILTN--LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270
Query: 407 GENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPAS 466
G N ++ P L GL +L+ +EL +N + S NL + L N +S P
Sbjct: 271 GANQISNISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP-- 324
Query: 467 IGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDL 526
+ + +Q+L NK S + + L ++ + HN+ S ++ +T + L
Sbjct: 325 VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT--PLANLTRITQLGL 380
Query: 527 SRN 529
+
Sbjct: 381 NDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.7 bits (247), Expect = 8e-23
Identities = 68/370 (18%), Positives = 140/370 (37%), Gaps = 35/370 (9%)
Query: 229 NLSSLVRFDAANCGLSGEIP-TDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLS 287
L+ ++ ++ + TD+ ++ L L + ++ G + YL +L ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 288 NNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLE------VLQLWENNFTG 341
NN T P L L + + N++ P + +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 342 SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITL-------GNFLFGPIPES 394
++ + S+ + + S + L+ L L +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 395 LGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICL 454
L K +L + N ++ P G+ +L ++ L N L + + NL + L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPE 514
+NNQ+S P + + + +L L N+ S P + L L+ ++ + N+
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL--EDISP 302
Query: 515 ISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDF 574
IS K LT++ L N +S P ++ + L L + N + S +S+A++ ++ +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSA 358
Query: 575 SYNNLSGLVP 584
+N +S L P
Sbjct: 359 GHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.5 bits (236), Expect = 2e-21
Identities = 75/390 (19%), Positives = 119/390 (30%), Gaps = 59/390 (15%)
Query: 80 PDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVL 139
D A L + ++ + + L + L + L +L +
Sbjct: 17 TDTA-LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQI 71
Query: 140 DLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEY------------- 186
+ NN +T PL L L + + N + P
Sbjct: 72 NFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 187 -------LAVSGNEL----------------GGKIPGEIGNLTKLQQLYIGYYNSYTGGL 223
L +S N + G ++ L L L +S
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 224 PPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKS 283
+ L++L A N +S P I NLD L L N L L L +L
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GTLASLTNLTD 245
Query: 284 MDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI 343
+DL+NN + P + L LT L L N++ I G+ + S
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISP 302
Query: 344 PQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSR 403
L L L L N ++ P LQ L N + SL +++
Sbjct: 303 ISNL---KNLTYLTLYFNNISDISPVSSL--TKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 404 MRMGENFLNGSIPKGLFGLPSLSQVELQDN 433
+ G N ++ P L L ++Q+ L D
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 5e-20
Identities = 52/204 (25%), Positives = 80/204 (39%), Gaps = 33/204 (16%)
Query: 83 AHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLY 142
A L L++L NQ+S P I ++L L+L+ N L+ L +L LDL
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 143 NNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIP--------------------PEYGIWE 182
NN ++ PL + L L L LG N S P +
Sbjct: 250 NNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 183 FLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCG 242
L YL + N + P + +LTKLQ+L+ N + + NL+++ A +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFA-NNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 243 LSGEIPTDIGRLQNLDTLFLQVNA 266
+S P + L + L L A
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.0 bits (214), Expect = 1e-18
Identities = 56/365 (15%), Positives = 130/365 (35%), Gaps = 38/365 (10%)
Query: 204 NLTKLQQLYIGYYN--SYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLF 261
+L ++ L S G + L++L + + +N L+ P + L L +
Sbjct: 42 DLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
Query: 262 LQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFA---------ELKNLTLLNLFR 312
+ N ++ + ++ + + + +++ L+
Sbjct: 95 MNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLT 154
Query: 313 NKLHGAIPEFIGVMPRLEVLQLWENNF----TGSIPQRLGSNGKLRILDLSSNKLTGTLP 368
+ + + + L L E S L L L ++N+++ P
Sbjct: 155 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP 214
Query: 369 PDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQV 428
+ L L GN L +L +L+ + + N ++ P L GL L+++
Sbjct: 215 LGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268
Query: 429 ELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIP 488
+L N ++ P++ ++ ++ + + + I + L L N S P
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLE----DISPISNLKNLTYLTLYFNNISDISP 324
Query: 489 AEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYL 548
+ L +L ++ F++NK S ++ + ++ N++S P L + + L
Sbjct: 325 --VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378
Query: 549 NLSRN 553
L+
Sbjct: 379 GLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.1 bits (152), Expect = 7e-11
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 6/95 (6%)
Query: 50 HCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISAL 109
+ + +++T L L N+S V+ L LQ L A N++S ++ L
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 110 SSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNN 144
+++ L+ +N + P L+ L + L L +
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.2 bits (243), Expect = 7e-23
Identities = 59/278 (21%), Positives = 100/278 (35%), Gaps = 17/278 (6%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
+P ++ LL+L NN L +L L L NN ++ P A L L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 162 HLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYI-GYYNSYT 220
L+L N +P + + + L+ L V NE+ L ++ + + +
Sbjct: 83 RLYLSKNQLKE-LPEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 221 GGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKS 280
G + L A+ ++ IP + +L L L N ++ L L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 281 LKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFT 340
L + LS N + S A +L L+L NKL +P + ++V+ L NN +
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 255
Query: 341 G------SIPQRLGSNGKLRILDLSSNKLT-GTLPPDM 371
P + L SN + + P
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 93.9 bits (232), Expect = 2e-21
Identities = 57/305 (18%), Positives = 98/305 (32%), Gaps = 41/305 (13%)
Query: 279 KSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENN 338
+DL NN T F LKNL L L NK+ P + +LE L L +N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 339 FTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLG-- 396
LP M LQ L N +
Sbjct: 91 LK-------------------------ELPEKMP--KTLQELRVHENEITKVRKSVFNGL 123
Query: 397 KCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSN 456
+ + +G G+ LS + + D +T + + +L ++ L
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDG 180
Query: 457 NQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEIS 516
N+++ AS+ + + KL L N S + L ++ ++NK ++
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLA 239
Query: 517 QCKLLTFVDLSRNELSG------EIPNQLTGMRILNYLNLSRNHL--VGSIPASIASMQS 568
K + V L N +S P T + ++L N + P++ +
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299
Query: 569 LTSVD 573
+V
Sbjct: 300 RAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.5 bits (223), Expect = 3e-20
Identities = 52/302 (17%), Positives = 98/302 (32%), Gaps = 46/302 (15%)
Query: 50 HCTWPGVTCDSRR----------HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLS 99
C V C LDL ++ D +L+ L L + N++S
Sbjct: 9 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 100 GPIPPEISALSSLRLLNLSNN---------------------VFNGSFPPQLSQLASLQV 138
P + L L L LS N + L + V
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 139 LDLYNNNM--TGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
++L N + +G A ++ L ++ + + IP G+ L L + GN++
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITK 185
Query: 197 KIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQN 256
+ L L +L + + + + + N L N L ++P + +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNS-ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243
Query: 257 LDTLFLQVNALSG------PLTTELGYLKSLKSMDLSNN-IFTGEI-PASFAELKNLTLL 308
+ ++L N +S S + L +N + EI P++F + +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
Query: 309 NL 310
L
Sbjct: 304 QL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 8e-19
Identities = 51/283 (18%), Positives = 99/283 (34%), Gaps = 14/283 (4%)
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKL 363
+L ++ L +P+ + P +L L N T + L L L +NK+
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 364 TGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLP 423
+ P L+ L N L + L + S+ GL +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 424 SLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKF 483
+ + +G + L I +++ ++ ++P + + +L LDGNK
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 183
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543
+ A + L L+K+ S N S ++ L + L+ N+L ++P L +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242
Query: 544 ILNYLNLSRNHL------VGSIPASIASMQSLTSVDFSYNNLS 580
+ + L N++ P S + V N +
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.5 bits (153), Expect = 2e-11
Identities = 28/163 (17%), Positives = 57/163 (34%), Gaps = 4/163 (2%)
Query: 424 SLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKF 483
L V+ D L V + + + L NN+++ + L+L NK
Sbjct: 11 HLRVVQCSDLGLEK---VPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 484 SGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543
S P L +L ++ S N+ + L + ++ + N L M
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
++ L + G + M+ L+ + + N++ + G
Sbjct: 128 VV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL 169
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.2 bits (147), Expect = 2e-10
Identities = 41/262 (15%), Positives = 88/262 (33%), Gaps = 35/262 (13%)
Query: 353 LRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLN 412
LR++ S L +P D+ L N + +L + + N ++
Sbjct: 12 LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 413 GSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSG 472
P L L ++ L N L + + + L ++ + N+++ + +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125
Query: 473 VQKLLLDG--NKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNE 530
+ + L K SG +++LS + + +
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---------------------T 164
Query: 531 LSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFS 590
+ +P LT L+L N + AS+ + +L + S+N++S + G+ +
Sbjct: 165 IPQGLPPSLT------ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218
Query: 591 YFNYTSFLGNSELCGPYLGPCK 612
L N++L G
Sbjct: 219 PHLRELHLNNNKLVKVPGGLAD 240
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.8 bits (120), Expect = 4e-07
Identities = 32/196 (16%), Positives = 64/196 (32%), Gaps = 10/196 (5%)
Query: 37 PQSSLAAWNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAAN 96
L + ++ V L + L SG + ++ L + +A
Sbjct: 101 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160
Query: 97 QLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQ 156
++ IP + SL L+L N L L +L L L N+++ ++
Sbjct: 161 NIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217
Query: 157 LRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG------KIPGEIGNLTKLQQ 210
+LR LHL N ++P ++++ + + N + PG
Sbjct: 218 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 276
Query: 211 LYIGYYNSYTGGLPPE 226
+ + + P
Sbjct: 277 VSLFSNPVQYWEIQPS 292
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 8e-21
Identities = 25/156 (16%), Positives = 51/156 (32%), Gaps = 17/156 (10%)
Query: 690 NIIGKGGAGIVYKGLMPNGDQVAVKRLPA--------MSRGSSHDHGFNAEIQTLGRIRH 741
++G+G V+ + VK + D F+ R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 742 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLH 801
R + +L G Y + N L E++ K+ + + ++ + + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 802 HDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837
H IVH D+ N+L+ + DF + +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (208), Expect = 1e-18
Identities = 59/280 (21%), Positives = 94/280 (33%), Gaps = 29/280 (10%)
Query: 279 KSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENN 338
+ + + L N + ASF +NLT+L L N L + LE L L +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 339 FTGSI-PQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGK 397
S+ P G+L L L L P LQ L N L ++
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 398 CDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNN 457
+L+ + + N ++ + GL SL ++ L N + P + L + L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 458 QLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQ 517
LS ++ +Q L L+ N + A
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-------------------------RPL 246
Query: 518 CKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVG 557
L S +E+ +P +L G + L+ N L G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (205), Expect = 4e-18
Identities = 53/280 (18%), Positives = 88/280 (31%), Gaps = 8/280 (2%)
Query: 231 SSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNI 290
V GL +P I +FL N +S ++L + L +N+
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 291 FTGEIPASFAELKNLTLLNLFRNKLHGAI-PEFIGVMPRLEVLQLWENNFTGSIPQRLGS 349
A+F L L L+L N ++ P + RL L L P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 350 NGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGEN 409
L+ L L N L L L GN + + SL R+ + +N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 410 FLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGK 469
+ P L L + L N L+ + + L + L++N +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPL 246
Query: 470 FSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSG 509
++ +QK ++ +P L + N G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (198), Expect = 3e-17
Identities = 56/265 (21%), Positives = 90/265 (33%), Gaps = 8/265 (3%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
+P I ++ + + L N + +L +L L++N + A T L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 162 HLHLGGNFFSGQIPPEY-GIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYT 220
L L N + P L L + L PG L LQ LY+ N+
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL-QDNALQ 142
Query: 221 GGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKS 280
+L +L +S L +LD L L N ++ L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 281 LKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFT 340
L ++ L N + + A L+ L L L N + L+ + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVP 261
Query: 341 GSIPQRLGSNGKLRILDLSSNKLTG 365
S+PQRL + L++N L G
Sbjct: 262 CSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (188), Expect = 6e-16
Identities = 45/244 (18%), Positives = 77/244 (31%), Gaps = 4/244 (1%)
Query: 342 SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSL 401
++P + + + + L N+++ A L L N L + L
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 402 SRMRMGENFLNGSIPKGLFG-LPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLS 460
++ + +N S+ F L L + L L P L + L +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 461 GSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKL 520
+ + L L GN+ S L L ++ N+ +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLS 580
L + L N LS L +R L YL L+ N V + L S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP 261
Query: 581 GLVP 584
+P
Sbjct: 262 CSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (188), Expect = 6e-16
Identities = 62/286 (21%), Positives = 106/286 (37%), Gaps = 10/286 (3%)
Query: 57 TCDSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLN 116
C + VT L A+ + Q + + N++S A +L +L
Sbjct: 7 VCYNEPKVT-TSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 117 LSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDL-PLAVTQLRNLRHLHLGGNFFSGQIP 175
L +NV + LA L+ LDL +N + P L L LHL P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 176 PEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVR 235
+ L+YL + N L +L L L++ + N + L SL R
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL-HGNRISSVPERAFRGLHSLDR 181
Query: 236 FDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEI 295
++ P L L TL+L N LS T L L++L+ + L++N + +
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 296 PASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTG 341
A L +++ ++P+ + ++ +L N+ G
Sbjct: 242 RAR-PLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (171), Expect = 1e-13
Identities = 53/238 (22%), Positives = 78/238 (32%), Gaps = 1/238 (0%)
Query: 158 RNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYN 217
+ + L GN S + L L + N L L L+QL +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 218 SYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGY 277
P L L CGL P L L L+LQ NAL
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 278 LKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWEN 337
L +L + L N + +F L +L L L +N++ P + RL L L+ N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 338 NFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESL 395
N + + L L+ L L+ N LQ + + +P+ L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW-LQKFRGSSSEVPCSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (131), Expect = 1e-08
Identities = 37/166 (22%), Positives = 60/166 (36%), Gaps = 5/166 (3%)
Query: 49 SHCTWPGVTCDSRRHVTSLDLSGL---NLSGALSPDVAHLRFLQNLSVAANQLSGPIPPE 105
C + R + +L L L L L +L + N++S
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 106 ISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHL 165
L SL L L N P L L L L+ NN++ A+ LR L++L L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 166 GGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQL 211
N + +W +L+ S +E+ +P + L++L
Sbjct: 233 NDNPWVCDCRARP-LWAWLQKFRGSSSEVPCSLPQRLAGR-DLKRL 276
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (125), Expect = 7e-08
Identities = 30/174 (17%), Positives = 61/174 (35%), Gaps = 3/174 (1%)
Query: 414 SIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGV 473
++P G+ + ++ L N ++ S NL + L +N L+ A+ + +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 474 QKLLLDGNKFSGQI-PAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELS 532
++L L N + PA L +L + L ++ L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 533 GEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGT 586
+ + L +L L N + + + SL + N ++ + P
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 1e-06
Identities = 33/152 (21%), Positives = 55/152 (36%), Gaps = 4/152 (2%)
Query: 455 SNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPE 514
L ++P I + Q++ L GN+ S A + L+ + N + A
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 515 ISQCKLLTFVDLSRNELSGEI-PNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVD 573
+ LL +DLS N + P G+ L+ L+L R L P + +L +
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 574 FSYNNLSGLVPGTGQFSYFNYTSFLGNSELCG 605
N L L T + FL + +
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.6 bits (192), Expect = 2e-16
Identities = 49/293 (16%), Positives = 88/293 (30%), Gaps = 23/293 (7%)
Query: 65 TSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNG 124
+LDL+G NL ++ + + + + + P+ S ++ ++LSN+V
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60
Query: 125 SFPPQ-LSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEF 183
S LSQ + LQ L L ++ + + + NL L+L G + + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 184 LEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGL 243
N E + + G N
Sbjct: 121 --SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK--------------NLQK 164
Query: 244 SGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSN-NIFTGEIPASFAEL 302
S + L E L L+ + LS E E+
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224
Query: 303 KNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRI 355
L L +F G + +P LQ+ ++FT +G+ I
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 45/232 (19%), Positives = 73/232 (31%), Gaps = 10/232 (4%)
Query: 49 SHCTWPGVTCDSRRHVTSLDLSGLNLSG-ALSPDVAHLRFLQNLSVAANQLSGPIPPEIS 107
S P S V +DLS + L ++ LQNLS+ +LS PI ++
Sbjct: 33 SFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 92
Query: 108 ALSSLRLLNLS--NNVFNGSFPPQLSQLASLQVLDLYNNNMTG------DLPLAVTQLRN 159
S+L LNLS + + LS + L L+L + +
Sbjct: 93 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ 152
Query: 160 LRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL-GGKIPGEIGNLTKLQQLYIGYYNS 218
L N + L +L +S + + E L LQ L +
Sbjct: 153 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 212
Query: 219 YTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGP 270
E+G + +L G + L +L ++ P
Sbjct: 213 IIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARP 264
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 40/275 (14%), Positives = 71/275 (25%), Gaps = 36/275 (13%)
Query: 137 QVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
Q LDL N+ D+ + + + +F +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA--------------------- 40
Query: 197 KIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQN 256
E + ++Q + + L + S L LS I + + N
Sbjct: 41 ----EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 96
Query: 257 LDTLFLQVNALSGPLTTE--------LGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLL 308
L L L + + L L D + + + L L
Sbjct: 97 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 156
Query: 309 NLFRNKLHGAIPEFIGVMPRLEVLQLWEN-NFTGSIPQRLGSNGKLRILDLSS-NKLTGT 366
+N + + P L L L ++ Q L+ L LS +
Sbjct: 157 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE 216
Query: 367 LPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSL 401
++ L+TL G G + L
Sbjct: 217 TLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL 251
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 1e-04
Identities = 10/87 (11%), Positives = 33/87 (37%), Gaps = 3/87 (3%)
Query: 499 KMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL-VG 557
+D + + + ++ F R+ + + + R + +++LS + + V
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAF-RCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 558 SIPASIASMQSLTSVDFSYNNLSGLVP 584
++ ++ L ++ LS +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (156), Expect = 7e-12
Identities = 33/213 (15%), Positives = 56/213 (26%), Gaps = 10/213 (4%)
Query: 105 EISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLH 164
E+S ++S +N + PP L +L L N + + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 165 LGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLP 224
L + + L L + T + + LP
Sbjct: 62 L-----DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 225 PEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTL-FLQVNALSGPLTTELGYLKSLKS 283
++ +P + L N L+ L L++L +
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 284 MDLSNNIFTGEIPASFAELKNLTLLNLFRNKLH 316
+ L N IP F L L N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 4e-09
Identities = 49/229 (21%), Positives = 73/229 (31%), Gaps = 49/229 (21%)
Query: 226 EIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMD 285
E+ ++S + + L+ +P D+ K +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--------------------------KDTTILH 37
Query: 286 LSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAI---------------------PEFIG 324
LS N+ A+ LT LNL R +L P
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQ 97
Query: 325 VMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLG 384
+P L VL + N T L G+L+ L L N+L P + L+ L
Sbjct: 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157
Query: 385 NFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDN 433
N L L ++L + + EN +IPKG FG L L N
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQEN-SLYTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 37/214 (17%), Positives = 56/214 (26%), Gaps = 8/214 (3%)
Query: 54 PGVTCDSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLR 113
P ++ NL+ AL PD+ + L ++ N L + + L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 114 LLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQ 173
LNL + L L LDL +N + L T S
Sbjct: 59 QLNLDR--AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-- 114
Query: 174 IPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSL 233
+P +P + T + N+ T + L +L
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 234 VRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNAL 267
L IP L FL N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 6e-06
Identities = 33/204 (16%), Positives = 66/204 (32%), Gaps = 24/204 (11%)
Query: 422 LPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGN 481
+ S +V LT + + + + LS N L A++ ++ + +L LD
Sbjct: 9 VASHLEVNCDKRNLTA---LPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 482 KFSGQIPAEIGKLQQLSKMDFSHNK---------------------FSGRIAPEISQCKL 520
+ + + + + + + +
Sbjct: 66 ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLS 580
L + L NEL P LT L L+L+ N+L + +++L ++ N+L
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
Query: 581 GLVPGTGQFSYFNYTSFLGNSELC 604
+ G + GN LC
Sbjct: 186 TIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.003
Identities = 15/65 (23%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 490 EIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLN 549
E+ K+ +++ + + P++ K T + LS N L L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 550 LSRNH 554
L R
Sbjct: 62 LDRAE 66
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 54.6 bits (130), Expect = 9e-09
Identities = 38/215 (17%), Positives = 72/215 (33%), Gaps = 27/215 (12%)
Query: 93 VAANQLSGPIP-PEI---SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTG 148
+ + ++ P P +I A + NL + ++L S+ + N+++
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS 60
Query: 149 DLPLAVTQLRNLRHLHLGGNFFSGQIP---------------PEYGIWEFLEYLAVSGNE 193
+ L N+ L L GN + P + + +
Sbjct: 61 VQGIQ--YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLS 118
Query: 194 LGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGR 253
L +I L L QL Y + + L+ L + +S +P +
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAG 176
Query: 254 LQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSN 288
L L L+L N +S L LK+L ++L +
Sbjct: 177 LTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 36/216 (16%), Positives = 63/216 (29%), Gaps = 21/216 (9%)
Query: 108 ALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGG 167
AL++ + + + + L + L + +T + V L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 168 NFF------SGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTG 221
N VS I T++ + S
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 222 GLPPEIGNLSSLVRFDAA-------NCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTE 274
L ++ ++++ T + L L TL N +S +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI--SP 190
Query: 275 LGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNL 310
L L +L + L NN + P A NL ++ L
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 7e-07
Identities = 27/227 (11%), Positives = 65/227 (28%), Gaps = 18/227 (7%)
Query: 278 LKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWEN 337
L + + + T + + A+L +T L+ F + E + + L L+L +N
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 338 NFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGK 397
T P + +L+ + + + L ++ +
Sbjct: 74 QITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 398 CDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNN 457
+ I + L + L + +N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 458 QLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSH 504
++S P + + ++ L N+ S P + L + ++
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 34/229 (14%), Positives = 74/229 (32%), Gaps = 20/229 (8%)
Query: 229 NLSSLVRFDAANCGLSGEIP-TDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLS 287
L++ ++ A ++ + D+ + L V + G + YL +L ++L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71
Query: 288 NNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRL 347
+N T P NL + + + + LQ + S
Sbjct: 72 DNQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 348 GSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMG 407
+ + L L+ ++
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 408 ENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSN 456
+N ++ P L LP+L +V L++N ++ P+++ + NL + L+N
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSPLAN--TSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 15/56 (26%), Positives = 29/56 (51%), Gaps = 4/56 (7%)
Query: 88 LQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYN 143
L L N++S P +++L +L ++L NN + P L+ ++L ++ L N
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 4/63 (6%)
Query: 103 PPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRH 162
++ LS L L +N + P L+ L +L + L NN ++ PLA NL
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFI 221
Query: 163 LHL 165
+ L
Sbjct: 222 VTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 27/220 (12%), Positives = 53/220 (24%), Gaps = 18/220 (8%)
Query: 332 LQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPI 391
+ ++N T ++ Q + L +T + N L L N +
Sbjct: 24 IAAGKSNVTDTVTQADLDG--ITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA 79
Query: 392 PESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQ 451
P + + +I ++D +
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQS----------IKTLDLTSTQITDVTPLAGLS 129
Query: 452 ICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRI 511
+ L + L +L+ + NK S
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-- 187
Query: 512 APEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLS 551
++ L V L N++S P L L + L+
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 38/246 (15%), Positives = 71/246 (28%), Gaps = 43/246 (17%)
Query: 123 NGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWE 182
N FP LA+ + +N+T + A L + L G +
Sbjct: 10 NVIFP--DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT----------- 54
Query: 183 FLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCG 242
I G + L L L + + NL+ + + +
Sbjct: 55 --------------TIEG-VQYLNNLIGLELKDNQITD---LAPLKNLTKITELELSGNP 96
Query: 243 LSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAEL 302
L + L PL L ++ + A L
Sbjct: 97 LKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL------QVLYLDLNQITNISPLAGL 150
Query: 303 KNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNK 362
NL L++ ++ + + +L L+ +N + P L S L + L +N+
Sbjct: 151 TNLQYLSIGNAQVS--DLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206
Query: 363 LTGTLP 368
++ P
Sbjct: 207 ISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 11/40 (27%), Positives = 21/40 (52%), Gaps = 2/40 (5%)
Query: 80 PDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSN 119
+A L L + + NQ+S P ++ S+L ++ L+N
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 6e-08
Identities = 15/92 (16%), Positives = 29/92 (31%), Gaps = 10/92 (10%)
Query: 280 SLKSMDLSNNIFTGE-IPASFAELKNLTLLNLFRNKLHG----AIPEFIGVMPRLEVLQL 334
++S+D+ + L+ ++ L L I + V P L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 335 WENNFTGSIPQRLGS-----NGKLRILDLSSN 361
N + + K++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 1e-07
Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 7/87 (8%)
Query: 304 NLTLLNLFRNKL-HGAIPEFIGVMPRLEVLQLWENNFTG----SIPQRLGSNGKLRILDL 358
++ L++ +L E + ++ + +V++L + T I L N L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 359 SSNKLTGTLPPDMCAG--NCLQTLITL 383
SN+L + G + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKL 89
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 9e-07
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 10/93 (10%)
Query: 64 VTSLDLSGLNLSGALSPDVA-HLRFLQNLSVAANQLSG----PIPPEISALSSLRLLNLS 118
+ SLD+ LS A ++ L+ Q + + L+ I + +L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 119 NNVFNGSFPPQLSQL-----ASLQVLDLYNNNM 146
+N + Q +Q L L N +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 12/72 (16%), Positives = 25/72 (34%), Gaps = 5/72 (6%)
Query: 111 SLRLLNLSNNVFNGSFPPQL-SQLASLQVLDLYNNNMTGD----LPLAVTQLRNLRHLHL 165
++ L++ + + +L L QV+ L + +T + A+ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 166 GGNFFSGQIPPE 177
N
Sbjct: 63 RSNELGDVGVHC 74
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 9/86 (10%)
Query: 470 FSGVQKLLLDGNKFSGQ----IPAEIGKLQQLSKMDFSHNKFSGRIAPEISQ-----CKL 520
S ++ L L S + A + L ++D S+N ++ + L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 521 LTFVDLSRNELSGEIPNQLTGMRILN 546
L + L S E+ ++L +
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 11/93 (11%), Positives = 31/93 (33%), Gaps = 5/93 (5%)
Query: 446 SVNLGQICLSNNQLSGS-LPASIGKFSGVQKLLLDGNKFSGQ----IPAEIGKLQQLSKM 500
S+++ + + +LS + + Q + LD + I + + L+++
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 501 DFSHNKFSGRIAPEISQCKLLTFVDLSRNELSG 533
+ N+ + Q + + L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 19/75 (25%), Positives = 31/75 (41%), Gaps = 9/75 (12%)
Query: 110 SSLRLLNLSNNVFNG----SFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQ-----LRNL 160
S LR+L L++ + S L SL+ LDL NN + L + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 161 RHLHLGGNFFSGQIP 175
L L ++S ++
Sbjct: 429 EQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 16/90 (17%), Positives = 25/90 (27%), Gaps = 5/90 (5%)
Query: 497 LSKMDFSHNKFSGRIAPEI-SQCKLLTFVDLSRNELSGE----IPNQLTGMRILNYLNLS 551
+ +D + S E+ + V L L+ I + L L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 552 RNHLVGSIPASIASMQSLTSVDFSYNNLSG 581
N L + S +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 16/109 (14%), Positives = 34/109 (31%), Gaps = 13/109 (11%)
Query: 44 WNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSG----ALSPDVAHLRFLQNLSVAANQLS 99
+ L L+ ++S +L+ + L+ L ++ N L
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410
Query: 100 GPIPPEISA-----LSSLRLLNLSNNVFNGSFPPQLSQLA----SLQVL 139
++ L L L + ++ +L L SL+V+
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 15/88 (17%), Positives = 29/88 (32%), Gaps = 5/88 (5%)
Query: 473 VQKLLLDGNKFSGQIPAEI-GKLQQLSKMDFSHNKFSGR----IAPEISQCKLLTFVDLS 527
+Q L + + S AE+ LQQ + + I+ + L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 528 RNELSGEIPNQLTGMRILNYLNLSRNHL 555
NEL + + + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 10/86 (11%)
Query: 88 LQNLSVAANQLSG----PIPPEISALSSLRLLNLSNNVFNGSFPPQLSQ-----LASLQV 138
L+ L +A +S + + A SLR L+LSNN + QL + L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 139 LDLYNNNMTGDLPLAVTQLR-NLRHL 163
L LY+ + ++ + L + L
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 29/111 (26%)
Query: 255 QNLDTLFLQVNALSG----PLTTELGYLKSLKSMDLSNNIFTGEIPASFAE-LKNLTLLN 309
L L+L +S L L SL+ +DLSNN E ++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL- 427
Query: 310 LFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLG----SNGKLRIL 356
LE L L++ ++ + RL LR++
Sbjct: 428 -------------------LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 14/82 (17%), Positives = 26/82 (31%), Gaps = 9/82 (10%)
Query: 495 QQLSKMDFSHNKFSGR----IAPEISQCKLLTFVDLSRNELSGEIPNQLTG-----MRIL 545
L + + S +A + L +DLS N L QL +L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 546 NYLNLSRNHLVGSIPASIASMQ 567
L L + + + +++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 15/92 (16%), Positives = 31/92 (33%), Gaps = 13/92 (14%)
Query: 229 NLSSLVRFDAANCGLSGEIPTDI-GRLQNLDTLFLQVNALSG----PLTTELGYLKSLKS 283
++ SL D LS ++ LQ + L L+ +++ L +L
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 284 MDLSNNIFTGEIPASFAEL-----KNLTLLNL 310
++L +N + + L+L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 19/79 (24%), Positives = 31/79 (39%), Gaps = 9/79 (11%)
Query: 326 MPRLEVLQLWENNFTG----SIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAG----NC- 376
L VL L + + + S+ L +N LR LDLS+N L + C
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 377 LQTLITLGNFLFGPIPESL 395
L+ L+ + + + L
Sbjct: 428 LEQLVLYDIYWSEEMEDRL 446
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 7e-08
Identities = 27/108 (25%), Positives = 39/108 (36%), Gaps = 6/108 (5%)
Query: 259 TLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGA 318
L L L+ L L + +DLS+N P + A L+ L +L N L
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 319 IPEFIGVMPRLEVLQLWENNFTG-SIPQRLGSNGKLRILDLSSNKLTG 365
+ L L N + Q L S +L +L+L N L
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 1e-06
Identities = 21/110 (19%), Positives = 40/110 (36%), Gaps = 6/110 (5%)
Query: 474 QKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSG 533
+ L L + + + +L ++ +D SHN+ P ++ + L + S N L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALEN 57
Query: 534 EIPNQLTGMRILNYLNLSRNHLVG-SIPASIASMQSLTSVDFSYNNLSGL 582
+ L L L N L + + S L ++ N+L
Sbjct: 58 VDGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 5e-06
Identities = 25/107 (23%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 67 LDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSF 126
L L+ +L+ + L + +L ++ N+L PP ++AL L +L +
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ--ASDNALEN 57
Query: 127 PPQLSQLASLQVLDLYNNNMTG-DLPLAVTQLRNLRHLHLGGNFFSG 172
++ L LQ L L NN + + L L+L GN
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 21/128 (16%), Positives = 43/128 (33%), Gaps = 8/128 (6%)
Query: 137 QVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196
+VL L + ++T + QL + HL L N P + + ++
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNAL 55
Query: 197 KIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAAN---CGLSGEIPTDIGR 253
+ + NL +LQ+L + + + LV + C G
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 254 LQNLDTLF 261
L ++ ++
Sbjct: 116 LPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 7/113 (6%)
Query: 224 PPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKS 283
+ L + D ++ L P + L+ L+ L NAL L L+
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVA--NLPRLQE 69
Query: 284 MDLSNN-IFTGEIPASFAELKNLTLLNLFRNKLHGA---IPEFIGVMPRLEVL 332
+ L NN + L LLNL N L ++P + +
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 23/123 (18%), Positives = 42/123 (34%), Gaps = 6/123 (4%)
Query: 331 VLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGP 390
VL L + T + L + LDLS N+L P + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNALE 56
Query: 391 IPESLGKCDSLSRMRMGENFLNG-SIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNL 449
+ + L + + N L + + L P L + LQ N L + + + ++ L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 450 GQI 452
+
Sbjct: 117 PSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 4e-04
Identities = 23/97 (23%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
+ + +L + L L N L L L+ L+ + + E A L L
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ--ASDNALENVDGVANLPRL 67
Query: 306 TLLNLFRNKL-HGAIPEFIGVMPRLEVLQLWENNFTG 341
L L N+L A + + PRL +L L N+
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 24/145 (16%), Positives = 45/145 (31%), Gaps = 31/145 (21%)
Query: 354 RILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNG 413
R+L L+ LT + L + ++ + + N L
Sbjct: 1 RVLHLAHKDLT--------------------------VLCHLEQLLLVTHLDLSHNRLRA 34
Query: 414 SIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQL-SGSLPASIGKFSG 472
P L L L ++ DN + + L ++ L NN+L + +
Sbjct: 35 LPP-ALAALRCLEVLQASDNA--LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 91
Query: 473 VQKLLLDGNKFSGQIPAEIGKLQQL 497
+ L L GN +L ++
Sbjct: 92 LVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 9/95 (9%)
Query: 261 FLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIP 320
+NA S + + SL+ +++SNN E+PA L L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHL-AEVP 320
Query: 321 EFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRI 355
E L+ L + N P S LR+
Sbjct: 321 ELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 6e-07
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 9/94 (9%)
Query: 116 NLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIP 175
N + SL+ L++ NN + +LP L L N + ++P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVP 320
Query: 176 PEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQ 209
L+ L V N L + P ++ L+
Sbjct: 321 ELPQN---LKQLHVEYNPL-REFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 9e-07
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 9/86 (10%)
Query: 284 MDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSI 343
N + EI + +L LN+ NKL +P PRLE L N+ +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EV 319
Query: 344 PQRLGSNGKLRILDLSSNKLTGTLPP 369
P+ + L+ L + N L P
Sbjct: 320 PELPQN---LKQLHVEYNPLR-EFPD 341
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 21/83 (25%), Positives = 30/83 (36%), Gaps = 8/83 (9%)
Query: 500 MDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSI 559
+ N S I L +++S N+L E+P L L S NHL +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEV 319
Query: 560 PASIASMQSLTSVDFSYNNLSGL 582
P Q+L + YN L
Sbjct: 320 PELP---QNLKQLHVEYNPLREF 339
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 21/81 (25%), Positives = 31/81 (38%), Gaps = 9/81 (11%)
Query: 96 NQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVT 155
N S I SL LN+SNN P L+ L N++ ++P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP---E 321
Query: 156 QLRNLRHLHLGGNFFSGQIPP 176
+NL+ LH+ N + P
Sbjct: 322 LPQNLKQLHVEYNPLR-EFPD 341
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 16/80 (20%), Positives = 34/80 (42%), Gaps = 8/80 (10%)
Query: 430 LQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPA 489
N + + + +L ++ +SNN+L LPA + +++L+ N + ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE 321
Query: 490 EIGKLQQLSKMDFSHNKFSG 509
L+QL +N
Sbjct: 322 LPQNLKQL---HVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 7e-05
Identities = 19/99 (19%), Positives = 37/99 (37%), Gaps = 11/99 (11%)
Query: 212 YIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPL 271
+ Y N+ + + SL + +N L E+P RL+ L S
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI--------ASFNH 315
Query: 272 TTEL-GYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLN 309
E+ ++LK + + N E P +++L + +
Sbjct: 316 LAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 48/326 (14%), Positives = 89/326 (27%), Gaps = 27/326 (8%)
Query: 223 LPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLK 282
LP +L SL A+ L+ E+P L++L + ALS L L YL
Sbjct: 53 LPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLEYLGVSN 107
Query: 283 SMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGS 342
+ ++ N +L L T
Sbjct: 108 NQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAI 167
Query: 343 IPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLS 402
+ + + G + +T + SL
Sbjct: 168 YADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE 227
Query: 403 RMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGS 462
+ + +N+L Q S L N S
Sbjct: 228 ALNVRDNYLTDLPELP------------QSLTFLDVSENIFSGLSELPPNLYYLNASSNE 275
Query: 463 LPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLT 522
+ + +++L + NK ++PA +L++L S N + + L
Sbjct: 276 IRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQN---LK 327
Query: 523 FVDLSRNELSG--EIPNQLTGMRILN 546
+ + N L +IP + +R+ +
Sbjct: 328 QLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (114), Expect = 5e-07
Identities = 27/133 (20%), Positives = 49/133 (36%), Gaps = 12/133 (9%)
Query: 88 LQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMT 147
++ L P++ A + +LN +++ + + L L+L NN +
Sbjct: 22 GSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY 78
Query: 148 G--DLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGE---- 201
D+ V + NL+ L+L GN + + LE L + GN L +
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138
Query: 202 ---IGNLTKLQQL 211
KL +L
Sbjct: 139 SAIRERFPKLLRL 151
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 3e-06
Identities = 26/115 (22%), Positives = 43/115 (37%), Gaps = 7/115 (6%)
Query: 63 HVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNN-- 120
+LDL GL PD+ L+ ++ + + + L LNLSNN
Sbjct: 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRL 77
Query: 121 VFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSGQIP 175
+ + +L++L+L N + + L + L L L GN S
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 4e-06
Identities = 21/125 (16%), Positives = 41/125 (32%), Gaps = 5/125 (4%)
Query: 246 EIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNL 305
++ + + + L + L +L ++ +++ + + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 306 TLLNLFRNKL--HGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKL 363
LNL N+L + + P L++L L N KL L L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 364 TGTLP 368
+ T
Sbjct: 128 SDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 4e-04
Identities = 27/155 (17%), Positives = 53/155 (34%), Gaps = 14/155 (9%)
Query: 342 SIPQRLGS--NGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCD 399
+ + +G + LDL + PD+ A N L + + +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRS----DPDLVAQNIDVVL-NRRSSMAATLRIIEENIP 65
Query: 400 SLSRMRMGENFLNG--SIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLSNN 457
L + + N L + + P+L + L N L + + + L ++ L N
Sbjct: 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125
Query: 458 QLSGSLPASIGKFSGVQKLL-----LDGNKFSGQI 487
LS + S +++ LDG++ I
Sbjct: 126 SLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 22/138 (15%), Positives = 42/138 (30%), Gaps = 6/138 (4%)
Query: 454 LSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAP 513
L Q+ L + K + LD + ++ ++ + + +
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSS-MAATLRI 59
Query: 514 EISQCKLLTFVDLSRNELSG--EIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTS 571
L ++LS N L ++ + + L LNLS N L L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 572 VDFSYNNLSGLVPGTGQF 589
+ N+LS +
Sbjct: 120 LWLDGNSLSDTFRDQSTY 137
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.004
Identities = 21/118 (17%), Positives = 41/118 (34%), Gaps = 10/118 (8%)
Query: 224 PPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSG--PLTTELGYLKSL 281
P++ + V + + ++ + + L +L L N L +++ + +L
Sbjct: 35 DPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNL 93
Query: 282 KSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEF-------IGVMPRLEVL 332
K ++LS N E + L L L N L + P+L L
Sbjct: 94 KILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.8 bits (104), Expect = 1e-05
Identities = 28/183 (15%), Positives = 62/183 (33%), Gaps = 9/183 (4%)
Query: 111 SLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQL-RNLRHLHLGGNF 169
++ + P + L L +N + + +L L L N
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 170 FSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGN 229
+G P + ++ L + N++ L +L+ L + Y N + +P +
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL-YDNQISCVMPGSFEH 124
Query: 230 LSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNN 289
L+SL + A+ + + L L A ++ ++ ++ DL ++
Sbjct: 125 LNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHS 180
Query: 290 IFT 292
F
Sbjct: 181 EFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 5e-05
Identities = 33/167 (19%), Positives = 56/167 (33%), Gaps = 6/167 (3%)
Query: 198 IPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNL 257
IP +I +L + G L LV+ + L+G P ++
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 258 DTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG 317
L L N + L LK+++L +N + +P SF L +LT LN +
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFN 139
Query: 318 AIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLT 364
L L P ++ ++I DL ++
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 39/168 (23%), Positives = 63/168 (37%), Gaps = 12/168 (7%)
Query: 50 HCTWPGVTCDSRR----------HVTSLDLSGLNLSGAL-SPDVAHLRFLQNLSVAANQL 98
HC V C R H T L L+ L L L L + NQL
Sbjct: 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 99 SGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLR 158
+G P S ++ L L N L L+ L+LY+N ++ +P + L
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 159 NLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLT 206
+L L+L N F+ + E+L +++G P ++ ++
Sbjct: 127 SLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKVRDVQ 173
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 37/313 (11%), Positives = 75/313 (23%), Gaps = 32/313 (10%)
Query: 301 ELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTG----SIPQRLGSNGKLRIL 356
E K+L L + ++ + ++ + L N + + + S L I
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 357 DLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIP 416
+ S A L + L + + + +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 417 KGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICL---SNNQLSGSLPASIGKFSGV 473
L Q + + N + N+L K
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 474 QKLLLDGNKFSGQIPAEIGK-------------LQQLSKMDFSHNKFSGRIAPEISQCKL 520
+LL I E + + + + S +A +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 521 LTFVDLSRNELSGEIPNQLTGM------RILNYLNLSRNHLVGSIPASIAS-----MQSL 569
L + L+ LS + L L L N + ++ + M L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 570 TSVDFSYNNLSGL 582
++ + N S
Sbjct: 305 LFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 43/322 (13%), Positives = 85/322 (26%), Gaps = 33/322 (10%)
Query: 279 KSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHG----AIPEFIGVMPRLEVLQL 334
KSLK ++ + A E ++ + L N + + E I LE+ +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 335 WENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDM-CAGNCLQTLITLGNFLFGPIPE 393
+ + + L L KL D + LI +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 394 SLGKCDSLSRM--RMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPV---------- 441
L + ++ ++ K P L + N L
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 442 ---SDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLS 498
+ + N + + L L + + S + + L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 499 KMDFSHNKFSGRIAPEISQC------KLLTFVDLSRNELSGEIPNQL-----TGMRILNY 547
++ + S R A + L + L NE+ + L M L +
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 548 LNLSRNHLVGSIPASIASMQSL 569
L L+ N + ++ +
Sbjct: 307 LELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 40/321 (12%), Positives = 79/321 (24%), Gaps = 32/321 (9%)
Query: 111 SLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGD----LPLAVTQLRNLRHLHLG 166
SL+L ++ S L + S++ + L N + + L + ++L
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 167 GNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQL--YIGYYNSYTGGLP 224
F L + +L + Q+ ++ L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 225 PEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALS----GPLTTELGYLKS 280
L A + L ++ N L +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 281 LKSMDLSNNIFTGEIPASFAELKNLTLLNL---------FRNKLHGAIPEFIGVMPRLEV 331
L ++ + N E L F + A+ + P L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 332 LQLWENNFTGSIPQRLG------SNGKLRILDLSSNKLTGTLP---PDMCAGNC--LQTL 380
L L + + + N L+ L L N++ + L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 381 ITLGNFLFGPIPESLGKCDSL 401
GN F + + + +
Sbjct: 308 ELNGNR-FSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 13/76 (17%), Positives = 22/76 (28%), Gaps = 12/76 (15%)
Query: 96 NQLSGPIPPEIS------ALSSLRLLNLSNNVFNGSFPPQL-----SQLASLQVLDLYNN 144
LS + L+ L L N L ++ L L+L N
Sbjct: 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 312
Query: 145 NMTGDLPLAVTQLRNL 160
+ V ++R +
Sbjct: 313 RF-SEEDDVVDEIREV 327
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 32/202 (15%), Positives = 61/202 (30%), Gaps = 17/202 (8%)
Query: 107 SALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLG 166
+AL+ L + L + L + + V L NL ++
Sbjct: 15 TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFS 70
Query: 167 GNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPE 226
N + + + + + N + NLT L L +
Sbjct: 71 NNQLTDI----TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126
Query: 227 IGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDL 286
+ NL+ L +S + N + + L L +L+ +D+
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-------LKPLANLTTLERLDI 179
Query: 287 SNNIFTGEIPASFAELKNLTLL 308
S+N + + A+L NL L
Sbjct: 180 SSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 27/195 (13%), Positives = 56/195 (28%), Gaps = 22/195 (11%)
Query: 80 PDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVL 139
D A L + ++ + + L + L + L +L +
Sbjct: 13 TDTA-LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQI 67
Query: 140 DLYNNNMTGDLPLA--------------VTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLE 185
+ NN +T PL + + L +L
Sbjct: 68 NFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127
Query: 186 YLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSG 245
I + + ++ L P + NL++L R D ++ +S
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKVSD 186
Query: 246 EIPTDIGRLQNLDTL 260
+ + +L NL++L
Sbjct: 187 --ISVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 8e-05
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 3/108 (2%)
Query: 278 LKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWEN 337
+ +DL I A L ++ N++ + ++ RL+ L + N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73
Query: 338 NFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGN 385
+ L L L++N L D A T + +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 121
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 8e-04
Identities = 20/137 (14%), Positives = 40/137 (29%), Gaps = 7/137 (5%)
Query: 79 SPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQV 138
+ + + L + ++ I + L ++ S+N L L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKT 67
Query: 139 LDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFFSG-QIPPEYGIWEFLEYLAVSG---NEL 194
L + NN + L +L L L N + L YL +
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 195 GGKIPGEIGNLTKLQQL 211
I + +++ L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 26/228 (11%), Positives = 55/228 (24%), Gaps = 6/228 (2%)
Query: 111 SLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNFF 170
S R+ + P L + L + A + +L + + N
Sbjct: 9 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 171 SGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPE---I 227
I + + Y+ N+ LP
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 228 GNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLS 287
L+ + E + +G L+L N + + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 288 NNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLW 335
NN F +L++ R ++H + + +L +
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 27/216 (12%), Positives = 50/216 (23%), Gaps = 5/216 (2%)
Query: 102 IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLR 161
IP ++ + L S L+ +++ N++ + V
Sbjct: 23 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 162 HLHLG---GNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNS 218
H N + L + +I +L K+ N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 219 YTGGLPPEIGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYL 278
+T +G V G+ Q + N L
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 279 KSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNK 314
+D+S LK L + + K
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 32/226 (14%), Positives = 57/226 (25%), Gaps = 9/226 (3%)
Query: 331 VLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGP 390
V E+ T IP L N L KL + +G I +
Sbjct: 12 VFLCQESKVT-EIPSDLPRN--AIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLE 67
Query: 391 IPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTG-----QFPVSDSI 445
+ E+ + + N + +L ++ TG S+
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 446 SVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHN 505
L I + N + + +G L L+ N Q +N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 506 KFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLS 551
+D+SR + L ++ L +
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 13/101 (12%), Positives = 24/101 (23%)
Query: 44 WNATTSHCTWPGVTCDSRRHVTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIP 103
+ H L L+ + + + + N L
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194
Query: 104 PEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNN 144
S +L++S + L L L+ YN
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 18/138 (13%), Positives = 33/138 (23%), Gaps = 2/138 (1%)
Query: 304 NLTLLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSN-GKLRILDLSSNK 362
+ L R+ + L L + + R G+LR L + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 363 LTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGL 422
L P L L N L +++ + G + L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127
Query: 423 PSLSQVELQDNYLTGQFP 440
+ + L
Sbjct: 128 EEEGLGGVPEQKLQCHGQ 145
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 20/120 (16%), Positives = 39/120 (32%), Gaps = 2/120 (1%)
Query: 495 QQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIP-NQLTGMRILNYLNLSRN 553
S + + + + + LT + + + + L G+ L L + ++
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 554 HLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCGPYLGPCKD 613
L P + L+ ++ S+N L L T Q GN C L +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 17/90 (18%), Positives = 28/90 (31%), Gaps = 2/90 (2%)
Query: 104 PEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQ-LRNLRH 162
P+ L + + L +L L + N L L + L LR+
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 163 LHLGGNFFSGQIPPEYGIWEFLEYLAVSGN 192
L + + P + L L +S N
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1010 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.95 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.9 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.84 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.84 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.83 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.76 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.71 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.7 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.64 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.59 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 99.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 99.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.81 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.97 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.82 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.67 Aligned_cols=263 Identities=29% Similarity=0.442 Sum_probs=214.6
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 25677677474308389999993699899999901688999763106999999850478630124426752894189998
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 762 (1010)
.+.|+..+.||+|+||+||+|+++ ..||||+++.........+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 22899987561247789888446999999999995687514999658515778928976899659900134311467998
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 842 (1010)
|+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 58998889998523-578999999999999999988875099---95161478997981899788750022133355677
Q ss_pred CCEEEEECCCCCCCCHHHHCCC---CCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 5100000253333681311149---9886376522669999989299988899997529999999831011230001499
Q 001816 843 SECMSAIAGSYGYIAPEYAYTL---KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDP 919 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (1010)
........||+.|||||++.+. .|+.++|||||||++|||+||+.||.+..........+.. . ...+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~---~-------~~~p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR---G-------YLSP 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH---T-------SCCC
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC---C-------CCCC
T ss_conf 63125665574317999995056899995315163599999999788998998969999999965---8-------8898
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9999997889999999984116598899999999999833999
Q 001816 920 RLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 920 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 962 (1010)
.....+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 6000365554999999999758897689299999999999997
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.95 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=209.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf 25677677474308389999993-69989999990168899976310699999985047863012442675289418999
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|++.+.||+|+||+||+|+. .+|+.||||++...... ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEE
T ss_conf 74608998972174809999999999979999998456641-27999999999998579988846965404674367988
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82289998756124778988844699999999999568751499965851577892897689965990013431146799
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 841 (1010)
||+++|+|.+++. ..+.+++.++..++.|++.|++|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 83 EYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp ECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ECCCCCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 6458980899975--3799999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCEEEEECCCCCCCCHHHHCCCCC-CCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 8510000025333368131114998-863765226699999892999888999975299999998310112300014999
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
........+||+.|||||++.+..+ +.++||||+||++|||++|+.||....+.......... . +.
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~---~----------~~ 224 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---K----------KT 224 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT---T----------CT
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC---C----------CC
T ss_conf 6531113255747428728618999997101617379999998299788889859999999863---8----------88
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999997889999999984116598899999999999
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
........+..+.+++.+|++.||++|||++|++++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 788644699999999999767996689099999619
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.36 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=211.7
Q ss_pred CCCCCCCEEEECCCEEEEEEEECC-C-----CEEEEEEECCCCCCCCCCCCHHHHHHHHHCC-CCCCCCEEEEEEECCCC
Q ss_conf 567767747430838999999369-9-----8999999016889997631069999998504-78630124426752894
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-G-----DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 756 (1010)
+.|++.+.||+|+||+||+|++.. + ..||+|.+..... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 99397019830788199999985788554204999999663358-78999999999999971589968687788862995
Q ss_pred CEEEEEECCCCCHHHHHCCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCC
Q ss_conf 1899982289998756124778---------------------9888446999999999995687514999658515778
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKG---------------------GHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKS 815 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp 815 (1010)
.|+||||+++|+|.++++.... ..+++..++.++.|++.|++|||+.+ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997399---05052703
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 928976899659900134311467998510000025333368131114998863765226699999892-9998889999
Q 001816 816 NNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGD 894 (1010)
Q Consensus 816 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~ 894 (1010)
+||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred CCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 7529999999831011230001499999999788999999998411659889999999999983
Q 001816 895 GVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~ 958 (1010)
.......+.. . ..+..+...+..+.+++.+||+.||++|||++||+++|.
T Consensus 273 ~~~~~~~~~~---~-----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANFYKLIQN---G-----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHHHHHHHT---T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHC---C-----------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9999999856---9-----------989988767899999999975889668939999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=375.49 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=213.5
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf 256776774743083899999936-9989999990168899976310699999985047863012442675289418999
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|+..+.||+|+||+||+|.+. +|+.||||+++... ...+.|.+|++++++++||||+++++++.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC---CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 799398659820888089999999999699999977761---03999999999998679998826775274578547876
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82289998756124778988844699999999999568751499965851577892897689965990013431146799
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 841 (1010)
||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 3146760677753035541579999999999999788898789---3057604576899899928983244546537887
Q ss_pred CCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 85100000253333681311149988637652266999998929998889999752999999983101123000149999
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
........|++.|+|||++.+..|+.++||||||+++|||++|..||....+.....+.+ ... ..
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i---~~~-----------~~ 234 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EKD-----------YR 234 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HTT-----------CC
T ss_pred -CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---HCC-----------CC
T ss_conf -221035566546669278727999810430217899999986799887742599999998---558-----------88
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 999978899999999841165988999999999998339999
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 922 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 963 (1010)
+..+...+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 888743309999999997577976893999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.95 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=208.8
Q ss_pred CCCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
Q ss_conf 11025677677474308389999993-69989999990168899976310699999985047863012442675289418
Q 001816 680 DDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 680 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 758 (1010)
.+..++|+..+.||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|++++++++||||+++++++.+++..|
T Consensus 16 ~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp SCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCCCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf 99510538878981285829999999899989999998430172--7999999999998679998805857798899989
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99982289998756124778988844699999999999568751499965851577892897689965990013431146
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 838 (1010)
+||||++||+|.+++.+ ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEECCCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEEC
T ss_conf 99970379808988641---59999999999999999999999879---7226776888688789968642515641321
Q ss_pred CCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 79985100000253333681311149988637652266999998929998889999752999999983101123000149
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....... ........
T Consensus 168 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~~-------- 233 (293)
T d1yhwa1 168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNGT-------- 233 (293)
T ss_dssp STT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHHCS--------
T ss_pred CCC--CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHCCC--------
T ss_conf 366--6444444477736826644799880120313729999980488998997999999----99985799--------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 99999997889999999984116598899999999999
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 919 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
+. ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 234 PE-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CC-CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 98-88855379999999999866996689099999649
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.99 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=208.6
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
Q ss_conf 56776774743083899999936998999999016889997631069999998504786301244267528941899982
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.|+..+.||+|+||+||+|++.+++.||||+++.. ....+.|.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC---CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEE
T ss_conf 995888898208882999999889999999998788---67689999999999966899756535243159933799983
Q ss_pred CCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 28999875612477898884469999999999956875149996585157789289768996599001343114679985
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 843 (1010)
+++|+|.+++.. ....+++..+..++.|++.||.|+|+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~- 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 156 (263)
T ss_dssp CTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC-
T ss_conf 699918997520-1347889999999999999877653164---31044315326666887768655321002368873-
Q ss_pred CEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 10000025333368131114998863765226699999892999888999975299999998310112300014999999
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPS 923 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (1010)
.......||+.|+|||++.+..|+.++||||||+++|||+|+..|+......... ...+... ..+.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~~-----------~~~~ 222 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTG-----------FRLY 222 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HHHHHHT-----------CCCC
T ss_pred EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHHC-----------CCCC
T ss_conf 3504300176667857860799984033210599999998789888778999999---9999806-----------8889
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 99788999999998411659889999999999983399
Q 001816 924 VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 924 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 961 (1010)
.|...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 95436799999999976579768919999999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.41 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=208.0
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 25677677474308389999993699899999901688999763106999999850478630124426752894189998
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 762 (1010)
.+.|+..+.||+|+||+||+|.++++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEE
T ss_conf 89938867981079828999999999999999986476---888999999999986799988578731045-97699999
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 22899987561247789888446999999999995687514999658515778928976899659900134311467998
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 842 (1010)
|+++|+|.+++.......+++..+..++.||++|+.|||+.+ |+||||||+||+++.++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC-
T ss_conf 578982888875147898878899999999999999997489---5467564225156202440423410147735886-
Q ss_pred CCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 51000002533336813111499886376522669999989299988899997529999999831011230001499999
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
........|++.|+|||++.+..++.++||||||+++|||+||..|+.......+..+ .+... ..+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---~i~~~-----------~~~ 229 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLERG-----------YRM 229 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTT-----------CCC
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHHC-----------CCC
T ss_conf 4420356774444582898379998245645257999999968988888889999999---99706-----------888
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 99978899999999841165988999999999998339
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 923 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~ 960 (1010)
..+...+..+.+++.+||+.||++|||++||++.|+++
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 89655719999999997588976893999999986113
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=376.11 Aligned_cols=261 Identities=25% Similarity=0.445 Sum_probs=210.3
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC-CC---EEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
Q ss_conf 2567767747430838999999369-98---9999990168899976310699999985047863012442675289418
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN-GD---QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 758 (1010)
.+.|+..+.||+|+||+||+|.++. ++ .||||++..... ....+.|.+|++++++++|||||++++++.+++..+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 0042785698027882999999957997889999999784459-899999999999998579988861899996288779
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99982289998756124778988844699999999999568751499965851577892897689965990013431146
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 838 (1010)
+||||+++|+|.+++.. ..+.+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEECCCCCCEEEECC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 99972279853002104-5679999999999999999889885279---8357615044898899919988844315756
Q ss_pred CCCCCC---EEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 799851---0000025333368131114998863765226699999892-999888999975299999998310112300
Q 001816 839 DSGTSE---CMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 839 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
...... ......|++.|||||++.+..++.++|||||||++|||+| |+.||.+... .+....+...
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~~~~~i~~~------ 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAIEQD------ 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTT------
T ss_pred CCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH----HHHHHHHHCC------
T ss_conf 777765365025666883003878883699786121445357899998679999999999----9999999737------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 0149999999978899999999841165988999999999998339999
Q 001816 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 963 (1010)
..+..+...+..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 250 -----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 -----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf -----88999742269999999997587976892999999999998418
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.87 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=208.8
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEEC--CCCCEE
Q ss_conf 25677677474308389999993-699899999901688999763106999999850478630124426752--894189
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN--HETNLL 759 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 759 (1010)
.+.|++.+.||+|+||+||+|+. .+|+.||+|++..........+.+.+|++++++++||||+++++++.+ ++..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 9982289998756124--77898884469999999999956875149--9965851577892897689965990013431
Q 001816 760 VYEYMPNGSLGEVLHG--KKGGHLHWDTRYKIAVEAAKGLCYLHHDC--SPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~ 835 (1010)
||||+++|+|.+++.. .....+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf 14679985100000253333681311149988637652266999998929998889999752999999983101123000
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK 915 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (1010)
.+.... .......||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+....+...
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----~~~~~~i~~~------- 229 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREG------- 229 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHT-------
T ss_pred ECCCCC--CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH----HHHHHHHHCC-------
T ss_conf 224577--755667788232799998399999389887527899998018899899899----9999999718-------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 14999999997889999999984116598899999999999
Q 001816 916 ILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
..+..+...+..+.+++.+||+.||++|||++|++++
T Consensus 230 ----~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 230 ----KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf ----9988974359999999999767995579189999729
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.57 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=207.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf 25677677474308389999993-69989999990168899976310699999985047863012442675289418999
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|+..+.||+|+||+||+|+. .+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 5688897897127780999999989996999999875409-789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 82289998756124778988844699999999999568751-49996585157789289768996599001343114679
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 840 (1010)
||++||+|.+++.+ .+.+++..+..++.|++.|+.|||+ ++ |+||||||+|||++.++.+||+|||+|+...+.
T Consensus 84 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp ECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 76799868998742--4999999999999999999999998599---971445779946878998999548776256788
Q ss_pred CCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCC---------
Q ss_conf 98510000025333368131114998863765226699999892999888999975299999998310112---------
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE--------- 911 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--------- 911 (1010)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...........+..........
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf ----6211137714119468758998948889989999999998889989988789999998875177545774212333
Q ss_pred ------------------CCCCCCCCCCCCCC-HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ------------------30001499999999-7889999999984116598899999999999
Q 001816 912 ------------------GVLKILDPRLPSVP-LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 912 ------------------~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
..........+..+ ...+..+.+++.+|+..||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 2211112223541347788766502687667644489999999999868994679089999609
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.33 Aligned_cols=253 Identities=24% Similarity=0.308 Sum_probs=206.3
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf 25677677474308389999993-69989999990168899976310699999985047863012442675289418999
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 761 (1010)
.+.|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 037598479930778199999999999399999987289--999999999999998679999884988980099589999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82289998756124778988844699999999999568751499965851577892897689965990013431146799
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 841 (1010)
||+++|+|.+++.+ ..+.+++.++..++.|++.|+.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp ECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred ECCCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-
T ss_conf 62799818899986-2899999999999999999999999889---887140700314878999899716123035778-
Q ss_pred CCCEEEEECCCCCCCCHHHHC-----CCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 851000002533336813111-----499886376522669999989299988899997529999999831011230001
Q 001816 842 TSECMSAIAGSYGYIAPEYAY-----TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
........||+.|+|||++. +..|+.++||||+||++|||++|+.||.+............ .
T Consensus 164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~----~-------- 230 (288)
T d2jfla1 164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK----S-------- 230 (288)
T ss_dssp -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH----S--------
T ss_pred -CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHC----C--------
T ss_conf -641001025626479999832025788888066578789999998208899999899999999970----7--------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4999999997889999999984116598899999999999
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
.+.....+...+..+.+++.+||+.||++|||++|++++
T Consensus 231 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 231 -EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -998777656699999999999766996689199999629
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.46 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=205.4
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCC-CCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 256776774743083899999936-998999999016889-997631069999998504786301244267528941899
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||+||+|+.+ +|+.||+|++..... .......+.+|++++++++||||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 53769988985177858999999899949999998168856768999999999999856888888599999989998999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 98228999875612477898884469999999999956875149996585157789289768996599001343114679
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 840 (1010)
|||+++|+|.+++. ..+.+++..+..++.|++.|++|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 mEy~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEECCCCCHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 85047985898875--0489999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 98510000025333368131114998863765226699999892999888999975299999998310112300014999
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
......||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+....+... .+.
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~---------~~~ 222 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRISRV---------EFT 222 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTT---------CCC
T ss_pred ----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC----HHHHHHHHHCC---------CCC
T ss_conf ----5235578876349999758998931440467599999832999988899----99999999718---------999
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999997889999999984116598899999999999
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
.+...+..+.+++.+|++.||++|||++|++++
T Consensus 223 ---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---986689999999999764797689099999719
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=367.15 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=210.1
Q ss_pred EEECCCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCC
Q ss_conf 33111025677677474308389999993-69989999990168899976310699999985047863012442675289
Q 001816 677 FTCDDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 755 (1010)
Q Consensus 677 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 755 (1010)
+.-+.+.++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+.++++++||||+++++++.+++
T Consensus 19 l~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 19 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 8988786575898898407681999999889998999999845243--16999999999998679979992999999899
Q ss_pred CCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC--CCCEEEEECCC
Q ss_conf 4189998228999875612477898884469999999999956875149996585157789289768--99659900134
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS--GFEAHVADFGL 833 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~--~~~~kl~DfG~ 833 (1010)
..|+||||++||+|.+++.. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEECCCCCCHHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCH
T ss_conf 99999985799889999976-2378999999999999999999997569---7600015467364168898699954521
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 31146799851000002533336813111499886376522669999989299988899997529999999831011230
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
|+.+... .......||+.|||||++.+..|+.++||||+||++|||++|+.||.+... .+....+....
T Consensus 173 a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~---- 241 (350)
T d1koaa2 173 TAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCD---- 241 (350)
T ss_dssp CEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTC----
T ss_pred HEECCCC---CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHCC----
T ss_conf 0442565---432000686242188997589987267655465999999859899899799----99999998478----
Q ss_pred CCCCCCCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0014999999-997889999999984116598899999999999
Q 001816 914 LKILDPRLPS-VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 914 ~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
...+. .....+..+.+++.+|+..||++|||++|++++
T Consensus 242 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 -----WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----898942235899999999999756896679089998629
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.41 Aligned_cols=254 Identities=23% Similarity=0.391 Sum_probs=211.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
Q ss_conf 56776774743083899999936998999999016889997631069999998504786301244267528941899982
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 763 (1010)
+.|+..+.||+|+||+||+|+++++..||||+++.... ..+.|.+|+.++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEC
T ss_conf 99799689820788399999988998999999874757---789999999999966898601588998507816999970
Q ss_pred CCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 28999875612477898884469999999999956875149996585157789289768996599001343114679985
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 843 (1010)
+++|++.+++... ...+++..+.+++.|+++|+.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 155 (258)
T d1k2pa_ 81 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 155 (258)
T ss_dssp CTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred CCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC-
T ss_conf 4899388864102-467768999999999999999875468---43466541358876998479886144202357872-
Q ss_pred CEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 10000025333368131114998863765226699999892-99988899997529999999831011230001499999
Q 001816 844 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
.......|++.|+|||++.+..++.++||||||+++|||+| |+.||...... +....+... ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~~~~i~~~-----------~~~ 220 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHIAQG-----------LRL 220 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHHHTT-----------CCC
T ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH----HHHHHHHHC-----------CCC
T ss_conf 25246578877578078637998852103364324673975599998899999----999999807-----------978
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 99978899999999841165988999999999998339
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 923 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~ 960 (1010)
..|...+..+.+++.+||+.||++|||++|++++|.++
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 99654659999999997668976893999999874188
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.89 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=208.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCC-CCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf 5677677474308389999993-6998999999016889-9976310699999985047863012442675289418999
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 761 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 761 (1010)
+.|++.+.||+|+||+||+|+. .+|+.||||+++.... .......+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 82289998756124778988844699999999999568751499965851577892897689965990013431146799
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSG 841 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 841 (1010)
||++||+|.+++. ..+.+++..+..++.|++.|++|+|+.+ |+||||||+||+++.++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ECCCCCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf 7048987777653--1599999999999999999997621650---8847677412366888538860321024225677
Q ss_pred CCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 85100000253333681311149988637652266999998929998889999752999999983101123000149999
Q 001816 842 TSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 842 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
........+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... .......+... ...+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~---------~~~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKIIKL---------EYDF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHTT---------CCCC
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHCC---------CCCC
T ss_conf 6433355567755258440026898966623045699999803889989959----99999999718---------9999
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 99997889999999984116598899999999999
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 922 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
+...+..+.+++.+|++.||++|||++|+...
T Consensus 230 ---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 ---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf ---85479999999999855797689197897377
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.30 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=203.8
Q ss_pred CEEEECCCEEEEEEEECC---CCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEECCC
Q ss_conf 747430838999999369---98999999016889997631069999998504786301244267528941899982289
Q 001816 690 NIIGKGGAGIVYKGLMPN---GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPN 766 (1010)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 766 (1010)
+.||+|+||+||+|.++. ++.||||+++.........+.|.+|++++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC-E
Q ss_conf 998756124778988844699999999999568751499965851577892897689965990013431146799851-0
Q 001816 767 GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE-C 845 (1010)
Q Consensus 767 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~ 845 (1010)
|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+|++|||+|+......... .
T Consensus 92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf 96899975--2257899999999999999976687479---556777611310235675123413453313432344322
Q ss_pred EEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 000025333368131114998863765226699999892-9998889999752999999983101123000149999999
Q 001816 846 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLPSV 924 (1010)
Q Consensus 846 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (1010)
.....||+.|+|||++.+..++.++||||||+++|||++ |+.||.+... .+....+.. ...+..
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i~~-----------~~~~~~ 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEK-----------GERMGC 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHT-----------TCCCCC
T ss_pred CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH----HHHHHHHHC-----------CCCCCC
T ss_conf 44567784203916653799984344303403132896589999999899----999999982-----------899999
Q ss_pred CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 978899999999841165988999999999998339
Q 001816 925 PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 925 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~ 960 (1010)
+...+..+.+++.+||+.||++|||+++|.+.|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf 865679999999997588976890989999985288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=365.43 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=209.5
Q ss_pred EECCCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCC
Q ss_conf 3111025677677474308389999993-699899999901688999763106999999850478630124426752894
Q 001816 678 TCDDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 678 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 756 (1010)
.-..+.+.|++.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|++++++++||||+++++++.+++.
T Consensus 23 ~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 899854035998999317782999999989997999999887264--679999999999986799798919999998999
Q ss_pred CEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC--CCCCEEEEECCCC
Q ss_conf 18999822899987561247789888446999999999995687514999658515778928976--8996599001343
Q 001816 757 NLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD--SGFEAHVADFGLA 834 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~--~~~~~kl~DfG~a 834 (1010)
.|+||||++||+|.+++.. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|
T Consensus 101 ~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEECCCCCHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCC
T ss_conf 9999982899808888986-3899899999999999999999999779---26513144553113467884899525630
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 11467998510000025333368131114998863765226699999892999888999975299999998310112300
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
..+... .......|++.|+|||++.+..|+.++||||+||++|||++|+.||.+... ......+...
T Consensus 177 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~------ 243 (352)
T d1koba_ 177 TKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRC------ 243 (352)
T ss_dssp EECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHHC------
T ss_pred EECCCC---CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHC------
T ss_conf 343788---720100476453489997479989763338989999999968899899799----9999999847------
Q ss_pred CCCCCCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 01499999-9997889999999984116598899999999999
Q 001816 915 KILDPRLP-SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
+...+ ......+..+.+++.+|++.||++|||++|++++
T Consensus 244 ---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 ---DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---8898930024799999999999756996689189999609
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=368.20 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=209.1
Q ss_pred ECCCCCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 1110256776774743083899999936-998999999016889997631069999998504786301244267528941
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 757 (1010)
.+++.+.|+..+.||+|+||+||+|+.. +|+.||||++....... ....+.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 7877666699889940658399999999999899999981577312-899999999999867998999198999989988
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC---CCCCEEEEECCCC
Q ss_conf 8999822899987561247789888446999999999995687514999658515778928976---8996599001343
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD---SGFEAHVADFGLA 834 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~---~~~~~kl~DfG~a 834 (1010)
|+||||++||+|.+++. ..+.+++..+..++.|++.|+.|||+.+ |+||||||+||++. .++.+||+|||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEECCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEECCCCCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEE
T ss_conf 89885268984888653--0367887899999999999987524130---556870463001104688824998315435
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 11467998510000025333368131114998863765226699999892999888999975299999998310112300
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVL 914 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (1010)
+..... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ......+.....
T Consensus 158 ~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~~---- 226 (307)
T d1a06a_ 158 KMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AKLFEQILKAEY---- 226 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHTTCC----
T ss_pred EECCCC---CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHCCCC----
T ss_conf 872589---704400328422591887379998078734515999999859799999899----999999861687----
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 014999999997889999999984116598899999999999
Q 001816 915 KILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
... .......+..+.+++.+|++.||++|||++|++++
T Consensus 227 ~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EFD----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCC----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 778----76666789999999999760897579189998629
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.46 Aligned_cols=256 Identities=26% Similarity=0.363 Sum_probs=204.8
Q ss_pred CCCCCC-EEEECCCEEEEEEEEC---CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 677677-4743083899999936---998999999016889997631069999998504786301244267528941899
Q 001816 685 CLKEDN-IIGKGGAGIVYKGLMP---NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 685 ~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 760 (1010)
.+...+ .||+|+||+||+|.++ ++..||||+++.... ....+.|.+|++++++++||||+++++++.. +..|+|
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 71887848730608099999996089768999999882039-7899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 98228999875612477898884469999999999956875149996585157789289768996599001343114679
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 840 (1010)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 980789968997521-2569999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCC-CEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 985-10000025333368131114998863765226699999892-9998889999752999999983101123000149
Q 001816 841 GTS-ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 841 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||.+.... +... .+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~---~i~~----------- 227 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMA---FIEQ----------- 227 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHH---HHHT-----------
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH-HHHH---HHHC-----------
T ss_conf 432113562113743358688727999954123220178999993899999997999-9999---9981-----------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9999999788999999998411659889999999999983399
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 919 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 961 (1010)
...+..|...+..+.+++.+||+.+|++||++.+|.+.|+...
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 8999999767899999999975779768909999999999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.06 Aligned_cols=259 Identities=28% Similarity=0.395 Sum_probs=212.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 25677677474308389999993699899999901688999763106999999850478630124426752894189998
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 762 (1010)
.+.|++.+.||+|+||.||+|+++++..||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEE
T ss_conf 79979846993079809999999999999999988044---888999999999986666788689999823-97599999
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 22899987561247789888446999999999995687514999658515778928976899659900134311467998
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 842 (1010)
|+++|+|.+++.......++|.++..++.||+.|++|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC-
T ss_conf 447994354200003553059999999999999999875411---4335312307999899929984425554256887-
Q ss_pred CCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 51000002533336813111499886376522669999989299988899997529999999831011230001499999
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRLP 922 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (1010)
........|++.|+|||++....++.++||||||+++|||++|..|+.......+....+. .. ..+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~~-----------~~~ 233 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RG-----------YRM 233 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TT-----------CCC
T ss_pred CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH---HC-----------CCC
T ss_conf 3352454556654580898379989177413235899999868999998888999999998---26-----------899
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 99978899999999841165988999999999998339999
Q 001816 923 SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 923 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 963 (1010)
..+...+..+.+++.+||+.||++||++++|++.|++....
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 99832379999999997566975891999999987666238
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.83 Aligned_cols=263 Identities=29% Similarity=0.454 Sum_probs=210.3
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCC-----CEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 25677677474308389999993699-----8999999016889997631069999998504786301244267528941
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNG-----DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 757 (1010)
...|+..++||+|+||+||+|.++.. ..||||+++.... ......|.+|++++++++|||||++++++.+.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89968615981177909999999689987879999999884459-68999999999999856898783236778338803
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 89998228999875612477898884469999999999956875149996585157789289768996599001343114
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~ 837 (1010)
++||||+++|++.+++.. ....+++.++..++.|++.|++|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 85 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEECCCCCCHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 899972135740222102-3454208999999999998541212123---425765644278889984998455103003
Q ss_pred CCCCCC-CEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 679985-1000002533336813111499886376522669999989299988899997529999999831011230001
Q 001816 838 QDSGTS-ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 838 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
...... .......||+.|+|||++.+..++.++||||||+++|||+++..|+.......+. ...+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~--------- 228 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAIND--------- 228 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHT---------
T ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH---HHHHHC---------
T ss_conf 57876526742677773434888870499997355634489899999679886556899999---999863---------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 499999999788999999998411659889999999999983399999
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKPP 964 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~~ 964 (1010)
+..+..+...+..+.+++.+||+.+|++||++.||++.|+.+.+.+
T Consensus 229 --~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 229 --GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp --TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --CCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf --5789985045799999999977679768939999999999986695
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.56 Aligned_cols=249 Identities=29% Similarity=0.419 Sum_probs=197.5
Q ss_pred CCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEEC----CCCCEEEE
Q ss_conf 76774743083899999936-99899999901688999763106999999850478630124426752----89418999
Q 001816 687 KEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN----HETNLLVY 761 (1010)
Q Consensus 687 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~ 761 (1010)
+..+.||+|+||+||+|... ++..||+|++............+.+|++++++++||||+++++++.+ +...|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC-CCCCEEEEECCCCCCCCCC
Q ss_conf 822899987561247789888446999999999995687514999658515778928976-8996599001343114679
Q 001816 762 EYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD-SGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 762 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 840 (1010)
||+++|+|.+++. +...+++..+..++.|++.|++|||+.+ ++|+||||||+|||++ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred ECCCCCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC-
T ss_conf 5789894899975--1355469999999999999999999789-97996876743511667999889800576542368-
Q ss_pred CCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 98510000025333368131114998863765226699999892999888999975299999998310112300014999
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
......+||+.|||||++.+ .++.++||||+||++|||++|+.||.+..+..... +.+.....
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~---~~i~~~~~---------- 230 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVK---------- 230 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCC----------
T ss_pred ---CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHCCCC----------
T ss_conf ---76677553813008988478-99986711007999999987889998765599999---99973899----------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999997889999999984116598899999999999
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
.+..+...+..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 865675578999999999763797589299999677
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=366.21 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=201.5
Q ss_pred CCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCC-CCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
Q ss_conf 025677677474308389999993-699899999901688999-763106999999850478630124426752894189
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 682 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 759 (1010)
..+.|+..+.||+|+||+||+|+. .+|+.||||+++...... .....+.+|++++++++||||+++++++.+++..|+
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 07856762797018880999999989993999999844443588999999999999997789998238999998998899
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99822899987561247789888446999999999995687514999658515778928976899659900134311467
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 839 (1010)
||||+++|++..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|.....
T Consensus 93 v~E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEECCCCCHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 998069994578997--3799999999999999999999998689---76667884217987999789844365334677
Q ss_pred CCCCCEEEEECCCCCCCCHHHHCC---CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 998510000025333368131114---99886376522669999989299988899997529999999831011230001
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYT---LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
. ....||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+.... +....+....
T Consensus 168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----~~~~~i~~~~------- 230 (309)
T d1u5ra_ 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNE------- 230 (309)
T ss_dssp B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSC-------
T ss_pred C------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHCC-------
T ss_conf 8------7313476636889983467888672145455899999998788999997999----9999998289-------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4999999997889999999984116598899999999999
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
.+.. .+...+..+.+++.+||+.||++|||++|++++
T Consensus 231 -~~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 231 -SPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -CCCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCC--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -9988--878889999999999773796579189999719
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.92 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=208.2
Q ss_pred ECCCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCC----CCCCHHHHHHHHHCCCCCCCCEEEEEEEC
Q ss_conf 111025677677474308389999993-6998999999016889997----63106999999850478630124426752
Q 001816 679 CDDVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSS----HDHGFNAEIQTLGRIRHRHIVRLLGFCSN 753 (1010)
Q Consensus 679 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 753 (1010)
-+++.+.|++.+.||+|+||+||+|+. .+|+.||||+++....... ..+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf 78855677982798117895999999999998999999875663213406899999999999986799899938899997
Q ss_pred CCCCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC----CEEEE
Q ss_conf 89418999822899987561247789888446999999999995687514999658515778928976899----65990
Q 001816 754 HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF----EAHVA 829 (1010)
Q Consensus 754 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~----~~kl~ 829 (1010)
++..|+||||+++|+|.+++.. .+.+++..+..++.|++.|++|||+.+ |+||||||+||+++.++ .+|++
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEECCCCCCCCCHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEEC
T ss_conf 9989999986778643100103--564215578999999999987666254---22113330127982589866646964
Q ss_pred ECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 01343114679985100000253333681311149988637652266999998929998889999752999999983101
Q 001816 830 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909 (1010)
Q Consensus 830 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 909 (1010)
|||+|...... .......|++.|+|||++.+..++.++||||+||++|||++|+.||.+... .+....+....
T Consensus 160 DfG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~ 232 (293)
T d1jksa_ 160 DFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVN 232 (293)
T ss_dssp CCTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHTTC
T ss_pred CHHHHHHCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHHCC
T ss_conf 33442105777---631224777743099998189999766522140999999708899889999----99999998168
Q ss_pred CCCCCCCCCCCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1230001499999-9997889999999984116598899999999999
Q 001816 910 KEGVLKILDPRLP-SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 910 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
...+ ..+...+..+.+++.+||+.||++|||++|++++
T Consensus 233 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 ---------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---------888701047889999999999863896689199999619
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.34 Aligned_cols=261 Identities=25% Similarity=0.416 Sum_probs=212.3
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCC
Q ss_conf 256776774743083899999936------99899999901688999763106999999850478630124426752894
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 756 (1010)
.+.|+..+.||+|+||+||+|+++ ++..||||+++... .......|.+|++++++++||||+++++++...+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf 88938867982078839999998887657788299999988210-85799999999999996689976552466605980
Q ss_pred CEEEEEECCCCCHHHHHCCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCC
Q ss_conf 189998228999875612477----------------------8988844699999999999568751499965851577
Q 001816 757 NLLVYEYMPNGSLGEVLHGKK----------------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVK 814 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk 814 (1010)
.++||||+++|+|.+++.... ...+++..+..++.|++.||+|+|+.+ |+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEEEEC
T ss_conf 3899981589929999985275542100001110012103467889899999999999999855413578---6854884
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCC-CCCCCCC
Q ss_conf 892897689965990013431146799851000002533336813111499886376522669999989299-9888999
Q 001816 815 SNNILLDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR-KPVGEFG 893 (1010)
Q Consensus 815 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~-~P~~~~~ 893 (1010)
|+|||++.++.+||+|||+|+...+...........|++.|+|||++.+..|+.++||||||+++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCC
T ss_conf 01168989992898331442113677641115777767676798997268898056302523629999806899999989
Q ss_pred CCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 975299999998310112300014999999997889999999984116598899999999999833999
Q 001816 894 DGVDIVQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 962 (1010)
..+. ...+.. ...+..+...+..+.+++.+||+.+|++||||.||++.|+++.+
T Consensus 248 -~~e~---~~~v~~-----------~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 248 -HEEV---IYYVRD-----------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -HHHH---HHHHHT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -HHHH---HHHHHC-----------CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf -9999---999973-----------99788873252999999999748896579399999999998429
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.45 Aligned_cols=251 Identities=23% Similarity=0.254 Sum_probs=206.6
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCC-CCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 25677677474308389999993-6998999999016889-997631069999998504786301244267528941899
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||.||+|+. .+|+.||+|+++.... .......+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 98228999875612477898884469999999999956875149996585157789289768996599001343114679
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 840 (1010)
|||++||+|.+++. +.+.+++..++.++.|++.|+.|+|+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EECCCCCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 00357986055553--2567759999999999965211343159---622464777847658998888205652003567
Q ss_pred CCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 98510000025333368131114998863765226699999892999888999975299999998310112300014999
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
.......+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ....+.+... ...
T Consensus 159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~~~---------~~~ 223 (337)
T d1o6la_ 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILME---------EIR 223 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC---------CCC
T ss_pred --CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH----HHHHHHHHCC---------CCC
T ss_conf --8620551008899666650489888333102230678899878999999699----9999998528---------998
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 99999788999999998411659889999-----9999999
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPT-----MREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ei~~~ 956 (1010)
.|...+..+.+++.+|+++||++|++ ++|++++
T Consensus 224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf ---98668999999998666389344225652349999729
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.14 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=209.0
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CCC----EEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
Q ss_conf 56776774743083899999936-998----9999990168899976310699999985047863012442675289418
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGD----QVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 758 (1010)
..|+..+.||+|+||+||+|.+. +|+ .||+|+++... .....+.|.+|++++++++|||||++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEE
T ss_conf 999783198208992999999958998898999999965134-979999999999999867998881589999619-836
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99982289998756124778988844699999999999568751499965851577892897689965990013431146
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 838 (1010)
+++|++.+|+|.+++.. ....+++..+..++.||+.||+|||..+ |+||||||+||+++.++.+||+|||+|+...
T Consensus 87 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEEECCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 99984268740101113-3457999999999999999999998769---5047621203116799875860255222335
Q ss_pred CCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 7998510000025333368131114998863765226699999892-999888999975299999998310112300014
Q 001816 839 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 839 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
............||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .+....+.. .
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~~~~i~~---~--------- 229 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK---G--------- 229 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGHHHHHHH---T---------
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHC---C---------
T ss_conf 444532236510586446708874699983565440799999999779999999998-999999975---9---------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 999999997889999999984116598899999999999833999
Q 001816 918 DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPK 962 (1010)
Q Consensus 918 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~ 962 (1010)
..+..+...+..+.+++.+||+.||++|||+.|+++.++.+..
T Consensus 230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --9899985568999999998478993469199999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=355.69 Aligned_cols=252 Identities=23% Similarity=0.256 Sum_probs=199.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCC-CCCCCCHHHH---HHHHHCCCCCCCCEEEEEEECCCCC
Q ss_conf 256776774743083899999936-9989999990168899-9763106999---9998504786301244267528941
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRG-SSHDHGFNAE---IQTLGRIRHRHIVRLLGFCSNHETN 757 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~E---~~~l~~l~hp~iv~~~~~~~~~~~~ 757 (1010)
.+.|++.+.||+|+||.||+|+.. +|+.||||++...... ......+.+| +.+++.++||||+++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 89998228999875612477898884469999999999956875149996585157789289768996599001343114
Q 001816 758 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFL 837 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~ 837 (1010)
|+||||++||+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~ivmE~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 99999148983899987--3255327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCEEEEECCCCCCCCHHHHC-CCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 6799851000002533336813111-499886376522669999989299988899997529999999831011230001
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
... ......||+.|+|||++. +..|+.++||||+||++|||++|+.||...... +.....+...
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~---------- 222 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTL---------- 222 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHHHHHHHSS----------
T ss_pred CCC----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHCC----------
T ss_conf 788----6433113455421687603899984410467789999998599988889989-9999998604----------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 499999999788999999998411659889999-----9999999
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPT-----MREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ei~~~ 956 (1010)
......+...+..+.+++.+|++.||++||+ ++|++++
T Consensus 223 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 --TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf --6888788778999999999985669888088743579999749
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=357.61 Aligned_cols=248 Identities=21% Similarity=0.254 Sum_probs=205.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC-CCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 25677677474308389999993-699899999901688-9997631069999998504786301244267528941899
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMS-RGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||.||+|+. .+|+.||||+++... ........+.+|+++++.++||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC
T ss_conf 23708988961176808999999899989999998267745889999999999999974877274034444322222322
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 98228999875612477898884469999999999956875149996585157789289768996599001343114679
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 840 (1010)
|||+.+|+|.+++. +.+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCCHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 22334662266675--1589899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 98510000025333368131114998863765226699999892999888999975299999998310112300014999
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
.....||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+.... +.
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~~---------~~ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVSGK---------VR 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC---------CC
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC----HHHHHHHHHCCC---------CC
T ss_conf -----643367635678899717998853311450078999975889989959----999999986179---------88
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCC-----CCHHHHHHH
Q ss_conf 999997889999999984116598899-----999999999
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVER-----PTMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~l~~li~~cl~~dP~~R-----Ps~~ei~~~ 956 (1010)
.+...+..+.+++.+|+..||.+| |++++++++
T Consensus 257 ---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf ---97668999999999983409986065534549999719
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.71 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=205.9
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCC-CCCCCCEEEEEEECC-C
Q ss_conf 56776774743083899999936------998999999016889997631069999998504-786301244267528-9
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNH-E 755 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-~ 755 (1010)
+.|++.+.||+|+||.||+|.+. +++.||||+++..... ...+.+.+|...+.++ +|++|+.+++++... .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCC-HHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
T ss_conf 997984498416783999999867775557839999998600171-7899999999998861499849974115404797
Q ss_pred CCEEEEEECCCCCHHHHHCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEEC
Q ss_conf 4189998228999875612477--------------89888446999999999995687514999658515778928976
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLD 821 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~ 821 (1010)
..++||||+++|+|.+++.... ...+++.++..++.|++.|+.|||+.+ |+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEC
T ss_conf 579999845899299999853666665322202332146899999999999999999887379---71786773106577
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHC-CCCCCCCCCCCCHHH
Q ss_conf 8996599001343114679985100000253333681311149988637652266999998929-998889999752999
Q 001816 822 SGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG-RKPVGEFGDGVDIVQ 900 (1010)
Q Consensus 822 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg-~~P~~~~~~~~~~~~ 900 (1010)
.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| ..||...........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 99828984575200113566522247516672102036864688996632213678999998688999989998999999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 999983101123000149999999978899999999841165988999999999998339
Q 001816 901 WVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~ 960 (1010)
.+.. . ..+..+...+..+.+++.+||+.||++|||++|++++|+.+
T Consensus 249 ~~~~---~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 249 RLKE---G-----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHH---T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHC---C-----------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 9963---8-----------98888865789999999997677966791999999999799
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.81 Aligned_cols=253 Identities=18% Similarity=0.250 Sum_probs=205.8
Q ss_pred CCCCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
Q ss_conf 10256776774743083899999936-99899999901688999763106999999850478630124426752894189
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 681 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 759 (1010)
++.++|++.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++++.++||||+++++++.+++..|+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf 87010588789831778399999998999699999975786---659999999999985799798909899988998899
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC--CCCEEEEECCCCCCC
Q ss_conf 998228999875612477898884469999999999956875149996585157789289768--996599001343114
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS--GFEAHVADFGLAKFL 837 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~--~~~~kl~DfG~a~~~ 837 (1010)
||||++||+|.+++.. .+..+++.++..++.||+.|+.|||+.+ |+||||||+||+++. ...+|++|||++...
T Consensus 79 vmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf 9953899808899875-3899999999999999999999998769---97513554443443788518997644111003
Q ss_pred CCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 67998510000025333368131114998863765226699999892999888999975299999998310112300014
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKIL 917 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (1010)
.. ........|++.|+|||...+..|+.++||||+||++|+|++|+.||..... ......+....
T Consensus 155 ~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----~~~~~~i~~~~-------- 219 (321)
T d1tkia_ 155 KP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAE-------- 219 (321)
T ss_dssp CT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTC--------
T ss_pred CC---CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHCC--------
T ss_conf 46---7753212233222340210487778401130279999999828999999899----99999998389--------
Q ss_pred CCCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999999-997889999999984116598899999999999
Q 001816 918 DPRLPS-VPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
..++. .....+..+.+++.+|+..||++|||++|++++
T Consensus 220 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 -YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -998802236789999999999866996689099999639
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=355.54 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=203.7
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCC-CCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 25677677474308389999993-6998999999016889-997631069999998504786301244267528941899
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 760 (1010)
.+.|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 54708888972076808999999899979999998457754889999999999999863696753303568528800567
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 98228999875612477898884469999999999956875149996585157789289768996599001343114679
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 840 (1010)
|||++||++..++. ....+++..+..++.|++.|++|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp ECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEECCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 65037863223432--2221110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 98510000025333368131114998863765226699999892999888999975299999998310112300014999
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. ..+....+... ...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~---------~~~ 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKTYEKILNA---------ELR 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHC---------CCC
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC----HHHHHHHHHCC---------CCC
T ss_conf -----643457634359999838999804304653336899975989999969----99999999708---------988
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 9999978899999999841165988999-----99999999
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 921 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ei~~~ 956 (1010)
. +...+..+.+++.+|+..||.+|+ ++++++++
T Consensus 220 ~---p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 F---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C---CCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 9---9778999999999995449976664310219999819
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.31 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=202.3
Q ss_pred CCCCCCCCCCC-EEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCC-CCCCCCEEEEEEEC---
Q ss_conf 11025677677-474308389999993-6998999999016889997631069999998504-78630124426752---
Q 001816 680 DDVLDCLKEDN-IIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSN--- 753 (1010)
Q Consensus 680 ~~~~~~~~~~~-~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--- 753 (1010)
..+.+.|++.+ +||+|+||.||+|+. .+|+.||||+++. ...+.+|+.++.++ +||||+++++++.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CCCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
T ss_conf 97014879810796545486999999889998999999897-------47799999999986699997829899950346
Q ss_pred -CCCCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC---CCCEEEE
Q ss_conf -894189998228999875612477898884469999999999956875149996585157789289768---9965990
Q 001816 754 -HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS---GFEAHVA 829 (1010)
Q Consensus 754 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~~kl~ 829 (1010)
+...|+|||||+||+|.+++.......+++.++..++.|++.|+.|||+.+ |+||||||+||+++. .+.+||+
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 8978999997789984999998627877579999999999999999999769---8644410022011355556631135
Q ss_pred ECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 01343114679985100000253333681311149988637652266999998929998889999752999999983101
Q 001816 830 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK 909 (1010)
Q Consensus 830 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 909 (1010)
|||+|+..... .......||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+............ ..
T Consensus 157 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~----~i 229 (335)
T d2ozaa1 157 DFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RI 229 (335)
T ss_dssp CCTTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CC
T ss_pred CCCEEEECCCC---CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHH----HH
T ss_conf 45512333688---864322677563792777489888888887645167788658899889887788999999----98
Q ss_pred CCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 123000149999999-97889999999984116598899999999999
Q 001816 910 KEGVLKILDPRLPSV-PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 910 ~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
. .....++.. ....+..+.+++.+|++.||++|||+.|++++
T Consensus 230 ~-----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 230 R-----MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp C-----SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-----CCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5-----388888985434699999999999756996579099999709
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.32 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=210.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCC-CCCCCCEEEEEEECCCC
Q ss_conf 56776774743083899999936------998999999016889997631069999998504-78630124426752894
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 756 (1010)
+.|+..+.||+|+||.||+|++. .+..||||+++.... ......+.+|+.+++++ +||||+++++++.+++.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 99698549820688299999980664477886999999874248-77999999999998762699988789989831997
Q ss_pred CEEEEEECCCCCHHHHHCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEE
Q ss_conf 189998228999875612477----------------8988844699999999999568751499965851577892897
Q 001816 757 NLLVYEYMPNGSLGEVLHGKK----------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILL 820 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill 820 (1010)
.++||||+++|+|.++++... ...+++..+..++.||+.|++|||..+ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHH
Q ss_conf 6899659900134311467998510000025333368131114998863765226699999892-999888999975299
Q 001816 821 DSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIV 899 (1010)
Q Consensus 821 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~ 899 (1010)
+.++.+|++|||.++...............|++.|+|||++.+..++.++||||||+++|||+| |.+||..........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899899999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 9999983101123000149999999978899999999841165988999999999998339
Q 001816 900 QWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~ 960 (1010)
..+.. +..+..+...+..+.+++.+||+.||++|||++++++.|+++
T Consensus 259 ~~i~~--------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 KMIKE--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHH--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHC--------------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 99866--------------898898543659999999997577965792999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.20 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=207.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEECC-CC--EEEEEEECCCCCCCCCCCCHHHHHHHHHCC-CCCCCCEEEEEEECCCCCEE
Q ss_conf 567767747430838999999369-98--999999016889997631069999998504-78630124426752894189
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN-GD--QVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 759 (1010)
+.|+..+.||+|+||+||+|++++ |. .||||+++..... ...+.|.+|+++++++ +||||+++++++.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 996887798207882899999989996999999997823385-7999999999999862289988367888841873699
Q ss_pred EEEECCCCCHHHHHCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCC
Q ss_conf 99822899987561247--------------7898884469999999999956875149996585157789289768996
Q 001816 760 VYEYMPNGSLGEVLHGK--------------KGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFE 825 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~ 825 (1010)
||||+++|+|.++++.. ....+++..+..++.||+.|+.|+|+.+ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCC
T ss_conf 99802898699998640355555123101234578999999999999999987663089---545550520489868876
Q ss_pred EEEEECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHH
Q ss_conf 59900134311467998510000025333368131114998863765226699999892999-88899997529999999
Q 001816 826 AHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRK-PVGEFGDGVDIVQWVRK 904 (1010)
Q Consensus 826 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~-P~~~~~~~~~~~~~~~~ 904 (1010)
+||+|||+|+...... ......||..|+|||.+.+..++.++||||||+++|||++|.. ||... + ..+....
T Consensus 166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~---~~~~~~~ 238 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-T---CAELYEK 238 (309)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-C---HHHHHHH
T ss_pred EEECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC-C---HHHHHHH
T ss_conf 3874344322444223---4553013775555387526999962215313889999983689999999-9---9999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 83101123000149999999978899999999841165988999999999998339999
Q 001816 905 MTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 963 (1010)
+... ..+..+...+..+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 239 i~~~-----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 LPQG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGGT-----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHC-----------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9826-----------88888766789999999997678966894999999999999861
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.97 Aligned_cols=261 Identities=22% Similarity=0.270 Sum_probs=200.8
Q ss_pred CCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCC---CCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEC
Q ss_conf 77474308389999993-699899999901688999---76310699999985047863012442675289418999822
Q 001816 689 DNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS---SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYM 764 (1010)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 764 (1010)
.++||+|+||+||+|+. .+|+.||||+++...... .....+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 89998756124778988844699999999999568751499965851577892897689965990013431146799851
Q 001816 765 PNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTSE 844 (1010)
Q Consensus 765 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 844 (1010)
+++++.... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||.|+...... .
T Consensus 83 ~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~ 155 (299)
T d1ua2a_ 83 ETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R 155 (299)
T ss_dssp SEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred CCHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC--C
T ss_conf 450776554--12667789999999999999998863163---5503577625885377841146576100057875--5
Q ss_pred EEEEECCCCCCCCHHHHCC-CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC-------C
Q ss_conf 0000025333368131114-9988637652266999998929998889999752999999983101123000-------1
Q 001816 845 CMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLK-------I 916 (1010)
Q Consensus 845 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 916 (1010)
.....+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||....+.+......+.......+.... .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf 43302047333639997267788805643630428999985969999999999999999851899725452100021344
Q ss_pred CCCCCCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4999999997-----889999999984116598899999999999
Q 001816 917 LDPRLPSVPL-----HEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 917 ~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
.....+..+. .....+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 303478988678565689999999999763894569089999679
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.91 Aligned_cols=250 Identities=30% Similarity=0.405 Sum_probs=206.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEEC-CCCCEEEEE
Q ss_conf 5677677474308389999993699899999901688999763106999999850478630124426752-894189998
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-HETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 762 (1010)
+.|+..+.||+|+||.||+|.+ +|..||||+++.. ...+.+.+|++++++++||||+++++++.+ .+..|+|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCH----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 9948857982079808999999-9909999998857----7799999999999867898985498788723892899996
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 22899987561247789888446999999999995687514999658515778928976899659900134311467998
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 842 (1010)
|+++|+|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC--
T ss_conf 369998999987457888899999999999985232113376---553666567601468997763245600344787--
Q ss_pred CCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 510000025333368131114998863765226699999892-9998889999752999999983101123000149999
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.....+++.|+|||++.+..++.++||||||+++|||+| |+.||... +..+....+ .. ...
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i---~~-----------~~~ 218 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRV---EK-----------GYK 218 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHH---TT-----------TCC
T ss_pred ---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHH---HC-----------CCC
T ss_conf ---765566646778178727988858877757999999997899999999-999999999---80-----------899
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9999788999999998411659889999999999983399
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 922 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 961 (1010)
+..+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9997657999999999975669768939999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.12 Aligned_cols=256 Identities=24% Similarity=0.367 Sum_probs=206.6
Q ss_pred CCCCCCCEEEECCCEEEEEEEECC----CCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
Q ss_conf 567767747430838999999369----9899999901688999763106999999850478630124426752894189
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPN----GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 759 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 759 (1010)
++|++.+.||+|+||.||+|++.. +..||||.++.... ......+.+|++++++++||||+++++++.+ +..|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 996987799307882999999936996449999999365668-7999999999999986899998569889953-74799
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99822899987561247789888446999999999995687514999658515778928976899659900134311467
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQD 839 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 839 (1010)
||||+++|++.+++.. ....+++..+..++.|++.|+.|+|+.+ |+||||||+||+++.++.+||+|||+|+....
T Consensus 85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 9984069807765422-4789999999999999987752302267---44141026553206789678765034213367
Q ss_pred CCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 998510000025333368131114998863765226699999892-9998889999752999999983101123000149
Q 001816 840 SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILD 918 (1010)
Q Consensus 840 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (1010)
.. ........||+.|+|||++.+..++.++||||||+++|||++ |.+||..... .+....+. .
T Consensus 161 ~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-~~~~~~i~---~----------- 224 (273)
T d1mp8a_ 161 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIE---N----------- 224 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHH---T-----------
T ss_pred CC-CEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-HHHHHHHH---C-----------
T ss_conf 76-23305400583103266751699887452444247899998269999888999-99999998---1-----------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9999999788999999998411659889999999999983399
Q 001816 919 PRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 919 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 961 (1010)
...+..+...+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 8999898777999999999976879768929999999999997
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.07 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=211.7
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCC
Q ss_conf 256776774743083899999936------99899999901688999763106999999850478630124426752894
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP------NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 756 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 756 (1010)
.+.|+..+.||+|+||+||+|.+. .+..||||+++.... ......|.+|+.++++++||||+++++++..++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 899188359820788189999987864477896899999870128-6899999999999997699988412547842881
Q ss_pred CEEEEEECCCCCHHHHHCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEE
Q ss_conf 189998228999875612477--------898884469999999999956875149996585157789289768996599
Q 001816 757 NLLVYEYMPNGSLGEVLHGKK--------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHV 828 (1010)
Q Consensus 757 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl 828 (1010)
.++||||+++|+|.+++...+ ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEE
T ss_conf 06777604899889998750332113444688799999999999999999876479---654328677540359964999
Q ss_pred EECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCC-CCCCCCCCCCCHHHHHHHHHH
Q ss_conf 0013431146799851000002533336813111499886376522669999989299-988899997529999999831
Q 001816 829 ADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGR-KPVGEFGDGVDIVQWVRKMTD 907 (1010)
Q Consensus 829 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~-~P~~~~~~~~~~~~~~~~~~~ 907 (1010)
+|||+|+...............|++.|+|||.+.+..++.++||||||+++|||+||. .||.... ..+....+.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~----~~~~~~~i~- 249 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQVLRFVM- 249 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HHHHHHHHH-
T ss_pred EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC----HHHHHHHHH-
T ss_conf 424542023577630313402316323788887369988333444378999999968999999989----999999998-
Q ss_pred HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 01123000149999999978899999999841165988999999999998339999
Q 001816 908 SKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 963 (1010)
++..+..+...+..+.+++.+||+.+|++|||+++|++.|+....+
T Consensus 250 ----------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 250 ----------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----------HCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf ----------0888888633539999999997577965893999999997876177
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.68 Aligned_cols=256 Identities=28% Similarity=0.412 Sum_probs=203.9
Q ss_pred CCEEEECCCEEEEEEEECCC----CEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEEC-CCCCEEEEEE
Q ss_conf 77474308389999993699----899999901688999763106999999850478630124426752-8941899982
Q 001816 689 DNIIGKGGAGIVYKGLMPNG----DQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-HETNLLVYEY 763 (1010)
Q Consensus 689 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~ 763 (1010)
.++||+|+||+||+|++..+ ..||||+++... .......|.+|++++++++||||++++|++.+ ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 669813688099999997799879999999988436-9789999999999998678999867867898069943899987
Q ss_pred CCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 28999875612477898884469999999999956875149996585157789289768996599001343114679985
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 843 (1010)
+++|+|.+++.. .....++..+..++.|++.|+.|+|+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 111 ~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 111 MKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EECCCHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 406741442101-3454048999999999887652003367---625776687576779998899106523225566555
Q ss_pred --CEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf --100000253333681311149988637652266999998929998889999752999999983101123000149999
Q 001816 844 --ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPRL 921 (1010)
Q Consensus 844 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (1010)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......+....+ ... ..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i---~~g-----------~~ 252 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQG-----------RR 252 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH---HTT-----------CC
T ss_pred CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HCC-----------CC
T ss_conf 3100256555645567688743799974574661999999997899998889999999999---808-----------98
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 999978899999999841165988999999999998339999
Q 001816 922 PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELPKP 963 (1010)
Q Consensus 922 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~~~ 963 (1010)
+..+...+..+.+++.+||+.||++||++.||++.|+.+...
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 899644759999999997688976893999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=350.48 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=209.1
Q ss_pred CCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCC-CCCCCHHHHHHHHHCCCCCCCCEEEEEEECCC---
Q ss_conf 1025677677474308389999993-699899999901688999-76310699999985047863012442675289---
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE--- 755 (1010)
Q Consensus 681 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 755 (1010)
.+.++|++.+.||+|+||+||+|+. .+|+.||||+++...... .....+.+|+++++.++||||+++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCC
T ss_conf 70620698689960899299999999999899999985566469899999999999998569998873114354326887
Q ss_pred -CCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf -4189998228999875612477898884469999999999956875149996585157789289768996599001343
Q 001816 756 -TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 756 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a 834 (1010)
..|+||||++||+|.+++. ..+.+++.++..++.|++.|++|||+.+ |+||||||+||+++.++..+++|||.+
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred CEEEEEEECCCCCEEHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf 66999997788987101120--3589999999999999999999998579---527634675566575432010034443
Q ss_pred CCCCCCCC-CCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 11467998-51000002533336813111499886376522669999989299988899997529999999831011230
Q 001816 835 KFLQDSGT-SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 835 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
........ ........||+.|+|||++.+..++.++||||+|+++|||+||+.||...... +.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~~~~~~---- 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVRED---- 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCC----
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHH----HHHHHHHHCC----
T ss_conf 22123544333346425762436999983999996632026528999997697998996999----9999998469----
Q ss_pred CCCCCCCCC-CCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHCC
Q ss_conf 001499999-99978899999999841165988999-999999998339
Q 001816 914 LKILDPRLP-SVPLHEVMHVFYVAMLCVEEQAVERP-TMREVVQILTEL 960 (1010)
Q Consensus 914 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ei~~~L~~~ 960 (1010)
+..+ ......+..+.+++.+|++.||++|| +++++.+.|..+
T Consensus 231 -----~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 231 -----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -----CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf -----99971003478999999999986679767773999999999997
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.17 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=210.7
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC--------CCEEEEEEECCCCCCCCCCCCHHHHHHHHHCC-CCCCCCEEEEEEEC
Q ss_conf 2567767747430838999999369--------98999999016889997631069999998504-78630124426752
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPN--------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI-RHRHIVRLLGFCSN 753 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 753 (1010)
.++|++.+.||+|+||.||+|+... +..||||+++.... ......+.+|+..+.++ +||||+++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128-68899999999999981399969734652201
Q ss_pred CCCCEEEEEECCCCCHHHHHCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEE
Q ss_conf 894189998228999875612477--------------898884469999999999956875149996585157789289
Q 001816 754 HETNLLVYEYMPNGSLGEVLHGKK--------------GGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNIL 819 (1010)
Q Consensus 754 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nil 819 (1010)
++..++||||+++|+|.+++.... ...+++.++..++.|++.|++|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEE
T ss_conf 88689999736999099999860677643222334574346799999999999999998766379---786302210224
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCH
Q ss_conf 76899659900134311467998510000025333368131114998863765226699999892-99988899997529
Q 001816 820 LDSGFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDI 898 (1010)
Q Consensus 820 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~ 898 (1010)
++.++.+||+|||+++...............|++.|+|||++.+..|+.++||||||+++|||++ |..||..... ...
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-~~~ 246 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EEL 246 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHH
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH-HHH
T ss_conf 5478976762211101135555543146678884663266751798882555477588888740179898999999-999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 99999983101123000149999999978899999999841165988999999999998339
Q 001816 899 VQWVRKMTDSKKEGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~ 960 (1010)
...+.. ...+..+...+..+.+++.+||+.||++|||++||++.|+.+
T Consensus 247 ---~~~i~~-----------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 ---FKLLKE-----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHT-----------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHC-----------CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ---999972-----------888898743529999999997667976793999999999888
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.93 Aligned_cols=272 Identities=20% Similarity=0.287 Sum_probs=208.3
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 5677677474308389999993-699899999901688999763106999999850478630124426752894189998
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 762 (1010)
+.|+..+.||+|+||+||+|+. .+|+.||||+++...........+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 22899987561247789888446999999999995687514999658515778928976899659900134311467998
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 842 (1010)
|+.+ .+.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCC--
T ss_conf 2377-4455544202568888999999999999999865288---992135711401134676210357861343688--
Q ss_pred CCEEEEECCCCCCCCHHHHCCCC-CCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCC---CCCC--
Q ss_conf 51000002533336813111499-88637652266999998929998889999752999999983101123---0001--
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG---VLKI-- 916 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 916 (1010)
........|++.|+|||+..... ++.++||||+|+++|+|++|+.||....................... ....
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCC
T ss_conf 64100103652154112213665777422103333134279668799898899999999998328983331444222421
Q ss_pred CCCCCCC---C-----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCCC
Q ss_conf 4999999---9-----97889999999984116598899999999999--83399
Q 001816 917 LDPRLPS---V-----PLHEVMHVFYVAMLCVEEQAVERPTMREVVQI--LTELP 961 (1010)
Q Consensus 917 ~~~~~~~---~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~--L~~~~ 961 (1010)
.....+. . ....+..+.+++.+|+..||++|||++|++++ ++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 2434543222204441667899999999997639955791899996787014699
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.73 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=206.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC--CC--CEEEEEEECCCCCC-CCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
Q ss_conf 56776774743083899999936--99--89999990168899-976310699999985047863012442675289418
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP--NG--DQVAVKRLPAMSRG-SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNL 758 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 758 (1010)
+.|+..+.||+|+||.||+|+.. ++ ..||||+++..... ....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99982289998756124778988844699999999999568751499965851577892897689965990013431146
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQ 838 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 838 (1010)
+||||+++|++.+++.. ..+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEECCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 14654238612544421-2689999999999999999998752178---7520566888156556543325611555303
Q ss_pred CCCCCCE-EEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 7998510-000025333368131114998863765226699999892-99988899997529999999831011230001
Q 001816 839 DSGTSEC-MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIT-GRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI 916 (1010)
Q Consensus 839 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (1010)
....... .....|+..|+|||++.+..++.++||||||+++|||+| |+.||.+.... +. ...+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~---~~~i~~~-------- 230 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QI---LHKIDKE-------- 230 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HH---HHHHHTS--------
T ss_pred CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH-HH---HHHHHHC--------
T ss_conf 58875265476325731079999837999942156614899999996899999996999-99---9999847--------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 49999999978899999999841165988999999999998339
Q 001816 917 LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTEL 960 (1010)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~ 960 (1010)
+..+..+...+..+.+++.+||+.||++|||++||.+.|++.
T Consensus 231 --~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 --GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf --999998544539999999997688966792999999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.29 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=200.7
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCC-CCCCCCCHHHHHHHHH-CCCCCCCCEEEEEEECCCCCEEE
Q ss_conf 56776774743083899999936-998999999016889-9976310699999985-04786301244267528941899
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSR-GSSHDHGFNAEIQTLG-RIRHRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv 760 (1010)
+.|++.+.||+|+||+||+|+.. +|+.||||+++.... .......+..|...+. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 98228999875612477898884469999999999956875149996585157789289768996599001343114679
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDS 840 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 840 (1010)
|||+++|+|.+++. ..+.+++.++..++.||+.|++|||+.+ |+||||||+|||++.++.+|++|||+++.....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEECCCCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf 75037980899864--0478999999999999999999998689---340347654044448996301555302323566
Q ss_pred CCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 98510000025333368131114998863765226699999892999888999975299999998310112300014999
Q 001816 841 GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKILDPR 920 (1010)
Q Consensus 841 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (1010)
........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... .+....+... .+.
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~---------~~~ 221 (320)
T d1xjda_ 157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMD---------NPF 221 (320)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC---------CCC
T ss_pred --CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHCC---------CCC
T ss_conf --5334545787776899998279988323201122789898738899999899----9999999718---------998
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 9999978899999999841165988999999-9999
Q 001816 921 LPSVPLHEVMHVFYVAMLCVEEQAVERPTMR-EVVQ 955 (1010)
Q Consensus 921 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ei~~ 955 (1010)
. +...+..+.+++.+|+..||++||++. ++++
T Consensus 222 ~---p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 Y---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C---CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 9---75679999999999654489878388999980
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=343.18 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=205.0
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCC-------CCCHHHHHHHHHCCC-CCCCCEEEEEEEC
Q ss_conf 25677677474308389999993-69989999990168899976-------310699999985047-8630124426752
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSH-------DHGFNAEIQTLGRIR-HRHIVRLLGFCSN 753 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~-------~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 753 (1010)
.+.|+..+.||+|+||+||+|+. .+|+.||||+++........ ...+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf 89418999822899987561247789888446999999999995687514999658515778928976899659900134
Q 001816 754 HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 754 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~ 833 (1010)
++..|+||||+++|+|.+++.. .+.+++.++..++.||+.|++|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCCEEEEEECCCCCHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 7605999976898668999986--599999999999999999999998759---94323462548986899838712403
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCHHHHCC------CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 311467998510000025333368131114------99886376522669999989299988899997529999999831
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYT------LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD 907 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 907 (1010)
++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... .. ...+..
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~---~~~i~~ 229 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LM---LRMIMS 229 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH---HHHHHH
T ss_pred EEECCCCC---CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH-HH---HHHHHH
T ss_conf 16726887---213452467888988860534456788992331856560231032288898899999-99---999981
Q ss_pred HCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 011230001499999-9997889999999984116598899999999999
Q 001816 908 SKKEGVLKILDPRLP-SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 908 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
... ..+ ......+..+.+++.+|++.||++|||++|++++
T Consensus 230 ~~~---------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNY---------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCC---------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCC---------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 898---------88985434689999999999765896689199999739
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.63 Aligned_cols=266 Identities=26% Similarity=0.340 Sum_probs=200.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCC----CCE
Q ss_conf 2567767747430838999999369989999990168899976310699999985047863012442675289----418
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE----TNL 758 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~ 758 (1010)
.+.|...+.||+|+||.||+|++ +|+.||||+++... .....++.|+..+..++||||+++++++.+.+ ..|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 86899988982078819999999-99899999987200---467999999999962799868326889983798604899
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf 999822899987561247789888446999999999995687514-----999658515778928976899659900134
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD-----CSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~ 833 (1010)
+||||+++|+|.+++++. .++|..+..++.|++.|+.|+|.. ++++|+||||||+|||++.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf 999646698989998658---99989999999999999999887665204689866153173135786887768876386
Q ss_pred CCCCCCCCCCC--EEEEECCCCCCCCHHHHCCCC------CCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCC--------
Q ss_conf 31146799851--000002533336813111499------88637652266999998929998889999752--------
Q 001816 834 AKFLQDSGTSE--CMSAIAGSYGYIAPEYAYTLK------VDEKSDVYSFGVVLLELITGRKPVGEFGDGVD-------- 897 (1010)
Q Consensus 834 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il~elltg~~P~~~~~~~~~-------- 897 (1010)
++......... ......||+.|+|||++.+.. ++.++||||||+++|||+||..||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC
T ss_conf 62346777620013552503547678221056545467776750122015999999962899887663112410122556
Q ss_pred --HHHHHHHHHHHCCCCCCCCCCCCCCCC--CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf --999999983101123000149999999--9788999999998411659889999999999983399
Q 001816 898 --IVQWVRKMTDSKKEGVLKILDPRLPSV--PLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 898 --~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 961 (1010)
......... ......|.++.. +......+.+++.+||+.||++|||+.||++.|+++.
T Consensus 235 ~~~~~~~~~~~------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 235 DPSVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SCCHHHHHHHH------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHH------HCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 43099999987------502468887765577689999999999976069858959999999999888
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.19 Aligned_cols=272 Identities=20% Similarity=0.251 Sum_probs=205.2
Q ss_pred CCCCCCCCCEEEECCCEEEEEEEE-CC-CCEEEEEEECCCCCCCCCCCCHHHHHHHHHCC---CCCCCCEEEEEEEC---
Q ss_conf 025677677474308389999993-69-98999999016889997631069999998504---78630124426752---
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PN-GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRI---RHRHIVRLLGFCSN--- 753 (1010)
Q Consensus 682 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~--- 753 (1010)
..++|++.+.||+|+||+||+|+. ++ ++.||||+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCCCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf --894189998228999875612477898884469999999999956875149996585157789289768996599001
Q 001816 754 --HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 754 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~Df 831 (1010)
....+++|||++++.+..... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCCEEEEEEEECCCCCHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 66746999997405871444443-03789998999999999999999997588---983579862789858997542100
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 34311467998510000025333368131114998863765226699999892999888999975299999998310112
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 832 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
|.+..... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||....+.................
T Consensus 161 g~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred HHHHHHCC---CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHH
T ss_conf 01011002---345777654851148310017988811100032899999987879989989899999999840799611
Q ss_pred CCC-------CCC----CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCC
Q ss_conf 300-------014----999999997889999999984116598899999999999--8339
Q 001816 912 GVL-------KIL----DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI--LTEL 960 (1010)
Q Consensus 912 ~~~-------~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~--L~~~ 960 (1010)
... ... ...........+..+.+++.+|++.||++|||++|++++ ++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 05321111033302234564544044589999999999874896679189999669634075
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=341.93 Aligned_cols=266 Identities=20% Similarity=0.276 Sum_probs=208.0
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
Q ss_conf 56776774743083899999936998999999016889997631069999998504786301244267528941899982
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 763 (1010)
++|+..+.||+|+||+||+|+.++|+.||||+++...........+.+|+.++++++||||+++++++..++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 28999875612477898884469999999999956875149996585157789289768996599001343114679985
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGTS 843 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 843 (1010)
+.++.+..+. ...+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EHHHHHHHHH--HHCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCC--
T ss_conf 0045678998--60477514456899999999999860574---8826787750568689978732366430114676--
Q ss_pred CEEEEECCCCCCCCHHHHCCC-CCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-----C
Q ss_conf 100000253333681311149-9886376522669999989299988899997529999999831011230001-----4
Q 001816 844 ECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGVLKI-----L 917 (1010)
Q Consensus 844 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 917 (1010)
.......|++.|+|||.+.+. .++.++||||+|+++|||++|+.||.+........+................ .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 54101024311013788717888884100211175899997797998988989999999986389971104212333221
Q ss_pred CCCC--------CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9999--------99997889999999984116598899999999999
Q 001816 918 DPRL--------PSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
+... .......+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43333356764666512589999999999866896689099998569
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.64 Aligned_cols=268 Identities=22% Similarity=0.338 Sum_probs=204.9
Q ss_pred CCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCC----
Q ss_conf 1025677677474308389999993-69989999990168899976310699999985047863012442675289----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE---- 755 (1010)
Q Consensus 681 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 755 (1010)
++.++|+..+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++++.++||||+++++++...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ECCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 44771899889801778199999999999899999985222596999999999999986689875479998635765555
Q ss_pred --CCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf --418999822899987561247789888446999999999995687514999658515778928976899659900134
Q 001816 756 --TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGL 833 (1010)
Q Consensus 756 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~ 833 (1010)
+.|+||||+ +++|..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEEECC-CCCHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 41599998405-521899987---402269999999999999999987378---76456685111121001221134310
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCHHHHCC-CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCC--
Q ss_conf 311467998510000025333368131114-99886376522669999989299988899997529999999831011--
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK-- 910 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 910 (1010)
|+..... .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||.....................
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred EECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHH
T ss_conf 2206876-----31024553335889981787899650103003899999978699888976899999985037884888
Q ss_pred -------------CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCC
Q ss_conf -------------2300014999999997889999999984116598899999999999--8339
Q 001816 911 -------------EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI--LTEL 960 (1010)
Q Consensus 911 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~--L~~~ 960 (1010)
....+................+.+++.+|+..||++|||++|++++ ++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 86530003443311578666556677556899999999999772995579299999639623758
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.02 Aligned_cols=272 Identities=18% Similarity=0.225 Sum_probs=205.8
Q ss_pred CCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEEC------
Q ss_conf 1025677677474308389999993-699899999901688999763106999999850478630124426752------
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN------ 753 (1010)
Q Consensus 681 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------ 753 (1010)
+-.++|++.+.||+|+||+||+|+. .+|+.||||++............+.+|++++++++|||++++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf 76279889999722748299999998999799999984222463789999999999998359996606765402465444
Q ss_pred --CCCCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf --894189998228999875612477898884469999999999956875149996585157789289768996599001
Q 001816 754 --HETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 754 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~Df 831 (1010)
.+..|+||||++++.+.... .....+++..+..++.|++.|+.|||+.+ |+||||||+|||++.++.+|++||
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCCCEEEEEEECCCCCCCCHHH--HCCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEEC
T ss_conf 4576389998535787410122--20344330899999999999998852299---885676722203668996876313
Q ss_pred CCCCCCCCCCC--CCEEEEECCCCCCCCHHHHCCC-CCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 34311467998--5100000253333681311149-98863765226699999892999888999975299999998310
Q 001816 832 GLAKFLQDSGT--SECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDS 908 (1010)
Q Consensus 832 G~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 908 (1010)
|++........ .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....+... ...+......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~ 240 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGS 240 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHH-HHHHHHHCCC
T ss_conf 500223554443211356602497874289970799989178700678646617448799899899999-9999984189
Q ss_pred CCCCC-CCCC---------CCCCCCCCHH-------HHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 11230-0014---------9999999978-------8999999998411659889999999999983
Q 001816 909 KKEGV-LKIL---------DPRLPSVPLH-------EVMHVFYVAMLCVEEQAVERPTMREVVQILT 958 (1010)
Q Consensus 909 ~~~~~-~~~~---------~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~ 958 (1010)
..... .... .......... ....+.+++.+|++.||++|||++|++++-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 9825534432034443320133445550334044459989999999987389658909999974950
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.46 Aligned_cols=243 Identities=21% Similarity=0.349 Sum_probs=196.8
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCC----CCCCCHHHHHHHHHCCC--CCCCCEEEEEEECCC
Q ss_conf 25677677474308389999993-699899999901688999----76310699999985047--863012442675289
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGS----SHDHGFNAEIQTLGRIR--HRHIVRLLGFCSNHE 755 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~ 755 (1010)
.++|++.+.||+|+||+||+|+. .+|+.||||+++...... .....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CCEEEEEECCC-CCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC-CCCEEEEECCC
Q ss_conf 41899982289-99875612477898884469999999999956875149996585157789289768-99659900134
Q 001816 756 TNLLVYEYMPN-GSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-GFEAHVADFGL 833 (1010)
Q Consensus 756 ~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-~~~~kl~DfG~ 833 (1010)
..|+||||+.+ +++.+++. ....+++..+..++.|++.|++|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEEECCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf 68999983368622899986--1589999999999999999999998779---755667611147744788489775465
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCC-CCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 311467998510000025333368131114998-8637652266999998929998889999752999999983101123
Q 001816 834 AKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKV-DEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG 912 (1010)
Q Consensus 834 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 912 (1010)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .+....
T Consensus 158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~--- 220 (273)
T d1xwsa_ 158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQ--- 220 (273)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCC---
T ss_pred CEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH----------HHHHCC---
T ss_conf 3532444----55665658774799998489978865332554034536756889988736----------776154---
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 00014999999997889999999984116598899999999999
Q 001816 913 VLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
.. .+...+..+.+++.+|++.||++|||++|++++
T Consensus 221 ------~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ------VF---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------CC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CC---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------47---787799999999999760897589399998539
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.52 Aligned_cols=266 Identities=26% Similarity=0.310 Sum_probs=195.5
Q ss_pred CCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECC------CCC
Q ss_conf 6776774743083899999936-998999999016889997631069999998504786301244267528------941
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------ETN 757 (1010)
Q Consensus 685 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~ 757 (1010)
.|+..++||+|+||+||+|+.. +|+.||||+++.... .+.+|++++++++||||+++++++... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 76751698217683999999999997999999881606------899999999866898987387899744765773189
Q ss_pred EEEEEECCCCCHHHHHC-CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC-CEEEEECCCCC
Q ss_conf 89998228999875612-47789888446999999999995687514999658515778928976899-65990013431
Q 001816 758 LLVYEYMPNGSLGEVLH-GKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAK 835 (1010)
Q Consensus 758 ~lv~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~~kl~DfG~a~ 835 (1010)
|+||||++++.+..... ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHH
T ss_conf 999841688607888863103689999999999999999999998668---76457886037873589711673366054
Q ss_pred CCCCCCCCCEEEEECCCCCCCCHHHHCC-CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCC---
Q ss_conf 1467998510000025333368131114-998863765226699999892999888999975299999998310112---
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYT-LKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE--- 911 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 911 (1010)
..... .......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.............+.......+
T Consensus 172 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 172 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp ECCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred HCCCC---CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHH
T ss_conf 40477---653200255555682776404688821000246527785502879989879999999999974898177654
Q ss_pred ----CCCCCCCCCCC------CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCCCC
Q ss_conf ----30001499999------9997889999999984116598899999999999--833999
Q 001816 912 ----GVLKILDPRLP------SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI--LTELPK 962 (1010)
Q Consensus 912 ----~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~--L~~~~~ 962 (1010)
......-+... .........+.+++.+|+..||++|||++|++++ ++++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 306210110355445674444315689999999999976589557929999966984524667
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.12 Aligned_cols=269 Identities=20% Similarity=0.276 Sum_probs=200.0
Q ss_pred CCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCC----
Q ss_conf 1025677677474308389999993-69989999990168899976310699999985047863012442675289----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE---- 755 (1010)
Q Consensus 681 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 755 (1010)
++..+|++.+.||+|+||+||+|.. .+|+.||||++.... .......+.+|+++++.++||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCC
T ss_conf 73898599789940648099999999999499999980310-95899999999999997689898858889950564554
Q ss_pred CCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 41899982289998756124778988844699999999999568751499965851577892897689965990013431
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~ 835 (1010)
..+++++++.+|+|.+++.. ..+++..+..++.|++.|++|||+.+ |+||||||+|||++.++.+||+|||+|.
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEEECCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 14999996259865664405---89999999999999999999999789---8677787643788799977875457056
Q ss_pred CCCCCCCC-CEEEEECCCCCCCCHHHHC-CCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCC-
Q ss_conf 14679985-1000002533336813111-49988637652266999998929998889999752999999983101123-
Q 001816 836 FLQDSGTS-ECMSAIAGSYGYIAPEYAY-TLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG- 912 (1010)
Q Consensus 836 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 912 (1010)
........ ......+|++.|+|||++. +..++.++||||+|+++|||++|+.||.......................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 50477764101011026520003878604788874101004670133776697997888889999987652069975664
Q ss_pred -------C--CCCCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------0--001499999999-----7889999999984116598899999999999
Q 001816 913 -------V--LKILDPRLPSVP-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 -------~--~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
. .....+.....+ ......+.+++.+|+..||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2343322220244677557787778378999999999999764895679089998619
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=322.51 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=200.4
Q ss_pred CCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCC-EEEEEEECCCCCEE
Q ss_conf 025677677474308389999993-6998999999016889997631069999998504786301-24426752894189
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIV-RLLGFCSNHETNLL 759 (1010)
Q Consensus 682 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~~~~l 759 (1010)
+-++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+..|+++++.++|++++ .+.+++.+++..++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred ECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
T ss_conf 88889996898507880999999988998999999721005----88899999999970389960179999951987789
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC---CCCEEEEECCCCCC
Q ss_conf 998228999875612477898884469999999999956875149996585157789289768---99659900134311
Q 001816 760 VYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS---GFEAHVADFGLAKF 836 (1010)
Q Consensus 760 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~---~~~~kl~DfG~a~~ 836 (1010)
||||+ ++++.+.+. ...+.+++..+..++.|++.|++|||+.+ |+||||||+||+++. +..++++|||+|+.
T Consensus 81 vme~~-~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 81 VMELL-GPSLEDLFN-FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEECC-CCBHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEC-CCCHHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEE
T ss_conf 99873-871333244-30688768999999999999999999799---44266787660643357776156504675134
Q ss_pred CCCCCCC-----CEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 4679985-----10000025333368131114998863765226699999892999888999975299999998310112
Q 001816 837 LQDSGTS-----ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKE 911 (1010)
Q Consensus 837 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 911 (1010)
+...... .......||+.|||||++.+..++.++||||||+++|||++|+.||.............+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred CCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf 25544554100013577678735329999918998983218861778999984987665530577999999852356789
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 30001499999999788999999998411659889999999999983399
Q 001816 912 GVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 961 (1010)
.... . ....+..+.+++..||+.+|++||+++++.+.|+.+.
T Consensus 236 ~~~~-~-------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 PIEV-L-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp CHHH-H-------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CHHH-H-------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 8357-5-------3478899999999984399557919999999999999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.64 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=209.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf 5677677474308389999993-699899999901688999763106999999850478630124426752894189998
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 762 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 762 (1010)
++|++.+.||+|+||+||+|+. .+|+.||||+++...........+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 22899987561247789888446999999999995687514999658515778928976899659900134311467998
Q 001816 763 YMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKFLQDSGT 842 (1010)
Q Consensus 763 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 842 (1010)
++.++++..++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||.|........
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ECCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC
T ss_conf 023322211212--3565403678999999999987743399---86001467612113378266520460110468875
Q ss_pred CCEEEEECCCCCCCCHHHHCCCC-CCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCC----CCCCC
Q ss_conf 51000002533336813111499-88637652266999998929998889999752999999983101123----00014
Q 001816 843 SECMSAIAGSYGYIAPEYAYTLK-VDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG----VLKIL 917 (1010)
Q Consensus 843 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 917 (1010)
......+++.|+|||++.... ++.++||||+||++|||++|+.||....+..+....+........+. .....
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCC
T ss_conf --100103443101466750698888044402654188998518999988999999999998611899735513443222
Q ss_pred ----------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----------999999997889999999984116598899999999999
Q 001816 918 ----------DPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 918 ----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
..............+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1133444544310433065689999999999864996689099999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.37 Aligned_cols=264 Identities=22% Similarity=0.260 Sum_probs=203.4
Q ss_pred CCCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECC------
Q ss_conf 0256776774743083899999936-998999999016889997631069999998504786301244267528------
Q 001816 682 VLDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH------ 754 (1010)
Q Consensus 682 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------ 754 (1010)
+.++|++.++||+|+||+||+|... +|+.||||+++...........+.+|+.++++++||||+++++++...
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 33775998896217585999999999998999999882336979999999999999864898764899897025643457
Q ss_pred CCCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 94189998228999875612477898884469999999999956875149996585157789289768996599001343
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a 834 (1010)
...|+||||+.++.+ +.+. ..+++..++.++.|++.|+.|||..| |+||||||+|||++.++.++++|||.+
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CEEEEEEECCCHHHH-HHHH----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 626999841446778-7650----38999999999999999998865221---124567763211365443132010232
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHC-----
Q ss_conf 114679985100000253333681311149988637652266999998929998889999752999999983101-----
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSK----- 909 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~----- 909 (1010)
+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+..................
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred HCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHH
T ss_conf 11466---655332214655558133147777877433356625789865989988897788999999720589879998
Q ss_pred --CCCC---------------CCC----CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --1230---------------001----4999999997889999999984116598899999999999
Q 001816 910 --KEGV---------------LKI----LDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 910 --~~~~---------------~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
.... ... ..+.........+..+.+++.+|+..||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 76566777764175435666421264333543210133379999999999876994579089999669
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=320.00 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=206.0
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCC-CCCCEEEEEEECCCCCEEE
Q ss_conf 256776774743083899999936-99899999901688999763106999999850478-6301244267528941899
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP-NGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRH-RHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 760 (1010)
-++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+|++.++.++| ++++.+++++..+...++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
T ss_conf 9806997998417882999999988997999999750258----299999999999964899987799996018811799
Q ss_pred EEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECC-----CCCEEEEECCCCC
Q ss_conf 98228999875612477898884469999999999956875149996585157789289768-----9965990013431
Q 001816 761 YEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS-----GFEAHVADFGLAK 835 (1010)
Q Consensus 761 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~-----~~~~kl~DfG~a~ 835 (1010)
|||+ +++|.+++.. .+..+++.++..++.|++.|++|+|+.+ |+||||||+||+++. ++.+||+|||+|+
T Consensus 80 me~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEC-CCCHHHHHHH-HCCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 9964-8887999975-2031106899999999999999999779---662667713152347543447956872366057
Q ss_pred CCCCCCCC-----CEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 14679985-----1000002533336813111499886376522669999989299988899997529999999831011
Q 001816 836 FLQDSGTS-----ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKK 910 (1010)
Q Consensus 836 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 910 (1010)
.+...... .......||+.|||||++.+..+++++||||+|+++|||++|+.||........... ...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-HHHHHHHHH
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHHHHCCC
T ss_conf 7146766541110246762775102679896488888699989831999999869876788530219999-999970567
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 230001499999999788999999998411659889999999999983399
Q 001816 911 EGVLKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQILTELP 961 (1010)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~~~ 961 (1010)
....+-+.+ .. +..+.+++..|+..+|++||+++.+.+.++++.
T Consensus 234 ~~~~~~l~~---~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 234 STPLRELCA---GF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HSCHHHHTT---TS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCHHHHCC---CC----CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 999589657---99----899999999984399300859999999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.78 Aligned_cols=256 Identities=24% Similarity=0.275 Sum_probs=207.1
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC----CCCEEEEEEECCCCC--CCCCCCCHHHHHHHHHCCCC-CCCCEEEEEEECCC
Q ss_conf 256776774743083899999936----998999999016889--99763106999999850478-63012442675289
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLMP----NGDQVAVKRLPAMSR--GSSHDHGFNAEIQTLGRIRH-RHIVRLLGFCSNHE 755 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~ 755 (1010)
.+.|+..+.||+|+||+||+|+.. +|+.||||+++.... .....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 10259998983287839999998765887948999998367721016899999999999986467983999620002487
Q ss_pred CCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 41899982289998756124778988844699999999999568751499965851577892897689965990013431
Q 001816 756 TNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLAK 835 (1010)
Q Consensus 756 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~ 835 (1010)
..++||||+.+|+|.+++. ..+.+++..+..++.|++.|+.|+|+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CEEEEEECCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 3001231234117999987--3045437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCCEEEEECCCCCCCCHHHHCCC--CCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 14679985100000253333681311149--9886376522669999989299988899997529999999831011230
Q 001816 836 FLQDSGTSECMSAIAGSYGYIAPEYAYTL--KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEGV 913 (1010)
Q Consensus 836 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (1010)
.+.... ........|++.|++||.+.+. .++.++||||+||++|||++|+.||.............+.....
T Consensus 178 ~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~----- 251 (322)
T d1vzoa_ 178 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----- 251 (322)
T ss_dssp ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred HHCCCC-CCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC-----
T ss_conf 203444-43221222333331068760577688713251777799999976899988887777999999833568-----
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 00149999999978899999999841165988999-----99999999
Q 001816 914 LKILDPRLPSVPLHEVMHVFYVAMLCVEEQAVERP-----TMREVVQI 956 (1010)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ei~~~ 956 (1010)
.+..+...+..+.+++.+|+++||++|| +++|++++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf -------99886547999999999974458988199974509999749
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=317.83 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=197.7
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCC-CCCCCEEEEEEEC--CCCCE
Q ss_conf 25677677474308389999993-69989999990168899976310699999985047-8630124426752--89418
Q 001816 683 LDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSN--HETNL 758 (1010)
Q Consensus 683 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~~~ 758 (1010)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|+++++.++ ||||+++++++.. ....+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEE
T ss_conf 86718978983174819999998899979999998889-----9999999999998515799876799999816877126
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 999822899987561247789888446999999999995687514999658515778928976899-6599001343114
Q 001816 759 LVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGF-EAHVADFGLAKFL 837 (1010)
Q Consensus 759 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~-~~kl~DfG~a~~~ 837 (1010)
+||||+++++|..+. +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+|++|||+|...
T Consensus 109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEEEECCCCCHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEEC
T ss_conf 888631798589974-----68999999999999999998876433---4434564412377489983664156542664
Q ss_pred CCCCCCCEEEEECCCCCCCCHHHHCCC-CCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH---------
Q ss_conf 679985100000253333681311149-9886376522669999989299988899997529999999831---------
Q 001816 838 QDSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTD--------- 907 (1010)
Q Consensus 838 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~--------- 907 (1010)
... .......+|+.|+|||...+. .++.++||||+|+++|||++|+.||....+..+....+.....
T Consensus 181 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 181 HPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 688---74443224864247610268888884523233545558760488999887601899999999878841555554
Q ss_pred ----HCCCCCCCCCCC--------CCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----011230001499--------999-9997889999999984116598899999999999
Q 001816 908 ----SKKEGVLKILDP--------RLP-SVPLHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 908 ----~~~~~~~~~~~~--------~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
............ ... ......+..+.+++.+|+..||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 22544474300000333433112115521124489999999999866995689089999649
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.98 Aligned_cols=265 Identities=20% Similarity=0.293 Sum_probs=201.2
Q ss_pred CCCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCCCEEEEEEECC-----
Q ss_conf 1025677677474308389999993-6998999999016889997631069999998504786301244267528-----
Q 001816 681 DVLDCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH----- 754 (1010)
Q Consensus 681 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 754 (1010)
++.++|++.+.||+|+||+||+|+. .+|+.||||+++...........+.+|+++++.++|||++++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 58987188889831788399999999999799999988200286899999999999986689874259999963464566
Q ss_pred CCCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEECCCC
Q ss_conf 94189998228999875612477898884469999999999956875149996585157789289768996599001343
Q 001816 755 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADFGLA 834 (1010)
Q Consensus 755 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a 834 (1010)
...+++++++.+|+|.+++.. +.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||.+
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred CCEEEEEEEECCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 864999996258862320022---45309999999999999999997388---765166776334554322001321000
Q ss_pred CCCCCCCCCCEEEEECCCCCCCCHHHHCCC-CCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHCCCC-
Q ss_conf 114679985100000253333681311149-988637652266999998929998889999752999999983101123-
Q 001816 835 KFLQDSGTSECMSAIAGSYGYIAPEYAYTL-KVDEKSDVYSFGVVLLELITGRKPVGEFGDGVDIVQWVRKMTDSKKEG- 912 (1010)
Q Consensus 835 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 912 (1010)
.... .......|++.|+|||...+. .++.++||||+|+++|+|++|+.||.....................+.
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCCC-----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 1257-----54444345435558355337756785512432058999997688997889889999999973079975773
Q ss_pred -------CCCCC--CCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------00014--99999999-----7889999999984116598899999999999
Q 001816 913 -------VLKIL--DPRLPSVP-----LHEVMHVFYVAMLCVEEQAVERPTMREVVQI 956 (1010)
Q Consensus 913 -------~~~~~--~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 956 (1010)
..... .+..+... ......+.+++.+|+..||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2001024454443035578755566267899999999999775883459389998559
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=307.68 Aligned_cols=292 Identities=37% Similarity=0.605 Sum_probs=227.8
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC--CCCCEEECCC---CCEEEEECCCCCCCC--CCCCCCCCCCCCCE
Q ss_conf 9944799999999936999988878968999998--7783484899---939999908998553--24846678898877
Q 001816 18 RTVPEYKALLSIKSSITDDPQSSLAAWNATTSHC--TWPGVTCDSR---RHVTSLDLSGLNLSG--ALSPDVAHLRFLQN 90 (1010)
Q Consensus 18 ~~~~~~~al~~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~---~~v~~L~l~~~~l~~--~~~~~~~~l~~L~~ 90 (1010)
+.+.|++||++||+++.+ | ..+++|..+.||| .|.||+|+.. .||+.|||+++++++ .+|+.+.++++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~-~-~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGN-P-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTC-C-GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCC-C-CCCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 898999999999997799-9-86778899999988948896974899947988998989988888879847846753352
Q ss_pred EECCC-CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCHHCCCCCCCEECCCCC
Q ss_conf 88136-61479899452133445331112632369888341246755432045753589998000101364401013665
Q 001816 91 LSVAA-NQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLHLGGNF 169 (1010)
Q Consensus 91 L~l~~-n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 169 (1010)
|+|++ |++.|.+|.+|+++++|++|+|++|++.+..+..+..+..|+++++++|.+.+.+|..+.+++.|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf 02026543330024311454200110203564344332222201110011112245555685122067400000023553
Q ss_pred CCCCCCCCCCCCCCC-CEEEECCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 777899888774558-6157035443222463223744046786102457777999333388778499834887888848
Q 001816 170 FSGQIPPEYGIWEFL-EYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPEIGNLSSLVRFDAANCGLSGEIP 248 (1010)
Q Consensus 170 l~~~~~~~~~~~~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 248 (1010)
+.+.+|..+..+..+ +.+++++|++++..+..+..+ ....+++..+...+.++
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l--------------------------~~~~l~l~~~~~~~~~~ 214 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL--------------------------NLAFVDLSRNMLEGDAS 214 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC--------------------------CCSEEECCSSEEEECCG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--------------------------CCCCCCCCCCCCCCCCC
T ss_conf 3562031214431123231022464353324332222--------------------------22233333343322222
Q ss_pred CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 22227788877881355577874200245676778975488576635811114689878965776246788800127785
Q 001816 249 TDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLFRNKLHGAIPEFIGVMPR 328 (1010)
Q Consensus 249 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 328 (1010)
..+..+.+++.+++.+|.+.+.+ ..+..+++|+.|+|++|++++.+|..|..+++|++|+|++|+++|.+|. ++.+.+
T Consensus 215 ~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~ 292 (313)
T d1ogqa_ 215 VLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQR 292 (313)
T ss_dssp GGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCC
T ss_conf 22222222111222222222222-2222455444444765706660876884799999897958835166898-666799
Q ss_pred CCCCCCCCCCC
Q ss_conf 46010345735
Q 001816 329 LEVLQLWENNF 339 (1010)
Q Consensus 329 L~~L~l~~N~l 339 (1010)
|+.+++++|+.
T Consensus 293 L~~l~l~~N~~ 303 (313)
T d1ogqa_ 293 FDVSAYANNKC 303 (313)
T ss_dssp SCGGGTCSSSE
T ss_pred CCHHHHCCCCC
T ss_conf 89788688950
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=281.15 Aligned_cols=262 Identities=19% Similarity=0.215 Sum_probs=190.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCC-----------CCCCCEEEEEE
Q ss_conf 5677677474308389999993-69989999990168899976310699999985047-----------86301244267
Q 001816 684 DCLKEDNIIGKGGAGIVYKGLM-PNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-----------HRHIVRLLGFC 751 (1010)
Q Consensus 684 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~~~~~~ 751 (1010)
.+|++.+.||+|+||+||+|+. .+|+.||||+++... .....+.+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEE
T ss_conf 85799899750778189999999999799999983431---336899999999998401455555422767647899876
Q ss_pred ECC--CCCEEEEEECCCCC-HHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEEECCCCCCEEECCCC---
Q ss_conf 528--94189998228999-8756124778988844699999999999568751-4999658515778928976899---
Q 001816 752 SNH--ETNLLVYEYMPNGS-LGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHH-DCSPLIVHRDVKSNNILLDSGF--- 824 (1010)
Q Consensus 752 ~~~--~~~~lv~e~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~Nill~~~~--- 824 (1010)
... ...+++++++..+. ............+++..+..++.|++.|+.|||+ .+ |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred EECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCC
T ss_conf 312565202343200035420000012234678689999999999999888764058---64656770570563057656
Q ss_pred ---CEEEEECCCCCCCCCCCCCCEEEEECCCCCCCCHHHHCCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCCCC---C-
Q ss_conf ---659900134311467998510000025333368131114998863765226699999892999888999975---2-
Q 001816 825 ---EAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGRKPVGEFGDGV---D- 897 (1010)
Q Consensus 825 ---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~elltg~~P~~~~~~~~---~- 897 (1010)
.++++|||.+...... .....|++.|+|||+..+..++.++||||+|+++++|++|+.||....... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHH
T ss_conf 4430567531442123445-----42236652105713214667776432012378999998788998987554321026
Q ss_pred --HHHHHHHHHHHCCC---------------CCCCCCCC-----------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf --99999998310112---------------30001499-----------999999788999999998411659889999
Q 001816 898 --IVQWVRKMTDSKKE---------------GVLKILDP-----------RLPSVPLHEVMHVFYVAMLCVEEQAVERPT 949 (1010)
Q Consensus 898 --~~~~~~~~~~~~~~---------------~~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 949 (1010)
....+..+.....+ .....+.. .........+..+.+++.+|+..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 89999999837998788624532200013201220243235776444210001567435899999999987799457908
Q ss_pred HHHHHHH
Q ss_conf 9999999
Q 001816 950 MREVVQI 956 (1010)
Q Consensus 950 ~~ei~~~ 956 (1010)
++|++++
T Consensus 322 a~e~L~H 328 (362)
T d1q8ya_ 322 AGGLVNH 328 (362)
T ss_dssp HHHHHTC
T ss_pred HHHHHCC
T ss_conf 9999669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=9.8e-45 Score=251.96 Aligned_cols=259 Identities=30% Similarity=0.527 Sum_probs=155.5
Q ss_pred CCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 67789754885766--3581111468987896577-62467888001277854601034573542379677788875379
Q 001816 280 SLKSMDLSNNIFTG--EIPASFAELKNLTLLNLFR-NKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRIL 356 (1010)
Q Consensus 280 ~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 356 (1010)
+++.|+|++|.+++ .+|..+.++++|++|+|++ |.+.+.+|..++.+++|++|++++|++.+..+..+..+..|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 98899898998888887984784675335202026543330024311454200110203564344332222201110011
Q ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 71685444678936679885115340366534665510125898866882797346887522689998976880176123
Q 001816 357 DLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLT 436 (1010)
Q Consensus 357 ~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 436 (1010)
++++|.+.+. +|..+..++.++.+++++|.+.
T Consensus 131 ~l~~N~~~~~------------------------------------------------~p~~l~~l~~L~~l~l~~n~l~ 162 (313)
T d1ogqa_ 131 DFSYNALSGT------------------------------------------------LPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp ECCSSEEESC------------------------------------------------CCGGGGGCTTCCEEECCSSCCE
T ss_pred CCCCCCCCCC------------------------------------------------CCHHHCCCCCCCEEECCCCCCC
T ss_conf 1122455556------------------------------------------------8512206740000002355335
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-EEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHH
Q ss_conf 3456786345433547424742458898777876674-198448984668783001133686689903872489995000
Q 001816 437 GQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGV-QKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEI 515 (1010)
Q Consensus 437 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 515 (1010)
+.+|..+..+..+ +.++++.|++++..+..+..+.. ..+++++|.+.+.++..+
T Consensus 163 ------------------------~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~ 217 (313)
T d1ogqa_ 163 ------------------------GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLF 217 (313)
T ss_dssp ------------------------EECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGC
T ss_pred ------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
T ss_conf ------------------------6203121443112323102246435332433222222-233333343322222222
Q ss_pred CCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 04786639985686322430001126430125770375456875143310244543136778455788998656677643
Q 001816 516 SQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYT 595 (1010)
Q Consensus 516 ~~~~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~ 595 (1010)
..++.++.+++++|.+.+.++ .+..++.|+.|+|++|+++|.+|..|.++++|+.|+|++|+++|.+|..+.+..+..+
T Consensus 218 ~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l 296 (313)
T d1ogqa_ 218 GSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS 296 (313)
T ss_dssp CTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGG
T ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHH
T ss_conf 222221112222222222222-2224554444447657066608768847999998979588351668986667998978
Q ss_pred CCCCCCCCCCCCCCCCC
Q ss_conf 56788667689999998
Q 001816 596 SFLGNSELCGPYLGPCK 612 (1010)
Q Consensus 596 ~~~~n~~lcg~~~~~c~ 612 (1010)
.+.||+.+||.|+|+|.
T Consensus 297 ~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 297 AYANNKCLCGSPLPACT 313 (313)
T ss_dssp GTCSSSEEESTTSSCCC
T ss_pred HHCCCCCCCCCCCCCCC
T ss_conf 86889500198988989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=4e-40 Score=227.35 Aligned_cols=81 Identities=23% Similarity=0.284 Sum_probs=37.8
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCHHCCCCCCCEE
Q ss_conf 89887788136614798994521334453311126323698883412467554320457535899980001013644010
Q 001816 85 LRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMTGDLPLAVTQLRNLRHLH 164 (1010)
Q Consensus 85 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 164 (1010)
+..|++|+++++.|+.. +.++.+++|++|+|++|+|++ ++ .++++++|++|++++|.+.+. + .+..+++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred HCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCC
T ss_conf 57878998999898776--242458999989681881798-86-334771101030134333222-2-111233433344
Q ss_pred CCCCCCC
Q ss_conf 1366577
Q 001816 165 LGGNFFS 171 (1010)
Q Consensus 165 L~~n~l~ 171 (1010)
+++|.++
T Consensus 117 ~~~~~~~ 123 (384)
T d2omza2 117 LFNNQIT 123 (384)
T ss_dssp CCSSCCC
T ss_pred CCCCCCC
T ss_conf 3322222
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=5e-40 Score=226.80 Aligned_cols=101 Identities=20% Similarity=0.365 Sum_probs=50.5
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEE
Q ss_conf 76674198448984668783001133686689903872489995000047866399856863224300011264301257
Q 001816 469 KFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYL 548 (1010)
Q Consensus 469 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L 548 (1010)
.+..++.+.++.|.+++ + ..+..++.++.|++++|++++.. .+..+++|+.|++++|++++ ++ .+..+++|++|
T Consensus 283 ~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L 356 (384)
T d2omza2 283 GLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWL 356 (384)
T ss_dssp TCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCC-C-CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEE
T ss_conf 56522223323233333-2-21000024676777788778984--53668988989898998999-74-67089999989
Q ss_pred EECCCCCCCCCHHHHHCCCCCCEECCCCC
Q ss_conf 70375456875143310244543136778
Q 001816 549 NLSRNHLVGSIPASIASMQSLTSVDFSYN 577 (1010)
Q Consensus 549 ~ls~N~l~~~~~~~~~~l~~L~~l~ls~N 577 (1010)
++++|++++..| +.++++|+.|++++|
T Consensus 357 ~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 897995899800--003999999639789
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-36 Score=206.24 Aligned_cols=242 Identities=21% Similarity=0.245 Sum_probs=109.5
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf 99089985532484667889887788136614798994521334453311126323698883412467554320457535
Q 001816 67 LDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNM 146 (1010)
Q Consensus 67 L~l~~~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l 146 (1010)
+|.++++++ .+|..+. +.+++|++++|+|+...+.+|.++++|++|++++|.+....|..|..+++|++|++++|++
T Consensus 15 ~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l 91 (305)
T d1xkua_ 15 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91 (305)
T ss_dssp EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCC
T ss_conf 985599988-5198889--9979897849918986965760465652311234434452356652798557831568756
Q ss_pred CCCCCCCHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCC
Q ss_conf 89998000101364401013665777899888774558615703544322246322374404678610245777799933
Q 001816 147 TGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGGKIPGEIGNLTKLQQLYIGYYNSYTGGLPPE 226 (1010)
Q Consensus 147 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~ 226 (1010)
+ .+|..+ ...++.|++.+|.+....+..+.....+..++...|...
T Consensus 92 ~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~------------------------------- 137 (305)
T d1xkua_ 92 K-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK------------------------------- 137 (305)
T ss_dssp S-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC-------------------------------
T ss_pred C-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC-------------------------------
T ss_conf 7-676400--111323210246102344445401331100001233333-------------------------------
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 33887784998348878888482222778887788135557787420024567677897548857663581111468987
Q 001816 227 IGNLSSLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLT 306 (1010)
Q Consensus 227 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 306 (1010)
.....+..+..+++|+.+++.+|.+.... .. ..++|+.|++++|.++...+..|..++.++
T Consensus 138 ----------------~~~~~~~~~~~l~~L~~l~l~~n~l~~l~-~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~ 198 (305)
T d1xkua_ 138 ----------------SSGIENGAFQGMKKLSYIRIADTNITTIP-QG--LPPSLTELHLDGNKITKVDAASLKGLNNLA 198 (305)
T ss_dssp ----------------GGGBCTTGGGGCTTCCEEECCSSCCCSCC-SS--CCTTCSEEECTTSCCCEECTGGGTTCTTCC
T ss_pred ----------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CC--CCCCCCEEECCCCCCCCCCHHHHHCCCCCC
T ss_conf ----------------46777642234565671203467745167-10--177667898978867788826764134133
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 89657762467888001277854601034573542379677788875379716854446
Q 001816 307 LLNLFRNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKLTG 365 (1010)
Q Consensus 307 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 365 (1010)
.|++++|.+.+..+..+..+++|++|++++|+++ .+|..+..+++|++|+|++|+++.
T Consensus 199 ~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp EEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 0154455332223454334433224302554002-463110334678989898986576
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-35 Score=203.70 Aligned_cols=126 Identities=27% Similarity=0.376 Sum_probs=65.5
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 78499834887888848222277888778813555778742002456767789754885766358111146898789657
Q 001816 232 SLVRFDAANCGLSGEIPTDIGRLQNLDTLFLQVNALSGPLTTELGYLKSLKSMDLSNNIFTGEIPASFAELKNLTLLNLF 311 (1010)
Q Consensus 232 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 311 (1010)
..+.++.++.+++ .+|..+. +++++|+|++|+++...+..|.++++|++|++++|.+....+..|..+++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCCEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCC
T ss_conf 5999985599988-5198889--997989784991898696576046565231123443445235665279855783156
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 7624678880012778546010345735423796777888753797168544
Q 001816 312 RNKLHGAIPEFIGVMPRLEVLQLWENNFTGSIPQRLGSNGKLRILDLSSNKL 363 (1010)
Q Consensus 312 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 363 (1010)
+|+++. +|.. ....+..|.+.+|.+....+..+.....+..++...|..
T Consensus 88 ~n~l~~-l~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~ 136 (305)
T d1xkua_ 88 KNQLKE-LPEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 136 (305)
T ss_dssp SSCCSB-CCSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred CCCCCC-CCCC--HHHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 875676-7640--011132321024610234444540133110000123333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-35 Score=199.74 Aligned_cols=125 Identities=24% Similarity=0.240 Sum_probs=48.7
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCC-CCC
Q ss_conf 9908998553248466788988778813661479899452133445331112632369888341246755432045-753
Q 001816 67 LDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLY-NNN 145 (1010)
Q Consensus 67 L~l~~~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~-~n~ 145 (1010)
+++++++++ .+|..+. +.+++|+|++|.|+...+.+|..+++|++|++++|.+....+..+..+..+..++.. .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 984799989-4497889--9988897748817987977864142130000134454332111212222222222221022
Q ss_pred CCCCCCCCHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEEECCCCC
Q ss_conf 5899980001013644010136657778998887745586157035443
Q 001816 146 MTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNEL 194 (1010)
Q Consensus 146 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~L~~N~l 194 (1010)
+....+..|.++++|++|++++|.+....+..+.....|+.+++++|.+
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l 141 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCC
T ss_conf 3544620101010277875688544320135332000121102001431
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-34 Score=194.72 Aligned_cols=112 Identities=17% Similarity=0.236 Sum_probs=46.1
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf 47424742458898777876674198448984668783001133686689903872489995000047866399856863
Q 001816 451 QICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNE 530 (1010)
Q Consensus 451 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ls~N~ 530 (1010)
.|++++|+++...+..+..+++|+.+++++|++++..|..|..+++|+.||+++|++.+..+..|..+++|++|++++|.
T Consensus 157 ~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~ 236 (284)
T d1ozna_ 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236 (284)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSC
T ss_pred HCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 22314176566256665465634131421143466281676653200023333352210000023554656889811998
Q ss_pred CCCCCCHHCCCCCCCCEEEECCCCCCCCCHHHH
Q ss_conf 224300011264301257703754568751433
Q 001816 531 LSGEIPNQLTGMRILNYLNLSRNHLVGSIPASI 563 (1010)
Q Consensus 531 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 563 (1010)
+....+. ..-...++++....+.+....|..+
T Consensus 237 l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 237 WVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp EECSGGG-HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred CCCCCCC-HHHHHHHHHCCCCCCCEEECCCHHH
T ss_conf 8787564-6999999867388886674796698
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-30 Score=175.30 Aligned_cols=205 Identities=21% Similarity=0.200 Sum_probs=0.0
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 77788875379716854446789366798851153403665346655101258988668827973468875226899989
Q 001816 346 RLGSNGKLRILDLSSNKLTGTLPPDMCAGNCLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSL 425 (1010)
Q Consensus 346 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L 425 (1010)
.......+..+|.+++.++ .+|..+. ++++.|++++|.+....+..|.++++|
T Consensus 5 ~~~~~~~~~~v~C~~~~L~-------------------------~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L 57 (266)
T d1p9ag_ 5 EVSKVASHLEVNCDKRNLT-------------------------ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRL 57 (266)
T ss_dssp EEECSTTCCEEECTTSCCS-------------------------SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTC
T ss_pred EECCCCCCEEEECCCCCCC-------------------------EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCC
T ss_conf 7742689869980699988-------------------------6196757--688989884992898597786345655
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 76880176123345678634543354742474245889877787667419844898466878300113368668990387
Q 001816 426 SQVELQDNYLTGQFPVSDSISVNLGQICLSNNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHN 505 (1010)
Q Consensus 426 ~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 505 (1010)
++|+|++|.++...+. ..+++|+.|++++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|
T Consensus 58 ~~L~L~~N~l~~l~~~--~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n 134 (266)
T d1p9ag_ 58 TQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (266)
T ss_dssp CEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
T ss_conf 2213566544443111--11223211111222221-11112122222222222223110110011222211112212434
Q ss_pred CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCEECCCCCCCCC
Q ss_conf 2489995000047866399856863224300011264301257703754568751433102445431367784557
Q 001816 506 KFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSG 581 (1010)
Q Consensus 506 ~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~ 581 (1010)
.++...+..+..++.|+.+++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+.+|+.|++++|++.+
T Consensus 135 ~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCC
T ss_conf 210221233322111000000015652237200134212423430139785-568667778889999836999878
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=3.2e-26 Score=153.26 Aligned_cols=33 Identities=33% Similarity=0.341 Sum_probs=12.0
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf 4533111263236988834124675543204575358
Q 001816 111 SLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNNNMT 147 (1010)
Q Consensus 111 ~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n~l~ 147 (1010)
+|++|+|++|+|+ .+|..+ .+|++|++++|.++
T Consensus 59 ~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~ 91 (353)
T d1jl5a_ 59 HLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK 91 (353)
T ss_dssp TCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS
T ss_pred CCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC
T ss_conf 9888989999796-336203---32033266551432
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=2.4e-26 Score=153.92 Aligned_cols=94 Identities=27% Similarity=0.373 Sum_probs=35.1
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCC
Q ss_conf 99999089985532484667889887788136614798994521334453311126323698883412467554320457
Q 001816 64 VTSLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYN 143 (1010)
Q Consensus 64 v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~ 143 (1010)
+++|||++++++. +|.. +++|++|++++|+|+ .+|+.+ .+|+.|++++|.++ .++. + .+.|++|++++
T Consensus 40 l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCS
T ss_pred CCEEEECCCCCCC-CCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHH-H--CCCCCCCCCCC
T ss_conf 9899937999887-8898---789888989999796-336203---32033266551432-0321-0--22111113345
Q ss_pred CCCCCCCCCCHHCCCCCCCEECCCCCCC
Q ss_conf 5358999800010136440101366577
Q 001816 144 NNMTGDLPLAVTQLRNLRHLHLGGNFFS 171 (1010)
Q Consensus 144 n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 171 (1010)
|.+. .+|. +..+++|++|++++|.+.
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred CCCC-CCCC-HHHHCCCEEECCCCCCCC
T ss_conf 5432-2210-011013123113565100
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.96 E-value=2.3e-29 Score=170.05 Aligned_cols=165 Identities=13% Similarity=0.163 Sum_probs=118.7
Q ss_pred CCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCC--------C--------CCCHHHHHHHHHCCCCCCCCEEEEEE
Q ss_conf 6774743083899999936998999999016889997--------6--------31069999998504786301244267
Q 001816 688 EDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSS--------H--------DHGFNAEIQTLGRIRHRHIVRLLGFC 751 (1010)
Q Consensus 688 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--------~--------~~~~~~E~~~l~~l~hp~iv~~~~~~ 751 (1010)
+.++||+|+||+||+|...+|+.||||+++....... . ......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf 27780248565999999799999999998604434666556563000888999999778999999981699914499862
Q ss_pred ECCCCCEEEEEECCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCEEECCCCCEEEEEC
Q ss_conf 52894189998228999875612477898884469999999999956875149996585157789289768996599001
Q 001816 752 SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSGFEAHVADF 831 (1010)
Q Consensus 752 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~Nill~~~~~~kl~Df 831 (1010)
..+++|||++++.+.+ ++......++.|++.++.|||+.+ |+||||||+|||++++ .++++||
T Consensus 84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred ----CCEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEEEC
T ss_conf ----8889999504565420---------015789999999999999982688---8983689036114289-8999877
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCCHH-----HHCCCCCCCCCCEEHHHHHH
Q ss_conf 3431146799851000002533336813-----11149988637652266999
Q 001816 832 GLAKFLQDSGTSECMSAIAGSYGYIAPE-----YAYTLKVDEKSDVYSFGVVL 879 (1010)
Q Consensus 832 G~a~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~Di~slG~il 879 (1010)
|.|+........ .|.... ....+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCCCCCCCCCH----------HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 884308998709----------9998779999999757899844689999987
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.4e-32 Score=187.07 Aligned_cols=108 Identities=19% Similarity=0.248 Sum_probs=42.6
Q ss_pred CCEEECCCCCCCCCC-CCCCCCCCCCCEECCCCCCCCC----CCCCCCCCCCCCCEECCCCCCCCCCCCCCHH-----CC
Q ss_conf 877881366147989-9452133445331112632369----8883412467554320457535899980001-----01
Q 001816 88 LQNLSVAANQLSGPI-PPEISALSSLRLLNLSNNVFNG----SFPPQLSQLASLQVLDLYNNNMTGDLPLAVT-----QL 157 (1010)
Q Consensus 88 L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~Ls~n~i~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-----~l 157 (1010)
|+.||+++|++++.. ..-+..+++++.|+|++|.++. .+...+..+++|++|||++|.|+......+. ..
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~ 83 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 83 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred CCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCC
T ss_conf 77798208958868999999767799999828999988999999999853999888979598597289999999984378
Q ss_pred CCCCCEECCCCCCCCC----CCCCCCCCCCCCEEEECCCCCC
Q ss_conf 3644010136657778----9988877455861570354432
Q 001816 158 RNLRHLHLGGNFFSGQ----IPPEYGIWEFLEYLAVSGNELG 195 (1010)
Q Consensus 158 ~~L~~L~L~~n~l~~~----~~~~~~~~~~L~~L~L~~N~l~ 195 (1010)
.+|++|+|++|+++.. ++..+...++|++|++++|+++
T Consensus 84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 877887788877543221012110000343200244433202
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.5e-31 Score=180.49 Aligned_cols=109 Identities=27% Similarity=0.302 Sum_probs=50.8
Q ss_pred CEEEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEECCCCCCCCCCC----CCCCCC-
Q ss_conf 3999990899855324-8466788988778813661479----89945213344533111263236988----834124-
Q 001816 63 HVTSLDLSGLNLSGAL-SPDVAHLRFLQNLSVAANQLSG----PIPPEISALSSLRLLNLSNNVFNGSF----PPQLSQ- 132 (1010)
Q Consensus 63 ~v~~L~l~~~~l~~~~-~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~i~~~~----p~~l~~- 132 (1010)
.+.+||++++++++.. ..-+..+++++.|+|++|+++. .+...+..+++|+.|||++|.|+... ...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEECCCCCCCCCC----CCCCHHCCCCCCCEECCCCCCC
Q ss_conf 67554320457535899----9800010136440101366577
Q 001816 133 LASLQVLDLYNNNMTGD----LPLAVTQLRNLRHLHLGGNFFS 171 (1010)
Q Consensus 133 l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~ 171 (1010)
..+|++|+|++|+++.. ++..+..+++|++|++++|.+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 8877887788877543221012110000343200244433202
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.3e-25 Score=147.29 Aligned_cols=103 Identities=18% Similarity=0.175 Sum_probs=58.5
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC-CCCCCCCCCCCEECCCC-
Q ss_conf 9990899855324846678898877881366147989945213344533111263236988-83412467554320457-
Q 001816 66 SLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGPIPPEISALSSLRLLNLSNNVFNGSF-PPQLSQLASLQVLDLYN- 143 (1010)
Q Consensus 66 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~-p~~l~~l~~L~~L~L~~- 143 (1010)
.+++++.+++ .+|..+. +.+++|++++|.++...+.+|.++++|++|++++|.+...+ +..|..++.+++|++..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
T ss_conf 9998189988-7688889--988999876991896496686146432321102211242010011222222222111112
Q ss_pred CCCCCCCCCCHHCCCCCCCEECCCCCCC
Q ss_conf 5358999800010136440101366577
Q 001816 144 NNMTGDLPLAVTQLRNLRHLHLGGNFFS 171 (1010)
Q Consensus 144 n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 171 (1010)
|.+....+..|.++++|+++++++|.+.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf 3432222221222222222234211112
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.8e-25 Score=147.02 Aligned_cols=34 Identities=15% Similarity=0.148 Sum_probs=10.7
Q ss_pred CCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEE
Q ss_conf 0478663998568632243000112643012577
Q 001816 516 SQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLN 549 (1010)
Q Consensus 516 ~~~~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 549 (1010)
..+++|++|++++|+++...+..|.+++.|++++
T Consensus 198 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~ 231 (242)
T d1xwdc1 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231 (242)
T ss_dssp TTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred CCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCC
T ss_conf 6899999898979928945977973771341476
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=1.1e-24 Score=145.13 Aligned_cols=16 Identities=31% Similarity=0.505 Sum_probs=5.6
Q ss_pred CCCCCCEEEECCCCCC
Q ss_conf 3368668990387248
Q 001816 493 KLQQLSKMDFSHNKFS 508 (1010)
Q Consensus 493 ~l~~L~~L~Ls~N~l~ 508 (1010)
.+++|+.|+|++|+++
T Consensus 171 ~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 171 NLSKLTTLKADDNKIS 186 (227)
T ss_dssp TCTTCCEEECCSSCCC
T ss_pred CCCCCEECCCCCCCCC
T ss_conf 6463356445888417
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.90 E-value=2e-23 Score=138.44 Aligned_cols=128 Identities=22% Similarity=0.255 Sum_probs=75.1
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCC
Q ss_conf 999089985532484667889887788136614798-9945213344533111263236988834124675543204575
Q 001816 66 SLDLSGLNLSGALSPDVAHLRFLQNLSVAANQLSGP-IPPEISALSSLRLLNLSNNVFNGSFPPQLSQLASLQVLDLYNN 144 (1010)
Q Consensus 66 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~L~~n 144 (1010)
.+++++++++ .+|..+. +.+++|+|++|+|+.. .+..|..+++|+.|+|++|.+....+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 9997089967-0298989--787889848987755302002578762721301363221212122211222210100355
Q ss_pred CCCCCCCCCHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 3589998000101364401013665777899888774558615703544322
Q 001816 145 NMTGDLPLAVTQLRNLRHLHLGGNFFSGQIPPEYGIWEFLEYLAVSGNELGG 196 (1010)
Q Consensus 145 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~L~~N~l~~ 196 (1010)
++....+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 3443497998079746552457745353597785687533420003644343
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=3.9e-23 Score=136.82 Aligned_cols=155 Identities=17% Similarity=0.205 Sum_probs=73.3
Q ss_pred CCCEEECCCCCCCC-CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEEC
Q ss_conf 33547424742458-89877787667419844898466878300113368668990387248999500004786639985
Q 001816 448 NLGQICLSNNQLSG-SLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDL 526 (1010)
Q Consensus 448 ~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~l 526 (1010)
++++|+|++|+|++ ..+..|..+++|+.|++++|++.+..+..+..++.|+.|+|++|+|++..+..|.++++|+.|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf 87889848987755302002578762721301363221212122211222210100355344349799807974655245
Q ss_pred CCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 6863224300011264301257703754568751433102445431367784557889986566776435678866768
Q 001816 527 SRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSGLVPGTGQFSYFNYTSFLGNSELCG 605 (1010)
Q Consensus 527 s~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg 605 (1010)
++|+|++..+..|..+++|++|+|++|.+...... ..-...+..+.+..|.+++..|.. +.......+..|...|.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCC
T ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCH-HHHHHHHHHHCCCCCCEEECCCHH--HCCCEEEECCHHHCCCC
T ss_conf 77453535977856875334200036443435302-777642354035689827689843--36988614487557589
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=4.3e-22 Score=131.31 Aligned_cols=185 Identities=22% Similarity=0.304 Sum_probs=0.0
Q ss_pred CCHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 51153403665346655101258988668827973468875226899989768801761233456786345433547424
Q 001816 376 CLQTLITLGNFLFGPIPESLGKCDSLSRMRMGENFLNGSIPKGLFGLPSLSQVELQDNYLTGQFPVSDSISVNLGQICLS 455 (1010)
Q Consensus 376 ~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls 455 (1010)
......+..+.....++. ..+.+++.|++.+|.+..... +..+++|++|++++|.+++..+ +..+++|+.|+++
T Consensus 25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf 999998575765775188--795484589782798887444--7648998987698960258601--1358621201433
Q ss_pred CCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCC
Q ss_conf 74245889877787667419844898466878300113368668990387248999500004786639985686322430
Q 001816 456 NNQLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEI 535 (1010)
Q Consensus 456 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~ 535 (1010)
+|+++ .++ .+..+++|+.|++++|.+. .++ .+..++.++.+++++|.+ ..+..+..+++|+.+++++|++++..
T Consensus 99 ~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l--~~~~~~~~l~~L~~l~l~~n~l~~i~ 172 (210)
T d1h6ta2 99 ENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIV 172 (210)
T ss_dssp SSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCC--CCCGGGGGCTTCSEEECCSSCCCCCG
T ss_pred CCCCC-CCC-CCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 33321-222-1212221112234565322-112-201111122211222333--45431000133210013464302564
Q ss_pred CHHCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCEECCCC
Q ss_conf 00112643012577037545687514331024454313677
Q 001816 536 PNQLTGMRILNYLNLSRNHLVGSIPASIASMQSLTSVDFSY 576 (1010)
Q Consensus 536 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~l~ls~ 576 (1010)
+ +.++++|+.|++++|+++ .++ .+.++++|+.|++++
T Consensus 173 ~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 P--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred C--CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf 5--367898999989799899-872-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=1e-21 Score=129.28 Aligned_cols=18 Identities=28% Similarity=0.486 Sum_probs=6.2
Q ss_pred HHCCCCCCCEECCCCCCC
Q ss_conf 010136440101366577
Q 001816 154 VTQLRNLRHLHLGGNFFS 171 (1010)
Q Consensus 154 l~~l~~L~~L~L~~n~l~ 171 (1010)
+..+++|++|++++|+++
T Consensus 58 l~~l~nL~~L~Ls~N~l~ 75 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLT 75 (199)
T ss_dssp GGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCCCC
T ss_conf 213788675754565566
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.84 E-value=2.9e-23 Score=137.54 Aligned_cols=86 Identities=20% Similarity=0.252 Sum_probs=35.4
Q ss_pred CCCEEEECCCCCCCC----CCCCCCCCCCCCCEEEECCCCCCCCCCHHHC------CCCCCCEEECCCCCCCCCC----C
Q ss_conf 674198448984668----7830011336866899038724899950000------4786639985686322430----0
Q 001816 471 SGVQKLLLDGNKFSG----QIPAEIGKLQQLSKMDFSHNKFSGRIAPEIS------QCKLLTFVDLSRNELSGEI----P 536 (1010)
Q Consensus 471 ~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------~~~~L~~L~ls~N~l~~~~----~ 536 (1010)
++|+.|++++|.++. .+...+..+++|+.|+|++|.|++.....+. ....|+.|++++|+++... .
T Consensus 215 ~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~ 294 (344)
T d2ca6a1 215 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHH
T ss_conf 12112223333222222223444332322111103004756715667888776315688889898989869808999999
Q ss_pred HHCC-CCCCCCEEEECCCCCC
Q ss_conf 0112-6430125770375456
Q 001816 537 NQLT-GMRILNYLNLSRNHLV 556 (1010)
Q Consensus 537 ~~~~-~l~~L~~L~ls~N~l~ 556 (1010)
..+. ..+.|++|++++|++.
T Consensus 295 ~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 295 TVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHHHCTTCCEEECTTSBSC
T ss_pred HHHHCCCCCCCEEECCCCCCC
T ss_conf 999703899998978798089
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.84 E-value=2.8e-23 Score=137.59 Aligned_cols=10 Identities=40% Similarity=0.743 Sum_probs=3.1
Q ss_pred CCEEECCCCC
Q ss_conf 6399856863
Q 001816 521 LTFVDLSRNE 530 (1010)
Q Consensus 521 L~~L~ls~N~ 530 (1010)
|+.|++++|+
T Consensus 304 L~~L~l~~N~ 313 (344)
T d2ca6a1 304 LLFLELNGNR 313 (344)
T ss_dssp CCEEECTTSB
T ss_pred CCEEECCCCC
T ss_conf 9989787980
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1e-22 Score=134.61 Aligned_cols=61 Identities=21% Similarity=0.233 Sum_probs=27.5
Q ss_pred CCCCCCEEEECCC-CCCCCCCHHHCCCCCCCEEECCC-CCCCCCCCHHCCCCCCCCEEEECCC
Q ss_conf 3368668990387-24899950000478663998568-6322430001126430125770375
Q 001816 493 KLQQLSKMDFSHN-KFSGRIAPEISQCKLLTFVDLSR-NELSGEIPNQLTGMRILNYLNLSRN 553 (1010)
Q Consensus 493 ~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~L~~L~ls~-N~l~~~~~~~~~~l~~L~~L~ls~N 553 (1010)
.+++|+.|++++| .+++.....+..+++|++|++++ +.+++.....+..+++|++|+++++
T Consensus 173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 322212355322347783033332135768779899999787378999726999898964488
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=9.9e-19 Score=113.39 Aligned_cols=64 Identities=22% Similarity=0.185 Sum_probs=20.6
Q ss_pred CCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC-HHCCCCCCCCEEEECCCCCC
Q ss_conf 33686689903872489995000047866399856863224300-01126430125770375456
Q 001816 493 KLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIP-NQLTGMRILNYLNLSRNHLV 556 (1010)
Q Consensus 493 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~ 556 (1010)
.+++|+.|++++|+|+...+..+..++.|+.|++++|+++.... ..+..+++|++|++++|+++
T Consensus 61 ~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 57613064310213457776322334534434203000166542110013653206640799634
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.71 E-value=4.9e-17 Score=104.38 Aligned_cols=41 Identities=22% Similarity=0.351 Sum_probs=14.3
Q ss_pred CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 787667419844898466878300113368668990387248
Q 001816 467 IGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFS 508 (1010)
Q Consensus 467 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 508 (1010)
+..+.+|++|++++|+++ .+|..+..+++|+.|++++|+|+
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 56 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC
T ss_conf 105898898979787168-65215655431354532432112
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.70 E-value=6.8e-17 Score=103.61 Aligned_cols=100 Identities=22% Similarity=0.341 Sum_probs=35.4
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCC
Q ss_conf 84489846687830011336866899038724899950000478663998568632243000112643012577037545
Q 001816 476 LLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMRILNYLNLSRNHL 555 (1010)
Q Consensus 476 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l 555 (1010)
|+|++|+++ .++ .+..++.|++|++++|+|+ .+|..++.+++|+.|++++|++++. + .+..+++|+.|++++|++
T Consensus 3 L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 3 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCC
T ss_pred EECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCCC
T ss_conf 986899898-871-0105898898979787168-6521565543135453243211235-7-412335557688889865
Q ss_pred CCCCH-HHHHCCCCCCEECCCCCCCC
Q ss_conf 68751-43310244543136778455
Q 001816 556 VGSIP-ASIASMQSLTSVDFSYNNLS 580 (1010)
Q Consensus 556 ~~~~~-~~~~~l~~L~~l~ls~N~l~ 580 (1010)
+.... ..+..+++|+.+++++|+++
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf 88888256537999999989799688
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.64 E-value=4.6e-18 Score=109.84 Aligned_cols=135 Identities=15% Similarity=0.212 Sum_probs=0.0
Q ss_pred CCCCCCEEECCCC--CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCC
Q ss_conf 4543354742474--24588987778766741984489846687830011336866899038724899950000478663
Q 001816 445 ISVNLGQICLSNN--QLSGSLPASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNKFSGRIAPEISQCKLLT 522 (1010)
Q Consensus 445 ~~~~L~~L~Ls~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 522 (1010)
....+..++++.+ .+. .++..+..+++|++|+|++|+|+ .++ .+..+++|+.|+|++|+|+ .++..+..++.|+
T Consensus 21 ~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~ 96 (198)
T d1m9la_ 21 VATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCC
T ss_pred CCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCC
T ss_conf 545331002555568520-02467762604615199446899-864-4247825357341353432-1000033221233
Q ss_pred EEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCH-HHHHCCCCCCEECCCCCCCCCCCCC
Q ss_conf 99856863224300011264301257703754568751-4331024454313677845578899
Q 001816 523 FVDLSRNELSGEIPNQLTGMRILNYLNLSRNHLVGSIP-ASIASMQSLTSVDFSYNNLSGLVPG 585 (1010)
Q Consensus 523 ~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~l~ls~N~l~~~~p~ 585 (1010)
.|++++|+++.. ..+..+++|+.|++++|+++.... ..+..+++|+.|++++|+++...+.
T Consensus 97 ~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
T ss_conf 333333222222--22222223411123410212554221236777630234279843467632
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=2.9e-15 Score=94.88 Aligned_cols=115 Identities=17% Similarity=0.073 Sum_probs=0.0
Q ss_pred CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCC-CCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHCCCCC
Q ss_conf 777876674198448984668783001133686689903872-4899950000478663998568632243000112643
Q 001816 465 ASIGKFSGVQKLLLDGNKFSGQIPAEIGKLQQLSKMDFSHNK-FSGRIAPEISQCKLLTFVDLSRNELSGEIPNQLTGMR 543 (1010)
Q Consensus 465 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~l~ 543 (1010)
...........++.+++++. ..|..+..+++|+.|++++|+ |+...+..|.++++|+.|+|++|+|+...+..|.+++
T Consensus 2 P~~C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~ 80 (156)
T d2ifga3 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80 (156)
T ss_dssp CSSSCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred CCCCCCCCCCEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 69788699996985289976-58600257656574316898664436921225666667216202124774201112455
Q ss_pred CCCEEEECCCCCCCCCHHHHHCCCCCCEECCCCCCCCC
Q ss_conf 01257703754568751433102445431367784557
Q 001816 544 ILNYLNLSRNHLVGSIPASIASMQSLTSVDFSYNNLSG 581 (1010)
Q Consensus 544 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~ 581 (1010)
+|++|+|++|+|+ .+|........|+.|++++|++..
T Consensus 81 ~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp CCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 4333322678785-157456335321243357986338
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.25 E-value=6e-11 Score=71.93 Aligned_cols=142 Identities=15% Similarity=0.093 Sum_probs=94.4
Q ss_pred CCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCC-CCCCCEEEEEEECCCCCEEEEEE
Q ss_conf 67767747430838999999369989999990168899976310699999985047-86301244267528941899982
Q 001816 685 CLKEDNIIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLVYEY 763 (1010)
Q Consensus 685 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~ 763 (1010)
.|+..+..+.+..+.||+... ++..+.+|+........ ...+.+|...+..+. +-.+.+++.+...++..++||++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCC--HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEE
T ss_conf 527997678998771899990-89869999848876532--556999999999876069987289997508964999986
Q ss_pred CCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q ss_conf 28999875612477898884469999999999956875149---------------------------------------
Q 001816 764 MPNGSLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHDC--------------------------------------- 804 (1010)
Q Consensus 764 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 804 (1010)
++|.++.+... +......++.++++.+..+|+..
T Consensus 92 l~G~~~~~~~~-------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 92 ADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CSSEEHHHHTT-------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred CCCCCCCCCCC-------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 04334354334-------40269999998999999985568421435764465655577899877655554303323200
Q ss_pred -----------------CCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----------------99658515778928976899659900134311
Q 001816 805 -----------------SPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 805 -----------------~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~ 836 (1010)
...++|+|+.+.||+++++..+.++||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 5799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.07 E-value=5.5e-12 Score=77.48 Aligned_cols=12 Identities=42% Similarity=0.354 Sum_probs=4.2
Q ss_pred CCEEEECCCCCC
Q ss_conf 125770375456
Q 001816 545 LNYLNLSRNHLV 556 (1010)
Q Consensus 545 L~~L~ls~N~l~ 556 (1010)
|+.|++++|++.
T Consensus 117 L~~L~L~~Npl~ 128 (162)
T d1koha1 117 LEELWLDGNSLS 128 (162)
T ss_dssp CSSCCCTTSTTS
T ss_pred CCEEECCCCCCC
T ss_conf 042664899767
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=99.03 E-value=1.4e-09 Score=64.65 Aligned_cols=131 Identities=16% Similarity=0.108 Sum_probs=86.2
Q ss_pred EEEECCC-EEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCC--CCCCCEEEEEEECCCCCEEEEEECCCC
Q ss_conf 4743083-8999999369989999990168899976310699999985047--863012442675289418999822899
Q 001816 691 IIGKGGA-GIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR--HRHIVRLLGFCSNHETNLLVYEYMPNG 767 (1010)
Q Consensus 691 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~~g 767 (1010)
.+..|.. +.||+.....+..+.+|..+... ...+..|+..++.+. .-.+++++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC-----HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECC
T ss_conf 7678654775899993898789999589667-----76899999999999865999886132224566159998744135
Q ss_pred CHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------
Q ss_conf 987561247789888446999999999995687514--------------------------------------------
Q 001816 768 SLGEVLHGKKGGHLHWDTRYKIAVEAAKGLCYLHHD-------------------------------------------- 803 (1010)
Q Consensus 768 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------- 803 (1010)
++.+.. .. ....+.++++.+.-||..
T Consensus 92 ~~~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 92 DLLSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp ETTTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CCCCCC-------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
T ss_conf 543221-------26---89999999999998736885448875541246889999998754110113401121379999
Q ss_pred -----------CCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----------999658515778928976899659900134311
Q 001816 804 -----------CSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 804 -----------~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~ 836 (1010)
....++|+|+.+.||+++.+..+.++||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 99998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.81 E-value=5.9e-08 Score=55.99 Aligned_cols=77 Identities=18% Similarity=0.194 Sum_probs=49.7
Q ss_pred CEEEECCCEEEEEEEECC-CCEEEEEEECCCCC--C---CCCCCCHHHHHHHHHCCC-C--CCCCEEEEEEECCCCCEEE
Q ss_conf 747430838999999369-98999999016889--9---976310699999985047-8--6301244267528941899
Q 001816 690 NIIGKGGAGIVYKGLMPN-GDQVAVKRLPAMSR--G---SSHDHGFNAEIQTLGRIR-H--RHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~-h--p~iv~~~~~~~~~~~~~lv 760 (1010)
+.||.|....||+....+ ++.|.||....... + .....+...|++.++.+. + ..+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EEECCCCC
Q ss_conf 98228999
Q 001816 761 YEYMPNGS 768 (1010)
Q Consensus 761 ~e~~~~g~ 768 (1010)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EECCCCCC
T ss_conf 71357765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.39 E-value=4.4e-08 Score=56.67 Aligned_cols=111 Identities=12% Similarity=0.101 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCC----CCCCCCCCCCCEEEECCCCCCC----CCCCCCCCCCCCCCEEEECCCCCCCCCCHH
Q ss_conf 3454335474247-424588----9877787667419844898466----878300113368668990387248999500
Q 001816 444 SISVNLGQICLSN-NQLSGS----LPASIGKFSGVQKLLLDGNKFS----GQIPAEIGKLQQLSKMDFSHNKFSGRIAPE 514 (1010)
Q Consensus 444 ~~~~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 514 (1010)
...++|+.|+|++ +.++.. +...+.....|+.|++++|.++ ..+...+...+.|+.|+|++|.|++.....
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred HCC----CCCCCEEECCCCCCCCC-------CCHHCCCCCCCCEEEECCCC
Q ss_conf 004----78663998568632243-------00011264301257703754
Q 001816 515 ISQ----CKLLTFVDLSRNELSGE-------IPNQLTGMRILNYLNLSRNH 554 (1010)
Q Consensus 515 ~~~----~~~L~~L~ls~N~l~~~-------~~~~~~~l~~L~~L~ls~N~ 554 (1010)
+.. .+.|+.|++++|.+... +...+...+.|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.35 E-value=5.1e-06 Score=45.68 Aligned_cols=73 Identities=16% Similarity=0.217 Sum_probs=49.1
Q ss_pred CEEEECCCEEEEEEEECC--------CCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCC-CCCCCEEEEEEECCCCCEEE
Q ss_conf 747430838999999369--------989999990168899976310699999985047-86301244267528941899
Q 001816 690 NIIGKGGAGIVYKGLMPN--------GDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIR-HRHIVRLLGFCSNHETNLLV 760 (1010)
Q Consensus 690 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 760 (1010)
+.++.|-.-.+|++...+ ...|.+++... ........+|..+++.+. +.-.+++++++.+ ++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC----CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEE
T ss_conf 9917853343489996887754457898179996599----61165899999999999757999808998189----569
Q ss_pred EEECCCCCHH
Q ss_conf 9822899987
Q 001816 761 YEYMPNGSLG 770 (1010)
Q Consensus 761 ~e~~~~g~L~ 770 (1010)
+||++|.++.
T Consensus 120 ~efi~g~~l~ 129 (395)
T d1nw1a_ 120 EEYIPSRPLS 129 (395)
T ss_dssp ECCCCEEECC
T ss_pred EEEECCCCCC
T ss_conf 9973455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.26 E-value=5.8e-06 Score=45.38 Aligned_cols=135 Identities=14% Similarity=0.123 Sum_probs=75.3
Q ss_pred CEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCCC--CEEEE-----EEECCCCCEEEEEECCCCCH
Q ss_conf 389999993699899999901688999763106999999850478630--12442-----67528941899982289998
Q 001816 697 AGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRHI--VRLLG-----FCSNHETNLLVYEYMPNGSL 769 (1010)
Q Consensus 697 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i--v~~~~-----~~~~~~~~~lv~e~~~~g~L 769 (1010)
--.||++...+|+.|++|+...... ...++..|...+..+....+ +.... ....++..+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCEEEEEECCCCCEEEEEEECCCCC---CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 2026999838999799998478778---8999999999999998559987875206898056653479999865277688
Q ss_pred HH-----------HH---CC----C---CCC-------------------CCCHHHHHHHHHHHHHHHHHHHH----CCC
Q ss_conf 75-----------61---24----7---789-------------------88844699999999999568751----499
Q 001816 770 GE-----------VL---HG----K---KGG-------------------HLHWDTRYKIAVEAAKGLCYLHH----DCS 805 (1010)
Q Consensus 770 ~~-----------~l---~~----~---~~~-------------------~l~~~~~~~i~~~i~~~l~~LH~----~~~ 805 (1010)
.. .+ +. . ... .++......+...+.+.+..+.. ...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 9658515778928976899659900134311
Q 001816 806 PLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 806 ~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~ 836 (1010)
..++|+|+.+.||+++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.97 E-value=2.3e-05 Score=42.24 Aligned_cols=141 Identities=9% Similarity=-0.021 Sum_probs=75.5
Q ss_pred EEEECCCEEEEEEEECCCCEEEEEEECCCCCCCCCCCCHHHHHHHHHCCCCCC--CCEEEEE------EECCCCCEEEEE
Q ss_conf 47430838999999369989999990168899976310699999985047863--0124426------752894189998
Q 001816 691 IIGKGGAGIVYKGLMPNGDQVAVKRLPAMSRGSSHDHGFNAEIQTLGRIRHRH--IVRLLGF------CSNHETNLLVYE 762 (1010)
Q Consensus 691 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~------~~~~~~~~lv~e 762 (1010)
.|..|.--+.|+....+| .+++|++.... ....+..|...+..+...+ ++..... ....+....++.
T Consensus 25 ~i~~G~~N~ny~v~t~~g-~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~ 99 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 99 (316)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred CCCCCCCCCEEEEEECCC-CEEEEECCCCC----CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEE
T ss_conf 378885267389997897-28999807899----9889999999987543025554556410489762134125502453
Q ss_pred ECCCCCHHHH--------------HCC---C----CCC------------------CCCHHHHHHHHHHHHHHHHHHHH-
Q ss_conf 2289998756--------------124---7----789------------------88844699999999999568751-
Q 001816 763 YMPNGSLGEV--------------LHG---K----KGG------------------HLHWDTRYKIAVEAAKGLCYLHH- 802 (1010)
Q Consensus 763 ~~~~g~L~~~--------------l~~---~----~~~------------------~l~~~~~~~i~~~i~~~l~~LH~- 802 (1010)
++.+...... ++. . ... ..........+......+.....
T Consensus 100 ~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (316)
T d2ppqa1 100 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 179 (316)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred ECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCC
T ss_conf 11465533320467888889987645444320245310111012002456777765311412799999998764204855
Q ss_pred CCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 4999658515778928976899659900134311
Q 001816 803 DCSPLIVHRDVKSNNILLDSGFEAHVADFGLAKF 836 (1010)
Q Consensus 803 ~~~~~i~H~Dlkp~Nill~~~~~~kl~DfG~a~~ 836 (1010)
.-..+++|+|+.+.||+++.+...-+.||+.+..
T Consensus 180 ~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 180 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 4545033378636564020454126742221236
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.82 E-value=9.8e-07 Score=49.50 Aligned_cols=111 Identities=16% Similarity=0.138 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCCCCCCCC----CCCCCEEEECCCCCCC----CCCCCCCCCCCCCCEEEECCCCCCCCCC--
Q ss_conf 3454335474247-424588987778----7667419844898466----8783001133686689903872489995--
Q 001816 444 SISVNLGQICLSN-NQLSGSLPASIG----KFSGVQKLLLDGNKFS----GQIPAEIGKLQQLSKMDFSHNKFSGRIA-- 512 (1010)
Q Consensus 444 ~~~~~L~~L~Ls~-N~l~~~~~~~~~----~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-- 512 (1010)
...+.|+.|++++ +.++......+. ..++|++|++++|.++ ..+...+.....++.++++.|.+.....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred --HHHCCCCCCCE--EECCCCCCCC----CCCHHCCCCCCCCEEEECCCC
Q ss_conf --00004786639--9856863224----300011264301257703754
Q 001816 513 --PEISQCKLLTF--VDLSRNELSG----EIPNQLTGMRILNYLNLSRNH 554 (1010)
Q Consensus 513 --~~~~~~~~L~~--L~ls~N~l~~----~~~~~~~~l~~L~~L~ls~N~ 554 (1010)
..+...+.|+. |+++.|.+.. .+...+...+.|+.|+++.|.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849984788581898
|